Citrus Sinensis ID: 048432
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 354 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.813 | 0.339 | 0.513 | 5e-89 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.813 | 0.352 | 0.507 | 4e-88 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.776 | 0.323 | 0.514 | 1e-85 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.847 | 0.354 | 0.514 | 9e-84 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.819 | 0.340 | 0.505 | 1e-83 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.867 | 0.364 | 0.481 | 2e-83 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.838 | 0.362 | 0.495 | 1e-82 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.889 | 0.373 | 0.515 | 3e-82 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.807 | 0.343 | 0.498 | 4e-82 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.790 | 0.341 | 0.504 | 2e-81 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 328 bits (840), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 172/335 (51%), Positives = 223/335 (66%), Gaps = 47/335 (14%)
Query: 28 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG 87
K +LP+FS ++++ ATN F N+LG GGFGPVYKGVL++G EIAVKRLSG+SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566
Query: 88 LRELKNKL------------RLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WV 127
+ E KN++ RLLGCC + +EK+L+YEYMPNKSLDFFLFD W
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626
Query: 128 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187
R IIEGIA+GLLYLH+ SR+RIIHRDLKVSN+LLD +MNPKISDFG+ARI GN+ +A
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686
Query: 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYIS 247
NT R+VGTY YMSPEYA++G+FS+KSDV+SFGVLLL+IVSGK+ T + +L+GY
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGY-- 744
Query: 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLC----ILRYVNIALLCVQ 303
+ + H +L + I C LR +++A+LCVQ
Sbjct: 745 --------------AWYLYTHGRSEEL-------VDPKIRVTCSKREALRCIHVAMLCVQ 783
Query: 304 ESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338
+SA +RP M V+ ML ++ A L P+QP F+ R
Sbjct: 784 DSAAERPNMASVLLMLESDTATLAAPRQPTFTSTR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 325 bits (833), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 175/345 (50%), Positives = 230/345 (66%), Gaps = 57/345 (16%)
Query: 21 SNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRL 80
S + KR+++K ++L +FSF SV +AT+ FSD NKLGEGGFGPVYKG L NG+E+A+KRL
Sbjct: 467 SCIHKRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRL 526
Query: 81 SGRSGQGLRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--- 125
S SGQGL E KN+ +++LGCCI+KDEK+LIYEYM NKSLD+FLFD
Sbjct: 527 SLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLR 586
Query: 126 -----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
W R RI+EGI QGLLYLH+YSR+++IHRD+K SNILLD+DMNPKISDFG+ARI
Sbjct: 587 KNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIF 646
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240
E +ANT R+ GT+ YMSPEY +G+FS KSDVFSFGVL+L+I+ G+K F+
Sbjct: 647 GAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFH----- 701
Query: 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLC---------- 290
H+++ L + ++ LF + + +++ L
Sbjct: 702 ------------------HDLEGPLNLIVHVWNLFKENKI---REVIDLSLRDSALDYPQ 740
Query: 291 ILRYVNIALLCVQESADDRPTMNDVVSMLTNEA-AALLPPKQPAF 334
+LR V +ALLCVQE+A+DRP+M DVVSM+ E AL PK+PAF
Sbjct: 741 VLRCVQVALLCVQENAEDRPSMLDVVSMIYGEGNNALSLPKEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 172/334 (51%), Positives = 220/334 (65%), Gaps = 59/334 (17%)
Query: 33 DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK 92
++L +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L +G+E+A+KRLS SGQGL E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569
Query: 93 NK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRI 132
N+ ++LLGCC++KDEK+LIYEYMPNKSLD+FLFD W R RI
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629
Query: 133 IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192
+EGI QGLLYLH+YSR+++IHRD+K NILLD+DMNPKISDFG+ARI E +ANT R+
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689
Query: 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252
GT+ YMSPEY +G+FS KSDVFSFGVL+L+I+ G+K F+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFH----------------- 732
Query: 253 FPSVDTHNVKTFGFLHLTIFKLF-----------SISSVGLSNDIVCLCILRYVNIALLC 301
H+ + L + ++ LF S+ + N V LR V +ALLC
Sbjct: 733 ------HDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQV----LRCVQVALLC 782
Query: 302 VQESADDRPTMNDVVSMLTNEA-AALLPPKQPAF 334
VQ++ADDRP+M DVVSM+ + AL PK+PAF
Sbjct: 783 VQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (794), Expect = 9e-84, Method: Compositional matrix adjust.
Identities = 173/336 (51%), Positives = 214/336 (63%), Gaps = 36/336 (10%)
Query: 24 TKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR 83
T + K + +LPL + +++ ATN FS NKLG+GGFG VYKG+L +G EIAVKRLS
Sbjct: 497 TSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKM 556
Query: 84 SGQGLRELKNKLRL------------LGCCIDKDEKILIYEYMPNKSLDFFLFD------ 125
S QG E N++RL LGCC+DK EK+LIYEY+ N SLD LFD
Sbjct: 557 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 616
Query: 126 --WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183
W R II GIA+GLLYLHQ SR RIIHRDLK SN+LLDK+M PKISDFG+ARI
Sbjct: 617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676
Query: 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTL 242
E +ANT R+VGTY YMSPEYA+ GIFS+KSDVFSFGVLLL+I+SGK+ GFY + L
Sbjct: 677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736
Query: 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCV 302
LG++ + E L I +I + LS++ ILR + I LLCV
Sbjct: 737 LGFVWRHWKEGK-------------ELEIVDPINIDA--LSSEFPTHEILRCIQIGLLCV 781
Query: 303 QESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338
QE A+DRP M+ V+ ML +E A+ PK+P F R
Sbjct: 782 QERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGR 817
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (794), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 174/344 (50%), Positives = 220/344 (63%), Gaps = 54/344 (15%)
Query: 19 VNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVK 78
+ S K+ + +D +P F ++ AT+ FS+ANKLG+GGFGPVYKG+ EIAVK
Sbjct: 502 IESGRFKQDDSQGID-VPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVK 560
Query: 79 RLSGRSGQGLRELKNKL------------RLLGCCIDKDEKILIYEYMPNKSLDFFLFD- 125
RLS SGQGL E KN++ RLLG C+ +EK+L+YEYMP+KSLDFF+FD
Sbjct: 561 RLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDR 620
Query: 126 -------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
W R II GIA+GLLYLHQ SR+RIIHRDLK SNILLD++MNPKISDFG+AR
Sbjct: 621 KLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLAR 680
Query: 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238
I G+E ANT R+VGTY YMSPEYA++G+FS KSDVFSFGV++++ +SGK+ TGF+
Sbjct: 681 IFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPE 740
Query: 239 -SFTLLGYISE------NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCI 291
S +LLG+ + I + +T GFL CL
Sbjct: 741 KSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLK-------------------CL-- 779
Query: 292 LRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP-PKQPAF 334
N+ LLCVQE +DRPTM++VV ML + AA LP PKQPAF
Sbjct: 780 ----NVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPTPKQPAF 819
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 167/347 (48%), Positives = 224/347 (64%), Gaps = 40/347 (11%)
Query: 27 SKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ 86
S + ++ +LPLF F ++T+T+ FS NKLG+GGFGPVYKG L G EIAVKRLS +SGQ
Sbjct: 501 SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQ 560
Query: 87 GLRELKNKL------------RLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------W 126
GL EL N++ +LLGCCI+ +E++L+YEYMP KSLD +LFD W
Sbjct: 561 GLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDW 620
Query: 127 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186
TR I+EGI +GLLYLH+ SR++IIHRDLK SNILLD+++NPKISDFG+ARI R NE +
Sbjct: 621 KTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDE 680
Query: 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGY 245
ANT R+VGTY YMSPEYA++G FS KSDVFS GV+ L+I+SG++ + ++ + LL Y
Sbjct: 681 ANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAY 740
Query: 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQES 305
+ + + + F K F I + V+I LLCVQE
Sbjct: 741 AWKLWNDGEAASLADPAVFD-------KCFEKE------------IEKCVHIGLLCVQEV 781
Query: 306 ADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTEE 352
A+DRP +++V+ MLT E +L PKQPAF R + SS +++
Sbjct: 782 ANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQK 828
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 170/343 (49%), Positives = 225/343 (65%), Gaps = 46/343 (13%)
Query: 29 KKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL 88
K ++ +LPLF F ++ ATN FS NKLG+GGFGPVYKG L+ G EIAVKRLS SGQGL
Sbjct: 488 KGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGL 547
Query: 89 REL------------KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVT 128
EL +N ++LLGCCI +E++L+YE+MP KSLD++LFD W T
Sbjct: 548 EELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKT 607
Query: 129 RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
R II GI +GLLYLH+ SR+RIIHRDLK SNILLD+++ PKISDFG+ARI GNE +AN
Sbjct: 608 RFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEAN 667
Query: 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248
T R+VGTY YM+PEYA+ G+FS KSDVFS GV+LL+I+SG+ R + TLL Y+
Sbjct: 668 TRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGR------RNSNSTLLAYV-W 720
Query: 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD 308
+I+ +++ + IF L I + ++I LLCVQE+A+D
Sbjct: 721 SIWNEGEINS-------LVDPEIFDLLFEKE-----------IHKCIHIGLLCVQEAAND 762
Query: 309 RPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 351
RP+++ V SML++E A + PKQPAF RN V S+ ++
Sbjct: 763 RPSVSTVCSMLSSEIADIPEPKQPAF-ISRNNVPEAESSENSD 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 182/353 (51%), Positives = 224/353 (63%), Gaps = 38/353 (10%)
Query: 24 TKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR 83
T + KK E +LPL +++TATN FS+ NKLG+GGFG VYKG L +G EIAVKRLS
Sbjct: 493 TSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKM 552
Query: 84 SGQGLRELKNKLRL------------LGCCIDKDEKILIYEYMPNKSLDFFLFD------ 125
S QG E N++RL LGCC+DK EK+LIYEY+ N SLD LFD
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 126 --WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183
W R II GIA+GLLYLHQ SR RIIHRDLK SN+LLDK+M PKISDFG+ARI
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTL 242
E +ANT R+VGTY YMSPEYA+ GIFS+KSDVFSFGVLLL+I+SGK+ GFY + L
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732
Query: 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCV 302
LG++ + E L I +I S LS+ ILR + I LLCV
Sbjct: 733 LGFVWRHWKEGN-------------ELEIVDPINIDS--LSSKFPTHEILRCIQIGLLCV 777
Query: 303 QESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVT--STSSTGKTEEA 353
QE A+DRP M+ V+ ML +E A+ PK+P F R+ + S+SST + +E
Sbjct: 778 QERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDEC 830
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 305 bits (780), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 162/325 (49%), Positives = 215/325 (66%), Gaps = 39/325 (12%)
Query: 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKN 93
+LPLF +++ ATN FS NKLG GGFGPVYKGVL+N EIAVKRLS SGQG+ E KN
Sbjct: 499 ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKN 558
Query: 94 KL------------RLLGCCIDKDEKILIYEYMPNKSLDFFLF--------DWVTRVRII 133
++ R+LGCC++ +EK+L+YEY+PNKSLD+F+F DW R+ I+
Sbjct: 559 EVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIV 618
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193
GIA+G+LYLHQ SR+RIIHRDLK SNILLD +M PKISDFG+ARI GN+++ T R+V
Sbjct: 619 RGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVV 678
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253
GT+ YM+PEYA++G FSIKSDV+SFGVL+L+I++GKK + F+ S L+G+I + ++E
Sbjct: 679 GTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHEESS-NLVGHIWD-LWE- 735
Query: 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313
G I L + +++ + I LLCVQE+A DR M+
Sbjct: 736 ----------NGEATEIIDNLMDQETYDERE------VMKCIQIGLLCVQENASDRVDMS 779
Query: 314 DVVSMLTNEAAALLPPKQPAFSYVR 338
VV ML + A L PK PAF+ R
Sbjct: 780 SVVIMLGHNATNLPNPKHPAFTSAR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 165/327 (50%), Positives = 221/327 (67%), Gaps = 47/327 (14%)
Query: 29 KKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL 88
++++ +LPLF F ++TAT+ FS +NKLG+GGFGPVYKG+L G EIAVKRLS SGQGL
Sbjct: 488 REKLKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGL 547
Query: 89 REL------------KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVT 128
EL +N ++L GCCI +E++L+YE+MP KSLDF++FD W T
Sbjct: 548 EELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNT 607
Query: 129 RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
R II GI +GLLYLH+ SR+RIIHRDLK SNILLD+++ PKISDFG+ARI GNE +AN
Sbjct: 608 RFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEAN 667
Query: 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248
T R+VGTY YM+PEYA+ G+FS KSDVFS GV+LL+I+SG+ R TLL ++
Sbjct: 668 TRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGR------RNSHSTLLAHV-W 720
Query: 249 NIYEFPSVDTHNVKTFGFLHLTIF-KLFSISSVGLSNDIVCLCILRYVNIALLCVQESAD 307
+I+ ++ G + IF +LF I + V+IALLCVQ++A+
Sbjct: 721 SIWNEGEIN-------GMVDPEIFDQLFEKE------------IRKCVHIALLCVQDAAN 761
Query: 308 DRPTMNDVVSMLTNEAAALLPPKQPAF 334
DRP+++ V ML++E A + PKQPAF
Sbjct: 762 DRPSVSTVCMMLSSEVADIPEPKQPAF 788
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 354 | ||||||
| 356514857 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.824 | 0.350 | 0.622 | 1e-108 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.915 | 0.374 | 0.592 | 1e-106 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.915 | 0.508 | 0.592 | 1e-106 | |
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.875 | 0.447 | 0.585 | 1e-102 | |
| 224106535 | 333 | predicted protein [Populus trichocarpa] | 0.822 | 0.873 | 0.608 | 1e-102 | |
| 359493709 | 894 | PREDICTED: receptor-like serine/threonin | 0.878 | 0.347 | 0.592 | 1e-102 | |
| 357516499 | 750 | S-locus receptor kinase [Medicago trunca | 0.822 | 0.388 | 0.574 | 1e-101 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.875 | 0.373 | 0.584 | 1e-101 | |
| 302143120 | 674 | unnamed protein product [Vitis vinifera] | 0.875 | 0.459 | 0.584 | 1e-101 | |
| 224106539 | 846 | predicted protein [Populus trichocarpa] | 0.875 | 0.366 | 0.573 | 1e-101 |
| >gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-108, Method: Compositional matrix adjust.
Identities = 214/344 (62%), Positives = 245/344 (71%), Gaps = 52/344 (15%)
Query: 28 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG 87
KKKEV +LPLFSF SV+ ATN FSDANKLGEGGFGPVYKG+L NGDE+AVKRLS RSGQG
Sbjct: 492 KKKEV-KLPLFSFVSVAAATNNFSDANKLGEGGFGPVYKGILLNGDEVAVKRLSRRSGQG 550
Query: 88 LRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WV 127
EL+N+ +RLLGCCID+DEK+LIYE MPNKSLD FLFD W
Sbjct: 551 WEELRNEALLIAKLQHNNLVRLLGCCIDRDEKMLIYELMPNKSLDVFLFDATKRRMLDWG 610
Query: 128 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187
TRVRII+GIAQG+LYLHQYSR RIIHRDLK SNILLD +MNPKISDFG+ARI NELQA
Sbjct: 611 TRVRIIDGIAQGILYLHQYSRFRIIHRDLKASNILLDTNMNPKISDFGMARIFGDNELQA 670
Query: 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYIS 247
NT RIVGTY YMSPEYA++G+FSIKSDVFSFGVLLL+I+SGKK TGFY+T SF LLGY
Sbjct: 671 NTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLLLEILSGKKNTGFYQTNSFNLLGYAW 730
Query: 248 E--------NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIAL 299
+ ++ + P++D + T +H + RYVNI L
Sbjct: 731 DLWTNNSGMDLMD-PALDDSDT-TSSSMH---------------------TVPRYVNIGL 767
Query: 300 LCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTS 343
LCVQES DRPTM+DVVSM+ N+ AL PK PAF VR S
Sbjct: 768 LCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLNVRGNQNS 811
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1003), Expect = e-106, Method: Compositional matrix adjust.
Identities = 217/366 (59%), Positives = 256/366 (69%), Gaps = 42/366 (11%)
Query: 4 LDLNLKANNVNIELPVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGP 63
DL+ + + N EL S L +KKEVD LP+FSF+SVS ATN FS NKLGEGGFGP
Sbjct: 505 FDLSNSSVDTNYELSETSKLWS-GEKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGP 562
Query: 64 VYKGVLKNGDEIAVKRLSGRSGQGLRELKNKL------------RLLGCCIDKDEKILIY 111
VYKG + G E+AVKRLS RSGQG ELKN++ +L G CI+KDEKILIY
Sbjct: 563 VYKGKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIY 622
Query: 112 EYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL 163
EYMPNKSLDFFLFD W TRV II+G+AQGLLYLHQYSR+RIIHRDLK SNILL
Sbjct: 623 EYMPNKSLDFFLFDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILL 682
Query: 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLL 223
DKDMNP+ISDFG+ARI GNE +A T IVGTY YMSPEYA++G+FS KSDVFSFGVLLL
Sbjct: 683 DKDMNPQISDFGMARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLL 741
Query: 224 KIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLS 283
+I+SGKK TGFY+T S LLGY + ++++ D+ + + GL
Sbjct: 742 EILSGKKNTGFYQTDSLNLLGY-AWDLWK----DSRGQE--------------LMDPGLE 782
Query: 284 NDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTS 343
+ +LRY+NI LLCVQESADDRPTM+DVVSML NE+ L PKQPAFS +R+ V
Sbjct: 783 ETLPTHILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEP 842
Query: 344 TSSTGK 349
S K
Sbjct: 843 HISQNK 848
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 389 bits (1000), Expect = e-106, Method: Compositional matrix adjust.
Identities = 217/366 (59%), Positives = 256/366 (69%), Gaps = 42/366 (11%)
Query: 4 LDLNLKANNVNIELPVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGP 63
DL+ + + N EL S L +KKEVD LP+FSF+SVS ATN FS NKLGEGGFGP
Sbjct: 277 FDLSNSSVDTNYELSETSKLWS-GEKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGP 334
Query: 64 VYKGVLKNGDEIAVKRLSGRSGQGLRELKNKL------------RLLGCCIDKDEKILIY 111
VYKG + G E+AVKRLS RSGQG ELKN++ +L G CI+KDEKILIY
Sbjct: 335 VYKGKSQKGYEVAVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIY 394
Query: 112 EYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL 163
EYMPNKSLDFFLFD W TRV II+G+AQGLLYLHQYSR+RIIHRDLK SNILL
Sbjct: 395 EYMPNKSLDFFLFDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILL 454
Query: 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLL 223
DKDMNP+ISDFG+ARI GNE +A T IVGTY YMSPEYA++G+FS KSDVFSFGVLLL
Sbjct: 455 DKDMNPQISDFGMARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLL 513
Query: 224 KIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLS 283
+I+SGKK TGFY+T S LLGY + ++++ D+ + + GL
Sbjct: 514 EILSGKKNTGFYQTDSLNLLGY-AWDLWK----DSRGQE--------------LMDPGLE 554
Query: 284 NDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTS 343
+ +LRY+NI LLCVQESADDRPTM+DVVSML NE+ L PKQPAFS +R+ V
Sbjct: 555 ETLPTHILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEP 614
Query: 344 TSSTGK 349
S K
Sbjct: 615 HISQNK 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 377 bits (969), Expect = e-102, Method: Compositional matrix adjust.
Identities = 205/350 (58%), Positives = 238/350 (68%), Gaps = 40/350 (11%)
Query: 22 NLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS 81
N + K K+ LPLFSF+SVS AT FS NKLG+GGFGPVYKG L NG EIAVKRLS
Sbjct: 348 NRVGKDKNKDA-WLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNGQEIAVKRLS 406
Query: 82 GRSGQGLRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---- 125
SGQGL ELKN+ +RLLGCCI++ EKILIYEYMPNKSLD FLFD
Sbjct: 407 RSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPNKR 466
Query: 126 ----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181
W RV IIEGIAQGLLYLH+YSR+RIIHRDLK SNILLD DMNPKISDFG+AR+
Sbjct: 467 GQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFG 526
Query: 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT 241
GNE ANT RIVGTY YMSPEYA++G+FS KSDVFSFGVL+L+I+SGKK TGFY + +
Sbjct: 527 GNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLN 586
Query: 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLC 301
L+GY +E D L G S+ + +LRY+N+ LLC
Sbjct: 587 LIGY----AWELWKSD------------MAINLMDPMLEGQSSQYM---LLRYINVGLLC 627
Query: 302 VQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 351
V+E A DRPT+++VVSMLTNE A L PK PAFS VR+ SS + E
Sbjct: 628 VEEIAADRPTLSEVVSMLTNELAVLPSPKHPAFSTVRSMENPRSSMSRPE 677
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106535|ref|XP_002333668.1| predicted protein [Populus trichocarpa] gi|222837959|gb|EEE76324.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 377 bits (968), Expect = e-102, Method: Compositional matrix adjust.
Identities = 202/332 (60%), Positives = 230/332 (69%), Gaps = 41/332 (12%)
Query: 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKN 93
+LPLFS+ SVS AT +FSD KLGEGGFGPVYKG L G EIAVKRLS RSGQGL E +N
Sbjct: 2 ELPLFSYESVSVATEQFSD--KLGEGGFGPVYKGKLPKGLEIAVKRLSERSGQGLEEFRN 59
Query: 94 K------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRII 133
+ +RLLG CI++DEK+LIYEYMPNKSLDFFLFD W TR+RII
Sbjct: 60 ETILIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDANRGQILDWGTRIRII 119
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193
EGIAQGLLYLH+YSR+RIIHRDLK SNILLD +MNPKISDFG+ARI GNE QANT RIV
Sbjct: 120 EGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGGNETQANTNRIV 179
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253
GTY YMSPEYA++G+FSIKSDVFSFGVL+L+IVSGKK T FY + S LLG
Sbjct: 180 GTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSGSLNLLG--------- 230
Query: 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313
H K + K + L + +LRY+NI LLCVQES DRPTM+
Sbjct: 231 -----HAWKLW-----NSNKALDLMDPILGDPPSTATLLRYINIGLLCVQESPADRPTMS 280
Query: 314 DVVSMLTNEAAALLPPKQPAFSYVRNTVTSTS 345
DV+SM+ NE AL PKQPAF RN S
Sbjct: 281 DVISMIVNEHVALPEPKQPAFVAGRNVAEPRS 312
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 377 bits (967), Expect = e-102, Method: Compositional matrix adjust.
Identities = 209/353 (59%), Positives = 249/353 (70%), Gaps = 42/353 (11%)
Query: 21 SNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRL 80
+N R +KKEVD LP+FSF SVS +TN F NKLGEGGFG VYKG + G E+AVKRL
Sbjct: 490 TNRLWRGEKKEVD-LPMFSFVSVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRL 548
Query: 81 SGRSGQGLRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--- 125
S RS QG ELKN+ +++LG CI++DEKILIYEYM NKSLDFFLFD
Sbjct: 549 SKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAK 608
Query: 126 -----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
W TRVRIIEG+AQGLLYLHQYSR+R+IHRDLK SNILLDKDMNPKISDFG+ARI
Sbjct: 609 RGILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 668
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240
GNE +A T IVGTY YMSPEYA++G+FS KSDVFSFGVLLL+I+SGKK TGFY+T S
Sbjct: 669 GGNESKA-TKHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSL 727
Query: 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL 300
LLGY + ++++ D+ + + GL + +LRY+N+ LL
Sbjct: 728 NLLGY-AWDLWK----DSRGQE--------------LMDPGLEETLPTHILLRYINVGLL 768
Query: 301 CVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRN-TVTSTSSTGKTEE 352
CVQESADDRPTM+DVVSML NE+ L PKQPAFS +R+ T S SS E+
Sbjct: 769 CVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGTHKSLSSNPDLEQ 821
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357516499|ref|XP_003628538.1| S-locus receptor kinase [Medicago truncatula] gi|355522560|gb|AET03014.1| S-locus receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 375 bits (964), Expect = e-101, Method: Compositional matrix adjust.
Identities = 205/357 (57%), Positives = 242/357 (67%), Gaps = 66/357 (18%)
Query: 28 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG 87
++KEV +LPLFS SVS ATN FSD KLGEGGFGPVYKG L NG E+A+KRLS SGQG
Sbjct: 386 RRKEV-KLPLFSLVSVSAATNNFSDTKKLGEGGFGPVYKGTLLNGGEVAIKRLSRISGQG 444
Query: 88 LRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------- 124
EL+N+ +RLLGCCI++DEK+LIYE+MPNKSLDFF+F
Sbjct: 445 WEELRNEALLIAKLQHNNLVRLLGCCIERDEKMLIYEFMPNKSLDFFIFGLYFSETKISI 504
Query: 125 -----------------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNI 161
DW TRVRII+GIAQGLLYLHQYSR RIIHRDLK SNI
Sbjct: 505 LFNSNCSCDIFLFKTDAVKRRMLDWETRVRIIDGIAQGLLYLHQYSRFRIIHRDLKASNI 564
Query: 162 LLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221
LLD +MNPKISDFG+ARI N LQANT RIVGTY YMSPEYA++G++SIKSDVFSFGVL
Sbjct: 565 LLDANMNPKISDFGMARIFGENVLQANTNRIVGTYGYMSPEYAMEGVYSIKSDVFSFGVL 624
Query: 222 LLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVG 281
LL+I+SGKK TGFY+T SF LLGY + + T+N + L KL IS+
Sbjct: 625 LLEIISGKKNTGFYQTNSFNLLGYAWD-------LWTNNSG----MDLIDSKLDDISNKH 673
Query: 282 LSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338
L + +YVNI LLCVQ+S +DRPTM+DVV+M+ N+ +LL PK PAF VR
Sbjct: 674 L--------VPKYVNIGLLCVQQSPEDRPTMSDVVTMIGNDTTSLLSPKPPAFQNVR 722
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 375 bits (962), Expect = e-101, Method: Compositional matrix adjust.
Identities = 205/351 (58%), Positives = 247/351 (70%), Gaps = 41/351 (11%)
Query: 21 SNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRL 80
+N R +K+EVD LP+FSF+SVS +TN FS NKLGEGGFG VYKG + E+AVKRL
Sbjct: 486 TNRLWRGEKREVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRL 544
Query: 81 SGRSGQGLRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--- 125
S RS QG ELKN+ +++LG CI++DEKILIYEYM NKSLDFFLFD
Sbjct: 545 SKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTK 604
Query: 126 -----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
W TRV IIEG+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNPKISDFG+ARI
Sbjct: 605 HGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIF 664
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240
GNE + T IVGTY YMSPEYA++G+FS KSDVFSFGVLLL+I+SGKK TGFY+T S
Sbjct: 665 GGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSL 723
Query: 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL 300
LLGY + ++++ D+ ++ + GL + +LRY+N+ LL
Sbjct: 724 NLLGY-AWDLWK----DSRGLE--------------LMDPGLEETLPTHILLRYINVGLL 764
Query: 301 CVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 351
CVQESADDRPTM+DVVSML NE+ L PKQPAFS +R+ V S + E
Sbjct: 765 CVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPE 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 374 bits (960), Expect = e-101, Method: Compositional matrix adjust.
Identities = 205/351 (58%), Positives = 247/351 (70%), Gaps = 41/351 (11%)
Query: 21 SNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRL 80
+N R +K+EVD LP+FSF+SVS +TN FS NKLGEGGFG VYKG + E+AVKRL
Sbjct: 330 TNRLWRGEKREVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRL 388
Query: 81 SGRSGQGLRELKNK------------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--- 125
S RS QG ELKN+ +++LG CI++DEKILIYEYM NKSLDFFLFD
Sbjct: 389 SKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTK 448
Query: 126 -----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
W TRV IIEG+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNPKISDFG+ARI
Sbjct: 449 HGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIF 508
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240
GNE + T IVGTY YMSPEYA++G+FS KSDVFSFGVLLL+I+SGKK TGFY+T S
Sbjct: 509 GGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSL 567
Query: 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL 300
LLGY + ++++ D+ ++ + GL + +LRY+N+ LL
Sbjct: 568 NLLGY-AWDLWK----DSRGLE--------------LMDPGLEETLPTHILLRYINVGLL 608
Query: 301 CVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTSTSSTGKTE 351
CVQESADDRPTM+DVVSML NE+ L PKQPAFS +R+ V S + E
Sbjct: 609 CVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPE 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106539|ref|XP_002333669.1| predicted protein [Populus trichocarpa] gi|222837960|gb|EEE76325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 374 bits (959), Expect = e-101, Method: Compositional matrix adjust.
Identities = 206/359 (57%), Positives = 241/359 (67%), Gaps = 49/359 (13%)
Query: 2 FDLDLNLKANNVNIELPVNSNLTKRSKKKEVD-QLPLFSFSSVSTATNKFSDANKLGEGG 60
FD D N N +S++ R K+ + + PLFS+ SVS AT +FSD KLGEGG
Sbjct: 489 FDADPNSTTNE-------SSSVDNRKKRWSKNIEFPLFSYESVSVATGQFSD--KLGEGG 539
Query: 61 FGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNK------------LRLLGCCIDKDEKI 108
FGPVYKG L G EIAVKRLS RSGQGL E +N+ +RLLG CI++DEK+
Sbjct: 540 FGPVYKGKLPTGLEIAVKRLSERSGQGLEEFRNETTLIAKLQHRNLVRLLGSCIERDEKM 599
Query: 109 LIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160
LIYEYMPNKSLDFFLFD W TR+RIIEGIAQGLLYLH+YSR+RIIHRDLK SN
Sbjct: 600 LIYEYMPNKSLDFFLFDANRGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSN 659
Query: 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGV 220
ILLD +MNPKISDFG+ARI GNE QA+T RIVGTY YMSPEYA++G+FSIKSDVFSFGV
Sbjct: 660 ILLDSEMNPKISDFGMARIFGGNETQAHTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGV 719
Query: 221 LLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSV 280
L+L+IVSGKK T FY + + LLG H K + K +
Sbjct: 720 LVLEIVSGKKNTSFYHSDTLHLLG--------------HAWKLW-----NSNKALDLMDP 760
Query: 281 GLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRN 339
L + +LRY+NI LLCVQES DRPTM+DV+SM+ NE AL PKQPAF RN
Sbjct: 761 ILGDPPSTATLLRYINIGLLCVQESPADRPTMSDVISMIANEHVALPEPKQPAFVACRN 819
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 354 | ||||||
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.692 | 0.290 | 0.531 | 5.6e-88 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.692 | 0.289 | 0.531 | 1.5e-87 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.692 | 0.367 | 0.453 | 2.2e-82 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.689 | 0.287 | 0.501 | 2.3e-82 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.677 | 0.360 | 0.467 | 2.6e-71 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.435 | 0.181 | 0.660 | 7.3e-63 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.435 | 0.181 | 0.613 | 5.5e-59 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.435 | 0.196 | 0.607 | 2e-58 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.437 | 0.190 | 0.597 | 4.2e-58 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.412 | 0.218 | 0.623 | 7.8e-58 |
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 5.6e-88, Sum P(2) = 5.6e-88
Identities = 144/271 (53%), Positives = 177/271 (65%)
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLH 144
N +RLLGCC+DK EK+LIYEY+ N SLD LFD W R II GIA+GLLYLH
Sbjct: 574 NLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLH 633
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
Q SR RIIHRDLK SN+LLDK+M PKISDFG+ARI E +ANT R+VGTY YMSPEYA
Sbjct: 634 QDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYA 693
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDTHNVKT 263
+ GIFS+KSDVFSFGVLLL+I+SGK+ GFY + LLG++ + E N
Sbjct: 694 MDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE------GN--- 744
Query: 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323
L I +I S LS+ ILR + I LLCVQE A+DRP M+ V+ ML +E
Sbjct: 745 ----ELEIVDPINIDS--LSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 798
Query: 324 AALLPPKQPAFSYVRNTVT--STSSTGKTEE 352
A+ PK+P F R+ + S+SST + +E
Sbjct: 799 TAIPQPKRPGFCIGRSPLEADSSSSTQRDDE 829
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.5e-87, Sum P(2) = 1.5e-87
Identities = 144/271 (53%), Positives = 179/271 (66%)
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLH 144
N +RLLGCC+DK EK+LIYEY+ N SLD LFD W R II GIA+GLLYLH
Sbjct: 578 NLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLH 637
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
Q SR RIIHRDLK SN+LLDK+M PKISDFG+ARI E +ANT R+VGTY YMSPEYA
Sbjct: 638 QDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYA 697
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDTHNVKT 263
+ GIFS+KSDVFSFGVLLL+I+SGK+ GFY + LLG++ + E
Sbjct: 698 MDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE----------- 746
Query: 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323
G L I +I + LS++ ILR + I LLCVQE A+DRP M+ V+ ML +E
Sbjct: 747 -G-KELEIVDPINIDA--LSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 802
Query: 324 AALLPPKQPAFSYVRNT--VTSTSSTGKTEE 352
A+ PK+P F R++ V S+SST + +E
Sbjct: 803 TAIPQPKRPGFCVGRSSLEVDSSSSTQRDDE 833
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 2.2e-82, Sum P(2) = 2.2e-82
Identities = 122/269 (45%), Positives = 171/269 (63%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYL 143
+N +RLLG C++++E+ILIYE++ NKSLD+FLFD W R +II GIA+G+LYL
Sbjct: 404 RNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYL 463
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
HQ SR++IIHRDLK SNILLD DMNPKI+DFG+A I + Q NT RI GTY YMSPEY
Sbjct: 464 HQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEY 523
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263
A+ G +S+KSD++SFGVL+L+I+SGKK +G Y+ + G N+ + S N
Sbjct: 524 AMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAG----NLVTYASRLWRNKSP 579
Query: 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323
+ T + + SN++ R ++IALLCVQE+ +DRP ++ ++ MLT+
Sbjct: 580 LELVDPTFGRNYQ------SNEVT-----RCIHIALLCVQENPEDRPMLSTIILMLTSNT 628
Query: 324 AALLPPKQPAFSYVRNTVTSTSSTGKTEE 352
L P+ P F + R+ S G +
Sbjct: 629 ITLPVPRLPGF-FPRSRQLKLVSEGSESD 656
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 2.3e-82, Sum P(2) = 2.3e-82
Identities = 135/269 (50%), Positives = 169/269 (62%)
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLH 144
N +RLL CC+D EK+LIYEY+ N SLD LFD W R II GIA+GLLYLH
Sbjct: 581 NLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLH 640
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
Q SR RIIHRDLK SNILLDK M PKISDFG+ARI +E +ANT ++VGTY YMSPEYA
Sbjct: 641 QDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYA 700
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTLLGYISENIYEFPSVDTHNVKT 263
+ GIFS+KSDVFSFGVLLL+I+S K+ GFY + LLG + N E ++
Sbjct: 701 MDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEI----- 755
Query: 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323
I + + SS ILR + I LLCVQE A+DRPTM+ V+ ML +E+
Sbjct: 756 -------IDPIITDSSSTFRQHE----ILRCIQIGLLCVQERAEDRPTMSLVILMLGSES 804
Query: 324 AALLPPKQPAFSYVRNTVTSTSSTGKTEE 352
+ PK P + R+ + + SS+ K +
Sbjct: 805 TTIPQPKAPGYCLERSLLDTDSSSSKQRD 833
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
Identities = 124/265 (46%), Positives = 167/265 (63%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYL 143
+N ++LLG I+ E++L+YE++P+ SLD F+FD W R +II G+A+GLLYL
Sbjct: 398 RNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYL 457
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR-GNELQANTGRIVGTYRYMSPE 202
HQ SR+RIIHRDLK SNILLD++M PKI+DFG+AR+ + Q T RIVGT+ YM+PE
Sbjct: 458 HQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPE 517
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
Y + G FS K+DV+SFGVL+L+I+SGKK +GF S +G + S N K
Sbjct: 518 YVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDS---MG-------DLISFAWRNWK 567
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322
L+L L ++SS SN I+R +NI LLCVQE +RP+M VV ML
Sbjct: 568 EGVALNLVDKILMTMSSYS-SN-----MIMRCINIGLLCVQEKVAERPSMASVVLMLDGH 621
Query: 323 AAALLPPKQPAFSYVRNTVTSTSST 347
AL P +PAF N V+ +SS+
Sbjct: 622 TIALSEPSKPAFFSHSNAVSDSSSS 646
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 7.3e-63, Sum P(2) = 7.3e-63
Identities = 107/162 (66%), Positives = 132/162 (81%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYL 143
+N +RLLGCC + +EK+L+YEYMPNKSLDFFLFD W R IIEGIA+GLLYL
Sbjct: 583 RNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYL 642
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H+ SR+RIIHRDLKVSN+LLD +MNPKISDFG+ARI GN+ +ANT R+VGTY YMSPEY
Sbjct: 643 HRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEY 702
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245
A++G+FS+KSDV+SFGVLLL+IVSGK+ T + +L+GY
Sbjct: 703 AMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGY 744
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 5.5e-59, Sum P(2) = 5.5e-59
Identities = 100/163 (61%), Positives = 127/163 (77%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLF--------DWVTRVRIIEGIAQGLLYL 143
+N +RLLGCCI ++EKIL+YEYMPNKSLD FLF DW R IIEGIA+GLLYL
Sbjct: 584 RNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYL 643
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H+ SR+R++HRDLK SNILLD DM PKISDFG+AR+ G++ Q NT R+VGT+ YMSPEY
Sbjct: 644 HRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEY 703
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFY-RTYSFTLLGY 245
A++GIFS+KSDV+ FGVL+L+I++GK+ F+ S + GY
Sbjct: 704 AMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGY 746
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 2.0e-58, Sum P(2) = 2.0e-58
Identities = 99/163 (60%), Positives = 126/163 (77%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYL 143
+N +++LG C+D++E++LIYEY PNKSLD F+FD W RV II+GIA+G+LYL
Sbjct: 519 RNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYL 578
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H+ SR+RIIHRDLK SN+LLD DMN KISDFG+AR G+E +ANT R+VGTY YMSPEY
Sbjct: 579 HEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEY 638
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTLLGY 245
I G FS+KSDVFSFGVL+L+IVSG++ GF + LLG+
Sbjct: 639 QIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGH 681
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 4.2e-58, Sum P(2) = 4.2e-58
Identities = 98/164 (59%), Positives = 126/164 (76%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYL 143
+N +RLLGCCI +E +LIYEYMPNKSLDFF+FD W R+ II G+A+G+LYL
Sbjct: 554 RNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYL 613
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
HQ SR+RIIHRDLK N+LLD DMNPKISDFG+A+ G++ +++T R+VGTY YM PEY
Sbjct: 614 HQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEY 673
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGF-YRTYSFTLLGYI 246
AI G FS+KSDVFSFGVL+L+I++GK GF + + LLG++
Sbjct: 674 AIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 7.8e-58, Sum P(2) = 7.8e-58
Identities = 96/154 (62%), Positives = 124/154 (80%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYL 143
+N +RLLG C+D +E++L+YEY+PNKSLD+FLFD W R +II G+A+G+LYL
Sbjct: 402 RNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYL 461
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
HQ SR+ IIHRDLK SNILLD DMNPKI+DFG+ARI ++ + NT RIVGTY YMSPEY
Sbjct: 462 HQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEY 521
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT 237
A+ G +S+KSDV+SFGVL+L+I+SGKK + FY+T
Sbjct: 522 AMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQT 555
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00003111001 | SubName- Full=Chromosome undetermined scaffold_139, whole genome shotgun sequence; (827 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 354 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-44
Identities = 86/300 (28%), Positives = 126/300 (42%), Gaps = 71/300 (23%)
Query: 54 NKLGEGGFGPVYKGVLKNGD----EIAVKRLSGRSGQG-----LRELK--------NKLR 96
KLGEG FG VYKG LK D E+AVK L + + L+E + N +R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------FDWVTRVRIIEGIAQGLLY 142
LLG C +++ L+ EYM L +L + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
L + +HRDL N L+ +D+ KISDFG++R ++ R+M+PE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS-FTLLGYISE-NIYEFPSVDTHN 260
GIF+ KSDV+SFGVLL +I + T Y S +L Y+ + P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEVLEYLRKGYRLPKPE----- 230
Query: 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320
+++ Y + L C Q +DRPT +++V L
Sbjct: 231 --------------------YCPDEL-------Y-ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 67/193 (34%), Positives = 98/193 (50%), Gaps = 30/193 (15%)
Query: 55 KLGEGGFGPVYKGVLKNGD-----EIAVKRLSGRSGQG-----LRELK--------NKLR 96
KLGEG FG VYKG LK E+AVK L + + LRE + N ++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
LLG C +++ ++ EYM L +L + IA+G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKN 122
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIF 209
IHRDL N L+ +++ KISDFG++R ++ G + R+M+PE +++ G F
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPE-SLKEGKF 180
Query: 210 SIKSDVFSFGVLL 222
+ KSDV+SFGVLL
Sbjct: 181 TSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 33/195 (16%)
Query: 55 KLGEGGFGPVYKGVLKNGD-----EIAVKRLSGRSGQG-----LRELK--------NKLR 96
KLGEG FG VYKG LK E+AVK L + + LRE + N ++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
LLG C +++ +++ EYMP L +L + IA+G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYAIQ-G 207
IHRDL N L+ +++ KISDFG++R + + + G++ R+M+PE +++ G
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPE-SLKEG 179
Query: 208 IFSIKSDVFSFGVLL 222
F+ KSDV+SFGVLL
Sbjct: 180 KFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-41
Identities = 72/196 (36%), Positives = 95/196 (48%), Gaps = 26/196 (13%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVKRLSGRS------GQGLRELK--------NKLRLLG 99
KLG G FG VYK K G +AVK L RS RE++ N +RL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
DKD L+ EY L +L +I I +GL YLH IIHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE-YAIQGIFSIKS 213
DLK NILLD++ KI+DFG+A+ + T VGT YM+PE + K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKV 180
Query: 214 DVFSFGVLLLKIVSGK 229
DV+S GV+L ++++GK
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 27/192 (14%)
Query: 56 LGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG-----------LRELKNK--LRLLGCC 101
LGEGGFG VY K G ++A+K + L++L + ++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 102 IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
D++ L+ EY SL L +RI+ I +GL YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 156 LKVSNILLDKD-MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKS 213
LK NILLD D K++DFG++++ ++ T IVGT YM+PE + G +S KS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 214 DVFSFGVLLLKI 225
D++S GV+L ++
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 29/199 (14%)
Query: 55 KLGEGGFGPVYKGVLKNGDE-----IAVKRLSGRSGQG-----LREL--------KNKLR 96
KLGEG FG VYKG LK E +AVK L + + L E N +R
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
LLG C + ++ EYMP L FL +++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
+HRDL N L+ +++ KISDFG++R I + + G + ++M+PE G F
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKF 181
Query: 210 SIKSDVFSFGVLLLKIVSG 228
+ KSDV+SFGVLL +I +
Sbjct: 182 TSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 31/202 (15%)
Query: 50 FSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG-----LRELK--------NKL 95
+ KLGEG FG VY K G +A+K + + + LRE+K N +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG--------IAQGLLYLHQYS 147
RL D+D+ L+ EY L L R R+ E I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHSK- 116
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
I+HRDLK NILLD+D + K++DFG+AR E VGT YM+PE +
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 208 IFSIKSDVFSFGVLLLKIVSGK 229
+ D++S GV+L ++++GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 27/199 (13%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVK--RLSGRSGQGLRELKNKLRLL------------ 98
LG G FG VY + K G+ +AVK LSG S + L L+ ++R+L
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 99 GCCIDKDEK-ILIY-EYMPNKSLDFFL--F----DWVTRVRIIEGIAQGLLYLHQYSRVR 150
G D+++ + I+ EY+ SL L F + V R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-ILEGLAYLH---SNG 121
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
I+HRD+K +NIL+D D K++DFG A+ E TG + GT +M+PE +
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 211 IKSDVFSFGVLLLKIVSGK 229
+D++S G ++++ +GK
Sbjct: 182 RAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 80/234 (34%), Positives = 105/234 (44%), Gaps = 49/234 (20%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVK------RLSGRSGQGLRELKNKLRLLGC-----C- 101
LG+G G VYK K G A+K R Q LRELK LR C
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-QLLRELKT-LRSCESPYVVKCY 65
Query: 102 --IDKDEKI-LIYEYMPNKSLDFFLFDWVTRVRII-EG--------IAQGLLYLHQYSRV 149
K+ +I ++ EYM SL D + +V I E I +GL YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-I 208
IIHRD+K SN+L++ KI+DFGI+++ Q NT VGT YMSPE IQG
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE-RIQGES 176
Query: 209 FSIKSDVFSFGVLLLKIVSGK------KTTGFYRTYSFTLLGYI-SENIYEFPS 255
+S +D++S G+ LL+ GK F F L+ I P+
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSF-----FELMQAICDGPPPSLPA 225
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 25/200 (12%)
Query: 49 KFSDANKLGEGGFGPVYKG-VLKNGDEIAVKRLSGRSGQGLRELKNKLRLL--------- 98
F K+G+GGFG VYK + G E+A+K + S + ++ N++++L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 99 ---GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVR------IIEGIAQGLLYLHQYSRV 149
G + KDE ++ E+ SL L + + + + +GL YLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN--- 117
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
IIHRD+K +NILL D K+ DFG++ + ++ +A +VGT +M+PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKARN-TMVGTPYWMAPEVINGKPY 174
Query: 210 SIKSDVFSFGVLLLKIVSGK 229
K+D++S G+ +++ GK
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 24/197 (12%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG----------QGLRELKNK--LRL 97
F+ KLG G FG V++G+ KN +A+K L Q L+ L++K + L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-------IAQGLLYLHQYSRVR 150
C + +I E M SL FL +V + +A+G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
IHRDL NIL+ +D+ K++DFG+AR+ + + ++ +I Y++ +PE A G FS
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 211 IKSDVFSFGVLLLKIVS 227
KSDV+SFG+LL ++ +
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 68/194 (35%), Positives = 103/194 (53%), Gaps = 28/194 (14%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRL-SG--------RSGQGLRELK-NKL-RLLGCCID 103
KLG G FG V+ G ++AVK L G + Q +++L+ +KL +L C +
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSRVRIIHRDL 156
++ ++ EYM SL FL + V + IA+G+ YL IHRDL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQGIFSIKS 213
NIL+ +++ KI+DFG+AR+ +E A G I ++ +PE A G F+IKS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI----KWTAPEAANYGRFTIKS 185
Query: 214 DVFSFGVLLLKIVS 227
DV+SFG+LL +IV+
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 32/198 (16%)
Query: 56 LGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQG----LRELK--------NKLRLL 98
+G G FG V +G LK + +A+K L +G S + L E N +RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G ++I EYM N SLD FL F V ++ GIA G+ YL S + +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYV 128
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT--GRIVGTYRYMSPEYAIQ-GIF 209
HRDL NIL++ ++ K+SDFG++R +E T G+I R+ +PE AI F
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPE-AIAYRKF 185
Query: 210 SIKSDVFSFGVLLLKIVS 227
+ SDV+SFG+++ +++S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS--GRSGQGLRELKNKLRLL------- 98
+ + +G G FG VYKG+ L+ GD +A+K++S + L+ + ++ LL
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 99 -----GCCIDKDEKILIYEYMPNKSL-----DFFLFDWVTRVRIIEGIAQGLLYLHQYSR 148
G D +I EY N SL F F + + QGL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG- 119
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
+IHRD+K +NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSG 175
Query: 209 FSIKSDVFSFGVLLLKIVSGK 229
S SD++S G ++++++G
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 42/202 (20%)
Query: 54 NKLGEGGFGPVYKGVLKN-----GDEIAVKRLSGRSG-QGLRELKNKLRLL--------- 98
+LGEG FG V G+++AVK L+ Q + + ++ +L
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 99 ---GCCIDKDEKI--LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYS 147
G C + LI EY+P+ SL +L + + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ- 128
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARIC-------RGNELQANTGRIVGTYRYMS 200
R IHRDL NIL++ + KISDFG+A++ E + + +
Sbjct: 129 --RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES------PIFWYA 180
Query: 201 PEYAIQGIFSIKSDVFSFGVLL 222
PE FS SDV+SFGV L
Sbjct: 181 PECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 64/190 (33%), Positives = 100/190 (52%), Gaps = 21/190 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRS---------GQGLRELK-NKLRLLGCCIDK 104
KLG G FG V+ G ++A+K L S +++L+ +L L + +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 105 DEKILIYEYMPNKSL-DFFLFDWVTRVRIIE------GIAQGLLYLHQYSRVRIIHRDLK 157
+ +I EYM N SL DF ++ I + IA+G+ ++ R IHRDL+
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLR 129
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
+NIL+ + + KI+DFG+AR+ NE A G ++ +PE G F+IKSDV+S
Sbjct: 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWS 188
Query: 218 FGVLLLKIVS 227
FG+LL +IV+
Sbjct: 189 FGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 68/207 (32%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSG-----QGLRELK--------N 93
K + ++LGEG G V K LKN I A+K ++ Q LREL+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 94 KLRLLGCCID-KDEKILI-YEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLY 142
++ G +D I I EY SLD R +I E + +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
LH +IIHRD+K SNILL + K+ DFG++ G + + G GT YM+PE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPE 173
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+SI SDV+S G+ LL++ +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-24
Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 21/190 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSG---------RSGQGLRELK-NKLRLLGCCIDK 104
KLG G FG V+ G ++AVK L Q +++L+ +KL L + +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 105 DEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSRVRIIHRDLK 157
+ ++ EYM SL FL D R V + +A G+ Y+ R+ IHRDL+
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLR 129
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
+NIL+ + KI+DFG+AR+ NE A G ++ +PE A+ G F+IKSDV+S
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 218 FGVLLLKIVS 227
FG+LL ++V+
Sbjct: 189 FGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 22/191 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSG---------RSGQGLRELK--NKLRLLGCCID 103
KLG G FG V++G+ N +AVK L Q +++L+ ++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSRVRIIHRDL 156
++ ++ E M SL +L R + + +A G+ YL + IHRDL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVF 216
N+L+ ++ K++DFG+AR+ + + +A G ++ +PE A+ FSIKSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREG-AKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 217 SFGVLLLKIVS 227
SFG+LL +IV+
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 29/203 (14%)
Query: 47 TNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVK--RLSGRSGQGL-------RELKNK-- 94
+ + K+GEG G VYK + G E+A+K RL ++ + + ++ K+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDWVTRVRIIEG-IA-------QGLLYLHQ 145
+ + DE ++ EYM SL D + VR+ E IA QGL YLH
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTD--IITQ-NFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
+IHRD+K NILL KD + K++DFG A + + ++ +VGT +M+PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 206 QGIFSIKSDVFSFGVLLLKIVSG 228
+ + K D++S G++ +++ G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-24
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 22/193 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVK--------RLSGRSGQGLRELK-----NKLRLLGCC 101
K+G+G FG VYKGVLK E+AVK L + Q LK N ++L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 102 IDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGI------AQGLLYLHQYSRVRIIHRD 155
+ K ++ E +P SL FL R+ + + + A G+ YL + IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
L N L+ ++ KISDFG++R G + G ++ +PE G ++ +SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 216 FSFGVLLLKIVSG 228
+S+G+LL + S
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 42/214 (19%)
Query: 56 LGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQGLRE-------------LKNKLR 96
LGEG FG V+ G + + +AVK L + R+ +N ++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-------------------FDWVTRVRIIEGIA 137
G C + D I+++EYM + L+ FL ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 138 QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYR 197
G++YL + +HRDL N L+ D+ KI DFG++R + G + R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 198 YMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKK 230
+M PE + F+ +SDV+SFGV+L +I + GK+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 43/208 (20%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKR--LSGRSGQGLRELKNKLRLLGCC--------- 101
++G+G FG VY +G +K LS S + + N++++L
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 102 ---IDKDEKILIYEYMPNKSLDFFL---------------FDWVTRVRIIEGIAQGLLYL 143
+K + ++ EY L + DW + + L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H SR +I+HRD+K NI L + K+ DFGI+++ A T +VGT Y+SPE
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE- 173
Query: 204 AIQGI-FSIKSDVFSFGVLLLKIVSGKK 230
Q ++ KSD++S G +L ++ + K
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 73/191 (38%), Positives = 103/191 (53%), Gaps = 22/191 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLS--GRSGQGLRELKN--------KLRLLGCCIDK 104
KLG G FG V+ G N ++AVK L S Q E N KL L + K
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 105 DEKI-LIYEYMPNKSL-DFFLFDWVTRV---RIIE---GIAQGLLYLHQYSRVRIIHRDL 156
+E I +I EYM SL DF D +V ++I+ IA+G+ Y+ R IHRDL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVF 216
+ +N+L+ + + KI+DFG+AR+ NE A G ++ +PE G F+IKSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVW 188
Query: 217 SFGVLLLKIVS 227
SFG+LL +IV+
Sbjct: 189 SFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-23
Identities = 61/190 (32%), Positives = 104/190 (54%), Gaps = 21/190 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSG---------RSGQGLRELKN-KLRLLGCCIDK 104
KLG+G FG V+ G +A+K L + Q +++L++ KL L + +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 105 DEKILIYEYMPNKSL-DFFLFDWVTRVRIIE------GIAQGLLYLHQYSRVRIIHRDLK 157
+ ++ EYM SL DF + +R+ + IA G+ Y+ R+ +HRDL+
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 129
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
+NIL+ +++ K++DFG+AR+ NE A G ++ +PE A+ G F+IKSDV+S
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 218 FGVLLLKIVS 227
FG+LL ++ +
Sbjct: 189 FGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 34/200 (17%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVK--RLSGRSG---QGLRELK--------NKLRLLG 99
+LG G G V K + + G +AVK RL Q LREL + G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRV------RIIEGIAQGLLYLHQYSRVRIIH 153
+ + + EYM SLD L + R+ +I + +GL YLH + +IIH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIH 124
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNEL---QANTGRIVGTYRYMSPEYAIQGI-F 209
RD+K SNIL++ K+ DFG++ +L A T VGT YM+PE IQG +
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLAKT--FVGTSSYMAPE-RIQGNDY 176
Query: 210 SIKSDVFSFGVLLLKIVSGK 229
S+KSD++S G+ L+++ +G+
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 27/202 (13%)
Query: 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKR--LSGRSGQGLRELKNKLRLLG------- 99
F NK+G+G FG V+K V K + A+K+ LS + + E ++ R+L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 100 -----CCIDKDEKILIYEYMPNKSLDFFLFDWVTRV-------RIIEGIAQGLLYLHQYS 147
+DK + ++ EY N L L R R I GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
+I+HRD+K N+ LD N KI D G+A++ N ANT IVGT Y+SPE
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDK 176
Query: 208 IFSIKSDVFSFGVLLLKIVSGK 229
++ KSDV++ GV+L + +GK
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 67/251 (26%), Positives = 100/251 (39%), Gaps = 49/251 (19%)
Query: 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK-----------NKL-------R 96
+GEG F V K E A+K L R Q ++E K +L +
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
L D++ + EY PN L ++ D I L YLH I
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGI 123
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARI------------------CRGNELQANTGRIV 193
IHRDLK NILLDKDM+ KI+DFG A++ + + + V
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253
GT Y+SPE + SD+++ G ++ ++++GK F + + I + Y F
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYLTFQKILKLEYSF 241
Query: 254 PSVDTHNVKTF 264
P + K
Sbjct: 242 PPNFPPDAKDL 252
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 44/211 (20%)
Query: 56 LGEGGFGPVYKGVLKNGD-------EIAVKRLSGRSGQGLRELK---------------N 93
LG G FG VY+G + +AVK L R G +E K N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------------WVTRVRIIEGIAQGLL 141
++LLG C+ + + +I E M L +L D + I +A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 142 YLHQYSRVRIIHRDLKVSNILL-----DKDMNPKISDFGIARICRGNELQANTGRIVGTY 196
YL Q + IHRDL N L+ D D KI DFG+AR ++ G +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
R+M+PE + G F+ +SDV+SFGVL+ +I++
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 23/193 (11%)
Query: 54 NKLGEGGFGPVYKGVLKN-GDEIAVKRLSG---------RSGQGLRELK--NKLRLLGCC 101
+KLG G +G VY+GV K +AVK L + ++E+K N ++LLG C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 102 IDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ +I E+M +L +L + V + + I+ + YL + + IHR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
DL N L+ ++ K++DFG++R+ G+ A+ G ++ +PE FSIKSD
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSD 187
Query: 215 VFSFGVLLLKIVS 227
V++FGVLL +I +
Sbjct: 188 VWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-22
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 37/195 (18%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAVKRL---SGRSGQGLREL--------KNKLRLLGCCIDK 104
+G+G FG V G + G ++AVK L S + L E N ++LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 105 DEKILIYEYMPNKSLDFFLFDWVTRVR-IIEG---------IAQGLLYLHQYSRVRIIHR 154
+ ++ EYM SL +L +R R +I + +G+ YL + +HR
Sbjct: 73 NPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY--RYMSPEYAIQGIFSIK 212
DL N+L+ +D+ K+SDFG+A+ +A+ G+ G ++ +PE + FS K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 213 SDVFSFGVLLLKIVS 227
SDV+SFG+LL +I S
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-22
Identities = 63/190 (33%), Positives = 104/190 (54%), Gaps = 21/190 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSG---------RSGQGLRELK-NKLRLLGCCIDK 104
KLG+G FG V+ G ++A+K L + Q +++L+ +KL L + +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 105 DEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSRVRIIHRDLK 157
+ ++ E+M SL FL + + V + IA G+ Y+ R+ IHRDL+
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLR 129
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
+NIL+ ++ KI+DFG+AR+ NE A G ++ +PE A+ G F+IKSDV+S
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 218 FGVLLLKIVS 227
FG+LL ++V+
Sbjct: 189 FGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 56 LGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQGLR-ELKNK------------LR 96
LG+G FG VY+G+ K +A+K ++ + R E N+ +R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------------FDWVTRVRIIE---GIAQGLL 141
LLG +++ E M L +L T + I+ IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
YL + +HRDL N ++ +D+ KI DFG+ R + G+ + R+M+P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 202 EYAIQGIFSIKSDVFSFGVLLLKIVS 227
E G+F+ KSDV+SFGV+L ++ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 45/208 (21%)
Query: 56 LGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSGQG-----LRELK--------NKLRL 97
LG G FG VYKGV G+ +A+K L + L E + +RL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFF------------LFDWVTRVRIIEGIAQGLLYLHQ 145
LG C+ + LI + MP L + L +W + IA+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG--NELQANTGRIVGTYRYMSPEY 203
R++HRDL N+L+ + KI+DFG+A++ E A G++ ++M+ E
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALES 182
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVS-GKK 230
+ I++ KSDV+S+GV + ++++ G K
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 38/200 (19%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCC-----------I 102
KLGEG +G VYK + + G +A+K + + L+E+ ++ +L C
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 103 DKDEKILI-YEY-----------MPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVR 150
K+ + I EY + NK+L + +GL YLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY-----QTLKGLEYLHS---NK 119
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-F 209
IHRD+K NILL+++ K++DFG++ + NT ++GT +M+PE IQ I +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE-VIQEIGY 176
Query: 210 SIKSDVFSFGVLLLKIVSGK 229
+ K+D++S G+ +++ GK
Sbjct: 177 NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-21
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 43/212 (20%)
Query: 56 LGEGGFGPVYKG--VLKNGDE----IAVKRLSGRSGQGLR-------ELKNKLR------ 96
LGEG FG VYKG N +A+K L + ++ EL + L+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEG 135
LLG C + +++EY+ + L FL D + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA G+ YL S +HRDL N L+ + + KISDFG++R + + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
R+M PE + G F+ +SD++SFGV+L +I S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 54 NKLGEGGFGPVYKGV--LKNGDEI--AVKRLSGRSGQG-----LRE------LKNK--LR 96
+LG G FG V KGV +K+G E+ AVK L LRE L + +R
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFDW--VTRVRIIE---GIAQGLLYLHQYSRVRI 151
L+G C + +L+ E P L +L + + E +A G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHF 116
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICR--GNELQANTGRIVGTY--RYMSPEYAIQG 207
+HRDL N+LL KISDFG++R + +A T G + ++ +PE G
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPECINYG 173
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
FS KSDV+S+GV L + S
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 21/194 (10%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRS---------GQGLRELK-NKLRLLGCCIDK 104
KLG G FG V+ ++AVK + S ++ L+ +KL L + K
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 105 DEKILIYEYMPNKSL-DFFLFDWVTRV---RIIE---GIAQGLLYLHQYSRVRIIHRDLK 157
+ +I E+M SL DF D ++ ++I+ IA+G+ ++ Q + IHRDL+
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLR 129
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
+NIL+ + KI+DFG+AR+ NE A G ++ +PE G F+IKSDV+S
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWS 188
Query: 218 FGVLLLKIVSGKKT 231
FG+LL++IV+ +
Sbjct: 189 FGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 21/194 (10%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVK--RLSGRSGQGLRE-----LK---NKL-RLLGCCID 103
++G G FG V+ G ++A+K R S + E +K KL +L G C +
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 104 KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK 157
+ L++E+M + L +L F T + + + +G+ YL + +IHRDL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
N L+ ++ K+SDFG+ R ++ ++TG ++ SPE +S KSDV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KWSSPEVFSFSKYSSKSDVWS 186
Query: 218 FGVLLLKIVSGKKT 231
FGVL+ ++ S KT
Sbjct: 187 FGVLMWEVFSEGKT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 68/205 (33%), Positives = 107/205 (52%), Gaps = 34/205 (16%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKR--LSGRSGQG-----------------LRELK--N 93
+G G FG VY G+ +G+ +AVK+ L S L+EL+ N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDW----VTRVR-IIEGIAQGLLYLHQYSR 148
++ LG +D D + EY+P S+ L ++ T VR + I +GL YLH +R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--NR 125
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR----IVGTYRYMSPEYA 204
IIHRD+K +NIL+D KISDFGI++ N L T + G+ +M+PE
Sbjct: 126 -GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGK 229
Q ++ K+D++S G L++++++GK
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 88.3 bits (217), Expect = 2e-19
Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 39/233 (16%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSG----------------RSGQGLRELKNKLRLL 98
KLGEG FG VY + +A+K L+ + L N ++L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
D+ L+ EY+ SL+ L + I+ I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 151 IIHRDLKVSNILLDKDMN-PKISDFGIARICRGN----ELQANTGRIVGTYRYMSPEYAI 205
IIHRD+K NILLD+D K+ DFG+A++ + A VGT YM+PE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 206 QGIF---SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
S SD++S G+ L ++++G F + + + I E P+
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPT 232
|
Length = 384 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 70/219 (31%), Positives = 102/219 (46%), Gaps = 49/219 (22%)
Query: 55 KLGEGGFGPVY----KGVLKNGDE-------------IAVKRLSGRSGQG-----LRELK 92
KLGEG FG V+ +G+ K D+ +AVK L + + L+E+K
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 93 --------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL----------------FDWVT 128
N +RLL CI D +I EYM N L+ FL + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 129 RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
+ + IA G+ YL S + +HRDL N L+ K+ KI+DFG++R +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
GR V R+MS E + G F+ SDV++FGV L +I++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 9e-19
Identities = 63/198 (31%), Positives = 89/198 (44%), Gaps = 32/198 (16%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLS-------GRSGQGLRELKNKLRL--------LG 99
LG+G FG V K+ ++ A+K L L E +N L L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTE-RNILSRINHPFIVKLH 59
Query: 100 CCIDKDEKI-LIYEYMPNKSLDFFL-----FDWVTRVRIIEG-IAQGLLYLHQYSRVRII 152
+EK+ L+ EY P L L F R R I L YLH + II
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERARFYAAEIVLALEYLH---SLGII 115
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARI-CRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
+RDLK NILLD D + K++DFG+A+ + NT GT Y++PE + +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT--FCGTPEYLAPEVLLGKGYGK 172
Query: 212 KSDVFSFGVLLLKIVSGK 229
D +S GVLL ++++GK
Sbjct: 173 AVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 31/198 (15%)
Query: 56 LGEGGFGPVYKGVLKNGDE----IAVKRL-------------SGRSGQGLRELKNKLRLL 98
+G G FG V++G+LK +A+K L S S G N +RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G ++I EYM N +LD +L F V ++ GIA G+ YL S + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT---GRIVGTYRYMSPEYAIQGIF 209
HRDL NIL++ ++ K+SDFG++R+ + T G+I R+ +PE F
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAYRKF 187
Query: 210 SIKSDVFSFGVLLLKIVS 227
+ SDV+SFG+++ +++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 54 NKLGEGGFGPVYKGVL--KNGD----EIAVKRLSGRSGQG-----LREL--------KNK 94
LG G FG VY+G+ ++GD ++AVK L + L E +N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR------------VRIIEGIAQGLLY 142
+RL+G ++ + ++ E M L FL + R + +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 143 LHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
L + IHRD+ N LL KI+DFG+AR GR + ++M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
PE + GIF+ K+DV+SFGVLL +I S
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 49/210 (23%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKRL---SGRSG---QGLRELK--------NKLRLL 98
++GEG +G VYK K G+ +A+K++ + + G +RE+K N +RL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 99 GCCIDKDEK--ILIYEYMPNKSLDFFLFDWVTRVRIIEG--------IAQGLLYLHQYSR 148
K + +++EYM + D V+ E + +GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS--- 118
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE------ 202
I+HRD+K SNIL++ D K++DFG+AR T R++ T Y PE
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 203 ---YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ D++S G +L ++ GK
Sbjct: 178 RYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 56 LGEGGFGPVYKGVLKNGDE------IAVKRLSG-RSGQGLREL-------------KNKL 95
LGEG FG V K D +AVK L + + L +L KN +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGI---------- 136
LLG C + ++ EY + +L FL E +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 137 --AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194
A+G+ +L + IHRDL N+L+ +D KI+DFG+AR + T
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++ +SDV+SFGVLL +I +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 56 LGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQGL-----REL--------KNKLR 96
LG G FG V+ K +E + VK L + L REL KN +R
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------FDWVTRVRIIEGIAQGLLY 142
LLG C + + +I EY L FL +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
L S R +HRDL N L+ K+S +++ +E ++ R+++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVS 227
+ FS KSDV+SFGVL+ ++ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 37/203 (18%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS-GRSGQGLRE----LKNKLRLL----------- 98
LG+G FG VY + G E+AVK++ ++ L+ +++LL
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 99 -GCCIDKDEKILIY-EYMPNKSL-DFF-----LFDWVTRVRIIEGIAQGLLYLHQYSRVR 150
GC D DE + I+ EYMP S+ D L + VTR + I +G+ YLH
Sbjct: 70 YGCLRD-DETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIAR----ICRGNELQANTGRIVGTYRYMSPEYAIQ 206
I+HRD+K +NIL D N K+ DFG ++ IC + GT +MSPE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS---GTGMKSVTGTPYWMSPEVISG 181
Query: 207 GIFSIKSDVFSFGVLLLKIVSGK 229
+ K+DV+S G ++++++ K
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 42/215 (19%)
Query: 55 KLGEGGFGPVY----KGVLKNGDE--IAVKRLS----------GRSGQGLRELKNK--LR 96
+LGEG FG V+ +L D+ +AVK L R + L L+++ +R
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG--------------------I 136
G C + ++++EYM + L+ FL +I+ G I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 137 AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY 196
A G++YL + + +HRDL N L+ + + KI DFG++R + GR +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKK 230
R+M PE + F+ +SD++SFGV+L +I + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 32/199 (16%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS----GRSGQG-LRELK------------NKLRL 97
LG G FG VY+G+ L +GD AVK +S G++GQ +++L+ N ++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 98 LGCCIDKDEKILIY-EYMPNKSLDFFL--FDWVTRVRII---EGIAQGLLYLHQYSRVRI 151
LG + ++ + I+ E +P SL L + I I GL YLH R
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH--DR-NT 123
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY-AIQGIFS 210
+HRD+K +NIL+D + K++DFG+A+ + G+ +M+PE A QG +
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 211 IKSDVFSFGVLLLKIVSGK 229
+ +D++S G +L++ +GK
Sbjct: 181 LAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (204), Expect = 6e-18
Identities = 58/170 (34%), Positives = 83/170 (48%), Gaps = 29/170 (17%)
Query: 55 KLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQG--------------LRELK--NKLRL 97
KLGEG +G VYK K EI A+K++ R L+ELK N ++L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 98 LGCCIDKDEKILIYEYMPN---KSLDFFLFDWVTRV--RIIEGIAQGLLYLHQYSRVRII 152
L + + L++EY K LD + I+ + +GL Y H RI+
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRIL 120
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
HRDLK NIL+++D K++DFG+AR G L+ T +V T Y +PE
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 56 LGEGGFGPVYKGVLKNGDE----IAVKRLSG-------------RSGQGLRELKNKLRLL 98
+G G FG V G LK + +A+K L S G + N + L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G +++ EYM N SLD FL F + V ++ GIA G+ YL V
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV--- 128
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT---GRIVGTYRYMSPEYAIQGIF 209
HRDL NIL++ ++ K+SDFG++R+ + A T G+I R+ +PE F
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKF 186
Query: 210 SIKSDVFSFGVLLLKIVS 227
+ SDV+S+G+++ +++S
Sbjct: 187 TSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 56 LGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQGLRELKNK-LRLLGC----CI-- 102
LG+GGFG V +K G A K RL R G+ + + K L + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 103 ---DKDEKILIYEYMPNKSLDFFLFDWVTRV----RIIEGIAQ---GLLYLHQYSRVRII 152
KD+ L+ M L + +++ R I AQ GL +LHQ RI+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIV 117
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIK 212
+RDLK N+LLD N +ISD G+A + GR GT YM+PE ++
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVYDFS 174
Query: 213 SDVFSFGVLLLKIVSGK 229
D F+ G L ++++G+
Sbjct: 175 VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 57/227 (25%)
Query: 55 KLGEGGFGPVYKGVLKNGDE-----------------IAVKRLSGRSGQG-----LRELK 92
KLGEG FG V+ + N + +AVK L + + L+E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 93 --------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL--------------------- 123
N +RLLG C+D+D +I EYM N L+ FL
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 124 ---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
+ + + + IA G+ YL S + +HRDL N L+ +++ KI+DFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ GR V R+M+ E + G F+ SDV++FGV L +I+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-17
Identities = 71/244 (29%), Positives = 103/244 (42%), Gaps = 52/244 (21%)
Query: 55 KLGEGGFGPVY----KGVLKNGDE-----------IAVKRLSGRSGQG-----LRELK-- 92
KLGEG FG V+ +G+ + E +AVK L + L+E+K
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 93 ------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG----------- 135
N +RLLG C+ D +I EYM N L+ FL
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 136 ------IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189
IA G+ YL + + +HRDL N L+ KI+DFG++R +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249
GR V R+M+ E + G F+ SDV++FGV L ++ + K + YS + EN
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE----QPYSLLSDEQVIEN 244
Query: 250 IYEF 253
EF
Sbjct: 245 TGEF 248
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 29/198 (14%)
Query: 56 LGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQGLREL------------KNKLRLL 98
+G G FG V +G LK + +A+K L SG + + R+ N + L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G ++I E+M N +LD FL F + V ++ GIA G+ YL + + V
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV--- 128
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG---TYRYMSPEYAIQGIF 209
HRDL NIL++ ++ K+SDFG++R + +G R+ +PE F
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 210 SIKSDVFSFGVLLLKIVS 227
+ SDV+S+G+++ +++S
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG-----------QGLRELK--N 93
F+ +G+G FG VYK + + +A+K + Q L + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRV 149
+ G + + +I EY S L D I+ + GL YLH+
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE--- 117
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
IHRD+K +NILL ++ + K++DFG++ + NT VGT +M+PE Q +
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGY 175
Query: 210 SIKSDVFSFGVLLLKIVSGK 229
K+D++S G+ +++ G+
Sbjct: 176 DEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 44/141 (31%), Positives = 74/141 (52%), Gaps = 21/141 (14%)
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV----------RIIEGIAQGLLYLHQYSR 148
G ++++ + E+M SLD + + +I + +GL YL Y+
Sbjct: 70 GAFLNENNICMCMEFMDCGSLD-----RIYKKGGPIPVEILGKIAVAVVEGLTYL--YNV 122
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
RI+HRD+K SNIL++ K+ DFG++ G + + VGT YMSPE G
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 209 FSIKSDVFSFGVLLLKIVSGK 229
+++KSDV+S G+ ++++ GK
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 67/200 (33%), Positives = 97/200 (48%), Gaps = 34/200 (17%)
Query: 56 LGEGGFGPV--YKGVLKN---GDEIAVKRLSGRSGQGLRE--------LK-----NKLRL 97
LGEG FG V Y N G+ +AVK L GQ LK N ++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 98 LGCCIDKDEKI--LIYEYMPNKSL-DFFLFDWVTRVRII---EGIAQGLLYLHQYSRVRI 151
GCC ++ K LI EY+P SL D+ + +++ + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HY 128
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNE---LQANTGRIVGTYRYMSPEYAIQG 207
IHRDL N+LLD D KI DFG+A+ + G+E ++ + V Y + E +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AVECLKEN 185
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
FS SDV+SFGV L ++++
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 25/195 (12%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAVKRLSGRSG-----QGLRELK--------NKLRLLGCCI 102
LG G FG V+ G + ++A+K + R G + E K N ++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 103 DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156
+ ++ EYM N L +L + + + + + YL IHRDL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVF 216
N L+ +D K+SDFG+AR ++ ++ G ++ PE FS KSDV+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKWAPPEVFDYSRFSSKSDVW 185
Query: 217 SFGVLLLKIVSGKKT 231
SFGVL+ ++ S K
Sbjct: 186 SFGVLMWEVFSEGKM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 42/209 (20%)
Query: 56 LGEGGFGPVYKGVLKNGD----EIAVK--RLSGRSGQGLREL------------KNKLRL 97
LGEG FG V +G L D ++AVK +L + + E N ++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 98 LGCCIDKDEK------ILIYEYMPNKSLDFFLF-----------DWVTRVRIIEGIAQGL 140
+G C + ++I +M + L FL T ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 141 LYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGT-YRY 198
YL S IHRDL N +L +DM ++DFG+++ I G+ + GRI ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR--QGRIAKMPVKW 181
Query: 199 MSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++ E +++ KSDV++FGV + +I +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 23/198 (11%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQG-LRELKNKLRLLGCCID---- 103
F+ ++G+G FG VYKG+ E+ A+K + + + +++ ++ +L C
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 104 -------KDEKI-LIYEYMPNKS-LDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
K K+ +I EY+ S LD + I+ I +GL YLH R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
IHRD+K +N+LL + + K++DFG+A +++ NT VGT +M+PE Q +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDF 180
Query: 212 KSDVFSFGVLLLKIVSGK 229
K+D++S G+ +++ G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 39/208 (18%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK------RLSGRSGQGLR----------------ELK 92
+G+G +G VY + + G+ +AVK ++GR + +
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 93 NKLRLLGCCIDKDEKILIY-EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY 146
N ++ LG +E + I+ EY+P S+ L F+ E + +GL YLH
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN--TGRIVGTYRYMSPE-- 202
I+HRDLK N+L+D D KISDFGI++ + +++ N + G+ +M+PE
Sbjct: 128 G---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKK 230
++ +S K D++S G ++L++ +G++
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 53/229 (23%)
Query: 43 VSTATNKFSDANKLGEGGFGPVYKGVL------KNGDEIAVKRLSGRSGQGLRE------ 90
++ +T +F + +LGE FG VYKG L + +A+K L ++ LRE
Sbjct: 2 INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 91 -LKNKLR------LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDWVTR------------- 129
++++L+ LLG + K++ + +I+ Y + L FL V R
Sbjct: 60 MMRSRLQHPNIVCLLGV-VTKEQPLSMIFSYCSHSDLHEFL---VMRSPHSDVGSTDDDK 115
Query: 130 -----------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
V I+ IA G+ +L + ++H+DL N+L+ +N KISD G+ R
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ G + R+MSPE + G FSI SD++S+GV+L ++ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 54 NKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG------------LRELKNK--LRLL 98
+G+G FG V K K+ G + K + + LRELK+ +R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 99 GCCIDKD-EKILIY-EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLH-----Q 145
ID+ + + I EY L + ++ I + Q LL L+
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
++HRDLK +NI LD + N K+ DFG+A+I + A T VGT YMSPE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGK 229
+ KSD++S G L+ ++ +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 32/215 (14%)
Query: 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKR--LSGRSGQGL----- 88
L + SV K++ K+G+G G VY + + G E+A+K+ L + + L
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 89 ---RELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-IA----- 137
RE K N + L + DE ++ EY+ SL D VT + EG IA
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 138 --QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVG 194
Q L +LH ++IHRD+K NILL D + K++DFG A+I Q+ +VG
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T +M+PE + + K D++S G++ +++V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 55 KLGEGGFGPVYKGVLKN----GDEI--AVKRLSGRSGQGLRELKNKLRLL---------- 98
+LGEG FG V+ N D+I AVK L S ++ + LL
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 99 --GCCIDKDEKILIYEYMPNKSLDFFL------------------FDWVTRVRIIEGIAQ 138
G C++ D I+++EYM + L+ FL + I + IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRY 198
G++YL + +HRDL N L+ +++ KI DFG++R + G + R+
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 199 MSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKK 230
M PE + F+ +SDV+S GV+L +I + GK+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 61/224 (27%)
Query: 56 LGEGGFGPVYK----GVLKNGDE--IAVKRL-SGRSGQGLRELK------------NKLR 96
+G+G FG V++ G+L +AVK L S + + N ++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----WV-----------------------TR 129
LLG C L++EYM L+ FL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR------ICRGN 183
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFG++R + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
E A R+M PE ++ +SDV+++GV+L +I S
Sbjct: 190 ENDAI------PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 42/241 (17%)
Query: 55 KLGEGGFGPVYKGVLKN----GDE--IAVKRLSGRSGQGLRELKNKLRLL---------- 98
+LGEG FG V+ N D+ +AVK L + ++ + + LL
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 99 --GCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEG 135
G C D D I+++EYM + L+ FL + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA G++YL + +HRDL N L+ ++ KI DFG++R + G +
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
R+M PE + F+ +SDV+SFGV+L +I + K F + + + + E P
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR 248
Query: 256 V 256
V
Sbjct: 249 V 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 36/174 (20%)
Query: 55 KLGEGGFGPVYK-GVLKNGDEIAVKRLSGRSGQG------LRELK--------NKLRLL- 98
++GEG G V+K + G+ +A+K+++ R +G LRE+K ++LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 99 ----GCCIDKDEKILIYEYMPN------KSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSR 148
G +L+ EYMP+ + + L + + + + +G+ Y+H
Sbjct: 67 VFPHGSGF-----VLVMEYMPSDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHA--- 117
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
I+HRDLK +N+L+ D KI+DFG+AR+ E + + + V T Y +PE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 66/286 (23%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL--SGRSGQG-----LRELK--------N 93
F+D ++G G FG VY ++ + +A+K++ SG+ ++E++ N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFF-----LFDWVTRVRIIEGIAQGLLYLHQYSR 148
+ GC + + L+ EY + D V I G QGL YLH + R
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI--- 205
IHRD+K NILL + K++DFG A + AN+ VGT +M+PE +
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMD 187
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265
+G + K DV+S G+ +++ K + + + L +I++N + P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQN--DSP----------- 232
Query: 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT 311
++SS S+ + N C+Q+ DRP+
Sbjct: 233 ----------TLSSNDWSDY--------FRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 32/215 (14%)
Query: 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------- 87
L S SV K++ K+G+G G VY + + G E+A+K+++ +
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 88 --LRELKNK--LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-IA----- 137
+RE KN + L + DE ++ EY+ SL D VT + EG IA
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 138 --QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVG 194
Q L +LH ++IHRD+K NILL D + K++DFG A+I Q+ +VG
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T +M+PE + + K D++S G++ +++V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 27/190 (14%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLS-GRSGQGLRE---------LKNKLRLLGCCIDK 104
+GEG FG V +G G ++AVK + + Q E KN +RLLG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 105 DEKILIYEYMPNKSL-DF------FLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK 157
I++ E M +L +F L + ++ +A+G+ YL +++HRDL
Sbjct: 72 GLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLA 127
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
NIL+ +D K+SDFG+AR+ + + ++ ++ +PE FS KSDV+S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWS 182
Query: 218 FGVLLLKIVS 227
+GVLL ++ S
Sbjct: 183 YGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 46 ATNKFSDANKLGEGGFGPVY----KGVLKNGDE--IAVKRLSGRSGQGLR-ELKNK---- 94
A K + + +LG+G FG VY KGV+K+ E +A+K ++ + R E N+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 95 --------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------------VR 131
+RLLG ++I E M L +L ++
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
+ IA G+ YL+ + +HRDL N ++ +D KI DFG+ R + G+
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ R+MSPE G+F+ SDV+SFGV+L +I +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRL---SGRSG---QGLRELK--------NKLRLLG 99
KLGEG FG VYK +K G +A+K++ + + G LRE+K N + L+
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 100 CCIDKDEKIL-----IYEYMPNKSLDFFLFDWVTRVR--------IIEGIAQGLLYLHQY 146
+++ +K +Y P D V+ + + +G+ YLH+
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200
I+HRD+K +NIL+D KI+DFG+AR G G GT +Y +
Sbjct: 135 ---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 35/224 (15%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------LRELK--------N 93
FSD ++G G FG VY ++N + +A+K++S Q ++E++ N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSR 148
++ GC + + L+ EY + D V + G QGL YLH ++
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI--- 205
+IHRD+K NILL + K+ DFG A I A VGT +M+PE +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMD 187
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249
+G + K DV+S G+ +++ ++ + + + L +I++N
Sbjct: 188 EGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQN 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 23/198 (11%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQG-LRELKNKLRLLGCCID---- 103
F+ ++G+G FG V+KG+ ++ A+K + + + +++ ++ +L C
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 104 -------KDEKI-LIYEYMPNKS-LDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
K K+ +I EY+ S LD FD +++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
IHRD+K +N+LL + + K++DFG+A +++ NT VGT +M+PE Q +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDS 180
Query: 212 KSDVFSFGVLLLKIVSGK 229
K+D++S G+ +++ G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 23/198 (11%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQG-LRELKNKLRLLGCCID---- 103
F+ K+G+G FG V+KG+ ++ A+K + + + +++ ++ +L C
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 104 -------KDEKI-LIYEYMPNKS-LDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
KD K+ +I EY+ S LD D I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
IHRD+K +N+LL + K++DFG+A +++ N VGT +M+PE Q +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYDS 180
Query: 212 KSDVFSFGVLLLKIVSGK 229
K+D++S G+ +++ G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 64/202 (31%), Positives = 84/202 (41%), Gaps = 47/202 (23%)
Query: 55 KLGEGGFGPVYKGVLKN--GDEI--AVK-----RLSGRSGQGLREL--------KNKLRL 97
KLG+G FG V +G G I AVK +LS L+E +N +RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 98 LGCCIDKDEKILIYEYMPNKSL---------DFF----LFDWVTRVRIIEGIAQGLLYLH 144
G + ++ E P SL F L D+ + IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE----LQANTGRIVGTYRYMS 200
R IHRDL NILL D KI DFG+ R NE ++ + V + + +
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--LKV-PFAWCA 168
Query: 201 PEYAIQGIFSIKSDVFSFGVLL 222
PE FS SDV+ FGV L
Sbjct: 169 PESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 37/233 (15%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------LRELK--------N 93
F+D ++G G FG VY ++ + +A+K++S Q ++E+K N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSR 148
+ GC + + L+ EY + D V I G QGL YLH ++
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 145
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI--- 205
+IHRD+K NILL + K++DFG A I AN+ VGT +M+PE +
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVILAMD 197
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258
+G + K DV+S G+ +++ K + + + L +I++N E P++ +
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQN--ESPTLQS 246
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 69/225 (30%), Positives = 99/225 (44%), Gaps = 61/225 (27%)
Query: 55 KLGEGGFGPVY------------KGVLKNGDE-----IAVKRL------SGRSGQGLREL 91
KLGEG FG V+ K +N + +AVK L + R L+E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF-LKEV 70
Query: 92 K--------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWV---------------- 127
K N RLLG C +I EYM N L+ FL V
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 128 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187
T + + IA G+ YL + +HRDL N L+ K+ KI+DFG++R L +
Sbjct: 131 TLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYS 182
Query: 188 NT-----GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ GR R+M+ E + G F+ KSDV++FGV L +I++
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 58/223 (26%)
Query: 49 KFSDANKLGEGGFGPVYKGVLKNGD---EIAVKRLSGRSGQG--------------LREL 91
KF D +GEG FG V K +K + A+KR+ + + L
Sbjct: 10 KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE----------------- 134
N + LLG C + L EY P+ +L D++ + R++E
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 135 --------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE-- 184
+A+G+ YL S+ + IHRDL NIL+ ++ KI+DFG++ RG E
Sbjct: 124 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVY 177
Query: 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++ GR+ R+M+ E +++ SDV+S+GVLL +IVS
Sbjct: 178 VKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 27/192 (14%)
Query: 55 KLGEGGFGPVY-----KGV----LKNGDEIAVKRL-------SGRSGQGLRELKNK--LR 96
+LG+G FG VY K V LK EI V L + + Q L +L + ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFDW------VTRVRIIEGIAQGLLYLHQYSRVR 150
+++D +I EY + LD L + ++ ++ E Q LL +H + R
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
I+HRDLK NI L ++ KI DFG++R+ G+ A T GT YMSPE +
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKHQGYD 183
Query: 211 IKSDVFSFGVLL 222
KSD++S G +L
Sbjct: 184 SKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 4e-15
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 32/215 (14%)
Query: 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------- 87
L S SV K++ K+G+G G VY + + G E+A+++++ +
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 88 --LRELKNK--LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-IA----- 137
+RE KN + L + DE ++ EY+ SL D VT + EG IA
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 138 --QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVG 194
Q L +LH ++IHRD+K NILL D + K++DFG A+I Q+ +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T +M+PE + + K D++S G++ ++++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 36/204 (17%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK------------NKLR 96
LG G F Y+ +K G +AVK+++ + + L+ + +R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 97 LLGCCIDKDEKILIYEYMPNKSL-----DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
+LG + L E+M S+ + F + E + +GL YLH+ +I
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QI 124
Query: 152 IHRDLKVSNILLDKD-MNPKISDFGIA-----RICRGNELQANTGRIVGTYRYMSPEYAI 205
IHRD+K +N+L+D +I+DFG A + E Q G+++GT +M+PE
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLLGTIAFMAPEVLR 181
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGK 229
+ DV+S G +++++ + K
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 69/226 (30%), Positives = 100/226 (44%), Gaps = 56/226 (24%)
Query: 41 SSVSTATNKFSD---ANKLGEGGFGPVYK------------GVLKNGDEIAVKRLSGRSG 85
S +A S+ N++G G G VYK V+ E V+R R
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREI 123
Query: 86 QGLRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLD-------FFLFDWVTRVRIIEGI 136
+ LR++ N ++ E ++ E+M SL+ FL D V R +I+ GI
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-VAR-QILSGI 181
Query: 137 AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY 196
A YLH R I+HRD+K SN+L++ N KI+DFG++RI N+ VGT
Sbjct: 182 A----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTI 232
Query: 197 RYMSPE-------------YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
YMSPE YA D++S GV +L+ G+
Sbjct: 233 AYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQG-------------LRELK--N 93
F +++G G FG VY + +E+ AVK++S Q L++LK N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSR 148
+ GC + + L+ EY + D V I G QGL YLH ++
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI--- 205
+IHRD+K NILL + K++DFG A AN+ VGT +M+PE +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVILAMD 193
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249
+G + K DV+S G+ +++ K + + + L +I++N
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQN 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 46/206 (22%)
Query: 55 KLGEGGFGPVYKGVLKNGDEI-AVKRLS------GRSGQGLRELK--------NKLRLLG 99
K+GEG +G VYK K EI A+K++ G LRE+K N ++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 100 CCIDKDEKILIYEYM---------------PNKSLDFFLFDWVTRVRIIEGIAQGLLYLH 144
K + L++E+M P + +L+ + QGL + H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQ----------LLQGLAFCH 115
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
+ I+HRDLK N+L++ + K++DFG+AR + T +V T Y +PE
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELL 170
Query: 205 I-QGIFSIKSDVFSFGVLLLKIVSGK 229
+ +S D++S G + +++S +
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 40/208 (19%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG--LRELKNKLRLLGCCIDK------ 104
NK+G G FG VY V L G+ +AVK + + ++E+ +++++L
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 105 -----DEKILIY-EYMPNKSLDFFLF------DWVTRVRIIEGIAQGLLYLHQYSRVRII 152
EK+ I+ EY +L+ L + V RV ++ + +GL YLH + I+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ-LLEGLAYLHSH---GIV 121
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI-------VGTYRYMSPEYAI 205
HRD+K +NI LD + K+ DFG A L+ NT + GT YM+PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 206 QGIFSIK---SDVFSFGVLLLKIVSGKK 230
G +D++S G ++L++ +GK+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 55/222 (24%)
Query: 56 LGEGGFGPVYKGV------LKNGDEIAVKRL-SGRSGQGLREL------------KNKLR 96
LGEG FG V K +AVK L S LR+L + ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL--------------------FDWVTRVRIIE-- 134
L G C +LI EY SL FL + R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 135 -------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE--L 185
I++G+ YL + ++++HRDL N+L+ + KISDFG++R + +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ + GRI ++M+ E I++ +SDV+SFGVLL +IV+
Sbjct: 185 KRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 57/213 (26%)
Query: 58 EGGFGPVYKGVLKNGD-----EIAVKRLSGRSGQ-----------GLREL--KNKLRLLG 99
EG FG ++ G+L + E+ VK + + + L L +N L +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 100 CCI-DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-----------------IAQGLL 141
CI D + ++Y YM +L FL + R+ E IA G+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFL----QQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI-------CRGNELQANTGRIVG 194
YLH+ +IH+D+ N ++D+++ KI+D ++R C G+ N R V
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENRPV- 183
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+ E + +S SDV+SFGVLL ++++
Sbjct: 184 --KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 38/206 (18%)
Query: 49 KFSDANKLGEGGFGPVYKG-VLKNGDEIAVKRLSGRSGQGLREL-------------KNK 94
+ K+GEG G V G ++AVK++ R Q REL N
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNI 78
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE-GIA-------QGLLYLHQY 146
+ + + DE ++ E++ +L D VT R+ E IA + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEY 203
+IHRD+K +ILL D K+SDFG C ++ R +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG---FC--AQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ + + D++S G++++++V G+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 42/210 (20%)
Query: 56 LGEGGFGPVYKGV-LKNGDEI----AVKRLSGRSG-------------QGLRELKNKLRL 97
LG G FG VYKG+ + G+ + A+K L+ +G + + +RL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 98 LGCCIDKDEKILIYEYMPNKSL------------DFFLFDWVTRVRIIEGIAQGLLYLHQ 145
LG C+ + L+ + MP+ L L +W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
R++HRDL N+L+ + KI+DFG+AR+ G+E + N ++M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 206 QGIFSIKSDVFSFGVLLLKIVS--GKKTTG 233
F+ +SDV+S+GV + ++++ GK G
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 58/223 (26%)
Query: 49 KFSDANKLGEGGFGPVYKGVLK-NGDEI--AVKRLSGRSGQG--------------LREL 91
KF D +GEG FG V + ++K +G ++ A+K L + + L
Sbjct: 5 KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE----------------- 134
N + LLG C ++ + EY P +L D++ + R++E
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNL----LDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 135 --------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE-- 184
+A G+ YL S + IHRDL N+L+ +++ KI+DFG++ RG E
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLS---RGEEVY 172
Query: 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++ GR+ R+M+ E +++ KSDV+SFGVLL +IVS
Sbjct: 173 VKKTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 41/212 (19%)
Query: 56 LGEGGFGPVYKGVLKNGDEI---AVKRLS------------GRSGQGLRELK--NKLRLL 98
LGEG FG V +G L D I AVK + ++E N +RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 99 GCCIDKDEK------ILIYEYMPNKSL-DFFLFDWV----------TRVRIIEGIAQGLL 141
G C+ E ++I +M + L F L+ + V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVGT-YRYM 199
YL S IHRDL N +L+++MN ++DFG++ +I G+ + GRI +++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVKWI 181
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231
+ E +++ KSDV+SFGV + +I + +T
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 26/195 (13%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRL---SGRSGQGLRELK--------NKLRLLGCCID 103
+LG G FG V G + ++A+K + S + + E K ++L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 104 KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYL--HQYSRVRIIHRD 155
+ ++ EYM N L +L F + + + + +G+ YL Q+ IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF-----IHRD 125
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
L N L+D K+SDFG++R +E ++ G R+ PE + FS KSDV
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLLYSKFSSKSDV 184
Query: 216 FSFGVLLLKIVS-GK 229
++FGVL+ ++ S GK
Sbjct: 185 WAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 39/189 (20%)
Query: 49 KFSDANKLGEGGFGPVYKGVLKNGD---EIAVKRLSGRSGQG-------------LRELK 92
K+ +G G +G VYK KNG E A+K+ G Q LRELK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 93 NK--LRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDWVTRVR---------IIEGIAQG 139
++ + L+ ++ +K L+++Y + F + ++ I G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNP----KISDFGIARICRGNELQ--ANTGRIV 193
+ YLH ++HRDLK +NIL+ + KI D G+AR+ L+ A+ +V
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN-APLKPLADLDPVV 176
Query: 194 GTYRYMSPE 202
T Y +PE
Sbjct: 177 VTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 27/193 (13%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAVK--------RLSGRSGQGLRELK-----NKLRLLGCCI 102
LG+G FG V+KG LK+ +AVK L + R LK N ++L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 103 DKDEKILIYEYMPNKSLDFFLF------DWVTR--VRIIEGIAQGLLYLHQYSRVRIIHR 154
+ ++ E +P DF F + T+ V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
DL N L+ ++ KISDFG++R + + +++G ++ +PE G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 215 VFSFGVLLLKIVS 227
V+S+G+LL + S
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 15/141 (10%)
Query: 100 CCIDKDEKI-LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
+ + L+ EY+P L L D I I L YLH IIH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIH 116
Query: 154 RDLKVSNILLDKDMNPKISDFG------IARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
RDLK NIL+D + + K++DFG + R N+ + RIVGT Y++PE +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 208 IFSIKSDVFSFGVLLLKIVSG 228
S D +S G +L + + G
Sbjct: 177 GHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 33/198 (16%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS-----------GRSGQGLRELK-----NKLRLL 98
+G G +G VY+G + G +A+K ++ R L +L+ N +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVR----IIEGIAQGLLYLHQYSRVRIIHR 154
G + +I EY S+ + + II + L Y+H +V +IHR
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHR 125
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQGI-FS 210
D+K +NIL+ N K+ DFG+A L N+ + VGT +M+PE +G +
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 211 IKSDVFSFGVLLLKIVSG 228
K+D++S G+ + ++ +G
Sbjct: 181 TKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 29/198 (14%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCI 102
LG+G +G VY L IA+K + R + ++ L +N ++ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 103 DKDEKILIYEYMPNKSLDFFL-FDW-------VTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ + E +P SL L W T + + I +GL YLH +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132
Query: 155 DLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI--FSI 211
D+K N+L++ KISDFG ++ G + T GT +YM+PE +G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 212 KSDVFSFGVLLLKIVSGK 229
+D++S G ++++ +GK
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 30/201 (14%)
Query: 55 KLGEGGFGPVYKGV--------------LKNGDEIAVKRLSGRSGQGLRELKNK--LRLL 98
+LG G FG V KGV LKN +E +V+ R + + +L N +R++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLF---DWVTRVRIIEGIAQ---GLLYLHQYSRVRII 152
G C + + +L+ E L+ FL D +T ++E + Q G+ YL + +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY--RYMSPEYAIQGIFS 210
HRDL N+LL KISDFG+++ G + R G + ++ +PE FS
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 211 IKSDVFSFGVLLLKIVS-GKK 230
+SDV+S+G+ + + S G+K
Sbjct: 177 SRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 34/154 (22%)
Query: 54 NKLGEGGFGPVYKGVLKN-GDEIAVK--RLSGRSGQG-------LRELK--------NKL 95
KLGEG + VYK K G +A+K +L R LRE+K N +
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 96 RLLGCCIDKDEKILIYEYMP--------NKSLDFFLFDWVTRVR-IIEGIAQGLLYLHQY 146
LL K L++E+M +KS+ D ++ + +GL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD----IKSYMLMTLRGLEYLHSN 121
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
I+HRDLK +N+L+ D K++DFG+AR
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 40/202 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEI----AVKRLSGRSG-QGLRELKNKL------------RL 97
LG G FG V+KG+ + GD I A+K + RSG Q +E+ + + RL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 98 LGCCIDKDEKILIYEYMPNKSL-DFF-----------LFDWVTRVRIIEGIAQGLLYLHQ 145
LG C + L+ + P SL D L +W + IA+G+ YL +
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
+ R++HR+L NILL D +I+DFG+A + ++ + ++M+ E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 206 QGIFSIKSDVFSFGVLLLKIVS 227
G ++ +SDV+S+GV + +++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 46/212 (21%)
Query: 52 DANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLRELKNKLRLLGCCI---DKDEK 107
D ++G G FG V K + K G +AVKR+ RS +E K L L + D
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 108 ILIY-------------EYMPNKSLDFF--LFDWVTRVRIIEGI--------AQGLLYLH 144
+ Y E M + SLD F V + I E I + L YL
Sbjct: 66 VKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ---ANTGRIVGTYRYMSP 201
+ ++IIHRD+K SNILLD++ N K+ DFGI+ +L A T R G YM+P
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKT-RDAGCRPYMAP 176
Query: 202 E----YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
E A G + ++SDV+S G+ L ++ +GK
Sbjct: 177 ERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 44/204 (21%)
Query: 56 LGEGGFGPVYKGV-LKNGDEI----AVKRL-SGRSGQGLRELKNKL------------RL 97
LG G FG VYKG+ + +G+ + A+K L S + +E+ ++ RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 98 LGCCIDKDEKILIYEYMPNKSL-DF-----------FLFDWVTRVRIIEGIAQGLLYLHQ 145
LG C+ + L+ + MP L D+ L +W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ--ANTGRIVGTYRYMSPEY 203
VR++HRDL N+L+ + KI+DFG+AR+ +E + A+ G++ ++M+ E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALES 182
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVS 227
+ F+ +SDV+S+GV + ++++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 33/195 (16%)
Query: 56 LGEGGFGPV----YKGVLKN-GDEIAVKRLSGRSGQGLRELKNKLRLL------------ 98
LG+G FG V Y + N G+ +AVK+L + + LR+ + ++ +L
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 99 GCCID--KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
G C + L+ EY+P SL +L D + I +G+ YL R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKR 128
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG---TYRYMSPEYAIQG 207
+HRDL NIL++ + KI DFG+ ++ ++ + R G + Y +PE +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTES 186
Query: 208 IFSIKSDVFSFGVLL 222
FS+ SDV+SFGV+L
Sbjct: 187 KFSVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-14
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL---------SGRSGQGLRE---------LKNKL 95
LG+G +G VY G+ G IAVK++ + + + L+E N +
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLD-----FFLFDWVTRVRIIEGIAQGLLYLHQYSRVR 150
+ LG C+D + + E++P S+ F + + I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV----GTYRYMSPEYAIQ 206
++HRD+K +N++L + K+ DFG AR L ++ GT +M+PE +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 207 GIFSIKSDVFSFGVLLLKIVSGK 229
+ KSD++S G + ++ +GK
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 38/104 (36%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 127 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186
+ I E I L YLH IIHRD+K NILLD+ + I+DF IA + L
Sbjct: 101 QVKFWICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155
Query: 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKK 230
T GT YM+PE + +S+ D +S GV + + GK+
Sbjct: 156 -TTST-SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 44/211 (20%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEI----AVKRL-SGRSGQGLRELKNK-------- 94
+F LG G FG VYKG+ + G+++ A+K L S + +E+ ++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 95 ----LRLLGCCIDKDEKILIYEYMPNKSL-DF-----------FLFDWVTRVRIIEGIAQ 138
RLLG C+ + LI + MP L D+ +L +W + IA+
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE--LQANTGRIVGTY 196
G+ YL + R++HRDL N+L+ + KI+DFG+A++ +E A G++
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PI 175
Query: 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+ E + I++ +SDV+S+GV + ++++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-14
Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 41/206 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-----SGRSGQGLRELKNKLRLL----------- 98
LG+G FG VY + G E+A K++ S + + + L+ +++LL
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 99 -GCCIDKDEKIL--IYEYMPNKSLD------FFLFDWVTRVRIIEGIAQGLLYLHQYSRV 149
GC D+ EK L EYMP S+ L + VTR + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSN--- 125
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR----ICRGNELQANTG--RIVGTYRYMSPEY 203
I+HRD+K +NIL D N K+ DFG ++ IC + TG + GT +MSPE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-----MSGTGIRSVTGTPYWMSPEV 180
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ K+DV+S G ++++++ K
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKR------LSGRSGQG-LRELK------ 92
F K+G+G F VYK + L +G +A+K+ + ++ Q L+E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 93 --NKLRLLGCCIDKDEKILIYEYMPNKSL---------DFFLFDWVTRVRIIEGIAQGLL 141
N ++ L I+ +E ++ E L L T + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
++H RI+HRD+K +N+ + K+ D G+ R A++ +VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 202 EYAIQGIFSIKSDVFSFGVLL 222
E + ++ KSD++S G LL
Sbjct: 176 ERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKRLS-GRSGQGLRELKNKLRLLGCC---------- 101
+G G VY + L N +++A+KR+ + + EL+ +++ + C
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 102 --IDKDEKILIYEYMPNKSL--------DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
+ DE L+ Y+ SL D +++ + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 152 IHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGR-IVGTYRYMSPEYAIQGI- 208
IHRD+K NILL +D + KI+DFG+ A + G + + VGT +M+PE Q
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 209 FSIKSDVFSFGVLLLKIVSGK 229
+ K+D++SFG+ +++ +G
Sbjct: 184 YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 41/206 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-----SGRSGQGLRELKNKLRLL----------- 98
LG G FG VY G E+AVK++ S + + + L+ +++LL
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 99 -GCCIDKDEKIL--IYEYMPNKSLDFFLFDW------VTRVRIIEGIAQGLLYLHQYSRV 149
GC D +EK L EYMP S+ L + VTR R I QG+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHSN--- 125
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFG----IARICRGNELQANTG--RIVGTYRYMSPEY 203
I+HRD+K +NIL D N K+ DFG I IC + TG + GT +MSPE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC-----MSGTGIKSVTGTPYWMSPEV 180
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ K+DV+S ++++++ K
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 29/198 (14%)
Query: 55 KLGEGGFGPVYKGVLKNGDEI-AVK--RLSG----------RSGQGLRELK--NKLRLLG 99
K+GEG +G VYK K EI A+K RL R L+EL N +RLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 100 CCIDKDEKILIYEYMP---NKSLDFFLFDWVTRVRIIEG----IAQGLLYLHQYSRVRII 152
+++ L++E++ K +D + +I+ + QG+ Y H + R++
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHSH---RVL 121
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSI 211
HRDLK N+L+D++ K++DFG+AR G ++ T +V T Y +PE + +S
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179
Query: 212 KSDVFSFGVLLLKIVSGK 229
D++S G + ++V+ +
Sbjct: 180 PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 56/216 (25%)
Query: 56 LGEGGFGPVYKGVLKNGD---EIAVKRLSGRSGQG--------------LRELKNKLRLL 98
+GEG FG V K +K + A+KR+ + + L N + LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE------------------------ 134
G C + L EY P+ +L D++ + R++E
Sbjct: 63 GACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 135 -GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE--LQANTGR 191
+A+G+ YL S+ + IHRDL NIL+ ++ KI+DFG++ RG E ++ GR
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGR 172
Query: 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ R+M+ E +++ SDV+S+GVLL +IVS
Sbjct: 173 L--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 41/206 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-----SGRSGQGLRELKNKLRLL----------- 98
LG+G FG VY G E+AVK++ S + + + L+ +++LL
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 99 -GCCIDKDEKIL--IYEYMPNKSLDFFLFDW------VTRVRIIEGIAQGLLYLHQYSRV 149
GC D E+ L E+MP S+ L + VTR + I +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHSN--- 125
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR----ICRGNELQANTG--RIVGTYRYMSPEY 203
I+HRD+K +NIL D N K+ DFG ++ IC + TG + GT +MSPE
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC-----LSGTGMKSVTGTPYWMSPEV 180
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ K+D++S G ++++++ K
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 51/209 (24%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK-------------NKLRLLGCC 101
KLG+G +G VYK VKRLS L+E+ N++R+L
Sbjct: 7 KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 102 ------------IDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE---------GIAQGL 140
+D ++ ++ EY P L + + ++I + +GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 141 LYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200
LH+ +I+HRDLK +NILL + KI D GI+++ + N A T +GT YM+
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKT--QIGTPHYMA 169
Query: 201 PEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
PE +S KSD++S G LL ++ +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 55/189 (29%), Positives = 92/189 (48%), Gaps = 41/189 (21%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKR-LSGRSGQG-----LRELK-------- 92
+K+ K+G+G FG V+K K +A+K+ L +G LRE+K
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 93 NKLRLLGCCIDKDEK--------ILIYEY--------MPNKSLDFFLFDWVTRVRIIEGI 136
N + L+ C K L++E+ + NK++ F L ++++ +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL---SEIKKVMKML 128
Query: 137 AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR---ICRGNELQANTGRIV 193
GL Y+H R +I+HRD+K +NIL+ KD K++DFG+AR + + ++ T R+V
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 194 GTYRYMSPE 202
T Y PE
Sbjct: 186 -TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 39/110 (35%), Positives = 63/110 (57%), Gaps = 7/110 (6%)
Query: 123 LFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182
LF+ + + I + Y+H+ I+HRD+K NI L K K+ DFGI++I
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153
Query: 183 NELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKT 231
A T +VGT YMSPE QG+ ++ KSD+++ G +L ++++ K+T
Sbjct: 154 EYSMAET--VVGTPYYMSPEL-CQGVKYNFKSDIWALGCVLYELLTLKRT 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 40/203 (19%)
Query: 55 KLGEGGFGPVYKGV-LKNGDE-IAVKRLSGRSGQG------------LRELK-----NKL 95
++GEG +G V+K LKNG +A+KR+ ++G+ LR L+ N +
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 96 RLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDWV--------TRVRIIEGIAQGLLY 142
RL C D++ K+ L++E++ ++ L +L D V T ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
LH + R++HRDLK NIL+ K++DFG+ARI Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 179
Query: 203 YAIQGIFSIKSDVFSFGVLLLKI 225
+Q ++ D++S G + ++
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 32/215 (14%)
Query: 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------- 87
L + S+ K++ K+G+G G V+ + + G E+A+K+++ +
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 88 --LRELKNK--LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-IA----- 137
++ELKN + L + DE ++ EY+ SL D VT + E IA
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 138 --QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVG 194
Q L +LH ++IHRD+K N+LL D + K++DFG A+I Q+ +VG
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T +M+PE + + K D++S G++ +++V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 41/209 (19%)
Query: 55 KLGEGGFGPVYKGVLKN---GD---EIAVKRLSGRSGQGLRE---------------LKN 93
+LG+G FG VY+G ++ G+ +AVK ++ LRE +
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHH 70
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------------VRIIEGIAQ 138
+RLLG +++ E M + L +L +++ IA
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRY 198
G+ YL+ + +HRDL N ++ D KI DFG+ R + G+ + R+
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 199 MSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
M+PE G+F+ SD++SFGV+L +I S
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 23/193 (11%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKR--------LSGRSGQGLRELK-----NKLRLLGC 100
++G G FG V+ G L+ + +AVK L + Q R LK N +RL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 101 CIDKDEKILIYEYMPNKSLDFFLFDWVTR------VRIIEGIAQGLLYLHQYSRVRIIHR 154
C K ++ E + FL R ++++E A G+ YL IHR
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
DL N L+ + KISDFG++R + G ++ +PE G +S +SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 215 VFSFGVLLLKIVS 227
V+SFG+LL + S
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-13
Identities = 46/127 (36%), Positives = 70/127 (55%), Gaps = 8/127 (6%)
Query: 109 LIYEYMPNKSLDFFLFD----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD 164
++ EY P +L ++ + I+ Q LL LH I+HRDLK NILLD
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
Query: 165 K-DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLL 223
K M KI DFGI++I ++ +A T +VGT Y+SPE ++ KSD+++ G +L
Sbjct: 136 KHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYISPELCEGKPYNQKSDIWALGCVLY 192
Query: 224 KIVSGKK 230
++ S K+
Sbjct: 193 ELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 31/198 (15%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRL------------SGRSGQGLRELKNK---LRLLG 99
LG+G FG V LK DE+ AVK L + + + L K L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 100 CCID-KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEG-IAQGLLYLHQYSRVRII 152
C KD + EY+ L F + FD R R I GL +LH+ II
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD-EPRARFYAAEIVLGLQFLHERG---II 118
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-IVGTYRYMSPEYAIQGIFSI 211
+RDLK+ N+LLD + + KI+DFG +C+ L T GT Y++PE +
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFG---MCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 212 KSDVFSFGVLLLKIVSGK 229
D ++ GVLL ++++G+
Sbjct: 176 AVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 37/194 (19%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCCID--------- 103
++G G +G VYK + G+ +A+K + G ++ ++ +L C
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 104 --KDEKILI-YEYMPNKSLDFFLFDWVTRVRIIEG-IA-------QGLLYLHQYSRVRII 152
+ +K+ I EY SL VTR + E IA +GL YLH+ + I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLHETGK---I 123
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYA---IQ 206
HRD+K +NILL +D + K++DFG++ +L A + +GT +M+PE A +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 207 GIFSIKSDVFSFGV 220
G + K D+++ G+
Sbjct: 179 GGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 55 KLGEGGFGPVYKGV--LKNGDEI--AVKRLSGRSGQGLREL-------------KNKLRL 97
+GEG FG VY+GV ++I AVK + +RE + ++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQ---GLLYLHQYSRVRI 151
+G + + ++ E P L +L + +I Q L YL R
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRF 128
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNEL-QANTGRIVGTYRYMSPEYAIQGIFS 210
+HRD+ N+L+ K+ DFG++R +A+ G++ ++M+PE F+
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRRFT 186
Query: 211 IKSDVFSFGVLLLKIVS-GKK 230
SDV+ FGV + +I+ G K
Sbjct: 187 SASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 29/196 (14%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLRELKN----KLRLLGCCID------- 103
LG GGFG V +K+ + A+K + R + ++ K L C
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 104 --KDEKIL--IYEYMPNKSL-----DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
KD+K + + EY L D LFD T I + YLH II+R
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYR 117
Query: 155 DLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
DLK N+LLD + K+ DFG A+ + G + T GT Y++PE + +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 214 DVFSFGVLLLKIVSGK 229
D +S G+LL ++++G+
Sbjct: 174 DYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 30/148 (20%)
Query: 55 KLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQ-----GLRELK---------NKLRLLG 99
+LG+G FG VY K E+ A+K++ + LRE+K N ++L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 100 CCIDKDEKILIYEYMPN------KSLDFFLFDWVTRVR-IIEGIAQGLLYLHQ--YSRVR 150
+ DE ++EYM K F + +R II I QGL ++H+ +
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHGF---- 120
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIAR 178
HRDLK N+L+ KI+DFG+AR
Sbjct: 121 -FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 61/214 (28%)
Query: 56 LGEGGFGPVYKG-VLKNGDEIAVKRLSGRSGQGLRELKNKLR------------------ 96
+G G G VYK K G +AVK++ R+G E K L
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNK-EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 97 --------------LLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLY 142
L+ C+DK I +P L ++ I + L Y
Sbjct: 81 GYFITDSDVFICMELMSTCLDK-LLKRIQGPIPEDILG----------KMTVAIVKALHY 129
Query: 143 L---HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
L H +IHRD+K SNILLD N K+ DFGI+ R + +A T R G YM
Sbjct: 130 LKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISG--RLVDSKAKT-RSAGCAAYM 181
Query: 200 SPEY----AIQGIFSIKSDVFSFGVLLLKIVSGK 229
+PE + I++DV+S G+ L+++ +G+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 42/125 (33%), Positives = 71/125 (56%), Gaps = 15/125 (12%)
Query: 112 EYMPNKSLDFFLFDWVTRV------RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK 165
E+M SLD L R+ +I + +GL YL + + +I+HRD+K SNIL++
Sbjct: 79 EHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNS 135
Query: 166 DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLK 224
K+ DFG++ G + + VGT YMSPE +QG ++++SD++S G+ L++
Sbjct: 136 RGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVE 190
Query: 225 IVSGK 229
+ G+
Sbjct: 191 MAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 52/218 (23%)
Query: 56 LGEGGFGPVYK----GVLKNGDE----IAVKRLSGR-SGQGLREL-------------KN 93
LGEG FG V + G+ K+ + +AVK L + + L +L KN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDWVTR-----------VR 131
+ LLG C + +I EY +L FL FD +T+ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD-ITKVPEEQLSFKDLVS 138
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT-- 189
+A+G+ YL SR R IHRDL N+L+ +D KI+DFG+AR + T
Sbjct: 139 CAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
GR+ ++M+PE +++ +SDV+SFG+L+ +I +
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 37/200 (18%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG------LRE---LK------- 92
+ + ++GEG +G VYK L G +A+K++ + LRE LK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 93 -NKLRLLGCC--IDKDEKI---LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQG 139
N +RLL C D ++ L++E++ ++ L +L T ++ + +G
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
+ +LH + RI+HRDLK NIL+ D KI+DFG+ARI E+ + +V T Y
Sbjct: 120 VDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEMALTS--VVVTLWYR 173
Query: 200 SPEYAIQGIFSIKSDVFSFG 219
+PE +Q ++ D++S G
Sbjct: 174 APEVLLQSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 43/213 (20%)
Query: 55 KLGEGGFGPVYKGVL-----KNGDEIAVKRLSG-----------RSGQGLRELK--NKLR 96
+LGE FG +YKG L + +A+K L + + EL N +
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLF--------------DWVTRVRIIEG------- 135
LLG + +++EY+ L FL D + + G
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 136 -IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194
IA G+ YL + +H+DL NIL+ + ++ KISD G++R + + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
R+M PE + G FS SD++SFGV+L +I S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 56 LGEGGFGPVYKGVLKNGDEI----AVKRLS-----GRSGQGLRE---LK-----NKLRLL 98
+G+G FG VY G L + D AVK L+ Q L+E +K N L LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 99 GCCIDKD-EKILIYEYMPNKSLDFFLFDWVTR---VRIIEG----IAQGLLYLHQYSRVR 150
G C+ + +++ YM + L F+ T V+ + G +A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK---K 118
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL----QANTGRIVGTYRYMSPEYAIQ 206
+HRDL N +LD+ K++DFG+AR E ++ ++M+ E
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALESLQT 176
Query: 207 GIFSIKSDVFSFGVLL 222
F+ KSDV+SFGVLL
Sbjct: 177 QKFTTKSDVWSFGVLL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 52/176 (29%), Positives = 72/176 (40%), Gaps = 26/176 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-------------AVKRLSGRSGQGLRELK-- 92
NK+ +GEG +G V K K EI VK+ + R + LR+L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFF------LFDWVTRVRIIEGIAQGLLYLHQY 146
N + L K L++EY+ L+ L R I + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR-SYIWQLLQAIAYCH-- 117
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
IIHRD+K NIL+ + K+ DFG AR R T V T Y +PE
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 52/224 (23%)
Query: 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLRLL------- 98
T F +GEG +G VYK K ++ ++ E+K + +L
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 99 ------GCCIDKDEKI------LIYEYMPNKSLDFFLFDWVTRVR-------------II 133
G I K+ L+ E S+ D V +R I+
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGLRKKGKRLKEEWIAYIL 119
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-- 191
+GL YLH+ ++IHRD+K NILL K+ K+ DFG++ +L + GR
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-----QLDSTLGRRN 171
Query: 192 -IVGTYRYMSPE-----YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+GT +M+PE + +SDV+S G+ +++ GK
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 38/209 (18%)
Query: 49 KFSDANKLGEGGFGPVYKGVLKN-GDEIAVK--RLSG----------RSGQGLRELK--N 93
++ K+GEG +G VYKG K G +A+K RL R L+EL+ N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 94 KLRLLGCCIDKDEKILIYEYM------------PNKSLDFFLFDWVTRVRIIEGIAQGLL 141
+ L + + LI+E++ + +D L I QG+L
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY-----QILQGIL 115
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
+ H R++HRDLK N+L+D K++DFG+AR G ++ T +V T Y +P
Sbjct: 116 FCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV-TLWYRAP 170
Query: 202 EYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
E + +S D++S G + ++ + K
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 44/207 (21%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLRELKNKLRLLGCCI---DKDEKILIY 111
LG G +G V K I AVKR+ R+ +E K L L + D + Y
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 112 -------------EYMPNKSLDFF---LFDWVTRV------RIIEGIAQGLLYLHQYSRV 149
E M + SLD F ++D + +I I + L YLH S++
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKL 123
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ--ANTGRIVGTYRYMSPE----- 202
+IHRD+K SN+L++++ K+ DFGI+ G + A T G YM+PE
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDA-GCKPYMAPERINPE 178
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+G + +KSDV+S G+ ++++ +G+
Sbjct: 179 LNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 34/203 (16%)
Query: 55 KLGEGGFGPVYKGVL---KNGDEIAVKRLSG------------RSGQGLRELKNK--LRL 97
+LG G FG V KG+ K+ +AVK L R +++L N +R+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLFD--WVTRVRIIEGIAQ---GLLYLHQYSRVRII 152
+G C + + +L+ E L+ FL VT I E + Q G+ YL + + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FV 117
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNE--LQANTGRIVGTY--RYMSPEYAIQGI 208
HRDL N+LL KISDFG+++ +E +A T G + ++ +PE
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH---GKWPVKWYAPECMNYYK 174
Query: 209 FSIKSDVFSFGVLLLKIVS-GKK 230
FS KSDV+SFGVL+ + S G+K
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 29/197 (14%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAV------KRLSGRSGQGLRELKNKL----------RLLG 99
LG+GGFG V +KN ++ KRL +SG+ + L+ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTR----VRIIEGIAQ---GLLYLHQYSRVRII 152
K L+ M L + +++ R R+I AQ G+L+LH + I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIK 212
+RD+K N+LLD N ++SD G+A + + + GT YM+PE + +S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYP 174
Query: 213 SDVFSFGVLLLKIVSGK 229
D F+ G + ++V+G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 78/271 (28%), Positives = 117/271 (43%), Gaps = 54/271 (19%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEI-AVKRL---SGRSG---QGLRELKNKLRLLGCCI---- 102
N++ EG +G VY+ K EI A+K+L + G LRE+ L+L I
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 103 -----DKDEKI-LIYEYMPN--KSL------DFFLFDWVTRVR-IIEGIAQGLLYLHQYS 147
+KI ++ EY+ + KSL F + + ++ G+A +LH
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA----HLHDNW 126
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-Q 206
I+HRDLK SN+LL+ KI DFG+AR G+ L+ T ++V T Y +PE +
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVTLWYRAPELLLGA 181
Query: 207 GIFSIKSDVFS----FGVLLLK--IVSGKKTTG-FYRTYSFTLLGYISENIY-EFPSVDT 258
+S D++S F LL K + GK + F LLG +E I+ F +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI--FKLLGTPTEKIWPGFSELP- 238
Query: 259 HNVKTFGFLHLTI------FKLFSISSVGLS 283
K F F S+S G
Sbjct: 239 -GAKKKTFTKYPYNQLRKKFPALSLSDNGFD 268
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 40/204 (19%)
Query: 56 LGEGGFGPV----YKGVLKN-GDEIAVKRLSGRSGQG-----------LREL--KNKLRL 97
LGEG FG V Y N G+++AVK L SG LR L +N ++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 98 LGCCI-DKDEKI-LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYL--HQYS 147
G C D I LI E++P+ SL +L + +++ I +G+ YL QY
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY- 130
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE----LQANTGRIVGTYRYMSPEY 203
+HRDL N+L++ + KI DFG+ + ++ ++ + V Y +PE
Sbjct: 131 ----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---APEC 183
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVS 227
IQ F I SDV+SFGV L ++++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 34/198 (17%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL-------------KNKLRLLGC 100
K+GEG G V K +G ++AVK + R Q REL +N + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 101 CIDKDEKILIYEYMPNKSLDFFLFDWVTRVR--------IIEGIAQGLLYLHQYSRVRII 152
+ +E ++ E++ +L D V++ R + E + Q L YLH +I
Sbjct: 87 YLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 153 HRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
HRD+K +ILL D K+SDFG A+I + + + +VGT +M+PE + +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVISRTPYGT 196
Query: 212 KSDVFSFGVLLLKIVSGK 229
+ D++S G++++++V G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRE-------LKNKL------RLLGCC 101
+LG G FG V+ G + ++A+K + G E + KL +L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 102 IDKDEKILIYEYMPNKSLDFFLFDWVTRVR------IIEGIAQGLLYLHQYSRVRIIHRD 155
+ ++ E+M N L +L ++ + + + +G+ YL + S IHRD
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
L N L+ K+SDFG+ R +E +++G ++ PE +S KSDV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSDV 184
Query: 216 FSFGVLLLKIVSGKK 230
+SFGVL+ ++ + K
Sbjct: 185 WSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 46/132 (34%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158
K+ + EY+ L F + FD I GL +LH I++RDLK+
Sbjct: 68 KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKL 124
Query: 159 SNILLDKDMNPKISDFGIARICRGNEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
NILLD D + KI+DFG +C+ N L A T GT Y++PE + ++ D +S
Sbjct: 125 DNILLDTDGHIKIADFG---MCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWS 181
Query: 218 FGVLLLKIVSGK 229
FGVLL +++ G+
Sbjct: 182 FGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-IVG 194
IA GL +LH II+RDLK+ N++LD + + KI+DFG +C+ N T R G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCG 163
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T Y++PE + D ++FGVLL ++++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 35/194 (18%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAVKRLSG-RSGQG----------LRELKNKLRLLGCCI-D 103
+G+G FG V G + G+++AVK + + Q LR N ++LLG + +
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEE 71
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG----------IAQGLLYLHQYSRVRIIH 153
K ++ EYM SL +L +R R + G + + + YL + +H
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
RDL N+L+ +D K+SDFG+ + + +TG++ ++ +PE + FS KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKS 180
Query: 214 DVFSFGVLLLKIVS 227
DV+SFG+LL +I S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 27/202 (13%)
Query: 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----------LRELK--NKL 95
F KLGEG + VYKG + G+ +A+K + + +G ++ELK N +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 96 RLLGCCIDKDEKILIYEYMPN---KSLDFF----LFDWVTRVRIIEGIAQGLLYLHQYSR 148
RL +++ +L++EYM K +D D T + +G+ + H+
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG- 207
R++HRDLK N+L++K K++DFG+AR G + + +V T Y +P+ +
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 208 IFSIKSDVFSFGVLLLKIVSGK 229
+S D++S G ++ ++++G+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A+G+ +L SR + IHRDL NILL ++ KI DFG+AR + G
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++ +SDV+SFGVLL +I S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I GL +LH+ II+RDLK+ N+LLDKD + KI+DFG+ + E +A+T GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE ++ D +SFGVLL +++ G+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 29/195 (14%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNKLRLLGCC----IDK----- 104
+LG+G FG VYK K G A K + +S + L + ++ +L C I K
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 105 --DEKILIY-EYMPNKSLDFFLFDW-----VTRVRII-EGIAQGLLYLHQYSRVRIIHRD 155
D K+ I E+ P ++D + + ++++I + + L YLH ++IIHRD
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRD 135
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-----QGIFS 210
LK N+LL D + K++DFG++ + + +GT +M+PE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 211 IKSDVFSFGVLLLKI 225
K+D++S G+ L+++
Sbjct: 194 YKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 31/195 (15%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLREL------------KNKLRLLGCCI 102
LG+G FG VYK K A K + S + L + N + L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIA-------QGLLYLHQYSRVRIIHRD 155
+++ ++ E+ +LD + + R I + L +LH + ++IHRD
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS----- 210
LK NILL D + K++DFG++ + + +T +GT +M+PE F
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 211 IKSDVFSFGVLLLKI 225
K+D++S G+ L+++
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 38/206 (18%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIA---VKRLSGRS-----------GQGLRELK--NKLRL 97
+++G G FG V G G A VK L + Q REL N L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYS 147
LG CI+ +L+ E+ P L +L R+ +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAI- 205
IH DL + N L D++ KI D+G+A + + E T R+++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 206 --QGIFSIK----SDVFSFGVLLLKI 225
Q + S+++S GV + ++
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 30/199 (15%)
Query: 56 LGEGGFGPVYK----GVLKNGD--EIAVKRL--SGRSGQG---LRELK---------NKL 95
LG G FG V + G+ K+ ++AVK L + S + + ELK N +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSR 148
LLG C ++I EY L FL + +A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN- 161
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
IHRDL N+LL KI DFG+AR + G ++M+PE +
Sbjct: 162 --CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 209 FSIKSDVFSFGVLLLKIVS 227
++ +SDV+S+G+LL +I S
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 57/243 (23%)
Query: 31 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKNGDEIAVKRLSG 82
E+ + P + FS +K + LGEG FG V K K +AVK L
Sbjct: 3 ELPEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57
Query: 83 RSGQ-GLREL-------------KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 123
+ + L +L KN + LLG C +I EY +L +L
Sbjct: 58 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117
Query: 124 ------FDWVTRV-----------RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166
+D + RV +A+G+ YL + + IHRDL N+L+ ++
Sbjct: 118 PGMEYSYD-IARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTEN 173
Query: 167 MNPKISDFGIARICRGNELQANT--GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLK 224
KI+DFG+AR + T GR+ ++M+PE +++ +SDV+SFGVL+ +
Sbjct: 174 NVMKIADFGLARDVNNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231
Query: 225 IVS 227
I +
Sbjct: 232 IFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 50 FSDANKLGEGGFGPV------YKGVLKNGDEIAVKRLSGRSGQGL----RELKNKLR--- 96
F LG+GGFG V G + ++ KR+ R G+ + +++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 97 ---LLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQY 146
L KD L+ M L F + F+ V I GL LHQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
RI++RDLK NILLD + +ISD G+A E Q GR VGT YM+PE
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKN 175
Query: 207 GIFSIKSDVFSFGVLLLKIVSGK 229
++ D ++ G LL ++++G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 37/195 (18%)
Query: 59 GGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNKL----------------RLLGCC 101
G FG VY + GD A+K L ++ N +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 102 IDKDEKILIYEYMPN-------KSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
KD L+ EY+ K+L DW + I E + G+ LHQ IIHR
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA-KQYIAE-VVLGVEDLHQRG---IIHR 121
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIK-S 213
D+K N+L+D+ + K++DFG++R N+ + VGT Y++PE I G+ K S
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDKMS 174
Query: 214 DVFSFGVLLLKIVSG 228
D +S G ++ + + G
Sbjct: 175 DWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 36/209 (17%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDE-IAVKRL------SGRSGQGLREL--------K 92
+++ K+GEG +G VYK + +E IA+K++ G +RE+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 93 NKLRLLGCCIDKDEKI-LIYEYMPNKSLDFFLF-----DWVTRVRIIEG----IAQGLLY 142
N +RL + ++++ L++EY+ LD D+ R+I+ I +G+ Y
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGRIVGTYRYMSP 201
H + R++HRDLK N+L+D+ N K++DFG+AR G ++ T +V T Y +P
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV-TLWYRAP 172
Query: 202 EYAIQG-IFSIKSDVFSFGVLLLKIVSGK 229
E + +S D++S G + ++V+ K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 35/205 (17%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLRELKNKL----------- 95
F ++G+GG+G V+ K+ EI A+KR+ L E+++ L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 96 ----RLLGCCIDKDEKILIYEYMPNKSLDF--------FLFDWVTRVRIIEGIAQGLLYL 143
+LL D + L EY+P DF L + R + E + L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDAL 117
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H+ IHRDLK N L+D + K++DFG++ +G AN+ +VG+ YM+PE
Sbjct: 118 HELG---YIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANS--VVGSPDYMAPEV 169
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSG 228
+ D +S G +L + + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA L YLH+ I+HRDLK N+ L + K+ D GIAR+ A+T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
YMSPE ++ KSDV++ G + ++ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 60/222 (27%)
Query: 56 LGEGGFGPVYKGVLKNGDE--------IAVKRL-SGRSGQGLREL-------------KN 93
LGEG FG V D+ +AVK L S + + L +L KN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------------------ 135
+ LLG C +I EY +L +L R R G
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 136 --------IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187
+A+G+ YL + + IHRDL N+L+ +D KI+DFG+AR +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 188 NT--GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
T GR+ ++M+PE I++ +SDV+SFGVLL +I +
Sbjct: 198 KTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 46/209 (22%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLRLL-------------GCCI 102
+G G +G VYKG ++A ++ +G E+K ++ +L G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 103 DK------DEKILIYEY---------MPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYS 147
K D+ L+ E+ + N + +W+ I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYA 204
++IHRD+K N+LL ++ K+ DFG++ +L GR +GT +M+PE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 205 I-----QGIFSIKSDVFSFGVLLLKIVSG 228
+ KSD++S G+ +++ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 34/198 (17%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLREL-------------KNKLRLLGC 100
K+GEG G V +K+ G +AVK++ R Q REL +N + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 101 CIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE--------GIAQGLLYLHQYSRVRII 152
+ DE ++ E++ +L D VT R+ E + + L LH +I
Sbjct: 86 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 153 HRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
HRD+K +ILL D K+SDFG A++ + E+ +VGT +M+PE + +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKS-LVGTPYWMAPELISRLPYGP 195
Query: 212 KSDVFSFGVLLLKIVSGK 229
+ D++S G++++++V G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 18/192 (9%)
Query: 52 DANKLGEGGFGPVYKG-VLKNGDEIAVKRL--------SGRSGQGLRELKNKLRLLGCCI 102
+ N + G G YKG +KNG + VK + S + G + N ++L+G C
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR 753
Query: 103 DKDEKILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160
+ LI+EY+ K+L L W R +I GIA+ L +LH ++ +L
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGV 220
I++D P + +C + ++ Y++PE + KSD++ FG+
Sbjct: 814 IIIDGKDEPHLRLSLPGLLCTDTKCFISSA-------YVAPETRETKDITEKSDIYGFGL 866
Query: 221 LLLKIVSGKKTT 232
+L+++++GK
Sbjct: 867 ILIELLTGKSPA 878
|
Length = 968 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I GL +LHQ RII+RDLK N+LLD D N +ISD G+A + Q+ T GT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGT 160
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+M+PE + D F+ GV L ++++ +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 39/208 (18%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL------SGRSGQGLREL--------KNK 94
F K+GEG +G VYK G+ +A+K++ G +RE+ N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIA------------QGLLY 142
++LL +++ L++E++ ++ L F+ + GI QGL +
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-----DASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
H + R++HRDLK N+L++ + K++DFG+AR G ++ T +V T Y +PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 170
Query: 203 YAI-QGIFSIKSDVFSFGVLLLKIVSGK 229
+ +S D++S G + ++V+ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 35/210 (16%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRL------------SGRSGQGLRE 90
+KF ++GEG +G VYK K+ G+ +A+K++ + R + LR+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 91 L--KNKLRLLGCCIDKDEKI----------LIYEYMPNKSLDFFLFDWVT----RVR-II 133
L +N + L DK + + L++EYM + + V ++ +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193
+ + +GL Y H+ + +HRD+K SNILL+ K++DFG+AR+ E + T +++
Sbjct: 123 KQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 194 GTYRYMSPEYAI-QGIFSIKSDVFSFGVLL 222
T Y PE + + + DV+S G +L
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 34/198 (17%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLREL-------------KNKLRLLGC 100
K+GEG G V K+ G ++AVK++ R Q REL +N + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ-RRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 101 CIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE--------GIAQGLLYLHQYSRVRII 152
+ DE ++ E++ +L D VT R+ E + + L YLH +I
Sbjct: 88 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 153 HRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
HRD+K +ILL D K+SDFG A++ + E+ +VGT +M+PE + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKS-LVGTPYWMAPEVISRLPYGT 197
Query: 212 KSDVFSFGVLLLKIVSGK 229
+ D++S G+++++++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 28/192 (14%)
Query: 56 LGEGGFGPVYKG-VLKNGDEIAVKRLSGRSGQGL-RELKNKLRLLGCCIDKDEKILIY-- 111
LG G G VYK L +AVK + L +++ ++L +L C D I Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGA 67
Query: 112 -----------EYMPNKSLDFF--LFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158
E+M SLD + + + V RI + +GL YL ++I+HRD+K
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-RIAVAVVKGLTYLWS---LKILHRDVKP 123
Query: 159 SNILLDKDMNPKISDFGIARICRGNELQANTGRI-VGTYRYMSPEYAIQGIFSIKSDVFS 217
SN+L++ K+ DFG++ +L + + VGT YM+PE + I SDV+S
Sbjct: 124 SNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178
Query: 218 FGVLLLKIVSGK 229
G+ +++ G+
Sbjct: 179 LGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 7e-11
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 49/204 (24%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSG----RSGQGLRELKNKLRLLG----------C 100
LG G FG V K + A+K LS + Q + + N+ R+L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 101 CIDKDEKIL--IYEYMPNKSLDFFLFDWVTRV-RIIEGIAQ--------GLLYLHQYSRV 149
+D+ L + EY+P L F + + R E +A+ L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD-- 121
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
I++RDLK N+LLD D KI+DFG A+ +G T + GT Y++PE I
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPE-----II 170
Query: 210 SIK-----SDVFSFGVLLLKIVSG 228
K D ++ G+L+ ++++G
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A+G+ +L SR + IHRDL NILL ++ KI DFG+AR + G
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++I+SDV+SFGVLL +I S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 23/150 (15%)
Query: 49 KFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLS------GRSGQGLREL--------KN 93
K+ K+GEG +G V+K + EI A+KR+ G LRE+ KN
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFF-----LFDWVTRVRIIEGIAQGLLYLHQYSR 148
+RL + L++EY +F D + + +GL + H +
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
++HRDLK N+L++K+ K++DFG+AR
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 42/125 (33%), Positives = 72/125 (57%), Gaps = 15/125 (12%)
Query: 112 EYMPNKSLDFFLFDWVTRV------RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK 165
E+M SLD L + R+ ++ + +GL YL + + +I+HRD+K SNIL++
Sbjct: 83 EHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 166 DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLK 224
K+ DFG++ G + + VGT YMSPE +QG +S++SD++S G+ L++
Sbjct: 140 RGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194
Query: 225 IVSGK 229
+ G+
Sbjct: 195 LAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 35/96 (36%), Positives = 60/96 (62%), Gaps = 8/96 (8%)
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194
+ +GL YL + + +I+HRD+K SNIL++ K+ DFG++ G + + VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 195 TYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
T YMSPE +QG +S++SD++S G+ L+++ G+
Sbjct: 165 TRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 59/188 (31%), Positives = 79/188 (42%), Gaps = 53/188 (28%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDEI-AVKRL------SGRSGQGLREL--------KNK 94
F N++GEG +G VY+ EI A+K++ G LRE+ N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 95 LRLLGCCIDK--DEKILIYEY-----------MPN-------KSLDFFLFDWVTRVRIIE 134
+ L + K D L+ EY MP K L L
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL---------- 118
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194
+GL YLH+ IIHRDLKVSN+LL KI+DFG+AR G + T ++V
Sbjct: 119 ---RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV- 170
Query: 195 TYRYMSPE 202
T Y +PE
Sbjct: 171 TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 42/219 (19%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGD----EIAVKRL------SGRSGQGLRELK------- 92
F+ LG+G FG V + LK+ D ++AVK L S + LRE
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 93 -NKLRLLGCCIDKDEK------ILIYEYMPNKSLDFFLF-----------DWVTRVRIIE 134
N ++L+G + K ++I +M + L FL T VR +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNEL-QANTGRI 192
IA G+ YL S IHRDL N +L+++M ++DFG+++ I G+ Q ++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231
++++ E +++ SDV++FGV + +I++ +T
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----------WVTRV 130
KN + LLG C ++ EY +L +L FD + V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 131 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT- 189
+A+G+ YL + + IHRDL N+L+ +D KI+DFG+AR + T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 190 -GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
GR+ ++M+PE +++ +SDV+SFGVLL +I +
Sbjct: 195 NGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A+G+ +L SR + IHRDL NILL ++ KI DFG+AR + G
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++ +SDV+SFGVLL +I S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 45/213 (21%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDE-IAVKRLSGRSGQGL-------RELKNKLRLLG 99
+++ + + +G G +G V +A+K+LS R Q REL RLL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYREL----RLLK 69
Query: 100 CCIDKDEKI-LIYEYMPNKSL-DFFLFDWVT-------------------RVR-IIEGIA 137
+D + I L+ + P SL DF VT ++ ++ I
Sbjct: 70 H-MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 138 QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYR 197
+GL Y+H IIHRDLK SNI +++D KI DFG+AR +E+ TG V T
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-DEM---TG-YVATRW 180
Query: 198 YMSPEYAIQGIFSIKS-DVFSFGVLLLKIVSGK 229
Y +PE + + ++ D++S G ++ ++++GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQ------GLRELKNKLRLLGC 100
NKF +GEG +G V K K EI A+K+ LRELK LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK-MLRTL-- 57
Query: 101 CIDKDEKILIYEYMPNKSLDFFLFDWVTR--VRIIEGIAQGLL------YLHQYSRV--- 149
++ + + E + + +F++V + + ++E + G+ Y++Q +
Sbjct: 58 --KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 150 ----RIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYA 204
I+HRD+K N+L+ + K+ DFG AR + G+ AN V T Y SPE
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELL 173
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGK 229
+ + D++S G +L ++ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 48/220 (21%)
Query: 40 FSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL------SGRSGQGLRELK 92
F +V TN++ D +G G FG V G +A+K++ + + RELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 93 --NKLR---LLGCC---IDKDEKI-LIYEYM-------------PNKSLDFFLFDWVTRV 130
LR ++ I E I + E + + + +FL+
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ----- 116
Query: 131 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190
I +GL Y+H ++HRDLK SNIL++++ + KI DFG+ARI + Q TG
Sbjct: 117 -----ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI---QDPQM-TG 164
Query: 191 RIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGK 229
V T Y +PE + + ++ D++S G + +++ GK
Sbjct: 165 -YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRS------------GQGLRELKNK---LRLLG 99
LG+G FG V LK DE+ A+K L + + L K L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 100 CCID-KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEG-IAQGLLYLHQYSRVRII 152
CC KD + EY+ L F + FD R R + L++LH++ +I
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG---VI 118
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN-TGRIVGTYRYMSPEYAIQGIFSI 211
+RDLK+ NILLD + + K++DFG +C+ L T GT Y++PE + +
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 212 KSDVFSFGVLLLKIVSGK 229
D ++ GVL+ ++++G+
Sbjct: 176 SVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 34/95 (35%), Positives = 58/95 (61%), Gaps = 7/95 (7%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-IVG 194
I+ GL +LH R II+RDLK+ N++LD + + KI+DFG +C+ + + T R G
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTTRTFCG 163
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T Y++PE + D +++GVLL ++++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 60/197 (30%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 56 LGEGGFGPV------YKGVLKNGDEIAVKRLSGRSGQGL----RELKNKLR------LLG 99
LG+GGFG V G + ++ KR+ R G+ + +++ K+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
KD L+ M L F + FD V I GL LH R RI+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIV 124
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIK 212
+RDLK NILLD + +ISD G+A E GR VGT YM+PE ++
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGR-VGTVGYMAPEVVKNERYTFS 181
Query: 213 SDVFSFGVLLLKIVSGK 229
D + G L+ +++ GK
Sbjct: 182 PDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 34/93 (36%), Positives = 59/93 (63%), Gaps = 5/93 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A L +LH + II+RDLK NILLD++ + K++DFG+++ +E +A + GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 161
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
YM+PE + + +D +SFGVL+ ++++G
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 45/135 (33%), Positives = 74/135 (54%), Gaps = 18/135 (13%)
Query: 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158
K+ + E++ L F + FD I GL +LH II+RDLK+
Sbjct: 68 KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKL 124
Query: 159 SNILLDKDMNPKISDFGIARICRGN---ELQANTGRIVGTYRYMSPEYAIQGI-FSIKSD 214
N++LD+D + KI+DFG +C+ N + +A+T GT Y++PE +QG+ ++ D
Sbjct: 125 DNVMLDRDGHIKIADFG---MCKENVFGDNRAST--FCGTPDYIAPE-ILQGLKYTFSVD 178
Query: 215 VFSFGVLLLKIVSGK 229
+SFGVLL +++ G+
Sbjct: 179 WWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 129 RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
VR+ IA+ +L L ++ II+RD+K+ NILLD + + ++DFG+++ E +
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 189 TGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSG 228
GT YM+PE G D +S GVL ++++G
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 56 LGEGGFGPV----YKG--------VLKNGDEIAVKRL-SGRSGQGLRELKNKLR------ 96
LG G FG V YK LK GD IA + S + + E N R
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFDWV-TRVRIIEGIAQ---GLLYLHQYSRVRII 152
L C +D + EY L + V + R + A GL YLH+ +I+
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIV 123
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICR-GNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
+RDLK+ N+LLD + KI+DFG +C+ G T GT +++PE + ++
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 212 KSDVFSFGVLLLKIVSG 228
D + GVL+ +++ G
Sbjct: 181 AVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 2/94 (2%)
Query: 138 QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-IVGTY 196
Q LL +H +IHRD+K +NILL + K+ DFG +++ + + GR GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDDVGRTFCGTP 209
Query: 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKK 230
Y++PE + +S K+D+FS GVLL ++++ K+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 63/222 (28%)
Query: 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLRELKNKLRLLGCCID 103
+ + + +GEG +G V K G ++A+K++S Q LRE+K R
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF------ 60
Query: 104 KDEKI-------------------LIYEYMP-------------NKSLDFFLFDWVTRVR 131
K E I ++ E M N + +FL+
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------ 114
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
I +GL Y+H ++HRDLK SN+LL+ + + KI DFG+ARI +TG
Sbjct: 115 ----ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH--DHTGF 165
Query: 192 I---VGTYRYMSPEYAIQGIFSIKS-DVFSFGVLLLKIVSGK 229
+ V T Y +PE + K+ D++S G +L +++S +
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 35/95 (36%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-IVG 194
IA GL +LH II+RDLK+ N++LD + + KI+DFG +C+ N T + G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFCG 163
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T Y++PE + D ++FGVLL ++++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 25/201 (12%)
Query: 50 FSDANKLGEGGFGPV------YKGVLKNGDEIAVKRLSGRSGQGL----RELKNKLR--- 96
F LG+GGFG V G + + KR+ R G+ + +++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 97 ---LLGCCIDKDEKILIYEYMPNKSLDFFLFDW----VTRVRIIEGIAQGLLYLHQYSRV 149
L KD L+ M L F +++ R + A+ L L R
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
++RDLK NILLD + +ISD G+A +I G ++ GR VGT YM+PE
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GR-VGTVGYMAPEVLNNQR 177
Query: 209 FSIKSDVFSFGVLLLKIVSGK 229
+++ D + G L+ +++ G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 33/198 (16%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRL---------------SGRSGQGLRELKNKLRLLG 99
LG+G FG V LK + AVK L + + L L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 100 CCIDKDEKIL-IYEYMPNKSLDFFL-----FDWVTRVRIIEG-IAQGLLYLHQYSRVRII 152
CC +++ + E++ L F + FD R R I L++LH II
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYAAEITSALMFLHDKG---II 118
Query: 153 HRDLKVSNILLDKDMNPKISDFGIAR--ICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+RDLK+ N+LLD + + K++DFG+ + I G T GT Y++PE + ++
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEMLYG 174
Query: 211 IKSDVFSFGVLLLKIVSG 228
D ++ GVLL +++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----------LRELKN 93
A + + KLGEG + VYKG+ + NG +A+K +S ++ +G L+ LK+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 94 -KLRLLGCCIDKDEKI-LIYEYMPNKSLDFF------LFDWVTRVRIIEGIAQGLLYLHQ 145
+ LL I E + ++EYM + L + R+ + + + +GL Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIH- 120
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
I+HRDLK N+L+ K++DFG+AR + Q + +V T Y P+ +
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDVLL 176
Query: 206 QGI-FSIKSDVFSFGVLLLKIVSGK 229
+S D++ G + ++++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 19/114 (16%)
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE----- 184
+ I I + Y+H S+ ++HRDLK NILL I D+G A + E
Sbjct: 116 LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 185 LQANT-----------GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ + G+IVGT YM+PE + S +D+++ GV+L ++++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 55 KLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLRELKNKLRLLGCC------------ 101
+LG+G FG VYK K + A K + +S + L + ++ +L C
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 102 -IDKDEKILIYEYMPNKSLDFFLFDW-----VTRVRII-EGIAQGLLYLHQYSRVRIIHR 154
+ + ILI E+ ++D + + ++R++ + + L YLH+ +IIHR
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-----QGIF 209
DLK NIL D + K++DFG++ + +GT +M+PE + +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 210 SIKSDVFSFGVLLLKI 225
K+DV+S G+ L+++
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 9/122 (7%)
Query: 110 IYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP 169
+Y Y+ +S + + I + I +GL YLH RIIHRD+K NI ++
Sbjct: 143 LYTYLTKRSRPLPIDQALI---IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQV 196
Query: 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
I D G A+ + + GT +PE + ++ K+D++S G++L ++++
Sbjct: 197 CIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253
Query: 230 KT 231
T
Sbjct: 254 ST 255
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A+G+ +L + IHRDL NILL KI DFG+AR R + G
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++ +SDV+S+G+LL +I S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 37/205 (18%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG------------LRELK-----NKLR 96
++G G +G VYK +G +A+K + ++ + L+ L+ N +R
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 97 LLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDW------VTRVR-IIEGIAQGLLYLH 144
L+ C D++ K+ L++E++ ++ L +L ++ ++ +GL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
I+HRDLK NIL+ K++DFG+ARI Q +V T Y +PE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVL 179
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGK 229
+Q ++ D++S G + ++ K
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 56 LGEGGFGPVYKGVLKNGDE-IAVKRLSGRSGQGLRE---LKNKLRLLG----------CC 101
+G G FG V+ + + A+K ++ L++ + N+ R+L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 102 IDKDEKIL--IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ D++ L + EY+P L +L F T + I L YLH I++R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYR 125
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS- 213
DLK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE IQ K+
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE-VIQSKGHNKAV 179
Query: 214 DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP-SVDTH 259
D ++ G+L+ +++ G F+ F + I EFP +D +
Sbjct: 180 DWWALGILIYEMLVGYPP--FFDDNPFGIYEKILAGKLEFPRHLDLY 224
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 32/86 (37%), Positives = 55/86 (63%), Gaps = 6/86 (6%)
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H ++R +++RDLK +NILLD+ + +ISD G+A C ++ + + VGT+ YM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166
Query: 204 AIQGI-FSIKSDVFSFGVLLLKIVSG 228
+G+ + +D FS G +L K++ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 33/86 (38%), Positives = 50/86 (58%), Gaps = 3/86 (3%)
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H + R +I+HRD+K NI L KD K+ DFGIAR+ A T +GT Y+SPE
Sbjct: 116 HVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGK 229
++ KSD+++ G +L ++ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 7/113 (6%)
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
L YLH+ R I+HRDL +NI+L +D I+DFG+A+ + ++ +VGT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQP-ESKLTSVVGTILYS 180
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252
PE + K+DV++FG +L ++ + + FY T +L I E +YE
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIVEAVYE 231
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 65/239 (27%), Positives = 102/239 (42%), Gaps = 35/239 (14%)
Query: 49 KFSDAN---KLGEGGFGPVYKGVLKNGD--EIAVKRLSG----RSGQ-----GLRELKNK 94
K+ D N LG G FG V KN D +A+KR + Q R++ N
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY 87
Query: 95 LR------LLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGI-----AQGLLYL 143
+ L G D+ L+ E++ +FF F + R + AQ +L
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNK-RFPNDVGCFYAAQIVLIF 144
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
+ I++RDLK N+LLDKD K++DFG A++ + T + GT Y++PE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEI 199
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
+ +D ++ G+ + +I+ G FY + I E I FP +N K
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG--CPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256
|
Length = 340 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKR------LSGRSGQG-------LRELK--N 93
F K+G G F VY+ L + +A+K+ + ++ Q L++L N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRII--EGIAQGLLYL-----HQY 146
++ L I+ +E ++ E L + + + R+I + + + L H +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
SR R++HRD+K +N+ + K+ D G+ R A++ +VGT YMSPE +
Sbjct: 124 SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHE 180
Query: 207 GIFSIKSDVFSFGVLLLKIVS 227
++ KSD++S G LL ++ +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRGNELQANTGRIVG 194
I+ GL ++H +I+HRD+K NI L K+ M K+ DFGIAR + A T VG
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVG 164
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T Y+SPE ++ K+D++S G +L ++ + K
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 35/207 (16%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKN---KLRLLGCCIDK 104
++ + + +G G +G V K G +AVK+LS R Q + K +LRLL +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 105 DEKILIYEYMPNKSL----DFFLF------DWVTRVR-----------IIEGIAQGLLYL 143
+ L+ + P +SL D +L D V+ +I I +GL Y+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 136
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H IIHRDLK SN+ +++D KI DFG+AR + TG V T Y +PE
Sbjct: 137 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTG-YVATRWYRAPEI 188
Query: 204 AIQGI-FSIKSDVFSFGVLLLKIVSGK 229
+ + ++ D++S G ++ ++++G+
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 56 LGEGGFGPV------YKGVLKNGDEIAVKRLSGRSGQGLRELKNKLRL----------LG 99
LG+GGFG V G + ++ KR+ R G+ + L K L L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKRILEKVNSRFVVSLA 66
Query: 100 CCID-KDEKILIYEYMPNKSLDFFLFDW----VTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ KD L+ M L F +++ R I A+ L R RI++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 155 DLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
DLK NILLD + +ISD G+A +I G ++ GR VGT YM+PE ++
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVR---GR-VGTVGYMAPEVINNEKYTFSP 182
Query: 214 DVFSFGVLLLKIVSGK 229
D + G L+ +++ G+
Sbjct: 183 DWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 53/168 (31%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS--------GRSGQGLRELKNKLRLLG 99
++ +G G +G V V + G ++A+K++S + + LRE+K LR L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--RILREIK-LLRHLR 57
Query: 100 C-----CID--------KDEKI-LIYEYMP---------NKSLD-----FFLFDWVTRVR 131
+D + ++ E M + L +FL+
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ------ 111
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179
I +GL YLH +IHRDLK SNIL++ + + KI DFG+AR
Sbjct: 112 ----ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 35/213 (16%)
Query: 42 SVSTATNKFSDANKLGEGGFGPV---YKGVLKNGDEIAVKRLSGRSGQGLRELKNKLR-- 96
S T ++ +G G G V + VL G +AVK+LS R Q K R
Sbjct: 15 STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-RPFQNQTHAKRAYREL 71
Query: 97 -LLGCCIDKDEKILIYEYMPNKSL----DFFL----------------FDWVTRVRIIEG 135
LL C K+ L+ + P KSL D +L D ++
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ 131
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+ G+ +LH IIHRDLK SNI++ D KI DFG+AR N + T +V
Sbjct: 132 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTR 186
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
Y Y +PE + + D++S G ++ ++V G
Sbjct: 187 Y-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 48/210 (22%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLL-------------GCC 101
+G G +G VYKG +K G A+K + + E+K ++ +L G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 102 IDK------DEKILIYEY---------MPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQY 146
I K D+ L+ E+ + N + DW+ I I +GL +LH +
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEY 203
++IHRD+K N+LL ++ K+ DFG++ +L GR +GT +M+PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTVGRRNTFIGTPYWMAPEV 192
Query: 204 AI-----QGIFSIKSDVFSFGVLLLKIVSG 228
+ +SD++S G+ +++ G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+AQG+ +L + IHRD+ N+LL KI DFG+AR + G
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++++SDV+S+G+LL +I S
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 59/217 (27%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVK--RLS----GRSGQGLRELKNKLRLLGCCI----- 102
K+GEG +G VYK G +A+K RL G LRE+ + L++L I
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI-SLLQMLSESIYIVRL 66
Query: 103 -------DKDEKILIY---EY-------------------MPNKSLDFFLFDWVTRVRII 133
+K+ K +Y EY +P K++ F++
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ-------- 118
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGRI 192
+ +G+ + H++ ++HRDLK N+L+DK KI+D G+ R +++ T I
Sbjct: 119 --LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEI 172
Query: 193 VGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSG 228
V T Y +PE + +S D++S G + ++
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 29/84 (34%), Positives = 49/84 (58%), Gaps = 3/84 (3%)
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H +SR R++HRD+K +N+ + K+ D G+ R A++ +VGT YMSPE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVS 227
+ ++ KSD++S G LL ++ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 36/200 (18%)
Query: 54 NKLGEGGFGPVYKG-VLKNGDEIAVKRL-----------SGRSGQGLRELK---NKLRLL 98
K+GEG F V K K G A+K + + R Q LR L N LRL+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 99 GCCIDKDEKIL----------IYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSR 148
D+ L +YE + + + + + L ++H R
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH---R 118
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-QG 207
I HRD+K NIL+ D K++DFG CRG + + T Y +PE + G
Sbjct: 119 NGIFHRDIKPENILIKDD-ILKLADFG---SCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
+ K D+++ G + +I+S
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 32/86 (37%), Positives = 54/86 (62%), Gaps = 6/86 (6%)
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H ++R +++RDLK +NILLD+ + +ISD G+A C ++ + + VGT+ YM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166
Query: 204 AIQGI-FSIKSDVFSFGVLLLKIVSG 228
+G + +D FS G +L K++ G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 25/174 (14%)
Query: 49 KFSDANKLGEGGFGPVYK-------------GVLKNGDEIAVKRLSGRSGQGLRELK--N 93
K+ +K+GEG +G V+K +++ D+ +K+++ R + L++LK N
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSR 148
+ L+ K + L++EY + L+ +II Q + + H+++
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN- 120
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
IHRD+K NIL+ K K+ DFG ARI G + V T Y +PE
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 41/202 (20%)
Query: 56 LGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQGLREL------------KNKLRLL 98
LG G FG + +G LK + +A+ L +G S + R N +RL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G + +++ EYM N +LD FL + ++ G+A G+ YL S + +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYV 129
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYR------YMSPEYAIQ 206
H+ L +L++ D+ KIS F R E ++ I T + +PE AIQ
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEA--IYTTMSGKSPVLWAAPE-AIQ 181
Query: 207 -GIFSIKSDVFSFGVLLLKIVS 227
FS SDV+SFG+++ +++S
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 12/131 (9%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG-IARICRGNELQANTGRIVG 194
+A+ +L + ++ +HRD+K N+LLDK+ + +++DFG R+ +Q+N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 195 TYRYMSPEY--AIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI--S 247
T Y+SPE A++ G + + D +S GV + +++ G T FY G I
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIMNH 223
Query: 248 ENIYEFPSVDT 258
+ ++FP T
Sbjct: 224 KEHFQFPPDVT 234
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I +GL YLH I+HRD+K N+L++ + KI DFG+AR+ +E + T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 196 YRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
Y Y +PE + ++ D++S G + +++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-------------AVKRLSGRSGQGLRELK-- 92
K+ + +GEG +G V K K +I VK+++ R + L++L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYS 147
N + L+ K L++E++ + LD D + + I +G+ + H ++
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYAIQ 206
IIHRD+K NIL+ + K+ DFG AR + E+ + V T Y +PE +
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVG 174
Query: 207 GI-FSIKSDVFSFGVLLLKIVSG 228
+ D+++ G L+ ++++G
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
YLH II+RDLK N+LLD + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 202 EYAIQGIFSIKS-DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
E IQ K+ D ++ GVLL + ++G F+ F + I +FP+
Sbjct: 185 E-VIQSKGHGKAVDWWTMGVLLYEFIAGYPP--FFDDTPFRIYEKILAGRLKFPN 236
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG---------IAQGLLYLHQYSRVRIIHR 154
KD + EY+ L F L +R R+ I L YLH +I++R
Sbjct: 67 KDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYR 119
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
DLK+ N++LDKD + KI+DFG+ + G A GT Y++PE + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 215 VFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264
+ GV++ +++ G+ FY L I +FP + + K+
Sbjct: 178 WWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEDIKFPRTLSADAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 20/132 (15%)
Query: 112 EYMPNKSLDFFLFDWVTRVRIIEG--------IAQGLLYLHQYSRVRIIHRDLKVSNILL 163
EYM SLD V I E + +GL +L + IIHRD+K +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLV 136
Query: 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY------AIQGIFSIKSDVFS 217
+ + K+ DFG++ GN + + +G YM+PE ++++SDV+S
Sbjct: 137 NGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 218 FGVLLLKIVSGK 229
G+ +L++ G+
Sbjct: 193 LGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A+G+ +L + +HRDL N+LL + KI DFG+AR + + G
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++ SDV+S+G+LL +I S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 42 SVSTATNKFSDANKLGEGGFGPV---YKGVLKNGDEIAVKRLSGRSGQGLRELKNKLR-- 96
S T ++ + +G G G V Y +L+ +A+K+LS R Q K R
Sbjct: 18 STFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97 -LLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQ----------------- 138
L+ C K+ L+ + P KSL+ F ++ + + Q
Sbjct: 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 139 ---GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
G+ +LH IIHRDLK SNI++ D KI DFG+AR + + T +V
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTR 189
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y Y +PE + + D++S G ++ +++ G
Sbjct: 190 Y-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 29/174 (16%)
Query: 55 KLGEGGFGPVYKGVLKNG---DEIAVKRLSGRSG-----------QGLRELK--NKLRLL 98
++G G FG V G + +G ++ VK L + Q R L+ N L+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLF----------DWVTRVRIIEGIAQGLLYLHQYSR 148
G C + +L+ E+ P L +L D T R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
IH DL + N LL D+ KI D+G++ + ++ R+++PE
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 51/222 (22%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKRL------SGRSGQG------------LRELK-- 92
LGEG +G V K G +A+K++ + + LRELK
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 93 ------NKLRLLGCCIDKDEKILIYEYMPN---KSLDFFLFDWVTRVR-IIEGIAQGLLY 142
N + L+ ++ D L+ + M + K +D + ++V+ I+ I GL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN-------------- 188
LH++ +HRDL +NI ++ KI+DFG+AR G ++
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLAR-RYGYPPYSDTLSKDETMQRREEM 190
Query: 189 TGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGK 229
T ++V T Y +PE + + D++S G + ++++GK
Sbjct: 191 TSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L YLH S +++RDLK+ N++LDKD + KI+DFG+ + G + A GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE + D + GV++ +++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 26/145 (17%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----------LRELK-NKLRLLGCC 101
KLGEG + VYKG K G +A+K + +G L++LK + L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 102 IDKDEKI-LIYEYMPNKSLDFFLFDWVTR------VRI-IEGIAQGLLYLHQYSRVRIIH 153
I + + L++EY+ + L ++ D VR+ + + +GL Y HQ R++H
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLH 126
Query: 154 RDLKVSNILLDKDMNPKISDFGIAR 178
RDLK N+L+ + K++DFG+AR
Sbjct: 127 RDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 27/197 (13%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE-IAVKRLSGRSGQG-----------LRELK--NKLRLLG 99
+KLGEG + VYKG K D +A+K + +G L++LK N + L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRI------IEGIAQGLLYLHQYSRVRIIH 153
+ L++EY+ +K L +L D + + + + +GL Y H R +++H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIK 212
RDLK N+L+++ K++DFG+AR + + + +V T Y P+ + +S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 213 SDVFSFGVLLLKIVSGK 229
D++ G + ++ +G+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 53/197 (26%), Positives = 101/197 (51%), Gaps = 27/197 (13%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE-IAVKRLSGRSGQG-----------LRELKN-KLRLLGC 100
KLGEG + V+KG K + +A+K + +G L++LK+ + L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 101 CIDKDEKI-LIYEYMPNKSLDFFLFDW-----VTRVRI-IEGIAQGLLYLHQYSRVRIIH 153
+ D+ + L++EY+ +K L ++ D + V+I + I +GL Y H R +++H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-QGIFSIK 212
RDLK N+L+++ K++DFG+AR + + + +V T Y P+ + +S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 213 SDVFSFGVLLLKIVSGK 229
D++ G + ++ SG+
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 42/239 (17%)
Query: 114 MPNKSLDFFLFDWVTRVR---------IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD 164
MP D LF +V R I + + L YLH IIHRD+K NI LD
Sbjct: 165 MPKYKCD--LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLD 219
Query: 165 KDMNPKISDFGIARICRGNELQANTGRI---VGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221
+ N + DFG A C+ + +T + GT SPE + K+D++S G++
Sbjct: 220 EPENAVLGDFGAA--CKLDA-HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 222 LLKIVSGKKTTGF---YRTYSFTLLGYI---SENIYEFPSVDTHN-VKTFGFLHLTIFKL 274
L ++ S K T F ++ S L I + EFP + N K F + +
Sbjct: 277 LFEM-SVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPP 335
Query: 275 FSISSV----GLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALL 327
++I V G+ D + Y+ +L + + RP+ D++S+ T E LL
Sbjct: 336 YTIPPVIRKYGMHMD------VEYLIAKMLTFDQ--EFRPSAQDILSLPLFTKEPINLL 386
|
Length = 392 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L YLH +++RDLK+ N++LDKD + KI+DFG+ + G A GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE + D + GV++ +++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
A+ L L + +I+RDLK NILLD + + DFG+ ++ ++ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
Y++PE + ++ D ++ GVLL ++++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 39/128 (30%), Positives = 71/128 (55%), Gaps = 12/128 (9%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG-IARICRGNELQANTGRIVG 194
IA+ +L +H ++ +HRD+K N+LLD + + +++DFG ++ + +Q++ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 195 TYRYMSPEY--AIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI--S 247
T Y+SPE A++ G + + D +S GV + +++ G+ T FY G I
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNH 223
Query: 248 ENIYEFPS 255
E ++FPS
Sbjct: 224 EERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I+ L YLH+ II+RDLK+ N+LLD + + K++D+G+ + G T GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE + D ++ GVL+ ++++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 29/65 (44%), Positives = 37/65 (56%), Gaps = 8/65 (12%)
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQAN---TGRIVGTYR 197
Y+H S +IHRDLK SNILL+ D K++DFG+AR + E N T V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT-DYVATRW 177
Query: 198 YMSPE 202
Y +PE
Sbjct: 178 YRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L YLH +++RD+K+ N++LDKD + KI+DFG+ + G A GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE + D + GV++ +++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI--- 192
I GL Y+H ++HRDLK N+L++ D KI DFG+AR N + N G +
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEY 169
Query: 193 VGTYRYMSPEYAIQGIFSIKS-DVFSFGVLLLKIVSGK 229
V T Y +PE + K+ DV+S G +L +++ K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS---------GRSGQGLRELK-----N 93
+++ ++G G +G V + + G+++A+K+LS R+ + L LK N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 94 KLRLLGCCIDK---DEKILIYEYMPNKSLDFFLFDWVTRVR-----------IIEGIAQG 139
+ LL DE Y MP ++ + ++ ++ + G
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
L Y+H IIHRDLK N+ +++D KI DFG+AR TG +V T Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVV-TRWYR 181
Query: 200 SPEYAIQGIFSIKS-DVFSFGVLLLKIVSGK 229
+PE + + ++ D++S G ++ ++++GK
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 2/98 (2%)
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
I++ Q L + R++HRD+K NI L ++ K+ DFG AR+ A T
Sbjct: 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-- 159
Query: 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
VGT Y+ PE ++ KSD++S G +L ++ + K
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
I+ G GL +LH RIIHRD+K +NILL + K+ DFG++ L+ NT
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 192 IVGTYRYMSPEY-----AIQGIFSIKSDVFSFGVLLLKIVSG 228
VGT +M+PE + + DV+S G+ +++ G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVK--RLSGRSGQGLRELKNKLRLLGCCIDK 104
+ + KLGEG + VYKG K NG +A+K RL G ++ L G +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG--LKH 62
Query: 105 DEKILIYEYMPNKSLDFFLFDWV-----------------TRVRI-IEGIAQGLLYLHQY 146
+L+++ + K +F++V V++ + + +GL Y+HQ
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
I+HRDLK N+L+ K++DFG+AR + + +V T Y P+ +
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLG 177
Query: 207 GI-FSIKSDVFSFGVLLLKIVSG 228
+S D++ G + ++++ G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 39/166 (23%)
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------IAQGLLYLHQYSRVRIIHRDL 156
D++ L+ EYMP L + + R + IA+ +L L ++ IHRD+
Sbjct: 72 DEEHLYLVMEYMPGGDL----MNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 157 KVSNILLDKDMNPKISDFGIA------------------RICRGNELQANTGR------- 191
K NIL+D D + K++DFG+ + R N L
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 192 --IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFY 235
VGT Y++PE + ++ D +S GV+L +++ G FY
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG--FPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 15/129 (11%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A G+ +L + +HRDL N+L+ + KI DFG+AR + + G
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT--------TGFY----RTYSFTLL 243
++M+PE +++ SDV+SFG+LL +I + T FY R Y
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364
Query: 244 GYISENIYE 252
+ S+ IYE
Sbjct: 365 AHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 41/210 (19%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGL---RELKNKLRLLGCCIDK 104
++ + +G G +G V + ++AVK+LS R Q L R +LRLL +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHE 74
Query: 105 DEKILIYEYMPNKSL-DFFLFDWVTRVR--------------------IIEGIAQGLLYL 143
+ L+ + P S+ +F VT + +I + +GL Y+
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN---TGRIVGTYRYMS 200
H IIHRDLK SN+ +++D +I DFG+AR QA+ TG V T Y +
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEMTG-YVATRWYRA 183
Query: 201 PEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
PE + + ++ D++S G ++ +++ GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 42 SVSTATNKFSDANKLGEGGFGPV---YKGVLKNGDEIAVKRLSGRSGQGLRELKNKLR-- 96
S T ++ + +G G G V Y VL +A+K+LS R Q K R
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLS-RPFQNQTHAKRAYREL 67
Query: 97 -LLGCCIDKDEKILIYEYMPNKSLDFF--------LFD----WVTRVRIIEGIAQGLLY- 142
L+ C K+ L+ + P KSL+ F L D V ++ + LLY
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 143 ----LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRY 198
+ IIHRDLK SNI++ D KI DFG+AR + + T +V Y Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 199 MSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+PE + + D++S G ++ ++V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L +LH+ II+RDLK+ N+LLD D + K++D+G+ + G T GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE + D ++ GVL+ ++++G+
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 8/87 (9%)
Query: 151 IIHRDLKVSNILL---DKDMNPKISDFGIARICRG----NELQAN-TGRIVGTYRYMSPE 202
I+HRDLK NI++ + K+ DFGI + G + T ++GT Y +PE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ SD++++G++ L+ ++G+
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRY 198
G+ +LH IIHRDLK SNI++ D KI DFG+AR + + T +V Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183
Query: 199 MSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
+PE I G+ + D++S G ++ +++ G
Sbjct: 184 RAPE-VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 78 KRLSGRSGQGLR---ELKNKLRLLGCC----IDKDEKILIYE---YMPNKSLDF----FL 123
+ ++ R G R +L+N++ LG I K E+IL E YM + DF F+
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM 253
Query: 124 FD-----------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172
+D TR I++ + + Y+H ++IHRD+K+ NI L+ D +
Sbjct: 254 YDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309
Query: 173 DFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
DFG A E +A VGT SPE + +D++S G++LL ++S
Sbjct: 310 DFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 41/210 (19%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG---LRELKNKLRLLGCCIDK 104
++ D ++G G +G V + + G ++A+K+L R Q + +LRLL +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHE 74
Query: 105 DEKILIYEYMPNKSLD----FFL--------------FDWVTRVRI---IEGIAQGLLYL 143
+ L+ + P+ SLD F+L + ++ RI + + +GL Y+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN---TGRIVGTYRYMS 200
H IIHRDLK N+ +++D KI DFG+AR Q + TG +V T Y +
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVV-TRWYRA 183
Query: 201 PEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
PE + + ++ D++S G ++ ++++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 12/143 (8%)
Query: 101 CIDKDEKIL--IYEYMPNKSLDFFLFDWVTRVRIIE-GIAQGLLYLHQYSRVRIIHRDLK 157
C +D+K L + EYMP L + ++ + + A+ +L L + +IHRD+K
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169
Query: 158 VSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVGTYRYMSPEY----AIQGIFSIK 212
N+LLDK + K++DFG ++ ++ +T VGT Y+SPE G + +
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRE 227
Query: 213 SDVFSFGVLLLKIVSGKKTTGFY 235
D +S GV L +++ G T FY
Sbjct: 228 CDWWSVGVFLFEMLVGD--TPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
+ +GL Y+H +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 30/82 (36%), Positives = 47/82 (57%), Gaps = 8/82 (9%)
Query: 109 LIYEYMPN---KSL--DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL 163
L+ EY+ KSL + FD V+ I +A L YLH++ IIHRDLK N+L+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLI 137
Query: 164 DKDMNPKISDFGIARICRGNEL 185
+ + K++DFG++++ EL
Sbjct: 138 SNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 130 VRIIEG-IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
VR G I L +LH ++ I++RD+K+ NILLD + + ++DFG+++ E +
Sbjct: 107 VRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KER 162
Query: 189 TGRIVGTYRYMSPEYAI-QGIFSIKSDVFSFGVLLLKIVSG 228
T GT YM+PE +G D +S G+L+ ++++G
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 22/149 (14%)
Query: 100 CCIDKDEKIL--IYEYMPNKSLDFFLFD------WVTRVRIIEGIAQGLLYLHQYSRVRI 151
+D+K L + EYMP L + + W R E + L +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-ARFYTAE-VVLALDAIHSMG---F 163
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVGTYRYMSPEY----AIQ 206
IHRD+K N+LLDK + K++DFG ++ ++ +T VGT Y+SPE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGD 221
Query: 207 GIFSIKSDVFSFGVLLLKIVSGKKTTGFY 235
G + + D +S GV L +++ G T FY
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGD--TPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKD-------- 105
++G G +G VYK L G+ AVK + G ++ ++ ++ C +
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 106 ---EKILI-YEYMPNKSLD--FFLFDWVTRVRI---IEGIAQGLLYLHQYSRVRIIHRDL 156
EK+ I EY SL + + ++ ++I QGL YLH + +HRD+
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDI 132
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI---QGIFSIKS 213
K +NILL + + K++DFG+A + A +GT +M+PE A G ++
Sbjct: 133 KGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190
Query: 214 DVFSFGVLLLKI 225
D+++ G+ +++
Sbjct: 191 DIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 16/128 (12%)
Query: 109 LIYEYMPNKSL-------DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNI 161
LI EY+ L F+ D T + I+ L +LHQ II+RDLK NI
Sbjct: 77 LILEYLSGGELFMHLEREGIFMED--TACFYLSEISLALEHLHQQG---IIYRDLKPENI 131
Query: 162 LLDKDMNPKISDFGIARICRGN-ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGV 220
LLD + K++DFG +C+ + T GT YM+PE ++ D +S G
Sbjct: 132 LLDAQGHVKLTDFG---LCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGA 188
Query: 221 LLLKIVSG 228
L+ +++G
Sbjct: 189 LMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVL--KNGDEIAVKRLSGRSG------------ 85
F S ++ + +G+G +G V+K VL KNG + AVK L
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNIL 68
Query: 86 QGLRELKNKLRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDWVTR---------VR 131
+ L + N ++ G KD K L+ E S+ + ++ R
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
I+ GL +LH + IHRD+K +NILL + K+ DFG++ L+ NT
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 192 IVGTYRYMSPEY-----AIQGIFSIKSDVFSFGVLLLKIVSG 228
VGT +M+PE + + + DV+S G+ +++ G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 35/114 (30%), Positives = 57/114 (50%), Gaps = 13/114 (11%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN--TGRIV 193
IA+ +L L + I++RDLK NILLD + + DFG+++ L N T
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFC 157
Query: 194 GTYRYMSPEYAI-QGIFSIKSDVFSFGVLLLKIVSG------KKTTGFYRTYSF 240
GT Y++PE + + ++ D +S GVL+ ++ G + T YR +F
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 45/197 (22%), Positives = 93/197 (47%), Gaps = 26/197 (13%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCC------- 101
F ++G G +G VYK + G+ A+K + G+ ++ ++ ++ C
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 102 -----IDKDEKILIYEYMPNKSLD--FFLFDWVTRVRII---EGIAQGLLYLHQYSRVRI 151
+ +D+ + E+ SL + + ++ +I QGL YLH +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--- 127
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI---QGI 208
+HRD+K +NILL + + K++DFG++ + A +GT +M+PE A +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 209 FSIKSDVFSFGVLLLKI 225
++ D+++ G+ +++
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-07
Identities = 36/142 (25%), Positives = 51/142 (35%), Gaps = 17/142 (11%)
Query: 51 SDANKLGEGGFGPVYKGVLKNGDE-IAVKRLSGRSGQGLRE--------LKNKL----RL 97
S L G VY L DE +K R RE L K ++
Sbjct: 1 SSIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV 58
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK 157
L L+ E++ ++LD + I E +A+ L LHQ + + H DL
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEV--SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116
Query: 158 VSNILLDKDMNPKISDFGIARI 179
NIL+D I D+ A
Sbjct: 117 PGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA L YLH + II+RDLK NILLD + ++DFG+ + G E T GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
Y++PE + + D + G +L +++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 31/109 (28%), Positives = 56/109 (51%), Gaps = 8/109 (7%)
Query: 127 VTRVRIIEG-----IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181
R R E + +L L ++ II+RD+K+ NILLD + + ++DFG+++
Sbjct: 97 SQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156
Query: 182 GNELQANTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSG 228
+E++ GT YM+P+ G D +S GVL+ ++++G
Sbjct: 157 EDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 29/94 (30%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I+ L +LH+ II+RDLK+ N+LLD + + K++D+G+ + G T GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y++PE + D ++ GVL+ ++++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN-ELQANTGRIVG 194
IA L YLH + I++RDLK NILLD + ++DFG +C+ N E T G
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHNGTTSTFCG 158
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
T Y++PE + + D + G +L +++ G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 55 KLGEGGFGPVYKGVLKNG---DEIAVKRLSG--------RSGQGLRELK--NKLRLLGCC 101
K+G G +G VYK K+G + A+K++ G R LRELK N + L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 102 IDK-DEKI-LIYEYMPNKSLDFFLFDWVTR-----VRIIEGIAQGLLY-----LHQYSRV 149
+ D K+ L+++Y + F ++ V++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 150 RIIHRDLKVSNILL----DKDMNPKISDFGIARICRGN-ELQANTGRIVGTYRYMSPEYA 204
++HRDLK +NIL+ + KI+D G AR+ + A+ +V T+ Y +PE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 205 IQGIFSIKS-DVFSFGVLLLKIVSGK 229
+ K+ D+++ G + ++++ +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 46/219 (21%)
Query: 49 KFSDANKLGEGGFGPVYKGVLKNGDE-IAVKRLSGRSGQ----GLRELKNKLRLLGCCID 103
++ D LG G G V+ V + D+ +AVK++ Q LRE+K RL D
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-----D 60
Query: 104 KDEKILIYEYMPNKSLDF-------FLFDWVTRV---------RIIE------------- 134
D + +YE + D + V V ++E
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 135 -GIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRGN-ELQANTGR 191
+ +GL Y+H ++HRDLK +N+ ++ +D+ KI DFG+ARI + +
Sbjct: 121 YQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 192 IVGTYRYMSPEYAIQGIFSIKS-DVFSFGVLLLKIVSGK 229
+ T Y SP + K+ D+++ G + ++++GK
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A + YLH + II+RDLK NILLD + ++DFG+ + G E + T GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
Y++PE + + D + G +L +++ G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 26/67 (38%), Positives = 38/67 (56%), Gaps = 5/67 (7%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+ +GL Y+H ++HRDLK SN+LL+ + + KI DFG+AR T +V T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVV-T 171
Query: 196 YRYMSPE 202
Y +PE
Sbjct: 172 RWYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 27/197 (13%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVK--RLSGRSG---QGLRE---LKN----KLRLLGC 100
+KLGEG + V+KG K + +A+K RL G +RE LKN + L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 101 CIDKDEKI-LIYEYMPNKSLDFFLFDW-----VTRVRI-IEGIAQGLLYLHQYSRVRIIH 153
I + + L++EY+ + L +L + + V+I + + +GL Y H + +I+H
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIK 212
RDLK N+L+++ K++DFG+AR + + + +V T Y P+ + +S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 213 SDVFSFGVLLLKIVSGK 229
D++ G +L ++ +G+
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 10/75 (13%)
Query: 109 LIYEYMPNKSLDFFLFDW------VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL 162
LI E++P L L + VTR + E + L + ++ IHRD+K NIL
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV----LAIEAVHKLGFIHRDIKPDNIL 133
Query: 163 LDKDMNPKISDFGIA 177
+D+ + K+SDFG++
Sbjct: 134 IDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 35/200 (17%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIA---VKRLSG-----------RSGQGLRELK--NKLRLL 98
++G G FG V + +A VK L + G R L+ N L+ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLF--DWVTR-------VRIIEGIAQGLLYLHQYSRV 149
G C++ +L++EY L +L W R R+ IA G+ ++H+++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ--- 206
+H DL + N L D+ K+ D+GI + R+++PE +
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 207 GIFSIK----SDVFSFGVLL 222
G+ + + S+V++ GV L
Sbjct: 179 GLITAEQTKPSNVWALGVTL 198
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA L YLH + I++RDLK NILLD + ++DFG+ + G T GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGT 159
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
Y++PE + + D + G +L +++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 20/141 (14%)
Query: 103 DKDEKILIYEYMP--------NKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
DKD L+ EY P N+ D F D +A+ +L +H ++ +HR
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLAIHSVHQMGYVHR 126
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY------AIQGI 208
D+K N+L+D+ + K++DFG A N+ N+ VGT Y++PE +G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 209 FSIKSDVFSFGVLLLKIVSGK 229
+ ++ D +S GV+ +++ G+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 109 LIYEYMPNKSLDFFLFDWVTRVRIIE-GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167
++ EYMP L + ++ + A+ +L L + IHRD+K N+LLDK
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179
Query: 168 NPKISDFGIA-RICRGNELQANTGRIVGTYRYMSPEY----AIQGIFSIKSDVFSFGVLL 222
+ K++DFG ++ + ++ +T VGT Y+SPE G + + D +S GV L
Sbjct: 180 HLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 223 LKIVSGKKTTGFY 235
+++ G T FY
Sbjct: 238 YEMLVGD--TPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 31/206 (15%)
Query: 55 KLGEGGFGPVYKGVLKNG---DEIAVKRLSG--------RSGQGLRELK--NKLRLLGCC 101
K+G G +G VYK K+G E A+K++ G R LRELK N + L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 102 ID-KDEKI-LIYEYMPNKSLDFFLFDWVTR-----VRIIEGIAQGLLY-----LHQYSRV 149
+ D K+ L+++Y + F ++ +++ + + LLY +H
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 150 RIIHRDLKVSNILL----DKDMNPKISDFGIARICRGN-ELQANTGRIVGTYRYMSPEYA 204
++HRDLK +NIL+ + KI+D G AR+ + A+ +V T+ Y +PE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 205 IQGIFSIKS-DVFSFGVLLLKIVSGK 229
+ K+ D+++ G + ++++ +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 52/234 (22%), Positives = 104/234 (44%), Gaps = 45/234 (19%)
Query: 56 LGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEKILI----- 110
+G G FG V LKN D++ ++ L + + R C ++ +L+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKI-------LNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 111 ------YEYMPNKSL----DFFLF-DWVTRVRIIEG----------IAQGLLYLHQYSRV 149
Y + +L D+++ D +T + E +A+ ++ + ++
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFG-IARICRGNELQANTGRIVGTYRYMSPEYAI--- 205
+HRD+K NIL+D + + +++DFG ++ +Q++ VGT Y+SPE
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAME 179
Query: 206 --QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI--SENIYEFPS 255
+G + + D +S GV + +++ G+ T FY G I + ++FP+
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHKERFQFPA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 57/177 (32%)
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------IAQGLLYLHQYSRVRIIHRDL 156
DKD + +Y+P + L R+ I E IA+ + ++ IHRD+
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDI 127
Query: 157 KVSNILLDKDMNPKISDFGIARICRG------------------------NELQANTGR- 191
K NIL+D+D + K++DFG +C G E
Sbjct: 128 KPDNILIDRDGHIKLTDFG---LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 192 -------------------IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+VGT Y++PE ++ ++ D +S GV+L +++ G+
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 56/250 (22%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQGL-------RELKNK 94
N++ K+G G FG V+ K E I+ + L R L RELK+K
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 95 --LRLLGCCIDK-DEKILI-YEYMPNKSLD------FFLFDWVTR---VRIIEGIAQGLL 141
+R + ++K ++K+ I E+ L + +F + V I + L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 142 YLHQY----SRVRIIHRDLKVSNILLD-------------KDMN----PKISDFGIARIC 180
Y H + R++HRDLK NI L ++N KI DFG+++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSI--KSDVFSFGVLLLKIVSGKKTTGFYRTY 238
G E A++ VGT Y SPE + S KSD+++ G ++ ++ SGK T F++
Sbjct: 193 -GIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKAN 247
Query: 239 SFTLLGYISE 248
+F+ L ISE
Sbjct: 248 NFSQL--ISE 255
|
Length = 1021 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 27/90 (30%), Positives = 49/90 (54%)
Query: 138 QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYR 197
Q +L L + +++HRDLK +NI L K+ DFG ++ + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 198 YMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
Y++PE + +S K+D++S GV+L ++++
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 28/118 (23%)
Query: 121 FFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
FFL+ + + L Y+H + + HRDLK NIL + D KI DFG+AR+
Sbjct: 107 FFLYQ----------LLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV- 152
Query: 181 RGNELQANTGRI-----VGTYRYMSPEYAIQGIFSIKS----DVFSFGVLLLKIVSGK 229
I V T Y +PE + G F K D++S G + ++++GK
Sbjct: 153 ---AFNDTPTAIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 49/213 (23%)
Query: 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSG-------------------RSGQGLRELKNK- 94
LG+G F +YKGVL+ D V + + +L +K
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 95 -LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRI------IEGIAQGLLYLHQYS 147
++L G C+ +DE I++ EY+ LD FL V + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-- 119
Query: 148 RVRIIHRDLKVSNILLDK-DMNP------KISDFGIAR-ICRGNELQANTGRIVGTYRYM 199
+++H ++ NIL+ + +N K+SD GI + E RI ++
Sbjct: 120 -KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RI----PWI 171
Query: 200 SPEY--AIQGIFSIKSDVFSFGVLLLKIVSGKK 230
+PE Q +I +D +SFG LL+I S +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 41/164 (25%)
Query: 103 DKDEKILIYEYMPNKSLDFFLF--DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160
DK LI E++P + L D +T IA+ +L + ++ IHRD+K N
Sbjct: 72 DKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDN 131
Query: 161 ILLDKDMNPKISDFGIARICRG---------------------------NELQANTGR-- 191
+LLD + K+SDFG +C G ++ +A T +
Sbjct: 132 LLLDSKGHVKLSDFG---LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 192 -------IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
VGT Y++PE +Q ++ D +S GV++ +++ G
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 15/87 (17%)
Query: 103 DKDEKILIYEYMPNKSL-------DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
D++ LI EY+P + D F + TR I E I L + ++ IHRD
Sbjct: 72 DENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETI----LAIDSIHKLGYIHRD 126
Query: 156 LKVSNILLDKDMNPKISDFGIARICRG 182
+K N+LLD + K+SDFG +C G
Sbjct: 127 IKPDNLLLDAKGHIKLSDFG---LCTG 150
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 41/164 (25%)
Query: 103 DKDEKILIYEYMPNKSLDFFLF--DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160
DK LI E++P + L D ++ IA+ +L + ++ IHRD+K N
Sbjct: 72 DKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDN 131
Query: 161 ILLDKDMNPKISDFGIARICRG---------------------------NELQANTGR-- 191
+LLD + K+SDFG +C G ++ +A T +
Sbjct: 132 LLLDAKGHVKLSDFG---LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 192 -------IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
VGT Y++PE +Q ++ D +S GV++ +++ G
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 16/102 (15%)
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN--------ELQANT-- 189
L YLH Y I+HRDLK N+L+ + K++DFG+++I + ++ +T
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 190 ---GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
++ GT Y++PE ++ + D ++ G++L + + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 55/178 (30%)
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------IAQGLLYLHQYSRVRIIHRDL 156
DKD + +Y+P + L R+ I IA+ + ++ IHRD+
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDI 127
Query: 157 KVSNILLDKDMNPKISDFGI--------------------------------ARICR-GN 183
K NIL+D+D + K++DFG+ CR G+
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 184 ELQANTGR------------IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
L+ R +VGT Y++PE ++ ++ D +S GV+L +++ G+
Sbjct: 188 RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 28/101 (27%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
I + + + YLH+ RIIHRD+K NI ++ + + DFG A C ++ AN
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYY 241
Query: 192 -IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231
GT +PE + + D++S G++L ++ + +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 38/205 (18%)
Query: 56 LGEGGFGPVYKGVLKN-GD-------EIAVKRLSG----------RSGQGLRELKNKLRL 97
LG+G F ++KG+ + GD E+ +K L + + +L +K +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 98 L--GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRI---IEGIAQGLLYLHQYSRVRII 152
L G C+ DE I++ EY+ SLD +L + I +E Q LH +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 153 HRDLKVSNILL-----DKDMNP---KISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
H ++ N+LL K NP K+SD GI+ E+ RI ++ PE
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWVPPECI 176
Query: 205 IQG-IFSIKSDVFSFGVLLLKIVSG 228
S+ +D +SFG L +I SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 7e-04
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 47/223 (21%)
Query: 21 SNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK---NGDEIAV 77
N K K +D F VS +K KL F V K + N E V
Sbjct: 14 KNCEIVKKLKLIDG----KFGKVSVLKHK--PTQKL----F--VQKIIKAKNFNAIEPMV 61
Query: 78 KRLSGRSGQGLRELKNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR-------- 129
+L +++ N ++L +LI +Y+ D LFD + +
Sbjct: 62 HQL-------MKDNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAE 110
Query: 130 -VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQA 187
+II + + L LH++ IIH D+K+ N+L D+ + + D+G+ +I G
Sbjct: 111 VKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSCY 166
Query: 188 NTGRIVGTYRYMSPEYAIQGIFSIKS-DVFSFGVLLLKIVSGK 229
+ GT Y SPE I+G S D ++ GVL ++++GK
Sbjct: 167 D-----GTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 55/178 (30%)
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------IAQGLLYLHQYSRVRIIHRDL 156
DKD + +Y+P + L R+ + IA+ L + ++ IHRD+
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDI 127
Query: 157 KVSNILLDKDMNPKISDFGI--------------------------------ARICR-GN 183
K NIL+D D + K++DFG+ CR G+
Sbjct: 128 KPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 184 ELQANTGR------------IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
L+ R +VGT Y++PE ++ ++ D +S GV+L +++ G+
Sbjct: 188 RLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 43/173 (24%), Positives = 64/173 (36%), Gaps = 48/173 (27%)
Query: 50 FSDANKLGEGGFGPVYKGVL-----KNGDEIAVKRLSGRSGQGLRELKNKLRLLGCCI-- 102
F KLGEG FG VYK L K + +K+ + G E+ R+ C
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA---TEYGAVEIWMNERVRRACPNS 190
Query: 103 ---------------DKDEKILIYEYMPNKSL-------DF------FLFDWVT------ 128
+DE L++ Y +L +F +L V
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGL 250
Query: 129 --RVRIIEGIAQGLLY-LHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIA 177
+II+ I + +L+ L I+HRD+K NI+ + KI D G A
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 44/221 (19%)
Query: 41 SSVSTATNK-FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELK-----N 93
+ ++ + NK + N +G G FG VY+ + + +++A+K++ REL N
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN 117
Query: 94 KLRLLGC-------CIDKDEKIL----IYEYMP-------------NKSLDFFLFDWVTR 129
+ ++ C K+EK + + E++P N +L FL +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQAN 188
+ + L Y+H I HRDLK N+L+D + + K+ DFG A+ Q +
Sbjct: 178 -----QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--QRS 227
Query: 189 TGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSG 228
I + Y +PE + ++ D++S G ++ +++ G
Sbjct: 228 VSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 24/128 (18%)
Query: 123 LFDWVTR---------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPK 170
L DW+ + +II L Y H + + ++H DLK NIL+ D ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 171 IS-----DFGIARICR----GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221
+ D RIC +E + T IV T Y SPE + + +D++S G +
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334
Query: 222 LLKIVSGK 229
+ ++ +GK
Sbjct: 335 IYELYTGK 342
|
Length = 467 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 133 IEGIAQGLL----YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
+ +A+ LL Y+H IIHRD+K N+L++ + + DFG A RG+
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLK 224
I GT +PE ++ D++S G+++ +
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 28/113 (24%), Positives = 46/113 (40%), Gaps = 14/113 (12%)
Query: 83 RSGQGLRELKN--KLRLLGCC------IDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE 134
R + RE + K R G +D D +++ EY+ + L L R ++
Sbjct: 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL--EEARPDLLR 99
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187
+ + + LH + I+H DL SNI+L DFG+ E +A
Sbjct: 100 EVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDKA 148
|
Length = 204 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 13/95 (13%)
Query: 110 IYEYMPNKSLDFFLFDWVTRVRIIEGIA-QGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168
I + MP D + +I+G+ Q L L + R+ I+HRD+K N+L+ D
Sbjct: 297 IPDNMPQDKRD---------INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ 347
Query: 169 PKISDFGIA-RICRGNELQANTGRIVGTYRYMSPE 202
KI DFG A +C G G + RY PE
Sbjct: 348 VKIIDFGAAVDMCTGINFNPLYGML--DPRYSPPE 380
|
Length = 507 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 354 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.76 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.33 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.2 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.12 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.98 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.72 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.61 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.22 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.06 | |
| PLN02236 | 344 | choline kinase | 95.86 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.51 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.91 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.85 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.62 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.51 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.24 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.02 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.28 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 92.52 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.39 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.29 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.56 Aligned_cols=233 Identities=30% Similarity=0.408 Sum_probs=191.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH-----HHHH--------HHHHHhceeecCCc-eEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL-----RELK--------NKLRLLGCCIDKDE-KILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~-----~~~~--------~i~~~~~~~~~~~~-~~lv~e 112 (354)
++++..+.||+|..|+||+++++ +++.+|+|++........ ++++ +||.+++.|..+.. +.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 37888999999999999999986 588899999965543332 2222 66778888888884 999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||++|+|+.++ +++....+++.++++||.|||. .+ |+||||||+|||++..|.+||+|||.+....+.
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999998 6888999999999999999995 77 999999999999999999999999998765555
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---cchhhhhhhhccccCCCCcccCCccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT---YSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.-...+||..|+|||.+.+..|+.++||||||++++|+..|+.|+..... +..+++..|-.+..+.....
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~------ 305 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG------ 305 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc------
Confidence 12336899999999999999999999999999999999999999765422 34555555544333221111
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+++++++||..||++||.+|||++|+++.
T Consensus 306 -------------------------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -------------------------EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------------------------cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 178899999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=334.38 Aligned_cols=230 Identities=26% Similarity=0.428 Sum_probs=204.1
Q ss_pred cCccccceecccCceeEEEEEE-cCCCEEEEEEecCCCh-------hhHHH--------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSG-------QGLRE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~-------~~~~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
.+|...++||+|||+.+|.+++ ..|..||+|++.+... ...++ ++|||+++.+|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 7899999999999999999997 6799999999976321 11122 238899999999999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+|..++|..++ +++..++.++.||+.||.|||+.+ |+|||||..|++++.+..+||+|||+|.......
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-- 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--
Confidence 999999999988 899999999999999999999999 9999999999999999999999999998766442
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
..+...+||+.|.|||++....++..+||||+||++|.|+.|++| |...+..+....|......+|..
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PP--Fetk~vkety~~Ik~~~Y~~P~~---------- 240 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPP--FETKTVKETYNKIKLNEYSMPSH---------- 240 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCC--cccchHHHHHHHHHhcCcccccc----------
Confidence 123346999999999999999999999999999999999999999 78888899999998888887762
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+....+||.++|+.||.+|||+++|+.
T Consensus 241 -----------------------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 241 -----------------------LSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----------------------cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4556689999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=323.59 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred CCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-------hH----HH--------HHHH
Q 048432 35 LPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-------GL----RE--------LKNK 94 (354)
Q Consensus 35 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-------~~----~~--------~~~i 94 (354)
.+..+..-.+...+.|.+.+.||+|+||.|-+|..+ +|+.||||++++.-.. .. ++ +.+|
T Consensus 159 s~d~~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I 238 (475)
T KOG0615|consen 159 SRDSSKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI 238 (475)
T ss_pred cchhccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE
Confidence 555566666678899999999999999999999954 6999999999654211 11 11 1266
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--- 166 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--- 166 (354)
|++.+++..++..|+||||++||.|-+.+ +.+.....++.|++.|+.|||++| |+||||||+|||+..+
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAED 315 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcc
Confidence 78889999999999999999999999988 677788999999999999999999 9999999999999876
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCccccc-chhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI---FSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTL 242 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~ 242 (354)
..+||+|||+|...+.... +...+||+.|.|||++.+.. +..++|+||+||+||-+++|.+| |.+.. ...+
T Consensus 316 ~llKItDFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP--FS~~~~~~sl 390 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP--FSEEYTDPSL 390 (475)
T ss_pred eEEEecccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC--cccccCCccH
Confidence 6799999999987765443 33469999999999998654 34588999999999999999999 55554 4447
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.++|.++...+-...|.. .+++..+||.+||..||++|||++++|..
T Consensus 391 ~eQI~~G~y~f~p~~w~~-----------------------------Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 391 KEQILKGRYAFGPLQWDR-----------------------------ISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHhcCcccccChhhhh-----------------------------hhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 788888877664433221 67888999999999999999999998753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=326.92 Aligned_cols=258 Identities=30% Similarity=0.460 Sum_probs=216.7
Q ss_pred ccCCCCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHH--------HHHHHHHhc
Q 048432 31 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRE--------LKNKLRLLG 99 (354)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~--------~~~i~~~~~ 99 (354)
..+..+.++...+....+.+++++.||+|.||.||.+.++....||+|.+....... .++ +.+++++++
T Consensus 189 ~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 189 TKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred CCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEE
Confidence 334444444677777888899999999999999999999877799999997753321 112 237889999
Q ss_pred eeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEe
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~ 172 (354)
+|..+..++||||||..|+|.+++ +.......++.|||.|++||++++ ++||||.++||||+.+..+||+
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEc
Confidence 999988999999999999999999 567888999999999999999999 9999999999999999999999
Q ss_pred ecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcccc
Q 048432 173 DFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 173 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
|||+++............ .....-|.|||.+..+.++.++||||||++||||+| |+.| +.+++..+.++.+.++-.
T Consensus 346 DFGLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~p--y~~msn~ev~~~le~GyR 422 (468)
T KOG0197|consen 346 DFGLARLIGDDEYTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVP--YPGMSNEEVLELLERGYR 422 (468)
T ss_pred ccccccccCCCceeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCC--CCCCCHHHHHHHHhccCc
Confidence 999999544443322221 233678999999999999999999999999999998 7777 777888888888877765
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
-..... ||+.+.++|..||+.+|++|||++.+...|+++....
T Consensus 423 lp~P~~--------------------------------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 423 LPRPEG--------------------------------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCC--------------------------------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 433333 9999999999999999999999999999999988543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=325.05 Aligned_cols=237 Identities=30% Similarity=0.401 Sum_probs=203.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh----------------HHHHHHHHHHhceeecCCc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----------------LRELKNKLRLLGCCIDKDE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~----------------~~~~~~i~~~~~~~~~~~~ 106 (354)
.-...+|.+++.||.|+|++|++|+.+ .++.||||++.+...-. +..+..+++++-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345679999999999999999999965 59999999986543211 1122345667778899999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+|+|+||+++|+|.+++ |++...+..+.+|+.||.|||++| |+||||||+|||++.+++++|+|||.|....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999999 889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCccc---------cc--cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 182 GNELQ---------AN--TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 182 ~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
..... .. ...++||..|.+||++.++..+..+|||+|||++|+|+.|.+| |.+.+...++++|....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PP--Fra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPP--FRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCC--CccccHHHHHHHHHHhc
Confidence 32221 11 1447999999999999999999999999999999999999999 88889999999999888
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+|... ++...+||.++|..||.+|+|+++|.+.
T Consensus 304 y~fp~~f---------------------------------p~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 YEFPEGF---------------------------------PEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ccCCCCC---------------------------------CHHHHHHHHHHHccCccccccHHHHhhC
Confidence 8776654 5667899999999999999999998875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.66 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=198.8
Q ss_pred cCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChh-h-----HHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ-G-----LREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~-~-----~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
+.|+.+..+|+|+||.||++++++ |+.||||++...+.. . ++++ +|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 578999999999999999999775 999999999765441 1 2222 388999999999999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
||+..-|+++- .+...+..++.|++.|+.|+|+++ ++||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GD 156 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--cc
Confidence 99986666655 678899999999999999999999 999999999999999999999999999866532 22
Q ss_pred ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
..+..+.|..|+|||++.+ .+|+.++|||++||++.||++|.+.| .+.++.+.+-.|.+..+......-.-.....+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~--PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW--PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC--CCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 3344578999999999987 67999999999999999999999984 45555555555544444443322111111111
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
... ..............-.+....-+.+|++.||..||.+|+|-+|+++
T Consensus 235 F~G--v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHG--VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eee--eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 100 0111122222233334446678899999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=301.32 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=198.4
Q ss_pred hhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhhH--H------------HHHHHHHHhc-eeecCCc-
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQGL--R------------ELKNKLRLLG-CCIDKDE- 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~~--~------------~~~~i~~~~~-~~~~~~~- 106 (354)
......|++.+.||+|.||.||++++ .+|..||.|.+........ + ++.||+++++ .+..++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34456799999999999999999994 5799999999874322111 1 1248888888 4555555
Q ss_pred eEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 107 KILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSR-VRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
++|+||||++|+|...+ +++..+++++.|++.||..+|..-+ ..|+||||||.||+++.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 89999999999999988 7899999999999999999998421 2399999999999999999999999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC-CCC
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE-FPS 255 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 255 (354)
++.......... ..+||+.|++||++.+.+|+.++||||+||++|||+.-++| |.+.+-..+.++|.++..+ .|.
T Consensus 175 ~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~P--F~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 175 GRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSP--FYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred HhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCC--cccccHHHHHHHHHcCCCCCCcH
Confidence 998777654433 36899999999999999999999999999999999999999 7777888889998888543 221
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
.. .+..+.+||..|+..||+.||+...++..+
T Consensus 251 ~~--------------------------------YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 251 EH--------------------------------YSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HH--------------------------------hhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 22 788899999999999999999864444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=308.41 Aligned_cols=233 Identities=29% Similarity=0.476 Sum_probs=190.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHH------------HHHHHHHHhceeecCCceEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLR------------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~------------~~~~i~~~~~~~~~~~~~~lv 110 (354)
..++|.+.+.||+|.||+||+|+++ ++..||||.+.... ....+ +++|||.+++++..++.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3478999999999999999999965 58999999997663 21111 134889999999999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC------CCeEEeeccccee
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD------MNPKISDFGIARI 179 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~------~~~~l~dfg~a~~ 179 (354)
||||.||+|.+++ +++.+++.++.||+.||++||+++ |+||||||+|||++.+ ..+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999 788999999999999999999999 9999999999999865 4689999999998
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
+..+.... ..+|++-|+|||++....|+.++|+||+|+++|++++|+.| |...+..++...+.++....|.....
T Consensus 165 L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P--f~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 165 LQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP--FDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred CCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC--ccccCHHHHHHHHhccccccCchhhh
Confidence 77655332 35899999999999999999999999999999999999999 66667777777776666544443311
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
....+.+|+...+..+|.+|.+..+-.
T Consensus 240 ------------------------------~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 240 ------------------------------LSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ------------------------------ccCchhhhhhHHHhcCccccCchHHhh
Confidence 333345666777777777776655433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.23 Aligned_cols=263 Identities=25% Similarity=0.316 Sum_probs=205.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-----hhHHH---------HHHHHHHhceeecCC-ce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----QGLRE---------LKNKLRLLGCCIDKD-EK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-----~~~~~---------~~~i~~~~~~~~~~~-~~ 107 (354)
....++|.+++.||.|.||.||+|+.+ .|..||||.++..-. ..+++ +.||+++.+++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 345689999999999999999999954 599999999965421 11222 338899999998888 99
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
|+|||||+. +|.+++ |++..++.|+.||++||+++|++| +.|||+||+|||+..+..+||+|||+|+...
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999999977 888887 899999999999999999999999 9999999999999999999999999998655
Q ss_pred CCccccccccccCcccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAI-QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
... ..+..+.|..|+|||++. .+.|+.+.|+|++||+++|+++-++. |.+.+..+.+.+|-+..+......+..
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL--FPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL--FPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc--CCCCcHHHHHHHHHHHhCCCccccchh
Confidence 443 233457899999999886 56689999999999999999999988 677777777777766666554443322
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
-. .......-.+............++++.+..++|.+|+++||.+||||+|+++.
T Consensus 237 g~---~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GY---NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HH---HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 10 00000111111112222333445588999999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=313.26 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=198.7
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh--HH------------HHHHHHHHhceeecCC-c
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LR------------ELKNKLRLLGCCIDKD-E 106 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~--~~------------~~~~i~~~~~~~~~~~-~ 106 (354)
........+.+.+.||.|+||+||++.++....||+|++....... .. ++.||++++++|.... .
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3344455667777799999999999999643349999997643211 11 1237888999999887 7
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccce
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIAR 178 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~ 178 (354)
+++||||+++|+|..++ +++..+++|+.||++||.|||+++. |+||||||+|||++.++ ++||+|||+++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccce
Confidence 99999999999999998 6788899999999999999999873 89999999999999998 99999999997
Q ss_pred eccCCccccccccccCcccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAI--QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
...... ...+...||+.|+|||++. +..++.++||||||+++|||++|..|| .+.........+..+..
T Consensus 193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf--~~~~~~~~~~~v~~~~~----- 263 (362)
T KOG0192|consen 193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF--EDLAPVQVASAVVVGGL----- 263 (362)
T ss_pred eecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC--CCCCHHHHHHHHHhcCC-----
Confidence 655432 2233368899999999999 568999999999999999999999995 44443333333322222
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCC
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~ 328 (354)
++..+..+++.+..||.+||..||+.||++.+++..|+.+......
T Consensus 264 --------------------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 264 --------------------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred --------------------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 2222222788999999999999999999999999999998875554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.67 Aligned_cols=228 Identities=26% Similarity=0.363 Sum_probs=189.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHHH---HH---------HHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---RELK---NK---------LRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~~---~i---------~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||+||+++.+ .++.+|+|++++...-.. .... +| |++.-.+++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 344689999999999999999999965 499999999977543222 1122 22 3455567899999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+|++|+.||.|...+ |++..++-++.+|+.||.|||+.| |+||||||+|||++..|+++|+|||++...-.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998877 889999999999999999999999 99999999999999999999999999974322
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ......+||+.|+|||++.+..|+.++|.||||+++|+|++|.+| |.+.+...+.+.+.++....+...
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pP--F~~~~~~~~~~~I~~~k~~~~p~~----- 248 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPP--FYAEDVKKMYDKILKGKLPLPPGY----- 248 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCC--CcCccHHHHHHHHhcCcCCCCCcc-----
Confidence 21 122236999999999999999999999999999999999999999 777787888888877774443332
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP 310 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 310 (354)
.+...++|+.++|..+|++|.
T Consensus 249 ---------------------------ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 ---------------------------LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---------------------------CCHHHHHHHHHHhccCHHHhc
Confidence 355678999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.12 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=206.8
Q ss_pred cCccccceecccCceeEEEEEE-cCCCEEEEEEecCCCh------hhHHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSG------QGLREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~------~~~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
.+|...+.||+|.||.||+|++ ++|+.||||++..... ...+++ +||+.++++|-+...+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5799999999999999999995 4699999999965432 233333 389999999999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|++. +|...+ +....+..++.++++|++|||.+. |+||||||.|+|++.+|.+||+|||+++.++.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 787777 677889999999999999999999 999999999999999999999999999988766544
Q ss_pred cccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.... +.|..|+|||++.+. .|+..+|+||.||++.||+.|.+. |.+.++.+.+..+-+..++.....|+......
T Consensus 158 ~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~--fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 QTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF--FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC--CCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 4432 568899999999876 489999999999999999998876 67777777777887777777666666554331
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
. +.+....... .....-+.+++...+|+.+||..||.+|+|+.|++++
T Consensus 234 d----Y~~~~~~P~~-~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 D----YVKIQQFPKP-PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred c----HHHHhcCCCC-ccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 1111111111 1111333467777999999999999999999998875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.39 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=221.8
Q ss_pred cCCCCcccccccccccCCCCCcc-ccchhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHH---
Q 048432 17 LPVNSNLTKRSKKKEVDQLPLFS-FSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLREL--- 91 (354)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~--- 91 (354)
++.+.+++++.....|+++.... ........+.|++++.||+|.-|+||+++.+. +..+|+|++.+.......++
T Consensus 45 ~s~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra 124 (459)
T KOG0610|consen 45 PSSSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRA 124 (459)
T ss_pred cCcccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHH
Confidence 33445788889999999988777 57777888999999999999999999999764 68999999987654433222
Q ss_pred ---HHHH---------HHhceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 048432 92 ---KNKL---------RLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152 (354)
Q Consensus 92 ---~~i~---------~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 152 (354)
+.|+ .+|..++.++..|++||||+||+|+.+. |+...++-++.+++-||+|||..| |+
T Consensus 125 ~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---iv 201 (459)
T KOG0610|consen 125 QTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IV 201 (459)
T ss_pred HHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---ee
Confidence 2343 4677889999999999999999999887 889999999999999999999999 99
Q ss_pred eCCCCCCCEEEcCCCCeEEeecccceeccCC----------------------------------cc-------------
Q 048432 153 HRDLKVSNILLDKDMNPKISDFGIARICRGN----------------------------------EL------------- 185 (354)
Q Consensus 153 H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~----------------------------------~~------------- 185 (354)
+|||||+||||.++|++.|+||.++..+... ..
T Consensus 202 YRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p 281 (459)
T KOG0610|consen 202 YRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLP 281 (459)
T ss_pred eccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccch
Confidence 9999999999999999999999987543210 00
Q ss_pred -------ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 186 -------QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 186 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
.......+||-.|.|||++.+..++.++|.|+||+++|||+.|..| |.+.+..+.+..+......+|....
T Consensus 282 ~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TP--FKG~~~~~Tl~NIv~~~l~Fp~~~~ 359 (459)
T KOG0610|consen 282 ELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTP--FKGSNNKETLRNIVGQPLKFPEEPE 359 (459)
T ss_pred hhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCC--cCCCCchhhHHHHhcCCCcCCCCCc
Confidence 0011235799999999999999999999999999999999999999 7888888888888888877776541
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT----MNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~~il~ 317 (354)
.+..+++||+++|.+||++|.- |+||-+
T Consensus 360 -------------------------------vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 360 -------------------------------VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -------------------------------chhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 6678899999999999999998 777654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=309.47 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=197.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHHHH---------------HHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNK---------------LRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~~i---------------~~~~~~~~~~~~~ 107 (354)
....++|++++.||+|+||.||+|+-+ .|..+|+|++++.......+..|+ |+++-.|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346789999999999999999999955 599999999998776665555433 5677788999999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+||||++||++--++ +++..++-.+.+++-||..||+.| ++||||||+|+||+..|++||+|||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999998888 788889999999999999999999 99999999999999999999999999843211
Q ss_pred C----------------------ccc------cc-----------------cccccCcccccCccccccCCCCchhhHHH
Q 048432 183 N----------------------ELQ------AN-----------------TGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217 (354)
Q Consensus 183 ~----------------------~~~------~~-----------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 217 (354)
. +.. .. ....+||+.|+|||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 000 00 01357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccchhhhhhhhccccC--CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHH
Q 048432 218 FGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE--FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYV 295 (354)
Q Consensus 218 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~ 295 (354)
||||+|||+.|.+| |...+..+..+.+..+... +|.... +..+..
T Consensus 374 LG~ImyEmLvGyPP--F~s~tp~~T~rkI~nwr~~l~fP~~~~-------------------------------~s~eA~ 420 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPP--FCSETPQETYRKIVNWRETLKFPEEVD-------------------------------LSDEAK 420 (550)
T ss_pred HHHHHHHHHhCCCC--CCCCCHHHHHHHHHHHhhhccCCCcCc-------------------------------ccHHHH
Confidence 99999999999999 7888888888888777643 333221 456778
Q ss_pred HHHhhccccCCCCCC---CHHHHHH
Q 048432 296 NIALLCVQESADDRP---TMNDVVS 317 (354)
Q Consensus 296 ~li~~cl~~~P~~Rp---s~~~il~ 317 (354)
+||.+|+- ||++|. .++||.+
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999 999997 4666654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=306.59 Aligned_cols=238 Identities=26% Similarity=0.372 Sum_probs=199.3
Q ss_pred hhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhh------------HHHHHHHHHHhceeecCCceEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQG------------LRELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~------------~~~~~~i~~~~~~~~~~~~~~lv 110 (354)
......|.....||+|+.|.||.|.. ..++.||+|.+....... ...++|+|.+++.|...+.+++|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 45667899999999999999999994 468899999986543221 12346999999999989999999
Q ss_pred EEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 111 YEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 111 ~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||++||+|.+.+ +++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++........
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999999998 889999999999999999999999 99999999999999999999999999876655443
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.+...+||+.|+|||+.....|++++||||||++++||+-|.+| |...+....+..|.....+.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPP--YlnE~PlrAlyLIa~ng~P~------------- 488 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYLIATNGTPK------------- 488 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCC--ccCCChHHHHHHHhhcCCCC-------------
Confidence 23346899999999999999999999999999999999999999 45455555555544333221
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+...++.+++|+.+||+.|+++|+||.++|+.
T Consensus 489 -----------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 -----------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -----------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11112278899999999999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=301.98 Aligned_cols=270 Identities=42% Similarity=0.709 Sum_probs=211.8
Q ss_pred CCCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh----hHHH--------HHHHHHHhcee
Q 048432 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ----GLRE--------LKNKLRLLGCC 101 (354)
Q Consensus 34 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~----~~~~--------~~~i~~~~~~~ 101 (354)
....|++.++..++++|.-.+.||+|+||.||+|...+|..||||++.....+ -..+ ++|+++++++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 67779999999999999999999999999999999988899999998776543 1111 23888999999
Q ss_pred ecCC-ceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 102 IDKD-EKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 102 ~~~~-~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
.+.+ ..++|+||+..|+|.+.+ ++|..+++|+.++++||+|||....++|+|||||++|||+|.+...||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 499999999999999997 47999999999999999999998877899999999999999999999999
Q ss_pred cccceeccC-Cccccccccc-cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-cchhhhhhhhccc
Q 048432 174 FGIARICRG-NELQANTGRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTLLGYISENI 250 (354)
Q Consensus 174 fg~a~~~~~-~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~ 250 (354)
||++..... ..... .. .||..|++||.+..+..+.++||||||+++.||++|+.+.+.... ....+..+.....
T Consensus 221 FGLa~~~~~~~~~~~---~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVS---TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCcccCCcccccee---eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999965443 22111 11 689999999999988999999999999999999999988654331 1222222221111
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHH-HHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVC-LCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
... ....++|+.... ..... .+...+..+..+|++.+|++||++.|+++.|+.+..
T Consensus 298 ~~~--------~~~eiiD~~l~~----------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEG--------KLREIVDPRLKE----------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCc--------chhheeCCCccC----------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 110 111233332111 11111 366678999999999999999999999999976653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=303.82 Aligned_cols=263 Identities=26% Similarity=0.334 Sum_probs=200.1
Q ss_pred hhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecC--Cc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDK--DE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~--~~ 106 (354)
+...+.|+.++.||+|.||.||+|++ .+|+.||+|++...... ..+++ +||+++.+.+... ..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 44556899999999999999999995 46999999998765421 12222 3788888887766 78
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
+|+|+|||++ +|..++ |+..++..++.||+.||.|||.+| |+|||||.+||||+.+|.+||+|||+|+++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999999988 676666 889999999999999999999999 999999999999999999999999999977
Q ss_pred cCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
......... ..+-|+.|+|||++.+. .|+.++|+||.||||.||+.|++. +.+.+..+.+..|-+..+......|.
T Consensus 269 ~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI--~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI--LQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC--cCCccHHHHHHHHHHHhCCCChhccc
Confidence 665544333 34569999999999875 599999999999999999999999 66777666666666666655444443
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+ +......+-...-...++.. -...++...+|+..+|..||.+|.||.++|.
T Consensus 346 ~~k---LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSK---LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccc---CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 11111001111001111111 2225677789999999999999999998875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.04 Aligned_cols=232 Identities=28% Similarity=0.394 Sum_probs=205.4
Q ss_pred hcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCCh---------------hhHHHHHHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSG---------------QGLRELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~---------------~~~~~~~~i~~~~~~~~~~~~~~lv 110 (354)
.+-|++++.||.|+.|.|-+|++ ..|+.+|||++.+... +.+.++.|++++++++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46789999999999999999995 4699999999977621 1223344888999999999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
.||++||.|.+++ +.+..+.+.+.||+.|+.|+|..+ |+||||||+|+|++..+.+||+|||+|.....+..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999999998 789999999999999999999999 99999999999999999999999999986655554
Q ss_pred ccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
... .||.+.|++||++.+.+| +.++||||+|+|||.|++|+.| |.+.+...++.++.+|...+|..
T Consensus 168 LeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP--FdDdNir~LLlKV~~G~f~MPs~-------- 234 (786)
T KOG0588|consen 168 LET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP--FDDDNIRVLLLKVQRGVFEMPSN-------- 234 (786)
T ss_pred ccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC--CCCccHHHHHHHHHcCcccCCCc--------
Confidence 433 389999999999999997 7899999999999999999999 55888899999999999988732
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
.+.+.++|+++||..||++|.|.+||++.-
T Consensus 235 -------------------------Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 235 -------------------------ISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -------------------------CCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 567789999999999999999999999863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=305.35 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=200.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCC----Ch---h--hHHH---------HHHHHHHhceeec
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGR----SG---Q--GLRE---------LKNKLRLLGCCID 103 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~----~~---~--~~~~---------~~~i~~~~~~~~~ 103 (354)
.....++|.+.+.||+|+||.|+.|.+. .|..||+|++... .. . ..++ +.||+++++++..
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 4456789999999999999999999854 6899999977553 11 1 0111 2377888899999
Q ss_pred CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccc
Q 048432 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIA 177 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a 177 (354)
...+++|||||.||.|.+++ +.+..++.++.|++.|++|||++| |+||||||+|++++.+ +.+||+|||++
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999998 678899999999999999999999 9999999999999999 99999999999
Q ss_pred eecc-CCccccccccccCcccccCccccccCC-C-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 178 RICR-GNELQANTGRIVGTYRYMSPEYAIQGI-F-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 178 ~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
.... ... .....+|++.|+|||++.+.. | +.++||||+|++||.|++|..| |.+.+...+...+.++...+|
T Consensus 169 ~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P--F~d~~~~~l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 169 AISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP--FDDSNVPNLYRKIRKGEFKIP 243 (370)
T ss_pred cccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC--CCCccHHHHHHHHhcCCccCC
Confidence 8763 222 223468999999999999877 7 5899999999999999999999 555677777777777777666
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.... +..+..|+.+||..||.+|+|+.+|+ .-.-..
T Consensus 244 ~~~~--------------------------------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 244 SYLL--------------------------------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred CCcC--------------------------------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 5431 45678999999999999999999999 444444
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.34 Aligned_cols=245 Identities=26% Similarity=0.359 Sum_probs=182.8
Q ss_pred hhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HH-------------HHHHHHHHhceeec
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LR-------------ELKNKLRLLGCCID 103 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~-------------~~~~i~~~~~~~~~ 103 (354)
....++|++.+.||+|+||.||+|.+. .++.||+|++....... .. .+.|++++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345679999999999999999999742 35679999987543211 11 23356666676654
Q ss_pred C-CceEEEEEecCCCCHhHHHh----------------------------------------------------------
Q 048432 104 K-DEKILIYEYMPNKSLDFFLF---------------------------------------------------------- 124 (354)
Q Consensus 104 ~-~~~~lv~e~~~~~~L~~~~~---------------------------------------------------------- 124 (354)
. ..++++|||+++|+|.+++.
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 3 45889999999999987762
Q ss_pred ---------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCc
Q 048432 125 ---------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195 (354)
Q Consensus 125 ---------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~ 195 (354)
++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++................++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23456788999999999999999 999999999999999999999999998754322211112223456
Q ss_pred ccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhh
Q 048432 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKL 274 (354)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 274 (354)
..|+|||++.+..++.++|||||||++|+|++ |..||...... ......+..+.....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~-------------------- 298 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTRMRA-------------------- 298 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCCCCCC--------------------
Confidence 78999999988889999999999999999997 99996433221 122222222111100
Q ss_pred hhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 275 FSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+..+++.+.+||.+||+.||++|||+.++++.|+++..
T Consensus 299 ------------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 299 ------------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11156678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=306.34 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=206.6
Q ss_pred CCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCC--hhhHHHHH------------HHHHHhce
Q 048432 35 LPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGC 100 (354)
Q Consensus 35 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~ 100 (354)
.+-.+..+|+...++..+...||+|.||+||+|+|. | .||||+++... ....+.++ ||+-++++
T Consensus 379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cCCccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 344677899999999999999999999999999984 3 49999997653 34455555 55556778
Q ss_pred eecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
+..++. .||+.+|+|.+|..++ |++.+.+.|+.||++|+.|||.++ |+|+|||..||++.++++|+|+||
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 877665 9999999999999988 888999999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
|++..-..-..........+...|+|||++. ..+|++.+|||||||++|||++|..| |.......++.++-++..
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lP--ysi~~~dqIifmVGrG~l 610 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELP--YSIQNRDQIIFMVGRGYL 610 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCC--cCCCChhheEEEeccccc
Confidence 9986543322222223345788999999986 35799999999999999999999999 446666677777666643
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
...... ...+|+.++.+|+..||.+++++||.+.+|+..|+.+..
T Consensus 611 ~pd~s~----------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLSK----------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Cccchh----------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 221111 112289999999999999999999999999999988774
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=311.18 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=205.8
Q ss_pred CccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHHH--------------HHHHHh
Q 048432 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---RELK--------------NKLRLL 98 (354)
Q Consensus 37 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~~--------------~i~~~~ 98 (354)
.+.+..-..+..+|.+.+.||+|.||+|.+|.+. +++.||||+++....-.. .++. |+|+++
T Consensus 175 dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 175 DYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred ceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 3555555666679999999999999999999965 599999999987643222 2221 667889
Q ss_pred ceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC--CCe
Q 048432 99 GCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNP 169 (354)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~ 169 (354)
+++.+.++.|||+|.+.. +|.+++ ++...++.++.||+.||.+||+.+ |+|+||||+|||+..- ..+
T Consensus 255 d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCce
Confidence 999999999999999855 999998 788999999999999999999999 9999999999999653 479
Q ss_pred EEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
||+|||.++....... ....+..|+|||++.+.+|+.+.||||||||++||++|.+. |.+.+..+.+..|.+.
T Consensus 331 KVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL--fpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL--FPGDNEYDQLARIIEV 403 (586)
T ss_pred eEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc--cCCCCHHHHHHHHHHH
Confidence 9999999987555443 23557899999999999999999999999999999999877 6777777777776666
Q ss_pred ccCCCCc-ccCCccccccchh-h---------------------------hhhhhhc-cccCCchhHHHHHHHHHHHHHh
Q 048432 250 IYEFPSV-DTHNVKTFGFLHL-T---------------------------IFKLFSI-SSVGLSNDIVCLCILRYVNIAL 299 (354)
Q Consensus 250 ~~~~~~~-~~~~~~~~~~~d~-~---------------------------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~ 299 (354)
.+..|.. .+...++..+.+. . ....... .+..+...........+.+|+.
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 6544432 2222222222222 0 0000000 1112222222246778899999
Q ss_pred hccccCCCCCCCHHHHHHH
Q 048432 300 LCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 300 ~cl~~~P~~Rps~~~il~~ 318 (354)
+||++||.+|+|+.++++.
T Consensus 484 ~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHhccCchhcCCHHHHhcC
Confidence 9999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.68 Aligned_cols=248 Identities=28% Similarity=0.388 Sum_probs=209.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HH------------HHHHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LR------------ELKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~------------~~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..... +. +++||++++++|.+..++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999966 58899999997654332 11 23489999999999999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
||.| +|..++ +++..++.++.+++.||.|||+.+ |.|||+||+||++..+|.+|++|||+|+..+... .
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--S 155 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc--e
Confidence 9988 888887 889999999999999999999999 9999999999999999999999999998766543 2
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
..+...||+.|+|||++.+.+|+..+|+||+||++||++.|++| |+......+.+.|.......|. .
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PP--F~a~si~~Lv~~I~~d~v~~p~-~---------- 222 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPP--FYARSITQLVKSILKDPVKPPS-T---------- 222 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCC--chHHHHHHHHHHHhcCCCCCcc-c----------
Confidence 33456899999999999999999999999999999999999999 7778888888888766655444 1
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HhhhhhhhcCCCCCCCccc
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALLPPKQPAFSY 336 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~~~~~~~~~~~~~~ 336 (354)
.+..+.+|+..+|.+||.+|.|..+++. +.++-......+..+.+..
T Consensus 223 ----------------------~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~s 271 (808)
T KOG0597|consen 223 ----------------------ASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDS 271 (808)
T ss_pred ----------------------ccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccC
Confidence 5777899999999999999999999885 3455444555555544443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=290.35 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=196.4
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh-hHHH------------HHHHHHHhceeecC
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ-GLRE------------LKNKLRLLGCCIDK 104 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~-~~~~------------~~~i~~~~~~~~~~ 104 (354)
+...++...+.|++...||.|..++||+|++ +.+..||||++....-. .+.. +.||+.++..|..+
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 4455667789999999999999999999995 46899999999643211 1122 23778888888999
Q ss_pred CceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 105 DEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
..+|+||+||.+|++.+++ +.+..+..|+.++++||.|||++| .+|||||+.||||+.+|.|+|+|||.+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999999999998 778889999999999999999999 999999999999999999999999986
Q ss_pred eecc-CCcccccc-ccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 178 RICR-GNELQANT-GRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 178 ~~~~-~~~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
...- .+...... ....|+++|+|||++.. ..|+.++||||||++..||.+|..||.- .-...++-+-.++..+.
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k--~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK--YPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc--CChHHHHHHHhcCCCCC
Confidence 5332 22222222 45689999999999654 3589999999999999999999999543 33333333333444333
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+... +...+........++++|..||+.||++||||+++++
T Consensus 252 ~~t~-----------------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTS-----------------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccc-----------------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 3211 1122333335668999999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=279.17 Aligned_cols=222 Identities=29% Similarity=0.419 Sum_probs=192.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------HHHH---------HHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------KNKL---------RLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------~~i~---------~~~~~~~~~~~~~ 108 (354)
....+|++.+.||.|+||.|.+++.+ +|..+|+|++.+...-.+.+. ++++ ++++.+.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 44578999999999999999999965 589999999977544333222 2333 3455678889999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||||.+||.|..++ |++..++-++.||+.||+|||+.+ |++|||||+|||++.+|.+||+|||.|......
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999888 899999999999999999999999 999999999999999999999999999865444
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
. ...+||+.|+|||++...+++.++|.|+||+++|||+.|.+| |++.+...+.+.|..+...+|.-.
T Consensus 198 T-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pP--F~~~~~~~iY~KI~~~~v~fP~~f------ 264 (355)
T KOG0616|consen 198 T-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPP--FYDDNPIQIYEKILEGKVKFPSYF------ 264 (355)
T ss_pred E-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCC--CcCCChHHHHHHHHhCcccCCccc------
Confidence 3 336899999999999999999999999999999999999999 677777899999988888777644
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCC
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR 309 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 309 (354)
+..+.+|+..+|+.|-.+|
T Consensus 265 ---------------------------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 ---------------------------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---------------------------CHHHHHHHHHHHhhhhHhh
Confidence 5567899999999999999
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.75 Aligned_cols=234 Identities=25% Similarity=0.406 Sum_probs=203.7
Q ss_pred hhhhhcCccccceecccCceeEEEEE-EcCCCEEEEEEecCCChhhHHHH---------------HHHHHHhceeecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLREL---------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~~~~~~---------------~~i~~~~~~~~~~~~ 106 (354)
-.....+|++.+.||+|.||.|-+|. +..|+.||||.+.++.....+.+ .||+.++++|.+.+.
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 34455799999999999999999999 46799999999987754433322 266778899999999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+.|||||..+|.|.+++ +++..+++++.||++|+.|+|+++ ++|||||.+|||+++++.+||+|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999999 889999999999999999999999 9999999999999999999999999998777
Q ss_pred CCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.....+. ++|++.|++||++.+.+| ++.+|.||||++||.|+.|..| |.+.+-..++++|.++.+..|.-
T Consensus 205 ~~kfLqT---FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP--FDG~Dhk~lvrQIs~GaYrEP~~---- 275 (668)
T KOG0611|consen 205 DKKFLQT---FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP--FDGRDHKRLVRQISRGAYREPET---- 275 (668)
T ss_pred cccHHHH---hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc--cCCchHHHHHHHhhcccccCCCC----
Confidence 6665443 589999999999999998 7899999999999999999999 66677778888898888765542
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+....-||++||..||++|.|+++|...
T Consensus 276 ------------------------------PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 276 ------------------------------PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ------------------------------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 3344679999999999999999998765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=290.95 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=186.1
Q ss_pred hcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCC--ceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKD--EKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~--~~~lv~ 111 (354)
..+|...+.||+|.||.||++...+ |...|||..........+.+ .|||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 6789999999999999999999764 89999999877642221111 25566666544444 589999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccceeccC-C
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARICRG-N 183 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a~~~~~-~ 183 (354)
||+.+|+|.+++ +++..+++.+.||++||+|||++| |+||||||+|||++. ++.+||+|||++..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999998 578899999999999999999999 999999999999999 79999999999876553 2
Q ss_pred ccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
..........||+.|+|||++..+ ....++|||||||++.||+||.+||... .......-.+.... ..|
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-~~P-------- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-SLP-------- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-CCC--------
Confidence 222233346899999999999853 3346999999999999999999996543 22222222221111 111
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
..+...+....+|+.+|+..+|++||||+++|+..--..
T Consensus 243 ----------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 ----------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 122226778899999999999999999999998765544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.09 Aligned_cols=234 Identities=23% Similarity=0.373 Sum_probs=190.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH-HHH------------HHHHHHhceeecCCceEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL-REL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~-~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
.....|.....||+|.||.||+|.+. .++.||+|++........ +.+ .++.++++.|..+..++++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34567888899999999999999954 588999999976543221 111 2677889999999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||.||++.+.+ +++..+.-++.+++.|+.|||..+ .+|||||+.||++..+|.++|+|||.+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999998 477778889999999999999999 99999999999999999999999999987665543
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.. ..++||+.|+|||++.+..|+.++||||||++.+||.+|.+|+ .+......+..|.+..++.-.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~--s~~hPmrvlflIpk~~PP~L~---------- 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH--SKLHPMRVLFLIPKSAPPRLD---------- 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC--cccCcceEEEeccCCCCCccc----------
Confidence 32 3468999999999999889999999999999999999999994 333333333333322222111
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+++.+++||..||+.||+.||||.++++
T Consensus 233 ----------------------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 ----------------------GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ----------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 117888999999999999999999988875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=291.89 Aligned_cols=248 Identities=29% Similarity=0.423 Sum_probs=183.3
Q ss_pred hhcCccccceecccCceeEEEEEEcC-----------------CCEEEEEEecCCChh-hHHHH------------HHHH
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN-----------------GDEIAVKRLSGRSGQ-GLREL------------KNKL 95 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~-----------------~~~vavK~~~~~~~~-~~~~~------------~~i~ 95 (354)
..++|++.+.||+|+||.||+|.+++ +..||+|++...... ....+ .|++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45789999999999999999998532 336999998764322 11122 2566
Q ss_pred HHhceeecCCceEEEEEecCCCCHhHHH------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 048432 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151 (354)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i 151 (354)
++++++...+..+++|||+.+++|.+++ +++.....++.||+.||.|||+.+ |
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 6777888888899999999999998876 134567899999999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 152 ~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
+|+||||+||+++.++.++|+|||++................++..|+|||++....++.++|+|||||++|+|+++..+
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999998754433322222223456789999999888899999999999999999875433
Q ss_pred CCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC
Q 048432 232 TGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT 311 (354)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 311 (354)
+++......+....+........... ....++.++..+.+||.+||+.+|++|||
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQV-------------------------YLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccc-------------------------cccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 33444443333332221110000000 00001126778999999999999999999
Q ss_pred HHHHHHHhhh
Q 048432 312 MNDVVSMLTN 321 (354)
Q Consensus 312 ~~~il~~L~~ 321 (354)
+++|.+.|++
T Consensus 295 ~~~i~~~l~~ 304 (304)
T cd05096 295 FSDIHAFLTE 304 (304)
T ss_pred HHHHHHHHhC
Confidence 9999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=288.67 Aligned_cols=228 Identities=25% Similarity=0.313 Sum_probs=185.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hH----HH--------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GL----RE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~----~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|.++ +++.||+|++...... .. .+ +.|++++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999975 5899999998643211 11 11 237888888899999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+.+++|.+++ +++.....++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 999999999887 677888999999999999999999 9999999999999999999999999987543321
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
....|+..|+|||++.+..++.++|||||||++|+|++|..|| ...+.......+..+...++.
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf--~~~~~~~~~~~i~~~~~~~~~----------- 219 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF--FDDNPFGIYEKILAGKLEFPR----------- 219 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCcCCCc-----------
Confidence 1246789999999998888999999999999999999999995 444444445544443322221
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
..+..+.+||.+||+.||++||+ ++++++.
T Consensus 220 ----------------------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 ----------------------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----------------------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 13556789999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.29 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred cCCCCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH------HHHH----------
Q 048432 32 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE------LKNK---------- 94 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~------~~~i---------- 94 (354)
.+..+.++-.+......+|.+.++||+|.||+|++|..+ +++.+|||++++...-...+ .++|
T Consensus 352 ~~~~~~~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL 431 (694)
T KOG0694|consen 352 NSGPPEFPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFL 431 (694)
T ss_pred CCCcccCCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeE
Confidence 444555555556777889999999999999999999976 48899999998765422221 1233
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
+.++..+++..++|+||||+.||++..++ |++..++-++..|+.||.|||++| |+|||||.+|||+|.+|.+|
T Consensus 432 ~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 432 VNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred eecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence 34667889999999999999999965444 899999999999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
|+|||++...-.. ....+.++||+.|+|||++.+..|+.++|.||||++||||+.|..| |.+.+.+++...|....
T Consensus 509 iADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~P--F~gddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 509 IADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESP--FPGDDEEEVFDSIVNDE 584 (694)
T ss_pred ecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCC--CCCCCHHHHHHHHhcCC
Confidence 9999999743211 2234457999999999999999999999999999999999999999 77788888888877666
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
...|.. .+.+..++|+++|..+|++|.-+
T Consensus 585 ~~yP~~---------------------------------ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPRF---------------------------------LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCc---------------------------------ccHHHHHHHHHHhccCcccccCC
Confidence 555443 46677899999999999999854
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=267.53 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=192.4
Q ss_pred cchhhhhcCccccceecccCceeEEEEE-EcCCCEEEEEEecCCChhhHHHH------------HHHHHHhceeec----
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCID---- 103 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~---- 103 (354)
..+-...++|++.+.||.|||+-||+++ ..+++.||+|++...+....+.. .|+++++++...
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3456678899999999999999999999 45688999999977664333222 256666666543
Q ss_pred -CCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 104 -KDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 104 -~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
....|++++|...|+|.+.+ +++.+++.|+.+|++||.+||... ++++||||||.||+++.++.+++.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence 34589999999999998887 678899999999999999999985 4799999999999999999999999
Q ss_pred cccceeccCC----c---cccccccccCcccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhh
Q 048432 174 FGIARICRGN----E---LQANTGRIVGTYRYMSPEYAIQG---IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLL 243 (354)
Q Consensus 174 fg~a~~~~~~----~---~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~ 243 (354)
||.+....-. . ..+.-.....|..|+|||++.-. ..+.++|||||||+||.|+.|..||...-.....+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998643211 1 01111223568899999998643 468999999999999999999999754322222222
Q ss_pred hhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 244 GYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
--+..+...+|.... .++.+.++|++||+.||.+||++.+++..++++.
T Consensus 253 LAv~n~q~s~P~~~~-------------------------------yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSR-------------------------------YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EeeeccccccCCCCC-------------------------------ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 222332333332221 6888999999999999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=286.51 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=185.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||+|+||.||+|+++ +++.||+|++...... ...+ +.|++++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999976 5888999998653211 1111 2377788889999999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|+.++++..+. +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA- 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence 99998776654 667888999999999999999999 999999999999999999999999998765332211
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
......++..|+|||++.+..++.++|+||+||++|+|++|++||.. .+..+....+.......+.............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG--ESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 11224678899999999888899999999999999999999999643 3322222222222222111100000000000
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...... ................+..+.+||.+||+.||++|||++++++
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFP-AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccC-cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 0000000011112225678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=312.51 Aligned_cols=245 Identities=30% Similarity=0.497 Sum_probs=206.8
Q ss_pred hhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~ 105 (354)
-...+-.+.+.||+|.||.||+|+.. ..+.||||.++..... ...++ +|||+++++|..++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34456678899999999999999944 2567999999877655 33333 38889999999999
Q ss_pred ceEEEEEecCCCCHhHHH-------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 106 EKILIYEYMPNKSLDFFL-------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
.+++|+|||..|+|.+++ ++..+.+.|+.||+.|+.||-++. +|||||..+|+||+++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 999999999999999998 345778999999999999999999 9999999999999999
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 245 (354)
..|||+|||+++.....+........--.+.|+|||.+..++++.++||||+|++|||+|+ |..| +++..+.+.++.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QP--y~glSn~EVIe~ 717 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQP--YYGLSNQEVIEC 717 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCc--ccccchHHHHHH
Confidence 9999999999986555443333322233579999999999999999999999999999998 8888 788888888988
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+.++.. .+.. .+||.++++||..||+.+|++|||+.||-.+|+....+
T Consensus 718 i~~g~l-L~~P-------------------------------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQL-LSCP-------------------------------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHcCCc-ccCC-------------------------------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 887775 2222 22999999999999999999999999999999998744
Q ss_pred c
Q 048432 326 L 326 (354)
Q Consensus 326 ~ 326 (354)
.
T Consensus 766 s 766 (774)
T KOG1026|consen 766 S 766 (774)
T ss_pred C
Confidence 3
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.99 Aligned_cols=239 Identities=30% Similarity=0.483 Sum_probs=191.5
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
....+|++.+.||.|++|.||+|.++++..+++|++..........+ .|++++++++......+++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45578999999999999999999988899999999976654222222 267788888888999999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++++|.+++ +++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999987 567888999999999999999999 99999999999999999999999999875543221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. ....++..|++||.+....++.++|+||||+++|+|++ |..|| ......+....+...... +.
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~--~~~~~~~~~~~~~~~~~~-~~--------- 225 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY--PGMNNHEVYDQITAGYRM-PC--------- 225 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCC--CcCCHHHHHHHHHhCCcC-CC---------
Confidence 11 12345678999999988889999999999999999998 78885 333333344433322111 00
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
+..+++.+.++|.+||+.+|++|||+.++++.|+.+
T Consensus 226 ----------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 ----------------------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.46 Aligned_cols=239 Identities=24% Similarity=0.403 Sum_probs=186.6
Q ss_pred hhcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
..++|++.+.||+|+||.||+|.++ .+..||+|.+....... ...+ .|++++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3568999999999999999999854 36689999987653222 1111 25667777888889999
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+||||+++++|.+++ +++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999887 577889999999999999999999 99999999999999999999999998754322
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... ......++..|+|||.+.+..++.++||||+||++|++++ |..|| ......+....+.++... +.
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~--~~~~~~~~~~~~~~~~~~-~~------ 229 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY--WDMSGQDVIKAVEDGFRL-PA------ 229 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCc--CcCCHHHHHHHHHCCCCC-CC------
Confidence 2111 1111234568999999998899999999999999999875 99884 444444444444333211 11
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
+..++..+.+++.+||+.+|++|||+++|++.|..+
T Consensus 230 -------------------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 -------------------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------------------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111677889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=295.54 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=184.5
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-----HH---------HHHHHHHHhcee
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-----LR---------ELKNKLRLLGCC 101 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-----~~---------~~~~i~~~~~~~ 101 (354)
.+....++|++.+.||+|+||.||+|.+. .+..||+|++....... .+ .+.|++++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34455668999999999999999999731 36689999986432111 11 235777888888
Q ss_pred ecCCceEEEEEecCCCCHhHHH----------------------------------------------------------
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL---------------------------------------------------------- 123 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~---------------------------------------------------------- 123 (354)
...+..++|||||++|+|.+++
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 8999999999999999998776
Q ss_pred ----------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 124 ----------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 124 ----------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 234557789999999999999999 9999999999999999999999999987554
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
............++..|+|||++.+..++.++|+|||||++|+|++ |..||..... .....+.+..+.....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~~------ 338 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIKEGYRMLS------ 338 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-hHHHHHHHHhCccCCC------
Confidence 3322111222234567999999999899999999999999999998 7888533211 1122222221111000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
+...+..+.+||.+||+.||++|||+.+|++.|++.
T Consensus 339 --------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 --------------------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=280.79 Aligned_cols=238 Identities=29% Similarity=0.492 Sum_probs=187.6
Q ss_pred hcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|++...... ....+ .|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998643 478999998765433 11112 2667778888888999
Q ss_pred EEEEEecCCCCHhHHH-------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 108 ILIYEYMPNKSLDFFL-------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
+++|||+++++|.+++ +++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999999887 345678899999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 247 (354)
++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..|| ...+.......+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~--~~~~~~~~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW--YGLSNEEVIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHHHH
Confidence 99999999875433222112222344678999999999999999999999999999998 99884 4444444444444
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
.+....+.. ..+..+.+++.+||+.+|++|||++++++.|++
T Consensus 239 ~~~~~~~~~--------------------------------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGRLLQRPR--------------------------------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCcCCCCC--------------------------------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 333222111 156778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=293.24 Aligned_cols=230 Identities=25% Similarity=0.326 Sum_probs=186.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH----H--------HHHHHHHhceeecCCceEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR----E--------LKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~----~--------~~~i~~~~~~~~~~~~~~l 109 (354)
..++|++.+.||+|+||.||+|+++ +++.||+|++..... .... + +.|++++++++.+++.+++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3578999999999999999999975 589999999865321 1111 1 1266778888889999999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
||||+.+++|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999998887 577888899999999999999999 9999999999999999999999999987653322
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
....|++.|+|||++.+..++.++|+|||||++|+|++|..|| .+.........+..+....|..
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf--~~~~~~~~~~~i~~~~~~~p~~-------- 237 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF--FDDTPFRIYEKILAGRLKFPNW-------- 237 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC--CCCCHHHHHHHHhcCCcCCCCC--------
Confidence 1246789999999999888999999999999999999999995 4444444555554443332211
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
.+..+.+||.+||+.||++||+ ++++++.
T Consensus 238 -------------------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 -------------------------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------------------------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 3456789999999999999997 6888754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=277.65 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=202.9
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhHHHH--------HHHHHHhceeecC--C
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGLREL--------KNKLRLLGCCIDK--D 105 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~~~~--------~~i~~~~~~~~~~--~ 105 (354)
.....+.|+.+..|++|.||.||+|+++ ++..||+|+++.... ..++++ .|||.+-.++... +
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 3556678999999999999999999975 588999999865432 223332 3777777776543 5
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.+|+|||||++ +|..++ |....+.-++.|+++|++|||.+. |+|||||++|+|++..|.+||+|||+|+.
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 69999999987 777776 778889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCccccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
++..... .+..+-|+.|+|||++.+.+ |+.+.|+||+|||+.|++++++. |.+....+.+.+|.+..+......|
T Consensus 227 ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl--f~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 227 YGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL--FPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC--CCCCchHHHHHHHHHHhCCCccccC
Confidence 7766322 23356699999999998865 89999999999999999999988 6777777777777777776666665
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCL-CILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+.+.....+.. .....+.-..++..+... ..+.-.+|+..+|.+||++|.||+|.|+.
T Consensus 303 pg~~~lp~~k~--~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKK--MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhc--cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 55543332210 001111111112222211 34666899999999999999999998764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=281.17 Aligned_cols=279 Identities=23% Similarity=0.306 Sum_probs=204.9
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---h---hHHH--------HHHHHHHhceeec-
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---Q---GLRE--------LKNKLRLLGCCID- 103 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~---~~~~--------~~~i~~~~~~~~~- 103 (354)
..........|...+.||.|+||.|..|.++ +|..||+|++...-. . ..++ ++|++.+.+++..
T Consensus 14 ~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 14 FGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred eeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 3455667788888999999999999999965 699999999973211 1 1111 2255666555543
Q ss_pred ----CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 104 ----KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 104 ----~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
-+.+|+|+|+| +.+|+..+ +....+..+++||++||+|+|+.+ ++||||||.|++++.+..+|++||
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence 35789999999 55888887 667889999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
|+|+...........+..+.|..|+|||++.. ..|+.+.||||.|||+.||++|++. |.+.+..+.++.|....+..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkpl--FpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPL--FPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCC--CCCCchHHHHHHHHHhcCCC
Confidence 99997765433334466788999999998864 5699999999999999999999999 66677666677776666655
Q ss_pred CCcccCCcc---ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhhhcCC
Q 048432 254 PSVDTHNVK---TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALLP 328 (354)
Q Consensus 254 ~~~~~~~~~---~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~~~~~ 328 (354)
+......+. ++.++.. ........+... -+...+...+|+.+||..||.+|+|++|+|+. |...-.....
T Consensus 248 ~~e~l~~i~s~~ar~yi~s----lp~~p~~~f~~~-fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKS----LPQIPKQPFSSI-FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred CHHHHHHhccHHHHHHHHh----CCCCCCCCHHHH-cCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 443322222 1111111 111111111111 12467788899999999999999999999874 5555544444
Q ss_pred C
Q 048432 329 P 329 (354)
Q Consensus 329 ~ 329 (354)
|
T Consensus 323 P 323 (359)
T KOG0660|consen 323 P 323 (359)
T ss_pred C
Confidence 4
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.81 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=186.2
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHH-------------HHHHHHHHhce
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLR-------------ELKNKLRLLGC 100 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~-------------~~~~i~~~~~~ 100 (354)
..|....++|++.+.||+|+||.||+|.+. ++..||+|.+...... ... .+.|+++++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 345666779999999999999999999843 2457999999754321 111 23366777788
Q ss_pred eecCCceEEEEEecCCCCHhHHH---------------------------------------------------------
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL--------------------------------------------------------- 123 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~--------------------------------------------------------- 123 (354)
+...+..++|||||.+|+|.+++
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 88889999999999999998876
Q ss_pred ------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 124 ------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 124 ------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
+++..+.+++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 234567899999999999999999 99999999999999999999999999875433322
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||..... ......+.......+.
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--~~~~~~~~~~~~~~~~--------- 336 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--NSKFYKMVKRGYQMSR--------- 336 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--cHHHHHHHHcccCccC---------
Confidence 111112234567999999988889999999999999999997 9999643221 1111111111111000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+...+..+.++|.+||+.+|++|||++++++.|+++.
T Consensus 337 ----------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 ----------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0013567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=284.91 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=185.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHHH--------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||.|+||.||+|..+ +++.||+|++...... ...+. .|++++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3568999999999999999999965 5889999998643221 11111 26677788888888899999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++ +|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99986 777766 467788999999999999999999 99999999999999999999999999875433221
Q ss_pred ccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||++.+ ..++.++|+||+||++|+|++|++|| .+.+..+....+.+.....+...++.....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF--PGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 1122456889999998875 45899999999999999999999995 444444444444433333333222221111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...... ..............+..+....+||.+||+.||++|||++|+++
T Consensus 235 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSY---LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhcc---ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00000000000111124567789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=292.04 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=184.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|.+. +++.||+|++...... .... +.|++++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999976 4899999999754211 1111 125566778888899999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999988 578888999999999999999999 99999999999999999999999999875433
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC--CCCcccCCcccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE--FPSVDTHNVKTF 264 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 264 (354)
......|+..|+|||++.+..++.++|||||||++|+|++|..||. ..+..+....+...... .+.....
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~----- 225 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS--GSTPNETWENLKYWKETLQRPVYDDP----- 225 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC--CCCHHHHHHHHHhccccccCCCCCcc-----
Confidence 1223468899999999998899999999999999999999999953 33433333333222111 1110000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..+.+||.+||..+|++|||++++++.
T Consensus 226 ----------------------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 ----------------------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----------------------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01156778899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=300.84 Aligned_cols=256 Identities=25% Similarity=0.307 Sum_probs=200.4
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcCC-CEEEEEEecCCChhhHHHHHHHHH-------------Hhc-eee-
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNG-DEIAVKRLSGRSGQGLRELKNKLR-------------LLG-CCI- 102 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-~~vavK~~~~~~~~~~~~~~~i~~-------------~~~-~~~- 102 (354)
....+.....+++|.+.|++|||+.||+|++.++ ..||+|++.....+.++.+.+++. +++ ...
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 3355666778899999999999999999997765 999999998877777666654443 333 111
Q ss_pred --c---CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 103 --D---KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 103 --~---~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
. .-.++|+||||.||.|-+++ |.+..+++|++++++|+++||.. +.+|+|||||-+|||++.+|.+|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 1 13467999999999998888 78999999999999999999998 47799999999999999999999
Q ss_pred EeecccceeccCCc-ccccc------ccccCcccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccch
Q 048432 171 ISDFGIARICRGNE-LQANT------GRIVGTYRYMSPEYA---IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240 (354)
Q Consensus 171 l~dfg~a~~~~~~~-~~~~~------~~~~~~~~y~aPE~~---~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~ 240 (354)
|||||.+...-... ..... -....|+.|++||++ .+.+.+.++|||+|||+||.|+....||...+.
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999986432221 11111 013578999999987 466789999999999999999999999643211
Q ss_pred hhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
-.|..+.+.+|... +.+..+.+||+.||+.||.+||++-|+++.+.
T Consensus 264 ---laIlng~Y~~P~~p-------------------------------~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 264 ---LAILNGNYSFPPFP-------------------------------NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ---eeEEeccccCCCCc-------------------------------cHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 22444555555532 28899999999999999999999999999999
Q ss_pred hhhhhcCCCCCC
Q 048432 321 NEAAALLPPKQP 332 (354)
Q Consensus 321 ~~~~~~~~~~~~ 332 (354)
.+.....+-..-
T Consensus 310 ~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 310 ELANKPCPIPDI 321 (738)
T ss_pred HHhcCCCCcccc
Confidence 988554444433
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=280.29 Aligned_cols=238 Identities=30% Similarity=0.493 Sum_probs=185.3
Q ss_pred hcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HHHHH------------HHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
.++|++.+.||+|++|.||+|.... ...|++|.+....... ...+. +++++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4589999999999999999998643 2579999987543221 11222 556667778888889
Q ss_pred EEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 108 ILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
+++|||+++++|.+++ +++..+..++.|++.||.|||..+ ++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999998887 234667899999999999999999 9999999999999999
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 245 (354)
+.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..|| .+....+....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~--~~~~~~~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY--YGFSNQEVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCC--CCCCHHHHHHH
Confidence 9999999999875433322222222345778999999988889999999999999999998 98884 44444444444
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+....... .+..++..+.+|+.+||+.+|++|||+++|+++|+.
T Consensus 239 i~~~~~~~--------------------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLLP--------------------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCC--------------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 33222111 111267889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=277.32 Aligned_cols=239 Identities=31% Similarity=0.487 Sum_probs=187.0
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|++|.||+|...++..||+|.+...... ...+ .|++++++.+...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 456789999999999999999999888889999998654322 1111 255666677888888999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+.+++|.+++ +++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999887 456778899999999999999999 99999999999999999999999999976544322
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||. ..........+..... .+...
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~--~~~~~~~~~~~~~~~~-~~~~~------- 227 (261)
T cd05072 159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP--GMSNSDVMSALQRGYR-MPRME------- 227 (261)
T ss_pred ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC--CCCHHHHHHHHHcCCC-CCCCC-------
Confidence 11 112234668999999988889999999999999999998 888853 3333333333322211 11100
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.++..+.+++.+||+.+|++|||++++++.|++.
T Consensus 228 ------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 ------------------------NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ------------------------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1466789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=290.36 Aligned_cols=225 Identities=24% Similarity=0.308 Sum_probs=176.6
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||+|+.+ +|+.||+|++..... ...... .+++++++++...+.+++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999965 689999999875321 111111 14455667788889999999999999
Q ss_pred CHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 118 SLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 118 ~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
+|..++ +++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccce
Confidence 998887 678889999999999999999999 9999999999999999999999999986422211 112234
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhh
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIF 272 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 272 (354)
.|+..|+|||++.+..++.++|+||+||++|+|++|..|| ...+.......+.......|.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf--~~~~~~~~~~~~~~~~~~~p~----------------- 216 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPR----------------- 216 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCC--CCCCHHHHHHHHHcCCCCCCC-----------------
Confidence 6899999999999888999999999999999999999995 444433444433332222211
Q ss_pred hhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 273 KLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..++.+.+||.+||+.||++|| ++.++++.
T Consensus 217 ----------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 ----------------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ----------------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1456788999999999999999 79998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=288.78 Aligned_cols=237 Identities=26% Similarity=0.362 Sum_probs=180.1
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HH----H--------HHHHHHHhceeecCCceEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LR----E--------LKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~----~--------~~~i~~~~~~~~~~~~~~lv 110 (354)
...++|++.+.||+|+||.||+|++. +++.||+|++....... .. + +.|++++++++...+.+++|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 34578899999999999999999965 58999999986543221 11 1 12777888889999999999
Q ss_pred EEecCCCCHhHHH-hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 111 YEYMPNKSLDFFL-FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 111 ~e~~~~~~L~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
|||+++++|.... .....+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ..
T Consensus 151 ~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PC 225 (353)
T ss_pred EecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cc
Confidence 9999999987665 566777889999999999999999 99999999999999999999999999875443221 11
Q ss_pred ccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccch-hhhhhhhccccCCCCcccCCccc
Q 048432 190 GRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF-TLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
....|+..|+|||++.. ...+.++|||||||++|+|++|+.||........ .....+.....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP------------ 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC------------
Confidence 22468899999998743 2245689999999999999999999752221111 11111110000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+..++..+.+||.+||+.||++|||+.|+++.
T Consensus 294 --------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 --------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111256788999999999999999999999975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=288.56 Aligned_cols=229 Identities=26% Similarity=0.341 Sum_probs=179.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH-------------HHHHHhceeecCCceEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK-------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~-------------~i~~~~~~~~~~~~~~lv~ 111 (354)
+|++.+.||+|+||.||+|+.+ +++.||+|++..... ....... +++.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999965 478899999875321 1111111 2344556677888899999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 999999998887 678889999999999999999999 99999999999999999999999999864322111
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......|+..|+|||++.+..++.++|+||+||++|+|++|..|| .+.+..+....+.......|..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf--~~~~~~~~~~~i~~~~~~~~~~---------- 223 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF--DGEDEDELFQSIMEHNVSYPKS---------- 223 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCC--CCCCHHHHHHHHHcCCCCCCCC----------
Confidence 122346899999999999988999999999999999999999995 4444445555554433322211
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM-----NDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~il~ 317 (354)
.+..+.+++.+||..||++|++. +++++
T Consensus 224 -----------------------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 224 -----------------------LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -----------------------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 35567899999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=280.38 Aligned_cols=242 Identities=28% Similarity=0.474 Sum_probs=189.0
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
..+|.+.+.||.|+||.||++... ++..+|+|.+..........+ .+++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467999999999999999999852 245689999876543332222 25566778888889999
Q ss_pred EEEEecCCCCHhHHH------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 109 LIYEYMPNKSLDFFL------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
+++||+.+++|.+++ +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 999999999998887 467788999999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |.+|| ...........+..+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~--~~~~~~~~~~~i~~~ 238 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW--YQLSNNEVIECITQG 238 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcC
Confidence 999999875433322111222344678999999988889999999999999999998 88884 333334444444333
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
....... .++..+.+|+.+||+.+|.+|||++++++.|+++...
T Consensus 239 ~~~~~~~--------------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQRPR--------------------------------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCCCCC--------------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2211000 0456789999999999999999999999999998843
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=277.71 Aligned_cols=265 Identities=22% Similarity=0.277 Sum_probs=201.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH--------HH-HHHHhceeecCC-----
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL--------KN-KLRLLGCCIDKD----- 105 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~--------~~-i~~~~~~~~~~~----- 105 (354)
...|+.++.||+|.||.||+|+.+ +|+.||+|++...... ..+++ .| ++.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 567888999999999999999955 6899999998654331 12222 25 788888887776
Q ss_pred -ceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 106 -EKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 106 -~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
.+++|+||++. +|..++ .+...+..++.||+.||+|||+++ |+||||||+||+|+.+|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999866 777776 223468999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
+|+...-.... .+..+.|..|+|||++.+. .|+...||||+||++.||+++++. |.+....+.+..|-+..+...
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L--FpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL--FPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC--CCCCcHHHHHHHHHHHcCCCC
Confidence 99865533322 2334678999999999887 689999999999999999999988 566666777777777777776
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhh
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNE 322 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~ 322 (354)
...|+........+.....+. .........+...+...+++.+||+.+|.+|.|++.++.+ +...
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~---~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWP---GPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCC---CccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 666666554433332111111 0111111112223578899999999999999999999886 5554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.90 Aligned_cols=231 Identities=24% Similarity=0.289 Sum_probs=176.1
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
.|++.+.||+|+||.||+|.+. +|+.||+|.+....... ...+. +++++++++.+.+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788999999999999999964 69999999986543211 11111 23445566778888999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++++|...+ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999998765 567788999999999999999999 99999999999999999999999999876433221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--hhhhhhhhccccCCCCcccCCccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS--FTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.....|+..|+|||++.+..++.++||||+||++|+|++|..||....... ......+......
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 223 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE----------- 223 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc-----------
Confidence 122467899999999998899999999999999999999999964322110 1111111111100
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
.+...+..+.+|+.+||+.||++||+ ++++++.
T Consensus 224 ----------------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 ----------------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----------------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01114667889999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.58 Aligned_cols=242 Identities=21% Similarity=0.251 Sum_probs=183.9
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHHHHHHHHh------------ceeecC
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLRELKNKLRLL------------GCCIDK 104 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~~~i~~~~------------~~~~~~ 104 (354)
........++|++.+.||+|+||.||+|++. +|+.||||++.... ........+++.++ ..+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3445556689999999999999999999954 69999999986543 22223333333322 222211
Q ss_pred --------CceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 048432 105 --------DEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167 (354)
Q Consensus 105 --------~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 167 (354)
..+++||||+.+|+|.+++ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 1367999999999998877 456788899999999999999999 99999999999999999
Q ss_pred CeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhh
Q 048432 168 NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 168 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 247 (354)
.++|+|||++................|+..|+|||++.+..++.++|||||||++|+|++|..||. +.+..+....+.
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~--~~~~~~~~~~~~ 258 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--GENMEEVMHKTL 258 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC--CCCHHHHHHHHh
Confidence 999999999876544322222334578999999999999899999999999999999999999953 333333333332
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+.... .+...++.+.+++.+||+.+|++|||+.++++.
T Consensus 259 ~~~~~~--------------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYDP--------------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCCC--------------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222110 011156778999999999999999999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=273.96 Aligned_cols=240 Identities=28% Similarity=0.419 Sum_probs=187.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHH--------HHHHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRE--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
....+|.+.+.||+|++|.||+|.++ .++.||+|++....... ..+ +.+++++++++..++..+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 34567899999999999999999965 48889999987543221 111 1267788888888999999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++++|.+++ +++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999887 567788999999999999999999 99999999999999999999999999876544322
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||. +.+..+....+..... .+
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~--~~~~~~~~~~~~~~~~-~~---------- 225 (263)
T cd05052 160 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKGYR-ME---------- 225 (263)
T ss_pred ec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHCCCC-CC----------
Confidence 11 111223567999999988889999999999999999998 888853 3333333333322111 00
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 226 ---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ---------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=279.65 Aligned_cols=245 Identities=20% Similarity=0.302 Sum_probs=187.6
Q ss_pred cCCCCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHH------------HHHHH
Q 048432 32 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL------------KNKLR 96 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~------------~~i~~ 96 (354)
.+.+..++.+++ +..-...||+|+++.||+|.+ +|+.||+|++....... ...+ .|+++
T Consensus 9 ~~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 9 INDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred cCcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 334444444444 222236799999999999998 68899999997643222 2112 25566
Q ss_pred Hhceeec----CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCC
Q 048432 97 LLGCCID----KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 97 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~ 166 (354)
+++++.+ ...++++|||+.+|+|.+++ +++.....++.+++.||.+||+. + ++||||||+||+++.+
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 7777655 45789999999999999998 67888999999999999999984 7 8899999999999999
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~ 244 (354)
+.++|+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+...
T Consensus 160 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~--~~~~~~~~~ 232 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE--NLTTKEIYD 232 (283)
T ss_pred CcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC--CCCHHHHHH
Confidence 999999999987543321 12356789999999876 678999999999999999999999953 444444444
Q ss_pred hhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 245 YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.+.......+.. ..+++.+.+||.+||+.||++|||++++++.|++..
T Consensus 233 ~i~~~~~~~~~~-------------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKNNSLKLP-------------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCCCCCC-------------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 443222221111 116778999999999999999999999999999865
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=279.86 Aligned_cols=241 Identities=27% Similarity=0.446 Sum_probs=188.5
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++|.+.+.||+|+||.||+|++. ++..+++|.+..........+. |++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 467899999999999999999843 3556899998765543332222 5566777888888999
Q ss_pred EEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 048432 109 LIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167 (354)
Q Consensus 109 lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 167 (354)
+||||+++++|.+++ +++..++.++.||+.|++|||+++ ++|+||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 999999999999987 356788999999999999999999 99999999999999999
Q ss_pred CeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhh
Q 048432 168 NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYI 246 (354)
Q Consensus 168 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~ 246 (354)
.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||. .....+....+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~--~~~~~~~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF--QLSNTEVIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 999999999875443322222223345778999999988889999999999999999998 898853 33333333333
Q ss_pred hccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 247 SENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..+...... ..++..+.+++.+||+.+|++|||++++++.|+++..
T Consensus 239 ~~~~~~~~~--------------------------------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 TQGRVLERP--------------------------------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred hCCCCCCCC--------------------------------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 222111100 0146678999999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=274.50 Aligned_cols=236 Identities=25% Similarity=0.430 Sum_probs=185.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHH--------HHHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRE--------LKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~--------~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.++|++.+.||+|+||.||++.++++..+|+|.+....... ..+ +.|++++++++......+++|||++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 36789999999999999999998888889999886543211 111 1266677888888899999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence 99999887 467888999999999999999999 999999999999999999999999988754332211 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.|| ...+..+....+.++.......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~--~~~~~~~~~~~i~~~~~~~~~~------------ 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF--EKKSNYEVVEMISRGFRLYRPK------------ 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHCCCCCCCCC------------
Confidence 12234568999999988889999999999999999999 88884 4444445555544432211000
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
..+..+.+++.+||+.+|++|||++++++.|.
T Consensus 225 --------------------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 --------------------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --------------------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 03456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=278.87 Aligned_cols=241 Identities=27% Similarity=0.451 Sum_probs=183.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecC
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDK 104 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~ 104 (354)
....++|++.+.||+|++|.||+|.++ .+..||+|++...... ...++ .|++++++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 446788999999999999999999854 2567999998654321 11111 2556677788888
Q ss_pred CceEEEEEecCCCCHhHHHh---------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 105 DEKILIYEYMPNKSLDFFLF---------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~~---------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
...++||||+++++|.+++. ++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence 89999999999999998872 34567889999999999999999 9999999999999999999
Q ss_pred EEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 248 (354)
+|+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||. ..........+..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~--~~~~~~~~~~~~~ 236 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--GMSNEQVLRFVME 236 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHc
Confidence 9999999875443322111112234678999999988889999999999999999998 677853 3333333333322
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
....... ..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ~~~~~~~--------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDKP--------------------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCCC--------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2111100 0146678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=286.06 Aligned_cols=229 Identities=24% Similarity=0.375 Sum_probs=182.2
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH---------------HHHHHHHHhceeecCCceEEE
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR---------------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~---------------~~~~i~~~~~~~~~~~~~~lv 110 (354)
|++.+.||+|+||.||+|.++ +++.||+|++..... .... .+.|++++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999965 589999999964321 1111 123777888889999999999
Q ss_pred EEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 111 YEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 111 ~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||+.+++|...+ +++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence 9999999998777 788899999999999999999999 9999999999999999999999999876422211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..|| ...+..+....+.......|.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf--~~~~~~~~~~~i~~~~~~~p~----------- 222 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF--PGDDEEEVFDSIVNDEVRYPR----------- 222 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCC-----------
Confidence 1122356889999999999888999999999999999999999995 344444444443333222211
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..+..+.++|.+||+.||++|| +++++++.
T Consensus 223 ----------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 223 ----------------------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----------------------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1456678999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.46 Aligned_cols=234 Identities=25% Similarity=0.342 Sum_probs=184.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|.+.+.||+|+||.||+|++. +|+.||+|++..... ..... +.+++++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999975 599999999865321 11111 126677888888999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc--
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE-- 184 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~-- 184 (354)
||+.+++|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999887 677889999999999999999999 9999999999999999999999999987544322
Q ss_pred -------------------------cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Q 048432 185 -------------------------LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS 239 (354)
Q Consensus 185 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~ 239 (354)
.........|+..|+|||++.+..++.++|||||||++|+|++|..|| .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf--~~~~~ 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF--YSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC--CCCCH
Confidence 001122346899999999999999999999999999999999999995 33333
Q ss_pred hhhhhhhhcccc--CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-HHHHH
Q 048432 240 FTLLGYISENIY--EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-MNDVV 316 (354)
Q Consensus 240 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~il 316 (354)
......+..... ..|... ..++.+.+||.+||. +|++||+ +++++
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~-------------------------------~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 236 QETYNKIINWKESLRFPPDP-------------------------------PVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred HHHHHHHhccCCcccCCCCC-------------------------------CCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 333443333111 111111 046678899999998 9999999 99999
Q ss_pred HH
Q 048432 317 SM 318 (354)
Q Consensus 317 ~~ 318 (354)
+.
T Consensus 284 ~h 285 (350)
T cd05573 284 SH 285 (350)
T ss_pred cC
Confidence 85
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=281.88 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=182.8
Q ss_pred cCccccceecccCceeEEEEEEc--CCCEEEEEEecCCChh------hHHH-----------HHHHHHHhceee-----c
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK--NGDEIAVKRLSGRSGQ------GLRE-----------LKNKLRLLGCCI-----D 103 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~--~~~~vavK~~~~~~~~------~~~~-----------~~~i~~~~~~~~-----~ 103 (354)
.+|++.+.||+|+||.||+|++. +++.||+|++...... ..++ +.|++++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999963 4788999988643211 1111 235666666664 3
Q ss_pred CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 104 KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
...++++|||+.+ +|..++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 4568999999975 777776 567888999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+....... ......++..|+|||++.+..++.++|+||+||++|+|++|.+|| .+....+....+..........
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f--~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChh
Confidence 87544332 222346789999999998888999999999999999999999994 4445445555544333221111
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+..... ... ...............+..++.+.+|+.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVA--LPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhc--ccc----hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1110000 000 000000111112222336778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=270.48 Aligned_cols=235 Identities=25% Similarity=0.375 Sum_probs=198.9
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCC-----ChhhHHH---------HHHHHHHhceeecCCceEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGR-----SGQGLRE---------LKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~-----~~~~~~~---------~~~i~~~~~~~~~~~~~~lv 110 (354)
..++|++.+.||+|.|+.|+++.+. .|+.+|+|++.-. ..+.+.+ +.||+++.+.+..+...|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3578999999999999999999854 6999999987432 2222222 22667777888889999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CCeEEeecccceeccC
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGIARICRG 182 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~~l~dfg~a~~~~~ 182 (354)
+|++.|+.|-.-+ +++..+...+.||+.+|.|+|.++ |+|||+||.|+++... .-+||+|||++...+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 9999999986554 778888999999999999999999 9999999999999643 3589999999987764
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
+..... ..||+.|++||++...+|+..+|||+.|++||-|+.|.+| |++.+...+.+.|.++...++...++.
T Consensus 166 g~~~~G---~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~P--F~~~~~~rlye~I~~g~yd~~~~~w~~-- 238 (355)
T KOG0033|consen 166 GEAWHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--FWDEDQHRLYEQIKAGAYDYPSPEWDT-- 238 (355)
T ss_pred cccccc---ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCC--CCCccHHHHHHHHhccccCCCCcccCc--
Confidence 443333 4799999999999999999999999999999999999999 899899999999999999988876654
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+..++|+++||..||.+|+|+.|.|+
T Consensus 239 ---------------------------is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 239 ---------------------------VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---------------------------CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 4667789999999999999999987764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=289.66 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=186.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC--CCEEEEEEecCCCh---hhHH----H--------HHHHHHHhceeecCCc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN--GDEIAVKRLSGRSG---QGLR----E--------LKNKLRLLGCCIDKDE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~--~~~vavK~~~~~~~---~~~~----~--------~~~i~~~~~~~~~~~~ 106 (354)
....++|++.+.||+|+||.||+|.+++ +..||+|++..... .... + +.|++++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 3456789999999999999999998653 36899999854321 1111 1 2367778888999999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.++||||+.+++|..++ +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999887 677888999999999999999999 9999999999999999999999999987643
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... ....|++.|+|||++.+..++.++|+||+||++|+|++|..|| ...+.......+..+....|..
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf--~~~~~~~~~~~i~~~~~~~p~~----- 250 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF--YANEPLLIYQKILEGIIYFPKF----- 250 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCC--CCCCHHHHHHHHhcCCCCCCCC-----
Confidence 321 2246889999999998888999999999999999999999995 4445444555554443322211
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
.+..+.++|.+||+.+|++|+ |++++++.
T Consensus 251 ----------------------------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 ----------------------------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------------------------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 345678999999999999995 89998875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.63 Aligned_cols=238 Identities=30% Similarity=0.460 Sum_probs=187.3
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHH--------HHHHHHhceeecCCceEEEEEec
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~--------~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
..++|++.+.||+|++|.||+|.+.+++.||+|.+....... ..+. .|++++++++...+..+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 457899999999999999999998778889999987643211 1111 25667778888889999999999
Q ss_pred CCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 115 PNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 115 ~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
.+++|.+++ +++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999887 567888999999999999999999 9999999999999999999999999987655322111
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.|| .+.........+..... .+..
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~--~~~~~~~~~~~~~~~~~-~~~~---------- 226 (261)
T cd05068 161 -REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY--PGMTNAEVLQQVDQGYR-MPCP---------- 226 (261)
T ss_pred -cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHHHHcCCC-CCCC----------
Confidence 111122457999999988889999999999999999999 88885 33333333333332211 1100
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 227 ---------------------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 ---------------------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---------------------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0146678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=284.84 Aligned_cols=224 Identities=28% Similarity=0.382 Sum_probs=176.0
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.++ +++.||+|++..... .... .+.+++++++++...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 488999999865321 1000 123667778888888999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 9998887 677888999999999999999999 9999999999999999999999999987543222 12223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..|| .+.+.......+.......|.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf--~~~~~~~~~~~i~~~~~~~~~---------------- 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF--HGEDEDELFDSILNDRPHFPR---------------- 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHcCCCCCCC----------------
Confidence 46899999999999888999999999999999999999995 444444444444332221111
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN-DVVS 317 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-~il~ 317 (354)
..+..+.+++.+||+.+|++||++. ++++
T Consensus 218 -----------------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 -----------------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -----------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1455678999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=284.93 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=199.6
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--------------hHHHH------------HHH
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--------------GLREL------------KNK 94 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--------------~~~~~------------~~i 94 (354)
+-..-.++|++.+.||+|.||.|-+|+.. +++.||+|++.+.... ..++. .|+
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33456789999999999999999999965 5999999999653211 01111 266
Q ss_pred HHHhceeec--CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 048432 95 LRLLGCCID--KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167 (354)
Q Consensus 95 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 167 (354)
|+++++..+ .+.+|+|+|||..|.+...- +...+++.++.+++.||.|||.+| |+||||||+|+|++.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 777777764 45799999999998875433 788899999999999999999999 99999999999999999
Q ss_pred CeEEeecccceeccCCc---cccccccccCcccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCcccccch
Q 048432 168 NPKISDFGIARICRGNE---LQANTGRIVGTYRYMSPEYAIQGI----FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240 (354)
Q Consensus 168 ~~~l~dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~ 240 (354)
++||+|||.+..+..+. .........||+.|+|||.+.++. -+.+.||||+|++||.|+.|+.| |.+....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P--F~~~~~~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP--FFDDFEL 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC--cccchHH
Confidence 99999999988663321 111223468999999999998733 36889999999999999999999 7888888
Q ss_pred hhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
++..+|......+|.... ..+.+.+||.++|.+||++|.+..+|....=
T Consensus 326 ~l~~KIvn~pL~fP~~pe-------------------------------~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENPE-------------------------------INEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHhcCcccCCCccc-------------------------------ccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 999999888887776542 5677899999999999999999999877654
Q ss_pred hhh
Q 048432 321 NEA 323 (354)
Q Consensus 321 ~~~ 323 (354)
-..
T Consensus 375 vt~ 377 (576)
T KOG0585|consen 375 VTR 377 (576)
T ss_pred ecc
Confidence 433
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.05 Aligned_cols=239 Identities=30% Similarity=0.479 Sum_probs=186.6
Q ss_pred hcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||.||+|.++. ...||+|.+....... ...+ .|++++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4679999999999999999999742 4579999987543221 1111 266677778888889999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|||+.+++|.+++ +++..+..++.|++.|+.|||+++ |+|+||+|+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999987 578889999999999999999999 999999999999999999999999999866422
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
..........++..|+|||.+.+..++.++|+||||+++|+|++ |..|| ...........+.+........
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~------ 231 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY--WDMSNQDVIKAVEDGYRLPPPM------ 231 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC--CCCCHHHHHHHHHcCCCCCCCC------
Confidence 21111112234568999999988889999999999999999997 88885 3333333333333221111000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 232 --------------------------~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 232 --------------------------DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------------------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=296.84 Aligned_cols=262 Identities=19% Similarity=0.208 Sum_probs=180.5
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH--H------------HHHHHhceee
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL--K------------NKLRLLGCCI 102 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~--~------------~i~~~~~~~~ 102 (354)
+++....++|++.+.||+|+||.||+|.+. .++.||||++....... ..++ . +++.+++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 334455689999999999999999999965 58889999996532211 1111 0 1334445554
Q ss_pred cC-CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCC--------
Q 048432 103 DK-DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDM-------- 167 (354)
Q Consensus 103 ~~-~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~-------- 167 (354)
.+ ..+|+||+++ +++|.+++ +++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 43 5688999988 55776666 6788899999999999999997 58 99999999999998765
Q ss_pred --------CeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Q 048432 168 --------NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS 239 (354)
Q Consensus 168 --------~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~ 239 (354)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|+|++|++|| .+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf--~~~~~ 350 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY--DTHDN 350 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCCh
Confidence 499999998753221 122357899999999999999999999999999999999999995 44444
Q ss_pred hhhhhhhhccccCCCCcccCCccc---cc----------cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCC
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKT---FG----------FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESA 306 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 306 (354)
.+....+.+.....|......... .. ..++... ...... .........+.+.+||.+||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL--ARIARA--RPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHH--Hhhhcc--cchhhhhchHHHHHHHHHhCCcCh
Confidence 444444444444333221111000 00 0000000 000000 000011135678899999999999
Q ss_pred CCCCCHHHHHH
Q 048432 307 DDRPTMNDVVS 317 (354)
Q Consensus 307 ~~Rps~~~il~ 317 (354)
++|||++|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999997
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=290.35 Aligned_cols=233 Identities=23% Similarity=0.352 Sum_probs=196.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------HHH--------HHHHHHHhceeecCCc-eEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LRE--------LKNKLRLLGCCIDKDE-KILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------~~~--------~~~i~~~~~~~~~~~~-~~lv 110 (354)
.++|..++.+|+|+||.+++++++ +++.|++|.+....... ..+ +.+|+.+.+.+..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999976 48889999986543211 111 1266777778877777 9999
Q ss_pred EEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 111 YEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 111 ~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
|+||+||++.+.+ |++..+.+|+.|++.|+.|||++. |+|||||+.||+++.++.|+|+|||+|......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999988 788999999999999999999988 999999999999999999999999999877666
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.... ....||+.|++||++.+.+|+.++|||||||++|||++-+++ |...+...+..++.+.....-...
T Consensus 160 ~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a--F~a~~m~~Li~ki~~~~~~Plp~~------ 229 (426)
T KOG0589|consen 160 DSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA--FKASNMSELILKINRGLYSPLPSM------ 229 (426)
T ss_pred hhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc--cCccchHHHHHHHhhccCCCCCcc------
Confidence 5222 235899999999999999999999999999999999999988 677777777777766663222222
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+++.+|+.||..+|+.||++.++|..
T Consensus 230 --------------------------ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 --------------------------YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --------------------------ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 67889999999999999999999999876
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=279.59 Aligned_cols=238 Identities=29% Similarity=0.442 Sum_probs=185.5
Q ss_pred hcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhhH-HHH------------HHHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQGL-REL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~~-~~~------------~~i~~~~~~~~~~~~~ 107 (354)
..+|++.+.||.|+||.||+|.+.. ++.||+|++........ ..+ .|++++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4568999999999999999998532 57899999976543221 112 2666777888888889
Q ss_pred EEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 108 ILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
++++||+.+++|..++ +++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999998886 345667889999999999999999 9999999999999999
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 245 (354)
+.++|+|||++................++..|+|||.+.++.++.++|+|||||++|+|++ |..|| .+....+....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~--~~~~~~~~~~~ 238 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDVIEM 238 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC--CCCCHHHHHHH
Confidence 9999999999875433322222222345678999999988889999999999999999998 77774 34444444444
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+......... ..++..+.+|+.+||+.+|++||++++|+.+|+.
T Consensus 239 i~~~~~~~~~--------------------------------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVLPCP--------------------------------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcCCCC--------------------------------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 4433321100 1167778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=285.04 Aligned_cols=219 Identities=26% Similarity=0.367 Sum_probs=175.4
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----H---------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----R---------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~---------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ +++.||+|++..... ... . .+.+++++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 588999999864321 100 1 123777888889999999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ ++...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccc
Confidence 9998877 678888999999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|++.|+|||++.+..++.++|+|||||++|+|++|+.|| ...+.......+.......+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf--~~~~~~~~~~~i~~~~~~~~~~--------------- 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF--EAENEDDLFEAILNDEVVYPTW--------------- 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCC--CCCCHHHHHHHHhcCCCCCCCC---------------
Confidence 46899999999999888999999999999999999999995 4444445555544333222111
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
.+..+.+||.+||+.||++||++
T Consensus 219 ------------------~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 ------------------LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------------------CCHHHHHHHHHHcccCHHHCCCC
Confidence 45677899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=285.80 Aligned_cols=229 Identities=26% Similarity=0.346 Sum_probs=179.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH-------------HHHHHHhceeecCCceEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL-------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~-------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+|.+.+.||+|+||.||+|.++ +++.||+|++...... ..... .+++.+++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999976 4789999998754211 11111 12334556677888899999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 999999998887 678889999999999999999999 99999999999999999999999999864322111
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......|++.|+|||++.+..++.++|+|||||++|+|++|..|| ...+.......+.......|.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf--~~~~~~~~~~~i~~~~~~~p~----------- 222 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPK----------- 222 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCC-----------
Confidence 122346889999999999999999999999999999999999995 444445555555443332221
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM-----NDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~il~ 317 (354)
..+..+.+++.+||+.+|++|++. +++++
T Consensus 223 ----------------------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 223 ----------------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ----------------------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 145567899999999999999985 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=297.63 Aligned_cols=234 Identities=18% Similarity=0.211 Sum_probs=184.7
Q ss_pred hcCccccceecccCceeEEEEEEc-C-CCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-N-GDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~-~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
...|.+.+.||+|++|.||.|... + ++.||+|.+..........+ .|++++++++...+..|+|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 345999999999999999999854 3 67889998755443322211 266778888889999999999
Q ss_pred ecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 113 YMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 113 ~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
|+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999998765 467788899999999999999999 999999999999999999999999999865443
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
..........||+.|+|||++.+..++.++|||||||++|+|++|..|| ...+..++...+..+.....
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf--~~~~~~~~~~~~~~~~~~~~--------- 291 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF--KGPSQREIMQQVLYGKYDPF--------- 291 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCC---------
Confidence 3222233456899999999999888999999999999999999999995 33444444444333222100
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+..++..+.+||.+||+.+|++|||+++++.
T Consensus 292 -----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 -----------------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----------------------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1115567899999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.01 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=185.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||+|+||.||+++++ +|..||+|++....... ...+ .|++++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3579999999999999999999976 58889999987543211 1112 15667778888889999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++++|.+++ +++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999988 56788899999999999999985 5 9999999999999999999999999986543322
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc-
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF- 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 264 (354)
.....++..|+|||++.+..++.++|+|||||++|+|++|+.||.... ..++...+..................
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccccCCccccCccc
Confidence 122467899999999998889999999999999999999999964332 22221111110000000000000000
Q ss_pred -------------ccchhhhhhhhhccccCCchhH-HHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 265 -------------GFLHLTIFKLFSISSVGLSNDI-VCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 265 -------------~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
...................+.. ....+..+.+||.+||++||++|||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000000000000110 112567899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=293.79 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=206.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCC---hhhHHH--HHHHHHHhceeecCCceEEEEEecCCCC
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS---GQGLRE--LKNKLRLLGCCIDKDEKILIYEYMPNKS 118 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~---~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (354)
..+++.-.-++-||+|+.|.||+|+.+ ++.||||+++... ...+++ ++||+.+.++|...+.+|||||||..|-
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 333334444678999999999999985 6779999886543 333333 3499999999999999999999999999
Q ss_pred HhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccccc
Q 048432 119 LDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193 (354)
Q Consensus 119 L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~ 193 (354)
|...+ +.......|..+|+.|+.|||.++ |+|||||.-||||+.+..|||+|||-++..... ..+-.+.
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 99988 566778899999999999999999 999999999999999999999999988754433 2334468
Q ss_pred CcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhh
Q 048432 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFK 273 (354)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 273 (354)
||..|+|||++...+.+.++||||||++||||+||..| |.+.+...++.-+-.+..
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiP--YkdVdssAIIwGVGsNsL---------------------- 328 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIP--YKDVDSSAIIWGVGSNSL---------------------- 328 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCC--ccccchheeEEeccCCcc----------------------
Confidence 99999999999999999999999999999999999999 555554444443333333
Q ss_pred hhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccc
Q 048432 274 LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSY 336 (354)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 336 (354)
...++..||+.+.-||++||+-.|..|||+.+|+..|+=..++......-.|+.
T Consensus 329 ---------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~ 382 (904)
T KOG4721|consen 329 ---------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFK 382 (904)
T ss_pred ---------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHH
Confidence 233344499999999999999999999999999999998877776666666654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.04 Aligned_cols=242 Identities=26% Similarity=0.458 Sum_probs=182.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCC----EEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
..+|++.+.||+|+||.||+|.+. ++. .||+|++..... .....+ .|++++++++.. ...+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCce
Confidence 467999999999999999999864 333 489999875432 111222 255666777665 4578
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++++|+.+|+|.+++ +++.....++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999887 456778899999999999999999 99999999999999999999999999976543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
............+..|++||.+.+..++.++|||||||++|+|++ |..||.. ....+....+.... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~--~~~~~~~~~~~~~~-~~~~~----- 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGE-RLPQP----- 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHhCCC-CCCCC-----
Confidence 322211112234568999999998889999999999999999997 8888543 22222222222111 11110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
+.++..+.+++.+||..+|++|||+.+++..|.++..+.
T Consensus 234 --------------------------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 234 --------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 014556789999999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=283.19 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=183.8
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HH-------------HHHHHHHHhceee
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LR-------------ELKNKLRLLGCCI 102 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~-------------~~~~i~~~~~~~~ 102 (354)
|..+.++|++.+.||.|+||.||+|... .++.||+|++....... .. .+.|++++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4556779999999999999999999732 25789999986432211 11 1236777777665
Q ss_pred -cCCceEEEEEecCCCCHhHHH----------------------------------------------------------
Q 048432 103 -DKDEKILIYEYMPNKSLDFFL---------------------------------------------------------- 123 (354)
Q Consensus 103 -~~~~~~lv~e~~~~~~L~~~~---------------------------------------------------------- 123 (354)
.+..+++++||+++++|.+++
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 345688999999999998776
Q ss_pred --------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCc
Q 048432 124 --------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195 (354)
Q Consensus 124 --------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~ 195 (354)
+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++................++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 245668899999999999999999 999999999999999999999999998754332221222223456
Q ss_pred ccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhh
Q 048432 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKL 274 (354)
Q Consensus 196 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 274 (354)
..|+|||++.+..++.++|||||||++|+|++ |..||..... .......+..+....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~--------------------- 296 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-DEEFCRRLKEGTRMR--------------------- 296 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-cHHHHHHHhccCCCC---------------------
Confidence 78999999999999999999999999999998 9888532111 111112221111100
Q ss_pred hhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 275 FSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.+...++.+.+++.+||+.+|++|||++++++.|+++.
T Consensus 297 -----------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 297 -----------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred -----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00114567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.76 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=188.4
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HH-------------HHHHHHHHh
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LR-------------ELKNKLRLL 98 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~-------------~~~~i~~~~ 98 (354)
..+.+....++|++.+.||+|+||.||+|.+.. +..||+|++....... .. .+.|+++++
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 335666778899999999999999999998531 3469999996543221 11 134677788
Q ss_pred ceeecCCceEEEEEecCCCCHhHHHh------------------------------------------------------
Q 048432 99 GCCIDKDEKILIYEYMPNKSLDFFLF------------------------------------------------------ 124 (354)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~~~------------------------------------------------------ 124 (354)
+++...+.+++|||||++|+|.+++.
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 88888899999999999999987752
Q ss_pred -----------------------------------------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 048432 125 -----------------------------------------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK 157 (354)
Q Consensus 125 -----------------------------------------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 157 (354)
++..+..++.|++.||.|||+.+ ++|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dik 264 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLA 264 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCC
Confidence 23445779999999999999999 9999999
Q ss_pred CCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccc
Q 048432 158 VSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYR 236 (354)
Q Consensus 158 p~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~ 236 (354)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999999999999999999875433222212222345678999999988889999999999999999997 888854321
Q ss_pred ccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 237 TYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
. .......+..+. ..+ .+..++..+.++|.+||+.+|++|||+.+|.
T Consensus 345 ~-~~~~~~~~~~~~-~~~-------------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 345 V-DSTFYNKIKSGY-RMA-------------------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred h-hHHHHHHHhcCC-CCC-------------------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 1 111222222111 000 0111567889999999999999999999999
Q ss_pred HHhhhhh
Q 048432 317 SMLTNEA 323 (354)
Q Consensus 317 ~~L~~~~ 323 (354)
+.|+++.
T Consensus 392 ~~l~~l~ 398 (400)
T cd05105 392 DIVESLL 398 (400)
T ss_pred HHHHHHc
Confidence 9999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=272.28 Aligned_cols=240 Identities=21% Similarity=0.342 Sum_probs=187.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||.|+||.||+|+.+ +++.||+|.+..... ..... +.+++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999965 689999998754221 11111 136677778888888999999
Q ss_pred EecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
||+++++|..++ ++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999998776 456778899999999999999999 99999999999999999999999999876543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.............+..... +..
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~------ 228 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPL------ 228 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--CCC------
Confidence 2211 112356789999999988888999999999999999999999964333233333333322111 110
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.....+..+.++|.+||..+|++|||+.++++.|+++.
T Consensus 229 -----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 -----------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01115677899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=290.65 Aligned_cols=236 Identities=23% Similarity=0.268 Sum_probs=182.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|++. +|+.||||++..... ..... +.|++++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999975 589999999965321 11111 125677788889999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999887 678889999999999999999999 999999999999999999999999998643221100
Q ss_pred c------------------------------------ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 048432 187 A------------------------------------NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKK 230 (354)
Q Consensus 187 ~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~ 230 (354)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0012358999999999998889999999999999999999999
Q ss_pred CCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC
Q 048432 231 TTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP 310 (354)
Q Consensus 231 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 310 (354)
|| ...+.......+..+.......... ..++.+.+||.+|+. +|.+|+
T Consensus 238 Pf--~~~~~~~~~~~i~~~~~~~~~~~~~-----------------------------~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 238 PF--CSDNPQETYRKIINWKETLQFPDEV-----------------------------PLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred CC--CCCCHHHHHHHHHcCCCccCCCCCC-----------------------------CCCHHHHHHHHHHcc-CHhhcC
Confidence 95 4444444444443322211110000 145677899999997 999999
Q ss_pred C---HHHHHHH
Q 048432 311 T---MNDVVSM 318 (354)
Q Consensus 311 s---~~~il~~ 318 (354)
+ ++++++.
T Consensus 286 ~~~~~~~ll~h 296 (364)
T cd05599 286 GNNGVNEIKSH 296 (364)
T ss_pred CCCCHHHHhcC
Confidence 8 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=284.17 Aligned_cols=225 Identities=25% Similarity=0.343 Sum_probs=178.5
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ .++.||+|++..... .... .+.+++++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 488999999865321 1100 123567778888889999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccc
Confidence 9998777 677888999999999999999999 99999999999999999999999999875322211 1223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..|| ...+..+....+.......|..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf--~~~~~~~~~~~i~~~~~~~p~~--------------- 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDLFESILHDDVLYPVW--------------- 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCC--CCCCHHHHHHHHHcCCCCCCCC---------------
Confidence 46889999999999888999999999999999999999995 4444445555544333222211
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-------CHHHHHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-------TMNDVVSM 318 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-------s~~~il~~ 318 (354)
.+..+.+++.+||+.+|++|| +++++++.
T Consensus 219 ------------------~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 ------------------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------------------CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 356678999999999999999 88888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=283.86 Aligned_cols=225 Identities=24% Similarity=0.305 Sum_probs=176.5
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||+++.+ +|+.||+|++..... ..... +.|++++++.+...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999965 589999999865321 11111 125566777888889999999999999
Q ss_pred CHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 118 SLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 118 ~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
+|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence 998776 678889999999999999999999 9999999999999999999999999886432211 111224
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhh
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIF 272 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 272 (354)
.|+..|+|||++.+..++.++|+|||||++|+|++|..|| ...+.......+.......|.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf--~~~~~~~~~~~~~~~~~~~p~----------------- 216 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPR----------------- 216 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCC--CCCCHHHHHHHHhcCCCCCCC-----------------
Confidence 6889999999999888999999999999999999999995 334433333333322222111
Q ss_pred hhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 273 KLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..++.+.++|.+||+.||++|+ ++.++++.
T Consensus 217 ----------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 ----------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ----------------CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1466788999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=271.83 Aligned_cols=236 Identities=27% Similarity=0.426 Sum_probs=184.4
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHH--------HHHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRE--------LKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~--------~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.++|++.+.||+|++|.||.|.+.++..+|+|.+....... .++ +.|++++++++......+++|||+.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 46789999999999999999998777779999987543211 111 1266777888888888999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++|.+++ +++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ec
Confidence 99999887 577889999999999999999999 999999999999999999999999998754332211 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
....++..|++||.+.+..++.++|+|||||++|+|++ |..||.. .........+.++........
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~----------- 225 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER--FNNSETVEKVSQGLRLYRPHL----------- 225 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc--CCHHHHHHHHhcCCCCCCCCC-----------
Confidence 11234568999999988889999999999999999998 8888533 333333333333222111100
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 226 ---------------------~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ---------------------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---------------------CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 4567899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.61 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=179.7
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHHH--------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||.|+||.||+|+.+ +++.||+|++...... ..++. .|++++++++.+....++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4578999999999999999999976 5889999998654321 11111 26677788888899999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+ ++.+++ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 99965 565554 567788999999999999999999 99999999999999999999999999864332211
Q ss_pred ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......+++.|+|||++.+. .++.++|+||+||++|+|++|..||..... ..+....+...........+......
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 --TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-IQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHHhCCCChhhccchhhc
Confidence 11224578899999988754 578999999999999999999999653322 12222222111111111111110000
Q ss_pred ccchhhhhhhhhccccCCchhHH-HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIV-CLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+.. ............... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPE--RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccc--cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000000000000000 012456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=284.54 Aligned_cols=225 Identities=25% Similarity=0.307 Sum_probs=176.0
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||+++.+ +|+.||+|++..... .....+ .++++++.++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999965 589999999975321 111111 14455667788889999999999999
Q ss_pred CHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 118 SLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 118 ~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
+|...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence 998777 678889999999999999999999 9999999999999999999999999986432211 112234
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhh
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIF 272 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 272 (354)
.|++.|+|||++.+..++.++|||||||++|+|++|..|| ...+.......+.......|.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf--~~~~~~~~~~~~~~~~~~~p~----------------- 216 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEDIKFPR----------------- 216 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCC--CCCCHHHHHHHhccCCccCCC-----------------
Confidence 6899999999998888999999999999999999999995 333333333333322222111
Q ss_pred hhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 273 KLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..+..+.+||.+||+.||++|+ ++.++++.
T Consensus 217 ----------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 ----------------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----------------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1456788999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=282.92 Aligned_cols=223 Identities=26% Similarity=0.372 Sum_probs=175.4
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ +|+.||+|++..... .... .+.+++++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 588999999865321 0110 112556677888888999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ ++...+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence 9998877 677888899999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+||+||++|+|++|..|| ...+.....+.+.......+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf--~~~~~~~~~~~~~~~~~~~~~~--------------- 218 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF--HGDDEDELFESIRVDTPHYPRW--------------- 218 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCCC---------------
Confidence 46899999999999989999999999999999999999995 4444444444443332222110
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN-DVV 316 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-~il 316 (354)
.+..+.+||.+||+.||++||++. +++
T Consensus 219 ------------------~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ------------------ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ------------------CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 455678999999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.84 Aligned_cols=276 Identities=20% Similarity=0.259 Sum_probs=210.3
Q ss_pred cCCCCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHH---HHH----------
Q 048432 32 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---REL---KNK---------- 94 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~---~~i---------- 94 (354)
+|.-..+-++......++|.+...+|+|.||.|-.+.+. .+..||||+++....... .++ +.+
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 455555777788888999999999999999999999954 478999999976543322 222 122
Q ss_pred -HHHhceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-
Q 048432 95 -LRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK- 165 (354)
Q Consensus 95 -~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~- 165 (354)
+.+.+|+...+++|||+|.+ |.++.+++ ++...++.|++|++.++++||+.+ ++|.||||+||++.+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEecc
Confidence 34667888999999999988 55777777 788999999999999999999999 999999999999942
Q ss_pred -------------------CCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHH
Q 048432 166 -------------------DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIV 226 (354)
Q Consensus 166 -------------------~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll 226 (354)
+..++++|||.|....+.. +..+.|..|+|||++.+-+++.++||||+||||+||+
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3358999999997644333 3457799999999999999999999999999999999
Q ss_pred hCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccC-----Cc--------hhHHHHHHHH
Q 048432 227 SGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVG-----LS--------NDIVCLCILR 293 (354)
Q Consensus 227 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~-----~~--------~~~~~~~~~~ 293 (354)
+|... |+..++.+.+.+++...+++|...........+....-..|.+....+ .. -.....+...
T Consensus 304 tG~~L--FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 304 TGETL--FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred cccee--cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 99988 777778887788888888777644333322222222222222222222 00 0011226777
Q ss_pred HHHHHhhccccCCCCCCCHHHHHHH
Q 048432 294 YVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 294 l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
|.+||++||++||.+|+|+.|++..
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999998853
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=270.56 Aligned_cols=240 Identities=20% Similarity=0.323 Sum_probs=187.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||.|++|.||+|.++ ++..|++|.+..... ..... +.|++++++++...+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999964 689999998764321 11111 126778888888889999999
Q ss_pred EecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
||+.+++|.+++ +++..+..++.||+.|+.|||+++ ++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999998876 467788999999999999999999 99999999999999999999999999875543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............+...... ...
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~----- 229 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLP----- 229 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC--CCC-----
Confidence 3211 1123577899999999888899999999999999999999999643322222332222211110 000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
....+..+.+++.+||+.+|++|||+++|++.+++..
T Consensus 230 ------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 ------------------------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ------------------------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0115678999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=270.85 Aligned_cols=240 Identities=30% Similarity=0.467 Sum_probs=188.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHH--------HHHHHHHhceeecCCceEEEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRE--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
+...++|++.+.||+|++|.||+|..++++.||+|.+....... ..+ +.+++++++++......+++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34568999999999999999999998888899999997643321 111 1255667777788888999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++++|.+++ +++..+..++.+++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999887 567888999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. .......+..|+|||.+.+..++.++|+||+|+++|++++ |+.|| .+.........+..+.... ..
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~--~~~~~~~~~~~~~~~~~~~-~~-------- 226 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY--PGMTNREVLEQVERGYRMP-RP-------- 226 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCC-CC--------
Confidence 1 1111233568999999998889999999999999999998 89885 4444444444443321110 00
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
...+..+.+++.+||..+|++|||++++++.|+.
T Consensus 227 -----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -----------------------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0035678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=283.54 Aligned_cols=222 Identities=21% Similarity=0.312 Sum_probs=174.8
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCC---hhhHH----H--------HHHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRS---GQGLR----E--------LKNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~---~~~~~----~--------~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||+|+||.||+|.+. +++.||+|++.... ..... + +.|++++++++...+..++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 58899999986432 11111 1 12667777888889999999999999999
Q ss_pred hHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccC
Q 048432 120 DFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194 (354)
Q Consensus 120 ~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 194 (354)
..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence 8887 678889999999999999999999 9999999999999999999999999986432221 11223468
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhh
Q 048432 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKL 274 (354)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 274 (354)
+..|+|||++.+..++.++|+||+||++|+|++|..|| .+.........+.......+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf--~~~~~~~~~~~~~~~~~~~~~------------------- 214 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF--YDENVNEMYRKILQEPLRFPD------------------- 214 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCc--CCCCHHHHHHHHHcCCCCCCC-------------------
Confidence 99999999999988999999999999999999999995 444444444444333222211
Q ss_pred hhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 048432 275 FSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT---MNDVVS 317 (354)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~il~ 317 (354)
..++.+.++|.+||+.||++||+ +.+++.
T Consensus 215 --------------~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 --------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --------------cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 14567889999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.58 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=189.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc--------CCCEEEEEEecCCCh-hhHH-------------HHHHHHHHhce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSG-QGLR-------------ELKNKLRLLGC 100 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vavK~~~~~~~-~~~~-------------~~~~i~~~~~~ 100 (354)
+.....+|.+.+.||+|+||.||.|++. .+..||+|.+..... .... .+.|+++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3456789999999999999999999742 245799999865321 1111 23477778888
Q ss_pred eecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
+......+++|||+.+++|..++ +++..+..++.||+.||.|||+++ ++|+||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 88889999999999999998886 234567889999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTY 238 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~ 238 (354)
||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..|| ....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~--~~~~ 244 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIP 244 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc--ccCC
Confidence 99999999999999999876544332222222344568999999988889999999999999999998 77774 3333
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+..+.+........ +..++..+.+|+.+||+.+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDK--------------------------------PANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCC--------------------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 3344443332211100 01156788999999999999999999999999
Q ss_pred hhhhhh
Q 048432 319 LTNEAA 324 (354)
Q Consensus 319 L~~~~~ 324 (354)
|+++..
T Consensus 293 l~~~~~ 298 (304)
T cd05101 293 LDRILT 298 (304)
T ss_pred HHHHHH
Confidence 998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=284.80 Aligned_cols=233 Identities=21% Similarity=0.250 Sum_probs=177.0
Q ss_pred CccccceecccCceeEEEEEEc----CCCEEEEEEecCCCh----hhHHH-------------HHHHHHHhceeecCCce
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSG----QGLRE-------------LKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~----~~~~~-------------~~~i~~~~~~~~~~~~~ 107 (354)
+|++.+.||+|+||.||+++.. .++.||+|++..... ..... +.+++++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999853 588999999864321 11111 12455666777888889
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+.+++|..++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999998887 678889999999999999999999 99999999999999999999999999875433
Q ss_pred CccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccCCCCcccC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... .......+.......+
T Consensus 158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (332)
T cd05614 158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----- 231 (332)
T ss_pred cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC-----
Confidence 2211 11234689999999998765 4788999999999999999999996432221 1112222211111111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
...+..+.+++.+||+.||++|| +++++++.
T Consensus 232 ----------------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 ----------------------------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----------------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11456788999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=275.57 Aligned_cols=232 Identities=32% Similarity=0.516 Sum_probs=177.2
Q ss_pred cccceecccCceeEEEEEEc-----CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 51 SDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
.+.+.||.|.||.||+|.+. .+..|+||.+...... ....+. |++++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999976 3677999999654322 122222 55677888888888999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++|+|.+++ +++..+..|+.||+.||.|||+.+ ++|+||+++||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999888 567889999999999999999999 99999999999999999999999999976633222
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
............|.|||.+.+..++.++||||||+++|||++ |..| +...........+.++........
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p--~~~~~~~~~~~~~~~~~~~~~~~~------- 229 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFP--FSDYDNEEIIEKLKQGQRLPIPDN------- 229 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGT--TTTSCHHHHHHHHHTTEETTSBTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccceeccc-------
Confidence 222223345779999999998889999999999999999999 6778 444455555555544333221111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
++..+.++|.+||+.+|++|||+++++++|
T Consensus 230 -------------------------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 -------------------------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------------------------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------------------------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 577789999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=273.53 Aligned_cols=242 Identities=25% Similarity=0.413 Sum_probs=181.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCC----EEEEEEecCCChhh-HHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSGQG-LRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
..+|++.+.||.|+||.||+|.+. +|+ .||+|++....... ...+. |++++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 468999999999999999999854 444 48999987543321 22222 44445555553 4578
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++++|+++|+|.+++ +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999887 567788999999999999999999 99999999999999999999999999876543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
...........++..|++||.+.+..++.++|||||||++|+|++ |..||. ..........+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~--~~~~~~~~~~~~~~~~~~~------- 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD--GIPAREIPDLLEKGERLPQ------- 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHCCCcCCC-------
Confidence 322111111234568999999988889999999999999999998 888853 2222333332222211110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
+..++..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 233 -------------------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 -------------------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0114567889999999999999999999999998887443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=279.61 Aligned_cols=245 Identities=28% Similarity=0.396 Sum_probs=187.5
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChh-hHH-------------HHHHHHHHhcee
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQ-GLR-------------ELKNKLRLLGCC 101 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~-~~~-------------~~~~i~~~~~~~ 101 (354)
.+....++|++.+.||+|+||.||++.... ...+|+|.+...... ... .+.|++++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556789999999999999999998642 367899998754221 111 123556677788
Q ss_pred ecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
...+..+++|||+.+++|..++ +++..+..++.|++.||.|||+.+ |+|+||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 8888999999999999998886 356678899999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYS 239 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~ 239 (354)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||. ....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~--~~~~ 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP--GIPV 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC--CCCH
Confidence 9999999999999999876544322111122234567999999988889999999999999999997 888843 3333
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
....+.+..+..... +..++..+.+|+.+||..+|++|||++++++.|
T Consensus 241 ~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 241 EELFKLLKEGYRMEK--------------------------------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHHHHHHHcCCcCCC--------------------------------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 333333322211100 011566788999999999999999999999999
Q ss_pred hhhh
Q 048432 320 TNEA 323 (354)
Q Consensus 320 ~~~~ 323 (354)
+++.
T Consensus 289 ~~~~ 292 (293)
T cd05053 289 DRML 292 (293)
T ss_pred HHhh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=274.54 Aligned_cols=239 Identities=28% Similarity=0.431 Sum_probs=181.7
Q ss_pred hhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HHHHH------------HHHHHhceeecCCc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~~~~ 106 (354)
..++|++.+.||+|++|.||+|.+.. +..|++|.+....... ...+. |++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35789999999999999999999753 5678999887543221 11121 45667777778888
Q ss_pred eEEEEEecCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeEE
Q 048432 107 KILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKI 171 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~l 171 (354)
.+++|||+.+++|.+++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .++|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 99999999999999886 466788999999999999999999 99999999999998755 5899
Q ss_pred eecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccc
Q 048432 172 SDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 172 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||. ..........+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~--~~~~~~~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP--GRTNQEVMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHcCC
Confidence 99999876533221111112233467999999988889999999999999999997 888853 333333333332221
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
... .+..++..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 239 ~~~--------------------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 RLD--------------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCC--------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 110 011146678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=272.46 Aligned_cols=240 Identities=26% Similarity=0.410 Sum_probs=182.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCC----EEEEEEecCCChh-hHHH------------HHHHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSGQ-GLRE------------LKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vavK~~~~~~~~-~~~~------------~~~i~~~~~~~~~~~~~~ 108 (354)
.++|++.+.||.|+||.||+|.+. +++ .+++|.+...... ...+ +.|++++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 468899999999999999999964 344 4788888644321 1122 226677777765 45578
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+++||+.+++|.+++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999888 467888999999999999999999 99999999999999999999999999876543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
...........++..|++||.+.+..++.++|+|||||++|++++ |..||. +.........+..+.......
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~--~~~~~~~~~~~~~~~~~~~~~----- 234 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA--GMRPHEVPDLLEKGERLAQPQ----- 234 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHCCCcCCCCC-----
Confidence 322222223356678999999988889999999999999999998 988853 333333222222222111000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.++..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 235 ---------------------------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 ---------------------------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---------------------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 044567889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=274.64 Aligned_cols=240 Identities=27% Similarity=0.446 Sum_probs=185.3
Q ss_pred hhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|..+. +..||+|.+....... ...+ .+++++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 456789999999999999999999652 3679999987553211 1111 25566777888888
Q ss_pred ceEEEEEecCCCCHhHHHh---------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 106 EKILIYEYMPNKSLDFFLF---------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~~---------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
..+++|||+.+++|.+++. .+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 9999999999999998872 45678899999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
|+|||++................++..|+|||.+.+..++.++|+|||||++|++++ |..|| ...+.....+.+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~--~~~~~~~~~~~~~~~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNEEVLKFVIDG 237 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCC--ccCCHHHHHHHHhcC
Confidence 999999875443322111222345678999999988889999999999999999998 88884 334444444443322
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
..... +..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 238 ~~~~~--------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDL--------------------------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCC--------------------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11100 01146678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=257.36 Aligned_cols=233 Identities=28% Similarity=0.338 Sum_probs=198.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---------------hhHHHHHHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---------------QGLRELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---------------~~~~~~~~i~~~~~~~~~~~~~ 107 (354)
....++|++++.||+|.||.||+|+.+ ++..||+|++.+... +..-.+.||+++|+++.++..+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 345678999999999999999999954 688899999865321 1112235999999999999999
Q ss_pred EEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 108 ILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
|+++||...|++...+ +++.....++.|++.|+.|+|..+ ++||||||+|+|++..+.++++|||-+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999998777 677888999999999999999999 999999999999999999999999988654
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... ....+||..|.+||...+..++..+|+|++|++.||++.|.+| |...+..+..++|.+....+|..
T Consensus 175 p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~pp--Fes~~~~etYkrI~k~~~~~p~~---- 244 (281)
T KOG0580|consen 175 PSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPP--FESQSHSETYKRIRKVDLKFPST---- 244 (281)
T ss_pred CCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCc--hhhhhhHHHHHHHHHccccCCcc----
Confidence 3222 2346899999999999999999999999999999999999999 66666778888887777666521
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+....++|.+||..+|.+|.+..|++..
T Consensus 245 -----------------------------is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 -----------------------------ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----------------------------cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 56778899999999999999999998764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=294.81 Aligned_cols=267 Identities=18% Similarity=0.250 Sum_probs=180.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH--------HHHHHHhceeecC--------Cc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL--------KNKLRLLGCCIDK--------DE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~--------~~i~~~~~~~~~~--------~~ 106 (354)
....++|++.+.||+|+||.||+|.+. +++.||||++........+++ .|++++++++... ..
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 345678999999999999999999965 588999999865433222222 2666666655321 24
Q ss_pred eEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeeccc
Q 048432 107 KILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGI 176 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~ 176 (354)
+++||||+++ ++..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 6789999986 555444 567788999999999999999999 99999999999999665 699999999
Q ss_pred ceeccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
+......... ....+++.|+|||++.+. .++.++|||||||++|+|++|.+|| .+....+....+.+.....+.
T Consensus 218 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf--~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF--SGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHHHhCCCCH
Confidence 9754432211 124678899999988764 6899999999999999999999995 444433333333332221111
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
....... ..+.+. .........+...++...++.+.+||.+||++||++|||+.|+++ .++++.
T Consensus 293 ~~~~~~~-~~~~~~---~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMN-PNYADI---KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhc-hhhhcc---cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000000 000000 000000001111122225678899999999999999999999984 344443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=281.13 Aligned_cols=224 Identities=25% Similarity=0.353 Sum_probs=177.1
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH-------------HHHHHHhceeecCCceEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL-------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~-------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+|++.+.||+|+||.||+|+++ +|+.||+|++..... ...... .+++++..++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999965 588999999875321 111111 13456677788888999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 999999998887 678899999999999999999999 99999999999999999999999999864322211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......|+..|+|||++.+..++.++|+||+||++|+|++|..|| .+.......+.+.......|.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf--~~~~~~~~~~~i~~~~~~~p~----------- 222 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF--DGEDEDELFQSIMEHNVSYPK----------- 222 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCc-----------
Confidence 122245889999999999888999999999999999999999995 444444445544433322221
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
..+..+.+++.+||+.+|++|++.
T Consensus 223 ----------------------~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ----------------------SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----------------------cCCHHHHHHHHHHcccCHhhCCCC
Confidence 134567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=270.86 Aligned_cols=237 Identities=30% Similarity=0.468 Sum_probs=184.4
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|+||.||+|..++++.||+|.+....... ..+. |++++++++ ..+..++++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH-HHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence 3467899999999999999999998889999999987644322 1222 334455554 3567899999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+.+++|.+++ +++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999886 567788999999999999999999 99999999999999999999999999876542221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. ......++..|+|||.+....++.++|+||||+++|++++ |++|| .+.+..+....+...... +.
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~--~~~~~~~~~~~~~~~~~~-~~--------- 224 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY--PGMTNPEVIQNLERGYRM-PR--------- 224 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCC--CCCChHHHHHHHHcCCCC-CC---------
Confidence 1 1112234678999999988889999999999999999998 99995 334444444443322111 00
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 225 ----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ----------------------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00145678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=289.44 Aligned_cols=242 Identities=22% Similarity=0.262 Sum_probs=186.0
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HH--------HHHHHHHhceeecCC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----RE--------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~--------~~~i~~~~~~~~~~~ 105 (354)
......++|++.+.||+|+||.||+|+++ +++.||+|++..... ... .+ +.+++++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 33455689999999999999999999975 588999999864321 111 11 125666777888889
Q ss_pred ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 106 EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.+++||||+++|+|..++ ++...+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999999887 567788889999999999999999 9999999999999999999999999987543
Q ss_pred CCccccccccccCcccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQG----IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
..... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..|| ...+.......+...........
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf--~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc--CCCCHHHHHHHHHcCCCcCCCCC
Confidence 32211 11234689999999998653 3788999999999999999999995 44444444444433222111100
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
. ...+..+.+||.+||+.+|++ |+|++++++.
T Consensus 271 ~-----------------------------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 D-----------------------------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c-----------------------------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 014677889999999999998 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=281.07 Aligned_cols=225 Identities=27% Similarity=0.369 Sum_probs=178.0
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.++ +++.||+|++..... .... .+.+++++++++...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 488999999875321 1110 123677788888889999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|...+ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence 9998877 678889999999999999999999 9999999999999999999999999986422211 11122
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..++..|+|||++.+..++.++|+|||||++|+|++|..|| ...+.......+.......+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf--~~~~~~~~~~~i~~~~~~~~~---------------- 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDELFQSILEDEVRYPR---------------- 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCC--CCCCHHHHHHHHHcCCCCCCC----------------
Confidence 46789999999999999999999999999999999999995 334444444443332222111
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM-----NDVVSM 318 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~il~~ 318 (354)
..+..+.+||.+||+.||++|||+ .++++.
T Consensus 218 -----------------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 -----------------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -----------------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 145678899999999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=269.49 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=187.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||.|++|.||+|... +|+.||+|.+..... .....+ .+++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999976 799999998864221 111122 14556677788888999999
Q ss_pred EecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
||+++++|..++ ++...+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999998876 467788999999999999999999 99999999999999999999999999875443
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... .....++..|.|||.+.+..++.++|+||+|+++|+|++|..||.............+..+... ...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~----- 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLP----- 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCC-----
Confidence 2211 1223567889999999888899999999999999999999999643332222222222221110 000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
....+..+.++|.+||..+|++|||+.+|++.|+++.
T Consensus 230 ------------------------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ------------------------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------------------------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0125667899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.24 Aligned_cols=235 Identities=23% Similarity=0.308 Sum_probs=177.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+.|++++.||+|+||+||+|++. +++.||+|++..... .....+ .+++++++++.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999965 588999999965421 111111 25667788888899999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL- 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~- 185 (354)
||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999887 667888899999999999999999 99999999999999999999999998753211000
Q ss_pred --------------------------------------------ccccccccCcccccCccccccCCCCchhhHHHHHHH
Q 048432 186 --------------------------------------------QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221 (354)
Q Consensus 186 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~ 221 (354)
........||..|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000012468999999999988889999999999999
Q ss_pred HHHHHhCCCCCCcccccchhhhhhhhcccc--CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHh
Q 048432 222 LLKIVSGKKTTGFYRTYSFTLLGYISENIY--EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIAL 299 (354)
Q Consensus 222 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 299 (354)
+|+|++|..||. ..+..+....+..... ..+... ..++.+.+||.
T Consensus 238 l~elltG~~Pf~--~~~~~~~~~~i~~~~~~~~~~~~~-------------------------------~~s~~~~dli~ 284 (381)
T cd05626 238 LFEMLVGQPPFL--APTPTETQLKVINWENTLHIPPQV-------------------------------KLSPEAVDLIT 284 (381)
T ss_pred HHHHHhCCCCCc--CCCHHHHHHHHHccccccCCCCCC-------------------------------CCCHHHHHHHH
Confidence 999999999954 3333332222222111 111100 14566778898
Q ss_pred h--ccccCCCCCCCHHHHHHH
Q 048432 300 L--CVQESADDRPTMNDVVSM 318 (354)
Q Consensus 300 ~--cl~~~P~~Rps~~~il~~ 318 (354)
+ |+..+|..|++++++++.
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHccCcccccCCCCHHHHhcC
Confidence 8 455666679999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=274.18 Aligned_cols=238 Identities=29% Similarity=0.476 Sum_probs=183.1
Q ss_pred hcCccccceecccCceeEEEEEEc-----CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++|++.+.||+|+||.||+|... .+..|++|.+..... .....+. |++++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 367899999999999999999842 467899999975432 2212222 5556677777888899
Q ss_pred EEEEecCCCCHhHHH----------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 109 LIYEYMPNKSLDFFL----------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 109 lv~e~~~~~~L~~~~----------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
++|||+.+++|.+++ +++.....++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999998886 345677889999999999999999 9999999999999999
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 245 (354)
+.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..|| .+.....+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~--~~~~~~~~~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY--YGFSNQEVIEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC--CCCCHHHHHHH
Confidence 9999999999875433222112222344667999999988889999999999999999998 88884 33343444444
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+...... +... .+++.+.+++.+||+.+|++||++.+|++.|+.
T Consensus 239 ~~~~~~~-~~~~-------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLL-PCSE-------------------------------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC-CCCC-------------------------------CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3322211 1000 156678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.79 Aligned_cols=235 Identities=22% Similarity=0.278 Sum_probs=178.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+. +++++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999965 588999999965321 1111111 4556677788888999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||++++|.+++ +++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999887 678889999999999999999999 999999999999999999999999998643221100
Q ss_pred ---------------------------------cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 048432 187 ---------------------------------ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTG 233 (354)
Q Consensus 187 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~ 233 (354)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf- 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF- 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC-
Confidence 0011246899999999999888999999999999999999999995
Q ss_pred cccccchhhhhhhhccccC--CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccc--cCCCCC
Q 048432 234 FYRTYSFTLLGYISENIYE--FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQ--ESADDR 309 (354)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~R 309 (354)
.+.+..+....+...... +|... +.++.+.++|.+++. .++..|
T Consensus 237 -~~~~~~~~~~~i~~~~~~~~~p~~~-------------------------------~~s~~~~~li~~l~~~~~~r~~r 284 (363)
T cd05628 237 -CSETPQETYKKVMNWKETLIFPPEV-------------------------------PISEKAKDLILRFCCEWEHRIGA 284 (363)
T ss_pred -CCCCHHHHHHHHHcCcCcccCCCcC-------------------------------CCCHHHHHHHHHHcCChhhcCCC
Confidence 444545555554432221 11110 034566778877554 233456
Q ss_pred CCHHHHHHH
Q 048432 310 PTMNDVVSM 318 (354)
Q Consensus 310 ps~~~il~~ 318 (354)
|+++||++.
T Consensus 285 ~~~~ei~~h 293 (363)
T cd05628 285 PGVEEIKTN 293 (363)
T ss_pred CCHHHHhCC
Confidence 899999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=273.91 Aligned_cols=243 Identities=27% Similarity=0.458 Sum_probs=185.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecC
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDK 104 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~ 104 (354)
....++|++.+.||+|+||.||+|..+ .+..||+|.+...... ....+ .+++++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456789999999999999999999754 2457999988654321 11111 1556677788888
Q ss_pred CceEEEEEecCCCCHhHHHh---------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 105 DEKILIYEYMPNKSLDFFLF---------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~~---------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
...+++|||+.+++|.+++. ....+..++.|++.||.|||+++ ++|+||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 88999999999999999982 23467889999999999999999 9999999999999999999
Q ss_pred EEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 248 (354)
+|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..|| .+....+....+..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~--~~~~~~~~~~~~~~ 236 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVLKFVMD 236 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHc
Confidence 9999999875433222111122234567999999988889999999999999999998 67784 33333333333322
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+..... +..+++.+.+++.+||+.+|++|||+.++++.|++..
T Consensus 237 ~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYLDQ--------------------------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCC--------------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 211000 0014678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=273.32 Aligned_cols=238 Identities=28% Similarity=0.449 Sum_probs=183.6
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++|.+.+.||+|+||.||++... .+..+++|.+..........+. |++++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 468899999999999999999742 3567899998765544333333 4556667777888899
Q ss_pred EEEEecCCCCHhHHH--------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 109 LIYEYMPNKSLDFFL--------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 109 lv~e~~~~~~L~~~~--------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
+++||+.+++|.+++ +++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 999999999998886 356778899999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 247 (354)
++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |.+|| ......+....+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~--~~~~~~~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW--YQLSNTEAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC--ccCCHHHHHHHHH
Confidence 99999999875433222111222334678999999988889999999999999999998 88884 3333333333332
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
.+...... ..+++.+.+||.+||..+|++||++++|++.|+.
T Consensus 239 ~~~~~~~~--------------------------------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGRELERP--------------------------------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCccCCCC--------------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 22211000 0156778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=270.55 Aligned_cols=235 Identities=28% Similarity=0.415 Sum_probs=182.2
Q ss_pred cCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHH--------HHHHHHhceeecCCceEEEEEecCC
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~--------~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
.+|++.+.||+|++|.||++.++.+..+|+|++....... ..++ .|++++++++...+..++|+||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 5689999999999999999998777789999986543211 1111 1455666777888889999999999
Q ss_pred CCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 117 KSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 117 ~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
++|.+++ +++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++......... ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 9999887 467888999999999999999999 999999999999999999999999998754332211 111
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...++..|+|||.+.+..++.++|+||||+++|++++ |..||. .....+....+.......
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~--~~~~~~~~~~~~~~~~~~---------------- 221 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE--RFSNSEVVESVSAGYRLY---------------- 221 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHcCCcCC----------------
Confidence 1223457999999988889999999999999999998 788853 333333333332221100
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.+..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 222 ----------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 ----------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ----------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 00115678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=277.00 Aligned_cols=245 Identities=29% Similarity=0.396 Sum_probs=186.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc--------CCCEEEEEEecCCCh-hhHHH-------------HHHHHHHhce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSG-QGLRE-------------LKNKLRLLGC 100 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vavK~~~~~~~-~~~~~-------------~~~i~~~~~~ 100 (354)
+....++|.+.+.||+|+||.||+|++. ++..+|+|.+..... ..... +.|+++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3444578999999999999999999853 235699999976422 11111 2245566777
Q ss_pred eecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
+...+..++||||+.+++|.+++ +++..+..++.|++.||+|||+.+ ++|+||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 88888999999999999998887 245678899999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTY 238 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~ 238 (354)
||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+|||||++|+|++ |..||. ...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~--~~~ 247 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--GVP 247 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC--cCC
Confidence 99999999999999999875443221111111233468999999988889999999999999999998 778853 333
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+....+...... ..+..++..+.+|+.+||..+|++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRM--------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCC--------------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33333333222110 0011156788899999999999999999999999
Q ss_pred hhhhhh
Q 048432 319 LTNEAA 324 (354)
Q Consensus 319 L~~~~~ 324 (354)
|+++..
T Consensus 296 l~~~~~ 301 (307)
T cd05098 296 LDRILA 301 (307)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=269.52 Aligned_cols=237 Identities=29% Similarity=0.488 Sum_probs=183.1
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|++|.||+|..+.+..||+|.+....... ..+. +++++++++ .....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH-HHHHHHHHHHHhcCCCceEEEEeEE-CCCCcEEEEE
Confidence 3457899999999999999999998888889999987643321 1222 333444444 3456899999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+.+++|.+++ +++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999887 567889999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+|| .+.+..+....+..... .+.
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~--~~~~~~~~~~~~~~~~~-~~~--------- 224 (260)
T cd05070 158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY--PGMNNREVLEQVERGYR-MPC--------- 224 (260)
T ss_pred cc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC--CCCCHHHHHHHHHcCCC-CCC---------
Confidence 11 111234567999999988889999999999999999999 88885 33444444444432211 100
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+...+..+.+|+.+||..+|++|||++++.+.|++
T Consensus 225 ----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ----------------------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----------------------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01145678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=269.47 Aligned_cols=239 Identities=28% Similarity=0.469 Sum_probs=182.7
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHH--------HHHHHHhceeecCCceEEEEEe
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~--------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
...++|++.+.||+|++|.||+|.+.++..||+|.+....... ..+. .+++++++.+ .....+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~ 81 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEY 81 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCcEEEEEc
Confidence 3457899999999999999999998777789999997533211 1111 1445555554 34568999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+.+++|.+++ +++..+..++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999998887 456788999999999999999999 999999999999999999999999998765433321
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
. .....++..|++||...+..++.++|+|||||++|+|++ |..||. ..........+..... .+
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~--~~~~~~~~~~~~~~~~-~~----------- 223 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYR-MP----------- 223 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC--CCChHHHHHHHhcCCC-CC-----------
Confidence 1 112345678999999988889999999999999999999 777743 3333333333222110 00
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
....++..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 224 --------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 --------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0112567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=267.77 Aligned_cols=231 Identities=27% Similarity=0.410 Sum_probs=175.7
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
+.||+|+||.||+|.++ +++.||+|.+...... ....+ .|++++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999965 6899999987644221 11111 2666777888888999999999999999
Q ss_pred hHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccccc
Q 048432 120 DFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193 (354)
Q Consensus 120 ~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~ 193 (354)
.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9887 567888999999999999999999 9999999999999999999999999986543322111111112
Q ss_pred CcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhh
Q 048432 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIF 272 (354)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 272 (354)
.+..|+|||.+.+..++.++|+|||||++|++++ |..||. ..........+...... +
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~--~~~~~~~~~~~~~~~~~-~------------------ 216 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA--NLSNQQTREAIEQGVRL-P------------------ 216 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc--ccCHHHHHHHHHcCCCC-C------------------
Confidence 3457999999988889999999999999999997 888853 22222222222211110 0
Q ss_pred hhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 273 KLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
.+..++..+.+|+.+||+.+|++|||++++++.|+.
T Consensus 217 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 217 -------------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred -------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 011156678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=279.98 Aligned_cols=224 Identities=27% Similarity=0.378 Sum_probs=175.4
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----H---------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----R---------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~---------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.++ +++.||+|++..... ... . .+.+++++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 478999999865311 000 0 123667778888889999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceee
Confidence 9998887 677888999999999999999999 99999999999999999999999999864322211 1123
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+||+||++|+|++|..|| ...+..+....+.......+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf--~~~~~~~~~~~i~~~~~~~~~---------------- 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF--HGHDEEELFQSIRMDNPCYPR---------------- 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCc----------------
Confidence 46789999999999888999999999999999999999995 334444444443322221111
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN-DVVS 317 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-~il~ 317 (354)
..+..+.+|+.+||+.+|++||++. +++.
T Consensus 218 -----------------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 -----------------WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -----------------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1345678999999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=270.33 Aligned_cols=236 Identities=25% Similarity=0.435 Sum_probs=178.9
Q ss_pred ccccceecccCceeEEEEEEcC----CCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCC------
Q 048432 50 FSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKD------ 105 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~------ 105 (354)
|++.+.||+|+||.||+|.... +..||+|++..... .....+. |++++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999999642 36799999875422 2222222 4455555554433
Q ss_pred ceEEEEEecCCCCHhHHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 106 EKILIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
..++++||+.+++|..++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 378999999999998776 466778999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
|++.................+..|++||.+.+..++.++|+|||||++|+|++ |..|| .+....+....+..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~--~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY--PGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCC
Confidence 99876543322111112234568999999988889999999999999999999 77884 3333334444333222110
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 --------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 --------------------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------------------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.23 Aligned_cols=251 Identities=27% Similarity=0.360 Sum_probs=208.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh----hhHHH-----------------HHHHHHHhceee
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG----QGLRE-----------------LKNKLRLLGCCI 102 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~----~~~~~-----------------~~~i~~~~~~~~ 102 (354)
..-..|.-.+.||.|..+.|-++.++ .|+.+|+|++..... ....+ +.+|+.+.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888999999999999999865 588999999843211 11111 114556778899
Q ss_pred cCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 103 DKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.+..+++|++.|+.|.|.+++ +++...++|+.|++.|+.|||.++ ||||||||+|||++++..++|+|||.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999998 789999999999999999999999 999999999999999999999999999
Q ss_pred eeccCCccccccccccCcccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQG------IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
+....+.... ..+||+.|+|||.+... .|+..+|+|++|+++|.|+.|.+| |+.....-++++|.++..
T Consensus 171 ~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpP--FwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 171 CQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPP--FWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred eccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCc--hhHHHHHHHHHHHHhccc
Confidence 8877666432 36899999999998642 478899999999999999999999 898889999999999999
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhhhcCCC
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALLPP 329 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~~~~~~ 329 (354)
++....|.. .+....+||.+||+.||++|.|+++.|+. +.++.....+.
T Consensus 246 qF~speWad-----------------------------is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ 296 (411)
T KOG0599|consen 246 QFRSPEWAD-----------------------------ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQ 296 (411)
T ss_pred ccCCcchhh-----------------------------ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccc
Confidence 887766544 46677899999999999999999999863 45555444444
Q ss_pred CCC
Q 048432 330 KQP 332 (354)
Q Consensus 330 ~~~ 332 (354)
..|
T Consensus 297 msP 299 (411)
T KOG0599|consen 297 MSP 299 (411)
T ss_pred cCC
Confidence 444
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=273.25 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=185.9
Q ss_pred cCccccceecccCceeEEEEEEcC-C--CEEEEEEecCCCh-hhH----H---------HHHHHHHHhceeecCCceEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKN-G--DEIAVKRLSGRSG-QGL----R---------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~-~--~~vavK~~~~~~~-~~~----~---------~~~~i~~~~~~~~~~~~~~lv 110 (354)
++|++.+.||.|+||.||+|..++ + ..+++|.++.... ... . .+.|++++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999998653 3 3478888864221 111 1 123777888888888899999
Q ss_pred EEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 111 YEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 111 ~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
+||+++++|.+++ +++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999998887 345678899999999999999999 9999999999999999999
Q ss_pred EEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~ 248 (354)
+|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..|| ...........+..
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf--~~~~~~~~~~~~~~ 233 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQ 233 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC--CCCCHHHHHHHHhc
Confidence 999999985322111 1111122457999999988889999999999999999997 98885 33333333333322
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCC
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~ 328 (354)
...... +..++..+.+|+.+||+.+|.+|||++++++.|+++.....+
T Consensus 234 ~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 234 GYRMEK--------------------------------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCC--------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 211100 011566789999999999999999999999999999876655
Q ss_pred CCC
Q 048432 329 PKQ 331 (354)
Q Consensus 329 ~~~ 331 (354)
...
T Consensus 282 ~~~ 284 (297)
T cd05089 282 YVN 284 (297)
T ss_pred ccc
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=284.13 Aligned_cols=265 Identities=17% Similarity=0.168 Sum_probs=185.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH------HHHHHHHHhceeecCCceEEEEEecCCCC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR------ELKNKLRLLGCCIDKDEKILIYEYMPNKS 118 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (354)
..++|.+.+.||+|+||.||+|.+. .++.||+|........... .+.|++++++++......++++|++. ++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 3468999999999999999999965 5889999986543221111 12377888888988999999999996 46
Q ss_pred HhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccccc
Q 048432 119 LDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193 (354)
Q Consensus 119 L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~ 193 (354)
|..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ .......
T Consensus 169 L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~ 244 (391)
T PHA03212 169 LYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWA 244 (391)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccccc
Confidence 76665 677889999999999999999999 99999999999999999999999999864322211 1122357
Q ss_pred CcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-----cchhhhhhhhccccCCCCcccCCccccccch
Q 048432 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-----YSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+..+.......|..... ......+
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~--~~~~~~~ 322 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI--DAQANLD 322 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc--chhHHHH
Confidence 89999999999988999999999999999999999988522111 1112222233222222221110 0000011
Q ss_pred hhhhhhhhccc--cCCch--hHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 269 LTIFKLFSISS--VGLSN--DIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 269 ~~~~~~~~~~~--~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
........... ...+. ......+..+.+||.+||++||++|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11100000000 01111 111235678999999999999999999999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=283.77 Aligned_cols=225 Identities=24% Similarity=0.297 Sum_probs=175.2
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||+|.++ +|+.||+|++..... ...... .+++++..++...+.+++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 689999999975321 111111 14455667778888999999999999
Q ss_pred CHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 118 SLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 118 ~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
+|..++ +++..+..++.||+.||.|||+ .+ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 998877 6788899999999999999997 78 99999999999999999999999999864322111 1122
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|||||||++|+|++|..|| ...+.......+.......|.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf--~~~~~~~~~~~i~~~~~~~p~---------------- 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPR---------------- 217 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCC--CCCCHHHHHHHHhcCCCCCCC----------------
Confidence 46889999999998888999999999999999999999995 333333343433322222211
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..++.+.+||.+||+.||++|+ ++.++++.
T Consensus 218 -----------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 -----------------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -----------------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1456688999999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=282.22 Aligned_cols=267 Identities=18% Similarity=0.260 Sum_probs=178.6
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhH----HH--------HHHHHHHhceeecC-----CceE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGL----RE--------LKNKLRLLGCCIDK-----DEKI 108 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~----~~--------~~~i~~~~~~~~~~-----~~~~ 108 (354)
+|++.+.||+|+||.||+|.++ +|+.||+|++..... ... .+ +.|++++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6899999999999999999965 589999999864211 111 11 12555566665432 3479
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|||||. ++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 5787776 678889999999999999999999 999999999999999999999999998754322
Q ss_pred cc-ccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 184 EL-QANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 184 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++|++||. +.+.......+.......+......
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP--GKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC--CCChHHHHHHHHHHhCCCCHHHHHH
Confidence 11 111123467899999998865 568999999999999999999999953 3332222222222222111111000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
+.... .......... ..........+..++.+.++|.+||+.+|++|||++++++. +++..
T Consensus 235 i~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 235 VRNEK-ARRYLSSMRK-KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhh-HHHHHHhhcc-cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 00000 0000000000 00000000011245678899999999999999999999965 44443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=284.91 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=179.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+ .++++++.++...+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999965 589999999975422 111111 14556667788888999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999887 567788899999999999999999 99999999999999999999999999876543322
Q ss_pred ccccccccCcccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 186 QANTGRIVGTYRYMSPEYAI------QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
. ......++..|+|||++. ...++.++|||||||++|+|++|..|| ...........+...........
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf--~~~~~~~~~~~i~~~~~~~~~~~-- 232 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF--HEGTSAKTYNNIMNFQRFLKFPE-- 232 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC--CCCCHHHHHHHHHcCCCccCCCC--
Confidence 1 112246789999999986 445788999999999999999999995 33333333333322211100000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+..+..+.+|+.+||. +|++|||++++++.
T Consensus 233 ---------------------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 233 ---------------------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---------------------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00146678899999998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=277.47 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=187.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC--------CCEEEEEEecCCChh-hHH-------------HHHHHHHHhce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN--------GDEIAVKRLSGRSGQ-GLR-------------ELKNKLRLLGC 100 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~--------~~~vavK~~~~~~~~-~~~-------------~~~~i~~~~~~ 100 (354)
+.....+|++.+.||+|+||.||.|++.. +..||+|.+...... ... .+.|+++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 33445689999999999999999998531 236899988753211 111 12366777788
Q ss_pred eecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
+...+.+++++||+.+++|.+++ +++..+..++.|++.||.|||.++ ++|+||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 88888999999999999998886 235667889999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTY 238 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~ 238 (354)
||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..|| ....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~--~~~~ 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY--PGIP 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC--CCCC
Confidence 99999999999999999875543322111111233467999999998889999999999999999998 78884 3333
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+....+....... . +..++..+.+++.+||+.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~-~-------------------------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMD-K-------------------------------PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCC-C-------------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 344444333221110 0 00156678899999999999999999999999
Q ss_pred hhhhhhhc
Q 048432 319 LTNEAAAL 326 (354)
Q Consensus 319 L~~~~~~~ 326 (354)
|+++....
T Consensus 290 l~~~~~~~ 297 (334)
T cd05100 290 LDRVLTVT 297 (334)
T ss_pred HHHHhhhc
Confidence 99988544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=279.47 Aligned_cols=226 Identities=25% Similarity=0.308 Sum_probs=177.4
Q ss_pred cceecccCceeEEEEEEc----CCCEEEEEEecCCCh----hh----HHH--------HHHHHHHhceeecCCceEEEEE
Q 048432 53 ANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSG----QG----LRE--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~----~~----~~~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++.||+|+||.||+++.. .++.||+|++..... .. ..+ +.|++++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999853 588999999864321 10 111 1377888889999999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|+.+++|..++ +....+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999998887 566778889999999999999999 99999999999999999999999999864322211
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
......|+..|+|||++.+..++.++|||||||++|+|++|..|| ...+.......+..+....|.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf--~~~~~~~~~~~~~~~~~~~~~------------ 221 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF--TAENRKKTIDKILKGKLNLPP------------ 221 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC--CCCCHHHHHHHHHcCCCCCCC------------
Confidence 112246889999999998888999999999999999999999995 333433444444333222211
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..++.+.+||.+||+.+|++|| +++++++.
T Consensus 222 ---------------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 ---------------------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---------------------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1456678999999999999999 88888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=281.66 Aligned_cols=239 Identities=27% Similarity=0.369 Sum_probs=203.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhh---HHH-------------HHHHHHHhceeecCC
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG---LRE-------------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~---~~~-------------~~~i~~~~~~~~~~~ 105 (354)
.......|++.+.||.|.||.||.++.+. |+.+|+|++.+..... ... +.|++.+.++|.+..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34556789999999999999999999775 9999999997654321 112 225566777889999
Q ss_pred ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC----CCeEEeecccc
Q 048432 106 EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD----MNPKISDFGIA 177 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~~l~dfg~a 177 (354)
.+++|||+|.||.|.+.+ +++..+..++.|++.+++|||+.| ++||||||+|+|+... +.++++|||++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999888 567889999999999999999999 9999999999999643 47999999999
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
....... .....+||+.|+|||++.+.+++..+|+||+|+++|.|++|.+| |++.+.......+..+...++...
T Consensus 187 ~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~P--F~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 187 KFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPP--FWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred eEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCC--CcCCChhHHHHHHHcCCCCCCCCC
Confidence 8776622 33446899999999999999999999999999999999999999 788887788888888888766655
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
++. .+..+.++|+.|+..||.+|+|+.++++.
T Consensus 262 w~~-----------------------------is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 262 WDD-----------------------------ISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ccc-----------------------------cCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 543 56778999999999999999999999984
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.46 Aligned_cols=236 Identities=22% Similarity=0.265 Sum_probs=179.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||.|+||.||+|..+ +++.||+|++..... .....+ .+++++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999965 689999999865321 111111 25677788889999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL- 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~- 185 (354)
||+++++|..++ ++...++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999887 567888899999999999999999 99999999999999999999999999853211000
Q ss_pred -----------cc---------------------------------ccccccCcccccCccccccCCCCchhhHHHHHHH
Q 048432 186 -----------QA---------------------------------NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221 (354)
Q Consensus 186 -----------~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~ 221 (354)
.. ......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00 0001358999999999988889999999999999
Q ss_pred HHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhc
Q 048432 222 LLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLC 301 (354)
Q Consensus 222 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 301 (354)
+|+|++|.+|| ......+....+..+......... ...+..+.+||.+|
T Consensus 238 l~elltG~~Pf--~~~~~~~~~~~i~~~~~~~~~p~~-----------------------------~~~s~~~~dli~~l 286 (377)
T cd05629 238 MFECLIGWPPF--CSENSHETYRKIINWRETLYFPDD-----------------------------IHLSVEAEDLIRRL 286 (377)
T ss_pred hhhhhcCCCCC--CCCCHHHHHHHHHccCCccCCCCC-----------------------------CCCCHHHHHHHHHH
Confidence 99999999995 333333444443332211110000 00355678999999
Q ss_pred cccCCCCC---CCHHHHHHH
Q 048432 302 VQESADDR---PTMNDVVSM 318 (354)
Q Consensus 302 l~~~P~~R---ps~~~il~~ 318 (354)
|. +|.+| +|+.+++..
T Consensus 287 L~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcC
Confidence 98 67765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=271.62 Aligned_cols=244 Identities=25% Similarity=0.447 Sum_probs=187.2
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-----CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeec-CC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-----GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCID-KD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~-~~ 105 (354)
...++|++.+.||+|+||.||+|.+.+ +..|++|.+....... ...+ .|++++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 356789999999999999999999765 7889999987543221 1212 245556666554 46
Q ss_pred ceEEEEEecCCCCHhHHH-------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEe
Q 048432 106 EKILIYEYMPNKSLDFFL-------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~ 172 (354)
..+++++|+.+++|..++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999998886 346778899999999999999999 9999999999999999999999
Q ss_pred ecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcccc
Q 048432 173 DFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 173 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
|||+++...............++..|+|||.+.+..++.++|||||||++|++++ |..||. ..+..++...+.....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~--~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV--EIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC--cCCHHHHHHHHHcCCC
Confidence 9999875433322222222345678999999988889999999999999999998 999853 3333333333222111
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.+. ...+++.+.+++.+||..+|++|||+.++++.|+++..+
T Consensus 238 -~~~-------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 -LAQ-------------------------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -CCC-------------------------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000 001567789999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=276.16 Aligned_cols=246 Identities=28% Similarity=0.401 Sum_probs=187.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEc--------CCCEEEEEEecCCChh-hHHH-------------HHHHHHHhcee
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSGQ-GLRE-------------LKNKLRLLGCC 101 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vavK~~~~~~~~-~~~~-------------~~~i~~~~~~~ 101 (354)
....++|.+.+.||+|+||.||+|+.. ....+|+|.+...... .... +.|++++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344578999999999999999999842 2456899998754321 1111 23556667777
Q ss_pred ecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
...+.+++++||+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 8888899999999999998887 345667889999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYS 239 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~ 239 (354)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..|| .....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~--~~~~~ 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY--PGIPV 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC--CCCCH
Confidence 9999999999999999875543222111111223457999999988889999999999999999998 78884 33333
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
.+....+....... .+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 243 ~~~~~~~~~~~~~~--------------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 243 EELFKLLREGHRMD--------------------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHHHHHHcCCCCC--------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 44444433221100 0011566788999999999999999999999999
Q ss_pred hhhhhhc
Q 048432 320 TNEAAAL 326 (354)
Q Consensus 320 ~~~~~~~ 326 (354)
.++....
T Consensus 291 ~~~~~~~ 297 (314)
T cd05099 291 DKVLAAV 297 (314)
T ss_pred HHHHHHh
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.63 Aligned_cols=236 Identities=25% Similarity=0.433 Sum_probs=176.4
Q ss_pred ccccceecccCceeEEEEEEcC-CC--EEEEEEecCCC--hhhHHHHH------------HHHHHhceeec------CCc
Q 048432 50 FSDANKLGEGGFGPVYKGVLKN-GD--EIAVKRLSGRS--GQGLRELK------------NKLRLLGCCID------KDE 106 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~-~~--~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~------~~~ 106 (354)
|.+.+.||+|+||.||+|++.. ++ .||+|.+.... ......+. |++++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999754 33 58999886532 22222222 45555555432 235
Q ss_pred eEEEEEecCCCCHhHHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 107 KILIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
.++++||+.+++|..++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998876 457778999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
++................++..|++||.+.+..++.++|+|||||++|+|++ |..||. ..........+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~--~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP--GVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHcCCCCCC
Confidence 9876543322111122235668999999988889999999999999999999 788853 3333344343333221100
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
+..++..+.++|.+||+.+|++|||++++++.|+++
T Consensus 236 --------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 --------------------------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=282.62 Aligned_cols=223 Identities=23% Similarity=0.269 Sum_probs=174.2
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HH---------HHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----RE---------LKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~---------~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ +++.||+|++..... ... .+ +.|++++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999976 478899999865321 110 01 12556677788888999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ +....+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence 9998887 567788889999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|||||||++|+|++|.+|| ...+..+....+.......+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~~----------------- 216 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLK----------------- 216 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCC--CCCCHHHHHHHHHhCCcCCC-----------------
Confidence 46899999999999988999999999999999999999995 44444444444333221111
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
+..+..+.+++.+||+.+|.+||++.+.+
T Consensus 217 ----------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 ----------------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ----------------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 01456788999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.76 Aligned_cols=257 Identities=30% Similarity=0.472 Sum_probs=207.1
Q ss_pred hhhcCccccceecccCceeEEEEEEcC--CC----EEEEEEecCCChhhH-H------------HHHHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN--GD----EIAVKRLSGRSGQGL-R------------ELKNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~--~~----~vavK~~~~~~~~~~-~------------~~~~i~~~~~~~~~~~ 105 (354)
....+.++.+.||+|.||.||.|...+ |. .||+|.+........ . .|+||+++++++....
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 335567889999999999999999653 43 389999977654332 1 1349999999999999
Q ss_pred ceEEEEEecCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 106 EKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
..+|++|||+||+|..++ +.....+.++.||++|+.||++++ ++||||..+|+|++....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999998 567888999999999999999999 99999999999999999999999
Q ss_pred cccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccC
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
||+|+.....+.-.......-...|+|||.+..+.++.++||||||+++||+++ |..| |.+.++.++......+..-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P--Y~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP--YPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC--CCCcchHHHHHHHHhCCcc
Confidence 999984333332222211122458999999999999999999999999999999 6778 5666666666654444422
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCC
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 332 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~ 332 (354)
.+ +..|++.++++|.+||+.+|++||++..|++.+.++.....+....
T Consensus 924 ~~--------------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~ 971 (1025)
T KOG1095|consen 924 DP--------------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYG 971 (1025)
T ss_pred CC--------------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccc
Confidence 22 2229999999999999999999999999999999999887776665
Q ss_pred Cccccc
Q 048432 333 AFSYVR 338 (354)
Q Consensus 333 ~~~~~~ 338 (354)
.+.-+.
T Consensus 972 ~~~a~~ 977 (1025)
T KOG1095|consen 972 PLPADY 977 (1025)
T ss_pred cccccc
Confidence 555443
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.66 Aligned_cols=220 Identities=24% Similarity=0.295 Sum_probs=172.6
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hH----HH---------HHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GL----RE---------LKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~----~~---------~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ +|+.||+|++...... .. .+ +.|++++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 5899999998653211 10 11 12456667778888899999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ +++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence 9998877 677888899999999999999999 9999999999999999999999999986432211 12223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..|| ...+..+....+.......+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf--~~~~~~~~~~~i~~~~~~~~~---------------- 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF--YSRDTAEMYDNILNKPLRLKP---------------- 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCC--CCCCHHHHHHHHHcCCCCCCC----------------
Confidence 46899999999999888999999999999999999999995 444444444444332221110
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 313 (354)
..+..+.++|.+||+.||++||++.
T Consensus 218 -----------------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -----------------NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----------------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1456688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=289.12 Aligned_cols=236 Identities=21% Similarity=0.265 Sum_probs=178.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+.|++.+.||+|+||.||+|+.+ +++.||+|++...... ....+ .+++++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 5899999998653211 11111 25667778888899999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL- 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~- 185 (354)
|||++++|.+++ ++...+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999987 567888899999999999999999 99999999999999999999999999743211000
Q ss_pred ----------------------------------------ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHH
Q 048432 186 ----------------------------------------QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKI 225 (354)
Q Consensus 186 ----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~l 225 (354)
........|++.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001124689999999999988899999999999999999
Q ss_pred HhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccC
Q 048432 226 VSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQES 305 (354)
Q Consensus 226 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 305 (354)
++|..||. .....+....+..+......... ...+..+.++|.+|+ .+
T Consensus 238 l~G~~Pf~--~~~~~~~~~~i~~~~~~~~~~~~-----------------------------~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 238 LVGQPPFL--ADTPAETQLKVINWETTLHIPSQ-----------------------------AKLSREASDLILRLC-CG 285 (376)
T ss_pred hhCCCCCC--CCCHHHHHHHHhccCccccCCCC-----------------------------CCCCHHHHHHHHHHh-cC
Confidence 99999953 33333333333222111110000 004556778888876 49
Q ss_pred CCCCC---CHHHHHHH
Q 048432 306 ADDRP---TMNDVVSM 318 (354)
Q Consensus 306 P~~Rp---s~~~il~~ 318 (354)
|++|+ |+.++++.
T Consensus 286 p~~R~~~~t~~ell~h 301 (376)
T cd05598 286 AEDRLGKNGADEIKAH 301 (376)
T ss_pred HhhcCCCCCHHHHhCC
Confidence 99999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.19 Aligned_cols=233 Identities=26% Similarity=0.412 Sum_probs=185.5
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
..++|++.+.||.|++|.||+|... |+.||+|.+..... ...++ .|++++++++.+....++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4678999999999999999999975 88999999987654 11121 2556677788888899999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+.+++|.+++ +++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999887 567889999999999999999999 99999999999999999999999999876533221
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
....+..|+|||.+....++.++|+||||+++|++++ |..||. .....+....+......
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~--~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPHVEKGYRM------------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHHhcCCCC-------------
Confidence 1233567999999988889999999999999999997 888853 33333333332221110
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
..+...++.+.++|.+||+.+|++|||++++++.|+.+
T Consensus 219 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 -------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00011467789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=276.77 Aligned_cols=183 Identities=29% Similarity=0.373 Sum_probs=153.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hH----HH--------HHHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GL----RE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~----~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||.|+||.||+|.++ .+..+|+|++...... .. .+ +.|++++++++...+.+++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4589999999999999999999976 5888999988654221 11 11 127778888999999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+++|.+++ ++...+..++.+++.||.|||+. + ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999987 56778889999999999999974 6 9999999999999999999999999986443221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFY 235 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~ 235 (354)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12236788999999998888999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=287.91 Aligned_cols=236 Identities=21% Similarity=0.286 Sum_probs=176.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+.|++++.||+|+||.||+|+.. +++.||+|++..... .....+ .+++++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999965 588999999865421 111111 25566778888899999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL- 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~- 185 (354)
|||++|+|..++ ++...+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999998887 567888899999999999999999 99999999999999999999999999753210000
Q ss_pred --------------------------------------------ccccccccCcccccCccccccCCCCchhhHHHHHHH
Q 048432 186 --------------------------------------------QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221 (354)
Q Consensus 186 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~ 221 (354)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999998899999999999999
Q ss_pred HHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhc
Q 048432 222 LLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLC 301 (354)
Q Consensus 222 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 301 (354)
+|+|++|.+||. ..+..+....+............ ...++...++|.+|
T Consensus 238 l~elltG~~Pf~--~~~~~~~~~~i~~~~~~~~~p~~-----------------------------~~~s~~~~~li~~l 286 (382)
T cd05625 238 LYEMLVGQPPFL--AQTPLETQMKVINWQTSLHIPPQ-----------------------------AKLSPEASDLIIKL 286 (382)
T ss_pred HHHHHhCCCCCC--CCCHHHHHHHHHccCCCcCCCCc-----------------------------ccCCHHHHHHHHHH
Confidence 999999999953 33433333333322111111000 01355667888887
Q ss_pred cccCCCCCCC---HHHHHHH
Q 048432 302 VQESADDRPT---MNDVVSM 318 (354)
Q Consensus 302 l~~~P~~Rps---~~~il~~ 318 (354)
+ .+|++|++ +++++..
T Consensus 287 ~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcC
Confidence 6 49999997 8887753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=283.12 Aligned_cols=246 Identities=21% Similarity=0.230 Sum_probs=186.5
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHH---H---------HHHHHHHhcee
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLR---E---------LKNKLRLLGCC 101 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~---~---------~~~i~~~~~~~ 101 (354)
.++..+....++|++.+.||+|+||.||+|+++ +++.||+|++...... ... + +.+++++++.+
T Consensus 33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345556667799999999999999999999976 5889999998642211 111 1 12556677788
Q ss_pred ecCCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.+.+.+++||||+++++|..++ ++...+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 8889999999999999999887 567778899999999999999999 999999999999999999999999998
Q ss_pred eeccCCccccccccccCcccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGI----FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
......... ......||+.|+|||++.... ++.++|||||||++|+|++|..|| ...+.......+.......
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf--~~~~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSL 266 (371)
T ss_pred eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC--CCCCHHHHHHHHHcCCCcc
Confidence 765432211 112346899999999987543 788999999999999999999995 4444444444444332221
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
+.... ...+..+.++|..||..++.+ |++++++++.
T Consensus 267 ~~~~~-----------------------------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFPDD-----------------------------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCc-----------------------------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11110 014667889999999844443 7899998885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=279.80 Aligned_cols=226 Identities=20% Similarity=0.298 Sum_probs=173.7
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ +++.||+|++..... .... .+.+++++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 588999999975321 1111 123566777888888999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ +++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccccc
Confidence 9998776 678899999999999999999999 9999999999999999999999999986422111 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-------hhhhhhhhccccCCCCcccCCcccc
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS-------FTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..||...+... ......+.......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 224 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----------- 224 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC-----------
Confidence 468999999999999889999999999999999999999975322111 01111111111111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC------HHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT------MNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps------~~~il~ 317 (354)
+...+..+.++|.+||+.||++|+| ++++++
T Consensus 225 ----------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 ----------------------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----------------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1114567889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=266.17 Aligned_cols=236 Identities=29% Similarity=0.471 Sum_probs=181.4
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
..++|++.+.||+|++|.||+|.++.+..+|+|.+....... ..+. +++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccH-HHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 446799999999999999999998777789999886543221 1222 3344445443 4568899999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999998887 467788999999999999999999 999999999999999999999999998765433211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
. .....++..|+|||...+..++.++|+||||+++|+|++ |..|| .+....+....+..... .+.
T Consensus 159 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~--~~~~~~~~~~~~~~~~~-~~~---------- 224 (260)
T cd05069 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY--PGMVNREVLEQVERGYR-MPC---------- 224 (260)
T ss_pred c-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCC-CCC----------
Confidence 1 112234668999999988889999999999999999999 88884 33433333333332211 110
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+...+..+.+++.+||+.+|++|||++++++.|++
T Consensus 225 ---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 ---------------------PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---------------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01146778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=273.54 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=180.5
Q ss_pred hcCccccceecccCceeEEEEEEcC---------------CCEEEEEEecCCChh-hHHHHH------------HHHHHh
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN---------------GDEIAVKRLSGRSGQ-GLRELK------------NKLRLL 98 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~---------------~~~vavK~~~~~~~~-~~~~~~------------~i~~~~ 98 (354)
.++|++.+.||+|+||.||++.... ...||+|.+...... ....+. ++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4789999999999999999998542 235899998765322 112222 456667
Q ss_pred ceeecCCceEEEEEecCCCCHhHHH-----------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 048432 99 GCCIDKDEKILIYEYMPNKSLDFFL-----------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNI 161 (354)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~~-----------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 161 (354)
+++...+..++||||+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 7888888999999999999998876 245677899999999999999999 99999999999
Q ss_pred EEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchh
Q 048432 162 LLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT 241 (354)
Q Consensus 162 ll~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~ 241 (354)
+++.++.++|+|||++................++..|+|||.+....++.++|+|||||++|+|+++..+.+|.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999987543322221222234467899999998888999999999999999999844333244433333
Q ss_pred hhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
....+........... ....+...++.+.+|+.+||+.+|++|||+++|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQI-------------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccc-------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 3332211000000000 000001146789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=268.66 Aligned_cols=239 Identities=22% Similarity=0.361 Sum_probs=180.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
..++|++.+.||+|+||.||+|... +++.||+|++..........+ .+++++++.+...+.+++|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3568999999999999999999964 588999999875433222222 255667778888889999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|+++++|.+++ ++...+..++.|++.|+.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 99999999886 577888999999999999999999 99999999999999999999999999875532211
Q ss_pred ccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 188 NTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||.+. ...++.++|+||+||++|+|++|+.||.. .........+.......+....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~------ 233 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD--LHPMRALFLMSKSNFQPPKLKD------ 233 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc--cchhhhheeeecCCCCCCCCcc------
Confidence 112235778999999874 34478899999999999999999999532 2221111111111111111000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
....+..+.++|.+||..+|++|||++++++.|
T Consensus 234 ----------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 ----------------------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----------------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001456789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=270.82 Aligned_cols=239 Identities=27% Similarity=0.450 Sum_probs=183.4
Q ss_pred hhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~ 106 (354)
..++|++.+.||+|+||.||+|..+ .+..||+|++...... ....+ .+++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3578999999999999999999864 3678999998754321 11222 256777788888889
Q ss_pred eEEEEEecCCCCHhHHHh---------------------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 107 KILIYEYMPNKSLDFFLF---------------------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~~---------------------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
.++++||+++++|.+++. ++..+..++.|++.||.+||..+ ++|+||+|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999988872 34567899999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTY 238 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~ 238 (354)
||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+|||||++|+|++ |..|| .+..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~--~~~~ 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY--YGMA 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC--CCCC
Confidence 99999999999999999875433221111112233567999999988889999999999999999997 77774 3444
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+....+..+.... . +..++..+.+||.+||+.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~-~-------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 238 HEEVIYYVRDGNVLS-C-------------------------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred HHHHHHHHhcCCCCC-C-------------------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 344443333222110 0 00146678999999999999999999999999
Q ss_pred hhh
Q 048432 319 LTN 321 (354)
Q Consensus 319 L~~ 321 (354)
|++
T Consensus 286 l~~ 288 (288)
T cd05050 286 LQR 288 (288)
T ss_pred hhC
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=275.97 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=181.5
Q ss_pred hhhhcCccccceecccCceeEEEEEE------cCCCEEEEEEecCCChh-hH----H---------HHHHHHHHhceeec
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVL------KNGDEIAVKRLSGRSGQ-GL----R---------ELKNKLRLLGCCID 103 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vavK~~~~~~~~-~~----~---------~~~~i~~~~~~~~~ 103 (354)
....++|++.+.||+|+||.||+|.+ ..++.||||++...... .. . .+.|++++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 34567999999999999999999974 24778999999754321 11 1 12367777777654
Q ss_pred -CCceEEEEEecCCCCHhHHHh----------------------------------------------------------
Q 048432 104 -KDEKILIYEYMPNKSLDFFLF---------------------------------------------------------- 124 (354)
Q Consensus 104 -~~~~~lv~e~~~~~~L~~~~~---------------------------------------------------------- 124 (354)
....+++||||++|+|.+++.
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 456789999999999987762
Q ss_pred --------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 125 --------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 125 --------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
++.....++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 34556789999999999999999 9999999999999999999999999987543222111111
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ......+..+.....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~--------------- 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRA--------------- 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCCCC---------------
Confidence 2234567999999988889999999999999999997 88885432211 112222211111000
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+...++.+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 304 -----------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 -----------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00034568899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=273.48 Aligned_cols=233 Identities=26% Similarity=0.305 Sum_probs=177.9
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-------HHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-------~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
+|++.+.||+|+||.||++.+. +++.||+|++....... .+++ .+++++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5889999999999999999964 58899999986532211 1111 144556667778889999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+.+++|..++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999998776 567788999999999999999999 99999999999999999999999999876433221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....++..|+|||++.+..++.++|+||+||++|++++|..||.. .........+.......+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~--~~~~~~~~~~~~~~~~~~----------- 221 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ--RKEKVKREEVERRVKEDQ----------- 221 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC--CchhhHHHHHHHHhhhcc-----------
Confidence 1223678899999999888899999999999999999999999643 222111111111111000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
...+...+..+.+||.+||+.||++|| +++++++.
T Consensus 222 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001111566789999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=270.62 Aligned_cols=239 Identities=29% Similarity=0.442 Sum_probs=182.4
Q ss_pred CccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
+|++.+.||+|+||.||+|... ....+++|.+...... ....+ .|++++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999853 2356899988755432 11222 266677778888888999
Q ss_pred EEEecCCCCHhHHH-----------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 110 IYEYMPNKSLDFFL-----------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
++||+.+++|.+++ +++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999998875 346677899999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYS 239 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~ 239 (354)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||. +...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~--~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP--GIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC--CCCH
Confidence 9999999999999999875433222111222345678999999888889999999999999999998 888853 3332
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
..+...+..... .+. +..++..+.+++.+||+.+|++||+++++++.|
T Consensus 236 ~~~~~~~~~~~~-~~~-------------------------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 236 ERLFNLLKTGYR-MER-------------------------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHhCCCC-CCC-------------------------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 232222221110 000 011456788999999999999999999999999
Q ss_pred hhhhh
Q 048432 320 TNEAA 324 (354)
Q Consensus 320 ~~~~~ 324 (354)
+++..
T Consensus 284 ~~~~~ 288 (290)
T cd05045 284 EKMMV 288 (290)
T ss_pred HHHHh
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=266.49 Aligned_cols=231 Identities=20% Similarity=0.273 Sum_probs=181.6
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceEEEEEec
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
+|++.+.||.|+||.||.++++ +++.||+|.+..... ...... .|++++.+.+.+.+.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999965 588999999864321 111111 25566777888899999999999
Q ss_pred CCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 115 PNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 115 ~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
++++|..++ ++......++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999998876 567788999999999999999999 99999999999999999999999999875543221
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
......++..|+|||++.+..++.++|+||+|+++|+|++|..||. ..+.......+..+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~------------- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ--ANSWKNLILKVCQGSYKPL------------- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC--CCCHHHHHHHHhcCCCCCC-------------
Confidence 1122457888999999988889999999999999999999999953 3333333333332221110
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+...+..+.+||.+||+.+|++|||+.+++.+
T Consensus 221 -------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -------------------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01145568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=265.45 Aligned_cols=234 Identities=26% Similarity=0.368 Sum_probs=180.1
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh--HHHH--------HHHHHHhcee-ecCCceEEEEEec
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LREL--------KNKLRLLGCC-IDKDEKILIYEYM 114 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~--~~~~--------~~i~~~~~~~-~~~~~~~lv~e~~ 114 (354)
...+|++.+.||+|++|.||++..+ |..|++|.+....... ..+. .+++++++++ ...+..++++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3468999999999999999999875 7889999987654321 1111 1445555554 3456789999999
Q ss_pred CCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 115 PNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 115 ~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
++++|.+++ +++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC--
Confidence 999999887 456788999999999999999999 99999999999999999999999999864332221
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
....+..|+|||++.+..++.++|+|||||++|+|++ |..||. .....+....+.+.....
T Consensus 158 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~--~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05082 158 ---TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMD------------- 219 (256)
T ss_pred ---CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHhcCCCCC-------------
Confidence 1233568999999988889999999999999999997 888853 333333333332221100
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 220 -------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0011567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=272.58 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=186.5
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HH-------------HHHHHHHHhcee
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LR-------------ELKNKLRLLGCC 101 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~-------------~~~~i~~~~~~~ 101 (354)
.+....++|.+.+.||+|+||.||+|... .+..||+|.+....... .. .+.|++++++.+
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 35566678999999999999999999742 24579999987543211 11 123667777888
Q ss_pred ecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
...+..+++|||+.+++|..++ +++.....++.+++.||.|||+++ ++|+||||+||+++.++.++++||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence 8888999999999999999887 467888999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhh-hhhhccccC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLL-GYISENIYE 252 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~-~~~~~~~~~ 252 (354)
|++................++..|+|||.+.+..++.++||||+||++|+|++ |..||. ........ ..+..+..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~--~~~~~~~~~~~~~~~~~- 262 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP--GMPVDSKFYKLIKEGYR- 262 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC--CCCchHHHHHHHHcCCc-
Confidence 99875443322111222345678999999988889999999999999999998 888853 22222211 11111110
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.+. +...++.+.+++.+||+.+|++|||+.++++.|++.
T Consensus 263 ~~~-------------------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQ-------------------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCC-------------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 001356789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=285.44 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=186.0
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---h---H-HH--------HHHHHHHhceeec
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---G---L-RE--------LKNKLRLLGCCID 103 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~---~-~~--------~~~i~~~~~~~~~ 103 (354)
+.......++|++.+.||+|+||.||+|.++ +++.||+|++...... . . ++ +.+++++++++.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3445566789999999999999999999976 4889999998642111 1 1 11 1256677888889
Q ss_pred CCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 104 KDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+..+++||||+++++|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999999887 567888999999999999999999 99999999999999999999999999876
Q ss_pred ccCCccccccccccCcccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGI----FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
....... ......||..|+|||++.+.. ++.++|+||+||++|+|++|..|| ...+.......+.........
T Consensus 192 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf--~~~~~~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 192 MDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF--YADSLVGTYSKIMDHKNSLNF 268 (370)
T ss_pred cccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCcccCC
Confidence 5432211 112346899999999987543 788999999999999999999995 444444444444332221111
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
... ...+..+.+++..||..++.+ |+|++++++.
T Consensus 269 p~~-----------------------------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PED-----------------------------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCc-----------------------------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 014566788999999866554 8999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=271.85 Aligned_cols=224 Identities=25% Similarity=0.328 Sum_probs=170.1
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCChhh-------HHHH--------HHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LREL--------KNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-------~~~~--------~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||+|+||.||+++.+ +|+.||+|.+....... ..+. .|++++.+++......++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999965 58999999986432110 1111 1455666778888899999999999999
Q ss_pred hHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 120 DFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 120 ~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
...+ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---ecc
Confidence 8776 566778889999999999999999 999999999999999999999999998765433211 123
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
.++..|+|||++.+..++.++|+||+||++|+|++|..||...... ...............+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 219 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH--------------- 219 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc---------------
Confidence 5788999999998888999999999999999999999996433221 11111111111100000
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+.+||.+||+.||++||++.++++
T Consensus 220 -----------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 -----------------QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred -----------------ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 014567899999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=265.11 Aligned_cols=235 Identities=25% Similarity=0.351 Sum_probs=181.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHHH------------HHHHHHhceeecCCceEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
++|++.+.||.|++|.||.|... +++.||+|.+...... ....+ .|++++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999964 5899999998643211 11111 255677788888899999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
++||+++++|.+++ ++...+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999998887 567788999999999999999999 9999999999999999999999999987543322
Q ss_pred cccc-cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQAN-TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.... .....++..|+|||++.+..++.++|+||+|+++|+|++|+.|| ...+...............
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~--~~~~~~~~~~~~~~~~~~~---------- 226 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW--AEFEAMAAIFKIATQPTNP---------- 226 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc--cccchHHHHHHHhccCCCC----------
Confidence 1111 12235678999999999888999999999999999999999995 3333222222221111110
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+...+..+.++|.+||..+|++|||+.++++.
T Consensus 227 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ---------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111156678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=278.45 Aligned_cols=221 Identities=21% Similarity=0.303 Sum_probs=170.6
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.++ +++.||+|++..... .... .+.+++++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 588999999875321 1111 123667788888899999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence 9998776 678889999999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-------hhhhhhhhccccCCCCcccCCcccc
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS-------FTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ......+.......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----------- 224 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----------- 224 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC-----------
Confidence 468999999999998889999999999999999999999974322111 01111111111111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
+...+..+.++|.+||+.||++|||+
T Consensus 225 ----------------------p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ----------------------PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----------------------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11145677899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=279.03 Aligned_cols=220 Identities=23% Similarity=0.298 Sum_probs=172.5
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHH-------------HHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLRE-------------LKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~-------------~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|++. +++.||+|++...... .... +.|++++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 5889999998653211 1100 12566777888888999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|...+ +....+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence 9998776 567788899999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..|| ...+.......+.......+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~~~---------------- 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF--YSRDVSQMYDNILHKPLQLPG---------------- 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCC--CCCCHHHHHHHHhcCCCCCCC----------------
Confidence 46889999999998888999999999999999999999995 444444444444333222211
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 313 (354)
..+..+.++|.+||+.+|++||++.
T Consensus 218 -----------------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 -----------------GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----------------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1355678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.93 Aligned_cols=223 Identities=24% Similarity=0.311 Sum_probs=172.6
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH------------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR------------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
||+|+||.||+|+++ +++.||+|++......... .+.++++++.++.+.+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 5899999998643211100 112445556677788899999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccC
Confidence 9998877 678889999999999999999999 99999999999999999999999999864322211 1223
Q ss_pred ccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 192 IVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
..|+..|+|||++.+. .++.++|||||||++|+|++|..|| ...+.....+.+..+....+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf--~~~~~~~~~~~i~~~~~~~~~~~------------- 220 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKNV------------- 220 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCC--CCCCHHHHHHHHHcCCCCCCCcc-------------
Confidence 4689999999998764 4789999999999999999999994 44444444454443333222111
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC----CHHHHHH
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP----TMNDVVS 317 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----s~~~il~ 317 (354)
.++.+.+||.+||+.||++|| +++++++
T Consensus 221 -------------------~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 -------------------LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -------------------CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 456678999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=275.38 Aligned_cols=261 Identities=19% Similarity=0.275 Sum_probs=183.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHHH--------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|.+.+.||+|+||.||+|.++ .++.||+|.+...... ..+++ .|++++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3478999999999999999999965 5888999998643221 11121 26677888888899999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+ ++..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99986 666665 567788899999999999999999 99999999999999999999999999875433221
Q ss_pred ccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||. +.+..+....+.......+...++.....
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP--GSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 1 122356889999998865 457899999999999999999999954 33433333333332222221111111100
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..... ...... .........+..++.+.+||.+||+.||++|||++|+++
T Consensus 236 ~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKN--YNFPKY-KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhh--hhcCcc-CCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 000000 000000111225667889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=264.56 Aligned_cols=230 Identities=29% Similarity=0.395 Sum_probs=175.2
Q ss_pred ceecccCceeEEEEEEc---CCCEEEEEEecCCChh--hHHHHH------------HHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ--GLRELK------------NKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~--~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.++ ++..+|+|++...... ...++. |++++++++. ....++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 36899999999999753 4788999998654321 122222 4455555554 4567899999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc-ccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA-NTG 190 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~-~~~ 190 (354)
++|.+++ +++..+..++.|++.||.+||+++ ++|+||||.||+++.++.++|+|||++.......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9998887 678889999999999999999999 9999999999999999999999999987554332111 111
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...++..|+|||.+....++.++|+|||||++|+|++ |..||. .....+....+.++.... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~--~~~~~~~~~~i~~~~~~~-~-------------- 219 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK--GMKGNEVTQMIESGERME-C-------------- 219 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHCCCCCC-C--------------
Confidence 1233578999999988888999999999999999998 898954 333344444443332110 0
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+..+++.+.++|.+||+.+|++|||+++|.+.|++
T Consensus 220 -----------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -----------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01156778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=262.71 Aligned_cols=231 Identities=28% Similarity=0.382 Sum_probs=181.6
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|.+.+.||+|++|.||+|..+ +++.|++|.+..... .....+ .|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4888999999999999999965 589999999864321 111111 2566778888888999999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+.+++|.+++ ++...+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999887 456778899999999999999999 999999999999999999999999998755433211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||.. .+.......+..+.....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~------------ 221 (256)
T cd08529 158 --ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQGALILKIIRGVFPPV------------ 221 (256)
T ss_pred --hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC------------
Confidence 1223567899999999888899999999999999999999999643 333333333322211110
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+...+..+.++|.+||+.+|++||++.++++.
T Consensus 222 --------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --------------------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --------------------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01156778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=268.73 Aligned_cols=234 Identities=28% Similarity=0.427 Sum_probs=180.6
Q ss_pred ccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHH------H--------HHHHHHhceeecCCceEEEEEec
Q 048432 50 FSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLRE------L--------KNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~------~--------~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
|++.+.||+|+||.||+++... ++.||+|++.......... . .+++++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 7889999999999999999765 6689999998775443322 1 14556777888899999999999
Q ss_pred CCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 115 PNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 115 ~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
.+++|.+++ ++...+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+...... ....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENF 155 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEB
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccc
Confidence 999998887 678899999999999999999999 999999999999999999999999998754111 1222
Q ss_pred ccccCcccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-cchhhhhhhhccccCCCCcccCCccccccc
Q 048432 190 GRIVGTYRYMSPEYAI-QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
....++..|+|||++. +..++.++|+||||+++|+|++|..||..... +...................
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ---------- 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----------
Confidence 3346788999999988 77889999999999999999999999543310 12222222111111000000
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.......+.++|.+||+.||++|||+.++++
T Consensus 226 -------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 -------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0002378999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=272.26 Aligned_cols=246 Identities=29% Similarity=0.436 Sum_probs=180.0
Q ss_pred hhcCccccceecccCceeEEEEEEc-----------------CCCEEEEEEecCCChh-hHHHH------------HHHH
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-----------------NGDEIAVKRLSGRSGQ-GLREL------------KNKL 95 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-----------------~~~~vavK~~~~~~~~-~~~~~------------~~i~ 95 (354)
+.++|++.+.||+|+||.||++.+. ++..||+|++...... ....+ .|++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3568999999999999999998643 2346899999754322 11111 2556
Q ss_pred HHhceeecCCceEEEEEecCCCCHhHHHh----------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLF----------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
++++++...+..+++|||+.+++|..++. ++..+..++.|++.||+|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 77788888889999999999999998872 34578999999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCcccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS--GKKTTGFYRT 237 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~--g~~p~~~~~~ 237 (354)
||+++.++.++|+|||++................++..|++||...++.++.++|+|||||++|+|++ |..|| ...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~--~~~ 237 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY--SQL 237 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc--ccc
Confidence 99999999999999999875433322111222234568999998888889999999999999999998 55664 333
Q ss_pred cchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 238 YSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+............ .. ......+..++..+.+||.+||+.||++|||+++|++
T Consensus 238 ~~~~~~~~~~~~~~~~--~~-----------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQ--GR-----------------------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhc--cc-----------------------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3222222111000000 00 0000001115678899999999999999999999999
Q ss_pred Hhhh
Q 048432 318 MLTN 321 (354)
Q Consensus 318 ~L~~ 321 (354)
.|++
T Consensus 293 ~l~~ 296 (296)
T cd05095 293 TLLE 296 (296)
T ss_pred HHhC
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=263.64 Aligned_cols=236 Identities=25% Similarity=0.437 Sum_probs=183.1
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh---hHHHH--------HHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ---GLREL--------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~---~~~~~--------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
..+|++.+.||.|++|.||+|.+.++..+|+|.+...... ...+. .+++++++++......++++||+.
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688999999999999999999877889999998754321 11111 144566677788888999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++|.+++ +++..+..++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence 99998887 467788999999999999999999 999999999999999999999999998755432211 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..|| ...........+..+.......
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~------------ 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY--ENRSNSEVVETINAGFRLYKPR------------ 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCC--CcCCHHHHHHHHhCCCCCCCCC------------
Confidence 12234568999999988889999999999999999998 88885 3333334444433221111000
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
..+..+.+|+.+||+.+|++|||++++++.|.
T Consensus 225 --------------------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --------------------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --------------------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 03567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=262.71 Aligned_cols=231 Identities=30% Similarity=0.464 Sum_probs=176.3
Q ss_pred ceecccCceeEEEEEEcCCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceEEEEEecCCCCHh
Q 048432 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKILIYEYMPNKSLD 120 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (354)
+.||.|++|.||+|.+.+++.||+|++...... ....+. +++++++++......++|+||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999777999999998765433 222222 3445566778888899999999999998
Q ss_pred HHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccC
Q 048432 121 FFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194 (354)
Q Consensus 121 ~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 194 (354)
+++ ++...+..++.+++.++.|||+++ ++|+||+|+||+++.++.++|+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 887 467788899999999999999999 99999999999999999999999999875443222111111233
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhh
Q 048432 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFK 273 (354)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 273 (354)
+..|+|||.+.++.++.++|+||||+++|+|++ |..||.. .........+..... .+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~--~~~~~~~~~~~~~~~-~~~------------------ 216 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG--MSNQQTRERIESGYR-MPA------------------ 216 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc--CCHHHHHHHHhcCCC-CCC------------------
Confidence 567999999988889999999999999999998 7777532 222222222221110 000
Q ss_pred hhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 274 LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+...+..+.++|.+||+.+|++|||++++++.|+.
T Consensus 217 -------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 -------------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred -------------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 01156688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=261.23 Aligned_cols=229 Identities=27% Similarity=0.399 Sum_probs=177.6
Q ss_pred ceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-HHH------------HHHHHHhceeecCCceEEEEEecCCCCHh
Q 048432 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-REL------------KNKLRLLGCCIDKDEKILIYEYMPNKSLD 120 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (354)
+.||+|+||.||+|...+++.||+|.+........ ..+ .|++++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47899999999999987889999999876543211 111 25566778888888999999999999999
Q ss_pred HHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccC
Q 048432 121 FFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194 (354)
Q Consensus 121 ~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 194 (354)
.++ +++..+..++.+++.+|.|+|+.+ ++|+||+|+||+++.++.++|+|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 887 467888999999999999999999 999999999999999999999999998654332211 1111233
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhh
Q 048432 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFK 273 (354)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 273 (354)
+..|+|||++.+..++.++|+||||+++|++++ |..||. ..........+..+....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~--~~~~~~~~~~~~~~~~~~-------------------- 214 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP--GMTNQQAREQVEKGYRMS-------------------- 214 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHcCCCCC--------------------
Confidence 567999999988889999999999999999998 888853 333333333322211100
Q ss_pred hhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 274 LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 215 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 ------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00115677899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.08 Aligned_cols=239 Identities=28% Similarity=0.490 Sum_probs=183.0
Q ss_pred hcCccccceecccCceeEEEEEEcC-C---CEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-G---DEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~---~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||.||+|..+. + ..||+|.+..... ....++ .|++++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 3568999999999999999999653 3 3699999876422 222222 255667777888888999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
++||+.+++|.+++ +++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999887 567889999999999999999999 999999999999999999999999998654432
Q ss_pred cccccccccc---CcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 184 ELQANTGRIV---GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 184 ~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.......... .+..|++||.+.+..++.++|+||+||++|++++ |..|| ...........+.... ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~--~~~~~~~~~~~i~~~~-~~~~~--- 233 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVINAIEQDY-RLPPP--- 233 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC--CCCCHHHHHHHHHcCC-cCCCc---
Confidence 2111111111 1347999999988889999999999999999886 88884 4444334444332211 11110
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
..++..+.+++.+||+.+|++||++++++..|+++
T Consensus 234 ----------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 234 ----------------------------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11566788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=264.01 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=185.0
Q ss_pred hhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
..++|.+.+.||.|+||.||+|.+.+ ...|++|....... .....+ .|++++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 45679999999999999999998643 34689999876542 222222 255666666654 5578
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++|||+++++|.+++ +++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999987 578888999999999999999999 99999999999999999999999999876544
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
..... .....++..|+|||.+....++.++|+||||+++|++++ |..||. .....+....+..+.....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~--~~~~~~~~~~~~~~~~~~~------- 229 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ--GVKNNDVIGRIENGERLPM------- 229 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC--CCCHHHHHHHHHcCCcCCC-------
Confidence 32111 112233467999999988889999999999999999986 999953 3333333333322211100
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+..++..+.++|.+||..+|++|||+.++++.|+++..+
T Consensus 230 -------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 230 -------------------------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011567889999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.96 Aligned_cols=265 Identities=22% Similarity=0.245 Sum_probs=180.5
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhH----HH--------HHHHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGL----RE--------LKNKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~----~~--------~~~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.+. .++.||||++..... ... ++ +.|++++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45689999999999999999999965 588999999865321 111 11 12556666665432
Q ss_pred -CceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 105 -DEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..+|+||||+++ ++...+ ++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999976 555554 677888899999999999999999 999999999999999999999999999754
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... .....++..|+|||++.+..++.++|||||||++|+|++|+.|| .+.+..+....+..............
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred CCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 33221 12246788999999999989999999999999999999999995 33443333333322222111100000
Q ss_pred cccc---------ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTF---------GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~---------~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.... .............................+.+||.+||+.||++|||++++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000000000000000000001111134578899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=263.76 Aligned_cols=237 Identities=28% Similarity=0.449 Sum_probs=182.7
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|+||.||++....+..+++|.+...... ...+. +++++.+.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH-HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 456889999999999999999999877888999998764322 12222 34455555555 67899999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999887 456788899999999999999999 99999999999999999999999999875443221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. ......++..|+|||++....++.++|+|||||++|++++ |..|| ...+..+....+..... .+.
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~--~~~~~~~~~~~~~~~~~-~~~--------- 224 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY--PGMSNPEVIRALERGYR-MPR--------- 224 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCC--CCCCHHHHHHHHhCCCC-CCC---------
Confidence 1 1112234567999999988889999999999999999998 88885 33333333333322211 000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ----------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----------------------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01146678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.69 Aligned_cols=260 Identities=23% Similarity=0.245 Sum_probs=177.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.+. .|+.||+|++..... ...... .|++++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999965 589999999864321 111111 2555666666433
Q ss_pred -CceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 105 -DEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..+|+||||++++ +...+ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 98 FQDVYLVMELMDAN-LCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred cceeEEEEeCCCcC-HHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 3479999999875 44443 677888899999999999999999 999999999999999999999999998643
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc---
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD--- 257 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 257 (354)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||. +.+..+....+.+.....+...
T Consensus 174 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 174 CTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ--GTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 2221 1223467889999999998889999999999999999999999964 3332222222211111110000
Q ss_pred -----------cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 -----------THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 -----------~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+...+.+.. ..+.. ..........++.+.+||.+||..||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELF-PDWIF----PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhc-ccccc----ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000 00000 00000111135678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.12 Aligned_cols=222 Identities=24% Similarity=0.281 Sum_probs=175.3
Q ss_pred cceecccCceeEEEEEE----cCCCEEEEEEecCCChhh------HHH--------HHHHHHHhceeecCCceEEEEEec
Q 048432 53 ANKLGEGGFGPVYKGVL----KNGDEIAVKRLSGRSGQG------LRE--------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~----~~~~~vavK~~~~~~~~~------~~~--------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
++.||+|+||.||+++. ..|+.||+|++....... ..+ +.|++++++++...+..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999985 258899999997532111 111 236777888888999999999999
Q ss_pred CCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 115 PNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 115 ~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
.+++|..++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 999998887 678889999999999999999999 99999999999999999999999999875433211 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....|+..|+|||.+.+..++.++|+|||||++|+|++|+.|| ...+.......+.......|.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~--~~~~~~~~~~~i~~~~~~~p~-------------- 219 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF--QGKDRKETMTMILKAKLGMPQ-------------- 219 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC--CCCCHHHHHHHHHcCCCCCCC--------------
Confidence 2346789999999998888899999999999999999999995 444444444444333222211
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
..++.+.+||.+||+.||++|||+.+
T Consensus 220 -------------------~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 -------------------FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -------------------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 14566789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=271.12 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=176.9
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH-----------HHHHHHHhceeec-----CC
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE-----------LKNKLRLLGCCID-----KD 105 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~-----------~~~i~~~~~~~~~-----~~ 105 (354)
+|++.+.||+|+||.||+|.++ +++.||+|.+...... ...+ +.|++++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999976 5899999988643211 1111 2355566666543 34
Q ss_pred ceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 106 EKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.+++++||+.+ +|..++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999986 676665 567889999999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... .....++..|+|||++.+..++.++||||+||++|+|++|.+||. .....+....+...........+
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC--GNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC--CCCHHHHHHHHHHHhCCCChhhC
Confidence 5433221 122456889999999988889999999999999999999999853 33333333222221111111000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..... ... ...............+..+..+.++|.+||+.||++|||+.+++.
T Consensus 232 ~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVT--LPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccc--ccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000 000000000111222235677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=279.50 Aligned_cols=221 Identities=23% Similarity=0.285 Sum_probs=172.7
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HH---------HHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----RE---------LKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~---------~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+++ +|+.||+|++..... ... .+ +.|++++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 589999999865321 110 11 12556777888888999999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence 9998777 678889999999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..|| ...+..+....+.......+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf--~~~~~~~~~~~~~~~~~~~~~---------------- 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF--YCRDVAEMYDNILHKPLVLRP---------------- 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCC--CCCCHHHHHHHHHcCCccCCC----------------
Confidence 46889999999999989999999999999999999999995 444444444443332211110
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
..+..+.++|.+||+.+|++||++.+
T Consensus 218 -----------------~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 -----------------GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -----------------CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 13456778999999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=272.82 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=190.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH--------HHHHHHHHhceeecC--C---ceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR--------ELKNKLRLLGCCIDK--D---EKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~--------~~~~i~~~~~~~~~~--~---~~~lv~e~ 113 (354)
-.|.-.+.+|+|.||.||+|... ++..||||+.-.+....-+ .+.||+++.-+|... . +..+||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 46788999999999999999954 5799999998655433322 234888887776422 2 44689999
Q ss_pred cCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccceeccCC
Q 048432 114 MPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRGN 183 (354)
Q Consensus 114 ~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a~~~~~~ 183 (354)
++. +|.+.+ ++...++-+..||++||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|.....+
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 987 777666 445567889999999999999999 9999999999999976 89999999999877666
Q ss_pred ccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
..... ..-+..|+|||++.+. .|+.+.||||.||++.||+.|++. |.+.+..+.+..|.+..+......-....
T Consensus 180 epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl--FpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 180 EPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL--FPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc--cCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 54422 2457899999999875 589999999999999999999988 66677666666666655544332111110
Q ss_pred cc--ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 263 TF--GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 263 ~~--~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
.. ....++ ...... ..-.....+++..+|+.++|.++|.+|.++.|++. .+.+++
T Consensus 255 ~~y~~~~~p~---ik~~~~---~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 255 PNYTEFKFPQ---IKAHPW---HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cccccccCcc---cccccc---eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00 011111 111110 00122336788899999999999999999998884 344444
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.19 Aligned_cols=225 Identities=24% Similarity=0.291 Sum_probs=171.0
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH------------HHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL------------KNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||+|+||+||++.++ +++.||+|.+....... ...+ .+++++..++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999965 58899999986542211 1111 1344556667788889999999999999
Q ss_pred hHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 120 DFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 120 ~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
...+ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 8765 567888999999999999999999 999999999999999999999999998754433211 12
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--hhhhhhhhccccCCCCcccCCccccccch
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS--FTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
...++..|+|||++.+..++.++|+||+||++|+|++|+.||...+... ......+.....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------- 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV----------------- 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-----------------
Confidence 2467889999999999999999999999999999999999964322211 111111111100
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..+...+..+.+++.+||+.||++|| |++++++.
T Consensus 219 ----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 ----------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ----------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00111567789999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=261.33 Aligned_cols=230 Identities=35% Similarity=0.541 Sum_probs=181.2
Q ss_pred ceecccCceeEEEEEEcC----CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.... +..|++|.+....... ...+ .+++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999653 8889999997664432 2222 2666777888888899999999999
Q ss_pred CCHhHHH--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 117 KSLDFFL--------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 117 ~~L~~~~--------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999887 256788999999999999999999 99999999999999999999999999976554
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
...........++..|+|||.+....++.++|+||+|+++|+|++ |..||. ..........+..+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~--~~~~~~~~~~~~~~~~---------- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP--GLSNEEVLEYLRKGYR---------- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHHHcCCC----------
Confidence 332122223456789999999988889999999999999999998 588853 3344444444332111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
...+..++..+.+++.+||..+|++|||++++++.|+
T Consensus 226 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111115678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=268.75 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=181.1
Q ss_pred cCc-cccceecccCceeEEEEEE-----cCCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeec--CCc
Q 048432 48 NKF-SDANKLGEGGFGPVYKGVL-----KNGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCID--KDE 106 (354)
Q Consensus 48 ~~y-~~~~~lg~G~~g~V~~a~~-----~~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~--~~~ 106 (354)
++| ++.+.||+|+||.||++.. .+++.||+|.+..... .....+. |++++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 9999999999999988763 2477899999976432 1112222 44455555544 345
Q ss_pred eEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 107 KILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
.+++|||+.+++|.+++ +++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 88999999999999887 678999999999999999999999 99999999999999999999999999875543
Q ss_pred Cccccc-cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQAN-TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+........+......... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~------ 232 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVR------ 232 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc-chhh------
Confidence 221111 11123456799999998888999999999999999999999996443222111111100000 0000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
..... ........+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 233 ---------~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 ---------LIELL---ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ---------hhhhh---hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000 000011111225778999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=264.82 Aligned_cols=239 Identities=29% Similarity=0.487 Sum_probs=184.3
Q ss_pred hcCccccceecccCceeEEEEEEc-C---CCEEEEEEecCCChhh-HHH------------HHHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-N---GDEIAVKRLSGRSGQG-LRE------------LKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~---~~~vavK~~~~~~~~~-~~~------------~~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||.||+|.+. + +..+|+|.+....... ... +.|++++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 468999999999999999999864 2 3369999986543211 111 1266677788888889999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|||+++++|.+++ +++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999887 567788999999999999999999 999999999999999999999999998765432
Q ss_pred ccccc-cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 184 ELQAN-TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 184 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
..... .....++..|++||.+.+..++.++|+|||||++|++++ |..|| ......+....+.+... .+..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~--~~~~~~~~~~~~~~~~~-~~~~----- 231 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--WEMSNQDVIKAIEEGYR-LPAP----- 231 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc--ccCCHHHHHHHHhCCCc-CCCC-----
Confidence 21111 111123457999999988889999999999999999886 99885 33333333443332211 1110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
..+++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 232 --------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 --------------------------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------------------------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01466788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=264.24 Aligned_cols=239 Identities=29% Similarity=0.520 Sum_probs=183.9
Q ss_pred hcCccccceecccCceeEEEEEEcC-C---CEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-G---DEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~---~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~l 109 (354)
.++|+..+.||+|++|.||+|..+. + ..+++|.+...... ....+. |++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578899999999999999999653 3 37999998755321 122222 44556677778888999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|||+.+++|..++ +++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999998887 567788999999999999999999 999999999999999999999999998755432
Q ss_pred ccccc-cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 184 ELQAN-TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 184 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
..... ......+..|+|||.+.+..++.++|+|||||++|++++ |..|| ......+....+.... ..+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~--~~~~~~~~~~~i~~~~-~~~~~~---- 233 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY--WDMSNHEVMKAINDGF-RLPAPM---- 233 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC--CcCCHHHHHHHHhcCC-CCCCCC----
Confidence 21111 111123457999999988888999999999999999997 99995 3334444444443321 111110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 234 ---------------------------~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 234 ---------------------------DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------------------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=267.19 Aligned_cols=238 Identities=23% Similarity=0.372 Sum_probs=181.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~l 109 (354)
.-.+.+.|++.+.||.|+||.||+|++. +++.|++|.+..........+. |++++++.+..++..++
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3445688999999999999999999975 4899999999766544333222 45667777788889999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
||||+++++|..++ +++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999998775 578889999999999999999999 999999999999999999999999987653322
Q ss_pred ccccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
. .......++..|+|||++. ...++.++|+|||||++|+|++|.+||.. .+.......+.....+ ...
T Consensus 164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~--~~~~~~~~~~~~~~~~--~~~- 236 (292)
T cd06644 164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAKSEPP--TLS- 236 (292)
T ss_pred c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc--ccHHHHHHHHhcCCCc--cCC-
Confidence 1 1112345678999999884 34467899999999999999999999533 2222222222211110 000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...+..+.++|.+||+.+|++||+++++++
T Consensus 237 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 ---------------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00114556889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.28 Aligned_cols=237 Identities=22% Similarity=0.260 Sum_probs=176.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHH---H---------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLR---E---------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~---~---------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+++.+ +++.||+|++...... ... + +.+++.+++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999965 5899999998642211 111 1 124566677888889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+++|..++ ++...+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999887 567788999999999999999999 99999999999999999999999999865433221
Q ss_pred ccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 186 QANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
. ......|++.|+|||++.. ..++.++|+||+||++|+|++|+.|| ......+....+.......+...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf--~~~~~~~~~~~i~~~~~~~~~~~--- 231 (331)
T cd05597 158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKEHFQFPP--- 231 (331)
T ss_pred c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC--CCCCHHHHHHHHHcCCCcccCCC---
Confidence 1 1122468999999999863 34788999999999999999999995 33333333333322211111000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
.....++.+.++|.+||..++++ |++++++++.
T Consensus 232 -------------------------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 -------------------------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -------------------------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00014667788999988654443 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=278.43 Aligned_cols=265 Identities=23% Similarity=0.265 Sum_probs=179.7
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hH----H--------HHHHHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GL----R--------ELKNKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~----~--------~~~~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.+. .++.||+|++...... .. + .+.|++++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 46789999999999999999999965 5889999998653211 11 1 123677777776533
Q ss_pred -CceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 105 -DEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
...+++|||+++ ++...+ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999977 454444 677888899999999999999999 999999999999999999999999998754
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC-CCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE-FPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 259 (354)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|..||. +.+..+....+...... .+.....
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 170 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP--GRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred CCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 33221 122467899999999998889999999999999999999999964 33322222221111111 0000000
Q ss_pred Cccc-cccch-------hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKT-FGFLH-------LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~-~~~~d-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+. ..+.+ .........................+.+||.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00000 00000000000000011111235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=275.71 Aligned_cols=221 Identities=23% Similarity=0.335 Sum_probs=168.9
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH-------------HHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL-------------KNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~-------------~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+.+ +++.||+|++...... ....+ .+++.+++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5889999999754221 11111 1445566777888899999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence 9998776 678889999999999999999999 9999999999999999999999999986432211 11223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-----hhhhhhhhccccCCCCcccCCcccccc
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS-----FTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
..|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ......+.......|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p------------ 223 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP------------ 223 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC------------
Confidence 468999999999998899999999999999999999999974322111 111111111111111
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
...+..+.+++.+||+.||++|+++
T Consensus 224 ---------------------~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 ---------------------RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---------------------CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1145667899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=282.43 Aligned_cols=234 Identities=22% Similarity=0.297 Sum_probs=177.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+. +++++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 589999999964321 1111111 3455667778888999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|.+++ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999887 678889999999999999999999 999999999999999999999999998643221100
Q ss_pred ---------------------------------cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 048432 187 ---------------------------------ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTG 233 (354)
Q Consensus 187 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~ 233 (354)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf- 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF- 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC-
Confidence 0011246899999999999989999999999999999999999995
Q ss_pred cccccchhhhhhhhccccC--CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC
Q 048432 234 FYRTYSFTLLGYISENIYE--FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT 311 (354)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 311 (354)
...+.......+...... +|... ..++.+.+||.+|+. +|++|++
T Consensus 237 -~~~~~~~~~~~i~~~~~~~~~p~~~-------------------------------~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 237 -CSETPQETYRKVMNWKETLVFPPEV-------------------------------PISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred -CCCCHHHHHHHHHcCCCceecCCCC-------------------------------CCCHHHHHHHHHhcc-ChhhcCC
Confidence 444444444444322111 11100 035567888988774 9999985
Q ss_pred ---HHHHHHH
Q 048432 312 ---MNDVVSM 318 (354)
Q Consensus 312 ---~~~il~~ 318 (354)
++++++.
T Consensus 284 ~~~~~ei~~h 293 (360)
T cd05627 284 SNGVEEIKSH 293 (360)
T ss_pred CCCHHHHhcC
Confidence 6676665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=270.47 Aligned_cols=241 Identities=28% Similarity=0.389 Sum_probs=181.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCC--EEEEEEecCCCh-hhHH-------------HHHHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGD--EIAVKRLSGRSG-QGLR-------------ELKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~--~vavK~~~~~~~-~~~~-------------~~~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+..... .... .+.|++++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468999999999999999999965 344 457777764321 1111 12255667778888899999
Q ss_pred EEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 110 IYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 110 v~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
++||+++++|.+++ +++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 99999999998877 246678999999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 247 (354)
++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..|| ......+....+.
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~--~~~~~~~~~~~~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP 237 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc--ccCChHHHHHHHh
Confidence 9999999985322111 1111123567999999988888999999999999999998 99885 3333333333322
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcC
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 327 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~ 327 (354)
..... . .+...+..+.+|+.+||+.+|++|||+++++..|.++...-.
T Consensus 238 ~~~~~-~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 QGYRL-E-------------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCcC-C-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11100 0 000145568899999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=263.85 Aligned_cols=234 Identities=24% Similarity=0.415 Sum_probs=179.7
Q ss_pred CccccceecccCceeEEEEEEcCCCEEEEEEecCCChh------hHHHH------------HHHHHHhceeecCCceEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ------GLREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~------~~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
+|++.+.||.|+||.||+|...+++.+|+|.+...... ....+ .|++++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58999999999999999999878999999988654211 11111 1455667778888899999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc-
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE- 184 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~- 184 (354)
+||+++++|.+++ +++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999987 567888899999999999999999 9999999999999999999999999886542211
Q ss_pred ---cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 185 ---LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 185 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.......+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~----- 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS--MDRLAAMFYIGAHRGLMPRL----- 230 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc--CChHHHHHHhhhccCCCCCC-----
Confidence 11111234578899999999888889999999999999999999999632 22221111111111111111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+...+..+.++|++||..+|++|||+.+++.
T Consensus 231 -------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 -------------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1115667899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=278.96 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=186.4
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HHH-------------HHHHHHHhc
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LRE-------------LKNKLRLLG 99 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~~-------------~~~i~~~~~ 99 (354)
-+.+....++|.+.+.||+|+||.||+|.++ .+..||+|++....... ... +.|++++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3446677788999999999999999999853 24679999997542211 111 235666777
Q ss_pred eeecCCceEEEEEecCCCCHhHHHh-------------------------------------------------------
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFLF------------------------------------------------------- 124 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~~------------------------------------------------------- 124 (354)
++...+..++|+||+.+|+|.+++.
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 8888889999999999999988762
Q ss_pred ------------------------------------------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 048432 125 ------------------------------------------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156 (354)
Q Consensus 125 ------------------------------------------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 156 (354)
++..+..++.||+.||.|||+.+ ++|+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccC
Confidence 23346778999999999999999 999999
Q ss_pred CCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Q 048432 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFY 235 (354)
Q Consensus 157 kp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~ 235 (354)
||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999875433221111222345778999999988889999999999999999998 88885432
Q ss_pred cccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 048432 236 RTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315 (354)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~i 315 (354)
... ......+..+.. .+ .+..++..+.+|+.+||+.+|++||++++|
T Consensus 346 ~~~-~~~~~~~~~~~~-~~-------------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 346 PMN-EQFYNAIKRGYR-MA-------------------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred Cch-HHHHHHHHcCCC-CC-------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 211 111122221111 00 011156788999999999999999999999
Q ss_pred HHHhhhhh
Q 048432 316 VSMLTNEA 323 (354)
Q Consensus 316 l~~L~~~~ 323 (354)
++.|+++.
T Consensus 393 l~~L~~~~ 400 (401)
T cd05107 393 VHLVGDLL 400 (401)
T ss_pred HHHHHHHh
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=264.61 Aligned_cols=241 Identities=26% Similarity=0.441 Sum_probs=184.4
Q ss_pred hcCccccceecccCceeEEEEEEcC-CC----EEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-GD----EIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~~----~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++|++.+.||+|+||.||+|.+++ |. .||+|.+...... ....+. |++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4789999999999999999999653 33 5899988765432 112222 55566666665 7889
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+++||+.+++|.+++ +++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999887 568889999999999999999999 99999999999999999999999999876543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
...........++..|++||.+....++.++|+||||+++|++++ |..||.. ....+....+..+.......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~----- 234 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG--IPAVEIPDLLEKGERLPQPP----- 234 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC--CCHHHHHHHHhCCCCCCCCC-----
Confidence 322111111223568999999988889999999999999999998 9999533 33333333333221110000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.++..+.+++.+||..+|++|||+.++++.|+++..+
T Consensus 235 ---------------------------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 235 ---------------------------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---------------------------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0455678999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=265.55 Aligned_cols=238 Identities=21% Similarity=0.357 Sum_probs=180.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
..++|++.+.||+|+||.||+|.+. +++.||+|++..........+ .|++++++.+...+..++++|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 3468999999999999999999964 588999999876543322222 255667777888899999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|+++++|.+++ ++...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 99999999987 678899999999999999999999 9999999999999999999999999986543221 1
Q ss_pred ccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 188 NTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||.+. ...++.++|+|||||++|+|++|..||.. .................+....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~------ 233 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD--LHPMRALFLMTKSNFQPPKLKD------ 233 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc--ccchhhHHhhhccCCCCCcccc------
Confidence 122346788999999874 44578899999999999999999999532 2211111111111111110000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..+.++|.+||+.+|++|||++++++.
T Consensus 234 ----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 ----------------------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ----------------------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00134567899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.08 Aligned_cols=254 Identities=31% Similarity=0.450 Sum_probs=205.9
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcC--C---CEEEEEEecCCC---hhhHHH------------HHHHHHH
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN--G---DEIAVKRLSGRS---GQGLRE------------LKNKLRL 97 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~--~---~~vavK~~~~~~---~~~~~~------------~~~i~~~ 97 (354)
++-..|.-..++-.+.+.||+|+||.||+|..+. + ..||+|...... .....+ |+|++++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 4445566777778888999999999999999553 2 228999988632 222222 2377888
Q ss_pred hceeecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 98 LGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
+++......+++|||+|.||+|.+++ ++.....+++.+.+.||+|||+++ ++||||..+|+|++.++.+||
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 99999999999999999999999999 567889999999999999999999 999999999999999999999
Q ss_pred eecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccc
Q 048432 172 SDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 172 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
+|||+++....-.... ....-...|+|||.+..+.++.++|||||||++||+++ |..| +.+....++...+....
T Consensus 304 SDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~P--y~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEP--YPGMKNYEVKAKIVKNG 379 (474)
T ss_pred CccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCC--CCCCCHHHHHHHHHhcC
Confidence 9999987654211111 01123579999999999999999999999999999998 6777 77788788888875544
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCC
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 329 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~ 329 (354)
...+.... .+..+..++.+||..+|++|||+.++.+.|+.+.....++
T Consensus 380 ~r~~~~~~-------------------------------~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 380 YRMPIPSK-------------------------------TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ccCCCCCC-------------------------------CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 44333221 6888899999999999999999999999999999766653
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=268.94 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=182.3
Q ss_pred hhcCccccceecccCceeEEEEEEcC-----------------CCEEEEEEecCCChh-hHHHHH------------HHH
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN-----------------GDEIAVKRLSGRSGQ-GLRELK------------NKL 95 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~-----------------~~~vavK~~~~~~~~-~~~~~~------------~i~ 95 (354)
..++|++.+.||+|+||.||+|.... +..||+|.+...... ....+. |++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34689999999999999999998542 245899998765432 122221 555
Q ss_pred HHhceeecCCceEEEEEecCCCCHhHHH----------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL----------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~----------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
++++++..++..++++||+.+++|..++ +++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 6677778888999999999999999886 356678999999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCcccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS--GKKTTGFYRT 237 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~--g~~p~~~~~~ 237 (354)
||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..|| ...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~--~~~ 237 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY--EHL 237 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC--CCc
Confidence 99999999999999999875443332222223345678999999988889999999999999999998 55664 333
Q ss_pred cchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 238 YSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.................... ....+..++..+.+++.+||+.+|++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQI-------------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccc-------------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 33333332221100000000 00001114578999999999999999999999999
Q ss_pred Hhhh
Q 048432 318 MLTN 321 (354)
Q Consensus 318 ~L~~ 321 (354)
.|++
T Consensus 293 ~L~~ 296 (296)
T cd05051 293 FLQR 296 (296)
T ss_pred HhcC
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=275.11 Aligned_cols=237 Identities=20% Similarity=0.239 Sum_probs=176.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+++++ +++.||+|++..... .....+. +++.++.++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999965 588899999865321 1111111 3344566778889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+|+|..++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999887 456778899999999999999999 99999999999999999999999999875543221
Q ss_pred ccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 186 QANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
. ......|++.|+|||++.+ +.++.++|+||+||++|+|++|+.|| ...+..+....+.......+...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf--~~~~~~~~~~~i~~~~~~~~~p~--- 231 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHEERFQFPS--- 231 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc--cCCCHHHHHHHHHcCCCcccCCC---
Confidence 1 1123468999999998875 45788999999999999999999995 34443344444332221111000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
.....+..+.++|.+||..++.+ |++++++++.
T Consensus 232 -------------------------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 -------------------------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -------------------------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00014567889999999876654 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=268.37 Aligned_cols=241 Identities=23% Similarity=0.380 Sum_probs=185.4
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCce
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
..+.....+|++.+.||.|++|.||+|... +++.|++|.+..........+ .|++++++.+......
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 445566789999999999999999999964 588999999876443322222 2556667777888899
Q ss_pred EEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 108 ILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
++||||+++++|.+++ +++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999999987 577888999999999999999999 999999999999999999999999988654322
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||. ..........+.... .+...
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~--~~~~~~~~~~~~~~~--~~~~~------ 237 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNG--TPELQ------ 237 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC--CCCHHHhHHHHhcCC--CCCCC------
Confidence 21 1122357889999999988888999999999999999999999963 222211111111111 00000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.++|.+||..+|++|||+.+++..
T Consensus 238 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 ----------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ----------------------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 001145678899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=264.30 Aligned_cols=235 Identities=23% Similarity=0.351 Sum_probs=175.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---H---------HHHHHHHHhceeec------CC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---R---------ELKNKLRLLGCCID------KD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~---------~~~~i~~~~~~~~~------~~ 105 (354)
.+.+.|++.+.||+|+||.||+|... .++.||+|++........ . .+.|++++++++.. ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 46788999999999999999999965 588999999865432211 1 12355556666543 24
Q ss_pred ceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 106 EKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.++++|||+.+++|..++ +++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 588999999999999887 567788899999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
....... ......++..|+|||++.+ ..++.++|+||+||++|+|++|..||.. ................
T Consensus 160 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~--~~~~~~~~~~~~~~~~- 234 (272)
T cd06637 160 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--MHPMRALFLIPRNPAP- 234 (272)
T ss_pred ecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc--cCHHHHHHHHhcCCCC-
Confidence 5433221 1223467889999998863 3578899999999999999999999632 2211111111111000
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
... ...++..+.+||.+||..+|++|||++++++
T Consensus 235 -~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 235 -RLK-----------------------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCC-----------------------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 0014567899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=276.66 Aligned_cols=266 Identities=19% Similarity=0.203 Sum_probs=185.4
Q ss_pred hcCccccceecccCceeEEEEEEc---CCCEEEEEEecCCChh--hHH-----HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ--GLR-----ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~--~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
..+|.+.+.||.|+||.||++... .+..|++|.+...... +.. .+.|++++++++......+++||++.+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCC
Confidence 457999999999999999999753 3678999998654321 111 123778888899989999999999965
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
+|..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..............
T Consensus 171 -~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~ 246 (392)
T PHA03207 171 -DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246 (392)
T ss_pred -CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence 666665 678899999999999999999999 99999999999999999999999999875544332222234
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ....+..+.+.....+........ ..+. ..
T Consensus 247 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~-~~~~-~~ 324 (392)
T PHA03207 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS-TNLC-KH 324 (392)
T ss_pred cccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc-hhHH-HH
Confidence 57899999999999888999999999999999999999996332221 222222222222211111100000 0000 00
Q ss_pred hhhhhhccccCCc-hhH--HHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 271 IFKLFSISSVGLS-NDI--VCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 271 ~~~~~~~~~~~~~-~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
........+.... +.. ....+..+.++|.+||..||++|||+.+++..
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 000 00135678899999999999999999999875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=278.78 Aligned_cols=258 Identities=20% Similarity=0.266 Sum_probs=179.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh----HHH--------HHHHHHHhceeecCC-----ceE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG----LRE--------LKNKLRLLGCCIDKD-----EKI 108 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~----~~~--------~~~i~~~~~~~~~~~-----~~~ 108 (354)
+|++.+.||+|+||.||+|.+. +|+.||+|++..... .. .++ +.|++++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999964 689999999865321 11 111 126677777777665 789
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|+||+.+ +|...+ ++...+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999975 666665 678889999999999999999999 999999999999999999999999998754332
Q ss_pred ccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
... ......++..|+|||++.+. .++.++||||+||++|+|++|+.||. +.+.......+.+.....+.......
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~--~~~~~~~~~~i~~~~g~~~~~~~~~~- 232 (372)
T cd07853 157 ESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ--AQSPIQQLDLITDLLGTPSLEAMRSA- 232 (372)
T ss_pred ccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC--CCCHHHHHHHHHHHcCCCCHHHHHHh-
Confidence 211 12223568899999998774 47899999999999999999999953 34433344443332222111000000
Q ss_pred ccccchhhhhhhhhcc-ccCC---chhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFGFLHLTIFKLFSIS-SVGL---SNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~-~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
............ .... ........++.+.+||.+||+.||++|||++++++.
T Consensus 233 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 ----CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred ----hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 0000 000111136678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=267.45 Aligned_cols=239 Identities=23% Similarity=0.391 Sum_probs=184.7
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceE
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
+......+|++.+.||.|++|.||+|.+. +++.|++|.+..........+ .|++++++++...+.++
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 34445568999999999999999999964 689999999865433322222 25667778888889999
Q ss_pred EEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 109 LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 109 lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
+|+||+.+++|..++ +++..+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999999887 678899999999999999999999 9999999999999999999999999876543322
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.. .+.......+..... +...
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~--~~~~~~~~~~~~~~~--~~~~------- 236 (296)
T cd06655 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIATNGT--PELQ------- 236 (296)
T ss_pred cc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcCC--cccC-------
Confidence 11 1223578899999999888899999999999999999999999533 222221111111110 0000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...++.+.+||.+||..+|++|||+.++++
T Consensus 237 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 ---------------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---------------------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00114567889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=267.92 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=185.6
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCce
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
.......++|++.+.||.|++|.||++... +++.||+|.+..........+ .|++++++.+...+..
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 334566689999999999999999999964 699999999865433222222 2556677888888999
Q ss_pred EEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 108 ILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
++||||+++++|.+++ +++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999999987 567888999999999999999999 999999999999999999999999998754332
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
... .....++..|++||.+.+..++.++|+||+||++|++++|..||. ..+.......+.... .+...
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~--~~~~~~~~~~~~~~~--~~~~~------ 236 (297)
T cd06656 169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNG--TPELQ------ 236 (297)
T ss_pred ccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCcchheeeeccCC--CCCCC------
Confidence 211 122356789999999988888999999999999999999999963 222211111111111 00000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...+..+.+|+.+||+.+|++|||++++++
T Consensus 237 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 ----------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01114566889999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=265.79 Aligned_cols=243 Identities=22% Similarity=0.336 Sum_probs=180.8
Q ss_pred CccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH--H----------HHHHHHHHhceee-
Q 048432 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--R----------ELKNKLRLLGCCI- 102 (354)
Q Consensus 37 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--~----------~~~~i~~~~~~~~- 102 (354)
..++++.....+.|++.+.||.|+||.||+|.+. .++.||+|++........ . .+.|++++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3567777778899999999999999999999964 588999999865432211 1 1124444455553
Q ss_pred -----cCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 103 -----DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 103 -----~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
....++++|||+.+++|..++ +++..+..++.||+.|+.|||+.+ ++|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 245789999999999999887 456677889999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~ 245 (354)
|+|||++........ ......++..|+|||.+. ...++.++|+|||||++|+|++|..||.. .........
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~--~~~~~~~~~ 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD--MHPMRALFL 237 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc--cCHHhhhhh
Confidence 999999865432211 122345788999999875 34578899999999999999999999632 221111111
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+...... .. ....++..+.+||.+||..+|++|||+.+|++
T Consensus 238 ~~~~~~~--~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRNPPP--KL-----------------------------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhCCCC--CC-----------------------------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111000 00 00115678899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.72 Aligned_cols=232 Identities=31% Similarity=0.447 Sum_probs=176.5
Q ss_pred ceecccCceeEEEEEEcC----CCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.+.. +..||+|.+...... ....+. +++++++++. .+..+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 368999999765542 112222 3445555554 4568999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc-cc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN-TG 190 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~-~~ 190 (354)
++|.+++ +++..+..++.|++.|+.+||..+ ++|+||||+||+++.++.++|+|||++........... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999988 678889999999999999999999 99999999999999999999999999876543322111 11
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...++..|+|||.+.+..++.++|+|||||++|++++ |.+||. ..+..+....+...... +.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~--~~~~~~~~~~~~~~~~~-~~-------------- 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG--EMKGAEVIAMLESGERL-PR-------------- 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc--cCCHHHHHHHHHcCCcC-CC--------------
Confidence 1123467999999988889999999999999999998 899853 33333444443332211 00
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+..++..+.++|.+||..+|++|||+.++++.|+++.
T Consensus 220 -----------------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 -----------------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0115667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=273.51 Aligned_cols=237 Identities=21% Similarity=0.240 Sum_probs=177.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+++.+ .++.||+|++...... ....+. ++++++..+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999976 4788999998643211 111121 3334556777888999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+|+|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999888 466788899999999999999999 99999999999999999999999999865432221
Q ss_pred ccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 186 QANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.......|++.|+|||++. ...++.++|+|||||++|+|++|+.|| ...+..+....+.......+...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf--~~~~~~~~~~~i~~~~~~~~~p~--- 231 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKERFQFPA--- 231 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC--CCCCHHHHHHHHhCCCccccCCC---
Confidence 1122346899999999886 345788999999999999999999995 44444444444433222111000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
....++..+.+||.+|+..++++ |++++++++.
T Consensus 232 -------------------------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 -------------------------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -------------------------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00114667889999988765554 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=278.33 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=182.7
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCC--ChhhHHHHH-------------HHHHHhceeecCC
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR--SGQGLRELK-------------NKLRLLGCCIDKD 105 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~--~~~~~~~~~-------------~i~~~~~~~~~~~ 105 (354)
.-+...+..|++.+.||+||.+.||++...+.+.||+|.+... ..+....+. +|+++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 3456778899999999999999999999877788888876432 223333333 4456677778899
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.+|+||||= ..+|..++ .....++.++.|++.++.++|+.| |||.||||.|+|+- .|.+||+|||+|..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 999999974 45888887 222377889999999999999999 99999999999985 46899999999998
Q ss_pred ccCCccccccccccCcccccCccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGI-----------FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
.........+...+||..|++||.+.... .+.++||||||||||+|+.|++||+-...... .+..|..
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-Kl~aI~~ 587 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-KLHAITD 587 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-HHHhhcC
Confidence 88877777777889999999999996532 45789999999999999999999753321111 1111111
Q ss_pred ccc--CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 249 NIY--EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 249 ~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
-.. ++|... ...++.++|+.||..||.+|||+.++|+.
T Consensus 588 P~~~Iefp~~~--------------------------------~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 588 PNHEIEFPDIP--------------------------------ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCccccccCCC--------------------------------CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 100 111111 22238899999999999999999999863
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=261.24 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=178.9
Q ss_pred cCccccceecccCceeEEEEEEc-----CCCEEEEEEecCCChhhHHHHHHH------------HHHhceee--cCCceE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQGLRELKNK------------LRLLGCCI--DKDEKI 108 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~~~~~~~~~i------------~~~~~~~~--~~~~~~ 108 (354)
.+|++.+.||+|+||.||.+..+ ++..||+|.+..........+.+. +++.+++. ....++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57899999999999999999843 488999999977655444444333 33444432 234688
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+|+||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999887 567888999999999999999999 99999999999999999999999999876543
Q ss_pred Ccccc-ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQA-NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..++..... .....+..... .+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~-~~~~----- 231 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQ-GQMI----- 231 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccc-cccc-----
Confidence 22111 11111234469999999888899999999999999999998766422211 11111000000 0000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.......... .........++..+.+|+.+||..+|++|||+++|++.|+.+
T Consensus 232 -----~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 -----VYHLIELLKN----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -----hHHHHHHHhc----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000 000011122567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=267.19 Aligned_cols=235 Identities=21% Similarity=0.262 Sum_probs=182.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||.|++|.||+|... +++.||+|.+....... ...+ .+++++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999976 48999999997653221 1111 26677888888889999999
Q ss_pred EecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 112 EYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 112 e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
||+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999886 567788899999999999999999 9999999999999999999999999986543221
Q ss_pred cc---------------------------cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 048432 185 LQ---------------------------ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT 237 (354)
Q Consensus 185 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~ 237 (354)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~--~~ 235 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK--GS 235 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC--CC
Confidence 10 01112357888999999988889999999999999999999999953 33
Q ss_pred cchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC----HH
Q 048432 238 YSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT----MN 313 (354)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~ 313 (354)
+.......+.......+... ..+..+.++|.+||+.+|++||| ++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 236 NRDETFSNILKKEVTFPGSP-------------------------------PVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred chHHHHHHHhcCCccCCCcc-------------------------------ccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 33333333322222111110 04678899999999999999999 77
Q ss_pred HHHHH
Q 048432 314 DVVSM 318 (354)
Q Consensus 314 ~il~~ 318 (354)
+++..
T Consensus 285 ~ll~~ 289 (316)
T cd05574 285 EIKQH 289 (316)
T ss_pred HHHcC
Confidence 77763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=258.81 Aligned_cols=231 Identities=22% Similarity=0.296 Sum_probs=176.4
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceee-cCCceEEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCI-DKDEKILIYE 112 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~-~~~~~~lv~e 112 (354)
+|++.+.||.|++|.||.+.++ +++.||+|.+..... .....+. +++++.+.+. .+..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999965 478899999865322 1222222 3334444444 3445789999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++++|.+++ +++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999998877 567888999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
......++..|+|||++.+..++.++|+||+||++|+|++|+.||.. .+.......+..+....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~--~~~~~~~~~~~~~~~~~------------ 221 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA--KDMNSLVYRIIEGKLPP------------ 221 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHhcCCCC------------
Confidence 11224578899999999988899999999999999999999999542 22222222222221110
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...++.+.+++.+||+.+|++|||+.++++.
T Consensus 222 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 --------------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --------------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011156778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=293.87 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=182.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|.+. .|+.||+|++...... .... +.|++++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999975 4899999998653221 1111 136677788888889999999
Q ss_pred EecCCCCHhHHHh----------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 112 EYMPNKSLDFFLF----------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 112 e~~~~~~L~~~~~----------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
||++|++|.+++. ++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999988762 23456789999999999999999 9999999999999999999999999
Q ss_pred cceeccCCcc----------------ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Q 048432 176 IARICRGNEL----------------QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS 239 (354)
Q Consensus 176 ~a~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~ 239 (354)
++........ ........||+.|+|||++.+..++.++|+||+||++|+|++|..||.. ...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~--~~~ 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR--KKG 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC--cch
Confidence 9876521100 0011124689999999999998999999999999999999999999632 221
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHH
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-TMNDVVSM 318 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~il~~ 318 (354)
...... .....+.... .....++.+.+++.+||+.||++|| +++++++.
T Consensus 237 ~ki~~~---~~i~~P~~~~---------------------------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 237 RKISYR---DVILSPIEVA---------------------------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred hhhhhh---hhccChhhcc---------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111110 0000000000 0011567788999999999999996 67788888
Q ss_pred hhhhhh
Q 048432 319 LTNEAA 324 (354)
Q Consensus 319 L~~~~~ 324 (354)
|+....
T Consensus 287 Le~~lq 292 (932)
T PRK13184 287 LEPHLQ 292 (932)
T ss_pred HHHHHh
Confidence 887653
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.13 Aligned_cols=230 Identities=25% Similarity=0.407 Sum_probs=174.5
Q ss_pred eecccCceeEEEEEEc---CCCEEEEEEecCCChhhH-HHHH------------HHHHHhceeecCCceEEEEEecCCCC
Q 048432 55 KLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQGL-RELK------------NKLRLLGCCIDKDEKILIYEYMPNKS 118 (354)
Q Consensus 55 ~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~~~-~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (354)
.||+|+||.||+|.+. .+..||+|++........ ..+. |++++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999854 355799999976543221 2222 4445555554 457899999999999
Q ss_pred HhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc-cccc
Q 048432 119 LDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA-NTGR 191 (354)
Q Consensus 119 L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~-~~~~ 191 (354)
|.+++ +++..+.+++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99887 577889999999999999999999 9999999999999999999999999987543322111 1111
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
..++..|+|||.+....++.++|+|||||++|++++ |..|| ......+....+.++....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~--~~~~~~~~~~~~~~~~~~~----------------- 218 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY--KKMKGPEVMSFIEQGKRLD----------------- 218 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc--CcCCHHHHHHHHHCCCCCC-----------------
Confidence 223568999999988889999999999999999996 89884 3334333333333322110
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.+..+++.+.++|.+||..+|++||++.+|.+.|+..
T Consensus 219 ---------------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 ---------------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0111577889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=257.67 Aligned_cols=232 Identities=34% Similarity=0.543 Sum_probs=181.5
Q ss_pred ccccceecccCceeEEEEEEcC-----CCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 50 FSDANKLGEGGFGPVYKGVLKN-----GDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~-----~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+++.+.||.|+||.||++.+.. +..||+|++...... ....+ .+++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999999754 388999999765432 12122 26677778888888999999
Q ss_pred EecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 112 EYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 112 e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
||+.+++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999998887 467778999999999999999999 9999999999999999999999999987655442
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
..... ...++..|++||.+.+..++.++|+||+|+++|+|++ |.+|| ...+.......+.........
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~-------- 226 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPY--PGMSNEEVLEYLKKGYRLPKP-------- 226 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHhcCCCCCCC--------
Confidence 21111 2235678999999988889999999999999999998 77774 333434444443332211100
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
...+..+.+++.+||..+|++|||+.++++.|
T Consensus 227 ------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ------------------------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------------------------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01566789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=259.52 Aligned_cols=233 Identities=28% Similarity=0.432 Sum_probs=172.7
Q ss_pred ceecccCceeEEEEEEcC----CCEEEEEEecCCCh-hhHHHH------------HHHHHHhceee-cCCceEEEEEecC
Q 048432 54 NKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCI-DKDEKILIYEYMP 115 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~-~~~~~~lv~e~~~ 115 (354)
+.||+|+||.||+|.+.+ +..||+|.+..... .....+ .|++++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 45799999864322 222222 25566666554 4556889999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc--cc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QA 187 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~--~~ 187 (354)
+++|.+++ ..+.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999987 355677889999999999999999 99999999999999999999999999865432211 01
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK-KTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||.+....++.++|||||||++|+|++|+ +|| ...+..+....+..+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~----------- 224 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVDSFDITVYLLQGRRLLQP----------- 224 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC--CCCCHHHHHHHHhcCCCCCCC-----------
Confidence 111224466899999998888999999999999999999954 553 333333344333322111100
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 225 ---------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 225 ---------------------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---------------------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 014567889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=260.59 Aligned_cols=232 Identities=28% Similarity=0.430 Sum_probs=178.2
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh--HHHH--------HHHHHHhceeecCCceEEEEEecC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LREL--------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~--~~~~--------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
..++|++.+.||+|+||.||++.. .++.||+|.+....... ..+. .|++++++++.. +..+++|||+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 346799999999999999999985 57889999987643221 1111 144555666654 45799999999
Q ss_pred CCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 116 NKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 116 ~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
+++|..++ +++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999887 467788899999999999999999 9999999999999999999999999987543221
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |.+|| ......+....+.++....+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~--~~~~~~~~~~~~~~~~~~~~------------- 218 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY--PKMSLKEVKECVEKGYRMEP------------- 218 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC--ccCCHHHHHHHHhCCCCCCC-------------
Confidence 11233567999999988889999999999999999997 88885 33333333333322211100
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+..++..+.+++.+||+.+|++|||++++++.|+.
T Consensus 219 -------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -------------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -------------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01156778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=258.56 Aligned_cols=236 Identities=22% Similarity=0.373 Sum_probs=182.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
.++|++.+.||.|++|.||+|... +++.+++|++..........+ .|++++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 478999999999999999999965 478899999876543322222 2667778888888999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+.+++|..++ ++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999877 567888999999999999999999 99999999999999999999999999865443211
Q ss_pred ccccccCcccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG---IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|++||.+... .++.++|+||+|+++|+|++|.+||. ..........+.......+..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~--~~~~~~~~~~~~~~~~~~~~~-------- 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF--DLHPMRALFLISKSNFPPPKL-------- 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHhccCCCccc--------
Confidence 11223567789999998776 78899999999999999999999953 222222222221111111000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
......+..+.++|.+||..+|++|||+++++.
T Consensus 227 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 --------------------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --------------------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011225677899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=263.01 Aligned_cols=236 Identities=25% Similarity=0.351 Sum_probs=179.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||+|++|.||+|.+. +++.||+|++..... .....+ .|++++++.+...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47899999999999999999964 688999999865422 111222 2556667788888899999999
Q ss_pred cCCCCHhHHH-hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 114 MPNKSLDFFL-FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 114 ~~~~~L~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
+++++|..+. +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~ 153 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTY 153 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCC
Confidence 9999997665 678888899999999999999999 9999999999999999999999999987543322 2234
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhh-hhhhhcccc-CCCCcccCCccccccchhh
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTL-LGYISENIY-EFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~d~~ 270 (354)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ......... ..+...
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 220 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------------- 220 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-------------
Confidence 67889999999998889999999999999999999999964322111000 000000000 000000
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.....++.+.++|.+||+.+|++||+++++++.
T Consensus 221 ---------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ---------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000145578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=266.03 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=174.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
.|++.+.||+|+||.||++.++ .++.||+|.+....... ...+. +++.+++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788899999999999999965 58899999986542211 11111 23344556677788999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+.+++|.+++ ++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998877 566788899999999999999999 99999999999999999999999999865433221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.....++..|+|||++.+..++.++|+||+||++|+|++|..||...... ..+..........
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------- 221 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ------------- 221 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-------------
Confidence 11236789999999998888999999999999999999999996432111 0111111100000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~ 317 (354)
...+...++.+.+|+.+||+.||++||| ++++++
T Consensus 222 -------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001114567889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.75 Aligned_cols=266 Identities=17% Similarity=0.142 Sum_probs=183.2
Q ss_pred hhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHH------HHHHHHHHhceeecCCceEEEEEecCCCC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLR------ELKNKLRLLGCCIDKDEKILIYEYMPNKS 118 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (354)
...+|.+.+.||+|+||.||+|.+.+ ++.||||........... .+.|++++++++...+..+++|+++. ++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 35589999999999999999999764 888999975433221111 12377888999888899999999996 46
Q ss_pred HhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 119 LDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 119 L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
|..++ +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...............
T Consensus 246 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 76665 678899999999999999999999 999999999999999999999999998765433222222234
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc------chhhhhhhhccccCCCCcccCCcccccc
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY------SFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.||..|+|||++.+..++.++|||||||++|+|++|..++...... ...+.+.+........... ..... .
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~--~~~~~-~ 399 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP--QHAGS-R 399 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC--CCcch-H
Confidence 6899999999999989999999999999999999988664221111 1222222222221111000 00000 0
Q ss_pred chhhhhhhh-hccccC-Cch--hHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLF-SISSVG-LSN--DIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~-~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
......... ...... ... .........+.+||.+||+.||++|||+.|+|+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 000000 000 0001134578899999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=272.06 Aligned_cols=231 Identities=23% Similarity=0.335 Sum_probs=196.7
Q ss_pred hhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh--------------hHHHHHHHHHHhceeecCCceEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ--------------GLRELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~--------------~~~~~~~i~~~~~~~~~~~~~~lv 110 (354)
+.+=|.+.+.||+|.|+.|-+|++ =.|..||||++.+.... .+.++.|||++|++..+.-.+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 456799999999999999999994 36999999999765321 123445999999999999999999
Q ss_pred EEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE-cCCCCeEEeecccceeccCC
Q 048432 111 YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 111 ~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|.-++|+|.+++ +.+....+++.||+.||.|+|+.. +|||||||+||++ ..-|.+||.|||++..+..+
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999999 677889999999999999999999 9999999999876 56789999999999877766
Q ss_pred ccccccccccCcccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFS-IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
..... .+|.+.|.|||++.+..|+ +++||||||+|||.|+.|++| |...++.+.+-+|..-.+..|.
T Consensus 173 ~kL~T---sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P--FqeANDSETLTmImDCKYtvPs------- 240 (864)
T KOG4717|consen 173 KKLTT---SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP--FQEANDSETLTMIMDCKYTVPS------- 240 (864)
T ss_pred chhhc---ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc--cccccchhhhhhhhcccccCch-------
Confidence 54433 4899999999999999885 789999999999999999999 6777777777776555544332
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+.++++||..||..||++|.|.++|..
T Consensus 241 --------------------------hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 241 --------------------------HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --------------------------hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 26788999999999999999999998865
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=271.69 Aligned_cols=257 Identities=22% Similarity=0.289 Sum_probs=178.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--h----HHH--------HHHHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--G----LRE--------LKNKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~----~~~--------~~~i~~~~~~~~~~----- 104 (354)
...++|++.+.||.|+||.||+|.+. +++.||+|++...... . .++ +.|++++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34589999999999999999999964 5889999998653211 1 111 12667777766432
Q ss_pred -CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 -DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
...+++++++ +++|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 4568999987 66887776 778899999999999999999999 99999999999999999999999999875
Q ss_pred ccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.......+....
T Consensus 168 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 168 ADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP--GNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred cCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC--CCCHHHHHHHHHHHhCCCCHHHH
Confidence 43321 22467889999999876 468899999999999999999999953 33333333332222111111000
Q ss_pred CCccccccchhhhhhhhhccccCCc----hhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLS----NDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.... .......... ..... ........+.+.+||.+||+.||++|||+.++++.
T Consensus 241 ~~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKIS-----SEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred Hhcc-----hhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000 00000 00001134567899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=262.65 Aligned_cols=234 Identities=24% Similarity=0.363 Sum_probs=179.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEEec
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
+-|++.+.||.|+||.||++.+. .+..+++|.+..........+. |++++++.+...+..++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999975 4778899998765543333222 5566777888888999999999
Q ss_pred CCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 115 PNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 115 ~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
.+++|..++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999998876 567889999999999999999999 9999999999999999999999999986543221 11
Q ss_pred cccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 189 TGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.....++..|+|||++. ...++.++|+||+||++|+|++|++||. ..+.......+....... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~--~~~~~~~~~~~~~~~~~~--~~------ 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH--ELNPMRVLLKIAKSEPPT--LA------ 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc--ccCHHHHHHHHhhcCCCC--CC------
Confidence 22346788999999874 3447789999999999999999999953 333333333322221110 00
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.+||.+||+.+|++|||++++++.
T Consensus 230 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 ----------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001145678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=264.17 Aligned_cols=230 Identities=25% Similarity=0.404 Sum_probs=174.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhH---HH---------HHHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGL---RE---------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~---~~---------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||+|+||.||+|.++ +|+.||+|++..... ... .+ +.|++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999975 599999999865421 111 11 1256677788888889999999
Q ss_pred ecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 113 YMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 113 ~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+++ +|..++ +++..+..++.||+.||.|||++ + ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9974 666554 56788999999999999999997 8 99999999999999999999999999875433
Q ss_pred CccccccccccCcccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc-ccCCCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQ----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN-IYEFPSVD 257 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 257 (354)
.. ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...... .+........ ....+.
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~-- 230 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVEEPSPQLPA-- 230 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHhcCCCCCCc--
Confidence 22 1122356788999998865 34688999999999999999999996432221 1111111111 111100
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+.++|.+||+.+|++|||++++++
T Consensus 231 ------------------------------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 ------------------------------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------------------------------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 014677899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.50 Aligned_cols=233 Identities=25% Similarity=0.311 Sum_probs=175.4
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-------HHHHH--------HHHHHhceeecCCceEEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LRELK--------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-------~~~~~--------~i~~~~~~~~~~~~~~lv~e 112 (354)
+|+..+.||.|+||.||.|.+. +++.||+|.+....... ..++. +++.+...+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788899999999999999965 58899999986542111 11111 34445566778889999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+.+++|...+ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998776 567889999999999999999999 99999999999999999999999999865432221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....++..|+|||.+.+..++.++|+||+||++|+|++|..||.. .........+...........
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~--~~~~~~~~~~~~~~~~~~~~~-------- 224 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG--RKEKVKREEVDRRVLETEEVY-------- 224 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHhhhcccccc--------
Confidence 1123678999999999888899999999999999999999999643 222111111111111100000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
+...+..+.+|+.+||+.+|++||| ++++++.
T Consensus 225 ---------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 ---------------------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---------------------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0114556789999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.64 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=183.2
Q ss_pred hcCccccceecccCceeEEEEEEc-----CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeec--CCc
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCID--KDE 106 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~--~~~ 106 (354)
.+.|++.+.||+|+||.||+|.+. .+..||+|++...... ....+. |++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 367889999999999999999853 3778999999766543 222222 44556666655 557
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+++|||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 89999999999999988 677888999999999999999999 999999999999999999999999998765
Q ss_pred cCCcccc-ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQA-NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
....... ......++..|.+||.+.+..++.++|+||||+++|+|++|..|+............. . ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~----~---~~~~-- 230 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI----A---QGQM-- 230 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc----c---cccc--
Confidence 4322111 1111234557999999988889999999999999999999998853221111000000 0 0000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.. . ..........+...+..++..+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus 231 ------~~-~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 231 ------IV-T---RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred ------cH-H---HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 00 0 000000000011111225678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=278.89 Aligned_cols=235 Identities=22% Similarity=0.366 Sum_probs=190.6
Q ss_pred hhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
+.+-|.|+..||.|+||.||+|..+. +-.-|.|++.-.+...++.+ .+|+++++.|..++.++++.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 34678999999999999999999775 44457888877666665543 488999999999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||.||-++..+ +...++.-+++|++.||.|||+++ |+|||||..|||++.+|.++|+|||.+...... .
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 99999999887 778999999999999999999999 999999999999999999999999987532221 2
Q ss_pred cccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 187 ANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.....+.||++|+|||+.. ..+|+.++||||||++|.+|..+.+| -...+..-.+-.+.+..++ ...
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP--HhelnpMRVllKiaKSePP--TLl---- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP--HHELNPMRVLLKIAKSEPP--TLL---- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC--ccccchHHHHHHHhhcCCC--ccc----
Confidence 2234468999999999885 46799999999999999999999998 4444444444444443322 111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.|......+.+|+.+||..||..||++.++++
T Consensus 257 ------------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11226778899999999999999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=294.63 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=179.7
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeec
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCID 103 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~ 103 (354)
.+.......++|++++.||.|+||.||+|++. .+..||+|++..... .....+ .|++++++++.+
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 45566778899999999999999999999975 477899999865321 111111 256667776643
Q ss_pred --CCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCC----CCeEeCCCCCCCEEEcC---
Q 048432 104 --KDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSR----VRIIHRDLKVSNILLDK--- 165 (354)
Q Consensus 104 --~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlkp~Nill~~--- 165 (354)
...+|+||||+.+++|..++ +++..++.|+.||+.||.|||..+. .+|+|+||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 35689999999999998877 5678899999999999999998431 23999999999999964
Q ss_pred --------------CCCeEEeecccceeccCCccccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCC
Q 048432 166 --------------DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGK 229 (354)
Q Consensus 166 --------------~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~ 229 (354)
.+.++|+|||++........ .....+++.|+|||++.+ ..++.++|||||||+||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 23589999999875433221 122468999999999864 35789999999999999999999
Q ss_pred CCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCC
Q 048432 230 KTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR 309 (354)
Q Consensus 230 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 309 (354)
.||.... ....+...+... ...+... .+..+.+||..||..+|++|
T Consensus 241 ~PF~~~~-~~~qli~~lk~~-p~lpi~~--------------------------------~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 241 TPFHKAN-NFSQLISELKRG-PDLPIKG--------------------------------KSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred CCCCcCC-cHHHHHHHHhcC-CCCCcCC--------------------------------CCHHHHHHHHHHhcCChhHC
Confidence 9963221 122222222211 1111100 45678899999999999999
Q ss_pred CCHHHHHH
Q 048432 310 PTMNDVVS 317 (354)
Q Consensus 310 ps~~~il~ 317 (354)
||+.|++.
T Consensus 287 PSa~QlL~ 294 (1021)
T PTZ00266 287 PSALQCLG 294 (1021)
T ss_pred cCHHHHhc
Confidence 99999984
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=262.25 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=182.3
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHH----------HHHHHHHHhceee--
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLR----------ELKNKLRLLGCCI-- 102 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~----------~~~~i~~~~~~~~-- 102 (354)
+.+..+....++|++.+.||+|+||.||+|..+ +++.+|+|++..... .... ++.|++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 567778889999999999999999999999965 588999999865322 1111 1235555666552
Q ss_pred ---cCCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 103 ---DKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 103 ---~~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
..+..+++|||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 345789999999999998875 456678889999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~ 245 (354)
|+|||++........ ......++..|+|||++.. ..++.++|+||+||++|+|++|..||... ........
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~--~~~~~~~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL--HPMRALFK 240 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC--chhHHHhh
Confidence 999999875433221 1122367889999998753 34788999999999999999999995322 21111111
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
..... .+.... +..++..+.++|.+||+.+|++|||+.++++.+
T Consensus 241 ~~~~~--~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPRNP--PPTLHQ----------------------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccccC--CCcccC----------------------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11110 000000 001355688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=259.34 Aligned_cols=232 Identities=30% Similarity=0.476 Sum_probs=178.9
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---------HHHH------------HHHHHHhceeecCCc
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---------LREL------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---------~~~~------------~~i~~~~~~~~~~~~ 106 (354)
+|.+.+.||.|++|.||+|.+. +++.||+|.+....... ...+ .+++++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999964 58899999886542211 0111 255667778888889
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.++++||+++++|..++ ++...+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999887 667788899999999999999999 9999999999999999999999999987554
Q ss_pred CCcc----ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 182 GNEL----QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 182 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
.... ........++..|+|||.+.+..++.++|+||+||++|+|++|..||.. .+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~------ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD--CTQLQAIFKIGENAS------ 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC--ccHHHHHHHHhccCC------
Confidence 2111 1111123567899999999888889999999999999999999999643 222222222111110
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+..+...+..+.++|.+||+.+|++||++.++++
T Consensus 230 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 --------------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011115677899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=259.83 Aligned_cols=234 Identities=26% Similarity=0.437 Sum_probs=181.9
Q ss_pred CccccceecccCceeEEEEEEcC--CCEEEEEEecCCC----------hhhHHH-------------HHHHHHHhceeec
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKN--GDEIAVKRLSGRS----------GQGLRE-------------LKNKLRLLGCCID 103 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~--~~~vavK~~~~~~----------~~~~~~-------------~~~i~~~~~~~~~ 103 (354)
.|++.+.||+|+||.||.|.++. ++.+|+|.+.... .....+ +.|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999764 7889999875321 111111 1355667778888
Q ss_pred CCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 104 KDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
.+..+++|||+++++|.+++ ++...+..++.|++.+|.+||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 89999999999999998776 4667789999999999999996 67 99999999999999999999999
Q ss_pred cccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..|| ...........+.......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--YSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcc--cccCHHHHHHHHhhccCCc
Confidence 99987644432 222346788999999999888999999999999999999999995 3333333333322222111
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
... ...++.+.++|.+||+.||++|||+.++.++|++
T Consensus 233 ~~~-------------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 233 LPE-------------------------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CCc-------------------------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 000 0145678999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=267.10 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=181.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHH--------HHHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLRE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||.|+||.||+|.++ +++.||+|.+...... ...+ +.|++++++++...+..++|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999965 5889999998643211 1111 137778888999999999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+ +|..++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99975 777766 567788999999999999999999 99999999999999999999999999865332221
Q ss_pred ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||++.+. .++.++|+|||||++|+|++|.+||. ..+..+....+...........+......
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP--GSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 11223557899999988654 47889999999999999999999954 33333333332222221111111110000
Q ss_pred c-cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 G-FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. +..... .. .............++.+.+||.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNY---PK-YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccc---Cc-cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000000 00 0000000111225667899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=262.54 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=178.5
Q ss_pred cCccccceecccCceeEEEEEEc-----CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecC--Cce
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDK--DEK 107 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~--~~~ 107 (354)
..|++.+.||+|+||.||+|++. .+..||+|.+..... .....+. |++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 46799999999999999999842 478899999875532 2222222 444555555543 568
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+++|||+++++|..++ +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999887 577888999999999999999999 9999999999999999999999999987544
Q ss_pred CCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... .......++..|+|||.+.+..++.++|+|||||++|+|+++..|...... ...... .+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~----~~~~~~---~~~~~~~--- 230 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT----LFLKMI---GPTHGQM--- 230 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc----hhhhhc---ccccccc---
Confidence 32211 111223456789999999888899999999999999999998766311100 000000 0000000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
..+......... .....+..++..+.+|+.+||+.+|++|||++++++.|+++
T Consensus 231 -----~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 -----TVTRLVRVLEEG----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -----cHHHHHHHHHcC----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000000000 00011112567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=260.95 Aligned_cols=231 Identities=30% Similarity=0.482 Sum_probs=175.6
Q ss_pred ceecccCceeEEEEEEcC-------CCEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 54 NKLGEGGFGPVYKGVLKN-------GDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~-------~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+.||+|+||.||+|+.++ ++.+++|.+..... .....+ .+++++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999999643 25789998865431 111111 2566677788888899999999
Q ss_pred cCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-----CeEEeeccc
Q 048432 114 MPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-----NPKISDFGI 176 (354)
Q Consensus 114 ~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~~l~dfg~ 176 (354)
+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999887 345778899999999999999999 99999999999999877 899999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCC
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
+.................+..|+|||.+.+..++.++|+|||||++|+|++ |..||. ..+..+....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~--~~~~~~~~~~~~~~~~~--- 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP--ALNNQEVLQHVTAGGRL--- 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc--ccCHHHHHHHHhcCCcc---
Confidence 865443322222222344678999999998889999999999999999998 998854 33333333332211110
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
..+...+..+.++|.+||+.+|++|||++++++.|++
T Consensus 233 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 -----------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0011156788999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=257.57 Aligned_cols=230 Identities=30% Similarity=0.409 Sum_probs=176.5
Q ss_pred ceecccCceeEEEEEEcC--C--CEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLKN--G--DEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~--~--~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|++|.||+|.+.+ + ..||+|.+..... .....+. |++++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3689999987655 3232322 55666677776 889999999999
Q ss_pred CCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc-c
Q 048432 117 KSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA-N 188 (354)
Q Consensus 117 ~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~-~ 188 (354)
++|..++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999887 456788999999999999999999 9999999999999999999999999987654322111 1
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....++..|+|||.+.+..++.++|+|||||++|+|++ |..||. ..+..+....+.......+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~--~~~~~~~~~~~~~~~~~~~~------------ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA--GLSGSQILKKIDKEGERLER------------ 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcCCcCCC------------
Confidence 112345678999999988889999999999999999998 999953 33333333333221111100
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
+...+..+.+++.+||+.+|++|||++++++.|.
T Consensus 223 -------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 -------------------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------------------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0014667899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=259.65 Aligned_cols=233 Identities=25% Similarity=0.374 Sum_probs=168.1
Q ss_pred ceecccCceeEEEEEEcC---CCEEEEEEecCCChhh-HHH------------HHHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLKN---GDEIAVKRLSGRSGQG-LRE------------LKNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~---~~~vavK~~~~~~~~~-~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||+|...+ ...+++|.+....... ... +.|++++++.+.+....++||||+.++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 468999999999997543 4568888876443211 111 226667778888889999999999999
Q ss_pred CHhHHH----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 118 SLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 118 ~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+|.+++ .++.....++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999987 235567899999999999999999 9999999999999999999999999986432221111
Q ss_pred ccccccCcccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhh-ccccCCCCccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQ-------GIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYIS-ENIYEFPSVDT 258 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 258 (354)
......++..|+|||++.. ..++.++|+|||||++|+|++ |..|| ......+...... ......+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~- 234 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQVLKQVVREQDIKLPKPQ- 234 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC--CcCCHHHHHHHHhhccCccCCCCc-
Confidence 1122344667999998743 346789999999999999998 67774 3333333333322 2211111111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.....+..+.+++..|| .||++|||+++|++.|.
T Consensus 235 ---------------------------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 ---------------------------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---------------------------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00115667788999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=260.84 Aligned_cols=233 Identities=24% Similarity=0.442 Sum_probs=182.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
...|+..+.||.|+||.||.|.+. ++..||+|++..... .....+. +++++++.+...+..++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 457889999999999999999965 588999999875432 2222222 45566777888899999999
Q ss_pred ecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 113 YMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 113 ~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
|+++++|.+++ ++...+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++++|||++........ .
T Consensus 83 ~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06640 83 YLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence 99999999887 577888899999999999999999 99999999999999999999999999876543321 1
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
.....++..|.|||.+.+..++.++|+|||||++|+|++|..||. ..........+....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~--~~~~~~~~~~~~~~~------------------ 217 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS--DMHPMRVLFLIPKNN------------------ 217 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC--CcChHhHhhhhhcCC------------------
Confidence 222356788999999988889999999999999999999999953 222222222111110
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+.....++..+.+++.+||+.+|++||++++++..
T Consensus 218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111122267788999999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=259.52 Aligned_cols=230 Identities=29% Similarity=0.415 Sum_probs=173.3
Q ss_pred ceecccCceeEEEEEEcC-CC--EEEEEEecCCCh-hhHH-------------HHHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLKN-GD--EIAVKRLSGRSG-QGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~-~~--~vavK~~~~~~~-~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|+.++ +. .+++|.+..... .... .+.|++++++++...+..+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 468888864321 1111 123666777888888889999999999
Q ss_pred CCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 117 KSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 117 ~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
++|.+++ +++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 9998886 246678999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
++....... .......+..|+|||.+.+..++.++|+|||||++|+|++ |..|| .+.+..+....+...... +
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf--~~~~~~~~~~~~~~~~~~-~ 231 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRL-E 231 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc--cccCHHHHHHHHhCCCCC-C
Confidence 975322111 1111123457999999988889999999999999999997 88885 333333333332221100 0
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.+..++..+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 232 -------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 232 -------------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00014567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.62 Aligned_cols=180 Identities=22% Similarity=0.280 Sum_probs=148.7
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH------HHHHHHHHhceeecCCceEEEEEecCCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR------ELKNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
....+|++.+.||+|+||.||+|... +++.||+|+.......... .+.|++++++++...+..++|+|++.+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 141 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS- 141 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-
Confidence 34567999999999999999999975 4788999986544322111 124889999999999999999999965
Q ss_pred CHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 118 SLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 118 ~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
+|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 142 ~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~ 215 (357)
T PHA03209 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLG 215 (357)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc---cccc
Confidence 666665 678889999999999999999999 9999999999999999999999999986432221 1122
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
..|+..|+|||++.+..++.++|+|||||++|+|+++..+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 4678999999999988999999999999999999986555
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=262.75 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=185.6
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---------hHHH--------HHHHHHHhceeecCCceEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---------GLRE--------LKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---------~~~~--------~~~i~~~~~~~~~~~~~~lv 110 (354)
+|++.+.||.|++|.||+|.++ +|+.||+|.+...... ...+ +.|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5889999999999999999965 5899999999754322 0111 13778889999999999999
Q ss_pred EEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 111 YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 111 ~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
|||+ +++|..++ +++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88998887 567888999999999999999999 9999999999999999999999999987654432
Q ss_pred cccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+|| ......+....+...........+.....
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL--PGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc--cCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 11 122345678999998865 45789999999999999999997774 33333333333322211111111000000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
. .+. ..................+..+.++|.+||+.+|++|||++++++. |++..
T Consensus 233 ~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 233 L--PDY---VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred c--ccc---ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 000 0000000000111112356788999999999999999999999985 54444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=259.07 Aligned_cols=235 Identities=26% Similarity=0.390 Sum_probs=181.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-H----HH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-L----RE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~----~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||.|++|.||+|.++ +++.|++|.+....... . .+ +.|++++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999976 58999999987653221 1 11 12677888888888999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+.+++|.+++ ++...+..++.|++.++++||+ .+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999888 4567888999999999999999 88 999999999999999999999999988644322211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............+.......+.
T Consensus 158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 222 (265)
T cd06605 158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP----------- 222 (265)
T ss_pred ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-----------
Confidence 14567899999999888899999999999999999999999654432111111111111110000
Q ss_pred chhhhhhhhhccccCCchhHHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCL-CILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+.. .+..+.++|.+||..+|++|||+.+++..
T Consensus 223 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 ------------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00000 46678999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=265.82 Aligned_cols=239 Identities=19% Similarity=0.308 Sum_probs=182.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||++.++ .++.|++|.+...... ....+ .|++++++.+...+.++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999975 4789999998654321 11111 25566777788888899999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL- 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~- 185 (354)
||+++++|..++ +++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999888 567788899999999999999999 99999999999999999999999998763211100
Q ss_pred ------------ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 186 ------------QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 186 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
........++..|+|||.+.+..++.++|+|||||++|++++|..|| .+....+....+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf--~~~~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF--FGDTPEELFGQVISDDIEW 235 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhcccCC
Confidence 00111235677899999998888999999999999999999999995 3444444444433332222
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+.... ..+..+.++|.+||+.+|++|||..++.+.|+.
T Consensus 236 ~~~~~------------------------------~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 236 PEGDE------------------------------ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCccc------------------------------cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22110 156678999999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=260.20 Aligned_cols=232 Identities=25% Similarity=0.445 Sum_probs=181.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHH------------HHHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LRE------------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~------------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+.|+..+.||.|++|.||+|.+. +++.||+|.+....... ... +.|++++++.+...+..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 56788899999999999999865 58889999987543211 111 23778888999999999999999
Q ss_pred cCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 114 MPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 114 ~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++++|..++ +.+..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++........ ..
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence 9999998887 678888999999999999999999 99999999999999999999999999865443221 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||. ..........+..... +
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~--~~~~~~~~~~~~~~~~--~--------------- 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS--DLHPMRVLFLIPKNSP--P--------------- 219 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc--ccchhhHHhhhhcCCC--C---------------
Confidence 22356788999999988888999999999999999999999953 2222222211111110 0
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.....++..+.+++.+||+.+|++|||+.++++.
T Consensus 220 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 ---------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011156678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=265.41 Aligned_cols=257 Identities=21% Similarity=0.274 Sum_probs=179.0
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||.|++|.||+|.++ +|+.||+|++...... ...+ +.|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999975 5899999998643211 1111 23777888888899999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+.+ +|..++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 976 666554 578889999999999999999999 999999999999999999999999998754332211
Q ss_pred ccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.|+ +.+.+..+....+.+.....+...+........
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC-cCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12235678999999887654 689999999999999999999885 222333333333222211111111000000000
Q ss_pred chhhhhhhhhcccc-CCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSV-GLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.. ....... .......+..++.+.+||.+||+.||++|||++++++
T Consensus 234 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YK-----PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cc-----ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000000 0001111225678889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=265.11 Aligned_cols=178 Identities=25% Similarity=0.438 Sum_probs=138.4
Q ss_pred cceecccCceeEEEEEEc---CCCEEEEEEecCCChh--hHHH--------HHHHHHHhceeec--CCceEEEEEecCCC
Q 048432 53 ANKLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ--GLRE--------LKNKLRLLGCCID--KDEKILIYEYMPNK 117 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~--~~~~--------~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 117 (354)
.+.||+|+||.||+|+.+ +++.||+|.+...... ..++ +.|++++++++.. +..+++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 578999999999999964 4678999998654321 1122 2266777777643 4568899999866
Q ss_pred CHhHHH--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCCeEEeeccccee
Q 048432 118 SLDFFL--------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGIARI 179 (354)
Q Consensus 118 ~L~~~~--------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~~l~dfg~a~~ 179 (354)
+|..++ ++...+..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 665554 456778899999999999999999 9999999999999 4567899999999976
Q ss_pred ccCCcc-ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Q 048432 180 CRGNEL-QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGF 234 (354)
Q Consensus 180 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~ 234 (354)
...... ........++..|+|||++.+. .++.++|+||+||++|+|++|.+||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 543221 1122234678899999998764 589999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=264.39 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=177.0
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|.+.+.||.|++|.||+|..+ +++.||+|++...... ...+ +.|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999965 5899999998643211 1111 12667788888889999999999
Q ss_pred cCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 114 MPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 114 ~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
+.+ +|..++ ++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 974 776665 567888999999999999999999 99999999999999999999999999875432221
Q ss_pred ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||.+.+. .++.++|+|||||++|+|++|++||. ..........+.+.........+......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH--GDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC--CCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 11123457889999988654 47889999999999999999999953 33222211111111111111110000000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.. ....................++.+.++|.+||..||++|||+.++++
T Consensus 233 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PD----YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HH----HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00000000000011111225677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=264.71 Aligned_cols=241 Identities=27% Similarity=0.462 Sum_probs=181.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCC----EEEEEEecCCChhh-HHH------------HHHHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSGQG-LRE------------LKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vavK~~~~~~~~~-~~~------------~~~i~~~~~~~~~~~~~~ 108 (354)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+....... ... +.|++++++++.. +..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCce
Confidence 467889999999999999999864 344 47899887553321 111 1256677777754 4567
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++++|+++|+|.+++ +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 899999999999887 456788999999999999999999 99999999999999999999999999976543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
...........++..|++||.+.+..++.++|||||||++|+|++ |..||.. .........+..+.. .+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~--~~~~~~~~~~~~~~~-~~~~----- 233 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--IPTREIPDLLEKGER-LPQP----- 233 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHCCCC-CCCC-----
Confidence 322211222334678999999988889999999999999999997 8888532 222222222221111 1110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..++..+.+++.+||..+|++||+++++++.|+.+..+
T Consensus 234 --------------------------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 234 --------------------------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01445678999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=259.79 Aligned_cols=233 Identities=23% Similarity=0.353 Sum_probs=178.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHH----H--------HHHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLR----E--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~----~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||+|+||.||+|.++ +++.||+|.+..... .... + +.|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999975 689999998865321 1111 1 12778889999999999999999
Q ss_pred cCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
+++++|..++ +++..+..++.+++.||.|||. .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999998776 4577889999999999999996 47 9999999999999999999999999986543222
Q ss_pred cccccccccCcccccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGI------FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
. ....++..|+|||.+.+.. ++.++|+||+||++|+|++|..||... ........+.......
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~----- 226 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE--TYANIFAQLSAIVDGD----- 226 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc--chhhHHHHHHHHhhcC-----
Confidence 1 1234677899999885543 478999999999999999999996432 2111111111111000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..++..+.+||.+||+.+|++||++++++..
T Consensus 227 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 ------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011112267778999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=257.25 Aligned_cols=232 Identities=24% Similarity=0.343 Sum_probs=183.4
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHH------------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLRE------------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~------------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||.|+||.||.++.. +++.+++|.+.... ...... +.|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999954 58899999876432 111111 12667778888888999999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+++++|.+++ +++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999887 566788999999999999999999 99999999999999999999999999876544331
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|.|||.+.+..++.++|+||+|+++|+|++|..|| ......+....+..+......
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~--~~~~~~~~~~~~~~~~~~~~~----------- 222 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPVV----------- 222 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC--CCCCHHHHHHHHHcCCCCCCc-----------
Confidence 122345788999999998888889999999999999999999985 333434444443322211100
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
...+..+.++|.+||+.+|++|||++++++.+
T Consensus 223 ---------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ---------------------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---------------------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11567788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=263.20 Aligned_cols=236 Identities=24% Similarity=0.381 Sum_probs=182.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
+.++|++.+.||.|++|.||++.++ ++..||+|++..........+ .+++++++.+......++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4578999999999999999999965 588999999876554433222 255667777888889999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+++++|..++ +++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999887 567889999999999999999999 99999999999999999999999998764432211
Q ss_pred cccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 187 ANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
......++..|++||.+. ...++.++|+||||+++|+|++|+.||. ..+.......+...... ...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~--~~~---- 229 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH--ELNPMRVLLKILKSEPP--TLD---- 229 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc--cCCHHHHHHHHhcCCCC--CcC----
Confidence 122345788999999875 3446789999999999999999999953 33333333333222111 000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.++|.+||+.+|++|||++++++.
T Consensus 230 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ------------------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------------------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001145678899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=286.81 Aligned_cols=243 Identities=30% Similarity=0.483 Sum_probs=206.2
Q ss_pred hcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
.+.-.|.++||.|.||.|++|+.+. -..||||.++...... .+++ .||+++.+++.....+.|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3455789999999999999999652 4469999998765433 2333 377777777777788899
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
|.|||++|+|+.++ |.+.+...|++.|+.|++||..++ +|||||..+||||+.+-..|++|||+++...+.
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999999 788899999999999999999999 999999999999999999999999999876544
Q ss_pred ccccccc-cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 184 ELQANTG-RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 184 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
......+ .-.-...|.|||.+...+++.++|+||+|+++||.++ |..| ++++.+.+.++.+.++-.-.|.+.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP--YWdmSNQdVIkaIe~gyRLPpPmD---- 858 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVIKAIEQGYRLPPPMD---- 858 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc--ccccchHHHHHHHHhccCCCCCCC----
Confidence 3211111 0112469999999999999999999999999999987 8899 899999999999988887766666
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
||..|++||.+||++|-.+||.++||+..|+++....
T Consensus 859 ----------------------------CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 859 ----------------------------CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ----------------------------CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999999999999999999999999976543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=256.86 Aligned_cols=234 Identities=23% Similarity=0.390 Sum_probs=182.0
Q ss_pred hcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChh-h-HHH--------HHHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ-G-LRE--------LKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~-~-~~~--------~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.++|++.+.||.|++|.||+|..++ ++.|++|.+...... . ..+ +.|++++++.+......++++||+.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 4789999999999999999999765 889999998765321 1 111 1255677788888899999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++|.+++ +++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KR 156 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--cc
Confidence 99999887 578889999999999999999999 99999999999999999999999999875543321 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....++..|+|||++.+..++.++|+||+|+++|+|++|..||...... .....+..... +
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--~--------------- 217 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--RAIFMIPNKPP--P--------------- 217 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--hhhhhhccCCC--C---------------
Confidence 2234678999999998888999999999999999999999996432211 11111110000 0
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+...+..+.++|.+||+.+|++|||+.++++
T Consensus 218 -------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 -------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00011125567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=261.96 Aligned_cols=237 Identities=22% Similarity=0.314 Sum_probs=183.1
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH------------HHHHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
.+.+.|.....||.|+||.||++... ++..||||.+.......... +.|++++++.+...+..++||
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34456666788999999999999964 58899999986543322221 237788888888899999999
Q ss_pred EecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 112 EYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 112 e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
||+++++|..++ +++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 999999998887 678889999999999999999999 99999999999999999999999999865432221
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||. ..........+..........
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~----------- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF--NEPPLQAMRRIRDNLPPRVKD----------- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHhcCCCcccc-----------
Confidence 1122457889999999988889999999999999999999999953 333222222221111100000
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..+.+++.+||..+|++|||++++++.
T Consensus 241 -------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -------------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00145678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=259.65 Aligned_cols=232 Identities=24% Similarity=0.398 Sum_probs=182.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||.|++|.||+|.+. +++.||+|++..... .....+ .|++++.+.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999965 588999999865431 111111 2556677778888899999999
Q ss_pred cCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 114 MPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 114 ~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+.+++|.+++ +++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR 155 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence 9999999887 688899999999999999999999 99999999999999999999999999876554321 11
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.......+.....+. ...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~--~~~~~~~~~~~~~~~~~--~~~----------- 220 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD--LHPMRVLFLIPKNNPPS--LEG----------- 220 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc--CchHHHHHHhhhcCCCC--Ccc-----------
Confidence 224567889999999888899999999999999999999999532 22222222222221100 000
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+.+++.+||..+|++|||++++++
T Consensus 221 ------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 ------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 004567889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=262.59 Aligned_cols=238 Identities=17% Similarity=0.197 Sum_probs=166.6
Q ss_pred hhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChhhHHHH--------H---------------HHHHH
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQGLREL--------K---------------NKLRL 97 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~~~~~~--------~---------------~i~~~ 97 (354)
...++|++.+.||+|+||.||+|.+.+ +..+|+|+..........+. . +++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445799999999999999999999654 44567776543322111110 0 11122
Q ss_pred hceeecCC----ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 98 LGCCIDKD----EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 98 ~~~~~~~~----~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
++.+.... ..+++++++.. ++...+ .++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 22221111 33567777644 444443 456678899999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCcc-----ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchh--
Q 048432 169 PKISDFGIARICRGNEL-----QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT-- 241 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~-- 241 (354)
++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|.+||.........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999876532211 11122346899999999999888999999999999999999999996443222111
Q ss_pred -----hhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 242 -----LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 242 -----~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
....+.++... ...++..+.+++..||+.+|++||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK----------------------------------IKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred HhHHHHHHHhhhhhhc----------------------------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 11111111110 011567789999999999999999999999
Q ss_pred HHhh
Q 048432 317 SMLT 320 (354)
Q Consensus 317 ~~L~ 320 (354)
+.|+
T Consensus 291 ~~~~ 294 (294)
T PHA02882 291 KIFD 294 (294)
T ss_pred HhhC
Confidence 8774
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=258.46 Aligned_cols=237 Identities=25% Similarity=0.370 Sum_probs=179.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---H---------HHHHHHHHhceeecCC-----
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---R---------ELKNKLRLLGCCIDKD----- 105 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~---------~~~~i~~~~~~~~~~~----- 105 (354)
+...++|++.+.||.|++|.||+|.++ +++.+++|++........ . .+.|++++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 456799999999999999999999975 578999999876543211 1 1236667777775544
Q ss_pred -ceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 106 -EKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 106 -~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
.+++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999998876 456778899999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
++........ ......++..|+|||++.. ..++.++|+||||+++|+|++|..||. ..........+....
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~ 234 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC--DMHPMRALFKIPRNP 234 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc--ccchHHHHHHhhccC
Confidence 9865433221 1122457889999998754 236788999999999999999999963 222222222222211
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.. ... .+...+..+.+||.+||..||++|||++++++
T Consensus 235 ~~--~~~----------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 PP--TLK----------------------------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CC--CCC----------------------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 000 01114567899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=257.83 Aligned_cols=233 Identities=25% Similarity=0.406 Sum_probs=167.9
Q ss_pred ceecccCceeEEEEEEcC---CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLKN---GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~---~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||+|...+ +..+|+|.+....... ...+ .|++++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998543 4578999886654221 1122 25566777788888899999999999
Q ss_pred CHhHHHh----------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 118 SLDFFLF----------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 118 ~L~~~~~----------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+|.+++. ++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9988872 34456789999999999999999 9999999999999999999999999986433322211
Q ss_pred ccccccCcccccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc-ccCCCCccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG-------IFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN-IYEFPSVDT 258 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 258 (354)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||..... .+........ ....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~- 234 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQQLKLPKPR- 234 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHhhcccCCCCCCc-
Confidence 22223457789999988642 35789999999999999996 9999643322 2221111111 11110000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.....++.+.++|.+|| .+|++|||+++|+..|+
T Consensus 235 ---------------------------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 ---------------------------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---------------------------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00014556788999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=260.99 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=183.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh----HHH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG----LRE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~----~~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||.|++|.||+|.+. +|+.||+|++..... .. ..+ +.|++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999965 689999999875432 11 111 12667788888888999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+ +++|.+++ +++..++.++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99998887 578889999999999999999999 99999999999999999999999999875543321 1
Q ss_pred ccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||.+.+.. ++.++||||+||++|+|++|.++| ...........+...........++.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF--PGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc--CCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 122245788999999886544 689999999999999999997774 33333333333332222111111110000000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
... ...............+..+..+.+++.+||+.+|++|||+++++..
T Consensus 234 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNK---ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhc---ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000000011112356889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=258.38 Aligned_cols=237 Identities=28% Similarity=0.431 Sum_probs=182.1
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
.++|++.+.||.|+||.||+|+.+ ..+.|++|.+...... ....+ .|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 378999999999999999999964 2467999998664433 11121 2566677888888889
Q ss_pred EEEEEecCCCCHhHHH--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 108 ILIYEYMPNKSLDFFL--------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~--------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999886 356778999999999999999999 99999999999999999999999
Q ss_pred cccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccC
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
||++......... ......++..|++||.+.+..++.++|+||||+++|+|++ |..|| ...........+..+...
T Consensus 161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~--~~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF--YGLSDEEVLNRLQAGKLE 237 (275)
T ss_pred cccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc--cccchHHHHHHHHcCCcC
Confidence 9998643322211 1112244667999999888888999999999999999998 77774 333333333333322221
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.+.. ..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 238 ~~~~-------------------------------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPVP-------------------------------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCC-------------------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 015678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=261.82 Aligned_cols=236 Identities=22% Similarity=0.320 Sum_probs=183.0
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH----H--------HHHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR----E--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~----~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
....|.....||.|+||.||+|... +++.||+|.+......... + +.|++++++.+...+..++++|
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3455666778999999999999965 5899999998643322111 1 2377888889999999999999
Q ss_pred ecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 113 YMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 113 ~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
|+++++|..++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99999998876 678889999999999999999999 99999999999999999999999999864433221 1
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
.....++..|+|||.+.+..++.++|+||+||++|+|++|+.||. .....+....+......... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~--~~~~~~~~~~~~~~~~~~~~-~----------- 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLK-N----------- 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHhccCCCCcc-c-----------
Confidence 122457889999999988889999999999999999999999963 33333333332211110000 0
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..+.++|.+||+.+|++|||++++++.
T Consensus 240 ------------------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 ------------------AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00145668899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=262.03 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=181.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--h----HHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--G----LREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~----~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||+|++|.||+|.++ +|+.||+|++...... . ..+. .|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999976 5899999988543211 1 1111 255667778888889999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|++++++..+. +++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 99999888776 678889999999999999999999 99999999999999999999999999876544321
Q ss_pred ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||. +....+....+.+.................+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP--GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC--CCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1112346788999998876 457889999999999999999999964 3332222222221111110000000000000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.... ...............+..+..+.+||.+||+.+|++|||+.+++.
T Consensus 234 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGL--SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccc--cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 000000000000111224678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.79 Aligned_cols=236 Identities=24% Similarity=0.403 Sum_probs=175.3
Q ss_pred ccccceecccCceeEEEEEEc----CCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeecCC------
Q 048432 50 FSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCIDKD------ 105 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~~~------ 105 (354)
|.+.+.||+|+||.||+|.++ +++.||+|++.... .....++. |++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999854 36889999987542 22222222 4444455443321
Q ss_pred ceEEEEEecCCCCHhHHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 106 EKILIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
..+++++|+.+++|..++ ++......++.|++.|++|||+.+ |+|+||||+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 246889999999998775 356678999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
|++................++..|++||.+.+..++.++|+|||||++|+|++ |.+||. ..+..+....+.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~--~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA--GVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC--CCCHHHHHHHHHcCCcCC
Confidence 99875543221111112234568999999988888999999999999999999 778853 333333333333221110
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.. ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 236 ~~--------------------------------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QP--------------------------------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC--------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.90 Aligned_cols=239 Identities=22% Similarity=0.255 Sum_probs=196.2
Q ss_pred hhhcCccc-cceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH--------HHHHHHHHHhceee----cCCceEEE
Q 048432 45 TATNKFSD-ANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--------RELKNKLRLLGCCI----DKDEKILI 110 (354)
Q Consensus 45 ~~~~~y~~-~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--------~~~~~i~~~~~~~~----~~~~~~lv 110 (354)
...++|.+ .++||-|-.|.|-.+.++ .|+++|+|++....+... ..+.|||.++++|. ....+.+|
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 35567766 468999999999999865 589999999865433221 12237888888764 44677899
Q ss_pred EEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCCeEEeecccceec
Q 048432 111 YEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARIC 180 (354)
Q Consensus 111 ~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~~l~dfg~a~~~ 180 (354)
||+++||.|...+ |++..+..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+|...
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 9999999998888 889999999999999999999999 999999999999964 457899999999865
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--cchhhhhhhhccccCCCCccc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT--YSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... ....+-|+.|.|||++.-.+|+..+|+||+|+++|-|+.|.+||..... ...++..+|..+...+|..+|
T Consensus 215 ~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 215 QEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred CCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 54222 2234679999999999888899999999999999999999999633222 267788889999999998876
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.. .++...++|+.+|+.+|++|.|++++++.
T Consensus 292 s~-----------------------------VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 292 SC-----------------------------VSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hH-----------------------------HHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 54 67888999999999999999999998764
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=256.61 Aligned_cols=231 Identities=24% Similarity=0.341 Sum_probs=180.1
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||+|+||.+|.+... +|+.||+|.+.... ......+. |++++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5899999999999999999964 58999999986432 11111222 455667778888899999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+.+++|.+.+ +++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999998876 457788999999999999999999 999999999999999999999999998754432211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||. ..+..+....+..+....
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~--~~~~~~~~~~~~~~~~~~------------- 220 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE--AGNMKNLVLKIIRGSYPP------------- 220 (256)
T ss_pred --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc--CCCHHHHHHHHhcCCCCC-------------
Confidence 112346788999999988888999999999999999999999953 333333333332222110
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.++|.+||+.+|++||++.++++.
T Consensus 221 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 -------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011156678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=260.92 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=182.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------HHH--------HHHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LRE--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------~~~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||+|++|.||+|.++ +++.||+|++....... .++ +.|++++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999976 48999999885432211 111 2377888999999999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|++++++..+. +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence 99999888775 678899999999999999999999 999999999999999999999999998754433211
Q ss_pred ccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||++.+. .++.++|+||||+++|+|++|.+||.. ....+....+....................
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG--DSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC--CchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 1223567899999988754 468899999999999999999988532 222222222221111111100000000000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+.. ...............+..+..+.+|+.+||+.+|++|||+.++++
T Consensus 234 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGM--RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhcc--ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 000000000000111235778999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=260.67 Aligned_cols=227 Identities=28% Similarity=0.377 Sum_probs=181.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH----H--------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR----E--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~----~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|++|.||++.+. +++.||+|++..... .... + +.|++++++++.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999965 589999999865321 1111 1 236777888888899999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+.+++|.+++ ++...+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999998887 678888999999999999999999 999999999999999999999999998765433
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|++||.+.+...+.++|+||||+++|+|++|..||. ..........+..+....+.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~----------- 219 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF--DDNPIQIYEKILEGKVRFPS----------- 219 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHhcCCccCCc-----------
Confidence 122357889999999988888999999999999999999999953 33333333333322222211
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
..+..+.+++.+||..+|++|+ +++++++
T Consensus 220 ----------------------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 ----------------------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----------------------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1356778999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=272.67 Aligned_cols=227 Identities=27% Similarity=0.405 Sum_probs=181.8
Q ss_pred ceecccCceeEEEEEEcC-CCEEEEEEecCCChhh------------HHHHHHHHHHhceeecCCceEEEEEecCCCCHh
Q 048432 54 NKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG------------LRELKNKLRLLGCCIDKDEKILIYEYMPNKSLD 120 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~------------~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (354)
-+||+|.||+||.|++.+ ...+|||.+....... .-.++|||++++.+..++..-|+||-.+||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999765 5568999997654322 224569999999999999999999999999999
Q ss_pred HHH------h--hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCeEEeecccceeccCCcccccccc
Q 048432 121 FFL------F--DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 121 ~~~------~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
.++ + .+.++--..+||+.||.|||.+. |||||||-+||||+ -.|.+||+|||-+.....-. .....
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence 998 2 56778889999999999999999 99999999999996 57899999999886544332 22334
Q ss_pred ccCcccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 192 IVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~--~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
+.||+.|+|||++-.++ |+.++|||||||++.||.||++||--.+.-...+.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk------------------------- 790 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK------------------------- 790 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-------------------------
Confidence 67899999999998765 899999999999999999999996332222222221
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...-+..+.+|...+.+.+.||.+|++.+|-+||+|.++|.
T Consensus 791 -------VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 -------VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -------hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11111233444457888999999999999999999999985
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=261.20 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=181.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...++ .|++++++.+..++.+++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999965 5888999988654221 11111 1666777888889999999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+++++|..++ +++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999998 5778889999999999999997 57 9999999999999999999999999886432221
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc--------cC
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD--------TH 259 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 259 (354)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||.... ...............+... ..
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCC
Confidence 122467889999999888888999999999999999999999964332 2221111111111000000 00
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
......-................. ....+..+.+||.+||..+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000000000000 01146678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=261.54 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=180.9
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hH-HH---------HHHHHHHhceeecC
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GL-RE---------LKNKLRLLGCCIDK 104 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~-~~---------~~~i~~~~~~~~~~ 104 (354)
+.++++..+.++|.+.+.||+|+||.||+|..+ +++.+|+|++...... .. .+ +.|++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 455677778899999999999999999999964 5889999998654221 11 11 12444455555432
Q ss_pred -----CceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 105 -----DEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 105 -----~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
...++|+||+++++|.+++ +.+..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999998775 567788999999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-----IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~ 245 (354)
|+|||++......... .....++..|+|||.+... .++.++|+||+||++|+|++|++||. ..........
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~--~~~~~~~~~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--DMHPVKTLFK 244 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC--CCcHHHHHHH
Confidence 9999998654332211 1223567899999987543 26789999999999999999999953 3332222222
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+...... ... .+......+.++|.+||+.+|++|||+.++++.
T Consensus 245 ~~~~~~~--~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRNPPP--TLL----------------------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcCCCC--CCC----------------------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2211110 000 001134568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=268.58 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=196.0
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhH-----------HHHHHHHHHhceeecCCceE
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGL-----------RELKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~-----------~~~~~i~~~~~~~~~~~~~~ 108 (354)
..|+-.-.+......||.|.||.||.+.|+. .--||||.++.+..... ..+.|+|+++++|..+...|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3444444556667899999999999999875 55689999987654332 23349999999999999999
Q ss_pred EEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 109 LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
||+|||..|+|.+++ .+....+.|+.||..|+.||.+++ ++||||..+|+||..+-.+|++|||+++...
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999998 445556899999999999999999 9999999999999999999999999999876
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
......... ....+-|.|||-+..+.++.++|+|+||++||||.| |..| +.+.+-......+.++-
T Consensus 417 gDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP--YPGidlSqVY~LLEkgy---------- 483 (1157)
T KOG4278|consen 417 GDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYGLLEKGY---------- 483 (1157)
T ss_pred CCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC--CCCccHHHHHHHHhccc----------
Confidence 655443322 233679999999999999999999999999999987 7778 44444333332222221
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+.+-+.-|++.+++||+.||+++|.+||++.++...|+...
T Consensus 484 ----------------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 ----------------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ----------------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 11112229999999999999999999999999999998754
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=260.76 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=180.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||+|++|.||++.+. +|+.||+|++....... ...+ .|++++++.+...+.+++|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3578999999999999999999965 58899999886543221 1112 25566777888889999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++++|..++ +++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999998887 5678889999999999999997 57 9999999999999999999999999876432221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc------h---hhhhhhhccccCCCCc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS------F---TLLGYISENIYEFPSV 256 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~------~---~~~~~~~~~~~~~~~~ 256 (354)
.....++..|+|||++.+..++.++|+||+||++|++++|..||....... . +....+..... +..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 233 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRL 233 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCC
Confidence 112467889999999988888999999999999999999999965332210 0 11111110000 000
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
.....+..+.+|+.+||+.||++|||++++++..
T Consensus 234 -----------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 -----------------------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----------------------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0011456789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=256.89 Aligned_cols=238 Identities=20% Similarity=0.270 Sum_probs=183.5
Q ss_pred ccchhhhhcCcccccee--cccCceeEEEEEEc-CCCEEEEEEecCCChhhH--------HHHHHHHHHhceeecCCceE
Q 048432 40 FSSVSTATNKFSDANKL--GEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--------RELKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--------~~~~~i~~~~~~~~~~~~~~ 108 (354)
..+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ ..+.|++++++.+...+..+
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 34445566788888887 99999999999965 588899999865422111 12346777888888889999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~ 182 (354)
+||||+++++|.+++ +++..+..++.|+++||.+||+.+ ++|+||+|+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999887 678899999999999999999999 99999999999999988 999999999875432
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ...++..|+|||++.+..++.++|+||+|+++|+|++|..||................. ..+
T Consensus 163 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~-------- 226 (267)
T PHA03390 163 PS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKK-------- 226 (267)
T ss_pred Cc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--ccc--------
Confidence 22 23568899999999888899999999999999999999999652222111111100000 000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-MNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~il~ 317 (354)
.......++.+.+||.+||+.+|++||+ ++++++
T Consensus 227 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ---------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0011126778899999999999999996 588874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=253.43 Aligned_cols=233 Identities=22% Similarity=0.356 Sum_probs=166.8
Q ss_pred ceecccCceeEEEEEEcCC---CEEEEEEecCCChh-hHHH------------HHHHHHHhceeecCCceEEEEEecCCC
Q 048432 54 NKLGEGGFGPVYKGVLKNG---DEIAVKRLSGRSGQ-GLRE------------LKNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~~---~~vavK~~~~~~~~-~~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.||+|+||.||++...++ ..+++|.+...... .... +.|++++++.+......+++|||+.++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985432 34677776654321 1111 237788888999889999999999999
Q ss_pred CHhHHHh---------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 118 SLDFFLF---------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 118 ~L~~~~~---------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
+|..++. +...+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9988872 33456789999999999999999 99999999999999999999999998753222211112
Q ss_pred cccccCcccccCcccccc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCcccccchhhhhhhhcccc-CCCCcccC
Q 048432 189 TGRIVGTYRYMSPEYAIQ-------GIFSIKSDVFSFGVLLLKIVSG-KKTTGFYRTYSFTLLGYISENIY-EFPSVDTH 259 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (354)
.....++..|+|||++.. ..++.++|+|||||++|+|+++ ..|| ......+....+..... ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~---- 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY--SHLSDREVLNHVIKDQQVKLFK---- 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHhhcccccCC----
Confidence 223456789999998753 2357789999999999999974 5563 33333333333222211 1000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
+.......+.+.+++..|| .+|++|||+++|++.|.
T Consensus 232 ------------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 ------------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ------------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0000114566788999999 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.00 Aligned_cols=230 Identities=28% Similarity=0.434 Sum_probs=179.4
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-----hhHHHH------------HHHHHHhceeecCCceEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----QGLREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-----~~~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
+|+..+.||+|++|.||+|..+ +++.|++|.+..... .....+ .+++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999976 689999999865431 111111 2667778888888899999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
+||+++++|..++ +++..+..++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999887 677888899999999999999999 9999999999999999999999999987544332
Q ss_pred ccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|++||.+.... ++.++|+||+|+++|+|++|..||.... .......+.... ..+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~-~~~---------- 221 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSK-ELP---------- 221 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcc-cCC----------
Confidence 112245678899999887666 8999999999999999999999964322 222111111100 000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+...++.+.+++.+||..+|++|||+.+++.
T Consensus 222 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011115677889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=259.25 Aligned_cols=239 Identities=24% Similarity=0.377 Sum_probs=184.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
+....++|.+.+.||+|+||.||++... +++.|++|.+..........+ .|++++++.+...+..++
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3445689999999999999999999864 588899999865433222222 255667788888889999
Q ss_pred EEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 110 IYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 110 v~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+||+++++|.+++ +++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999999887 567888999999999999999999 99999999999999999999999998765433221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
......++..|++||.+....++.++|+||||+++|++++|..||... +.......+.... .+...
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~--~~~~~~~~~~~~~--~~~~~-------- 236 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNG--TPELQ-------- 236 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChhhheeehhcCC--CCCCC--------
Confidence 112235778899999998888899999999999999999999996432 2211111111111 00000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.++|.+||..+|++||++++++..
T Consensus 237 --------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001145678899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=264.40 Aligned_cols=262 Identities=17% Similarity=0.200 Sum_probs=175.7
Q ss_pred cccceeccc--CceeEEEEEEc-CCCEEEEEEecCCCh--hhHH------------HHHHHHHHhceeecCCceEEEEEe
Q 048432 51 SDANKLGEG--GFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLR------------ELKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 51 ~~~~~lg~G--~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~------------~~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++.+.||+| ++++||++..+ +|+.||+|++..... .... .+.|++++++++..++..++|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 367889999 67899999964 689999999965421 1111 123667788889999999999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL- 185 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~- 185 (354)
+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999887 567888999999999999999999 99999999999999999999999986543211110
Q ss_pred ----ccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC------
Q 048432 186 ----QANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF------ 253 (354)
Q Consensus 186 ----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 253 (354)
........++..|+|||++.+ ..++.++||||+||++|+|++|..||..... .........+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch--hHHHHHHhcCCccccccccc
Confidence 001111245678999999876 3588999999999999999999999643221 11111111111100
Q ss_pred -CCcccCCccccccchhhhhh------hhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 254 -PSVDTHNVKTFGFLHLTIFK------LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 254 -~~~~~~~~~~~~~~d~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+.............+..... .................++.+.+|+.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000000000000000 00000001111122335678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=255.51 Aligned_cols=227 Identities=23% Similarity=0.294 Sum_probs=175.3
Q ss_pred ceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHH-------------HHHHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLRE-------------LKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~-------------~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||.|++|.||+|... +|+.||+|++...... .... +.|++++++++...+..++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999964 5899999998654321 1111 12566778888888899999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
++|..++ ++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 9999887 677888999999999999999999 99999999999999999999999998865332 122
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..++..|++||.+.+..++.++|+||+|+++|+|++|..||. ..+.......+.......+...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~-------------- 216 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH--AETPDAVFDNILSRRINWPEEV-------------- 216 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC--CCCHHHHHHHHHhcccCCCCcc--------------
Confidence 356788999999988888999999999999999999999953 3333333333222221111100
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
...+++.+.++|.+||+.+|++|||+.++.+.|.
T Consensus 217 ---------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 ---------------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ---------------cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1115778899999999999999998765554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.95 Aligned_cols=234 Identities=26% Similarity=0.441 Sum_probs=180.1
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||.|++|.||++... +++.|++|++...... ....+ .+++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 6899999999999999999965 6889999998765442 22222 2566777788888899999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
+++++|.+++ +++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999987 567888899999999999999999 99999999999999999999999999876543322111
Q ss_pred --cccccCcccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc-ccCCCCcccCCcc
Q 048432 189 --TGRIVGTYRYMSPEYAIQGI---FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN-IYEFPSVDTHNVK 262 (354)
Q Consensus 189 --~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 262 (354)
.....++..|++||.+.+.. ++.++|+||+|+++|++++|..||..... .......+... ....|...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~----- 231 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGAGHKPPIPDSL----- 231 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHHHhcCCCCCCCccc-----
Confidence 11235678999999998766 78999999999999999999999643221 11111111111 11111100
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+..+.++|.+||+.+|++|||+.+++.
T Consensus 232 --------------------------~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 232 --------------------------QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --------------------------ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 13667789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=270.97 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=201.2
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-HH----H--------HHHHHHhceeecCCceEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-RE----L--------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~~----~--------~~i~~~~~~~~~~~~~~lv 110 (354)
+.+.+.+.+.+.||+|.||.|.++....+..||+|.++....... .+ + .||++++++|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 445567889999999999999999987789999999987654333 22 2 2888899999999999999
Q ss_pred EEecCCCCHhHHHh-------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 111 YEYMPNKSLDFFLF-------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 111 ~e~~~~~~L~~~~~-------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||++.|+|.+++. ......+|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++....+
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999982 33456789999999999999999 999999999999999999999999999866555
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS--GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
+........+-.+.|+|+|-+.-++++.++|+|++|+++||+++ ...| |....++...+........-+..
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~P--y~~lt~e~vven~~~~~~~~~~~----- 763 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQP--YSQLTDEQVVENAGEFFRDQGRQ----- 763 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCc--hhhhhHHHHHHhhhhhcCCCCcc-----
Confidence 54444444566789999999999999999999999999999865 6677 55555555555433222211111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.....|+-|+..+.++|.+||+.+-++|||++++...|.+..
T Consensus 764 --------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 --------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred --------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 122233448999999999999999999999999999987653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=251.70 Aligned_cols=230 Identities=25% Similarity=0.348 Sum_probs=178.3
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||+|++|.||+|... +++.+|+|.+..... .....+ .+++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5899999999999999999964 588999999865421 112222 2556667777788889999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCCcc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGNEL 185 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~~~ 185 (354)
+++++|.+++ +++..+..++.+++.++.+||+++ ++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999887 567788999999999999999999 99999999999998654 579999999876543321
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
. ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||. ..+.......+.......
T Consensus 158 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd08220 158 A---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE--AANLPALVLKIMSGTFAP------------ 220 (256)
T ss_pred c---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcc--cCchHHHHHHHHhcCCCC------------
Confidence 1 12356789999999988888999999999999999999999953 333333333322211110
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.+++.+||..+|++|||+.+++..
T Consensus 221 --------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 --------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000156678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=257.72 Aligned_cols=235 Identities=22% Similarity=0.375 Sum_probs=189.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHH---------HHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LREL---------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~---------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.+-|.++..||+|+||.||+|.++ .|+.+|+|.....+.-. +.+. +++|++|+.|-....+++|||||.
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 345688999999999999999976 59999999997765422 1111 267888998888899999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
-|++.+.+ +.+..+..++...++||.|||... -+|||||..|||++.+|..||+|||.+......- ...
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--Hhh
Confidence 99999998 778889999999999999999998 9999999999999999999999999986544332 223
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
+...||+-|+|||++..-.|+..+||||||++..||..|++| +.+.-....+.++...+++ ...
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PP--YsDIHPMRAIFMIPT~PPP--TF~------------ 250 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPP--YSDIHPMRAIFMIPTKPPP--TFK------------ 250 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCC--cccccccceeEeccCCCCC--CCC------------
Confidence 345799999999999999999999999999999999999999 4444333333333222211 111
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+.++.+|+++||..+|++|-||-++++.
T Consensus 251 ----------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 ----------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ----------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 122268889999999999999999999887753
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=253.80 Aligned_cols=237 Identities=25% Similarity=0.348 Sum_probs=176.8
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
...+++.....||+|+||.||+|.+. ++..|++|.+..........+. |++++++++...+..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34455566679999999999999965 5788999998766544333332 5566777888888999999
Q ss_pred EecCCCCHhHHHh--------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFLF--------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~~--------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a~~~~~ 182 (354)
||+.+++|..++. +...+..++.||+.||.|||+.+ |+|+||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999998872 55677889999999999999999 999999999999976 67899999999865433
Q ss_pred CccccccccccCcccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... .....++..|+|||.+.... ++.++|+||+|+++|+|++|..||............... ...
T Consensus 162 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------- 229 (268)
T cd06624 162 INPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKI-------- 229 (268)
T ss_pred CCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hcc--------
Confidence 2211 12235688999999886543 788999999999999999999996432211111111000 000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+...++.+.+|+.+||..+|++|||+.+++..
T Consensus 230 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 ----------------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001111256778999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=274.09 Aligned_cols=230 Identities=29% Similarity=0.464 Sum_probs=187.3
Q ss_pred hhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhhHHHHHHH---H------------HHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQGLRELKNK---L------------RLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~~~~~~~i---~------------~~~~~~~~~~~~~ 108 (354)
.+...|.-++.||.|+||.||-|++ ++.+.||||.+....++..++...| | .+-++|.-+...+
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 3445788899999999999999995 4688999999988877666555433 3 3344555566678
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+|||||-| +-.+++ +.+..+..|+.+.+.||+|||+.+ .+|||||..|||++..|.|||+|||.+....
T Consensus 103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 99999976 666666 677888999999999999999999 9999999999999999999999999985422
Q ss_pred CccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..+.++||+.|+|||++. .+.|+-++||||||++..+|.-+++| .+.++....+-.|.++..+. ...
T Consensus 178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPP--lFnMNAMSALYHIAQNesPt--Lqs- 247 (948)
T KOG0577|consen 178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPT--LQS- 247 (948)
T ss_pred -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCC--ccCchHHHHHHHHHhcCCCC--CCC-
Confidence 233468999999999986 46799999999999999999999999 66777777777776655432 111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+++|+..||++-|++|||.+++++
T Consensus 248 ----------------------------~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 248 ----------------------------NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ----------------------------chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 117888999999999999999999988765
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=252.49 Aligned_cols=231 Identities=25% Similarity=0.355 Sum_probs=178.6
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceee--cCCceEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCI--DKDEKILIY 111 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~--~~~~~~lv~ 111 (354)
+|++.+.||.|++|.||+|.+. +++.||+|++..... .....+ .|++++++++. .....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5889999999999999999964 588999999865322 111111 25566666554 345679999
Q ss_pred EecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 112 EYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 112 e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
||+++++|..++ +++..+..++.+|+.||.+|| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999998887 456788999999999999999 777 999999999999999999999999998
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.....+.+..+....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~---- 229 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA--RNQLQLASKIKEGKFRR---- 229 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC--cCHHHHHHHHhcCCCCC----
Confidence 765443321 1123578899999999888899999999999999999999999643 33333333333222110
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...+..+.+++.+||+.+|++|||+++|++.
T Consensus 230 ----------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ----------------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----------------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011156778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.41 Aligned_cols=238 Identities=26% Similarity=0.401 Sum_probs=179.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||.|++|.||+|... ++..+++|++...... ....+. +++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999965 5889999998654321 222232 333455566778889999999
Q ss_pred cCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 114 MPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 114 ~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
+.+++|.+++ +++..+..++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999887 356778899999999999999999 99999999999999999999999999865443322
Q ss_pred cc--ccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 186 QA--NTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 186 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ......++..|++||.+... .++.++|+||||+++|+|++|..||.. ................ ... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~--~~~~~~~~~~~~~~~~--~~~-~--- 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK--YPPMKVLMLTLQNDPP--SLE-T--- 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc--cChhhhHHHHhcCCCC--CcC-C---
Confidence 21 22234578899999998776 688999999999999999999999632 2222222222211110 000 0
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.......++.+.+++.+||+.+|++|||++++++
T Consensus 230 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 ---------------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---------------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001125678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.93 Aligned_cols=221 Identities=22% Similarity=0.329 Sum_probs=165.1
Q ss_pred ceecccCceeEEEEEEcC-------------CCEEEEEEecCCChhhHHH------------HHHHHHHhceeecCCceE
Q 048432 54 NKLGEGGFGPVYKGVLKN-------------GDEIAVKRLSGRSGQGLRE------------LKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~-------------~~~vavK~~~~~~~~~~~~------------~~~i~~~~~~~~~~~~~~ 108 (354)
+.||+|+||.||+|.... ...|++|++.......... +.|++++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998431 2358999876543322111 236677888888888999
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC-------eEEeecc
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-------PKISDFG 175 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------~~l~dfg 175 (354)
++|||+++++|..++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999998876 577888999999999999999999 999999999999987664 8999999
Q ss_pred cceeccCCccccccccccCcccccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCcccccchhhhhhhhccccCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAI-QGIFSIKSDVFSFGVLLLKIV-SGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
++...... ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||.. ....+... .......
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~--~~~~~~~~-~~~~~~~- 227 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD--KTLAEKER-FYEGQCM- 227 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--cchhHHHH-HHhcCcc-
Confidence 88643221 1234677899999886 456899999999999999997 57777432 21111111 1000000
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
. ..+....+.+||.+||+.||++||++.+|++.|
T Consensus 228 -~-------------------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 -L-------------------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -C-------------------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=285.41 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=208.8
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCC------ChhhHHHHH---------HHHHHhceeec
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGR------SGQGLRELK---------NKLRLLGCCID 103 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~------~~~~~~~~~---------~i~~~~~~~~~ 103 (354)
+..+....++|.+++.||+|+||.|.+++.++ ++.||.|++.+- ......+.+ =|+.+.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34445667899999999999999999999764 888999998662 223333333 34667778899
Q ss_pred CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
++++|+||+|++||+|..++ +++..++-++..|+-||.-||+.| +|||||||+|||++..|+++|+|||.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999998888 678888999999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc--cc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN--IY 251 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~ 251 (354)
....... ...+..+||+.|.+||++.. +.|+..+|.||+|+++|||+.|..| |+..+-.+....|... ..
T Consensus 224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP--FYadslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP--FYADSLVETYGKIMNHKESL 300 (1317)
T ss_pred hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc--chHHHHHHHHHHHhchhhhc
Confidence 6553321 22345699999999999962 5689999999999999999999999 7777777777777665 44
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC---HHHHHHH--h-----hh
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT---MNDVVSM--L-----TN 321 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~il~~--L-----~~ 321 (354)
.+|.... .+++..+||++.+- +|+.|.. ++++... + ..
T Consensus 301 ~FP~~~~-------------------------------VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 301 SFPDETD-------------------------------VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred CCCcccc-------------------------------cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence 4442221 67788899998664 6788887 8877653 2 23
Q ss_pred hhhhcCCCCCCCcccccccccc
Q 048432 322 EAAALLPPKQPAFSYVRNTVTS 343 (354)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~ 343 (354)
++ ...||..|.++.+.-++..
T Consensus 349 iR-~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 349 IR-ESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred hh-hcCCCCCCcCCCCCccccc
Confidence 44 7778888888876654443
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.72 Aligned_cols=238 Identities=26% Similarity=0.397 Sum_probs=178.3
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------h----HHHH------------HHHHHHhceeecCC
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------G----LREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~----~~~~------------~~i~~~~~~~~~~~ 105 (354)
+|.+.+.||.|++|.||+|... +|+.||+|.+...... . ...+ .+++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5889999999999999999864 5899999988532110 0 0111 25566777888888
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..++|+||+.+++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999887 667788899999999999999999 999999999999999999999999998754
Q ss_pred cCCccccccccccCcccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
.............++..|+|||.+.... ++.++|+||||+++|++++|..||. ..........+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~--- 233 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS--DEEAIAAMFKLGNKRSAPPI--- 233 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc--CcchHHHHHHhhccccCCcC---
Confidence 3322111122345778999999987654 7889999999999999999999953 22222222211111110000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
........+..+.++|.+||..+|++|||++++++.
T Consensus 234 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 ------------------------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ------------------------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111156788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=253.83 Aligned_cols=229 Identities=24% Similarity=0.265 Sum_probs=179.8
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
+|++.+.||.|+||.||+|.+. +++.||+|++..... ..... +.|++++++.+...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999975 589999999965321 11111 2377888888888999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|+.+++|..++ ++...+..++.|++.||.|||.++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 99999999887 667788999999999999999999 99999999999999999999999999876543321
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||.+....++.++|+||+|+++|+|++|..||...... ..............
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 220 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL-------------- 220 (258)
T ss_pred -ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc--------------
Confidence 12245678999999998888899999999999999999999996543322 11111111111111
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH--HHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM--NDVV 316 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~--~~il 316 (354)
.+...+..+.++|.+||+.+|.+||++ +|++
T Consensus 221 -------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 -------------------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------------------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111156788899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=255.50 Aligned_cols=222 Identities=25% Similarity=0.382 Sum_probs=167.0
Q ss_pred ceecccCceeEEEEEEcC--------CCEEEEEEecCCChhhHHH------------HHHHHHHhceeecCCceEEEEEe
Q 048432 54 NKLGEGGFGPVYKGVLKN--------GDEIAVKRLSGRSGQGLRE------------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~--------~~~vavK~~~~~~~~~~~~------------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+.||.|+||.||+|..+. ...|++|.+.......... +.|++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 2348888876543322221 23778888888888899999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC--------eEEeeccccee
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--------PKISDFGIARI 179 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~~l~dfg~a~~ 179 (354)
+.+++|..++ +++..+..++.||+.||+|||+.+ |+|+||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999887 577888899999999999999999 999999999999987765 68999998754
Q ss_pred ccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCcccccchhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGK-KTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++|. .|+ ...+...... ........|
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~--~~~~~~~~~~-~~~~~~~~~--- 225 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL--SALDSQKKLQ-FYEDRHQLP--- 225 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh--hhccHHHHHH-HHHccccCC---
Confidence 3221 123567889999998764 4789999999999999999985 453 2222111111 111111111
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
......+.+||.+||+.+|++|||++++++.|.
T Consensus 226 ------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 ------------------------------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------------------------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 013456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=257.40 Aligned_cols=225 Identities=24% Similarity=0.276 Sum_probs=168.9
Q ss_pred eecccCceeEEEEEEc-CCCEEEEEEecCCChh--h----HHHH------------HHHHHHhceeecCCceEEEEEecC
Q 048432 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--G----LREL------------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 55 ~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~----~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.||+|+||.||++... +++.||+|.+...... . .... .+++.++..+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 5889999988653211 1 0011 123334455667788999999999
Q ss_pred CCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 116 NKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 116 ~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
+++|..++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----c
Confidence 99998887 678889999999999999999999 99999999999999999999999999865433221 1
Q ss_pred cccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...++..|+|||.+.. ..++.++|+||+||++|+|++|..||............... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~---------------- 214 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTV---------------- 214 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcC----------------
Confidence 2357899999998864 55789999999999999999999996433222111111111 000
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
....+...+..+.++|.+||+.||++|| |++++++.
T Consensus 215 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 -------------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -------------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011112567789999999999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=256.19 Aligned_cols=237 Identities=27% Similarity=0.425 Sum_probs=180.0
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhh-----HHH---------HHHHHHHhceeecCCce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG-----LRE---------LKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~-----~~~---------~~~i~~~~~~~~~~~~~ 107 (354)
+....++|++.+.||+|++|.||+|.++. ++.||+|.+....... ..+ +.|++++++++......
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 34566889999999999999999999764 8999999986532111 111 24788899999999999
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
+++|||+.+ ++..+. +++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999854 666555 5677888999999999999997 57 999999999999999999999999998654
Q ss_pred cCCccccccccccCcccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc-CCCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGI----FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY-EFPS 255 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 255 (354)
...... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ..+....+..... ..+.
T Consensus 166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 166 VDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-EFEVLTKILQEEPPSLPP 241 (296)
T ss_pred cCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-HHHHHHHHhcCCCCCCCC
Confidence 332211 1234677899999987553 78899999999999999999999643211 2222222222211 1100
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.. .++..+.+||.+||..+|++|||+++++..
T Consensus 242 ~~-------------------------------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 NE-------------------------------GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-------------------------------CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 145678999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=251.80 Aligned_cols=235 Identities=25% Similarity=0.413 Sum_probs=179.9
Q ss_pred CccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh------hHHH------------HHHHHHHhceeecCCceEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ------GLRE------------LKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~------~~~~------------~~~i~~~~~~~~~~~~~~l 109 (354)
+|+..+.||+|++|.||.+.. .+++.||+|++...... .... +.|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999995 46899999998754310 1111 1267788889999999999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~ 183 (354)
|+||+.+++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999887 567888999999999999999999 99999999999998776 5899999998654432
Q ss_pred cc--ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCcccCC
Q 048432 184 EL--QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 184 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.. ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---------- 227 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC----------
Confidence 11 11122235678999999998888899999999999999999999996432211 111111110000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.....+...++.+.+++.+||..+|++|||+.++++
T Consensus 228 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ---------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011112225678899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=255.25 Aligned_cols=233 Identities=22% Similarity=0.352 Sum_probs=180.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEEec
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
.+|...+.||.|++|.||++..+ +++.+++|++..........+ .|++++++++...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 45677789999999999999964 588999998864432222111 25667777888889999999999
Q ss_pred CCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 115 PNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 115 ~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
.+++|.+++ ++...+..++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 999999887 677888999999999999999999 99999999999999999999999998764433221 112
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..|| ...+.......+....... ...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~--~~~~~~~~~~~~~~~~~~~--~~~------------ 237 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY--FNEPPLQAMKRIRDNLPPK--LKN------------ 237 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCC--cCCCHHHHHHHHHhcCCCC--Ccc------------
Confidence 245788999999998888999999999999999999999995 3333333333332221110 000
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+..+.++|.+||..+|++|||+.++++
T Consensus 238 ----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 ----------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----------------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0014567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=259.30 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=183.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--h----hHHH--------HHHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--Q----GLRE--------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~----~~~~--------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||+|++|.||+|.++ +++.||+|++..... . ...+ +.|++++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999976 588999998864321 1 1111 2266778888888899999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|++++.+..+. ++...+..++.||+.|+.|||..+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~- 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS- 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence 99997777655 568888999999999999999999 999999999999999999999999998765443321
Q ss_pred ccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||++.+. .++.++|+||+|+++|+|++|.+||.. ....+....+.......+............
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG--DSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 11224567889999999887 789999999999999999999998643 222222222222111111110000000000
Q ss_pred chhhhhhhhhcc-ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSIS-SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
... ....... ........+..++..+.+||++||..+|++|||++++++
T Consensus 235 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAG--VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccc--cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000000 000001111124788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=250.76 Aligned_cols=221 Identities=26% Similarity=0.424 Sum_probs=166.7
Q ss_pred ceecccCceeEEEEEEcCCC-----------EEEEEEecCCChh--h-HHH--------HHHHHHHhceeecCCceEEEE
Q 048432 54 NKLGEGGFGPVYKGVLKNGD-----------EIAVKRLSGRSGQ--G-LRE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~~~-----------~vavK~~~~~~~~--~-~~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
+.||+|+||.||+|.+++.. .+++|++...... . .++ +.|++++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999976432 5788887654432 1 111 2377778888877 7789999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-------CeEEeecccce
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-------NPKISDFGIAR 178 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~~l~dfg~a~ 178 (354)
||+++++|..++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++ .++|+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999887 467788999999999999999999 99999999999999887 79999999987
Q ss_pred eccCCccccccccccCcccccCccccccC--CCCchhhHHHHHHHHHHHHhC-CCCCCcccccchhhhhhhhccccCCCC
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGVLLLKIVSG-KKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
..... ....++..|+|||++.+. .++.++|+||||+++|+|++| ..||.... ......... .....+.
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~-~~~~~~~ 227 (259)
T cd05037 157 TVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQ-DQHRLPM 227 (259)
T ss_pred ccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHh-cCCCCCC
Confidence 54331 123456789999998876 689999999999999999994 66643221 111111110 0000000
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
. ....+.++|.+||..+|++|||+.++++.|+
T Consensus 228 ~---------------------------------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 228 P---------------------------------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C---------------------------------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 1257789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=251.79 Aligned_cols=234 Identities=28% Similarity=0.395 Sum_probs=183.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||.|++|.||+|.++ +++.|++|++..... .....+. +++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999976 499999999877643 2222222 445566778888999999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+++++|.+++ ++...+..++.|++.++.+||+ .+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999998 5788899999999999999999 99 9999999999999999999999999987554333221
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-cchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
....++..|+|||.+....++.++|+||||+++|+|++|..||..... ...+....+......
T Consensus 158 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 221 (264)
T cd06623 158 --NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-------------- 221 (264)
T ss_pred --cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC--------------
Confidence 123567899999999888889999999999999999999999644331 222222222211110
Q ss_pred chhhhhhhhhccccCCchhHHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCL-CILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+.. .+..+.++|.+||+.+|++|||+.++++.
T Consensus 222 ------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00111 46678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=254.30 Aligned_cols=232 Identities=25% Similarity=0.421 Sum_probs=179.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+-|++.+.||.|+||.||+|.+. ++..||+|++..... .....+. |++++++.+...+..++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45889999999999999999864 688999999865432 1112222 445566777888899999999
Q ss_pred cCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 114 MPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 114 ~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++++|..++ +++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++++|||++......... .
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~ 158 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--R 158 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh--h
Confidence 9999999887 678889999999999999999999 999999999999999999999999998654432211 1
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....++..|+|||.+.+..++.++|+||+||++|+|++|..||.. .........+.....+ .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~--~-------------- 220 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE--LHPMKVLFLIPKNNPP--T-------------- 220 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc--cchHHHHHHHhcCCCC--C--------------
Confidence 223567889999999888889999999999999999999999532 2222222222111110 0
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.....+..+.+++.+||..+|++||++.++++.
T Consensus 221 ----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ----------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011156678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=266.56 Aligned_cols=237 Identities=25% Similarity=0.407 Sum_probs=194.1
Q ss_pred CccccceecccCceeEEEEEEcC---CC--EEEEEEecCCChhhH-H------------HHHHHHHHhceeecCCceEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKN---GD--EIAVKRLSGRSGQGL-R------------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~---~~--~vavK~~~~~~~~~~-~------------~~~~i~~~~~~~~~~~~~~lv 110 (354)
.-.+.+.||.|.||.||.|.+.+ |. .||||..+.+..... + .+.||++++++|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34457889999999999999542 33 488998877433221 1 23499999999986 558999
Q ss_pred EEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 111 YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 111 ~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
||.++-|.|..++ ++..+....+.||+.||+|||+.. +|||||..+||||....-+||+|||+++......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999998 677788899999999999999999 9999999999999999999999999998776654
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.-... .-.-.+-|+|||-+.-..++.++|+|-||+++||++. |..| |.+..+.+.+..+.++..
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkP--fqgvkNsDVI~~iEnGeR------------ 610 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKP--FQGVKNSDVIGHIENGER------------ 610 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCc--cccccccceEEEecCCCC------------
Confidence 32222 1233568999999999999999999999999999976 8889 666666677776665553
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..+|++||+.++.||.+||.++|.+||++.+|...|.++.-
T Consensus 611 --------------------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 --------------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --------------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 33444599999999999999999999999999999988654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=255.53 Aligned_cols=222 Identities=22% Similarity=0.323 Sum_probs=165.0
Q ss_pred ceecccCceeEEEEEEcC-------------------------CCEEEEEEecCCChhhHHH------------HHHHHH
Q 048432 54 NKLGEGGFGPVYKGVLKN-------------------------GDEIAVKRLSGRSGQGLRE------------LKNKLR 96 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~-------------------------~~~vavK~~~~~~~~~~~~------------~~~i~~ 96 (354)
..||+|+||.||+|.... ...|++|++.......... +.|+++
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 369999999999997421 2358899886543322111 236777
Q ss_pred HhceeecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---
Q 048432 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM--- 167 (354)
Q Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--- 167 (354)
+++++...+..++||||+++++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 888888889999999999999998887 567888999999999999999999 99999999999997643
Q ss_pred ----CeEEeecccceeccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCcccccchh
Q 048432 168 ----NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIV-SGKKTTGFYRTYSFT 241 (354)
Q Consensus 168 ----~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll-~g~~p~~~~~~~~~~ 241 (354)
.++++|||++....... ...++..|+|||.+.+ ..++.++|+|||||++|+++ +|..||.. ....+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--~~~~~ 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE--RTPSE 229 (274)
T ss_pred CccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc--cChHH
Confidence 37999999875432211 1245678999998865 45799999999999999995 68888532 22221
Q ss_pred hhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
...... .....+. ...+.+.++|.+||+.+|++|||++++++.|+
T Consensus 230 ~~~~~~-~~~~~~~---------------------------------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYE-KKHRLPE---------------------------------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH-hccCCCC---------------------------------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111 0000100 02345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=255.97 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=177.1
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh---HHH---------HHHHHHHhceeecC--CceEEEEE
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG---LRE---------LKNKLRLLGCCIDK--DEKILIYE 112 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~---~~~---------~~~i~~~~~~~~~~--~~~~lv~e 112 (354)
|++.+.||+|++|.||+|..+ +++.||+|++..... .. ..+ +.|++++++++.+. +.+++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 778999999999999999965 588999999865321 11 111 23667788888877 88999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+.+ ++.+.+ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9976 665555 578889999999999999999999 999999999999999 99999999998754332211
Q ss_pred cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
....++..|+|||.+.. ..++.++|+||+||++|+|++|.+|| ...+..+....+.......+...........
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF--PGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC--CCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12346789999997654 45788999999999999999999995 3333333333332222211110000000000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.... .................+..+.+||.+||+.+|++|||+++++..
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNY----NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccc----cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 000000000011122367899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=258.25 Aligned_cols=178 Identities=26% Similarity=0.452 Sum_probs=136.8
Q ss_pred cceecccCceeEEEEEEc---CCCEEEEEEecCCChh--hHHHH--------HHHHHHhceee--cCCceEEEEEecCCC
Q 048432 53 ANKLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ--GLREL--------KNKLRLLGCCI--DKDEKILIYEYMPNK 117 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~--~~~~~--------~~i~~~~~~~~--~~~~~~lv~e~~~~~ 117 (354)
.+.||+|+||.||+|+.+ .+..||+|.+...... ..++. .|++++++++. .+...++++||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 468999999999999965 3578999998754321 11111 25566666663 35678899999876
Q ss_pred CHhHHH--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCCeEEeeccccee
Q 048432 118 SLDFFL--------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGIARI 179 (354)
Q Consensus 118 ~L~~~~--------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~~l~dfg~a~~ 179 (354)
+|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 554443 456678899999999999999999 9999999999999 5667899999999976
Q ss_pred ccCCcc-ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Q 048432 180 CRGNEL-QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGF 234 (354)
Q Consensus 180 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~ 234 (354)
...... ........++..|+|||++.+. .++.++||||+||++|+|++|.+||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 543321 1112234678899999998764 478999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=255.05 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=178.9
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||.|++|.||+|.++ +|+.||+|.+...... ...+ +.|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999975 5899999988643211 1111 23777888899999999999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+. ++|..++ +++..+..++.|++.||+|||..+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 4777665 567889999999999999999999 999999999999999999999999998654332211
Q ss_pred cccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||. ..+.......+.+.....+...++.....
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T cd07860 157 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP--GDSEIDQLFRIFRTLGTPDEVVWPGVTSL- 231 (284)
T ss_pred --cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC--CCCHHHHHHHHHHHhCCCChhhhhhhhHH-
Confidence 11224577899999887654 5889999999999999999999964 33322222222221111111110000000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+..................+..+..+.++|.+||+.||++|||++++++
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 ---PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ---HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000111112235667889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=259.51 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=181.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecC--CceE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDK--DEKI 108 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~--~~~~ 108 (354)
..++|++.+.||.|++|.||+|.++ +|+.||+|++...... ...++ .|++++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4578999999999999999999975 5899999998643211 11121 2556667776544 5689
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+||||+.+ +|..++ +++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999975 676665 578888999999999999999999 99999999999999999999999999876543
Q ss_pred CccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+|| ...+..+....+...........+...
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL--PGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 3211 112234678999998865 45789999999999999999999995 444544444444433222222111111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.......... ...... ..........++.+.++|.+||+.||++|||+++++..
T Consensus 237 ~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFT--LPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hccccccccc--ccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1100000000 000000 00000011136677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=256.68 Aligned_cols=235 Identities=28% Similarity=0.414 Sum_probs=173.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHH----H---------HHHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLR----E---------LKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~----~---------~~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|+..+.||+|+||.||++.+. +++.||+|.+...... ... + +.|++++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778899999999999999965 5899999998754321 111 1 1256677788888888999999
Q ss_pred ecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 113 YMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 113 ~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
|+.. ++..+. +++..+..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9865 443322 56678899999999999999975 7 9999999999999999999999999986543
Q ss_pred CCccccccccccCcccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQG---IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... ....++..|+|||++.+. .++.++|+||+||++|+|++|+.||..... ..+....+.... .+....
T Consensus 160 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~~~ 233 (288)
T cd06616 160 DSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVKGD--PPILSN 233 (288)
T ss_pred cCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcCCC--CCcCCC
Confidence 32211 123567889999998766 588999999999999999999999754331 111111111111 111100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.....++..+.+||.+||+.+|++|||+++|++.
T Consensus 234 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 --------------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --------------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001156778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=245.52 Aligned_cols=233 Identities=28% Similarity=0.371 Sum_probs=190.9
Q ss_pred cceecccCceeEEEEE-EcCCCEEEEEEecCCChhhHH-------------HHHHHHHHhceeecCCceEEEEEecCCCC
Q 048432 53 ANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLR-------------ELKNKLRLLGCCIDKDEKILIYEYMPNKS 118 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~~~~-------------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (354)
.+.||+|+|+.|--+. ..+|..||||++.+....... .++||++++++|.++...|+|||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5789999999999888 568999999999876544322 23499999999999999999999999999
Q ss_pred HhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC---eEEeecccceeccCCc-c----
Q 048432 119 LDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGIARICRGNE-L---- 185 (354)
Q Consensus 119 L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~~l~dfg~a~~~~~~~-~---- 185 (354)
|...+ |++..+.++..+|+.||.|||.+| |.||||||+|||-..... +||+||.+........ .
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 98887 889999999999999999999999 999999999999976554 7999999875322111 1
Q ss_pred ccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-------------chhhhhhhh
Q 048432 186 QANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-------------SFTLLGYIS 247 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-------------~~~~~~~~~ 247 (354)
...-...+|+..|+|||+.. ...|+.++|.||||+++|-|++|.+||...... ...+...|+
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 11112357888999999873 234899999999999999999999997433222 245677799
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+.+.+|...|.. .+.+..++|..+|..++.+|.++.+++.
T Consensus 320 EGkYeFPdkdWah-----------------------------IS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYEFPDKDWAH-----------------------------ISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCcCChhhhHH-----------------------------hhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 9999999877654 5667789999999999999999999887
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=254.53 Aligned_cols=231 Identities=23% Similarity=0.423 Sum_probs=175.7
Q ss_pred CccccceecccCceeEEEEEE-cCCCEEEEEEecCCCh-hhHHH---------------HHHHHHHhceeecCCceEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSG-QGLRE---------------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~-~~~~~---------------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
.|++.+.||.|+||.||+|.+ .+++.||+|.+..... ..... +.+++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999996 4689999999865422 11111 123445566677788899999
Q ss_pred EecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 112 EYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 112 e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
||+++++|.+++ +++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 999999999887 678889999999999999999999 99999999999999999999999999876544331
Q ss_pred ccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||.+.++ .++.++|+||||+++|+|++|..||.. .........+... ..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~--~~~~~~~~~~~~~--~~~~~~~-------- 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD--VDAFRAMMLIPKS--KPPRLED-------- 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC--CChhhhhhccccC--CCCCCCc--------
Confidence 12224578899999988654 468899999999999999999999642 2221111111111 0000000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+.++|.+||+.+|++||++.++++
T Consensus 225 ---------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 ---------------------NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---------------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 003567889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=252.82 Aligned_cols=232 Identities=28% Similarity=0.386 Sum_probs=182.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH-------------HHHHHHHhceeecCCceEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE-------------LKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~-------------~~~i~~~~~~~~~~~~~~lv 110 (354)
++|++.+.||+|++|.||+|..+ +|+.||+|++..... ..... +.|++++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999965 699999999865321 11111 33677788888888999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||++.+++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999888 688899999999999999999999 99999999999999999999999999875543321
Q ss_pred c------------------cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhh
Q 048432 186 Q------------------ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 186 ~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 247 (354)
. .......++..|++||.+....++.++|+||||++++++++|..||.. .+.....+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~ 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG--SNEYLTFQKIL 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC--ccHHHHHHHHH
Confidence 1 112223567899999998888889999999999999999999999543 33222233322
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH----HHHHH
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM----NDVVS 317 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~~il~ 317 (354)
......+. ..++.+.++|.+||+.+|++|||+ +++++
T Consensus 236 ~~~~~~~~---------------------------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KLEYSFPP---------------------------------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hcCCCCCC---------------------------------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 21111111 146678899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=249.26 Aligned_cols=231 Identities=23% Similarity=0.351 Sum_probs=179.7
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh----HHH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG----LRE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~----~~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|.+.+.||.|++|.||++..+ +|..||+|.+..... .. ..+ +.|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999975 488999999865311 11 111 23778888899999999999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC-eEEeecccceeccCCcc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-PKISDFGIARICRGNEL 185 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-~~l~dfg~a~~~~~~~~ 185 (354)
+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++. ++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999998887 467889999999999999999999 999999999999998864 69999998875543221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
. .....++..|+|||.+.+..++.++|+||+|+++|++++|..||. ..+.......+...... ..
T Consensus 158 ~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~--~~--------- 222 (257)
T cd08225 158 L--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE--GNNLHQLVLKICQGYFA--PI--------- 222 (257)
T ss_pred c--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC--CccHHHHHHHHhcccCC--CC---------
Confidence 1 112357889999999988889999999999999999999999953 33322222222211110 00
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+..+..+.++|.+||..+|++|||++++++.
T Consensus 223 ---------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ---------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01145678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=257.18 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=178.7
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHH--------HHHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLRE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||.|++|.||+|..+ +++.||+|.+...... ...+ +.|++++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 3578999999999999999999976 5899999998643211 1112 236677888888899999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+ +|..++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 99986 787776 567889999999999999999999 99999999999999999999999999864322111
Q ss_pred ccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||..... ..+....+.+.........+......
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-VEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1112245778999998875 4578999999999999999999999643321 22222222222111111111110000
Q ss_pred c-cchhhhhhhhhccccCCchhHHHHH--HHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 G-FLHLTIFKLFSISSVGLSNDIVCLC--ILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~-~~d~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. .... . ................ ...+.+++.+||+.+|++|||+++++.
T Consensus 236 ~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPY---S-FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccc---c-ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000 0 0000000000000001 256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=261.10 Aligned_cols=269 Identities=21% Similarity=0.288 Sum_probs=182.9
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HH----H--------HHHHHHHhceeecC-----Cc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LR----E--------LKNKLRLLGCCIDK-----DE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~----~--------~~~i~~~~~~~~~~-----~~ 106 (354)
..++|++.+.||+|++|.||+|.+. +|+.||+|.+....... .. + +.|++++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4579999999999999999999964 58999999986432211 11 1 12556666665433 35
Q ss_pred eEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 107 KILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
.++++||+.+ ++...+ +++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 7999999976 666665 678889999999999999999999 99999999999999999999999999875433
Q ss_pred Ccccc-ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 183 NELQA-NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 183 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|++||. +.+.......+.......+......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP--GKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 22111 1122457889999998754 458899999999999999999999963 3332222222222111111100000
Q ss_pred ccccccchhhhhhhhh---ccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhhh
Q 048432 261 VKTFGFLHLTIFKLFS---ISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAA 325 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~~ 325 (354)
..+........ ...........+..+..+.++|.+||+.+|++|||+.++++. |++....
T Consensus 237 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 -----IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred -----hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000000000 000000011112246778999999999999999999999987 7766643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.13 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=179.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------HHHH--------HHHHHHhceeecC--CceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LREL--------KNKLRLLGCCIDK--DEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------~~~~--------~~i~~~~~~~~~~--~~~~l 109 (354)
.++|++.+.||.|++|.||+|.++ +++.+++|.+....... .+++ .|++++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999976 58899999986432211 1121 2555566666666 88999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
|+||+.+ +|..++ +++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999975 777766 578889999999999999999999 999999999999999999999999998765443
Q ss_pred ccccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|.+||.. ....+....+...........++.+.
T Consensus 160 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG--KSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHHHhCCCchHHHHHhh
Confidence 211 12235678899999887654 68899999999999999999999543 33333333322221111111110000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCL-CILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....... ..............++.. .++.+.++|.+||+.+|++|||++|+++.
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKK--KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcc--cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 000000000001111111 36778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=247.26 Aligned_cols=229 Identities=27% Similarity=0.337 Sum_probs=180.9
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhH----HH--------HHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGL----RE--------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~----~~--------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||.|++|.||++.++ +++.+++|.+..... ... .+ +.|++++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999865 588999999865321 111 11 12677788888888999999999
Q ss_pred cCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
+++++|..++ +++..+..++.|++.||.+||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999998876 456778899999999999999999 9999999999999999999999999987654431
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.....++..|++||.+.+..++.++|+||+|+++|+|++|+.||. ..+.......+......
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~--~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--ARSMQDLRYKVQRGKYP------------ 219 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHhcCCCC------------
Confidence 112356789999999988889999999999999999999999953 33332222222221111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 220 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 --------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111267778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=249.33 Aligned_cols=233 Identities=24% Similarity=0.320 Sum_probs=172.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC-----hhhHHHHH------------HHHHHhceeec--CCce
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS-----GQGLRELK------------NKLRLLGCCID--KDEK 107 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~-----~~~~~~~~------------~i~~~~~~~~~--~~~~ 107 (354)
.+|++.+.||+|+||.||.+.+. +|..||+|.+.... ......+. +++++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999965 48999999885322 11122222 33445555544 3467
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++++||+++++|.+++ ++......++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999887 466778899999999999999999 99999999999999999999999998875432
Q ss_pred Cccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.. ...............
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~--~~~~~~~~~~~~~~~---------- 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE--FEAMAAIFKIATQPT---------- 226 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc--cchHHHHHHHhcCCC----------
Confidence 2111 112223578899999999888889999999999999999999999632 221111111111110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+...+..+.+++.+|+. +|++|||+++++.
T Consensus 227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011112256678889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=247.70 Aligned_cols=288 Identities=22% Similarity=0.262 Sum_probs=196.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC-----CCEEEEEEecCC------ChhhHHHH--------HHHHHHhceeec-
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN-----GDEIAVKRLSGR------SGQGLREL--------KNKLRLLGCCID- 103 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~vavK~~~~~------~~~~~~~~--------~~i~~~~~~~~~- 103 (354)
......|++++.||+|.||.||+|..++ ...+|+|.++.. +....+++ +|++.+..++..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3455789999999999999999996432 336899999765 22333332 377788877765
Q ss_pred CCceEEEEEecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC----CCe
Q 048432 104 KDEKILIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD----MNP 169 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~ 169 (354)
+..++++++|++. +|.+.+ ++...+..|+.||+.|+.|||++- |+||||||.||+|..+ |.+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCee
Confidence 8899999999987 565555 566788999999999999999999 9999999999999887 899
Q ss_pred EEeecccceeccCCcc-ccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCccccc-------ch
Q 048432 170 KISDFGIARICRGNEL-QANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-------SF 240 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-------~~ 240 (354)
||+|||+++.+.+.-. .......+-|..|+|||++.+.. |+.+.|+|++|||+.||++-.+.|...... ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999999987765432 22334456789999999998865 899999999999999999998885333222 12
Q ss_pred hhhhhhhccccCCCCcccCCccccccchhhhh--hhhhccccCCchhHHHH--HHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIF--KLFSISSVGLSNDIVCL--CILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
+.+.+|....+......|+..+....-..... +.......++...+-.. -++.-.+|+.++|+.||-+|.|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 23344544455444444443332211100000 00011111111111100 133367899999999999999999998
Q ss_pred HHhhhhhhhcCCCCCCCcc
Q 048432 317 SMLTNEAAALLPPKQPAFS 335 (354)
Q Consensus 317 ~~L~~~~~~~~~~~~~~~~ 335 (354)
+..==...+..|-+...+.
T Consensus 336 eh~yF~~d~lpp~pt~~~v 354 (438)
T KOG0666|consen 336 EHPYFTEDPLPPLPTSDNV 354 (438)
T ss_pred cccccccCCCCCCccccee
Confidence 7643333333333333333
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=245.69 Aligned_cols=238 Identities=24% Similarity=0.398 Sum_probs=179.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHH-HH-------------HHHHHHhceeecCCce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLR-EL-------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~-~~-------------~~i~~~~~~~~~~~~~ 107 (354)
-....++.+.+..||+|..|.||++++++ |...|||.+......+.. ++ ..||+.+++|..+..+
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 35566778889999999999999999764 889999999776443321 11 1455667777777777
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++.||.|.- -.+.++ +++.-.-++...+++||.||..+. +|+|||+||+|||++..|.+|++|||++...-
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 777776532 222222 566667788888999999998765 59999999999999999999999999997655
Q ss_pred CCccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-cchhhhhhhhccccCCCCcc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT-YSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 257 (354)
....+ +...|.+.|+|||.+. ...|+.++|+||||++++||.||..|| .+. .+++.+-.+.+..+ |...
T Consensus 244 dSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy--~~c~tdFe~ltkvln~eP--P~L~ 316 (391)
T KOG0983|consen 244 DSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY--KGCKTDFEVLTKVLNEEP--PLLP 316 (391)
T ss_pred ccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC--CCCCccHHHHHHHHhcCC--CCCC
Confidence 54422 2346889999999985 345899999999999999999999995 433 35666666655333 2211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
. ... .++.+++|+..||..|+.+||...++++.
T Consensus 317 ~-~~g---------------------------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 G-HMG---------------------------FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c-ccC---------------------------cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 000 57788999999999999999999998864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=252.83 Aligned_cols=257 Identities=21% Similarity=0.244 Sum_probs=176.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH---------HHHHHHHhceeecCCc-----
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE---------LKNKLRLLGCCIDKDE----- 106 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~---------~~~i~~~~~~~~~~~~----- 106 (354)
++|++.+.||+|+||.||+|.+. +++.||+|.+...... ...+ +.|++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999965 5899999987643211 1111 1366677777766555
Q ss_pred eEEEEEecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecc
Q 048432 107 KILIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFG 175 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg 175 (354)
.|++|||+++ ++..++ +++..+..++.||+.||.|||..+ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 676665 367788999999999999999999 999999999999998 8899999999
Q ss_pred cceeccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
++......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||. +.+.......+.......+
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP--GDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC--CCCHHHHHHHHHHHhCCCC
Confidence 98754322111 1112457789999988653 47899999999999999999999954 3333332322222211111
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...++........ ...............+..++.+.+||.+||..+|++|||+++++.
T Consensus 233 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDW-----HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccch-----hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1110000000000 000000000011111235778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=256.18 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=176.4
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-----HHHH--------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----LREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-----~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+.++|++.+.||+|+||.||+|... +|+.||+|++....... .++. .|++++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999964 58899999986542211 1121 25566677888888999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+. +++..++ +.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 4665554 356778889999999999999999 99999999999999999999999999865332211
Q ss_pred ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ..+...+++.................
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD-VFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-HHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11223467899999988754 478899999999999999999999643322 22222222221111111100000000
Q ss_pred ccchhhhhhhhhccccCCchh--HHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSND--IVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..... ............. .....+..+.+++.+|++.||++|||++|++.
T Consensus 236 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKP---EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccc---hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 0000000000000 00012567789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=250.57 Aligned_cols=237 Identities=29% Similarity=0.395 Sum_probs=175.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeec--CCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCID--KDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~--~~~~~lv~ 111 (354)
++|...+.||.|++|.||++.++ +++.||+|.+..... .....+. |++++++++.. .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999975 588999999875433 1222222 45556666543 34689999
Q ss_pred EecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
||+++++|.+++ ++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998775 456678899999999999999999 99999999999999999999999999764332
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---cchhhhhhhhccccCCCCcccC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT---YSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
... ....++..|++||.+.+..++.++|+|||||++|+|++|..||..... ...+....+..... +.....
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PELKDE 231 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hhhccC
Confidence 221 123467789999999888899999999999999999999999654322 11122221111100 000000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.......++.+.++|.+||+.+|++|||+.|+++
T Consensus 232 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ------------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ------------------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000014677899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=247.54 Aligned_cols=254 Identities=25% Similarity=0.330 Sum_probs=197.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHHHHH---------------HHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNKL---------------RLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~~i~---------------~~~~~~~~~~~~~ 108 (354)
.-.++|..++.||+|.||.|-+++-+ .|+.+|+|++++.-.-...+..|.+ .+--.++..+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34578999999999999999999965 5999999999876543333333221 1223467889999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||||..||.|...+ |++...+-....|+.||.|||+++ |++||||.+|.+++.+|++||+|||++... -
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--c
Confidence 999999999986555 888888999999999999999999 999999999999999999999999998631 2
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
........++||+.|+|||++....|+.++|.|.+|+++|||++|+.| |+..+...+.+.|.-....+|..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLP--Fyn~dh~kLFeLIl~ed~kFPr~------- 390 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLP--FYNKDHEKLFELILMEDLKFPRT------- 390 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCc--ccccchhHHHHHHHhhhccCCcc-------
Confidence 223334557999999999999999999999999999999999999999 66666556666555444444443
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC--CHHHHHHHhhh-----------hhhhcCCCC
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP--TMNDVVSMLTN-----------EAAALLPPK 330 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp--s~~~il~~L~~-----------~~~~~~~~~ 330 (354)
.+++...|+..+|..||.+|. -.+++.+..+. ...++.||-
T Consensus 391 --------------------------ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 391 --------------------------LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred --------------------------CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 345667899999999999996 33444333222 344667777
Q ss_pred CCCccccc
Q 048432 331 QPAFSYVR 338 (354)
Q Consensus 331 ~~~~~~~~ 338 (354)
-|.+..+.
T Consensus 445 KPqVtSet 452 (516)
T KOG0690|consen 445 KPQVTSET 452 (516)
T ss_pred CCCccccc
Confidence 66665543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=249.30 Aligned_cols=233 Identities=24% Similarity=0.363 Sum_probs=172.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-----hhHHHHH------------HHHHHhceeec--CCce
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----QGLRELK------------NKLRLLGCCID--KDEK 107 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-----~~~~~~~------------~i~~~~~~~~~--~~~~ 107 (354)
.+|++.+.||+|+||.||+|... .+..|++|.+..... .....+. |++++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999965 588999998864321 1111222 44445555543 3567
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++++||+++++|.+++ +++.....++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 8999999999999887 567788899999999999999999 99999999999999999999999999865432
Q ss_pred Ccc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||.. .........+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~--~~~~~~~~~~~~~~~---------- 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE--YEAMAAIFKIATQPT---------- 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc--cchHHHHHHHhcCCC----------
Confidence 111 1111223567899999999888889999999999999999999999532 221111111111000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+..+...++.+.+++ +||..+|++|||++++++
T Consensus 227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0111122456677888 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=252.19 Aligned_cols=223 Identities=26% Similarity=0.297 Sum_probs=169.0
Q ss_pred eecccCceeEEEEEEc-CCCEEEEEEecCCChh--h-----HHH-----------HHHHHHHhceeecCCceEEEEEecC
Q 048432 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--G-----LRE-----------LKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 55 ~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~-----~~~-----------~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.||+|+||.||+|.+. +++.||+|.+...... . ..+ +.+++.+.+.+...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 5889999998654211 0 000 0133445566777888999999999
Q ss_pred CCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 116 NKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 116 ~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
+++|..++ +++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----c
Confidence 99998887 678899999999999999999999 99999999999999999999999999864432221 1
Q ss_pred cccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh-hhccccCCCCcccCCccccccch
Q 048432 191 RIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY-ISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
...++..|+|||.+.++ .++.++|+||+|+++|+|++|..||............. ........
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--------------- 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC---------------
Confidence 23678899999998754 58899999999999999999999964332211111111 11111110
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
+...+..+.+++.+||..+|++|| +++++++
T Consensus 219 ------------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 ------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ------------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111456789999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=256.51 Aligned_cols=268 Identities=22% Similarity=0.270 Sum_probs=188.8
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--h----hHHH--------HHHHHHHhceeecCC-----ceE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--Q----GLRE--------LKNKLRLLGCCIDKD-----EKI 108 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~----~~~~--------~~~i~~~~~~~~~~~-----~~~ 108 (354)
+|++.+.||.|++|.||+|+.. +++.||+|++..... . ...+ +.|++++.+++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999975 489999999875431 1 1111 236777888877665 789
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
++|+|+.+ +|..++ +++..+..++.+|+.||++||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999985 677766 678889999999999999999999 999999999999999999999999998765443
Q ss_pred ccc-cccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 184 ELQ-ANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 184 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+|| ...+..+....+.......+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF--PGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 210 111223567889999999887 7899999999999999999999995 444444444443333222221111100
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA 324 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~ 324 (354)
......+ .. ...............+..+..+.++|.+||+.+|++|||+++++.. |++...
T Consensus 235 ~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARN-YL-KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhh-HH-hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000 00 0000000011111222357789999999999999999999999985 666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.66 Aligned_cols=231 Identities=23% Similarity=0.349 Sum_probs=181.3
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|.+.+.||.|++|.||++.+. +++.|++|++..... .....+ .|++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999965 589999999876432 111111 2556677777788899999999
Q ss_pred cCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
+++++|..++ ++......++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999998877 456788999999999999999999 9999999999999999999999999987654433
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.. .+............... .
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~--~-------- 223 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG--ENLLELALKILKGQYPP--I-------- 223 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC--CcHHHHHHHHhcCCCCC--C--------
Confidence 1 12223578889999999888899999999999999999999999543 33333333322221110 0
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+...+..+.+++.+||..+|++|||+.++++.
T Consensus 224 ----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00156778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=259.58 Aligned_cols=265 Identities=22% Similarity=0.254 Sum_probs=179.5
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHH------------HHHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLREL------------KNKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~------------~~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....... .|++++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999965 68999999986431 1111111 2445555555432
Q ss_pred -CceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 105 -DEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
...++||||+.+ +|...+ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999976 666655 677888899999999999999999 999999999999999999999999999765
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.. .+.......+.......+......
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 169 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG--TDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHHhcCCCCHHHHHH
Confidence 43321 1223567899999999988899999999999999999999999643 332222222222111111100000
Q ss_pred cc--------ccc-cchhhhhhhhh-ccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VK--------TFG-FLHLTIFKLFS-ISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~--------~~~-~~d~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.. ... ........... ..............+..+.++|.+||+.||++|||+.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000 00000000000 000000000011246678999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=250.91 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=178.4
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEEec
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
|++.+.||.|++|.||+|.++ +|..||+|++...... ...+ +.+++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 788999999999999999965 6999999998643211 1111 236678888999999999999999
Q ss_pred CCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 115 PNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 115 ~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
. ++|..++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 5787776 567888999999999999999999 999999999999999999999999998654322211
Q ss_pred ccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||++.+. .++.++|+||||+++|+|++|.+||. ..+.......+.+.........+......
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP--GDSEIDQLFRIFRTLGTPDEDVWPGVTSL-- 230 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHhCCCChHHhhhhhhc--
Confidence 1122457789999988664 46889999999999999999999953 33322222222222111111110000000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+..................+..+..+.++|.+||+.+|++|||++++++
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 --PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred --hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000111112225578889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=245.38 Aligned_cols=231 Identities=28% Similarity=0.450 Sum_probs=179.3
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEEecC
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.|.+.+.||+|++|.||++.++ +++.+++|++..........+. +++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4888999999999999999975 6889999999776543333333 33345566777788999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++|.+++ +++..+..++.|++.++.+||..+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999887 577888999999999999999999 99999999999999999999999999876544332 2
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....++..|++||.+.+..++.++|+||||+++|+|++|..||... +.......+.. ...+....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~--~~~~~~~~----------- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL--PPMKALFKIAT--NGPPGLRN----------- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--chHHHHHHHHh--cCCCCcCc-----------
Confidence 2345678999999998888899999999999999999999995432 21122111111 10111000
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+..+.++|.+||+.+|++|||+.++++
T Consensus 220 -----------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -----------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -----------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0003667899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.34 Aligned_cols=229 Identities=24% Similarity=0.342 Sum_probs=177.2
Q ss_pred ecccCceeEEEEEEcC-CCEEEEEEecCCChh---hHHH------------HHHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ---GLRE------------LKNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~---~~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||.|++|.||++.+.. |+.|++|++...... .... +.|++++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 999999998765331 1111 23778888888889999999999999999
Q ss_pred hHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc------ccc
Q 048432 120 DFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL------QAN 188 (354)
Q Consensus 120 ~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~------~~~ 188 (354)
..++ +++..+..++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 8887 577888999999999999999999 99999999999999999999999999865433211 011
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
.....++..|++||.+.....+.++|+||||+++|+|++|..||. ..........+..+....+...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~----------- 224 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH--GETPEEIFQNILNGKIEWPEDV----------- 224 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHhcCCcCCCccc-----------
Confidence 223456778999999988888999999999999999999999953 3333333433333222211110
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
..+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus 225 --------------------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 --------------------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --------------------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 03677889999999999999999955555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=248.53 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=182.2
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEEec
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
|.+.+.||.|++|.||+|... +++.+++|.+...... ...+ +.+++++++++......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999965 6899999998654322 1111 126677888888889999999999
Q ss_pred CCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 115 PNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 115 ~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
.+ ++.+.+ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 76 666665 567888999999999999999999 99999999999999999999999999876544331 1
Q ss_pred cccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|| ...+..+....+...........+.......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF--PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA-- 230 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHcCCCchHhcccchhhh--
Confidence 1223467789999998776 6899999999999999999999885 3333333333322221111111111000000
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...................+..+..+.++|.+||+.+|.+||++.+++.
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 -RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred -hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000001112233447889999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=252.75 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=180.2
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHH--------HHHHHHHhceeecCCceEEEEEec
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLRE--------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~--------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
+|++.+.||.|++|.||+|.++ +|+.||+|++...... ...+ +.|++++++.+...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999975 5889999998654321 1111 126677888888889999999999
Q ss_pred CCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 115 PNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 115 ~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
.+ +|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 86 676665 577888999999999999999999 99999999999999999999999999865433221
Q ss_pred cccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
......++..|++||.+.+. .++.++|+||||+++|+|++|..||. +.+..+....+...................
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP--GTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 11223457889999988664 46889999999999999999999953 333333333322221111110000000000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.... ..............+..+..+.+++.+||+.+|++|||+.++++
T Consensus 233 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKP----TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcc----cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00000000011222345788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.57 Aligned_cols=234 Identities=27% Similarity=0.410 Sum_probs=181.9
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecC--CceEEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDK--DEKILIY 111 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~--~~~~lv~ 111 (354)
+|.+.+.||+|++|.||+|... +++.|++|++..... .....+. +++++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999999999999976 689999999876552 2222222 444555666666 7899999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+.+++|.+++ +++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999987 678889999999999999999999 999999999999999999999999998766554431
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.......++..|.+||.+.+...+.++|+||||+++|+|++|..||.... +.......+.....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~--------------- 221 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGE--------------- 221 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCC---------------
Confidence 11223457889999999988889999999999999999999999965443 11111111111000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+...+..+.++|.+||+.+|++|||+.+++.
T Consensus 222 ----------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 ----------------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----------------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111124678899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=248.47 Aligned_cols=225 Identities=25% Similarity=0.333 Sum_probs=174.8
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||.|++|.||+|... +++.||+|++...... ....+ .|++++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 4899999998654321 11112 2556677788888899999999999999
Q ss_pred hHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccC
Q 048432 120 DFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194 (354)
Q Consensus 120 ~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 194 (354)
.+++ ++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 9887 577888999999999999999999 9999999999999999999999999987654432 1122356
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhh
Q 048432 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKL 274 (354)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 274 (354)
+..|++||.+.+..++.++|+||+|+++|+|++|..||.....+.......+..+.....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------- 214 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE-------------------- 214 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--------------------
Confidence 789999999888888999999999999999999999965443323333333321111110
Q ss_pred hhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 048432 275 FSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVS 317 (354)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~ 317 (354)
.+...+..+.++|.+||..+|++||+ ++|+++
T Consensus 215 -----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 -----------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -----------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11114667899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.34 Aligned_cols=232 Identities=22% Similarity=0.323 Sum_probs=179.4
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEEecC
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.|+....||+|++|.||++..+ +++.||+|++..........+ .|++++++.+...+..+++|||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3445678999999999999964 689999999865433222111 277888888888999999999999
Q ss_pred CCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 116 NKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 116 ~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
+++|.+++ +++..+..++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 99998887 678889999999999999999999 99999999999999999999999998765433221 1223
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 271 (354)
..++..|++||.+.+..++.++|+||+|+++|+|++|..||. ..........+......... .
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~--~~~~~~~~~~~~~~~~~~~~-~-------------- 238 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKAMKMIRDNLPPKLK-N-------------- 238 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHhhCCcccC-C--------------
Confidence 457789999999888888999999999999999999999953 33322222222211110000 0
Q ss_pred hhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+..+.+++.+||..+|.+||++.++++
T Consensus 239 ---------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 ---------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0014566789999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=255.75 Aligned_cols=183 Identities=26% Similarity=0.417 Sum_probs=145.6
Q ss_pred CccccceecccCceeEEEEEEcC---CCEEEEEEecCCC---h----hhHHH--------HHHHHHHhceeecC--CceE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKN---GDEIAVKRLSGRS---G----QGLRE--------LKNKLRLLGCCIDK--DEKI 108 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~---~~~vavK~~~~~~---~----~~~~~--------~~~i~~~~~~~~~~--~~~~ 108 (354)
+|++.+.||+|++|.||+|..+. ++.||+|.+.... . ...++ +.|++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999654 7899999997632 1 11112 23677888888877 7899
Q ss_pred EEEEecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC----CCCeEEeec
Q 048432 109 LIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK----DMNPKISDF 174 (354)
Q Consensus 109 lv~e~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~~l~df 174 (354)
+||||+.+ ++...+ ++...+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 454443 456778899999999999999999 999999999999999 999999999
Q ss_pred ccceeccCCcc-ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 048432 175 GIARICRGNEL-QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFY 235 (354)
Q Consensus 175 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~ 235 (354)
|++........ ........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99876543322 1112234567889999988764 4789999999999999999999996433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=251.81 Aligned_cols=237 Identities=25% Similarity=0.408 Sum_probs=183.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
.....+.|++.+.||.|++|.||+|.++ .++.|++|++..... ....+ .|++++++.+...+..++
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567788999999999999999999976 588999999976553 11111 144556677788899999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
++||+++++|.+++ +++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999987 566788999999999999999999 999999999999999999999999987644322
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. ......++..|++||.+.+..++.++|+||||+++|+|++|..||.. .........+..... +...
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~--~~~~~~~~~~~~~~~--~~~~------ 237 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR--EPPLRALFLITTKGI--PPLK------ 237 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcCC--CCCc------
Confidence 21 11223467789999999888889999999999999999999999543 222222222211111 0000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....++..+.++|.+||+.+|.+|||+.++++
T Consensus 238 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ----------------------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----------------------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00114567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=254.32 Aligned_cols=231 Identities=28% Similarity=0.464 Sum_probs=175.2
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.....|++.+.||+|++|.||+|... +++.||+|++..... .....+. |++++.+++...+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34467999999999999999999965 589999999864322 1111222 4455667778888899
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+|+||+.+ ++.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99999975 555544 577888999999999999999999 99999999999999999999999998865432
Q ss_pred CccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.. ...++..|+|||++. ...++.++|+||||+++|+|++|..|| ...+.......+..... +...
T Consensus 168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~--~~~~~~~~~~~~~~~~~--~~~~-- 235 (307)
T cd06607 168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNDS--PTLS-- 235 (307)
T ss_pred CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCC--CCccHHHHHHHHhcCCC--CCCC--
Confidence 21 235677899999874 355788999999999999999999995 33333332222221110 0000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...++..+.++|.+||..+|++|||+.+++..
T Consensus 236 ---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 ---------------------------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---------------------------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01156678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=258.03 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=182.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---h---hHHH--------HHHHHHHhceeecC-----C
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---Q---GLRE--------LKNKLRLLGCCIDK-----D 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~---~~~~--------~~~i~~~~~~~~~~-----~ 105 (354)
..++|.+.+.||.|+||.||+|.+. +++.||+|.+..... . ...+ +.|++++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3568999999999999999999964 589999999864311 1 1111 23666777766533 3
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..++++||+. ++|..++ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 5899999996 5777766 678889999999999999999999 999999999999999999999999998755
Q ss_pred cCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... .......++..|+|||.+.. ..++.++|+|||||++|+|++|++||.. .+.......+.......+.....
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG--KDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC--CChHHHHHHHHHHhCCCChHHhh
Confidence 4332 11122356789999998865 4588999999999999999999999643 22222222222111111110000
Q ss_pred Cccccccchhhhhhhhhcc---ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSIS---SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA 324 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~ 324 (354)
. ..+.......... .........+.+++.+.++|.+||+.+|++|||++++++. |+.+..
T Consensus 235 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 235 F-----IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred h-----cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0 0000000000000 0000011123367788999999999999999999999987 666543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=255.51 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=178.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCC--
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKD-- 105 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~-- 105 (354)
+....++|++.+.||+|++|.||+|..+ +++.||+|.+...... ...+ +.+++++++++...+
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3445678999999999999999999965 5899999988543211 1111 125666777665443
Q ss_pred ------ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 106 ------EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 106 ------~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
..++|+||+.+ ++...+ +++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 45999999976 666654 578889999999999999999999 99999999999999999999999
Q ss_pred cccceeccCCccc--cccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 174 FGIARICRGNELQ--ANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 174 fg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
||++......... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|.+||. ..+.......+....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~--~~~~~~~~~~~~~~~ 240 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ--GNTEQHQLTLISQLC 240 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHh
Confidence 9998754432211 1112235677899999886654 6889999999999999999999853 333333333322222
Q ss_pred cCCCCcccCCccccccch------hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 251 YEFPSVDTHNVKTFGFLH------LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+....+........+ ........... .......+.+||.+||..||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-------~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK-------PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcc-------cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 222221111111000000 00000000000 0002456679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=244.08 Aligned_cols=230 Identities=28% Similarity=0.425 Sum_probs=179.8
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+. +++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999965 588999999977653 2222332 334455667778889999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
+.+++|.+++ +++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 9999999887 678888999999999999999999 999999999999999999999999998765543321
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
.....++..|++||.+.+..++.++|+|++|+++|+|++|..||.. .............. .+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~--~~-------------- 217 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD--LNPMAALFRIVQDD--HP-------------- 217 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC--ccHHHHHHHHhccC--CC--------------
Confidence 1223567899999998887789999999999999999999999532 22222221111111 00
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 218 ----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 ----------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 011114677889999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.24 Aligned_cols=257 Identities=24% Similarity=0.297 Sum_probs=178.9
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHH---------HHHHHHHhceeecCCceEEEEEec
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLRE---------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~---------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
|++.+.||.|++|.||+|... +++.|++|.+...... ..++ +.+++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 788999999999999999975 4888999998654221 1111 347788888888899999999999
Q ss_pred CCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 115 PNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 115 ~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+++|.+.+ +++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 67887665 467888999999999999999999 999999999999999999999999998754432211
Q ss_pred ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
....++..|+|||++.+ ..++.++|+||||+++|+|++|++||... ...+....+...........+.... .
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---~ 228 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS--SEIDQLYKICSVLGTPTKQDWPEGY---K 228 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC--ChHHHHHHHHHhcCCCChhhhhhHh---h
Confidence 12356788999998854 44789999999999999999999985333 3222222222222111111000000 0
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+...................+..+..+.++|++||+.+|++|||++|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000000011111235778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=271.90 Aligned_cols=267 Identities=19% Similarity=0.199 Sum_probs=171.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC--CCEEEEE------------------EecCCChh---hHH--------HHH
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN--GDEIAVK------------------RLSGRSGQ---GLR--------ELK 92 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~--~~~vavK------------------~~~~~~~~---~~~--------~~~ 92 (354)
....++|++++.||+|+||.||++..+. +..++.| .+...... ..+ .+.
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 4456899999999999999999987542 2222222 11111100 011 123
Q ss_pred HHHHHhceeecCCceEEEEEecCCCCHhHHHh----------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 048432 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLF----------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL 162 (354)
Q Consensus 93 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 162 (354)
|++++++++...+..|++++++.+ ++..++. ....++.++.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 677788888889999999999865 5555441 23456789999999999999999 999999999999
Q ss_pred EcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCcccccchh
Q 048432 163 LDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT-TGFYRTYSFT 241 (354)
Q Consensus 163 l~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p-~~~~~~~~~~ 241 (354)
++.++.++|+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|..+ +.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999765433211 12235689999999999998999999999999999999998754 3222222222
Q ss_pred hhhhhhccccCCCC-cccCCccccccchhhhhhhhhccccCCchhH-HHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 242 LLGYISENIYEFPS-VDTHNVKTFGFLHLTIFKLFSISSVGLSNDI-VCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+.++......... ........+.+++.. ............. ....+..+.++|.+||++||++|||+.|+++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSA---EIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhh---hcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22222221111100 000000000000000 0000000000000 01135567889999999999999999999863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=264.06 Aligned_cols=229 Identities=21% Similarity=0.222 Sum_probs=186.9
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---------hHHHHHHHHHHhceeecCCceEEEEEecC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---------GLRELKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---------~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
...+|.+...+|.|+|+.|-.+.+. +++..++|++...... ....++|++++.+.+.+....|+|||.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 4678999999999999999888854 6888999999776222 12345699999999999999999999999
Q ss_pred CCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE-cCCCCeEEeecccceeccCCccccccc
Q 048432 116 NKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 116 ~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
|+.+.+.+ .....+..|+.+|+.|+.|||.+| ++||||||+|||+ ++.+.++|+|||.+....... .
T Consensus 400 g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-----~ 471 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-----D 471 (612)
T ss_pred ccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhh-----c
Confidence 99888777 222566789999999999999999 9999999999999 689999999999987554441 1
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
..+-|..|.|||++....++.+||+||||++||+|++|+.||.....+ .++..++..+...
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s------------------ 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFS------------------ 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccc------------------
Confidence 135588999999999889999999999999999999999996433333 4555554433322
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...++..++|+.+||+.||.+|++++++...
T Consensus 533 -----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1167788999999999999999999998764
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=262.76 Aligned_cols=236 Identities=23% Similarity=0.310 Sum_probs=199.8
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH------H--------HHHHHHHHhceeecCCc
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL------R--------ELKNKLRLLGCCIDKDE 106 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~------~--------~~~~i~~~~~~~~~~~~ 106 (354)
.-....+.|.+.+.||+|.|+.|.+|++. .+..||+|.+.+...... + .+.||++++.+......
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 33455678999999999999999999964 599999999976543221 1 12388999999999999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+|+||||+.+|.+.+++ .....++.+..|+.+|++|||++. |+|||||++|++++.+..++|+|||++..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999998 455889999999999999999999 9999999999999999999999999998877
Q ss_pred CCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.+...+. ++|++.|+|||++.+..+ ++.+|+||+|+++|.|+.|.+| |.+.+-.++......+....|...
T Consensus 207 ~~~~lqt---~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLP--FDG~~lk~Lr~rvl~gk~rIp~~m--- 278 (596)
T KOG0586|consen 207 YGLMLQT---FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLP--FDGQNLKELRPRVLRGKYRIPFYM--- 278 (596)
T ss_pred ccccccc---cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccc--cCCcccccccchheeeeeccccee---
Confidence 5554433 589999999999998876 7899999999999999999999 666777777777766666555433
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+.++|+++|..+|.+|++.+++.+.
T Consensus 279 ------------------------------s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 279 ------------------------------SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ------------------------------echhHHHHHHhhccCccccCCHHHhhhh
Confidence 4456789999999999999999998753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=248.78 Aligned_cols=237 Identities=22% Similarity=0.231 Sum_probs=178.9
Q ss_pred CccccceecccCceeEEEEEEc----CCCEEEEEEecCCChhh--------HH---------HHHHHHHHhceeecCCce
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQG--------LR---------ELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~~--------~~---------~~~~i~~~~~~~~~~~~~ 107 (354)
+|++.+.||+|++|.||+++.. ++..||+|++....... .. .+.+++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999843 47889999986432100 01 123677788888888899
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+.+++|..++ +.+..+..++.|++++|.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999998887 567788899999999999999999 99999999999999999999999999865433
Q ss_pred CccccccccccCcccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccCCCCccc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 258 (354)
.... ......++..|++||.+.+.. .+.++|+||+|+++|+|++|..||...+.. ..+....+......
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 230 (288)
T cd05583 158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP------ 230 (288)
T ss_pred cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC------
Confidence 2211 112235688999999887654 688999999999999999999996432211 11111111111111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.+...+..+.+++.+||+.+|++|||+.++.+.|...
T Consensus 231 ---------------------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 231 ---------------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---------------------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111456788999999999999999988887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=250.00 Aligned_cols=261 Identities=26% Similarity=0.339 Sum_probs=191.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH-----------HHHHHHhceeecC----CceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL-----------KNKLRLLGCCIDK----DEKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~-----------~~i~~~~~~~~~~----~~~~lv~ 111 (354)
....++...||+|.||.||+|+.. ++.||||++.....+..... +||+++++.-... ..+++|+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 556788999999999999999985 69999999988776655433 4778887765433 3789999
Q ss_pred EecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcC------CCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 112 EYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYS------RVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 112 e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+|.+.|+|.+++ .+|....+|+..+++||+|||.-- +++|+|||||.+||||.++++..|+|||+|..+.
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999999999 899999999999999999999654 3569999999999999999999999999998776
Q ss_pred CCccccccccccCcccccCccccccCC-C-----CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGI-F-----SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-----~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
.+.........+||..|+|||++.+.- + -.+.||||+|.++|||+++..-+.......+.+.-+ ...+..|.
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe--~evG~hPt 445 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE--AEVGNHPT 445 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh--HHhcCCCC
Confidence 555444444479999999999997642 2 246999999999999998754321111111111111 01111111
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHH-----HHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVC-----LCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.... .....+.+.|+..+. .....+++.+..||..||+.|.|+.=+-+++.++..
T Consensus 446 ~e~m--------------q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEM--------------QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHH--------------HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1100 000011111222111 156778999999999999999999999999998873
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=247.20 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=178.9
Q ss_pred ccccceecccCceeEEEEEEcC-CCEEEEEEecCCChh------hHHH-----------HHHHHHHhceeecCCc-----
Q 048432 50 FSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ------GLRE-----------LKNKLRLLGCCIDKDE----- 106 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~------~~~~-----------~~~i~~~~~~~~~~~~----- 106 (354)
|++.+.||.|++|.||+|.++. ++.||+|++...... ...+ +.+++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7789999999999999999764 899999999643211 1011 1356667777776666
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
++++|||+.+ +|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999976 676665 577889999999999999999999 99999999999999999999999999876
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
....... ....++..|+|||.+.+..++.++|+||+||++|+|++|.+||. .....+....+.+.........++
T Consensus 157 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR--GTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc--CCChHHHHHHHHHHcCCCChHhcC
Confidence 5433211 12246788999999998889999999999999999999998853 343333333332211110000000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.... ..................+..+..+.++|.+||+.||++||++++++.
T Consensus 232 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVS------LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcc------cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 000000000001112222345788899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=252.84 Aligned_cols=236 Identities=28% Similarity=0.439 Sum_probs=178.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..|...+.||+|+||.||+|++. ++..||+|.+..... .....+ .|++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45889999999999999999964 588999999864322 111122 24455667777888899999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+.+ ++.+.+ +++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99976 665555 567888999999999999999999 999999999999999999999999987643322
Q ss_pred ccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 186 QANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
....++..|+|||.+. .+.++.++|+||+||++|+|++|..|| ...........+..........
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~------ 246 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPTLQS------ 246 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCC--CCccHHHHHHHHHhccCCCCCC------
Confidence 1235678899999874 356788999999999999999999995 3333333333332222111000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
...+..+.++|.+||+.+|++||++.++++.+-......
T Consensus 247 -------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 247 -------------------------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -------------------------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 015667899999999999999999999998766555333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=248.02 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=179.7
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hh----hHHH--------HHHHHHHhceeecC--CceEEEEE
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQ----GLRE--------LKNKLRLLGCCIDK--DEKILIYE 112 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~----~~~~--------~~~i~~~~~~~~~~--~~~~lv~e 112 (354)
|++.+.||.|++|.||+|... +++.+|+|++.... .. ...+ +.|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999976 48899999997653 11 1111 12566777888777 88999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+++ +|..++ +++..+..++.||+.||++||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9976 776665 677888999999999999999999 999999999999999999999999998765443311
Q ss_pred cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|| ...+.......+.+.....+...+.......
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF--QGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 1122345778999998765 35789999999999999999999995 3333333333333322222211111111000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.. ... .................++..+.+++++||..+|++|||+.++++
T Consensus 234 ~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WF-ENL-KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hh-hhc-cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 000 000000000000001113778899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=257.01 Aligned_cols=283 Identities=18% Similarity=0.260 Sum_probs=189.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hH----HH--------HHHHHHHhceee----cCCc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GL----RE--------LKNKLRLLGCCI----DKDE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~----~~--------~~~i~~~~~~~~----~~~~ 106 (354)
..++|++.+.||.|++|.||+|..+ +|+.||+|++...... .. .+ +.|++++++++. ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3489999999999999999999965 5999999998654221 11 11 125556666654 3356
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+++|+||+. ++|..++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 899999996 4787776 688899999999999999999999 9999999999999999999999999986543
Q ss_pred CCccc--cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 182 GNELQ--ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 182 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||. +.+.......+....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~--~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP--GKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC--CCChHHHHHHHHHHhCCChhHhh
Confidence 32211 11123467889999998865 457899999999999999999999953 33322222222222221111110
Q ss_pred CCccccccchhhhhhhhhc---cccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhhhcC-CCCCC
Q 048432 259 HNVKTFGFLHLTIFKLFSI---SSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALL-PPKQP 332 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~~~~-~~~~~ 332 (354)
.... .......... ..........+..++.+.++|.+||+.+|++|||+++++.. +++...... +...+
T Consensus 237 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~ 311 (334)
T cd07855 237 NRIG-----SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP 311 (334)
T ss_pred hhhc-----hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCC
Confidence 0000 0000000000 00000111223357889999999999999999999998873 333333222 22335
Q ss_pred Ccccccc
Q 048432 333 AFSYVRN 339 (354)
Q Consensus 333 ~~~~~~~ 339 (354)
+++++..
T Consensus 312 ~~~~~~~ 318 (334)
T cd07855 312 PFDFDFE 318 (334)
T ss_pred CCCCChh
Confidence 5665544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=255.75 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=184.6
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh----HHH--------HHHHHHHhceeecCCc-
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG----LRE--------LKNKLRLLGCCIDKDE- 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~----~~~--------~~~i~~~~~~~~~~~~- 106 (354)
.....++|++.+.||.|++|.||+|++. +++.||+|++..... .. ..+ +.|++++.+++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3445789999999999999999999975 588999999864311 11 111 2366777776665544
Q ss_pred -----eEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 107 -----KILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 107 -----~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.++|+||+ +++|.+++ +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 56888876 788899999999999999999999 999999999999999999999999998
Q ss_pred eeccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||. ..+.......+.......+..
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~--~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP--GSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC--CCChHHHHHHHHHhcCCCCHH
Confidence 754332 122356778999998865 357899999999999999999999953 333333333333322221111
Q ss_pred ccCCccccccchhhhhhhhhccccCCc---hhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLS---NDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
....+. ................ .......++.+.+||.+||+.+|++|||+.+|+.. |.+..
T Consensus 239 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 239 LLQKIS-----SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHhhcc-----chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 111000 0000000000000000 11111246789999999999999999999999873 44444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=248.31 Aligned_cols=261 Identities=17% Similarity=0.174 Sum_probs=170.0
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCCC--hhhHHH------------HHHHHHHhceeecCCceEEEEEecCC
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--GQGLRE------------LKNKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--~~~~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
.+.+.+|.|+++.|+++.. +++.||+|++.... ...... +.|++++++++...+..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444444454444444433 59999999987541 111111 23778888899999999999999999
Q ss_pred CCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc----
Q 048432 117 KSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL---- 185 (354)
Q Consensus 117 ~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~---- 185 (354)
+++..++ ++......++.|++.||.|||+.+ |+|+||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999887 456778899999999999999999 99999999999999999999999998764432111
Q ss_pred -ccccccccCcccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 186 -QANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 186 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
........++..|+|||++.+. .++.++|+||+||++|+|++|..||..... .......+. +....... ....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~-~~~~~ 237 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA-TQMLLEKVR-GTVPCLLD-KSTYP 237 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-ccCccccc-cCchh
Confidence 1111223466789999998763 478899999999999999999999643221 111111111 11100000 00000
Q ss_pred ccc--cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFG--FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~--~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
... ............................+.+|+.+||+.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000000000000011112223356788999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=248.94 Aligned_cols=258 Identities=22% Similarity=0.276 Sum_probs=176.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||.|++|.||+|.++ +|+.||+|.+...... ...++ .|++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999975 5889999998643211 11111 256677788888899999999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccceeccCCc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARICRGNE 184 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a~~~~~~~ 184 (354)
|+++ ++...+ +++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9965 666555 356778899999999999999999 999999999999985 5578999999986543322
Q ss_pred cccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. .....++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||. ..+..+....+...........+.....
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 RT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP--GDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred cc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 11 1123557899999988664 47899999999999999999999954 3333233222221111111111100000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. .+. ................+..++.+.+++.+||+.+|++||++.++++
T Consensus 234 ~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 L--PDY--KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred c--hhh--hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 0000000000001111225667899999999999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=286.26 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=187.0
Q ss_pred hhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhhHH--------HHHHHHHHhceeecCCceEEEEEecC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQGLR--------ELKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~~~--------~~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.....|...+.||+|+||.||+|+. .++..||+|.+......... ++.|++++++++.+.+..++||||++
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 3345678889999999999999996 46899999998654322111 24588999999999999999999999
Q ss_pred CCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccccc
Q 048432 116 NKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193 (354)
Q Consensus 116 ~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~ 193 (354)
+++|.+++ +++..+.+++.|+++|++|||.....+|+||||||+||+++.++..++. |+........ ....
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~ 839 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCF 839 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCcc
Confidence 99999998 7899999999999999999994422339999999999999998877765 5544321111 1125
Q ss_pred CcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhh
Q 048432 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFK 273 (354)
Q Consensus 194 ~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 273 (354)
++..|+|||++.+..++.++||||+||++|||++|+.||..................... ....+.|+..
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~-- 909 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--------HLDMWIDPSI-- 909 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--------chhheeCccc--
Confidence 678999999999888999999999999999999999996322111111111111000000 0000111100
Q ss_pred hhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 274 LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.........+...+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 910 -------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 910 -------RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred -------cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 001112233566788999999999999999999999999998743
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=258.50 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=181.8
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh----------HH---HHHHHHHHhceeecC--Cc
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG----------LR---ELKNKLRLLGCCIDK--DE 106 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~----------~~---~~~~i~~~~~~~~~~--~~ 106 (354)
...++|++.+.||.|+||.||+|.+. +|+.||+|++..... .. .. .+.|++++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678999999999999999999975 588999998854211 00 01 334677778876543 46
Q ss_pred eEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 107 KILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
.++|+||+.+ +|..++ +++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 8999999975 787776 677888899999999999999999 99999999999999999999999999875433
Q ss_pred Cccc---cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 183 NELQ---ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 183 ~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.. ....+....+.......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG--TSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHHHhCCCCHHHH
Confidence 2211 11223457889999998765 4578899999999999999999999643 3322223332222221111000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..... ...+...... ............+..+..+.++|.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKS-PFAATMLDSL-PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHh-hhHHHhhhhc-ccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 0000000000 0000000111112257788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=248.01 Aligned_cols=225 Identities=26% Similarity=0.355 Sum_probs=168.5
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCChh---hH----HHH--------HHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GL----REL--------KNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~----~~~--------~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||+|+||+||+|..+ +|+.||+|.+...... .. .+. .+++++++.+...+..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 5889999998653211 11 111 1445666777888899999999999999
Q ss_pred hHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccc
Q 048432 120 DFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192 (354)
Q Consensus 120 ~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~ 192 (354)
.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 9887 566778899999999999999999 9999999999999999999999999886543321 11223
Q ss_pred cCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhh
Q 048432 193 VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIF 272 (354)
Q Consensus 193 ~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 272 (354)
.++..|++||.+.+..++.++|+||+|+++|+|++|+.||...... .....+.......+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~------------------ 214 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK--VEKEELKRRTLEMA------------------ 214 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc--ccHHHHHhcccccc------------------
Confidence 5677999999998888999999999999999999999996433221 00111111111000
Q ss_pred hhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 273 KLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
...+...++.+.++|.+||+.+|++|| ++.+++.
T Consensus 215 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 215 -----------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -----------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 001111467789999999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=247.54 Aligned_cols=233 Identities=21% Similarity=0.245 Sum_probs=175.4
Q ss_pred CccccceecccCceeEEEEEEc----CCCEEEEEEecCCChh----h----HH---------HHHHHHHHhceeecCCce
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQ----G----LR---------ELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~----~----~~---------~~~~i~~~~~~~~~~~~~ 107 (354)
+|++.+.||.|+||.||.|... +|..||+|++...... . .. .+.+++.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5889999999999999999863 6889999998653211 0 01 122556666777888889
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++|+||+++++|.+++ +....+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999887 677888899999999999999999 99999999999999999999999999875433
Q ss_pred CccccccccccCcccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccCCCCccc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 258 (354)
.... ......++..|++||.+... .++.++|+||+|+++|+|++|..||...+.. .......+.......
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (290)
T cd05613 158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----- 231 (290)
T ss_pred cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC-----
Confidence 2211 11224578899999988753 4678999999999999999999996532211 111222221111111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
+...+..+.+++.+||+.+|++|| +++++++.
T Consensus 232 ----------------------------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 ----------------------------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----------------------------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111456788999999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=250.89 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=179.4
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCC---
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKD--- 105 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~--- 105 (354)
....++|++.+.||.|++|.||+|.++ +|+.||+|++...... ...+ +.|++++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345688999999999999999999976 4889999998643211 1111 125556666665443
Q ss_pred -------ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEe
Q 048432 106 -------EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172 (354)
Q Consensus 106 -------~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~ 172 (354)
.+++++||+++ ++...+ +++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 555544 578899999999999999999999 9999999999999999999999
Q ss_pred ecccceeccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 173 DFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 173 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
|||++......... ......++..|++||.+.+. .++.++|+||+||++|+|++|++||. ..+..+....+.+...
T Consensus 159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~--~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ--ANQELAQLELISRLCG 235 (302)
T ss_pred cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC--CCChHHHHHHHHHHhC
Confidence 99998754433211 11112346789999988654 46889999999999999999999953 3444444433333222
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+....+............ . ........+.. ....+..+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMK-P-KKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccc-c-ccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22111111111100000000 0 00000000000 0114667899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=253.40 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=181.5
Q ss_pred hhhcCcc-ccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------------------HHH--------HHHHHH
Q 048432 45 TATNKFS-DANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------------------LRE--------LKNKLR 96 (354)
Q Consensus 45 ~~~~~y~-~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------------------~~~--------~~~i~~ 96 (354)
...++|. +.+.||.|+||.||+|.++ .++.||+|++....... .++ +.|+++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 3457786 4678999999999999965 58999999986432211 111 136677
Q ss_pred HhceeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
+++++...+..+++|||+.+ +|.+++ ++......++.|++.||.+||+.+ ++|+||+|+||+++.++.++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 78888888999999999975 777776 678889999999999999999999 999999999999999999999
Q ss_pred eecccceeccCCcc------------ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccc
Q 048432 172 SDFGIARICRGNEL------------QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238 (354)
Q Consensus 172 ~dfg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~ 238 (354)
+|||++........ ........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||. ..+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~--~~~ 238 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP--GEN 238 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCC
Confidence 99999876541110 0111123457789999988764 36899999999999999999999953 333
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+....+.......+...++.......... ................+..+.++|.+||+.+|++|||+++++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTE-----FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccc-----cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 3333333332222111111111000000000 0000000001111224677899999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=251.07 Aligned_cols=260 Identities=20% Similarity=0.195 Sum_probs=172.6
Q ss_pred cceeccc--CceeEEEEEEc-CCCEEEEEEecCCCh--hhHHH------------HHHHHHHhceeecCCceEEEEEecC
Q 048432 53 ANKLGEG--GFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRE------------LKNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 53 ~~~lg~G--~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
...||.| +||+||+|++. .|+.||+|++..... ..... +.|++++++++...+..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3456666 99999999975 699999999865431 11111 2367788888988999999999999
Q ss_pred CCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc-cc-
Q 048432 116 NKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE-LQ- 186 (354)
Q Consensus 116 ~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~-~~- 186 (354)
++++.+++ +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+....... ..
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998887 456778899999999999999999 9999999999999999999999997643221110 00
Q ss_pred ---cccccccCcccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 187 ---ANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 187 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.......++..|++||++.+. .++.++|+||+||++|+|++|..||.... ...............+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML--RTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHhcCCCCCCccccccc
Confidence 001112345679999998764 47899999999999999999999964332 22222221111111111000000
Q ss_pred ccccc-------chhh-hhhh------hhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGF-------LHLT-IFKL------FSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~-------~d~~-~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+. .+.. .... ...............++..+.+||++||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0000 0000 0000001122223447788999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=250.74 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=176.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecC------
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDK------ 104 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~------ 104 (354)
..++|++.+.||.|++|.||+|.++ +++.||+|++...... ..+++ .|++++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3689999999999999999999965 5889999988543211 11121 2566666665433
Q ss_pred --CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 105 --DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 105 --~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
..+++++||+.+ ++...+ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999876 455443 678899999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCccccc---------cccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhh
Q 048432 177 ARICRGNELQAN---------TGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI 246 (354)
Q Consensus 177 a~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 246 (354)
+........... .....++..|+|||.+.+. .++.++|+||+||++|+|++|++|| .+.+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~--~~~~~~~~~~~~ 239 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL--QGKSDIDQLHLI 239 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC--CCCCHHHHHHHH
Confidence 875433221111 1123457789999987654 4789999999999999999999995 344433333333
Q ss_pred hccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 247 SENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.......+....+.+......... ......... .........+.+.++|.+||+.+|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGV--HSFTNYPRT-LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhccccccc--ccCCCCCcc-HHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 222221111111111100000000 000000000 00001113467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=245.92 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=181.0
Q ss_pred ccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecCCceEEEEEec
Q 048432 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
|++.+.||+|++|.||+|+.. +++.||+|++...... ...+ +.+++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999975 4999999999764311 1111 237778888888889999999999
Q ss_pred CCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 115 PNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 115 ~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
.+ +|.+++ +++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--
Confidence 85 788777 567889999999999999999999 999999999999999999999999998765433211
Q ss_pred cccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....++..|+|||.+... .++.++|+|||||++|++++|.+|| ......+....+.+.........+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF--PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC--CCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1123446789999998766 7889999999999999999999885 333333333333222221111111110000000
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+....... ........+..+..+.++|.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFP----PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccC----ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 00001111223678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=247.42 Aligned_cols=228 Identities=26% Similarity=0.356 Sum_probs=187.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHH----------------HHHHHHhceeecCCc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLREL----------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~----------------~~i~~~~~~~~~~~~ 106 (354)
-....+|.++.+||+|+||.|.+|..+. ...+|||+++++-.-+.... .-++.+...+++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4455789999999999999999999764 66799999877543221111 144677778899999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+|+||||+.||+|-..+ |.++.+.-.+..|+-||-+||++| |++||||.+||+++.+|++||+|||++...-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999997666 778888899999999999999999 9999999999999999999999999986322
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... ......+||+.|.|||++...+|+.++|.||+|++||||+.|++| |.+.+..++.+.|....-..|-.
T Consensus 502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpP--FdGeDE~elF~aI~ehnvsyPKs----- 572 (683)
T KOG0696|consen 502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP--FDGEDEDELFQAIMEHNVSYPKS----- 572 (683)
T ss_pred cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCC--CCCCCHHHHHHHHHHccCcCccc-----
Confidence 221 223346999999999999999999999999999999999999999 67777888888877666554432
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT 311 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 311 (354)
.+.+..+++...|..+|.+|.-
T Consensus 573 ----------------------------lSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 573 ----------------------------LSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----------------------------ccHHHHHHHHHHhhcCCccccC
Confidence 3555678999999999999963
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=253.70 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=175.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecC--------
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDK-------- 104 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~-------- 104 (354)
..++|.+.+.||.|+||.||+|... +|+.||+|.+........... .|++++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 3589999999999999999999965 589999999866543322222 2555666554432
Q ss_pred ------CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEee
Q 048432 105 ------DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISD 173 (354)
Q Consensus 105 ------~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~d 173 (354)
...++++||+.+ +|..++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++. ++.++++|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 357899999975 787766 678899999999999999999999 999999999999974 55789999
Q ss_pred cccceeccCCcccc-ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 174 FGIARICRGNELQA-NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 174 fg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
||++.......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..|| ......+....+.+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf--~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF--AGAHELEQMQLILESVP 236 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcC
Confidence 99986543221111 1122356788999998755 45788999999999999999999995 33333333322222111
Q ss_pred CCCCcccCCccccccchhhhhhhh--hccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLF--SISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...... ... .......... ............+..+..+.+||.+||+.||++|||+++++.
T Consensus 237 ~~~~~~---~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREED---RNE--LLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHH---hhh--hhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 000 0000000000 000000011111235677889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=249.44 Aligned_cols=234 Identities=29% Similarity=0.431 Sum_probs=175.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC---hhhHHHH------------HHHHHHhceeecCCceEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS---GQGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~---~~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
..+.|...+.||.|++|.||+|+.. ++..+++|.+.... ......+ .+++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4456888999999999999999965 58889999986421 1111111 145566777788888999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
|+||+.+ ++.+.+ ++...+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9999975 666554 577888999999999999999999 999999999999999999999999998654322
Q ss_pred ccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 184 ELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
....++..|+|||.+. ...++.++|||||||++|+|++|..||. ..+.......+..+... ...
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~--~~~~~~~~~~~~~~~~~--~~~--- 235 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMNAMSALYHIAQNESP--ALQ--- 235 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc--cccHHHHHHHHhhcCCC--CcC---
Confidence 1235678999999875 3457889999999999999999999953 22222222222211110 000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
....+..+.+||.+||..+|++||+++++++..-..
T Consensus 236 --------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 236 --------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred --------------------------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 011566788999999999999999999999764433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=253.59 Aligned_cols=267 Identities=20% Similarity=0.255 Sum_probs=181.9
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHH------------HHHHHHhceeecCC-----
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLREL------------KNKLRLLGCCIDKD----- 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~------------~~i~~~~~~~~~~~----- 105 (354)
..++|++.+.||.|++|.||+|... +|..||+|++...... ....+ .|++++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 5688999999999999999999954 6899999998543211 11111 25566666665443
Q ss_pred -ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 -EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 -~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..++|+||+ +++|..++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 66887776 778899999999999999999999 999999999999999999999999998754
Q ss_pred cCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... ....++..|++||.+.+ ..++.++|+||||+++|++++|..||. +.+.......+.+.....+.....
T Consensus 169 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK--GHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHhcCCCCHHHHH
Confidence 3321 12356788999998876 357899999999999999999999954 333323333222222211111100
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH--HHhhhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV--SMLTNEAAA 325 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il--~~L~~~~~~ 325 (354)
...... ......................++..+.++|.+||+.||++|||+.+++ ..++.....
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 242 KLQSED--AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhcchh--HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000000 0000000000000000111123566789999999999999999999999 455555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=244.19 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=191.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh-----------HHHHHHHHHHhceeecCC----ceE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-----------LRELKNKLRLLGCCIDKD----EKI 108 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~-----------~~~~~~i~~~~~~~~~~~----~~~ 108 (354)
-+...+-++.+.||+|-||.||+|+++ |..||||+|....... +-+++||+.+++.-..++ .++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 455678899999999999999999996 9999999997765433 234568888887755443 578
Q ss_pred EEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 109 LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 109 lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+|++|.+.|+|.+++ ++.....+++..++.||++|| .+|+++|.|||||..||||..++...|+|+|+|..
T Consensus 286 LvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred EeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999999999 778899999999999999999 45677899999999999999999999999999987
Q ss_pred ccCCc--cccccccccCcccccCccccccCC----C--CchhhHHHHHHHHHHHHhC----------CCCCCccccc---
Q 048432 180 CRGNE--LQANTGRIVGTYRYMSPEYAIQGI----F--SIKSDVFSFGVLLLKIVSG----------KKTTGFYRTY--- 238 (354)
Q Consensus 180 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DiwSlG~~l~~ll~g----------~~p~~~~~~~--- 238 (354)
..... .....+..+||..|+|||++...- + -..+||||||.++||+.-+ .+||...-..
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 66542 233345568999999999985431 1 2469999999999998753 2453222111
Q ss_pred chhhhhh--hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 239 SFTLLGY--ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 239 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
..++.+- +.+..+..|..+. ..++-..+..||+.||..||.-|.||=-+.
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~----------------------------s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWK----------------------------SDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHhcceeecccCCCCCcccc----------------------------cCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 1111111 2222233333221 112667788999999999999999999999
Q ss_pred HHhhhhh
Q 048432 317 SMLTNEA 323 (354)
Q Consensus 317 ~~L~~~~ 323 (354)
+.|.++.
T Consensus 498 Ktl~~l~ 504 (513)
T KOG2052|consen 498 KTLAKLS 504 (513)
T ss_pred HHHHHHh
Confidence 9998887
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=248.52 Aligned_cols=230 Identities=27% Similarity=0.470 Sum_probs=173.0
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
..+.|...+.||+|++|.||+|+.. .|+.|++|++..... .....+ .|++++++++.+....++
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3445888889999999999999964 588999999864322 111111 155666778888889999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|||+.+ ++.+++ +++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 9999975 565554 567888899999999999999999 99999999999999999999999998753221
Q ss_pred ccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 184 ELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..|| ...+.......+..... +...
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~--~~~~~~~~~~~~~~~~~--~~~~--- 241 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNDS--PTLQ--- 241 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHhcCC--CCCC---
Confidence 12245778999999874 355788999999999999999999994 33333232222221111 1100
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..+.+|+.+||+.+|++||++.+++..
T Consensus 242 --------------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --------------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00134568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=236.66 Aligned_cols=219 Identities=27% Similarity=0.335 Sum_probs=172.2
Q ss_pred ecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHH------------HHHHHHHhceeecCCceEEEEEecCCCCH
Q 048432 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRE------------LKNKLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 56 lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~------------~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
||.|++|.||++... +++.|++|++....... ... +.+++++++.+..++.++++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 48999999986543211 111 12667788888899999999999999999
Q ss_pred hHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccC
Q 048432 120 DFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194 (354)
Q Consensus 120 ~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 194 (354)
.+++ +++.....++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence 9887 578889999999999999999999 9999999999999999999999999987654332 11223456
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhh
Q 048432 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKL 274 (354)
Q Consensus 195 ~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 274 (354)
+..|++||...+...+.++|+||||+++|++++|..||.. .+.......+.......+.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~------------------- 214 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA--EDRKEIYEKILKDPLRFPE------------------- 214 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHhcCCCCCCC-------------------
Confidence 7899999999888889999999999999999999999633 2223333333322111111
Q ss_pred hhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 275 FSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
..+..+.++|.+||..+|++|||+.+
T Consensus 215 --------------~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 --------------FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --------------CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 13567789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=240.52 Aligned_cols=230 Identities=25% Similarity=0.347 Sum_probs=174.3
Q ss_pred CccccceecccCceeEEEEEEcC-CCEEEEEEecCCC------hh---hHH--------HHHHHHHHhceeecCCceEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRS------GQ---GLR--------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~------~~---~~~--------~~~~i~~~~~~~~~~~~~~lv 110 (354)
+|.+.+.||+|++|.||++.+.. +..+++|+.+... .. ... .+.|++++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58999999999999999999653 4455566554211 11 111 123788899999888999999
Q ss_pred EEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 111 YEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 111 ~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+||+.+++|..++ +++..+..++.|++.|+.+||+.+ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998776 567888999999999999999999 999999999999975 569999999986543
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||. ..........+..+.. +.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~--~~------ 224 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE--GQNFLSVVLRIVEGPT--PS------ 224 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC--CccHHHHHHHHHcCCC--CC------
Confidence 3221 1112356788999999888888899999999999999999999953 2222222222221111 10
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+..++..+.++|.+||..+|++||++.++++.
T Consensus 225 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111266788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=240.84 Aligned_cols=233 Identities=25% Similarity=0.312 Sum_probs=173.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC-----hhhHHHHH------------HHHHHhceeecC--Cce
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS-----GQGLRELK------------NKLRLLGCCIDK--DEK 107 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~-----~~~~~~~~------------~i~~~~~~~~~~--~~~ 107 (354)
.+|++.+.||+|++|.||+|.+. ++..||+|.+.... ......+. +++++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999965 58999999875321 11122222 444555555443 457
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++++||+++++|.+++ ++......++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 8999999999998887 567788899999999999999999 99999999999999999999999999875432
Q ss_pred Ccc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||. ..........+..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~-~-------- 227 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA--EYEAMAAIFKIATQPT-K-------- 227 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC--ccCHHHHHHHHHcCCC-C--------
Confidence 211 111122457889999999988888999999999999999999999963 2222222222111110 0
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+...++.+.+++.+||. +|.+|||+.+++.
T Consensus 228 ----------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ----------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111256778999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=223.53 Aligned_cols=258 Identities=20% Similarity=0.275 Sum_probs=192.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhHH--------HHHHHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGLR--------ELKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~~--------~~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|.-.+.||+|.||+||+|+.+ .+..||+|....+.. ..++ +++||++++++.-.++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5667889999999999999955 588899999865432 2222 346999999999999999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|+. .|..+. ++...++.++.|+++|+.|+|+.+ +.||||||+|.+++.+|.+|++|||+++.++-...-
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 977 666665 778889999999999999999999 999999999999999999999999999876544322
Q ss_pred ccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.+..+-|..|++|.++.+.. |+...|+||-||++.|+.....|. |.+.+..+.+++|-...+......|+.......
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl-fpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC-CCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 22235689999999999876 789999999999999998755453 667777777777776666555544443322111
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
... .... .....-....+.....=++++.+.|.-+|.+|++++..++
T Consensus 236 yk~--yp~y--pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKP--YPIY--PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred Ccc--cCCc--cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000 0000001112223344478999999999999999998764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=253.12 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=180.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHH--------HHHHHHHhceeecC------C
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLRE--------LKNKLRLLGCCIDK------D 105 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~--------~~~i~~~~~~~~~~------~ 105 (354)
.++|.+.+.||.|++|.||+|.+. +|+.||+|++...... ...+ +.|++++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999965 5899999998653211 1111 12666777776543 2
Q ss_pred ceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 106 EKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
..++++||+.. ++..+. +++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 46899999865 676654 678889999999999999999999 99999999999999999999999999865322
Q ss_pred CccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.. ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||. +.+.......+...............
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 170 EM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK--GKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 21 12356778999998876 457899999999999999999999964 33322222222221111100000000
Q ss_pred cccccchhhhhhhhhccccCCch---hHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSN---DIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA 324 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~ 324 (354)
.. ................ ...+..+..+.+||.+||+.||++|||+++++.. +++...
T Consensus 243 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 ED-----KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cc-----cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 0000000000000000 0111245678899999999999999999999955 877764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=253.00 Aligned_cols=230 Identities=26% Similarity=0.305 Sum_probs=180.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-------HHHHHHHH--------HHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LRELKNKL--------RLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-------~~~~~~i~--------~~~~~~~~~~~~ 107 (354)
+...+.|..-++||+||||.|+-++.+ +|+.||+|.+.+.+... +.+-+.+- .+--.|.+.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 455678899999999999999999954 59999999875543222 11111111 122246788999
Q ss_pred EEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 108 ILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
|+|+..|.||+|...+ |++..++-.+.+|+-||.+||..+ ||+|||||+|||+|+.|++.|+|+|+|...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999998777 889999999999999999999999 999999999999999999999999999887
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--hhhhhhhhccccCCCCccc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS--FTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 258 (354)
..+..... -+||..|+|||++.+..|+..+|.|||||+||+|+.|+.||....... .++-+++....
T Consensus 338 ~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------- 406 (591)
T KOG0986|consen 338 PEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------- 406 (591)
T ss_pred CCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------
Confidence 77664433 289999999999999999999999999999999999999964433321 12222222111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
.+.+...+++..+|.+..|..||++|.-.
T Consensus 407 -------------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 -------------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -------------------------hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22223378889999999999999999743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=262.57 Aligned_cols=235 Identities=26% Similarity=0.365 Sum_probs=190.4
Q ss_pred hcCccccceecccCceeEEEEEEcC--CC--EEEEEEecCCChh-hHHH------------HHHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN--GD--EIAVKRLSGRSGQ-GLRE------------LKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~--~~--~vavK~~~~~~~~-~~~~------------~~~i~~~~~~~~~~~~~~l 109 (354)
.++..+.+.||+|.||.||+|.|+. |+ .||||.+...... .+.. +.|++++|+++.+ ..+.+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3456778999999999999999863 43 5799999766443 2222 2366788888887 67889
Q ss_pred EEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 110 IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 110 v~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+|.+..|+|.+.+ |.......++.||+.|+.||..++ ++||||..+|+++-....+||+|||+.+..+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999998 456677899999999999999999 99999999999999999999999999998777
Q ss_pred Cccccccccc-cCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 183 NELQANTGRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 183 ~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.+....+... .-...|+|||-+.-..++.++|+|++|++|||||+ |..| +.+.....+++.+..+..-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP--W~G~~g~qIL~~iD~~erL-------- 334 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP--WVGCRGIQILKNIDAGERL-------- 334 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC--CCCCCHHHHHHhccccccC--------
Confidence 6655444332 22458999999999999999999999999999998 6678 5566667777776533321
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
.-+..|++.++++|+.||..+|++|||+..|.+.+
T Consensus 335 ------------------------pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 ------------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ------------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11223999999999999999999999999997544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=253.39 Aligned_cols=236 Identities=22% Similarity=0.280 Sum_probs=195.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCC-EEEEEEecCCChhhHHHH---------------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGD-EIAVKRLSGRSGQGLREL---------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-~vavK~~~~~~~~~~~~~---------------~~i~~~~~~~~~~~~~ 107 (354)
.....+++++..||.||||.|=+++.++.. .+|+|++++...-...+. .-||++|..|.+++++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 345678889999999999999999975433 389998876543211111 1568999999999999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|++||-|-||.+...+ |+..+.+-++..++.|+.|||..+ |++|||||+|.+++.+|-+||.|||+|...+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999998887 888999999999999999999999 99999999999999999999999999987776
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
+... ..++||+.|.|||++....++.++|.|+||+++|||++|.+| |.+.+.......|.++......
T Consensus 573 g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pP--Fs~~dpmktYn~ILkGid~i~~------- 640 (732)
T KOG0614|consen 573 GRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPP--FSGVDPMKTYNLILKGIDKIEF------- 640 (732)
T ss_pred CCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCC--CCCCchHHHHHHHHhhhhhhhc-------
Confidence 6533 346999999999999999999999999999999999999999 7778877777777776653322
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
|........+||+++.+.+|.+|.- +.||.+.
T Consensus 641 ------------------------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 641 ------------------------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ------------------------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1225666788999999999999976 5666553
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=282.92 Aligned_cols=236 Identities=25% Similarity=0.338 Sum_probs=185.2
Q ss_pred hcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh---------h-----HHHHHHHHHHhceeecCCceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ---------G-----LRELKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~---------~-----~~~~~~i~~~~~~~~~~~~~~lv~ 111 (354)
.-+|+-..+||.|.||.||.|.. .+|...|+|-+.-.... . .-.|.|+++.+++-.+....+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 35889999999999999999995 45888899977432111 1 122348888999989999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||++|+|.+.+ .++........|++.|++|||+.| ||||||||.||+++.+|.+|++|||.|.........
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999999988 566777889999999999999999 999999999999999999999999999876654311
Q ss_pred c--ccccccCcccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 187 A--NTGRIVGTYRYMSPEYAIQGI---FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 187 ~--~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
. .-....||+.|+|||++.+.. ..-++|||||||+..||+||+.||...+.+=.-+..-.....
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~----------- 1459 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK----------- 1459 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC-----------
Confidence 1 122357999999999997643 567899999999999999999997554443222222222222
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+.+|...+++=++||.+||+.||++|+++.|+++.
T Consensus 1460 ----------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ----------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22222356667899999999999999999988764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=250.49 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=179.0
Q ss_pred cchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh--hHH----H--------HHHHHHHhceeecC-
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ--GLR----E--------LKNKLRLLGCCIDK- 104 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~--~~~----~--------~~~i~~~~~~~~~~- 104 (354)
.++....++|++.+.||+|+||.||+|.. .+++.||+|++...... ... + +.|++++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44556679999999999999999999995 46899999998653211 111 1 12556666665422
Q ss_pred -----CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 105 -----DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 105 -----~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
...+++++++ +++|..++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccc
Confidence 3467788776 67887766 678889999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
++...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||. ..........+.+.....+
T Consensus 166 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~--~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 166 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP--GTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred cccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHhCCCC
Confidence 98753322 122356788999998866 467889999999999999999999953 3333333333322222111
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
........... ............... ........+..+.++|.+||+.+|++|||+.+++..
T Consensus 239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSES-ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHh-HHHHHHHhcccCCcc-hhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11110000000 000000000000000 000000145678899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=249.44 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=177.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhHHHH--------HHHHHHhceeec-CCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGLREL--------KNKLRLLGCCID-KDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~~~~--------~~i~~~~~~~~~-~~~ 106 (354)
+....++|++.+.||.|+||.||+|..+ +++.||+|++..... ....+. .|++++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999965 689999998754211 111111 255666676654 567
Q ss_pred eEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 107 KILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
.++++||+. ++|..++ ++......++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 899999984 5787776 567778889999999999999999 99999999999999999999999999864322
Q ss_pred CccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.. ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.... .......+.+.....+.......
T Consensus 161 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 QM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD--HVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred Cc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHhc
Confidence 11 12345778999998766 468999999999999999999999964332 21111111111111111000000
Q ss_pred cccccchhhhhhhhhcc---ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSIS---SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+.......... .........+..++.+.++|.+||+.+|++|||+++++..
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 -----CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred -----cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 0000001111246789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=239.08 Aligned_cols=238 Identities=27% Similarity=0.378 Sum_probs=181.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH-HH-------------HHHHHHhceeecCCceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR-EL-------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~-~~-------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..+++-+..||.|+||+|++..++ .|+..|||.+........+ ++ .+||++++.+-.++..++.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 456777889999999999999976 5999999999776542211 11 29999999999999999999
Q ss_pred EecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 112 EYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 112 e~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
|.|+- +++.+. +++.-.-+|.-..+.||.||...- .|+|||+||+|||++..|.+||+|||++....
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99965 676654 445555666667789999997654 49999999999999999999999999986544
Q ss_pred CCccccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
++- .++...|...|+|||.+.. ..|+.++|+||||++|||+.||..|+..+.. ..+.+.++..+.++.-.....
T Consensus 220 ~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 220 DSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCCCCeecCccc
Confidence 432 2344578899999999853 3489999999999999999999999766544 333344443333222111111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
. ......+..+|.-||.+|-.+||..+++++.
T Consensus 296 ~---------------------------~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 C---------------------------VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c---------------------------cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0 1156678999999999999999999988764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=258.25 Aligned_cols=264 Identities=23% Similarity=0.274 Sum_probs=188.4
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH-------------HHHHHHHHHhceeecC------C
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL-------------RELKNKLRLLGCCIDK------D 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~-------------~~~~~i~~~~~~~~~~------~ 105 (354)
....|...+.||+|+||.||+++++ .|+.||||.+........ -++.|||+.+++-.+. .
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3467888999999999999999954 699999999977432211 1245888888775433 3
Q ss_pred ceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--CC--CeEEee
Q 048432 106 EKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DM--NPKISD 173 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~--~~~l~d 173 (354)
...++||||.||+|...+ +++...+.++.+++.||.|||.++ |+||||||.||++-. +| ..||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeec
Confidence 457999999999999998 788999999999999999999999 999999999999953 34 369999
Q ss_pred cccceeccCCccccccccccCcccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccc
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAI-QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENI 250 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~ 250 (354)
||.|+....... .....||..|++||++. ...|+..+|.|||||++|++.||..||-..... ..++...+....
T Consensus 168 fG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 168 FGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999987666652 33468999999999998 478999999999999999999999996433332 333333332222
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC--CHHHHHHHhhhhh
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP--TMNDVVSMLTNEA 323 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp--s~~~il~~L~~~~ 323 (354)
+........... . +...+....-......+.....+...+..+|+.+|++|. ...+..+.+.++.
T Consensus 245 p~~v~i~~~~~e-N-------gpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 245 PSGVAIGAQEEE-N-------GPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CCceeEeeeccc-C-------CceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 221111100000 0 000000000111122233455666778888999999999 7777777777665
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=248.47 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=174.9
Q ss_pred CccccceecccCceeEEEEEEc-C--CCEEEEEEecCCChh------hHH---------HHHHHHHHhceee----cCCc
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-N--GDEIAVKRLSGRSGQ------GLR---------ELKNKLRLLGCCI----DKDE 106 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~--~~~vavK~~~~~~~~------~~~---------~~~~i~~~~~~~~----~~~~ 106 (354)
+|++.+.||+|+||.||++... . +..||+|++...... ... .+.|++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999965 3 778999998643111 111 1235555555432 2245
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++++++|+. ++|..++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788889886 4787776 678889999999999999999999 9999999999999999999999999987544
Q ss_pred CCccc--cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 182 GNELQ--ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 182 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+|| ...+.......+.......+....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF--KGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC--CCCCHHHHHHHHHHHhCCCCHHHH
Confidence 32211 11223467889999998765 45789999999999999999999985 333333344333333222111100
Q ss_pred CCccccccchhhhh-hhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 259 HNVKTFGFLHLTIF-KLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 259 ~~~~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..... ...... ...............+..+..+.+++.+||+.+|++|||++++++.
T Consensus 235 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGS---PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred Hhhhh---hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 000000 0000000000011111245678999999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=236.41 Aligned_cols=207 Identities=17% Similarity=0.110 Sum_probs=162.4
Q ss_pred cCceeEEEEEEc-CCCEEEEEEecCCChhhHHH-------HHHHHHHhceeecCCceEEEEEecCCCCHhHHH-----hh
Q 048432 59 GGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE-------LKNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FD 125 (354)
Q Consensus 59 G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~-------~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~ 125 (354)
|.+|.||+++++ +++.||+|++.......... +.|++++++++...+..+++|||+.+++|.+++ ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 899999999965 58999999997653222111 237788888888899999999999999998887 67
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccc
Q 048432 126 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205 (354)
Q Consensus 126 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (354)
+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+....... ....++..|+|||.+.
T Consensus 84 ~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 84 EECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGG 155 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccC
Confidence 7888999999999999999999 9999999999999999999999999875443321 1123466799999998
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchh
Q 048432 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSND 285 (354)
Q Consensus 206 ~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 285 (354)
+..++.++|+||+|+++|+|++|..|+........ . .. ...
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---~-----~~-------------------------------~~~ 196 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---T-----HT-------------------------------TLN 196 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---c-----cc-------------------------------ccC
Confidence 88889999999999999999999987432110000 0 00 000
Q ss_pred HHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 286 IVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
.+...+..+.++|.+||+.||++|||+
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 011145678899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=261.26 Aligned_cols=255 Identities=20% Similarity=0.219 Sum_probs=163.5
Q ss_pred hhhcCccccceecccCceeEEEEEEc-C----CCEEEEEEecCCChhhHH---HHH-----HHHHHhce------eecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-N----GDEIAVKRLSGRSGQGLR---ELK-----NKLRLLGC------CIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~----~~~vavK~~~~~~~~~~~---~~~-----~i~~~~~~------~~~~~ 105 (354)
...++|.+.+.||+|+||.||+|.+. + +..||+|++......... .+. ++..+... .....
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCC
Confidence 36689999999999999999999965 3 689999998654332211 111 11111111 24566
Q ss_pred ceEEEEEecCCCCHhHHHhh-------------------------HHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 106 EKILIYEYMPNKSLDFFLFD-------------------------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~~~-------------------------~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
.+++|+||+.+++|.+++.. ...+..++.||+.||.|||+.+ |+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHH
Confidence 79999999999999887621 1235579999999999999999 9999999999
Q ss_pred EEEcC-CCCeEEeecccceeccCCccccccccccCcccccCccccccCC----------------------CCchhhHHH
Q 048432 161 ILLDK-DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI----------------------FSIKSDVFS 217 (354)
Q Consensus 161 ill~~-~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~DiwS 217 (354)
||++. ++.++|+|||++........ .......+++.|+|||.+.... ++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99986 57899999999975433221 1222346788999999764322 334569999
Q ss_pred HHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHH
Q 048432 218 FGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNI 297 (354)
Q Consensus 218 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 297 (354)
+||++|+|+++..++. .........+.........+.. ........+ ... ..+..........+|
T Consensus 365 lGviL~el~~~~~~~~---~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~--~~~---------~~~~~d~~~~~~~dL 429 (566)
T PLN03225 365 AGLIFLQMAFPNLRSD---SNLIQFNRQLKRNDYDLVAWRK-LVEPRASPD--LRR---------GFEVLDLDGGAGWEL 429 (566)
T ss_pred HHHHHHHHHhCcCCCc---hHHHHHHHHHHhcCCcHHHHHH-hhccccchh--hhh---------hhhhccccchHHHHH
Confidence 9999999998765521 1111111111111110000000 000000000 000 000001123345689
Q ss_pred HhhccccCCCCCCCHHHHHHH
Q 048432 298 ALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 298 i~~cl~~~P~~Rps~~~il~~ 318 (354)
|.+||+.||++|||++++++.
T Consensus 430 i~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHccCCcccCCCHHHHhCC
Confidence 999999999999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=249.00 Aligned_cols=271 Identities=20% Similarity=0.233 Sum_probs=203.1
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH-----------------HHHHHHhc
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL-----------------KNKLRLLG 99 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~-----------------~~i~~~~~ 99 (354)
|.+.-....-++|.+....|+|-||.|-+|.+. .|+.||||+|...+.+..... .|.++++.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 677777888899999999999999999999965 488999999988765543322 27789999
Q ss_pred eeecCCceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeE
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPK 170 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~ 170 (354)
.|.+.+++|+|||-+ ..+|.+.+ +...+++.++.|++-||..|...+ |+|+||||+||||+.. ..+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999987 45888887 667889999999999999999999 9999999999999865 5679
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
|||||.|...+...... ..-+.-|+|||++.+.+|+...|+||.||+||||+||+.. |.+.++.++++......
T Consensus 578 LCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl--FpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 578 LCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL--FPGRTNNQMLRLFMELK 651 (752)
T ss_pred eccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeecccee--cCCCCcHHHHHHHHHhc
Confidence 99999997665554322 2235689999999999999999999999999999999988 56666666666655555
Q ss_pred cCCCCcc--cCCcc------cccc----chhhhhhhhhc------------cccCC---chhHHHHHHHHHHHHHhhccc
Q 048432 251 YEFPSVD--THNVK------TFGF----LHLTIFKLFSI------------SSVGL---SNDIVCLCILRYVNIALLCVQ 303 (354)
Q Consensus 251 ~~~~~~~--~~~~~------~~~~----~d~~~~~~~~~------------~~~~~---~~~~~~~~~~~l~~li~~cl~ 303 (354)
+.+|.-. ..... .+.+ .|....+.... +.... .++--+....++.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 5555411 00000 0000 00000000000 00000 111223367889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 048432 304 ESADDRPTMNDVVSM 318 (354)
Q Consensus 304 ~~P~~Rps~~~il~~ 318 (354)
.||++|.|..|+|+.
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999998863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=266.35 Aligned_cols=129 Identities=30% Similarity=0.460 Sum_probs=110.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++.+.||.|+||.||+|.+. .++.||+|++..... .....+ .++++++.++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999976 589999999975431 111111 2456667777888899999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
|||+.+++|..++ ++...++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999887 577888999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=257.15 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=193.9
Q ss_pred CccccchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh--hHHHHHHHH----------HHhceee-
Q 048432 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ--GLRELKNKL----------RLLGCCI- 102 (354)
Q Consensus 37 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~--~~~~~~~i~----------~~~~~~~- 102 (354)
.+.+...+.+...|+++..||.|.+|.||+++. ++++..|+|+....... +++...||+ .+++++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 466778888999999999999999999999994 46889999998766543 333333454 4455543
Q ss_pred ----cCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 103 ----DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 103 ----~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
.++.+++|||||.+|++.+++ +.+..+..|+..++.|+.+||.+. ++|||||-.|||++.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 457899999999999999998 788999999999999999999999 999999999999999999999
Q ss_pred eecccceeccCCccccccccccCcccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhh
Q 048432 172 SDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-----IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI 246 (354)
Q Consensus 172 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 246 (354)
+|||.+......... .....||+.|+|||++... .|+..+|+||||++..||--|.+| +.++-..-.+-.|
T Consensus 165 vDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP--l~DmHPmraLF~I 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP--LCDMHPMRALFLI 240 (953)
T ss_pred eeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC--ccCcchhhhhccC
Confidence 999998765544322 2234799999999999754 377899999999999999999999 4444444444444
Q ss_pred hccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 247 SENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+++++. . ..+....+.+.+||..||..|.++||+..++++
T Consensus 241 pRNPPPk--L----------------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 PRNPPPK--L----------------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCcc--c----------------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 3333221 1 112237888999999999999999999988775
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=263.62 Aligned_cols=176 Identities=24% Similarity=0.348 Sum_probs=137.9
Q ss_pred ceEEEEEecCCCCHhHHH----h--hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL----F--DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~----~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.+||=||||+..++.+++ + .....++++.+|+.||+|+|++| |+||||||.||+++.++.|||+|||++..
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 467889999998888887 3 36678899999999999999999 99999999999999999999999999976
Q ss_pred cc----------------CCccccccccccCcccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCcccccch
Q 048432 180 CR----------------GNELQANTGRIVGTYRYMSPEYAIQGI---FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240 (354)
Q Consensus 180 ~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~ 240 (354)
.. .+......+..+||.-|+|||++.+.. |+.++|+||||++|+||+. || ...++..
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF-~TsMERa 822 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PF-GTSMERA 822 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cC-CchHHHH
Confidence 11 011111234568999999999997654 9999999999999999985 33 3445667
Q ss_pred hhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++..+.++..+.+...+.. ..+.=..+|++|++.||.+||||.|+|.
T Consensus 823 ~iL~~LR~g~iP~~~~f~~~-----------------------------~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 823 SILTNLRKGSIPEPADFFDP-----------------------------EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcccCCCCCCcccccc-----------------------------cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 77777776666665211100 2222357999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=232.63 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=189.2
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCC---Ch---hhHHH--------HHHHHHHhceee-------
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGR---SG---QGLRE--------LKNKLRLLGCCI------- 102 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~---~~---~~~~~--------~~~i~~~~~~~~------- 102 (354)
...+.|+-...||+|.||.||+|+.++ |+.||+|+.--. .+ ..+++ ++|++.+++.|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 345788899999999999999999664 888998875321 11 11111 334455544442
Q ss_pred -cCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 103 -DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 103 -~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
+...+|+||.+|+. +|..++ ++...+.+++.+++.||.|+|.+. |+|||+|+.|+|++.+|.++|+|||
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 23457999999987 555555 788999999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCcc--ccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC
Q 048432 176 IARICRGNEL--QANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 176 ~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
+++.+..... ....++.+-|+.|++||.+.+.. ++++.|||.-||++.+||+|.+. +.+.+....+..|....+.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi--mqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI--MQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc--ccCChHHHHHHHHHHHhcc
Confidence 9976554332 22223345689999999998764 89999999999999999999988 6667766666666666666
Q ss_pred CCCcccCCccccccchhh---------hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 253 FPSVDTHNVKTFGFLHLT---------IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+....|++.......... ..+......+.. -.+...+|+.+++..||.+|+++++++..
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~-------kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYV-------KDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhccccc-------CChhHHHHHHHHhccCcccCcchHhhhch
Confidence 666665555433222111 111111110000 13456799999999999999999998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=255.20 Aligned_cols=245 Identities=28% Similarity=0.400 Sum_probs=191.9
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcC--------CCEEEEEEecCCChhhH--------------HHHHHHHHHhc
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKN--------GDEIAVKRLSGRSGQGL--------------RELKNKLRLLG 99 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~--------~~~vavK~~~~~~~~~~--------------~~~~~i~~~~~ 99 (354)
.+....++..+.+.||+|.||.||+|.... ...||||..+....... ..+.|++.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 566666777888899999999999998431 34689999876544311 11238899999
Q ss_pred eeecCCceEEEEEecCCCCHhHHHh---------------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFLF---------------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~~---------------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 158 (354)
+|...+.+++|+||+..|+|..++. .......++.||+.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999998872 23467899999999999999999 99999999
Q ss_pred CCEEEcCCCCeEEeecccceeccCCccccccccc-cCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccc
Q 048432 159 SNILLDKDMNPKISDFGIARICRGNELQANTGRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYR 236 (354)
Q Consensus 159 ~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~ 236 (354)
+|||+..+..+|++|||+++.............. .-...|+|||.+....++.++||||+|++||||++ |..|++.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 9999999999999999999854443322211110 12346999999999999999999999999999998 6777432
Q ss_pred cc-chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 048432 237 TY-SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315 (354)
Q Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~i 315 (354)
.. ..++.+.+.++.. .+.|..|+++++++|+.||+.+|++||++.++
T Consensus 525 ~~~~~~l~~~l~~G~r--------------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGNR--------------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred CCcHHHHHHHHhcCCC--------------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 22 3333444444333 23333389999999999999999999999999
Q ss_pred HHHhhhhh
Q 048432 316 VSMLTNEA 323 (354)
Q Consensus 316 l~~L~~~~ 323 (354)
.+.|+...
T Consensus 573 ~~~~~~~l 580 (609)
T KOG0200|consen 573 VEFFEKHL 580 (609)
T ss_pred HHHHHHHH
Confidence 99999954
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=251.41 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=194.6
Q ss_pred CccccceecccCceeEEEEEE-cC----CCEEEEEEecCCChhh-----HH--------HHHHHHHHhceeecCCceEEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVL-KN----GDEIAVKRLSGRSGQG-----LR--------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~-~~----~~~vavK~~~~~~~~~-----~~--------~~~~i~~~~~~~~~~~~~~lv 110 (354)
.....++||+|+||+||+|.+ .. .-+||+|++....... ++ ++.|++++++++.... +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445678999999999999994 44 4468999986554321 11 1238999999998765 8899
Q ss_pred EEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 111 YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 111 ~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
++|+++|.|.+++ +.....+.|..||++|+.|||.+. ++||||..+||||.....+|+.|||++.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999998 567788999999999999999998 9999999999999999999999999998766554
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.......-.-.+.|+|-|.+....+++++||||+|+++||++| |..| +.+....++...+..+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~P--y~gi~~~eI~dlle~ge------------- 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKP--YDGIPAEEIPDLLEKGE------------- 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCc--cCCCCHHHhhHHHhccc-------------
Confidence 4333322334568999999999999999999999999999988 7778 44444444444333332
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCC
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 333 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~ 333 (354)
+...++.|+-.+.-+|.+||..|+..||+++++.++++....+...=..+.
T Consensus 918 -------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~ 968 (1177)
T KOG1025|consen 918 -------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ 968 (1177)
T ss_pred -------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence 222334488899999999999999999999999999999886654433333
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=248.86 Aligned_cols=235 Identities=25% Similarity=0.365 Sum_probs=185.8
Q ss_pred hhhhcCc-cccceecccCceeEEEEEEc-CCCEEE---EEEecCC-ChhhHHHH------------HHHHHHhceeecCC
Q 048432 44 STATNKF-SDANKLGEGGFGPVYKGVLK-NGDEIA---VKRLSGR-SGQGLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 44 ~~~~~~y-~~~~~lg~G~~g~V~~a~~~-~~~~va---vK~~~~~-~~~~~~~~------------~~i~~~~~~~~~~~ 105 (354)
....++| ++...||+|.|-+||+|-+. .|..|| +|.-... .....+.+ .||++++..+.+..
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 4455666 67889999999999999965 376665 2322111 11212222 37777777776555
Q ss_pred c--eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccc
Q 048432 106 E--KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIA 177 (354)
Q Consensus 106 ~--~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a 177 (354)
. +.+|+|.+..|+|..|. .+...+..|++||++||.|||++. ++|+|||||.+||+|+. .|.|||+|+|+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHH
Confidence 4 78999999999999998 677889999999999999999984 78999999999999974 589999999999
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
......... ...||+.|+|||++. ..|+..+||||||+++.||+|+..|| ....+...+.+++.+|..+-....
T Consensus 194 tl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY-sEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 194 TLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY-SECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred HHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh-hhhCCHHHHHHHHHcCCCHHHhhc
Confidence 865554422 247999999999886 77999999999999999999999995 456678889999888876532211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
- -.+++++||.+||.. .++|+|+.|+|+
T Consensus 268 V-------------------------------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 V-------------------------------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred c-------------------------------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 0 356789999999999 999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=216.27 Aligned_cols=221 Identities=29% Similarity=0.359 Sum_probs=172.1
Q ss_pred CceeEEEEEEc-CCCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEEEEEecCCCCHhHHH--
Q 048432 60 GFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-- 123 (354)
Q Consensus 60 ~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-- 123 (354)
+||.||+|.+. +|+.+++|++....... ...+ .+++++++.+......++++|++.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997654322 1111 26677888888888999999999999999887
Q ss_pred ---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccC
Q 048432 124 ---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200 (354)
Q Consensus 124 ---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~a 200 (354)
++......++.+++.++.+||+.+ ++|+||+|.||+++.++.++++|||.+....... ......++..|++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 577888999999999999999999 9999999999999999999999999987655432 1122456789999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhcccc
Q 048432 201 PEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSV 280 (354)
Q Consensus 201 PE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 280 (354)
||.+....++.++|+|++|+++|++++|..||... ......................
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~---------------------- 211 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPKPPFPPPEW---------------------- 211 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCccccc----------------------
Confidence 99998888899999999999999999999995332 2222233333222221111100
Q ss_pred CCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 281 GLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+..+.+++.+||..+|++||++.++++
T Consensus 212 --------~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 --------KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred --------cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 03457889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=235.63 Aligned_cols=245 Identities=29% Similarity=0.406 Sum_probs=184.0
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCC--h---------hhHHH--------HHHHHHHhc
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRS--G---------QGLRE--------LKNKLRLLG 99 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~--~---------~~~~~--------~~~i~~~~~ 99 (354)
+.+-+...++|.++..||+|||+.||+|-+ ...++||||+-.... . ...++ +.+||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 344467788999999999999999999994 458889999853321 1 11111 127788898
Q ss_pred eee-cCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCCeE
Q 048432 100 CCI-DKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPK 170 (354)
Q Consensus 100 ~~~-~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~~ 170 (354)
++. +.+..|-|+|||+|.+|+.++ +++..++.|+.||+.||.||... +.+|+|-||||.|||+. .-|.+|
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 885 566789999999999999998 78899999999999999999987 57899999999999995 457899
Q ss_pred EeecccceeccCCcccc-----ccccccCcccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCcccccchh
Q 048432 171 ISDFGIARICRGNELQA-----NTGRIVGTYRYMSPEYAIQG----IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT 241 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~ 241 (354)
|.|||++.......... ..+-..||+.|++||-+.-+ ..+.++||||+|+|+|+.+.|+.||+-. ....+
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn-qsQQd 692 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN-QSQQD 692 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc-hhHHH
Confidence 99999998765433221 12335789999999987643 3688999999999999999999997533 22333
Q ss_pred hhhhhh---ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 242 LLGYIS---ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+++.-. ...-.+|.- +-+..+...||++||++.-++|....++..
T Consensus 693 ILqeNTIlkAtEVqFP~K-------------------------------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPK-------------------------------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhchhcceeccCCCC-------------------------------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 333211 001111110 115667789999999999999998887643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=238.43 Aligned_cols=248 Identities=20% Similarity=0.246 Sum_probs=162.6
Q ss_pred hhhcCccccceecccCceeEEEEEE-----------------cCCCEEEEEEecCCChhhHHHH----------------
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-----------------KNGDEIAVKRLSGRSGQGLREL---------------- 91 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-----------------~~~~~vavK~~~~~~~~~~~~~---------------- 91 (354)
...++|.+.++||+|+||.||+|.. ..++.||||.+.........++
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3577999999999999999999963 2356899999865432111110
Q ss_pred ---------------HHHHHHhceeec--------CCceEEEEEecCCCCHhHHHh------------------------
Q 048432 92 ---------------KNKLRLLGCCID--------KDEKILIYEYMPNKSLDFFLF------------------------ 124 (354)
Q Consensus 92 ---------------~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~------------------------ 124 (354)
.+.++++++|.. .+..++|+||+.+++|.+++.
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 012344555432 356899999999999988762
Q ss_pred -----hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCccccc
Q 048432 125 -----DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199 (354)
Q Consensus 125 -----~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~ 199 (354)
++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++.......... ......++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCccee
Confidence 24457789999999999999999 9999999999999999999999999986443322111 11123367999
Q ss_pred CccccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCcccccchhhhhhhhccccCCCCc
Q 048432 200 SPEYAIQGI--------------------F--SIKSDVFSFGVLLLKIVSGKK-TTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 200 aPE~~~~~~--------------------~--~~~~DiwSlG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+||.+.... + ....|+||+||++|+|++|.. |+.....-..+. +.......
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~-~~~~~~~~----- 451 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL-RQYDNDLN----- 451 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH-hhccchHH-----
Confidence 999875322 1 124799999999999999875 532110000000 00000000
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCC---CCCCCHHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESA---DDRPTMNDVVSM 318 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rps~~~il~~ 318 (354)
.+................++...+|+.+||..+| .+|+|++|++++
T Consensus 452 ----------------~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 452 ----------------RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----------------HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000000000000111256778899999999876 689999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=238.60 Aligned_cols=229 Identities=24% Similarity=0.360 Sum_probs=180.0
Q ss_pred Cccc--cceecccCceeEEEEEE-cCCCEEEEEEecCCC--hhhHHHHHHHHHHhc------------eeecCCceEEEE
Q 048432 49 KFSD--ANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRS--GQGLRELKNKLRLLG------------CCIDKDEKILIY 111 (354)
Q Consensus 49 ~y~~--~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~--~~~~~~~~~i~~~~~------------~~~~~~~~~lv~ 111 (354)
=|++ .+.||+|.||+||-|++ ++|+.||||++.+.. ......++|++.++. -|.+.+.+|+||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 3444 57999999999999995 469999999997653 333456666666654 356778899999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~~l~dfg~a~~~~~ 182 (354)
|-+.|.-|.-.+ +++....-++.||+-||+|||.++ |+|+||||+|||+... ..+||+|||.|+..++
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 999764444333 556667788999999999999999 9999999999999654 4689999999998776
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... ...+||+.|+|||++....|...-|+||.|+++|--++|..||. ++.++-.+|+......|...|..
T Consensus 720 ksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN----EdEdIndQIQNAaFMyPp~PW~e-- 790 (888)
T KOG4236|consen 720 KSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN----EDEDINDQIQNAAFMYPPNPWSE-- 790 (888)
T ss_pred hhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC----CccchhHHhhccccccCCCchhh--
Confidence 6532 23589999999999999999999999999999999999998863 33445555555555555544322
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
.++...+||..+|+..=.+|.|.+.-+
T Consensus 791 ---------------------------is~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 ---------------------------ISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---------------------------cCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 566778999999999999999987654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=239.15 Aligned_cols=195 Identities=25% Similarity=0.344 Sum_probs=156.5
Q ss_pred cCccccceecccCceeEEEEE-EcCCCEEEEEEecCCChhhHHHHH---------------HHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELK---------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~~~~~~~---------------~i~~~~~~~~~~~~~~lv~ 111 (354)
+-|..++.||-|+||.|-+++ ......||.|.+.+..--..++.. =+|++|-.|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 456778999999999999998 334778899988765432222221 2256777889999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
+|++||++-.++ |.+..++-++.++.-|+++.|++| ++||||||+|||||.+|++||.|||++..+......
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999998777 788889999999999999999999 999999999999999999999999998655322110
Q ss_pred -----------ccc-----------------------------ccccCcccccCccccccCCCCchhhHHHHHHHHHHHH
Q 048432 187 -----------ANT-----------------------------GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIV 226 (354)
Q Consensus 187 -----------~~~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll 226 (354)
..+ ...+||..|.|||++....++..||.||.|++||+|+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 000 1357999999999999999999999999999999999
Q ss_pred hCCCCCCcccccchhhhhhhh
Q 048432 227 SGKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 227 ~g~~p~~~~~~~~~~~~~~~~ 247 (354)
.|++| |...+..+...++.
T Consensus 866 ~g~~p--f~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 866 VGQPP--FLADTPGETQYKVI 884 (1034)
T ss_pred hCCCC--ccCCCCCcceeeee
Confidence 99999 55555444444443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=229.56 Aligned_cols=114 Identities=26% Similarity=0.348 Sum_probs=93.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHHH----------------HHHHHhceeec----
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---RELK----------------NKLRLLGCCID---- 103 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~~----------------~i~~~~~~~~~---- 103 (354)
++|.+.++||=|.|++||+|.+. +.+.||+|+.+....... .+++ ++|++++.|.+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 79999999999999999999964 588899999976543222 2221 55677777754
Q ss_pred CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 048432 104 KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD 164 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~ 164 (354)
..++|+|+|++ |.+|..++ ++...+..|+.||+.||.|||..- +|+|.||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999998 55777777 778899999999999999999876 599999999999993
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=215.92 Aligned_cols=265 Identities=19% Similarity=0.281 Sum_probs=189.2
Q ss_pred hhcCccccceecccCceeEEEEE-EcCCCEEEEEEecCCChhhH-HHHH---------HHHHHhceeecC--CceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGL-RELK---------NKLRLLGCCIDK--DEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~~~-~~~~---------~i~~~~~~~~~~--~~~~lv~e 112 (354)
..++|++.+.+|+|.|+.||.|. ..++++++||++++.....+ ++++ ||+.+++++.+. ....+|+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 67899999999999999999999 45788999999987654433 2222 667778877654 45679999
Q ss_pred ecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccceeccCCcccccc
Q 048432 113 YMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 113 ~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
|..+.+...+. ++...++..+.++++||.|+|++| |+|||+||.|++++.. -.++|+|+|+|.+.-.+.. -
T Consensus 116 ~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---Y 189 (338)
T KOG0668|consen 116 YVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y 189 (338)
T ss_pred hhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce---e
Confidence 99888776665 777888999999999999999999 9999999999999965 4699999999986544432 2
Q ss_pred ccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 190 GRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
+..+.+..|--||++..-+ |+..-|+|||||+|..|+..+.|| |.+.++.+.+-.|.+..+.......-..-. -..|
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF-FhG~dN~DQLVkIakVLGt~el~~Yl~KY~-i~Ld 267 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVKIAKVLGTDELYAYLNKYQ-IDLD 267 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc-cCCCCCHHHHHHHHHHhChHHHHHHHHHHc-cCCC
Confidence 2335677889999987654 789999999999999999999998 666666665555555444321100000000 0011
Q ss_pred hhhhhhhhccccCCchhHH----HH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIV----CL-CILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~----~~-~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+.+.......+...-..+. .. ..++..+|+.++|..|-++|+||+|.+..
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111111111111110 00 45778899999999999999999998753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-31 Score=225.12 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=174.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHH------------HHHHHHHhceeecCC-----ce
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRE------------LKNKLRLLGCCIDKD-----EK 107 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~------------~~~i~~~~~~~~~~~-----~~ 107 (354)
-+-+--+.||.|+||.||.+.+. +|+.||+|++...-. ..... +.|++..+++.+-.. .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34566799999999999999964 699999999865311 11112 224555555443222 34
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+++|.+. .+|+..+ ++...+.-+++||++||+|||+.+ |+||||||.|.+++.+..+||+|||+++....
T Consensus 133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 56777664 3666666 667778889999999999999999 99999999999999999999999999986544
Q ss_pred CccccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... .++-.+-|-.|+|||++.+.. |+.+.||||.||++.||+.++.. |...+..+.++.|.+..+.... +....
T Consensus 209 d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL--FQAq~PiqQL~lItdLLGTPs~-EaMr~ 284 (449)
T KOG0664|consen 209 RDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL--FQAAGPIEQLQMIIDLLGTPSQ-EAMKY 284 (449)
T ss_pred hhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh--hhccChHHHHHHHHHHhCCCcH-HHHHH
Confidence 3322 233345578999999999865 89999999999999999998877 5555555555555444443221 11000
Q ss_pred cccc---------cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 262 KTFG---------FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 262 ~~~~---------~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
.+.. ...+....+...++ +.........++..+|..+|.+|.+.++.+..+..
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS-------~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIAS-------PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecC-------CcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0000 00000001111110 00123344567888999999999999988876543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=221.86 Aligned_cols=192 Identities=23% Similarity=0.339 Sum_probs=157.7
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH------HHHHH----------HHHHhceeecC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL------RELKN----------KLRLLGCCIDK 104 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~------~~~~~----------i~~~~~~~~~~ 104 (354)
.+.....+|.++++||+|+|++|.+++++ ..+.||+|++++.--... +..++ ++-+...++++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 34455678999999999999999999965 588899999875421111 11111 23455678899
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..+++|.||..||+|-..+ +++..++-....|+-||.|||++| |++||||.+|||++..|.+||.|+|++..
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999999985444 788889999999999999999999 99999999999999999999999999863
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~ 238 (354)
. .......+.++||+.|.|||++.+..|+..+|.|+||++++||+.|+.||+.-+.+
T Consensus 401 ~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~ 457 (593)
T KOG0695|consen 401 G--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD 457 (593)
T ss_pred C--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC
Confidence 2 22233445579999999999999999999999999999999999999998665544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=229.14 Aligned_cols=273 Identities=21% Similarity=0.273 Sum_probs=190.4
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCChhhHHH-----------HHHHHHHhceeecCCc
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQGLRE-----------LKNKLRLLGCCIDKDE 106 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~~~~~-----------~~~i~~~~~~~~~~~~ 106 (354)
.++...+.|.++.+||.|.|++||+|.+. ..+.||+|.+...+...... ..|++.+.+.+...+.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 46778889999999999999999999943 47789999997765543211 1378888899999999
Q ss_pred eEEEEEecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCeEEeecccceeccC-
Q 048432 107 KILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRG- 182 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~~~~~- 182 (354)
..+|+||+++....++. ++...++..+..++.||+++|++| |+||||||.|++.+ ..+...|+|||++.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 99999999999999888 778889999999999999999999 99999999999997 467889999999872110
Q ss_pred -------C----cccc------------------------------ccccccCcccccCccccccCC-CCchhhHHHHHH
Q 048432 183 -------N----ELQA------------------------------NTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGV 220 (354)
Q Consensus 183 -------~----~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~ 220 (354)
. .... ......||++|+|||++...+ .+.++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0000 001346999999999998654 689999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhhhhhhcc--------ccCCCCc--cc--CCccccccchhhhhhh-hhcccc-----CC
Q 048432 221 LLLKIVSGKKTTGFYRTYSFTLLGYISEN--------IYEFPSV--DT--HNVKTFGFLHLTIFKL-FSISSV-----GL 282 (354)
Q Consensus 221 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~--~~~~~~~~~d~~~~~~-~~~~~~-----~~ 282 (354)
++..++++..||... .++.+.+.++... ....+.. .+ .++......-..+... .+.... ..
T Consensus 267 I~Lslls~~~PFf~a-~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKA-KDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred eeehhhccccccccC-ccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999998433 3333322222111 1111111 11 1111100000000000 000000 01
Q ss_pred chhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 283 SNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+.....-.+..+.+|+.+||+.||.+|.||++.|+.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 111122245588999999999999999999998863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=203.17 Aligned_cols=202 Identities=27% Similarity=0.358 Sum_probs=157.8
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH-HHH-------------HHHHHhceee
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR-ELK-------------NKLRLLGCCI 102 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~-~~~-------------~i~~~~~~~~ 102 (354)
+..+.+....+.+.-+..||+|+||.|-+.++. +|+..|+|.+...-....+ +.. -++.+++.+.
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 444556777788888999999999999888854 6999999999765432221 222 2245667777
Q ss_pred cCCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 103 DKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
.+..+++.||.|+- +|+.+. .++.-.-+|+..+..||.|||++- .++|||+||+|||++..|.+|++|
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 88899999999965 776665 567778899999999999999876 499999999999999999999999
Q ss_pred cccceeccCCccccccccccCcccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhh
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAIQ----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI 246 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 246 (354)
||++....++- ..+...|...|+|||.+.. ..|+.++||||||+++.||.+++.|++.+... ++.++++
T Consensus 193 FGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp-F~qLkqv 265 (282)
T KOG0984|consen 193 FGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP-FQQLKQV 265 (282)
T ss_pred cccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH-HHHHHHH
Confidence 99987654433 1223467789999998853 35899999999999999999999997665443 4444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=217.04 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=192.4
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhhHH-------------HHHHHHHHhceeec-
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQGLR-------------ELKNKLRLLGCCID- 103 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~~~-------------~~~~i~~~~~~~~~- 103 (354)
..-..+++....+-+|.||.||.|.+++ .+.|.+|..+....+-.- .++|++.+.+++.+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 3344578888889999999999997652 334556665443322111 12366667676654
Q ss_pred CCceEEEEEecCCCCHhHHH-------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 104 KDEKILIYEYMPNKSLDFFL-------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
....+++++++.-|+|..++ ....+...++.|++.|+++||+.+ ++|.||..+|.++++.-.+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEE
Confidence 45678999999999999988 345677899999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
|+|=.+++..-..+.+.-.........|++||.+....|+.++|+||||+++|||++ |+.| +...+++++.-.+.++
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~P--yaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLP--YAEIDPFEMEHYLKDG 514 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCC--ccccCHHHHHHHHhcc
Confidence 999999876555444444334455779999999999999999999999999999998 8888 6666677766666555
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
-.-- .|-+||+++..+|.-||+..|++||+++|+...|++.-+.+
T Consensus 515 yRla--------------------------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 515 YRLA--------------------------------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ceec--------------------------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 4322 22239999999999999999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=229.85 Aligned_cols=238 Identities=23% Similarity=0.386 Sum_probs=194.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH------------HHHHHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR------------ELKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~------------~~~~i~~~~~~~~~~~~~~lv~ 111 (354)
.+..+|+++..+|+|.||.||+|+++ ++...|+|+++........ .+.||+.+++.|.....+++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 56689999999999999999999965 5889999998765443322 2349999999999999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||.+|+|++.. +.+.++...++..++|++|||+++ -+|||||-.||+++..|.++++|||.+......-
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--
Confidence 999999999886 778888999999999999999999 9999999999999999999999999876443322
Q ss_pred cccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 187 ANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.....+.||+.|+|||+.. .+.|...+|+|++|++..|+-.-++| ..+.-....+..+.+..++.|...+...
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp--lfdlhpmr~l~LmTkS~~qpp~lkDk~k-- 242 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP--LFDLHPMRALFLMTKSGFQPPTLKDKTK-- 242 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc--ccccchHHHHHHhhccCCCCCcccCCcc--
Confidence 1123468999999999874 56689999999999999999877777 4444455555666666666665543221
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+.+.+|++.||..+|++|||++.+|.
T Consensus 243 --------------------------ws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 243 --------------------------WSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --------------------------chHHHHHHHHHHhcCCCccCCChhhhee
Confidence 6778999999999999999999987653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=236.67 Aligned_cols=229 Identities=28% Similarity=0.389 Sum_probs=170.5
Q ss_pred ccccceecccCcee-EEEEEEcCCCEEEEEEecCCCh-hhHH---------HHHHHHHHhceeecCCceEEEEEecCCCC
Q 048432 50 FSDANKLGEGGFGP-VYKGVLKNGDEIAVKRLSGRSG-QGLR---------ELKNKLRLLGCCIDKDEKILIYEYMPNKS 118 (354)
Q Consensus 50 y~~~~~lg~G~~g~-V~~a~~~~~~~vavK~~~~~~~-~~~~---------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (354)
|--.+.+|.|..|+ ||+|.+ .|+.||||.+-...- -..+ ++.|+++++..-.+...+||..|.|.. +
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 34456788999875 599999 488999999854332 1122 234777777777888899999999976 9
Q ss_pred HhHHHhh---------HHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---C--CCeEEeecccceeccCCc
Q 048432 119 LDFFLFD---------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---D--MNPKISDFGIARICRGNE 184 (354)
Q Consensus 119 L~~~~~~---------~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~--~~~~l~dfg~a~~~~~~~ 184 (354)
|++++-. ....+..+.|++.||++||+.+ |+||||||+||||+. + ..++|+|||++.....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999822 1335788999999999999999 999999999999976 3 468999999998765543
Q ss_pred cc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 185 LQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG-KKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 185 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ...+...||-+|.|||++....-+.++||||+||++|+.++| .+||+..-.... .|..+..........
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----NIl~~~~~L~~L~~~--- 738 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----NILTGNYTLVHLEPL--- 738 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----hhhcCccceeeeccC---
Confidence 22 223456799999999999988888899999999999999986 789754322211 222233222221100
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++ ...+||.+|++.+|..||+|.+|+.
T Consensus 739 -------------------------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 739 -------------------------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------------------------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 002 6689999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-28 Score=213.04 Aligned_cols=262 Identities=23% Similarity=0.247 Sum_probs=183.1
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH-----------HHHHHHHHHhceeecC--
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL-----------RELKNKLRLLGCCIDK-- 104 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~-----------~~~~~i~~~~~~~~~~-- 104 (354)
+..+...+|.-.+.+|.|.. .|-.|-+. .+++||+|....... ... -.++|+++++.++.-.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 44556689999999999998 56555543 488999998743311 111 1234777887777543
Q ss_pred ----CceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 105 ----DEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 105 ----~~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
...|+|||+|+. +|...+ ++..++..+..|++.|+++||+.+ |+||||||+||++..++.+||.|||++
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 346899999965 777776 678889999999999999999999 999999999999999999999999999
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
+..+.. -..+..+.+..|+|||++.+..+...+||||+||++.||++|+..|. +.+..+...++.+..+......
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~--g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP--GKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec--CchHHHHHHHHHHHhcCCCHHH
Confidence 754433 23445677899999999999889999999999999999999998854 4443333333333332221110
Q ss_pred --------------cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 --------------THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 --------------~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+....+.+ .+.+....--...+.++......++++.+||.++|++|.|++++|..
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f-----~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISF-----SELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccch-----hhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 01110000000011112245667899999999999999999999976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=220.41 Aligned_cols=188 Identities=27% Similarity=0.355 Sum_probs=158.2
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------------------hH-----HHHHH
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------------------GL-----RELKN 93 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------------------~~-----~~~~~ 93 (354)
...+........|...+.||.|+||.|++|.++ +...|+||.+.+.+.- -+ ..++|
T Consensus 551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 334444556678999999999999999999976 4667899988654321 11 11459
Q ss_pred HHHHhceeecCCceEEEEEec-CCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 048432 94 KLRLLGCCIDKDEKILIYEYM-PNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167 (354)
Q Consensus 94 i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 167 (354)
|++++++|.+++++|++||-. +|.+|.+++ +++..+..|..|++.|+++||++| |+|||||=+||.++.+|
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence 999999999999999999986 455677777 789999999999999999999999 99999999999999999
Q ss_pred CeEEeecccceeccCCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 048432 168 NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTT 232 (354)
Q Consensus 168 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~ 232 (354)
.++|+|||.+....++. ...++||..|+|||++.+.+| +...|||+||++||.++....||
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99999999987655443 234689999999999999886 78899999999999999988884
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=199.34 Aligned_cols=241 Identities=16% Similarity=0.226 Sum_probs=172.4
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------------HHHHHHHHHHhce-eecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------------LRELKNKLRLLGC-CIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------------~~~~~~i~~~~~~-~~~~~~~~lv~ 111 (354)
..+.|.+.+.||+|.||.+-++.++ +.+.+++|.++..-... +..+.||+.-|++ ++..+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4578999999999999999999976 47789999987653322 2233578877664 67778888999
Q ss_pred EecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||++.|+|..-+ +.+....+++.|+++||.|+|+.+ +||||||.+||||- +..++||+|||.....+....
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 999999998888 677788999999999999999999 99999999999994 334799999999875443321
Q ss_pred ccccccccCcccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 186 QANTGRIVGTYRYMSPEYAIQG-----IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
. ..-+..|.+||++... ...+.+|+|.||+++|.+++|.+||.-....+.-..+.. ++........
T Consensus 179 ~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~-~w~~rk~~~~--- 249 (378)
T KOG1345|consen 179 Y-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE-QWLKRKNPAL--- 249 (378)
T ss_pred h-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH-HHhcccCccC---
Confidence 1 1235688999977432 246889999999999999999999752222221111111 1111000000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+..-...++.+..+.++-|..+|++|--..++-+.-+.
T Consensus 250 -----------------------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 250 -----------------------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred -----------------------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 00001156777889999999999999544444444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=192.97 Aligned_cols=193 Identities=36% Similarity=0.594 Sum_probs=158.6
Q ss_pred ecccCceeEEEEEEcC-CCEEEEEEecCCChh-----hHHHHH--------HHHHHhceeecCCceEEEEEecCCCCHhH
Q 048432 56 LGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ-----GLRELK--------NKLRLLGCCIDKDEKILIYEYMPNKSLDF 121 (354)
Q Consensus 56 lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~-----~~~~~~--------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 121 (354)
||+|++|.||++...+ ++.+++|++...... ...+.. +++++++++......++++|++.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999876542 111111 33445566666778999999999999998
Q ss_pred HH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccceeccCCccccccccccC
Q 048432 122 FL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARICRGNELQANTGRIVG 194 (354)
Q Consensus 122 ~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 194 (354)
++ ++......++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 87 467788999999999999999999 999999999999999 89999999999876544321 1122346
Q ss_pred cccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhh
Q 048432 195 TYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFK 273 (354)
Q Consensus 195 ~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 273 (354)
...|.+||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7789999998877 788999999999999999
Q ss_pred hhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 274 LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
..+.+++.+|+..+|++||+++++++.|
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2357899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=188.87 Aligned_cols=197 Identities=30% Similarity=0.408 Sum_probs=156.8
Q ss_pred ccccceecccCceeEEEEEEcC-CCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEEEEEecC
Q 048432 50 FSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
|.+.+.||.|++|.||++.... ++.+++|.+...... ....+ .+++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999765 889999999765432 22222 256677778888889999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+++|.+++ +++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999887 466778999999999999999999 999999999999999999999999998765443211 12
Q ss_pred ccccCcccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 190 GRIVGTYRYMSPEYA-IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
....+...|++||.+ ....++.++|+|+||+++++|++|+.||.........+.+.+..+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 224567789999998 5666788999999999999999999996221234445555555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=185.49 Aligned_cols=163 Identities=18% Similarity=0.142 Sum_probs=120.0
Q ss_pred CCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 117 KSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 117 ~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
|+|.+++ +++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 4566655 678999999999999999999885 999999999999999 99987543322
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
..++..|+|||++.+..++.++||||+||++|+|++|..||..... .......+...........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~------------- 128 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPADDPRD------------- 128 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccCCccc-------------
Confidence 2578999999999999999999999999999999999999632211 1111112111111100000
Q ss_pred hhhhhhccccCCchhHHHHHHH--HHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 271 IFKLFSISSVGLSNDIVCLCIL--RYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+ ........ .+.++|.+||+.+|++|||+.++++.+.....
T Consensus 129 ------------~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 ------------R-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ------------c-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0 00111233 68999999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=229.49 Aligned_cols=186 Identities=18% Similarity=0.228 Sum_probs=129.9
Q ss_pred HHHHHHhcee-------ecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 048432 92 KNKLRLLGCC-------IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158 (354)
Q Consensus 92 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 158 (354)
.|++++++++ .+...++.++|++ +++|.+++ ++...++.++.||+.||.|||+++ |+||||||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP 108 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRP 108 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCc
Confidence 4888888877 3334567788877 55999888 678889999999999999999999 99999999
Q ss_pred CCEEEcCCCC-------------------eEEeecccceeccCCcc--------------ccccccccCcccccCccccc
Q 048432 159 SNILLDKDMN-------------------PKISDFGIARICRGNEL--------------QANTGRIVGTYRYMSPEYAI 205 (354)
Q Consensus 159 ~Nill~~~~~-------------------~~l~dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~ 205 (354)
+||||+..+. ++++|||+++....... ........+|+.|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999965444 45555555542111000 00001134688899999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchh
Q 048432 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSND 285 (354)
Q Consensus 206 ~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 285 (354)
+..++.++|||||||+||||++|.+|+.... .....+.... .+. .
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~~--~~~-----------------------------~ 233 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHRV--LPP-----------------------------Q 233 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHhh--cCh-----------------------------h
Confidence 9999999999999999999999887742111 0111110000 000 0
Q ss_pred HHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 286 IVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..........++.+||+.+|.+|||+.|+++
T Consensus 234 -~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 -ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0001233467889999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-23 Score=190.87 Aligned_cols=258 Identities=22% Similarity=0.269 Sum_probs=186.8
Q ss_pred CccccceecccCceeEEEEEEcCC--CEEEEEEecCCChhhH----------HHHH------HHHHHhcee-ecCCceEE
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKNG--DEIAVKRLSGRSGQGL----------RELK------NKLRLLGCC-IDKDEKIL 109 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~~--~~vavK~~~~~~~~~~----------~~~~------~i~~~~~~~-~~~~~~~l 109 (354)
+|.+.+.||+|+||.||.+...+. ..+|+|.......... ..+. ++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 4789998866432211 1111 122223333 35567899
Q ss_pred EEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-----CCeEEeecccc
Q 048432 110 IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-----MNPKISDFGIA 177 (354)
Q Consensus 110 v~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~~l~dfg~a 177 (354)
||+.+ |.+|.++. ++..++.+++.|++.+|.+||+.| ++||||||.|+++... -.++|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 77998876 788999999999999999999999 9999999999999865 35899999999
Q ss_pred eecc--CCc----ccc-c-cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc
Q 048432 178 RICR--GNE----LQA-N-TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 178 ~~~~--~~~----~~~-~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
+... ... ... . .....||..|+++..+.+...+.+.|+||++.++.+++.|..||........ .....+.
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~~ 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEKD 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHHH
Confidence 8322 111 111 1 2345699999999999999999999999999999999999999743332211 1111111
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCC
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 329 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~ 329 (354)
........ .....+..+..++..+-..+...+|....+...|++........
T Consensus 253 ~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 253 PRKLLTDR----------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred hhhhcccc----------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 11000000 00114566777777777899999999999999999998877667
Q ss_pred CCCCccccccc
Q 048432 330 KQPAFSYVRNT 340 (354)
Q Consensus 330 ~~~~~~~~~~~ 340 (354)
...+++|+...
T Consensus 305 ~~~~~dw~~~~ 315 (322)
T KOG1164|consen 305 EDSPFDWEVKL 315 (322)
T ss_pred CCCCCcccccc
Confidence 77777776543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=172.44 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=195.7
Q ss_pred hhcCccccceecccCceeEEEEE-EcCCCEEEEEEecCCChhhH----HHHHHHH-------HHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGL----RELKNKL-------RLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~~~----~~~~~i~-------~~~~~~~~~~~~~lv~e~ 113 (354)
..+.|.+++.||+|+||.+|+|. ..+|..||||+-........ ..+-+++ .+.-+..+..+-.+||+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45799999999999999999999 56799999999876544332 2222332 234455677788899998
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CCeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~~l~dfg~a~~~~~~~ 184 (354)
+ |.+|.++. |+..+++-++.|++.-++|+|.++ ++||||||+|+|+.-+ ..+.++|||++..+....
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 7 77999887 889999999999999999999999 9999999999999743 468999999998765433
Q ss_pred ccc-----ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCccc
Q 048432 185 LQA-----NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 185 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 258 (354)
... ......||..|++--.+.+...+...|+-|+|.+|.++--|..||...... .....++|.+.....+...
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~- 247 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV- 247 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH-
Confidence 211 123467899999877777777788999999999999999999997554333 3333344433332221111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccccc
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~ 338 (354)
+.. -.|.++.-.+.-|-....++-|...-+...++-+....-....=.|+|.-
T Consensus 248 ---------------LC~------------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~ 300 (341)
T KOG1163|consen 248 ---------------LCK------------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM 300 (341)
T ss_pred ---------------HhC------------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence 000 04667777888898899999999988888888888777777777788843
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=175.30 Aligned_cols=260 Identities=19% Similarity=0.262 Sum_probs=198.7
Q ss_pred hhcCccccceecccCceeEEEEE-EcCCCEEEEEEecCCChh-hHHHHHHHH----------HHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQ-GLRELKNKL----------RLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vavK~~~~~~~~-~~~~~~~i~----------~~~~~~~~~~~~~lv~e~ 113 (354)
-+-.|++++.||+|.||.+|.|+ .-+++.||||.-...+.. .++..-+.- .++-+-....+..+|++.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 34589999999999999999999 457999999987655432 222222222 233333445566788997
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-----CeEEeecccceeccC
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-----NPKISDFGIARICRG 182 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~~l~dfg~a~~~~~ 182 (354)
+ |.+|.++. |+..++.-++.|++.-++++|++. +++|||||+|+||...+ .+.++|||+|..+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 6 77999887 889999999999999999999999 99999999999997443 589999999987765
Q ss_pred Cccccc-----cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCc
Q 048432 183 NELQAN-----TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSV 256 (354)
Q Consensus 183 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 256 (354)
...... .....||..|++=-...+...+...|+-|||-++++.+-|..||...... ..+..++|-......|.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i- 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI- 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH-
Confidence 443222 23457899999988788888899999999999999999999997554332 44444444333322211
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccc
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSY 336 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 336 (354)
.+.-...|.++..-++-.-+.+.++-|..+-+...+.++....-...+..|+|
T Consensus 261 ---------------------------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 261 ---------------------------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred ---------------------------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 11112257777788888888999999999999999999999988888888888
Q ss_pred c
Q 048432 337 V 337 (354)
Q Consensus 337 ~ 337 (354)
-
T Consensus 314 ~ 314 (449)
T KOG1165|consen 314 M 314 (449)
T ss_pred c
Confidence 4
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=175.75 Aligned_cols=218 Identities=19% Similarity=0.261 Sum_probs=140.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhh---HHHHHHH-------------------HHH---
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG---LRELKNK-------------------LRL--- 97 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~---~~~~~~i-------------------~~~--- 97 (354)
.....++...+.||.|+++.||.+.+.. |+.+|+|++.-..... ..++++. .++
T Consensus 8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 8 GQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp S--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred CCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3445577889999999999999999764 8999999985443322 2222211 111
Q ss_pred hcee---------ecC---C-----ceEEEEEecCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhcCC
Q 048432 98 LGCC---------IDK---D-----EKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQYSR 148 (354)
Q Consensus 98 ~~~~---------~~~---~-----~~~lv~e~~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~~~ 148 (354)
++.. ... . ..+++|+-+ .++|..++ ........+..|+++.+++||..|
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G- 165 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG- 165 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-
Confidence 1111 111 1 236778877 45887776 223445677799999999999999
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccC--------CCCchhhHHHHHH
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG--------IFSIKSDVFSFGV 220 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DiwSlG~ 220 (354)
++|+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+
T Consensus 166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred --eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999987655443322 1234678999977442 4788999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhh
Q 048432 221 LLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL 300 (354)
Q Consensus 221 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 300 (354)
++|.|+++..||+.......... . -..+. +.|+.++.||..
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~-------------~-------------------------f~~C~-~~Pe~v~~LI~~ 279 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW-------------D-------------------------FSRCR-DMPEPVQFLIRG 279 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG-------------G-------------------------GTTSS----HHHHHHHHH
T ss_pred HHHHHHHccCCCCCCCccccccc-------------c-------------------------chhcC-CcCHHHHHHHHH
Confidence 99999999999764422211110 0 00011 278999999999
Q ss_pred ccccCCCCC
Q 048432 301 CVQESADDR 309 (354)
Q Consensus 301 cl~~~P~~R 309 (354)
+|+.||++|
T Consensus 280 lL~~~~~~R 288 (288)
T PF14531_consen 280 LLQRNPEDR 288 (288)
T ss_dssp HT-SSGGGS
T ss_pred HccCCcccC
Confidence 999999988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=178.90 Aligned_cols=163 Identities=18% Similarity=0.226 Sum_probs=118.2
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEc--CCCEEEEEEecCC-----ChhhHHHHHHHHHHhce---------ee
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK--NGDEIAVKRLSGR-----SGQGLRELKNKLRLLGC---------CI 102 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vavK~~~~~-----~~~~~~~~~~i~~~~~~---------~~ 102 (354)
+-+......++|.+.+.||+|+||+||+|.++ +++.||||++... .......+.++++++.. +.
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 34455666789999999999999999999865 5778899987533 11122334444443321 12
Q ss_pred cCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCEEEcCCCCeEEeecccceecc
Q 048432 103 DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL-KVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
..+..|+||||++|++|... .. .....++.+++.+|.|||+.| |+|||| ||+||+++.++.++|+|||++....
T Consensus 89 ~~~~~~LVmE~~~G~~L~~~-~~-~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 89 ATGKDGLVRGWTEGVPLHLA-RP-HGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EcCCcEEEEEccCCCCHHHh-Cc-cchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 23567999999999999632 11 122578899999999999999 999999 9999999999999999999998665
Q ss_pred CCccccc------cccccCcccccCcccccc
Q 048432 182 GNELQAN------TGRIVGTYRYMSPEYAIQ 206 (354)
Q Consensus 182 ~~~~~~~------~~~~~~~~~y~aPE~~~~ 206 (354)
....... -....++..|.+||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4321111 023456778999998853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-22 Score=199.68 Aligned_cols=234 Identities=19% Similarity=0.224 Sum_probs=162.8
Q ss_pred CccccceecccCceeEEEEEEcCCCEEEEEEecCCC-hhhH-------HHHH-------HHHHHhceeecCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS-GQGL-------RELK-------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~-~~~~-------~~~~-------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+|...+.||++-|=+|.+|++++|. |++|++-+.. .-.+ .+++ |.+.+..+...++.-|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 8899999999999999999998887 8999985543 2222 2222 223333444556666788888
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc--CCccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR--GNELQ 186 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~--~~~~~ 186 (354)
..+ +|.+.+ +..-...-|+-|++.||..+|..| |+|||||.+||||+.-..++|+||..-..+. ...+.
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 755 777777 566778889999999999999999 9999999999999999999999998754221 11111
Q ss_pred cc---cccccCcccccCccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcccc
Q 048432 187 AN---TGRIVGTYRYMSPEYAIQG----------I-FSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 187 ~~---~~~~~~~~~y~aPE~~~~~----------~-~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
.. ...-....+|.|||.+... + .+++.||||+||++.||++ |.+||.... ++..- .+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr-~~~~ 252 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYR-SGNA 252 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHh-ccCc
Confidence 11 1111234599999998541 2 5789999999999999988 567753210 00000 0000
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
..+.. .+. .-....++.||..|++.||++|.||++.|+--++
T Consensus 253 ~~~e~----------------~Le------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 253 DDPEQ----------------LLE------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCHHH----------------HHH------------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00000 000 0034467899999999999999999999987544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=193.93 Aligned_cols=240 Identities=20% Similarity=0.276 Sum_probs=168.1
Q ss_pred cCc-cccceecccCceeEEEEEEcC-CCEEEEEEec----CCChhhH-H-------------HHHHHHHHhceeecCCce
Q 048432 48 NKF-SDANKLGEGGFGPVYKGVLKN-GDEIAVKRLS----GRSGQGL-R-------------ELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 48 ~~y-~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~----~~~~~~~-~-------------~~~~i~~~~~~~~~~~~~ 107 (354)
..| ...+.+|.|.+|.|+.+.... ...++.|.+. ....... . .+.+++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 578899999999888887443 3334444433 1111111 1 112444444444444444
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
.-.||||++ +|..++ +....+--++.|++.|++|+|..| |.|||+|++|++++.+|.++++|||.+..+..
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 455999999 887777 456778889999999999999999 99999999999999999999999999875543
Q ss_pred Cccc--cccccccCcccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 183 NELQ--ANTGRIVGTYRYMSPEYAIQGIFS-IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 183 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... ......+|+..|.|||++.+..|. ...||||.|++++.|.+|+.||............. .....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--~~~~~------- 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--NYSDQ------- 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--ccccc-------
Confidence 3322 344557899999999999998886 46999999999999999999975443332211000 00000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..............+...+.+|.+||+.+|.+|.|+++|++
T Consensus 544 -----------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 -----------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -----------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001122223346788899999999999999999999875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=190.28 Aligned_cols=244 Identities=18% Similarity=0.193 Sum_probs=183.0
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh-------hhHHHH-----HHHHHHhceeecCCce
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG-------QGLREL-----KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~-------~~~~~~-----~~i~~~~~~~~~~~~~ 107 (354)
..+.+.-+..|.|.+.||.|+||+||.|...+|+.||||+-+.... +.+.++ .-+..+...+...+.-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3455667789999999999999999999988899999999876542 222222 3556677778888899
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-------CCCeEEeecc
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-------DMNPKISDFG 175 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~~~~~l~dfg 175 (354)
++|++|.+.|+|.+++ +++..+..++.|+++.+..||..+ |+|+||||+|+++.. ...++|+|||
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999998 889999999999999999999999 999999999999952 3458999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
.+--..-...........+|-.+-++|+..+.+|+..+|.|.|+.+++-|+.|+..- .+.+......
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~~g~~~~~~ 913 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VKNGSSWMVK 913 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hcCCcceecc
Confidence 875332222222233346788999999999999999999999999999999998551 1111110000
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
.. .+ +.. --+.+..|+..+|+.+-..=|...+|...|+++....
T Consensus 914 ~~---~~--------------------Ry~----~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 914 TN---FP--------------------RYW----KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred cc---ch--------------------hhh----hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 00 00 000 2334567888888844444578888888888877543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=155.39 Aligned_cols=124 Identities=20% Similarity=0.204 Sum_probs=95.1
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEecCCChh--h----------------------------HHHHHHHHHHhcee
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ--G----------------------------LRELKNKLRLLGCC 101 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~--~----------------------------~~~~~~i~~~~~~~ 101 (354)
+...||+|++|.||+|...+|+.||+|++...... . ..+++++.++....
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999999999878999999999654211 0 11334444443211
Q ss_pred e------cCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHH-HhcCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 102 I------DKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYL-HQYSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 102 ~------~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
. .....++||||++++++.... ++......++.|++.+|.++ |+.| |+||||||+||+++ ++.+
T Consensus 81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 1 112338999999988765442 67788999999999999999 6888 99999999999998 5789
Q ss_pred EEeeccccee
Q 048432 170 KISDFGIARI 179 (354)
Q Consensus 170 ~l~dfg~a~~ 179 (354)
+|+|||++..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-18 Score=159.78 Aligned_cols=239 Identities=27% Similarity=0.343 Sum_probs=175.3
Q ss_pred ccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHHH-------------HHHHHhceeecCCceEEEEEe
Q 048432 50 FSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK-------------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~~-------------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
|.+.+.||.|+||.||.+.+. ..+++|.+....... ...+. +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788999999999999999986 778999886543322 22221 355556666666667999999
Q ss_pred cCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~~ 184 (354)
+.++++..++ +.......++.|++.++.++|..+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999998555 234577899999999999999999 99999999999999988 79999999987544433
Q ss_pred ccc----ccccccCcccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccC-CC
Q 048432 185 LQA----NTGRIVGTYRYMSPEYAIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYE-FP 254 (354)
Q Consensus 185 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-~~ 254 (354)
... ......++..|.+||.+.+ .......|+|++|+++++++.|..||...... .......+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2345678999999999987 57889999999999999999999995444331 23333333322222 11
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
........ ......+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP-------------------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc-------------------------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10000000 1134677899999999999999998877764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=167.56 Aligned_cols=181 Identities=20% Similarity=0.222 Sum_probs=130.4
Q ss_pred cCCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CC--CCeEEeec
Q 048432 103 DKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KD--MNPKISDF 174 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~--~~~~l~df 174 (354)
+...+|+||...+. +|..++ .+.....-|+.|++.|+.+||++| +.|||+|.+|||+. ++ ..+.++||
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccc
Confidence 34578999999877 888888 567778889999999999999999 99999999999994 23 35799999
Q ss_pred ccceeccCCcccccc----ccccCcccccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhh
Q 048432 175 GIARICRGNELQANT----GRIVGTYRYMSPEYAIQGI------FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244 (354)
Q Consensus 175 g~a~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~------~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~ 244 (354)
|++............ -..-|.-..+|||+....+ .-.++|.|+.|.+.||+++...||...+.--.+...
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 998765542221111 1124667889999887543 125799999999999999999995332222222222
Q ss_pred hhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 245 YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
..+... +.++..+++.+++++...|+.||++|+|+.-....|.
T Consensus 470 Yqe~qL---------------------------------Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 470 YQESQL---------------------------------PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhhC---------------------------------CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 222222 2222337888999999999999999999865555443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.8e-19 Score=150.42 Aligned_cols=126 Identities=23% Similarity=0.279 Sum_probs=95.3
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEecCCChh------------------------------hHHHHHHHHHHhcee
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ------------------------------GLRELKNKLRLLGCC 101 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~------------------------------~~~~~~~i~~~~~~~ 101 (354)
+.+.||+|++|.||+|.+.+|+.||||++...... ...++.++.++....
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999999778999999998764211 012233444432221
Q ss_pred ec------CCceEEEEEecCCCCHhHH-H----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 102 ID------KDEKILIYEYMPNKSLDFF-L----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 102 ~~------~~~~~lv~e~~~~~~L~~~-~----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
.. ....++||||++|+++... + ++......++.|++.++.++|+ .| |+|+||||+||+++ ++.+
T Consensus 81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence 11 1224899999998855433 2 5566888999999999999999 98 99999999999999 8899
Q ss_pred EEeecccceecc
Q 048432 170 KISDFGIARICR 181 (354)
Q Consensus 170 ~l~dfg~a~~~~ 181 (354)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=155.81 Aligned_cols=232 Identities=24% Similarity=0.326 Sum_probs=171.8
Q ss_pred cCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh-----hh---------HHHHHHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG-----QG---------LRELKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~-----~~---------~~~~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
+++.+..+|.....|..|++++. |..+++|++....- .. +-.+.||+.+++.|...+.+.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 46677889999999999999995 55677777643211 11 11234999999999999999999999
Q ss_pred cCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE--eecccceeccCCc
Q 048432 114 MPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI--SDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l--~dfg~a~~~~~~~ 184 (354)
|+.|+|...+ .+..++.+++.++++|++|||+..+ -|.---|....|+++.+.+.+| +|-.++......
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfqe~gr- 346 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGR- 346 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeeecccc-
Confidence 9999999888 6788999999999999999999862 2333457888999998876544 444443321111
Q ss_pred cccccccccCcccccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIF---SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.-.+.|++||.+...+- -.++|+|||++++|||.|+..||.. -.+.+.--++
T Consensus 347 --------~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad--lspmecgmki--------------- 401 (448)
T KOG0195|consen 347 --------AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD--LSPMECGMKI--------------- 401 (448)
T ss_pred --------ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc--CCchhhhhhh---------------
Confidence 12578999999977653 3579999999999999999999532 2222221111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
...+++...++-.+..+..||.-|.+.||.+||.++.|+-.|+...
T Consensus 402 ----------------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ----------------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----------------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1123344444447788899999999999999999999999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=155.56 Aligned_cols=161 Identities=14% Similarity=0.109 Sum_probs=114.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-------------HHHHHHHH--------Hhceee
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-------------RELKNKLR--------LLGCCI 102 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-------------~~~~~i~~--------~~~~~~ 102 (354)
....++|++.+.||.|+||.||++.. ++..+|+|++........ ++..+..+ +..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999766 577899999965422111 11111222 222222
Q ss_pred --------cCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 103 --------DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 103 --------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
.....+++|||++|.+|.++.... .....+++.++..+|..| ++|+|++|.||+++.+| ++++||
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~---~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPEIS---EDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhhcc---HHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEEC
Confidence 134578999999999998774111 235669999999999999 99999999999999988 999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHH
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIV 226 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll 226 (354)
|.......... ...++....++.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 98754321110 011333445667899999999988664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=163.84 Aligned_cols=204 Identities=24% Similarity=0.368 Sum_probs=157.1
Q ss_pred HHHHHHHHhceeecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCe-EeCCCCCCCEE
Q 048432 90 ELKNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRI-IHRDLKVSNIL 162 (354)
Q Consensus 90 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~dlkp~Nil 162 (354)
.+.|+.++++.+.+.+..++|.+||..|+|.+.+ +++.-...++++|+.||.|||... | .|+.++..|.+
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKSSNCL 81 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeeccccce
Confidence 4678999999999999999999999999999998 667778899999999999999887 6 99999999999
Q ss_pred EcCCCCeEEeecccceeccCCccccccccccCcccccCccccccC---C----CCchhhHHHHHHHHHHHHhCCCCCCcc
Q 048432 163 LDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG---I----FSIKSDVFSFGVLLLKIVSGKKTTGFY 235 (354)
Q Consensus 163 l~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~----~~~~~DiwSlG~~l~~ll~g~~p~~~~ 235 (354)
++....+|+.|||+.....................|.|||.+... . .+.++|+||+|++++|+++...||...
T Consensus 82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR 161 (484)
T ss_pred eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence 999999999999997654321111111112235689999988763 1 467899999999999999999997664
Q ss_pred ccc--chhhhhhhhc-ccc-CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC
Q 048432 236 RTY--SFTLLGYISE-NIY-EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT 311 (354)
Q Consensus 236 ~~~--~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 311 (354)
... ..++...+.+ +.. ..|..... . ..++.+..++.+||..+|++||+
T Consensus 162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~------------------------~----e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 162 NLVEDPDEIILRVKKGGSNPFRPSIELL------------------------N----ELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred cccCChHHHHHHHHhcCCCCcCcchhhh------------------------h----hcchHHHHHHHHhcccChhhCcc
Confidence 333 3345555444 111 11111100 0 14557889999999999999999
Q ss_pred HHHHHHHhhhhhh
Q 048432 312 MNDVVSMLTNEAA 324 (354)
Q Consensus 312 ~~~il~~L~~~~~ 324 (354)
++++...++.+..
T Consensus 214 ~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 214 IEQIRSKLLTINK 226 (484)
T ss_pred HHHHHhhhhhhcc
Confidence 9999999888774
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.8e-19 Score=175.32 Aligned_cols=214 Identities=21% Similarity=0.314 Sum_probs=154.1
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHHHHHHHHhceeecCCceEEEEEecCCCCHh
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEKILIYEYMPNKSLD 120 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (354)
......++|..++.|..|+||.||.++++. .+.+|+|+-+. .. -.+||+.+ .+..++| -+..+|.
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l----ilRnilt~------a~npfvv---gDc~tll 142 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----ILRNILTF------AGNPFVV---GDCATLL 142 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhccccc-ch----hhhccccc------cCCccee---chhhhhc
Confidence 444556789999999999999999999864 77888843322 11 12233222 2233333 1111221
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc-------------c
Q 048432 121 FFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ-------------A 187 (354)
Q Consensus 121 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~-------------~ 187 (354)
..+ -..-.+++.+++|||..+ |+|||+||+|.+|+.-|++|+.|||+.......... .
T Consensus 143 k~~------g~lPvdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef 213 (1205)
T KOG0606|consen 143 KNI------GPLPVDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEF 213 (1205)
T ss_pred ccC------CCCcchhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHh
Confidence 111 011112277999999999 999999999999999999999999987543221110 0
Q ss_pred ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....+||+.|.|||++.-..|+..+|.|++|+++|+.+-|..| |.+.+..+++.........+|...+.
T Consensus 214 ~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvp--ffGdtpeelfg~visd~i~wpE~dea-------- 283 (1205)
T KOG0606|consen 214 QDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP--FFGDTPEELFGQVISDDIEWPEEDEA-------- 283 (1205)
T ss_pred hhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeee--ccCCCHHHHHhhhhhhhccccccCcC--------
Confidence 11224899999999999999999999999999999999999999 77888888888877666665554322
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP 310 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 310 (354)
.+++.+++|.++|+.+|..|.
T Consensus 284 ----------------------~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 284 ----------------------LPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----------------------CCHHHHHHHHHHHHhChHhhc
Confidence 566788999999999999996
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-19 Score=167.91 Aligned_cols=208 Identities=24% Similarity=0.303 Sum_probs=158.8
Q ss_pred eecccCceeEEEEE----EcCCCEEEEEEecCCChhhH--------HHHH-------HHHHHhceeecCCceEEEEEecC
Q 048432 55 KLGEGGFGPVYKGV----LKNGDEIAVKRLSGRSGQGL--------RELK-------NKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 55 ~lg~G~~g~V~~a~----~~~~~~vavK~~~~~~~~~~--------~~~~-------~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.+|.|.||.|++++ ...|+.+|+|+.++...... +.+. -++++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999887 22477889888765432111 1111 22334445677788899999999
Q ss_pred CCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccc
Q 048432 116 NKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190 (354)
Q Consensus 116 ~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~ 190 (354)
+|.+...+ +++.........++-++..+|+.+ ++|+|+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 98876555 677778888889999999999999 999999999999999999999999998754333322
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 270 (354)
+|+..|+|||++. ....++|.||+|++.++|++|..||.- +....|.+.....|.
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~~p~--------------- 208 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELEMPR--------------- 208 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccCCch---------------
Confidence 8899999999998 567899999999999999999999543 444444443333322
Q ss_pred hhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
......++++..++..+|.+|.-.
T Consensus 209 ------------------~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ------------------ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ------------------hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 245667789999999999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-18 Score=158.35 Aligned_cols=117 Identities=31% Similarity=0.444 Sum_probs=104.2
Q ss_pred CceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 105 DEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
.++||.|++|...+|.+++ .++.....++.|++.++.| ++ .+|+|+||.||++..+..++|.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999 5678889999999999999 77 99999999999999999999999999
Q ss_pred ceeccCCc----cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 048432 177 ARICRGNE----LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227 (354)
Q Consensus 177 a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~ 227 (354)
........ ....++...||..|++||.+.+..|+.++|||+||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87655444 3334556789999999999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=135.58 Aligned_cols=134 Identities=22% Similarity=0.199 Sum_probs=100.8
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh--------------------------hHHHHHHHHHH
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ--------------------------GLRELKNKLRL 97 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~i~~~ 97 (354)
......|.+.+.||.|++|.||++..++|+.||||++...... ...++..+..+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 3344458899999999999999999888999999987643210 11112222222
Q ss_pred hce------eecCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 98 LGC------CIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 98 ~~~------~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
... .......+++|||++|++|..... ......++.+++.++.++|+.+ ++|+||+|.||+++.++.++|
T Consensus 91 ~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~-~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 91 YEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRV-LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred HHcCCCCCceeecCCceEEEEEeCCcchhhccc-cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEE
Confidence 221 112345689999999999876642 2456688999999999999999 999999999999999999999
Q ss_pred eecccceecc
Q 048432 172 SDFGIARICR 181 (354)
Q Consensus 172 ~dfg~a~~~~ 181 (354)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999986433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.7e-16 Score=131.62 Aligned_cols=175 Identities=17% Similarity=0.106 Sum_probs=121.7
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH----HHHHHHHHHhcee---------ecCCceEEEEEecCCC
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL----RELKNKLRLLGCC---------IDKDEKILIYEYMPNK 117 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~----~~~~~i~~~~~~~---------~~~~~~~lv~e~~~~~ 117 (354)
.+...|++|+||+|+.+.. .+.+++.+.+....--.. ..+.++++++..+ ..-+..+++|+|+.|.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 4678999999999998877 688888887765543111 1122333222221 1124569999999999
Q ss_pred CHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCEEEcCCCCeEEeecccceeccCCccc----cc----
Q 048432 118 SLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL-KVSNILLDKDMNPKISDFGIARICRGNELQ----AN---- 188 (354)
Q Consensus 118 ~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~~l~dfg~a~~~~~~~~~----~~---- 188 (354)
+|...... ....++.|++.+|.++|..| |+|||| ||+||+++.++.++|+|||++......... ..
T Consensus 84 ~L~~~~~~--~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 84 AMYQRPPR--GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred cHHhhhhh--hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence 98755421 12457889999999999999 999999 799999999999999999999754432210 00
Q ss_pred ---cccccCcccccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCC
Q 048432 189 ---TGRIVGTYRYMSPEYAIQG-IFS-IKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 189 ---~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwSlG~~l~~ll~g~~p 231 (354)
+.....++.++.|+...-. ..+ ...+.++.|+-+|.++|++.+
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 1111245566777654322 233 567888999999999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=139.38 Aligned_cols=137 Identities=20% Similarity=0.178 Sum_probs=102.0
Q ss_pred cccchhhhhcCccccceecccCceeEEEEE--EcCCCEEEEEEecCCChh----------------------------hH
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGV--LKNGDEIAVKRLSGRSGQ----------------------------GL 88 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~--~~~~~~vavK~~~~~~~~----------------------------~~ 88 (354)
.+-.+...+.-|.+.+.||+|++|.||+|. ..+|+.||+|++...... ..
T Consensus 19 ~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (237)
T smart00090 19 ALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE 98 (237)
T ss_pred HHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence 334444455568999999999999999998 457999999998653210 01
Q ss_pred HHHHHHHHHhc-------eeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 048432 89 RELKNKLRLLG-------CCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156 (354)
Q Consensus 89 ~~~~~i~~~~~-------~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 156 (354)
.++.+..++.. .+. ....++||||+.+.++.... ........++.|++.++.+||+.+ .++|+||
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~-~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIA-WRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeE-ecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 23333333322 122 23458999999998876554 344556789999999999999886 4999999
Q ss_pred CCCCEEEcCCCCeEEeeccccee
Q 048432 157 KVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 157 kp~Nill~~~~~~~l~dfg~a~~ 179 (354)
||+||+++ ++.++|+|||.+..
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhc
Confidence 99999999 88999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.6e-15 Score=127.15 Aligned_cols=123 Identities=24% Similarity=0.271 Sum_probs=91.0
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEecCCChhh----------------------------HHHHHHHHHHhce---
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG----------------------------LRELKNKLRLLGC--- 100 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~----------------------------~~~~~~i~~~~~~--- 100 (354)
+.+.||+|++|.||+|...+|+.||+|++....... ..++.++.++...
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467899999999999998789999999986532110 0112222222221
Q ss_pred ---eecCCceEEEEEecCCCC-----HhHHHhhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 101 ---CIDKDEKILIYEYMPNKS-----LDFFLFDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 101 ---~~~~~~~~lv~e~~~~~~-----L~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
.......+++|||++++. +...... .....++.+++.++.++|. .+ |+|+||+|+||+++ ++.+++
T Consensus 81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~l 155 (187)
T cd05119 81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYI 155 (187)
T ss_pred CCceEecCCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEE
Confidence 111234689999999943 3333222 6678999999999999999 88 99999999999999 889999
Q ss_pred eeccccee
Q 048432 172 SDFGIARI 179 (354)
Q Consensus 172 ~dfg~a~~ 179 (354)
+|||.+..
T Consensus 156 iDfg~a~~ 163 (187)
T cd05119 156 IDVPQAVE 163 (187)
T ss_pred EECccccc
Confidence 99999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-14 Score=125.45 Aligned_cols=122 Identities=21% Similarity=0.317 Sum_probs=92.8
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChh--h------HHHHHHHHHH------------hceeecCCceEEEEE
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ--G------LRELKNKLRL------------LGCCIDKDEKILIYE 112 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~--~------~~~~~~i~~~------------~~~~~~~~~~~lv~e 112 (354)
.+.||+|++|.||+|.+ .|..|++|+....... . .....++..+ ..++......+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999988 6788999987543211 0 0111122111 123345667889999
Q ss_pred ecCCCCHhHHHhh-HHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 113 YMPNKSLDFFLFD-WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 113 ~~~~~~L~~~~~~-~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
|++|++|.+++.. ......++.+++.++.++|..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988721 1267899999999999999999 99999999999999 78899999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.7e-14 Score=123.02 Aligned_cols=118 Identities=26% Similarity=0.378 Sum_probs=88.8
Q ss_pred eecccCceeEEEEEEcCCCEEEEEEecCCCh--hh------HHHHHHHHHHh------------ceeecCCceEEEEEec
Q 048432 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QG------LRELKNKLRLL------------GCCIDKDEKILIYEYM 114 (354)
Q Consensus 55 ~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~------~~~~~~i~~~~------------~~~~~~~~~~lv~e~~ 114 (354)
.||+|++|.||+|.+ +|..|++|+...... .. .....++++++ .++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 578899998654321 10 11122222211 1233455678999999
Q ss_pred CCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 115 PNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 115 ~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+|++|.+++..... .++.+++.+|.+||..+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887633222 88999999999999999 99999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=125.40 Aligned_cols=120 Identities=23% Similarity=0.287 Sum_probs=86.6
Q ss_pred ccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh----HH-------------HHHHHHHHhceeecCC---ceE-
Q 048432 50 FSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG----LR-------------ELKNKLRLLGCCIDKD---EKI- 108 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~----~~-------------~~~~i~~~~~~~~~~~---~~~- 108 (354)
+.-...||+|++|.||. ++.....+||++....... .+ .+.||+++++++.++. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568899999999996 4433334799886542211 11 1247778888887764 334
Q ss_pred EEEEe--cCCCCHhHHHh----hHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCCEEEcC----CCCeEEeeccc
Q 048432 109 LIYEY--MPNKSLDFFLF----DWVTRVRIIEGIAQGL-LYLHQYSRVRIIHRDLKVSNILLDK----DMNPKISDFGI 176 (354)
Q Consensus 109 lv~e~--~~~~~L~~~~~----~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nill~~----~~~~~l~dfg~ 176 (354)
+|+|| +.+++|.+++- +.. ..++.+++.++ .|||+++ |+||||||+||+++. ++.++|+||+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 55799999982 333 35677888777 8999999 999999999999974 34799999543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8e-16 Score=152.31 Aligned_cols=236 Identities=21% Similarity=0.274 Sum_probs=178.0
Q ss_pred hhcCccccceecccCceeEEEEEEcC--CCEEEEEEecCCCh---------------hhHHHHHHHHHHhceeecCCceE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN--GDEIAVKRLSGRSG---------------QGLRELKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~--~~~vavK~~~~~~~---------------~~~~~~~~i~~~~~~~~~~~~~~ 108 (354)
....|.+.+.||+|.++.|-++.... ...+|.|.+..... .....+.|++.+++...+....+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 56788899999999999998888533 44456665543321 01112558888899999999999
Q ss_pred EEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCCCEEEcCCC-CeEEeeccccee
Q 048432 109 LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLH-QYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARI 179 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~ 179 (354)
+++++..|+++...+ .+....-....|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999887666 334567889999999999999 888 99999999999999999 999999999987
Q ss_pred ccC-CccccccccccC-cccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc--CCC
Q 048432 180 CRG-NELQANTGRIVG-TYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY--EFP 254 (354)
Q Consensus 180 ~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 254 (354)
+.. ..........+| +..|.|||...+. ...+..|+||+|+++.-+++|..||.+...........+..... ..+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 666 333333344577 9999999998874 45789999999999999999999987665554333333222111 111
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
+.. ......+++.+++..+|+.|.+.+++-
T Consensus 255 ~~~--------------------------------~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 255 WNS--------------------------------ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccc--------------------------------CChhhhhcccccccCCchhcccccccc
Confidence 100 445567899999999999999987654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.1e-14 Score=138.78 Aligned_cols=132 Identities=21% Similarity=0.337 Sum_probs=94.8
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCC--Chh------hHHHHHHHHHHh------------c
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR--SGQ------GLRELKNKLRLL------------G 99 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~--~~~------~~~~~~~i~~~~------------~ 99 (354)
..........|...+.||+|+||.||++.+... .+++|+.... ... ....+.++++++ .
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333344455667799999999999999987543 3444443211 111 112222333222 2
Q ss_pred eeecCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
++......++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||++..
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 2334556789999999999988764 45788999999999999999 9999999999999 678899999999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-13 Score=129.37 Aligned_cols=126 Identities=25% Similarity=0.249 Sum_probs=91.8
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChhhHH-------------------------------------------
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLR------------------------------------------- 89 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~------------------------------------------- 89 (354)
.+.||+|++|+||+|+.++|+.||||+.++.......
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5789999999999999999999999998765322111
Q ss_pred -HHHHHHHHhceeec-------------CCceEEEEEecCCCCHhHHHhhH---HHHHHHHHHHHH-HHHHHHhcCCCCe
Q 048432 90 -ELKNKLRLLGCCID-------------KDEKILIYEYMPNKSLDFFLFDW---VTRVRIIEGIAQ-GLLYLHQYSRVRI 151 (354)
Q Consensus 90 -~~~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~---~~~~~i~~~i~~-~l~~LH~~~~~~i 151 (354)
+..|..++...+.+ ....++||||++|+++.+..... .....++..++. .+..+|..| +
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g---~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG---F 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---c
Confidence 11122233222222 23457999999999998765211 123456666666 467899999 9
Q ss_pred EeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 152 IHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 152 ~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+|+|++|.||+++.++.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=9e-13 Score=107.43 Aligned_cols=124 Identities=25% Similarity=0.243 Sum_probs=93.9
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEecCCCh--hhHHHHH---H-------HHHHhceeecCCceEEEEEecCCCCH
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QGLRELK---N-------KLRLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~~~~~~---~-------i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
+.+.||.|.++.||++...+ ..+++|....... ....+.. . +.+++.+....+..++++||+.+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46789999999999999854 7799999876543 1111111 1 11223334445678999999999877
Q ss_pred hHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 120 DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 120 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..+ +......++.+++.+++.+|.....+++|+|++|.||+++..+.++++||+.+.
T Consensus 81 ~~~--~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 81 DEV--SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ccC--CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 654 556677889999999999998633349999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-12 Score=126.71 Aligned_cols=134 Identities=21% Similarity=0.183 Sum_probs=91.7
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhh------------------------------------
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG------------------------------------ 87 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~------------------------------------ 87 (354)
.....|.. +.||+|++|+||+|+.++ |+.||||+..+.-...
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34456776 899999999999999887 9999999997542111
Q ss_pred --------HHHHHHHHHHhceeecCCc-------------eEEEEEecCCCCHhHHH-hhH--HHHHHHHHHHHHH-HHH
Q 048432 88 --------LRELKNKLRLLGCCIDKDE-------------KILIYEYMPNKSLDFFL-FDW--VTRVRIIEGIAQG-LLY 142 (354)
Q Consensus 88 --------~~~~~~i~~~~~~~~~~~~-------------~~lv~e~~~~~~L~~~~-~~~--~~~~~i~~~i~~~-l~~ 142 (354)
..+..|+.++...+.+.+. .++||||++|+.+.+.. +.. .....++...+.. +..
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1112255555555444433 35999999999997753 111 0111233332222 334
Q ss_pred HHhcCCCCeEeCCCCCCCEEEcCCC----CeEEeecccceeccC
Q 048432 143 LHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGIARICRG 182 (354)
Q Consensus 143 LH~~~~~~i~H~dlkp~Nill~~~~----~~~l~dfg~a~~~~~ 182 (354)
+...| ++|+|++|.||+++.+| .++++|||+......
T Consensus 276 if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 55677 99999999999999888 999999999876543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-12 Score=115.29 Aligned_cols=123 Identities=20% Similarity=0.228 Sum_probs=85.1
Q ss_pred cceec-ccCceeEEEEEEcCCCEEEEEEecCCCh-----------------hhHHHHHHHHHH----------hceeec-
Q 048432 53 ANKLG-EGGFGPVYKGVLKNGDEIAVKRLSGRSG-----------------QGLRELKNKLRL----------LGCCID- 103 (354)
Q Consensus 53 ~~~lg-~G~~g~V~~a~~~~~~~vavK~~~~~~~-----------------~~~~~~~~i~~~----------~~~~~~- 103 (354)
...|| .||.|+||.+... +..++||.+..... ...+++....++ +++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999884 77899998843110 011122211111 122111
Q ss_pred CCc---eEEEEEecCC-CCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 104 KDE---KILIYEYMPN-KSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 104 ~~~---~~lv~e~~~~-~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
... .++|+|+++| .+|.+++-........+.+|+.+|.+||+.| |+|+||||.|||++.++.++|+|||.+..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 111 2499999997 6887776222112334678999999999999 99999999999999999999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.6e-12 Score=111.98 Aligned_cols=137 Identities=23% Similarity=0.277 Sum_probs=104.5
Q ss_pred HHHHHHhceeecC-----CceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 048432 92 KNKLRLLGCCIDK-----DEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK 157 (354)
Q Consensus 92 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 157 (354)
.|++++..++.+. ....++.||+..|++..++ +......+|+.||+.||.|||+.. +.|+|+++.
T Consensus 127 snlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlT 205 (458)
T KOG1266|consen 127 SNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLT 205 (458)
T ss_pred HHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcc
Confidence 3778888877544 4578899999999999998 456677899999999999999984 679999999
Q ss_pred CCCEEEcCCCCeEEeecccc--eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCC
Q 048432 158 VSNILLDKDMNPKISDFGIA--RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229 (354)
Q Consensus 158 p~Nill~~~~~~~l~dfg~a--~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~ 229 (354)
.+.|++..+|-+++.--... +..-.......++...+.++|.+||.-.....+-++|||++|....+|..+.
T Consensus 206 c~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 206 CDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred hhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999998887532211 1111122222334456678999999666666778899999999999998766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-10 Score=105.70 Aligned_cols=260 Identities=15% Similarity=0.132 Sum_probs=165.4
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH-HHH-------------HHHhce-e-ecC-CceEEEEEe
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL-KNK-------------LRLLGC-C-IDK-DEKILIYEY 113 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~-~~i-------------~~~~~~-~-~~~-~~~~lv~e~ 113 (354)
...+.||+|+.+.+|-.-.- + ..+.|++.........+. ... +--... + -+. ..+-++|+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CCCccccCCccceeeecchh-h-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 35789999999999976521 1 135588876544332221 111 110111 1 112 225678888
Q ss_pred cCCCCHh-HHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 114 MPNKSLD-FFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 114 ~~~~~L~-~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+.+..-- .+. .+|.-..+.+..++.+.+.||..| .+-+|++++|+||+.++.+.|+|-+.-..+.
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeecc
Confidence 8775222 222 678889999999999999999999 9999999999999999999999887665554
Q ss_pred CCccccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhC-CCCCCccccc--chhhhh-hhhccccC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSG-KKTTGFYRTY--SFTLLG-YISENIYE 252 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g-~~p~~~~~~~--~~~~~~-~~~~~~~~ 252 (354)
++.... ..+|...|.+||...- ...+...|.|.||+++++++.| ++||..-... .....+ .|..+...
T Consensus 169 ng~~~~---cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 169 NGTLHL---CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred CCceEe---cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 444333 2478889999997752 2356789999999999999886 7885322111 001111 12222211
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhcccc--CCCCCCCHHHHHHHhhhhhhhcCCCC
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQE--SADDRPTMNDVVSMLTNEAAALLPPK 330 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~Rps~~~il~~L~~~~~~~~~~~ 330 (354)
......... .+ ..+...-...++.+..|..+|+.. ++.-|||++..+.+|..+...+.++.
T Consensus 246 ya~~~~~g~------~p-----------~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 246 YASDQRRGL------KP-----------PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred echhccCCC------CC-----------CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 111000000 00 000011112577788899999976 46789999999999999998888776
Q ss_pred CCCcc
Q 048432 331 QPAFS 335 (354)
Q Consensus 331 ~~~~~ 335 (354)
...--
T Consensus 309 v~a~H 313 (637)
T COG4248 309 VSAMH 313 (637)
T ss_pred hcccc
Confidence 55443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=97.66 Aligned_cols=119 Identities=24% Similarity=0.213 Sum_probs=84.5
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCCh---hhHHHHHHHH---------HHhceeecCCceEEEEEecCCCCHh
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG---QGLRELKNKL---------RLLGCCIDKDEKILIYEYMPNKSLD 120 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~---~~~~~~~~i~---------~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (354)
++.|+.|..+.||++... +..|++|+...... ....+..... +++. ......++|||+++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~--~~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYY--FDPETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEE--EeCCCCeEEEEecCCCccc
Confidence 467899999999999975 77899999865532 1111111111 1111 2233458999999998876
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 121 FFLFDWVTRVRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 121 ~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.. .......+.+++++++.||..+ ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 80 ~~---~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TE---DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc---cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 43 1123456788999999999987 12359999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-11 Score=115.82 Aligned_cols=180 Identities=24% Similarity=0.322 Sum_probs=136.9
Q ss_pred hcCccccceecc--cCceeEEEEEE--c-CCCEEEEEEecCCC------hhhHH---------HHHHHHHHhceeecCCc
Q 048432 47 TNKFSDANKLGE--GGFGPVYKGVL--K-NGDEIAVKRLSGRS------GQGLR---------ELKNKLRLLGCCIDKDE 106 (354)
Q Consensus 47 ~~~y~~~~~lg~--G~~g~V~~a~~--~-~~~~vavK~~~~~~------~~~~~---------~~~~i~~~~~~~~~~~~ 106 (354)
...+.+.+.+|. |.+|.+|.+.. + ++..+|+|.-+... ....+ .+.+.++....+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 346788999999 99999999996 3 58889999842211 11111 22355677778888899
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecc
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQ----GLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFG 175 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg 175 (354)
.|+-+|+|. .++..+. ++....+....+..+ |+..+|... ++|.|++|.||+...+ ...+++|||
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 999999987 4666665 445566677777777 999999999 9999999999999999 889999999
Q ss_pred cceeccCCcccccc---ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 176 IARICRGNELQANT---GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 176 ~a~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
+....+........ ....+...|++||.. .+.++...|++++|.++.+...+...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccc
Confidence 98877665532222 122567789999955 55678999999999999998877644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.2e-10 Score=95.30 Aligned_cols=123 Identities=14% Similarity=0.114 Sum_probs=85.8
Q ss_pred cceecccCceeEEEEEEcC-------CCEEEEEEecCCCh---------------------hh---------HHHHHHHH
Q 048432 53 ANKLGEGGFGPVYKGVLKN-------GDEIAVKRLSGRSG---------------------QG---------LRELKNKL 95 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~-------~~~vavK~~~~~~~---------------------~~---------~~~~~~i~ 95 (354)
...||.|.-+.||.|...+ +..+|||+++-... .. ..++.++.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998543 47899998732100 00 02223333
Q ss_pred HHhcee------ecCCceEEEEEecCCCCH-----hHHHhhHHHHHHHHHHHHHHHHHH-HhcCCCCeEeCCCCCCCEEE
Q 048432 96 RLLGCC------IDKDEKILIYEYMPNKSL-----DFFLFDWVTRVRIIEGIAQGLLYL-HQYSRVRIIHRDLKVSNILL 163 (354)
Q Consensus 96 ~~~~~~------~~~~~~~lv~e~~~~~~L-----~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nill 163 (354)
++...- ..-...++||||+.+..+ .+..++......+..+++.+|..+ |+.+ ++|+||++.||++
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~ 158 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLW 158 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 333321 122456799999977433 222344455677889999999988 8999 9999999999999
Q ss_pred cCCCCeEEeeccccee
Q 048432 164 DKDMNPKISDFGIARI 179 (354)
Q Consensus 164 ~~~~~~~l~dfg~a~~ 179 (354)
. ++.++++|||.+..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 7 46799999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-09 Score=104.97 Aligned_cols=131 Identities=15% Similarity=0.188 Sum_probs=96.1
Q ss_pred HHHHHHHhceeecCCceEEEEEecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 91 LKNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 91 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
|.+|+++++.+..++.+|+|+|.+. -|..++ +....+...+.||+.||.|||..+ .++|+||....|+|+..|.
T Consensus 68 HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~Ge 143 (690)
T KOG1243|consen 68 HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGE 143 (690)
T ss_pred CchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCc
Confidence 4488999999999999999999963 344343 445556678899999999998444 3999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCC
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~ 229 (354)
.+|++|.++......... .....-...|..|+.+.... -..|.|.|||++++++.|.
T Consensus 144 WkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 144 WKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred EEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 999999987543332210 00111223456666443221 3479999999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.7e-09 Score=86.04 Aligned_cols=118 Identities=25% Similarity=0.377 Sum_probs=85.2
Q ss_pred ceecccCceeEEEEEEcCCCEEEEEEecCC--ChhhH----HH--HHHHHHHh------c------eeecCCceEEEEEe
Q 048432 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGR--SGQGL----RE--LKNKLRLL------G------CCIDKDEKILIYEY 113 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~~~~vavK~~~~~--~~~~~----~~--~~~i~~~~------~------~~~~~~~~~lv~e~ 113 (354)
..+++|+-+.++.+.+. |..+++|.-.+. ....+ +. -.++.+++ + +..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999874 545777764322 11111 11 11333222 2 23456667799999
Q ss_pred cCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 114 MPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 114 ~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.+|..|.+.+... ...++..+..-+.-||..| |+|+||.++||+++..+ ++++|||++.
T Consensus 81 I~G~~lkd~l~~~--~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA--RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc--chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 9999888777443 4667778888889999999 99999999999998876 9999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.9e-10 Score=114.60 Aligned_cols=234 Identities=18% Similarity=0.172 Sum_probs=164.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH--------HH-HH------HhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK--------NK-LR------LLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~--------~i-~~------~~~~~~~~~~~~ 108 (354)
...+.+.+.+.+-+|.++.++.+.-. .|...++|+......-...+.+ +| ++ ....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 44567788889999999999998832 3544444443322211111111 22 11 111122445678
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC-
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG- 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~- 182 (354)
++++|+.+++|...+ .+....+..+..+.++..+||... +.|+|++|.|.+...++...+.+|+.....+.
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 999999888887776 445566777888889999999998 99999999999999999999999983221100
Q ss_pred ------------------------Cccc----cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCc
Q 048432 183 ------------------------NELQ----ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGF 234 (354)
Q Consensus 183 ------------------------~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~ 234 (354)
.... .......+|..|.+||...+......+|.|+.|+++++.++|.+| |
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp--~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP--F 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC--C
Confidence 0000 112235689999999999999999999999999999999999999 5
Q ss_pred ccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 048432 235 YRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313 (354)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 313 (354)
.........+.+.......|..... .+...++++...+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~------------------------------~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEE------------------------------GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccc------------------------------cChhhhhhhhhhhccCchhccCcc
Confidence 5566666666665555544443211 456678899999999999998775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.9e-10 Score=107.86 Aligned_cols=233 Identities=18% Similarity=0.122 Sum_probs=157.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc--CCCEEEEEEecCCChhhHHHHH---------------HHHHHhceeecCCc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK--NGDEIAVKRLSGRSGQGLRELK---------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vavK~~~~~~~~~~~~~~---------------~i~~~~~~~~~~~~ 106 (354)
.....+|..+..||.|.|+.|+....+ ++..|++|-..........++. +.+.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 446678999999999999999988743 5778898877654433322222 22222233344456
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a~~~ 180 (354)
.|+=.|||+++++.... ++....+++..|++.++.++|+.. ++|.|++|+||++..+ +..++.||++....
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 67889999998886655 677788999999999999999999 9999999999999887 67789999987531
Q ss_pred cCCccccccccccCcccc-cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRY-MSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
...... ....+..| .++.+.....+..+.|++|||..+.+..++...- ..... ...+..+.....
T Consensus 418 ~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls-~~~~~----~~~i~~~~~p~~----- 483 (524)
T KOG0601|consen 418 AFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS-ESGVQ----SLTIRSGDTPNL----- 483 (524)
T ss_pred ceeccc----ccccccccccchhhccccccccccccccccccccccccCcccC-ccccc----ceeeecccccCC-----
Confidence 111100 01123334 3555555667889999999999999999876431 11000 011111110000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
+.....+..+.+.+...++..||.+.++....+-
T Consensus 484 ----------------------------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 ----------------------------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----------------------------CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0023566778888999999999999877655443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.7e-10 Score=108.38 Aligned_cols=157 Identities=19% Similarity=0.269 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc-------cccccccCccccc
Q 048432 127 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ-------ANTGRIVGTYRYM 199 (354)
Q Consensus 127 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~-------~~~~~~~~~~~y~ 199 (354)
...+.=+.+++.|+.|+|... ++||++|.|++|+++.++..|++.|+.+......... ...........|.
T Consensus 99 e~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ 176 (700)
T KOG2137|consen 99 EDGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL 176 (700)
T ss_pred cHhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence 333444455669999999876 5999999999999999999999999987543331110 0011123456899
Q ss_pred CccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhcc
Q 048432 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT-TGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSIS 278 (354)
Q Consensus 200 aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 278 (354)
|||++.....+.++|++|+|+.+|.++.|+.+ +...+.. .......+........
T Consensus 177 apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~---~~~~~~~~~~~~~~~~--------------------- 232 (700)
T KOG2137|consen 177 APEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL---LSYSFSRNLLNAGAFG--------------------- 232 (700)
T ss_pred cchhhccccccccccceeeeeEEEEEecCCcchhhccCCc---chhhhhhccccccccc---------------------
Confidence 99999998889999999999999999955544 3222211 1111111111111111
Q ss_pred ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 279 SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
+....++++.+=+.+++..++.-||++..+.
T Consensus 233 -------~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 233 -------YSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred -------ccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 0122788899999999999999999776554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-08 Score=83.88 Aligned_cols=123 Identities=28% Similarity=0.397 Sum_probs=87.1
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEe-cCCC-hhh----HH--HHHHHHH------Hhc------eeecCCceEEEE
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRL-SGRS-GQG----LR--ELKNKLR------LLG------CCIDKDEKILIY 111 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~-~~~~-~~~----~~--~~~~i~~------~~~------~~~~~~~~~lv~ 111 (354)
....+-+|+-+.|+++.+. |+..+||.- .+.. ... +. ..+++.+ .++ ++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 6788999999999999984 887777754 2221 111 11 1112222 222 345566778999
Q ss_pred EecCC-CCHhHHHhh------H-HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeEEeecccce
Q 048432 112 EYMPN-KSLDFFLFD------W-VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGIAR 178 (354)
Q Consensus 112 e~~~~-~~L~~~~~~------~-~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~l~dfg~a~ 178 (354)
||++| .++.+++.. . ......+..|.+.+.-||.++ |+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99988 466676621 1 223688899999999999999 99999999999997655 35899999975
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-08 Score=89.64 Aligned_cols=132 Identities=23% Similarity=0.209 Sum_probs=96.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh--------------------------hhHHHHHHHHHH
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--------------------------QGLRELKNKLRL 97 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~i~~~ 97 (354)
.....=+.++..||.|.-|.||.|...+|.++|+|.=..... ...++++-..++
T Consensus 87 ~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 87 VKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 333334567899999999999999999999999996422111 112222233333
Q ss_pred hce--e----ecCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 98 LGC--C----IDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 98 ~~~--~----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
+.. . .+.+...+|||+++|-.|...-++......++..|+..+.-+-..| |+|+|+++-||+++.+|.+++
T Consensus 167 ~~~G~~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 167 YPEGVKVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred hhcCCCCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEE
Confidence 332 1 2345678999999997776655556666777778887777666888 999999999999999999999
Q ss_pred eecccce
Q 048432 172 SDFGIAR 178 (354)
Q Consensus 172 ~dfg~a~ 178 (354)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.7e-08 Score=88.08 Aligned_cols=126 Identities=20% Similarity=0.276 Sum_probs=88.0
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCCh-----hhHHHHHHH----------HHHhceeecC---CceEEEEEec
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG-----QGLRELKNK----------LRLLGCCIDK---DEKILIYEYM 114 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~-----~~~~~~~~i----------~~~~~~~~~~---~~~~lv~e~~ 114 (354)
.+.|+.|..+.+|++...+|..+++|....... ....+.... .+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 467899999999999987678899999865432 111111111 1122222222 2568999999
Q ss_pred CCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 048432 115 PNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYS------------------------------------------- 147 (354)
Q Consensus 115 ~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 147 (354)
+|.++.... ++......++.++++++..||+..
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 998887654 455666777778888888887431
Q ss_pred ----------CCCeEeCCCCCCCEEEcC--CCCeEEeecccce
Q 048432 148 ----------RVRIIHRDLKVSNILLDK--DMNPKISDFGIAR 178 (354)
Q Consensus 148 ----------~~~i~H~dlkp~Nill~~--~~~~~l~dfg~a~ 178 (354)
...++|+|+++.||+++. ++.+.++||+.+.
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134899999999999998 5668999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.5e-08 Score=83.69 Aligned_cols=113 Identities=28% Similarity=0.406 Sum_probs=70.8
Q ss_pred eEEEEEEcCCCEEEEEEecCCChhh------------------------------HHHHHHHHHHhceee------cCCc
Q 048432 63 PVYKGVLKNGDEIAVKRLSGRSGQG------------------------------LRELKNKLRLLGCCI------DKDE 106 (354)
Q Consensus 63 ~V~~a~~~~~~~vavK~~~~~~~~~------------------------------~~~~~~i~~~~~~~~------~~~~ 106 (354)
.||.|...+|..+|+|+.......- ..++.++.++...-. .-..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4899998889999999975321100 111222223322211 1123
Q ss_pred eEEEEEecC--CCCHhHHH---hhHHHHHHHHHHHHHHHHH-HHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMP--NKSLDFFL---FDWVTRVRIIEGIAQGLLY-LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~--~~~L~~~~---~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++||||++ |..+..+. +.......++.+++..+.. +|..| |+|+||.+.||+++.+ .++++|||.+..
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCccee
Confidence 469999998 65554443 3345677788888886554 67998 9999999999999988 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.7e-08 Score=94.99 Aligned_cols=147 Identities=22% Similarity=0.318 Sum_probs=96.5
Q ss_pred cCCCCCccccch------------hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHH-H-------
Q 048432 32 VDQLPLFSFSSV------------STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRE-L------- 91 (354)
Q Consensus 32 ~~~~~~~~~~~~------------~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~-~------- 91 (354)
.|.+|.++.+.. ......|. ...|+.++-|+||+|..++|+.||||+.++.-...... +
T Consensus 98 QD~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a 176 (517)
T COG0661 98 QDRVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLA 176 (517)
T ss_pred hcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHH
Confidence 455566655544 22333444 48999999999999999999999999987654332211 0
Q ss_pred ------------------------------------HHHHHHhc------------ee-ecCCceEEEEEecCCCCHhHH
Q 048432 92 ------------------------------------KNKLRLLG------------CC-IDKDEKILIYEYMPNKSLDFF 122 (354)
Q Consensus 92 ------------------------------------~~i~~~~~------------~~-~~~~~~~lv~e~~~~~~L~~~ 122 (354)
.|.-++-. +| .......++|||++|..+.+.
T Consensus 177 ~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~ 256 (517)
T COG0661 177 RLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDI 256 (517)
T ss_pred HHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccH
Confidence 01111111 11 234556799999999888877
Q ss_pred H-hhH--HHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 123 L-FDW--VTRVRIIEGIAQGL-LYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 123 ~-~~~--~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
. +.. .....++..++.+. ..+-..| +.|+|.+|.||+++.+|.+.+.|||+......
T Consensus 257 ~~l~~~g~d~k~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 257 AALKSAGIDRKELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5 111 11334444444432 3333456 99999999999999999999999999865443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=4e-07 Score=81.78 Aligned_cols=120 Identities=22% Similarity=0.176 Sum_probs=83.9
Q ss_pred eecccCceeEEEEEEcCCCEEEEEEecCCCh---------------hhHHHHHHHHHHh----------ceeec-----C
Q 048432 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG---------------QGLRELKNKLRLL----------GCCID-----K 104 (354)
Q Consensus 55 ~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~---------------~~~~~~~~i~~~~----------~~~~~-----~ 104 (354)
.+-......|++... +|+.|.||....... ...++..++.++. .+... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333444666655 577899997744331 1334555554442 22221 2
Q ss_pred CceEEEEEecCCC-CHhHHHhh-------HHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-------CCCe
Q 048432 105 DEKILIYEYMPNK-SLDFFLFD-------WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-------DMNP 169 (354)
Q Consensus 105 ~~~~lv~e~~~~~-~L~~~~~~-------~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~~~~ 169 (354)
..-++|+|++++. +|.+++.. ......++.+++..+..||..| |+|+|+++.|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 2467999999986 78887632 2356789999999999999999 999999999999975 4679
Q ss_pred EEeecccce
Q 048432 170 KISDFGIAR 178 (354)
Q Consensus 170 ~l~dfg~a~ 178 (354)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.5e-07 Score=77.44 Aligned_cols=126 Identities=18% Similarity=0.186 Sum_probs=89.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH-------------HHHHHhc--e--------
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK-------------NKLRLLG--C-------- 100 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~-------------~i~~~~~--~-------- 100 (354)
....++|.+.+.+-......|.+... +|..+++|..........+.+. ++.++.. +
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34567888889998888888877776 5788999998765433332222 2222211 1
Q ss_pred ------eecCCceEEEEEecCCCCHhHHH-hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 101 ------CIDKDEKILIYEYMPNKSLDFFL-FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 101 ------~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
+......+++|||++|..|.+.. ++. .++..+.+++..||+.| ++|+|++|.|++++.++ ++++|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIEDIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchhcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEE
Confidence 11223446899999998876653 222 34566778899999999 99999999999999655 99999
Q ss_pred cccce
Q 048432 174 FGIAR 178 (354)
Q Consensus 174 fg~a~ 178 (354)
|+...
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-06 Score=76.58 Aligned_cols=138 Identities=19% Similarity=0.234 Sum_probs=94.8
Q ss_pred ccccchhhhhcCccccce---ecccCceeEEEEEEcCCCEEEEEEecCCChhh---------------------------
Q 048432 38 FSFSSVSTATNKFSDANK---LGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--------------------------- 87 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~---lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~--------------------------- 87 (354)
.+.+.+....++..+... |+.|.-+.||+|...++..+|+|++.......
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445555555566665554 44677789999998889999999986432211
Q ss_pred -HHHHHHHHHHhceeecC------CceEEEEEecCCC-----CHhHHHhhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeC
Q 048432 88 -LRELKNKLRLLGCCIDK------DEKILIYEYMPNK-----SLDFFLFDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHR 154 (354)
Q Consensus 88 -~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~~-----~L~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~ 154 (354)
..++.|+.++++...-- ....+||||+... .|.+.-........+..++++.+.-|-. .+ +||+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHg 191 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHG 191 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 12234666666653322 2346899998654 2222223333577778888888877766 77 9999
Q ss_pred CCCCCCEEEcCCCCeEEeeccccee
Q 048432 155 DLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 155 dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
||+.-|||+. ++.++++|++-+..
T Consensus 192 DLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 192 DLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cchhhheEEE-CCeEEEEECccccc
Confidence 9999999999 88899999998753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.4e-07 Score=86.16 Aligned_cols=147 Identities=21% Similarity=0.294 Sum_probs=94.5
Q ss_pred ccCCCCCccccchhhhh------------cCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-H--------
Q 048432 31 EVDQLPLFSFSSVSTAT------------NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-R-------- 89 (354)
Q Consensus 31 ~~~~~~~~~~~~~~~~~------------~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~-------- 89 (354)
-.|..|.++.+++.... ..|. .+.||..+.|+||+|+.++|+.||||+-++.-.... .
T Consensus 133 LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~ 211 (538)
T KOG1235|consen 133 LQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLL 211 (538)
T ss_pred HhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHH
Confidence 34677777777763322 2332 689999999999999999999999999876532221 0
Q ss_pred --------------------------------HHHHHHHHhcee----------------ecCCceEEEEEecCCCCHhH
Q 048432 90 --------------------------------ELKNKLRLLGCC----------------IDKDEKILIYEYMPNKSLDF 121 (354)
Q Consensus 90 --------------------------------~~~~i~~~~~~~----------------~~~~~~~lv~e~~~~~~L~~ 121 (354)
+.+|.-++-..+ .......++||||+|..+.+
T Consensus 212 ~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~D 291 (538)
T KOG1235|consen 212 AKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKIND 291 (538)
T ss_pred HHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCC
Confidence 011221111111 12335679999999988776
Q ss_pred HH-hh--HHHHHHHHHHHHHHHH-HHHhcCCCCeEeCCCCCCCEEEcC----CCCeEEeecccceecc
Q 048432 122 FL-FD--WVTRVRIIEGIAQGLL-YLHQYSRVRIIHRDLKVSNILLDK----DMNPKISDFGIARICR 181 (354)
Q Consensus 122 ~~-~~--~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlkp~Nill~~----~~~~~l~dfg~a~~~~ 181 (354)
.- +. -.....++..+.++.. -|=..| ++|+|-+|.||+++. ++.+.+.|||+.....
T Consensus 292 l~~i~~~gi~~~~i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 292 LDAIDKRGISPHDILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHcCCCHHHHHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 64 10 0112244555544432 334455 999999999999984 5689999999976433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-06 Score=75.93 Aligned_cols=70 Identities=31% Similarity=0.374 Sum_probs=61.4
Q ss_pred eEEEEEecCCC-CHhHHHhh-----HHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeEEeecccc
Q 048432 107 KILIYEYMPNK-SLDFFLFD-----WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGIA 177 (354)
Q Consensus 107 ~~lv~e~~~~~-~L~~~~~~-----~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~l~dfg~a 177 (354)
-++|+|++++. +|.+++.. ......++.+++..++-||..| |+|+|+++.|||++.++ .+.++||+.+
T Consensus 92 s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 92 SYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred EEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 47899999884 78888743 6677899999999999999999 99999999999999887 8999999977
Q ss_pred ee
Q 048432 178 RI 179 (354)
Q Consensus 178 ~~ 179 (354)
..
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 64
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.7e-05 Score=68.09 Aligned_cols=119 Identities=18% Similarity=0.152 Sum_probs=84.7
Q ss_pred ecccCceeEEEEEEcCCCEEEEEEecCC----------ChhhHHHHHHHHHHhce---------ee-----cCCceEEEE
Q 048432 56 LGEGGFGPVYKGVLKNGDEIAVKRLSGR----------SGQGLRELKNKLRLLGC---------CI-----DKDEKILIY 111 (354)
Q Consensus 56 lg~G~~g~V~~a~~~~~~~vavK~~~~~----------~~~~~~~~~~i~~~~~~---------~~-----~~~~~~lv~ 111 (354)
-|+||.|.|++.... |+.+-+|....- .....+++.++.++... +. ....-++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467999999998874 557888976421 12233455555443321 11 012246888
Q ss_pred EecCC-CCHhHHHh-------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC--eEEeecccce
Q 048432 112 EYMPN-KSLDFFLF-------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--PKISDFGIAR 178 (354)
Q Consensus 112 e~~~~-~~L~~~~~-------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~~l~dfg~a~ 178 (354)
|-+.+ .+|.+++. +......++.+++++++-||..| +.|+|+.+.||+++.++. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 87764 57777762 34456799999999999999999 999999999999987777 8999998764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.3e-05 Score=74.62 Aligned_cols=150 Identities=22% Similarity=0.342 Sum_probs=108.1
Q ss_pred CceeEEEEEE-cCCCEEEEEEecCCChhhH-------HHHH-----HHHHHhceee----cCCceEEEEEecCC-CCHhH
Q 048432 60 GFGPVYKGVL-KNGDEIAVKRLSGRSGQGL-------RELK-----NKLRLLGCCI----DKDEKILIYEYMPN-KSLDF 121 (354)
Q Consensus 60 ~~g~V~~a~~-~~~~~vavK~~~~~~~~~~-------~~~~-----~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 121 (354)
.-.+.|++.. .+|..|++|+++....+.. +.++ |++.+-+++. ++..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4467788884 4799999999965544332 2333 4555555554 45678999999876 46655
Q ss_pred HH--------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 122 FL--------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 122 ~~--------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.- .++...+.++.|+..||.++|+.| +.-+-|.+.+|+++.+.+++|...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54 345678899999999999999999 9999999999999999999998777654332
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
... .+| +.+ -.+-|.=-||.++..|.+|..-
T Consensus 445 ~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 222 011 111 1357888999999999998643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.8e-05 Score=68.34 Aligned_cols=121 Identities=20% Similarity=0.225 Sum_probs=70.9
Q ss_pred ceecccCceeEEEEEEcCCCEEEEEEecCCChh-hH-HHHHHH--H--------HHhceeecCCceEEEEEecCCCC-Hh
Q 048432 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ-GL-RELKNK--L--------RLLGCCIDKDEKILIYEYMPNKS-LD 120 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~-~~-~~~~~i--~--------~~~~~~~~~~~~~lv~e~~~~~~-L~ 120 (354)
..||.|..+.||+. .|..+++|........ .. ++++.. + +++.+....+...+||++++|.. +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 67899999999984 2556889998764321 12 222211 1 12333445566788999999963 22
Q ss_pred HHH-hhHHHHHHHHHHHHHHHHHHHh---------------------------------------c-CCCCeEeCCCCCC
Q 048432 121 FFL-FDWVTRVRIIEGIAQGLLYLHQ---------------------------------------Y-SRVRIIHRDLKVS 159 (354)
Q Consensus 121 ~~~-~~~~~~~~i~~~i~~~l~~LH~---------------------------------------~-~~~~i~H~dlkp~ 159 (354)
... .+......++..+++.+.-||+ . ....++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 221 1111111222222222222221 1 1234789999999
Q ss_pred CEEEcCCCCeEEeecccce
Q 048432 160 NILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~ 178 (354)
||+++.++ +.++||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.5e-05 Score=62.21 Aligned_cols=135 Identities=21% Similarity=0.235 Sum_probs=86.2
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh-hhHHHHHHHHHHhceeecC------CceEEE
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG-QGLRELKNKLRLLGCCIDK------DEKILI 110 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~-~~~~~~~~i~~~~~~~~~~------~~~~lv 110 (354)
..+..+.......++.+.||+|.+|.||++.+. |..+|+|+-..++. ..+.....+++++.-.... +..++.
T Consensus 12 ~~i~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~ 90 (201)
T COG2112 12 IEILNVEEGKYELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIR 90 (201)
T ss_pred eeeeeeeccchhhhhhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhh
Confidence 334444555566788999999999999999996 55889998876543 2333333444433322112 223466
Q ss_pred EEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC-CCCEEEcCCCCeEEeecccce
Q 048432 111 YEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK-VSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 111 ~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-p~Nill~~~~~~~l~dfg~a~ 178 (354)
|||++|..|....... -.+-+..++..---|-..| |-|+.|. |...++..++.++|+||..|.
T Consensus 91 me~i~G~~L~~~~~~~--~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIGG--DRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhcc--cHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9999998887665311 1222333444444566667 9999986 455555555589999999886
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.4e-05 Score=65.30 Aligned_cols=125 Identities=26% Similarity=0.242 Sum_probs=69.0
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCC-ChhhHHHHHHHH-----------HHhcee---ecCCceEEEEEecCCC
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR-SGQGLRELKNKL-----------RLLGCC---IDKDEKILIYEYMPNK 117 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~-~~~~~~~~~~i~-----------~~~~~~---~~~~~~~lv~e~~~~~ 117 (354)
++.|+.|..+.||++...+ ..+++|..... ..........+. +++... ......+++|++++|.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 4689999999999999876 68999998765 111111111111 122211 1223468999999998
Q ss_pred CHhH---------HH------------h-------hH-H--------HHHH------------HHHHHHH-HHHHHHh--
Q 048432 118 SLDF---------FL------------F-------DW-V--------TRVR------------IIEGIAQ-GLLYLHQ-- 145 (354)
Q Consensus 118 ~L~~---------~~------------~-------~~-~--------~~~~------------i~~~i~~-~l~~LH~-- 145 (354)
.+.. .+ . .. . .... ....+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 00 0 00 0 0000 0111122 2233332
Q ss_pred --cCCCCeEeCCCCCCCEEEc-CCCCeEEeecccce
Q 048432 146 --YSRVRIIHRDLKVSNILLD-KDMNPKISDFGIAR 178 (354)
Q Consensus 146 --~~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~ 178 (354)
.....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1233599999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00029 Score=62.50 Aligned_cols=29 Identities=24% Similarity=0.320 Sum_probs=25.8
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00058 Score=58.28 Aligned_cols=125 Identities=22% Similarity=0.314 Sum_probs=80.2
Q ss_pred ccCCCCCccccchhhhhcCccccceecccCc-eeEEEEEEcCCCEEEEEEecC---CCh------------------hhH
Q 048432 31 EVDQLPLFSFSSVSTATNKFSDANKLGEGGF-GPVYKGVLKNGDEIAVKRLSG---RSG------------------QGL 88 (354)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~-g~V~~a~~~~~~~vavK~~~~---~~~------------------~~~ 88 (354)
.-++++.|+. ....++.++.||.|.. |.||+++. +|+.||+|++.. ... ...
T Consensus 25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 98 (207)
T PF13095_consen 25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA 98 (207)
T ss_pred CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence 4455566666 2388999999999999 99999998 488999999321 110 001
Q ss_pred HHHHHHHHHhceeec-----------------------------------CCceEEEEEecCCCCHhHHHhhHHHHHHHH
Q 048432 89 RELKNKLRLLGCCID-----------------------------------KDEKILIYEYMPNKSLDFFLFDWVTRVRII 133 (354)
Q Consensus 89 ~~~~~i~~~~~~~~~-----------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~ 133 (354)
..+.++++.++-..+ .....||.||.+... ....+-+
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~~ 170 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRDI 170 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhHH
Confidence 112244443332211 112235555544322 2234456
Q ss_pred HHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 134 ~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.+|.+-+..+|+.| |+-+|+++.|.. .-+|+|||.+
T Consensus 171 ~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 66778888899999 999999999986 3488999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00067 Score=62.17 Aligned_cols=68 Identities=12% Similarity=0.099 Sum_probs=42.4
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCC-Ch-hhHHHHHHH-----------HHHhceeec---CCceEEEEEec
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR-SG-QGLRELKNK-----------LRLLGCCID---KDEKILIYEYM 114 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~-~~-~~~~~~~~i-----------~~~~~~~~~---~~~~~lv~e~~ 114 (354)
.-.+.||.|..+.||+....+++ +++|..+.. .. ....+..+. .++++++.. .+..++|||++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 44678999999999999875554 677776542 22 222222222 123333332 35589999999
Q ss_pred CCCCH
Q 048432 115 PNKSL 119 (354)
Q Consensus 115 ~~~~L 119 (354)
+|.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00081 Score=61.45 Aligned_cols=125 Identities=18% Similarity=0.180 Sum_probs=71.2
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHHHHHH-----------Hhc------eeecCCceEEEEEecC
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLR-----------LLG------CCIDKDEKILIYEYMP 115 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~~i~~-----------~~~------~~~~~~~~~lv~e~~~ 115 (354)
.+.|..|....+|+....+ ..+++|+..............+++ ++. +....+..++|+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 5677788889999998654 468889987532222111111111 111 1122345678999999
Q ss_pred CCCHhH----HH----------------h----------hHHHH----------HHHHHHHHHHHHHHHhc----CCCCe
Q 048432 116 NKSLDF----FL----------------F----------DWVTR----------VRIIEGIAQGLLYLHQY----SRVRI 151 (354)
Q Consensus 116 ~~~L~~----~~----------------~----------~~~~~----------~~i~~~i~~~l~~LH~~----~~~~i 151 (354)
|..+.. .. + .|... ......+..++.++... ....+
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 876532 11 0 00000 00111122334444431 12349
Q ss_pred EeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 152 IHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 152 ~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
+|+|+.|.||+++.++.+.|+||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCceEEEeehhhhc
Confidence 999999999999998777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.001 Score=58.77 Aligned_cols=29 Identities=28% Similarity=0.399 Sum_probs=24.7
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.++|+|+.+.||+++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876555799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0036 Score=57.85 Aligned_cols=30 Identities=33% Similarity=0.393 Sum_probs=25.5
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 359999999999999976656899999764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0039 Score=54.81 Aligned_cols=29 Identities=28% Similarity=0.389 Sum_probs=26.0
Q ss_pred CeEeCCCCCCCEEEcC-CCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDK-DMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~-~~~~~l~dfg~a~ 178 (354)
.++|+|+.+.||+++. ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4999999999999998 5789999999764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0028 Score=54.36 Aligned_cols=117 Identities=20% Similarity=0.273 Sum_probs=75.5
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEecCCC--------------------hhhHHHHH--------------HHHHH
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--------------------GQGLRELK--------------NKLRL 97 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--------------------~~~~~~~~--------------~i~~~ 97 (354)
-...||+|+.-.||.-- +....+||+..... .+..+++. ++.++
T Consensus 5 ~~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35689999999999644 45557999987766 22222222 34456
Q ss_pred hceeecCCceEEEEEecCC------CCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----
Q 048432 98 LGCCIDKDEKILIYEYMPN------KSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---- 167 (354)
Q Consensus 98 ~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---- 167 (354)
+++..++-..-+|+|.+.+ .+|.+++........+...+-.-..+|-..+ |+.+|++|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCce
Confidence 7788888888999998643 3566666211111133333334456777777 99999999999996432
Q ss_pred CeEEee
Q 048432 168 NPKISD 173 (354)
Q Consensus 168 ~~~l~d 173 (354)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00031 Score=63.77 Aligned_cols=132 Identities=17% Similarity=0.180 Sum_probs=87.0
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh--------------------------hHHHHHHHHH
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ--------------------------GLRELKNKLR 96 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~i~~ 96 (354)
+.....=+-+++.||-|.-+.||.+-+.+|++.++|.=...+.. ...++.-.-.
T Consensus 87 L~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 87 LSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred HHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 33344456789999999999999999999999999953221110 0011111111
Q ss_pred Hhc--e----eecCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 97 LLG--C----CIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 97 ~~~--~----~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
+++ + ..+.+..++|||++.|-.|...- .......+...+..-|.-|-..| ++|+|.+-=||++..++.++
T Consensus 167 L~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~-~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 167 LYERGFPVPKPIDHNRHCVVMELVDGYPLRQVR-HVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred HHHcCCCCCCcccccceeeHHHhhcccceeeee-ecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEE
Confidence 221 1 23456778999999887765443 11222333444445556677778 99999999999999999999
Q ss_pred Eeecccce
Q 048432 171 ISDFGIAR 178 (354)
Q Consensus 171 l~dfg~a~ 178 (354)
++||--..
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0024 Score=57.10 Aligned_cols=28 Identities=21% Similarity=0.324 Sum_probs=25.2
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.++|+|+.|.||+++.++ +.++||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999999877 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0077 Score=51.24 Aligned_cols=83 Identities=24% Similarity=0.289 Sum_probs=65.7
Q ss_pred HHHHHhceeecCCceEEEEEecCCCCH-------hHHH-hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 048432 93 NKLRLLGCCIDKDEKILIYEYMPNKSL-------DFFL-FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD 164 (354)
Q Consensus 93 ~i~~~~~~~~~~~~~~lv~e~~~~~~L-------~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~ 164 (354)
+..+++++| ..+++.||...+++ .++. .+|..+.+|+.+++..+.+++......+.-.|++++|+-++
T Consensus 21 ~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~ 96 (188)
T PF12260_consen 21 PFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN 96 (188)
T ss_pred CCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe
Confidence 334455554 34678899886644 3433 78999999999999999999986544599999999999999
Q ss_pred CCCCeEEeeccccee
Q 048432 165 KDMNPKISDFGIARI 179 (354)
Q Consensus 165 ~~~~~~l~dfg~a~~ 179 (354)
.+++++++|.+.+..
T Consensus 97 ~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 97 DDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEEechhcch
Confidence 999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.011 Score=56.31 Aligned_cols=29 Identities=24% Similarity=0.431 Sum_probs=25.1
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++|||+++.||++..+ .++++||..+..
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 49999999999999876 589999987753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0067 Score=56.24 Aligned_cols=125 Identities=20% Similarity=0.220 Sum_probs=84.5
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCC------C--------------------hh----hHHHHHHHHHHhce
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR------S--------------------GQ----GLRELKNKLRLLGC 100 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~------~--------------------~~----~~~~~~~i~~~~~~ 100 (354)
.+-..|..|.-+-||.|...+|..+|||+++-. + .+ ...+++|..++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456677889999999999889999999987311 0 00 01234577777766
Q ss_pred eecCC------ceEEEEEecCCCCH-----hHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 101 CIDKD------EKILIYEYMPNKSL-----DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 101 ~~~~~------~~~lv~e~~~~~~L-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
-+-.+ ...+||+|+..... .+.-++...+..+-.+++.-+.-|-+.. ++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCEE
Confidence 54333 23589999864322 2222555566666666666666554333 29999999999987 45679
Q ss_pred EEeecccce
Q 048432 170 KISDFGIAR 178 (354)
Q Consensus 170 ~l~dfg~a~ 178 (354)
+++|.+-+.
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999988664
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.01 Score=54.67 Aligned_cols=30 Identities=37% Similarity=0.442 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.+++|+|+++.||+++.++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 359999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.005 Score=64.46 Aligned_cols=31 Identities=19% Similarity=0.450 Sum_probs=24.8
Q ss_pred CeEeCCCCCCCEEEcCC-CC-eEEeecccceec
Q 048432 150 RIIHRDLKVSNILLDKD-MN-PKISDFGIARIC 180 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~-~~-~~l~dfg~a~~~ 180 (354)
.++|+|+++.||+++.+ +. .-|+||.++...
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 49999999999999853 33 578999987643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.019 Score=52.78 Aligned_cols=131 Identities=15% Similarity=0.164 Sum_probs=77.7
Q ss_pred cCccccceecccCceeEEEEEEcCCCEEEEEEecCC--Chh----hHHHHHHHHH----------HhceeecCC--ceEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR--SGQ----GLRELKNKLR----------LLGCCIDKD--EKIL 109 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~--~~~----~~~~~~~i~~----------~~~~~~~~~--~~~l 109 (354)
....+++.+..|..-.+|..... ++.++++ .+.. ... ..++++-+-. .+..|..+. ..|.
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34455666666666677777765 8888998 4321 111 1222333322 233455444 6799
Q ss_pred EEEecCCCCHhHHHhhHHHHHHHHH-HHHHHHHHHHh-------------------------------------------
Q 048432 110 IYEYMPNKSLDFFLFDWVTRVRIIE-GIAQGLLYLHQ------------------------------------------- 145 (354)
Q Consensus 110 v~e~~~~~~L~~~~~~~~~~~~i~~-~i~~~l~~LH~------------------------------------------- 145 (354)
||++++|..+...........+.+. .++..|+-||+
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999998544333211111112222 44444444442
Q ss_pred -------cC-----CCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 146 -------YS-----RVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 146 -------~~-----~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
+. ...++|+|+++.|+++++.+-+=|+||+++...
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22 134999999999999999988999999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.031 Score=51.17 Aligned_cols=30 Identities=37% Similarity=0.412 Sum_probs=26.5
Q ss_pred CCeEeCCCCCCCEEEcCC----CCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKD----MNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~----~~~~l~dfg~a~ 178 (354)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 459999999999999985 889999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.00044 Score=67.74 Aligned_cols=177 Identities=18% Similarity=0.106 Sum_probs=119.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-HHHH------H-HHHHhceeecCCceEEEEEecC
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-RELK------N-KLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~~~~------~-i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
+....-|.....+++|+++++++.+-...+....+.+........ .++. | .+..++-+..+.+..+.++++.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 344455667778899999999998854344444555544311100 0000 1 2233344555667788999988
Q ss_pred CC-CH------hHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 116 NK-SL------DFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 116 ~~-~L------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
++ +. .+..+...+...+...-.++++++|+.. -+|+| ||+..+ +..+..+|+......... .
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~ 386 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K 386 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---c
Confidence 77 22 2333556666777777889999999885 58888 666554 668999999876554443 2
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
.....++..+++||+...+.+....|.|++|.-..++--|-+|
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 2335678999999999999999999999999877777666665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0095 Score=54.21 Aligned_cols=66 Identities=15% Similarity=0.218 Sum_probs=35.9
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-HHHHH-----------HHHHhceeecCCceEEEEEecCCC
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-RELKN-----------KLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~~~~~-----------i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+-.+.++.|....+|+.. .+++.+.||+-........ .+... +.+++.+....+.-++|+||++.+
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 446778889999999988 4688899999874332222 22221 224455555566679999998776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.066 Score=49.67 Aligned_cols=28 Identities=43% Similarity=0.635 Sum_probs=25.2
Q ss_pred eEeCCCCCCCEEEcCCCC-eEEeecccce
Q 048432 151 IIHRDLKVSNILLDKDMN-PKISDFGIAR 178 (354)
Q Consensus 151 i~H~dlkp~Nill~~~~~-~~l~dfg~a~ 178 (354)
++|+|+.|.||+++.+.. .-++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899999764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.058 Score=48.84 Aligned_cols=29 Identities=31% Similarity=0.559 Sum_probs=24.7
Q ss_pred CeEeCCCCCCCEEEcCCCC-eEEeecccce
Q 048432 150 RIIHRDLKVSNILLDKDMN-PKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~-~~l~dfg~a~ 178 (354)
.++|+|++|.||+++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.064 Score=48.35 Aligned_cols=47 Identities=19% Similarity=0.237 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 132 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.+..+-..+.-.+... ..++|+|+.|.|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 4444444444444330 1399999999999999999999999987753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.028 Score=52.60 Aligned_cols=29 Identities=31% Similarity=0.486 Sum_probs=25.6
Q ss_pred CeEeCCCCCCCEEEcC-CCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDK-DMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~-~~~~~l~dfg~a~ 178 (354)
.++|+|+++.||+++. ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5999999999999986 4679999999874
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.039 Score=51.98 Aligned_cols=123 Identities=20% Similarity=0.248 Sum_probs=73.3
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc----------------CCCEEEEEEecCCChhhHHHHHHHH--------
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK----------------NGDEIAVKRLSGRSGQGLRELKNKL-------- 95 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~----------------~~~~vavK~~~~~~~~~~~~~~~i~-------- 95 (354)
...++.+...|. -..||.|.-++||+|..+ ..+.+|+|+.++.....++.-..|+
T Consensus 182 ~~~~~eiF~efn-~~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~ 260 (565)
T KOG1236|consen 182 VKKIEEIFSEFN-REPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLIN 260 (565)
T ss_pred cCcHHHHHHhcC-CcccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhh
Confidence 335555555555 568999999999999733 1456899999876554443322111
Q ss_pred -----------------------------------HHhce-------------eecCCceEEEEEecCCCCHhHHH----
Q 048432 96 -----------------------------------RLLGC-------------CIDKDEKILIYEYMPNKSLDFFL---- 123 (354)
Q Consensus 96 -----------------------------------~~~~~-------------~~~~~~~~lv~e~~~~~~L~~~~---- 123 (354)
++..- +.......++-+|..|.++..++
T Consensus 261 ~vP~l~wL~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~ 340 (565)
T KOG1236|consen 261 NVPDLSWLSLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS 340 (565)
T ss_pred hcCccccccCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc
Confidence 11000 11112234666677787877777
Q ss_pred hhHHHHHHHHHHHHHHHHH-HHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 124 FDWVTRVRIIEGIAQGLLY-LHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 124 ~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
.++.-+.+++.=.+.|+-. +--.+ ++|.|++|.||++.-+
T Consensus 341 ~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 341 QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN 381 (565)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence 2333444555555555532 23334 9999999999999643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.15 Score=47.01 Aligned_cols=30 Identities=23% Similarity=0.360 Sum_probs=27.2
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.+++|+|+.+.|++++.++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 359999999999999999999999999775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.034 Score=58.54 Aligned_cols=161 Identities=19% Similarity=0.203 Sum_probs=100.9
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC---CEEEcCCCCeEEe--eccccee
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS---NILLDKDMNPKIS--DFGIARI 179 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~---Nill~~~~~~~l~--dfg~a~~ 179 (354)
..++|..-++...+ .+..+.+.+..++..|+.++|+.. +.|.-+... +.-++..+.+.+. ||+....
T Consensus 264 ~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~ 340 (1351)
T KOG1035|consen 264 LQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP 340 (1351)
T ss_pred HHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhccccc
Confidence 34444444444443 567788889999999999999986 666555554 4444555666666 7777654
Q ss_pred ccCCccccccccccCcccccCccccccCCCCc--hhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSI--KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
......... ......+.++|......... ..|+|.+|..+..+..|..+-.... ..... .
T Consensus 341 l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~-----~~~~~----------l 402 (1351)
T KOG1035|consen 341 LPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA-----VPVSL----------L 402 (1351)
T ss_pred CCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc-----chhhh----------h
Confidence 443332111 12344667777666555444 4799999999999988775511100 00000 0
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~ 320 (354)
.......+.++..+|+.-++++|+++.+++...-
T Consensus 403 -----------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 403 -----------------------------DVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred -----------------------------ccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 0001224567889999999999999999987643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.091 Score=49.15 Aligned_cols=29 Identities=24% Similarity=0.370 Sum_probs=24.5
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++|||+.+.||+++.++ .+++|+..+..
T Consensus 193 ~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred eeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 489999999999997765 77999987654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.084 Score=49.13 Aligned_cols=29 Identities=24% Similarity=0.376 Sum_probs=25.5
Q ss_pred CeEeCCCCCCCEEEcC-CCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDK-DMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~-~~~~~l~dfg~a~ 178 (354)
.++|+|+.+.||+++. ++.++++||..+.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 4899999999999975 5789999999875
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.18 Score=54.18 Aligned_cols=31 Identities=39% Similarity=0.491 Sum_probs=25.7
Q ss_pred CCeEeCCCCCCCEEEcCCC--CeE-Eeeccccee
Q 048432 149 VRIIHRDLKVSNILLDKDM--NPK-ISDFGIARI 179 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~--~~~-l~dfg~a~~ 179 (354)
..++|+|+++.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4499999999999999875 555 999997753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.12 Score=48.19 Aligned_cols=71 Identities=20% Similarity=0.204 Sum_probs=54.3
Q ss_pred CceEEEEEecCCCCHhHHH-hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
-+.|++|++- |+.+..+- ..+.++..++.+.+..+.-+.+.- ++-|||+.-.||+++ +|.+.|+||.+++.
T Consensus 299 ~y~yl~~kdh-gt~is~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-CceeeeeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 3456667664 33443332 567888888888888777776654 589999999999999 99999999999974
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.12 Score=48.98 Aligned_cols=29 Identities=28% Similarity=0.432 Sum_probs=25.0
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++||||.|.|||++.++ .+++|...+..
T Consensus 228 aLlHGDlHtGSI~v~~~~-~kvIDpEFAfy 256 (409)
T PRK12396 228 ALIHGDLHTGSVFVKNDS-TKVIDPEFAFY 256 (409)
T ss_pred hhccCcCCCCCEEecCCc-eEEEccccccc
Confidence 499999999999999864 89999887754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.46 Score=45.35 Aligned_cols=29 Identities=21% Similarity=0.381 Sum_probs=24.3
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++|||+.+.||+++.++ .+++|...+.
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 3599999999999999876 7888877654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=1.6 Score=40.41 Aligned_cols=27 Identities=37% Similarity=0.492 Sum_probs=23.1
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.++|+|+.+.||+++ + .+.++||+-+.
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 489999999999995 3 57899999764
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.028 Score=43.96 Aligned_cols=44 Identities=23% Similarity=0.358 Sum_probs=35.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL 88 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~ 88 (354)
......|. .+.||.|+.|+||+|+.++|+.||||+.++.-....
T Consensus 8 ~~~F~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i 51 (119)
T PF03109_consen 8 DEIFDEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQI 51 (119)
T ss_pred HHHHHHCC-cchhhheehhhheeeeecccchhhhhhcchHHHHHH
Confidence 33445555 689999999999999999999999999988755443
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.28 E-value=3.4 Score=36.31 Aligned_cols=67 Identities=18% Similarity=0.270 Sum_probs=39.9
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChhhHH-HHH-----------HHHHHhceeecCCceEEEEEecCCCCHh
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLR-ELK-----------NKLRLLGCCIDKDEKILIYEYMPNKSLD 120 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~-~~~-----------~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (354)
.+.+..|.--..|...+ ....+.+|+-...-..... +.. ++.+++.+-....+-|+|+||++-+.++
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44555555556666665 4667888876543211111 111 2234555556778899999999887665
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.63 E-value=0.48 Score=45.91 Aligned_cols=29 Identities=24% Similarity=0.417 Sum_probs=24.3
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++|+|+.+.||+.+.++ ++++||..|.
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeecccc
Confidence 3589999999999876554 9999998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=92.52 E-value=0.02 Score=61.87 Aligned_cols=125 Identities=14% Similarity=0.050 Sum_probs=86.5
Q ss_pred ceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 106 EKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
..+..++|+.+|.+-..+ ++..-+.....+.+....-+|... ++.-+|++||+.|.++..+..++++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 446778888888887776 122222333333244444444333 455899999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTT 232 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~ 232 (354)
|+.+..... ....+...+++.|+.|++...-.++.++|+|+.|+-+|....|..+|
T Consensus 1385 gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1385 GLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 998721111 11122235566788888887778888899999999999998888775
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.39 E-value=0.12 Score=43.66 Aligned_cols=29 Identities=17% Similarity=0.242 Sum_probs=25.6
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998877 99999998753
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.29 E-value=1.4 Score=39.36 Aligned_cols=35 Identities=11% Similarity=0.040 Sum_probs=28.5
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCCCh
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG 85 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~ 85 (354)
.....+..|..+.|+.++..+|.+.++|+......
T Consensus 5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~ 39 (253)
T PF04655_consen 5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE 39 (253)
T ss_pred ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCccc
Confidence 34456778999999999988999999999875443
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 354 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-110
Identities = 106/322 (32%), Positives = 155/322 (48%), Gaps = 55/322 (17%)
Query: 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-----L 88
QL FS + A++ FS+ N LG GGFG VYKG L +G +AVKRL QG
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 89 REL--------KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------DWVTRVR 131
E+ +N LRL G C+ E++L+Y YM N S+ L DW R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
I G A+GL YLH + +IIHRD+K +NILLD++ + DFG+A++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194
Query: 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY---SFTLLG---- 244
+ GT +++PEY G S K+DVF +GV+LL++++G++ R LL
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 245 -YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQ 303
+ + VD L + + + + +ALLC Q
Sbjct: 255 LLKEKKLEAL--VDV----------------------DLQGNYKDEEVEQLIQVALLCTQ 290
Query: 304 ESADDRPTMNDVVSMLTNEAAA 325
S +RP M++VV ML + A
Sbjct: 291 SSPMERPKMSEVVRMLEGDGLA 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-106
Identities = 102/330 (30%), Positives = 150/330 (45%), Gaps = 71/330 (21%)
Query: 34 QLPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR---- 83
+ FSF + TN F + NK+GEGGFG VYKG + N +AVK+L+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 84 SGQGLRELK------------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLF------- 124
+ + ++ N + LLG D D+ L+Y YMPN SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 125 -DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183
W R +I +G A G+ +LH+ IHRD+K +NILLD+ KISDFG+AR
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLL 243
T RIVGT YM+PE ++G + KSD++SFGV+LL+I++G +R LL
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LL 244
Query: 244 GYI------SENIYEFPSVDTHNVKTFGFLHLTIFKL--FSISSVGLSNDIVCLCILRYV 295
+ I ++ +D K+ +SV
Sbjct: 245 DIKEEIEDEEKTIEDY--IDK--------------KMNDADSTSV-----------EAMY 277
Query: 296 NIALLCVQESADDRPTMNDVVSMLTNEAAA 325
++A C+ E + RP + V +L A+
Sbjct: 278 SVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 7e-98
Identities = 98/304 (32%), Positives = 154/304 (50%), Gaps = 44/304 (14%)
Query: 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKN---- 93
+ ATN F +G G FG VYKGVL++G ++A+KR + S QG+ E +
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 94 --KLR------LLGCCIDKDEKILIYEYMPNKSLDFFLF---------DWVTRVRIIEGI 136
R L+G C +++E ILIY+YM N +L L+ W R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 137 AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC-RGNELQANTGRIVGT 195
A+GL YLH + IIHRD+K NILLD++ PKI+DFGI++ ++ +T + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
Y+ PEY I+G + KSDV+SFGV+L +++ + I +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS------------------AIVQSLP 246
Query: 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ N+ + +L I L++ I + ++ + A+ C+ S++DRP+M DV
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 316 VSML 319
+ L
Sbjct: 307 LWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 5e-76
Identities = 65/317 (20%), Positives = 110/317 (34%), Gaps = 48/317 (15%)
Query: 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LREL----- 91
++ + G FG V+K L + +AVK + Q E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 92 -----KNKLRLLGCCI----DKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQ 138
+N L+ +G + LI + SL FL W I E +A+
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMAR 132
Query: 139 GLLYLHQ-------YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
GL YLH+ + I HRD+K N+LL ++ I+DFG+A + +T
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 192 IVGTYRYMSPEYAIQGI-----FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI 246
VGT RYM+PE I ++ D+++ G++L ++ S G +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD----------GPV 242
Query: 247 SENIYEFPSVDTHNVKTFGFLHLTIFKLF--SISSVGLSNDIVCLCILRYVNIALLCVQE 304
E + F + + + K + + + C
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA----MLCETIEECWDH 298
Query: 305 SADDRPTMNDVVSMLTN 321
A+ R + V +T
Sbjct: 299 DAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 70/335 (20%), Positives = 117/335 (34%), Gaps = 49/335 (14%)
Query: 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LREL----- 91
+ S S + +G G +G VYKG L + +AVK S + Q + E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61
Query: 92 -----KNKLRLLGCCI-----DKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIA 137
N R + + E +L+ EY PN SL +L DWV+ R+ +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVT 121
Query: 138 QGLLYLHQ------YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI------CRGNEL 185
+GL YLH + + I HRDL N+L+ D ISDFG++ R E
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 186 QANTGRIVGTYRYMSPEYAIQGI-------FSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238
VGT RYM+PE + + D+++ G++ +I +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIA 298
+ + +E D + + + + +S+ +
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR---------SLKETI 292
Query: 299 LLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPA 333
C + A+ R T + K +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 66/297 (22%), Positives = 104/297 (35%), Gaps = 66/297 (22%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGC 100
LG+G FG K + G+ + +K L + R N L+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 101 CIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
I EY+ +L + + W RV + IA G+ YLH + IIHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHR 132
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR------------IVGTYRYMSPE 202
DL N L+ ++ N ++DFG+AR+ + Q R +VG +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
+ K DVFSFG++L +I+ P +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRV------NADP-----------DYLPRTMDFGLN 235
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
GFL + C + I + C + RP+ + L
Sbjct: 236 VRGFLDRYC-----------PPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 65/303 (21%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGR--SGQGLRELKN------KLR------LLG 99
K+G G FG V++ G ++AVK L + + + E +LR +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
++ EY+ SL L D R+ + +A+G+ YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
+HR+LK N+L+DK K+ DFG++R+ L + + GT +M+PE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNE 218
Query: 212 KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271
KSDV+SFGV+L ++ + ++ P + +L
Sbjct: 219 KSDVYSFGVILWELATLQQ-----------------------P-----------WGNLNP 244
Query: 272 FKLFSISSVGLSN---DIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328
++ +++VG +I + I C RP+ ++ +L + +P
Sbjct: 245 AQV--VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
Query: 329 PKQ 331
P
Sbjct: 303 PPN 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 63/317 (19%), Positives = 119/317 (37%), Gaps = 59/317 (18%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--------LRELK--NKLRL 97
+ +G G FG V K + ++A+K++ S + L + N ++L
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
G C++ L+ EY SL L + + +QG+ YLH
Sbjct: 67 YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 150 RIIHRDLKVSNILLDKDMN-PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 209 FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268
+S K DVFS+G++L ++++ +K +F ++ +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----------------TR 222
Query: 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328
+ I + ++ C + RP+M ++V ++T+
Sbjct: 223 PPL-----IKN----------LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267
Query: 329 PKQPAFSYVRNTVTSTS 345
+P ++++
Sbjct: 268 ADEPLQYPCQHSLPPGE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-47
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 33/204 (16%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL----------------KNKLRL 97
+G GGFG VY+ GDE+AVK + + + N + L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
G C+ + L+ E+ L+ L V IA+G+ YLH + V IIH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 154 RDLKVSNILLDKDMNP--------KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
RDLK SNIL+ + + KI+DFG+AR + G Y +M+PE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIR 187
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGK 229
+FS SDV+S+GVLL ++++G+
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-47
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 37/203 (18%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGR--SGQGLRELK------------NKLRLLG 99
KL E G ++KG + G++I VK L R S + R+ N L +LG
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 100 CCIDKDEKIL--IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
C I +MP SL L D V+ +A+G+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG--- 207
I L ++++D+DM +IS + + GR+ +++PE A+Q
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS------FQSPGRM-YAPAWVAPE-ALQKKPE 185
Query: 208 -IFSIKSDVFSFGVLLLKIVSGK 229
+D++SF VLL ++V+ +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-47
Identities = 68/307 (22%), Positives = 126/307 (41%), Gaps = 72/307 (23%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----------------LR 89
N+ ++G+GGFG V+KG L + +A+K L +G +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 90 ELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLL 141
L N ++L G + ++ E++P L L W ++R++ IA G+
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 142 YLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGIARICRGNELQANTGRIVGTY 196
Y+ I+HRDL+ NI L + K++DFG+++ + + ++G +
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190
Query: 197 RYMSPE--YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254
++M+PE A + ++ K+D +SF ++L I++G+ + YS+ + +I+ E
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREE-- 245
Query: 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314
GL I C R N+ LC RP +
Sbjct: 246 --------------------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY 279
Query: 315 VVSMLTN 321
+V L+
Sbjct: 280 IVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-46
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 29/199 (14%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL--SGRSGQGLRELKN------KLR------LLG 99
++G G FG VYKG ++AVK L + + Q L+ KN K R +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
+ ++ ++ SL L F+ + I A+G+ YLH IIH
Sbjct: 88 YST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE---YAIQGIFS 210
RDLK +NI L +D KI DFG+A ++ G+ +M+PE +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 211 IKSDVFSFGVLLLKIVSGK 229
+SDV++FG++L ++++G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LREL----------KNKLRLLGCCI 102
+G+G +G V++G G+ +AVK S R + RE +N L + +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 103 DKDEKI----LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLH-----QYSRV 149
LI Y SL +L D V+ +RI+ IA GL +LH +
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI---CRGNELQANTGRIVGTYRYMSPE---- 202
I HRDLK NIL+ K+ I+D G+A + N R VGT RYM+PE
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPEVLDE 191
Query: 203 --YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238
+ D+++FG++L ++ + G Y
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 68/301 (22%), Positives = 107/301 (35%), Gaps = 48/301 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LREL----------KNKLRLLGCCI 102
++G+G +G V+ G + G+++AVK RE +N L + I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 103 DKDEKI----LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLH-----QYSRV 149
LI +Y N SL +L D + +++ GL +LH +
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI---CRGNELQANTGRIVGTYRYMSPE---- 202
I HRDLK NIL+ K+ I+D G+A R VGT RYM PE
Sbjct: 162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYMPPEVLDE 220
Query: 203 --YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260
I +D++SFG++L ++ + G Y L Y + D
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ---LPYHDLVPSDPSYEDMRE 277
Query: 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320
+ L + +S C+ + + C + R T V L
Sbjct: 278 IVCIKKLRPSFPNRWSSDE----------CLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 321 N 321
Sbjct: 328 K 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-44
Identities = 64/301 (21%), Positives = 106/301 (35%), Gaps = 48/301 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LREL----------KNKLRLLGCCI 102
+G+G FG V++G + G+E+AVK S R + RE +N L +
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 103 DKDEKI----LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQ-----YSRV 149
+ L+ +Y + SL +L +++ A GL +LH +
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI---CRGNELQANTGRIVGTYRYMSPE---- 202
I HRDLK NIL+ K+ I+D G+A A R VGT RYM+PE
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYMAPEVLDD 225
Query: 203 --YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260
++D+++ G++ +I G + Y + +
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 285
Query: 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320
+ L I + C + I C + R T + L+
Sbjct: 286 EQK---LRPNI----------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 321 N 321
Sbjct: 333 Q 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 45/208 (21%), Positives = 83/208 (39%), Gaps = 38/208 (18%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL--SGRSGQGLRELKN------KLR------LLG 99
+G+G FG VY G E+A++ + + L+ K + R +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
C+ +I ++L + D +I + I +G+ YLH I+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI---VGTYRYMSPE-------- 202
+DLK N+ D + I+DFG+ I + ++ G +++PE
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 203 -YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ FS SDVF+ G + ++ + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 23/193 (11%)
Query: 55 KLGEGGFGPVYKGVLKNGD-EIAVKRL-SGRSGQGLREL------------KNKLRLLGC 100
++G G FG V+ G L+ + +AVK + N +RL+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 101 CIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
C K ++ E + FL T ++++ A G+ YL IHR
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
DL N L+ + KISDFG++R A+ G ++ +PE G +S +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 215 VFSFGVLLLKIVS 227
V+SFG+LL + S
Sbjct: 298 VWSFGILLWETFS 310
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-38
Identities = 54/192 (28%), Positives = 96/192 (50%), Gaps = 23/192 (11%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL-SGRSGQG--LRELK--------NKLRLLGCCI 102
++G G FG V+ G N D++A+K + G + + E + ++L G C+
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 103 DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156
++ L+ E+M + L +L F T + + + +G+ YL +IHRDL
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDL 130
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKSDV 215
N L+ ++ K+SDFG+ R ++ ++TG + ++ SPE +S KSDV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDV 188
Query: 216 FSFGVLLLKIVS 227
+SFGVL+ ++ S
Sbjct: 189 WSFGVLMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRLSGRSGQG-----LREL--------KNKLR 96
+G G FG VY G L + D AVK L+ + G L E N L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 97 LLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
LLG C+ + L + YM + L F+ + +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY--RYMSPEYAIQG 207
+ +HRDL N +LD+ K++DFG+AR E + + ++M+ E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
F+ KSDV+SFGVLL ++++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 27/194 (13%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL-SGRSGQG--LRELK--------NKLRLLGCCI 102
+LG G FG V G + ++A+K + G + + E K ++L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 103 DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156
+ +I EYM N L +L F + + + + + + YL + +HRDL
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDL 146
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQGIFSIKS 213
N L++ K+SDFG++R +E ++ G + R+ PE + FS KS
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV----RWSPPEVLMYSKFSSKS 202
Query: 214 DVFSFGVLLLKIVS 227
D+++FGVL+ +I S
Sbjct: 203 DIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK--------NKLRLLGCCID 103
+LG G FG V G K ++AVK + S +E + ++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 104 KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLK 157
+ ++ EY+ N L +L + + + + +G+ +L + IHRDL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLA 131
Query: 158 VSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKSDVF 216
N L+D+D+ K+SDFG+ R ++ ++ G + ++ +PE +S KSDV+
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSKSDVW 189
Query: 217 SFGVLLLKIVS 227
+FG+L+ ++ S
Sbjct: 190 AFGILMWEVFS 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 25/194 (12%)
Query: 54 NKLGEGGFGPVYKGVLKNGD-EIAVKRLSGRSGQG---LRELK--------NKLRLLGCC 101
+KLG G +G VY+GV K +AVK L + + L+E N ++LLG C
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 102 IDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ +I E+M +L +L V + + I+ + YL + IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKS 213
DL N L+ ++ K++DFG++R+ G+ A+ G + ++ +PE FSIKS
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKS 193
Query: 214 DVFSFGVLLLKIVS 227
DV++FGVLL +I +
Sbjct: 194 DVWAFGVLLWEIAT 207
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 35/205 (17%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE-----IAVKRLSGRSGQG-----LRELK--------NKL 95
LG G FG VYKG+ E +A+K L + L E +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
RLLG C+ LI + MP L ++ + IA+G+ YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGRI-VGTYRYMSPEYAIQ 206
R++HRDL N+L+ + KI+DFG+A++ E A G++ + ++M+ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI---KWMALESILH 193
Query: 207 GIFSIKSDVFSFGVLLLKIVS-GKK 230
I++ +SDV+S+GV + ++++ G K
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 63/193 (32%), Positives = 94/193 (48%), Gaps = 25/193 (12%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK--------NKLRLLGCCI 102
+LG G FG V+ G ++AVK L S L E +RL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 103 DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
++ +I EYM N SL FL + + IA+G+ ++ IHRD
Sbjct: 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKSD 214
L+ +NIL+ ++ KI+DFG+AR+ NE A G + ++ +PE G F+IKSD
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSD 192
Query: 215 VFSFGVLLLKIVS 227
V+SFG+LL +IV+
Sbjct: 193 VWSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL-SGRSGQG--LREL--------KNKLRLLGCCI 102
KLG G FG V+ ++AVK + G L E ++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 103 DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
K+ +I E+M SL FL + IA+G+ ++ + IHRD
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKSD 214
L+ +NIL+ + KI+DFG+AR+ NE A G + ++ +PE G F+IKSD
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSD 367
Query: 215 VFSFGVLLLKIVS 227
V+SFG+LL++IV+
Sbjct: 368 VWSFGILLMEIVT 380
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRLSGRSGQG-----LREL--------KNKLR 96
+G+G FG VY G + + A+K LS + LRE N L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 97 LLGCCIDKDEKILI-YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
L+G + + + YM + L F+ + +A+G+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY--RYMSPEYAIQG 207
+ +HRDL N +LD+ K++DFG+AR E + ++ + E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
F+ KSDV+SFGVLL ++++
Sbjct: 204 RFTTKSDVWSFGVLLWELLT 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRLSGRSGQG-----LREL--------KNKLR 96
+G G FG VY G L + D AVK L+ + G L E N L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 97 LLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
LLG C+ + L + YM + L F+ + +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 211
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTY--RYMSPEYAIQG 207
+ +HRDL N +LD+ K++DFG+AR E + + ++M+ E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
F+ KSDV+SFGVLL ++++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 36/203 (17%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE-----IAVKRLSGRSGQG-----LRELK--------NKL 95
LGEG FG V ++ +AVK L +G +E+ + +
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 96 RLLGCCIDKDEK--ILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRV 149
+ GCC D L+ EY+P SL +L + + I +G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA---Q 153
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGR---IVGTYRYMSPEYA 204
IHRDL N+LLD D KI DFG+A+ + + + +PE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV----FWYAPECL 209
Query: 205 IQGIFSIKSDVFSFGVLLLKIVS 227
+ F SDV+SFGV L ++++
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 23/193 (11%)
Query: 54 NKLGEGGFGPVYKGVLKNGD-EIAVKRL-SGRSGQG--LREL--------KNKLRLLGCC 101
+KLG G +G VY+GV K +AVK L L+E N ++LLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 102 IDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ +I E+M +L +L V + + I+ + YL + IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 342
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
+L N L+ ++ K++DFG++R+ G+ A+ G ++ +PE FSIKSD
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSD 401
Query: 215 VFSFGVLLLKIVS 227
V++FGVLL +I +
Sbjct: 402 VWAFGVLLWEIAT 414
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 37/221 (16%)
Query: 54 NKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQGLREL------------KNKLR 96
+LG+G FG V G+ +AVK+L + + LR+ N ++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 97 LLGCCIDKDEK--ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSR 148
G C + LI EY+P SL +L D + ++ I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGR---IVGTYRYMSPEY 203
R IHRDL NIL++ + KI DFG+ ++ ++ + I + +PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAPES 188
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244
+ FS+ SDV+SFGV+L ++ + + + ++G
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 37/221 (16%)
Query: 54 NKLGEGGFGPVYKGVL-----KNGDEIAVKRLSGRSGQGLREL------------KNKLR 96
+LG+G FG V G+ +AVK+L + + LR+ N ++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 97 LLGCCIDKDEK--ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSR 148
G C + LI EY+P SL +L D + ++ I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GT 163
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGR---IVGTYRYMSPEY 203
R IHRDL NIL++ + KI DFG+ ++ ++ + I + +PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAPES 219
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244
+ FS+ SDV+SFGV+L ++ + + + ++G
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 31/200 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRLSGRSGQG-----LRELK--------NKLR 96
+G G G V G L+ + +A+K L + L E N +R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
L G +++ EYM N SLD FL F + V ++ G+ G+ YL S +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT---GRIVGTYRYMSPEYAIQG 207
+HRDL N+L+D ++ K+SDFG++R+ + A T G+I R+ +PE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEAIAFR 229
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
FS SDV+SFGV++ ++++
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 38/205 (18%)
Query: 54 NKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQG-----LRELK--------NKL 95
LGEG FG V G+++AVK L SG +E++ N +
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 96 RLLGCCIDKDEK--ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYS 147
+ G C + LI E++P+ SL +L + +++ I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGR---IVGTYRYMSPE 202
+ +HRDL N+L++ + KI DFG+ + ++ R + + +PE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYAPE 199
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVS 227
+Q F I SDV+SFGV L ++++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LREL--------KNKLRLLGCCID 103
+G+G FG V G + G+++AVK + + L E N ++LLG ++
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 104 KDEKI-LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
+ + ++ EYM SL +L ++ + + + YL +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRD 314
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKSD 214
L N+L+ +D K+SDFG+ + ++ ++ +PE + FS KSD
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 215 VFSFGVLLLKIVS 227
V+SFG+LL +I S
Sbjct: 369 VWSFGILLWEIYS 381
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 32/200 (16%)
Query: 55 KLGEGGFGPVYKGVLKNGDE-----IAVKRL-SGRSGQGLREL------------KNKLR 96
+G G FG VYKG+LK +A+K L +G + + + N +R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
L G ++I EYM N +LD FL F + V ++ GIA G+ YL + +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMN 167
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT---GRIVGTYRYMSPEYAIQG 207
+HRDL NIL++ ++ K+SDFG++R+ + T G+I R+ +PE
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAISYR 225
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
F+ SDV+SFG+++ ++++
Sbjct: 226 KFTSASDVWSFGIVMWEVMT 245
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRL-SGRSGQG-LRELK--------NKLRLLGCCID 103
+G+G FG V G + G+++AVK + + + Q L E N ++LLG ++
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 104 KDEKILI-YEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
+ + I EYM SL +L ++ + + + YL +HRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRD 142
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGIFSIKSD 214
L N+L+ +D K+SDFG+ + ++ ++ +PE + FS KSD
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 215 VFSFGVLLLKIVS 227
V+SFG+LL +I S
Sbjct: 197 VWSFGILLWEIYS 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 31/200 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQGLREL------------KNKLR 96
+G G FG V G LK + +A+K L G + + R+ N +R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
L G +++ EYM N SLD FL F + V ++ GIA G+ YL S +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT---GRIVGTYRYMSPEYAIQG 207
+HRDL NIL++ ++ K+SDFG+ R+ + A T G+I R+ SPE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYR 225
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
F+ SDV+S+G++L +++S
Sbjct: 226 KFTSASDVWSYGIVLWEVMS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 34/201 (16%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE-----IAVKRLSGRSGQG-----LREL--------KNKL 95
LG G FG VYKG+ E +A+K L + L E +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
RLLG C+ LI + MP L ++ + IA+G+ YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGRI-VGTYRYMSPEYAIQ 206
R++HRDL N+L+ + KI+DFG+A++ E A G++ + ++M+ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI---KWMALESILH 193
Query: 207 GIFSIKSDVFSFGVLLLKIVS 227
I++ +SDV+S+GV + ++++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 48/214 (22%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE---IAVKRL-SGRSGQGLREL-------------KNKLR 96
+ +GEG FG V K +K A+KR+ S R+ N +
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEG 135
LLG C + L EY P+ +L FL +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT-GRI-V 193
+A+G+ YL S+ + IHRDL NIL+ ++ KI+DFG++R T GR+ V
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
R+M+ E +++ SDV+S+GVLL +IVS
Sbjct: 206 ---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 55 KLGEGGFGPVYKGVLKNGDE---IAVKRL-SGRSGQGLREL------------KNKLRLL 98
+LG G FG V +GV + + +A+K L G E+ +RL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 99 GCCIDKDEKILI-YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
G C + E +++ E L FL ++ ++ G+ YL
Sbjct: 77 GVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT---GRIVGTYRYMSPEYAIQGI 208
+HRDL N+LL KISDFG+++ ++ G+ ++ +PE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPECINFRK 189
Query: 209 FSIKSDVFSFGVLLLKIVS 227
FS +SDV+S+GV + + +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 34/201 (16%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE-----IAVKRLSGRSGQG-----LRELK--------NKL 95
LG G FG V+KGV E + +K + +SG+ + + +
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
RLLG C L+ +Y+P SL + + IA+G+ YL
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE--LQANTGRI-VGTYRYMSPEYAIQ 206
++HR+L N+LL +++DFG+A + ++ L + + + ++M+ E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHF 191
Query: 207 GIFSIKSDVFSFGVLLLKIVS 227
G ++ +SDV+S+GV + ++++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 37/204 (18%)
Query: 54 NKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQGLREL------------KNKLR 96
++LG+G FG V G +AVK+L R+ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 97 LLGCCIDKDEK--ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSR 148
G + L+ EY+P+ L FL D + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGR---IVGTYRYMSPEY 203
R +HRDL NIL++ + + KI+DFG+A++ ++ I + +PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI----FWYAPES 201
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVS 227
IFS +SDV+SFGV+L ++ +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 43/211 (20%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRLSGRSGQG------LREL--------KNKL 95
LGEG FG V +G LK D +AVK + + L E N +
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 96 RLLGCCIDKD-----EKILIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQG 139
RLLG CI+ + ++I +M L +L T ++ + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE--LQANTGRI-VGTY 196
+ YL S +HRDL N +L DM ++DFG+++ + Q ++ V
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 213
Query: 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++++ E +++ KSDV++FGV + +I +
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 42/213 (19%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQGLREL------------KNKL 95
+LGEG FG V+ N +AVK L + ++ ++ +
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIE 134
+ G C D D I+++EYM + L+ FL + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVG 194
IA G++YL + +HRDL N L+ ++ KI DFG++R + G +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
R+M PE + F+ +SDV+SFGV+L +I +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 56/257 (21%), Positives = 100/257 (38%), Gaps = 54/257 (21%)
Query: 9 KANNVNIELPVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV 68
K + + + N + + + +LGEG FG V+
Sbjct: 15 KGSGLQGHIIENPQYFSDACVHHIKR-------------RDIVLKWELGEGAFGKVFLAE 61
Query: 69 LKNGDE------IAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILI 110
N +AVK L S ++ ++ +R G C + +++
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121
Query: 111 YEYMPNKSLDFFL--------------------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
+EYM + L+ FL + + +A G++YL + +
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLH 178
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+HRDL N L+ + + KI DFG++R + GR + R+M PE + F+
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 211 IKSDVFSFGVLLLKIVS 227
+SDV+SFGV+L +I +
Sbjct: 239 TESDVWSFGVVLWEIFT 255
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 43/197 (21%), Positives = 82/197 (41%), Gaps = 30/197 (15%)
Query: 55 KLGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQGLREL------------KNKLRL 97
+GEG FG V++G+ + + +A+K + S + + ++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 98 LGCCIDKDEKILI-YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
+G + + I E L FL D + + ++ L YL R
Sbjct: 82 IGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+HRD+ N+L+ + K+ DFG++R + + + ++M+PE F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFT 195
Query: 211 IKSDVFSFGVLLLKIVS 227
SDV+ FGV + +I+
Sbjct: 196 SASDVWMFGVCMWEILM 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 44/212 (20%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQG-----LREL--------KNKL 95
LG+G FG V + LK D +AVK L + LRE +
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 96 RLLGCCIDKDEKI------LIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQ 138
+L+G + K +I +M + L FL T VR + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE--LQANTGRI-VGT 195
G+ YL S IHRDL N +L +DM ++DFG++R + Q ++ V
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV-- 203
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++++ E ++++ SDV++FGV + +I++
Sbjct: 204 -KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCI 102
KLG+G FG V+ G +A+K L + L+E + ++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 103 DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
++ I + EYM SL FL V + IA G+ Y+ R+ +HRD
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
L+ +NIL+ +++ K++DFG+AR+ NE A G ++ +PE A+ G F+IKSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDV 447
Query: 216 FSFGVLLLKIVS 227
+SFG+LL ++ +
Sbjct: 448 WSFGILLTELTT 459
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQG-----LREL--------KNK 94
+LG+G FG VY+GV K + +A+K ++ + L E +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL------------FDWVTRVRIIE---GIAQG 139
+RLLG ++I E M L +L + ++I+ IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
+ YL + + +HRDL N ++ +D KI DFG+ R + G+ + R+M
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
SPE G+F+ SDV+SFGV+L +I +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 34/199 (17%)
Query: 55 KLGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQG----LRELK--------NKLRL 97
LGEG FG VY+GV N +AVK + + E + ++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
+G +++ +I E P L +L +T V I + + YL +
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINC 134
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQGI 208
+HRD+ V NIL+ K+ DFG++R + + I ++MSPE
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI----KWMSPESINFRR 190
Query: 209 FSIKSDVFSFGVLLLKIVS 227
F+ SDV+ F V + +I+S
Sbjct: 191 FTTASDVWMFAVCMWEILS 209
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCI 102
KLG+G FG V+ G +A+K L + L+E + ++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 103 DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
++ I + EYM SL FL V + IA G+ Y+ R+ +HRD
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
L+ +NIL+ +++ K++DFG+AR+ NE A G ++ +PE A+ G F+IKSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDV 364
Query: 216 FSFGVLLLKIVS 227
+SFG+LL ++ +
Sbjct: 365 WSFGILLTELTT 376
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 51/218 (23%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRL-SGRSGQGLREL------------KNK 94
+LGE FG VYKG L +A+K L G E N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRII 133
+ LLG +I+ Y + L FL + V ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGR- 191
IA G+ YL S ++H+DL N+L+ +N KISD G+ R + + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 192 --IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
I R+M+PE + G FSI SD++S+GV+L ++ S
Sbjct: 192 LPI----RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 35/200 (17%)
Query: 55 KLGEGGFGPVYKGVLKNGD---EIAVKRL-SGRSGQGLREL-------------KNKLRL 97
+LG G FG V KG + +AVK L + + L++ +R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
+G C + + +L+ E L+ +L + ++ ++ G+ YL +
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL---EESNFV 139
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGR---IVGTYRYMSPEYAIQG 207
HRDL N+LL KISDFG+++ R +E +A T + ++ +PE
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECINYY 195
Query: 208 IFSIKSDVFSFGVLLLKIVS 227
FS KSDV+SFGVL+ + S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 55/221 (24%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRL-SGRSGQGLREL-------------KN 93
LG G FG V + D+ +AVK L G + R L N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 94 KLRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDWVTRVRIIEG----------------- 135
+ LLG C + +I E+ +L +L R +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 136 ------IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQAN 188
+A+G+ +L + + IHRDL NILL + KI DFG+AR I + +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 189 T-GRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
R+ + ++M+PE +++I+SDV+SFGVLL +I S
Sbjct: 208 GDARLPL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 60/205 (29%), Positives = 85/205 (41%), Gaps = 35/205 (17%)
Query: 55 KLGEGGFGPVYKGVLK--NGDEI--AVKRL-SGRSGQG------LRELK--------NKL 95
KLG+G FG V +G +G + AVK L Q +RE+ N +
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
RL G + K+ + E P SL L F T R +A+G+ YL
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESK 140
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT---YRYMSPEYAIQ 206
R IHRDL N+LL KI DFG+ R N+ + + +PE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKT 198
Query: 207 GIFSIKSDVFSFGVLLLKIVS-GKK 230
FS SD + FGV L ++ + G++
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 48/218 (22%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQG-----LREL---------KN 93
LG G FG V + + +AVK L + + EL N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEG----------- 135
+ LLG C ++I EY L FL T I+E
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 136 -----IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANT 189
+A+G+ +L + IHRDL NILL KI DFG+AR I +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ ++M+PE +++ +SDV+S+G+ L ++ S
Sbjct: 206 NARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 29/197 (14%)
Query: 55 KLGEGGFGPVYKGVLKNGDE---IAVKRL-SGRSGQGLREL------------KNKLRLL 98
+LG G FG V +GV + + +A+K L G E+ +RL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G C + +L+ E L FL ++ ++ G+ YL +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFV 458
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNEL--QANTGRIVGTYRYMSPEYAIQGIFS 210
HR+L N+LL KISDFG+++ ++ A + ++ +PE FS
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW-PLKWYAPECINFRKFS 517
Query: 211 IKSDVFSFGVLLLKIVS 227
+SDV+S+GV + + +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 58/208 (27%), Positives = 84/208 (40%), Gaps = 37/208 (17%)
Query: 54 NKLGEGGFGPVYKGVLKNGD------EIAVKRLSGRSGQG-----LREL--------KNK 94
LG G FG VY+G + ++AVK L + L E +N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLY 142
+R +G + + ++ E M L FL + + + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 143 LHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
L IHRD+ N LL KI DFG+AR G + ++M
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
PE ++GIF+ K+D +SFGVLL +I S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 52/220 (23%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE--------IAVKRLSGRSGQG-----LREL--------- 91
LGEG FG V D+ +AVK L + + + E+
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEG--------- 135
KN + LLG C +I EY +L +L ++ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 136 -----IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANT 189
+A+G+ YL + + IHRDL N+L+ ++ KI+DFG+AR I + + T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 190 -GRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
GR+ V ++M+PE +++ +SDV+SFGVL+ +I +
Sbjct: 218 NGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 44/214 (20%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRL-SGRSGQGLREL-------------KN 93
LG G FG V + + +AVK L S L +N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL----------------FDWVTRVRIIE--- 134
+ LLG C ++I EY L FL + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIV 193
+AQG+ +L + IHRD+ N+LL KI DFG+AR I + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++++SDV+S+G+LL +I S
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 45/213 (21%), Positives = 84/213 (39%), Gaps = 54/213 (25%)
Query: 55 KLGEGGFGPVYKGVLKNGD--------EIAVKRLSGRSGQGLREL------------KNK 94
LG+G F ++KGV + E+ +K L K+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSR 148
+ G C+ DE IL+ E++ SLD +L + + ++ + + +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EE 131
Query: 149 VRIIHRDLKVSNILLDKDMNP--------KISDFGIARICRGNELQANTGRIVGTYRY-- 198
+IH ++ NILL ++ + K+SD GI+ + +
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------ILQERI 181
Query: 199 --MSPEYAIQ--GIFSIKSDVFSFGVLLLKIVS 227
+ PE I+ ++ +D +SFG L +I S
Sbjct: 182 PWVPPE-CIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 43/196 (21%), Positives = 83/196 (42%), Gaps = 28/196 (14%)
Query: 55 KLGEGGFGPVYKGVLKNGDE----IAVKRL-SGRSGQGLREL------------KNKLRL 97
+GEG FG V++G+ + + +A+K + S + + ++L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
+G ++ +I E L FL D + + ++ L YL R
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRF 512
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
+HRD+ N+L+ + K+ DFG++R + + + ++M+PE F+
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTS 571
Query: 212 KSDVFSFGVLLLKIVS 227
SDV+ FGV + +I+
Sbjct: 572 ASDVWMFGVCMWEILM 587
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 52/220 (23%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE--------IAVKRL-SGRSGQGLREL------------- 91
LGEG FG V D+ +AVK L + + L +L
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEG--------- 135
KN + LLG C +I EY +L +L ++ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 136 -----IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANT 189
+A+G+ YL + + IHRDL N+L+ ++ KI+DFG+AR I + + T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 190 -GRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
GR+ V ++M+PE +++ +SDV+SFGVL+ +I +
Sbjct: 264 NGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 57/225 (25%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQG-----LREL--------KNK 94
LGEG FG V K + +AVK L + L E +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDWVTRVRIIEG------ 135
++L G C +LI EY SL FL +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 136 ----------IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNE 184
I+QG+ YL + ++++HRDL NIL+ + KISDFG++R + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 185 LQANTGRI--VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+ V ++M+ E I++ +SDV+SFGVLL +IV+
Sbjct: 206 YVKRSQGRIPV---KWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 52/220 (23%)
Query: 54 NKLGEGGFGPVYKGVLKNGD--------EIAVKRL-SGRSGQGLREL------------- 91
LGEG FG V D ++AVK L S + + L +L
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 92 KNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEG--------- 135
KN + LLG C +I EY +L +L ++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 136 -----IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANT 189
+A+G+ YL + + IHRDL N+L+ +D KI+DFG+AR I + + T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 190 -GRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
GR+ V ++M+PE I++ +SDV+SFGVLL +I +
Sbjct: 252 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 58/208 (27%), Positives = 84/208 (40%), Gaps = 37/208 (17%)
Query: 54 NKLGEGGFGPVYKGVLKNGD------EIAVKRLSGRSGQG-----LREL--------KNK 94
LG G FG VY+G + ++AVK L + L E +N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLY 142
+R +G + + ++ E M L FL + + + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 143 LHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
L IHRD+ N LL KI DFG+AR G + ++M
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
PE ++GIF+ K+D +SFGVLL +I S
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 57/225 (25%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRL-SGRSGQGLREL-------------KN 93
LG G FG V + +AVK L L +N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDWVTRVRIIEG------- 135
+ LLG C LI+EY L +L ++ + R+ E
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 136 ----------IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNE 184
+A+G+ +L +HRDL N+L+ KI DFG+AR I +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 185 LQANTGRI--VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
V ++M+PE +GI++IKSDV+S+G+LL +I S
Sbjct: 228 YVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 39/224 (17%)
Query: 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKR--LSGRSGQGLRELKN--- 93
F S+S +S ++G GG V++ + + A+K L Q L +N
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 94 ---KL--------RLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIA 137
KL RL I ++ E N L+ +L D R + +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 138 QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYR 197
+ + +HQ+ I+H DLK +N L+ K+ DFGIA + + VGT
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 198 YMSPEYAIQGI------------FSIKSDVFSFGVLLLKIVSGK 229
YM PE AI+ + S KSDV+S G +L + GK
Sbjct: 194 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 57/225 (25%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQG-----LRELK--------NK 94
+GEG FG V++ +AVK L + RE N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTR------------------ 129
++LLG C L++EYM L+ FL ++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 130 ----VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNE 184
+ I +A G+ YL S + +HRDL N L+ ++M KI+DFG++R I +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 185 LQANT-GRI-VGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
+A+ I + R+M PE ++ +SDV+++GV+L +I S
Sbjct: 230 YKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 33/231 (14%)
Query: 24 TKRSKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLS 81
+ R + E Q P + S + F ++LG G +G V+K K + AVKR
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM 91
Query: 82 GRSGQGLRELKNKL----------------RLLGCCIDKDEKILIYEYMPNKSLDFFLFD 125
+G ++ KL RL + L E SL
Sbjct: 92 -SPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA 149
Query: 126 WVTRV------RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179
W + + L +LH ++H D+K +NI L K+ DFG+
Sbjct: 150 WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKK 230
G G RYM+PE +QG + +DVFS G+ +L++ +
Sbjct: 207 L-GTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 39/209 (18%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKR--LSGRSGQGLRELKN------KL--------RL 97
++G GG V++ + + A+K L Q L +N KL RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
I ++ E N L+ +L D R + + + + +HQ+ I+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 177
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI---- 208
H DLK +N L+ D K+ DFGIA + + VG YM PE AI+ +
Sbjct: 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSR 235
Query: 209 --------FSIKSDVFSFGVLLLKIVSGK 229
S KSDV+S G +L + GK
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 39/209 (18%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKR--LSGRSGQGLRELKN------KL--------RL 97
++G GG V++ + + A+K L Q L +N KL RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
I ++ E N L+ +L D R + + + + +HQ+ I+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 130
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI---- 208
H DLK +N L+ K+ DFGIA + + VGT YM PE AI+ +
Sbjct: 131 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSR 188
Query: 209 --------FSIKSDVFSFGVLLLKIVSGK 229
S KSDV+S G +L + GK
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVK--RLSGRSGQGLRELKNKLRLL------ 98
K+ K+GEG FG ++G + +K +S S + E + ++ +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 99 ------GCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQ 145
+ ++ +Y L + F + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
+I+HRD+K NI L KD ++ DFGIAR+ A +GT Y+SPE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE-IC 197
Query: 206 QGI-FSIKSDVFSFGVLLLKIVSGK 229
+ ++ KSD+++ G +L ++ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-29
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELK--------NK 94
F + +G GGFG V+K +G +KR+ + + RE+K N
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNI 66
Query: 95 LRLLGCCIDKDEKI----------------LIYEYMPNKSLDFFL-------FDWVTRVR 131
+ GC D + E+ +L+ ++ D V +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
+ E I +G+ Y+H ++I+RDLK SNI L KI DFG+ + N+ +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTR-- 180
Query: 192 IVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKT 231
GT RYMSPE I + + D+++ G++L +++ T
Sbjct: 181 SKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 36/236 (15%)
Query: 16 ELPVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEI 75
EL ++ KR + + + + F ++LG G G V+K K +
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 76 -AVKRLSGRSG-----QGLRELK--------NKLRLLGCCIDKDEKILIYEYMPNKSLDF 121
A K + Q +REL+ + G E + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 122 FL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176
L ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG+
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 177 ARICRGNEL---QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ +L AN+ VGT YMSPE +S++SD++S G+ L+++ G+
Sbjct: 179 SG-----QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 41/239 (17%)
Query: 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----QGLRELKNKL 95
S+ + +LG G +G V K +G +AVKR+ + L +L +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 96 RLLGC--------CIDKDEKILIY-EYMPNKSLDFFLFDWVTRV---------RIIEGIA 137
R + C + ++ + I E M + SLD F + + +I I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 138 QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYR 197
+ L +LH S++ +IHRD+K SN+L++ K+ DFGI+ +++ + G
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGCKP 174
Query: 198 YMSPE----YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGF-YRTYS--FTLLGYISEN 249
YM+PE Q +S+KSD++S G+ ++++ + F Y ++ F L + E
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLKQVVEE 229
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 31/230 (13%)
Query: 25 KRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVK--RLS 81
+R+++++ + +S ++G G F VYKG+ + E+A +
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62
Query: 82 GRSGQGLRELKNKLRLL------------GCCIDKDEK----ILIYEYMPNKSLDFFL-- 123
+ + K + +L + +L+ E M + +L +L
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 124 ---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARI 179
I +GL +LH IIHRDLK NI + + KI D G+A +
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
R + +A ++GT +M+PE + + DV++FG+ +L++ + +
Sbjct: 182 KRASFAKA----VIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 44/243 (18%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCC 101
KLGEGGF V L +G A+KR+ Q E + N LRL+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 102 IDKDEK----ILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSR 148
+ + L+ + +L + + + ++ GI +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV-------GTYRYMSP 201
HRDLK +NILL + P + D G + + + T Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 202 E----YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGF-YRTYSFTLLGYISENIYEFPSV 256
E + I ++DV+S G +L ++ G+ + + +N P
Sbjct: 213 ELFSVQSHCVI-DERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 257 DTH 259
H
Sbjct: 270 PRH 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 33/200 (16%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLL------------GCCI 102
LG+G +G VY G L N IA+K + R + + L ++ L G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 103 DKDEKILIY-EYMPNKSLDFFLFDWVTRVRIIEG--------IAQGLLYLHQYSRVRIIH 153
+ + I I+ E +P SL L ++ E I +GL YLH +I+H
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 154 RDLKVSNILLD-KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI---F 209
RD+K N+L++ KISDFG ++ G T GT +YM+PE I +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE-IIDKGPRGY 202
Query: 210 SIKSDVFSFGVLLLKIVSGK 229
+D++S G ++++ +GK
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 49/220 (22%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLS-GRSGQGLRELKNKLRLL------- 98
F LG GGFG V++ K D A+KR+ ++ +++ L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 99 -----GCCIDKDE---------KILIY---EYMPNKSLDFFL--------FDWVTRVRII 133
++K+ K+ +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-- 191
IA+ + +LH ++HRDLK SNI D K+ DFG+ +E +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 192 --------IVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLL 222
VGT YMSPE I G +S K D+FS G++L
Sbjct: 182 PAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLIL 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 48/231 (20%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-------SGRSGQGLRELK--------NKLRLLG 99
LG+GGF ++ + A K + + + E+ + + G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFD-WVTRVRIIE--------GIAQGLLYLHQYSRVR 150
D D ++ E +SL + R + E I G YLH+ R
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQG 207
+IHRDLK+ N+ L++D+ KI DFG+A +++ + R + GT Y++PE +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 208 IFSIKSDVFSFGVLLLKIVSGK---KTTGFYRTYSFTLLGYISENIYEFPS 255
S + DV+S G ++ ++ GK +T+ TY I +N Y P
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-----RIKKNEYSIPK 236
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 47/208 (22%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL---SGRSGQGLRELKNKLRLL----- 98
F K+G G F VY+ L +G +A+K++ + + ++ LL
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 99 -------GCCIDKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLY 142
I+ +E ++ E L + T + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
+H R++HRD+K +N+ + K+ D G+ R A++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 203 YAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
I ++ KSD++S G LL ++ + +
Sbjct: 207 -RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-------SGRSGQGLRELK--------NKLRLLG 99
LG+GGF ++ + A K + + + E+ + + G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLYLHQYSRVR 150
D D ++ E +SL + R + I G YLH+ R
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 161
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQG 207
+IHRDLK+ N+ L++D+ KI DFG+A +++ + R + GT Y++PE +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 208 IFSIKSDVFSFGVLLLKIVSGK---KTTGFYRTYSFTLLGYISENIYEFPS 255
S + DV+S G ++ ++ GK +T+ TY I +N Y P
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-----RIKKNEYSIPK 262
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 49/220 (22%), Positives = 82/220 (37%), Gaps = 47/220 (21%)
Query: 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---------LRELK--NK 94
+ F + LG+G FG V K + A+K++ + L L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFF---------LFDWVTR----------VRIIEG 135
+R +++ + + KS F L+D + R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI--- 192
I + L Y+H IIHRDLK NI +D+ N KI DFG+A+ +
Sbjct: 125 ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 193 ---------VGTYRYMSPE-YAIQGIFSIKSDVFSFGVLL 222
+GT Y++ E G ++ K D++S G++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 66/340 (19%), Positives = 111/340 (32%), Gaps = 89/340 (26%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCCID-------KDE 106
L EGGF VY+ + +G E A+KRL + R + ++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 107 KILIYEYMPNKSLDFF---------LFDWVTRVR------------IIEGIAQGLLYLHQ 145
+ E +F L +++ ++ I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI----------VGT 195
+ IIHRDLKV N+LL K+ DFG A + + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 196 YRYMSPE----YAIQGIFSIKSDVFSFGVLLLKIVSGK---KTTGFYRTYSFTLLGYISE 248
Y +PE Y+ I K D+++ G +L + + + R I
Sbjct: 214 PMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR---------IVN 263
Query: 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD 308
Y P DT L I +Q + ++
Sbjct: 264 GKYSIPPHDTQ-----------------------YTVFHSL-IRA-------MLQVNPEE 292
Query: 309 RPTMNDVVSMLTNEAAAL-LPPKQPAFSYVRNTVTSTSST 347
R ++ +VV L AAA + PK P + S+T
Sbjct: 293 RLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSAT 332
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 41 SSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----LRELK-- 92
+ + ++G G FG V++ + G + AVK++ + L
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSP 110
Query: 93 NKLRLLGCCIDKDEKILIY-EYMPNKSLDFFLFDW------VTRVRIIEGIAQGLLYLHQ 145
+ L G + + I+ E + SL + + +GL YLH
Sbjct: 111 RIVPLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-YLGQALEGLEYLHT 168
Query: 146 YSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGR---IVGTYRYMSP 201
RI+H D+K N+LL D + + DFG A + + L + I GT +M+P
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 202 EYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
E + G K D++S ++L +++G
Sbjct: 226 E-VVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 39/206 (18%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----QGLRELKNKLRLL---------G 99
++G G +G V K V K +G +AVKR+ Q L +L +R G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRV----------RIIEGIAQGLLYLHQYSRV 149
+ + + E M + S D F + + +I + L +L +
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENL 145
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR--IVGTYRYMSPE----Y 203
+IIHRD+K SNILLD+ N K+ DFGI+ +L + + G YM+PE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG-----QLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGK 229
A + + ++SDV+S G+ L ++ +G+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 32/204 (15%)
Query: 55 KLGEGGFGPVYKGVLKNGDEI-AVK--RLSGRSGQGLRELKNKLRLLGCC---------- 101
+G G +G K K+ +I K + + L +++ LL
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 102 --IDKDEKIL--IYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQ--Y 146
ID+ L + EY L + +R++ + L H+
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
++HRDLK +N+ LD N K+ DFG+ARI + A T VGT YMSPE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPE-QMN 189
Query: 207 GI-FSIKSDVFSFGVLLLKIVSGK 229
+ ++ KSD++S G LL ++ +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALM 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 43/229 (18%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-------SGRSGQGLRELK--------NKLRLLG 99
LG+G F VY+ + G E+A+K + +G + E+K + L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 100 CCIDKDEKILIYEYMPNKSL-DF------FLFDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
D + L+ E N + + + R + I G+LYLH + I+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---GIL 134
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR---IVGTYRYMSPEYAIQGIF 209
HRDL +SN+LL ++MN KI+DFG+A +L+ + + GT Y+SPE A +
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 210 SIKSDVFSFGVLLLKIVSGK---KTTGFYRTYSFTLLGYISENIYEFPS 255
++SDV+S G + ++ G+ T T + + YE PS
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-----KVVLADYEMPS 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 30/204 (14%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLL------- 98
K++ K+G+G G VY + + G E+A+++++ + + N++ ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 99 -----GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-IA-------QGLLYLHQ 145
+ DE ++ EY+ SL D VT + EG IA Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
++IHRD+K NILL D + K++DFG + + +T +VGT +M+PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGK 229
+ + K D++S G++ ++++ G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 20 NSNLTKRSKKKEVDQLP--LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIA 76
NL +S +Q L K+GEG G V +G ++A
Sbjct: 15 TENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVA 74
Query: 77 VKRLSGRSGQGLRELKNKLRLL------------GCCIDKDEKILIYEYMPNKSLDFFLF 124
VK + R Q L N++ ++ + +E ++ E++ +L
Sbjct: 75 VKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT---- 130
Query: 125 DWVTRVRIIEG-IA-------QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176
D V++VR+ E IA Q L YLH +IHRD+K +ILL D K+SDFG
Sbjct: 131 DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ + + +VGT +M+PE + +++ + D++S G++++++V G+
Sbjct: 188 CAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 37/199 (18%), Positives = 71/199 (35%), Gaps = 36/199 (18%)
Query: 55 KLGEGGFGPVYKG---VLKNGDEIAVKRLSGRSGQG-----LRELKNKLRL--------- 97
+ GG G +Y + NG + +K L + E + +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 98 -LGCCIDKDEKILIY---EYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
D+ + Y EY+ +SL + + I L YLH +
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIG 202
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+++ DLK NI+L ++ K+ D G + G + GT + +PE + +
Sbjct: 203 LVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIV-RTGPT 254
Query: 211 IKSDVFSFGVLLLKIVSGK 229
+ +D+++ G L +
Sbjct: 255 VATDIYTVGRTLAALTLDL 273
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 54/249 (21%), Positives = 99/249 (39%), Gaps = 40/249 (16%)
Query: 30 KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSG--- 85
K+ L + N + ++G G G V+K + + AVK++
Sbjct: 8 KQTGYLTI-GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE 66
Query: 86 --QGLRELKNKLRLLGC--------CIDKDEKILIY-EYMPNKSLDFFLFDWVTRV---- 130
+ L +L L+ C + + I E M + +
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERI 125
Query: 131 --RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188
++ I + L YL + +IHRD+K SNILLD+ K+ DFGI+ ++ +
Sbjct: 126 LGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG-RLVDDKAKD 182
Query: 189 TGRIVGTYRYMSPE-----YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGF-YRTYS--F 240
G YM+PE + + I++DV+S G+ L+++ +G+ F Y+ F
Sbjct: 183 R--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ----FPYKNCKTDF 236
Query: 241 TLLGYISEN 249
+L + +
Sbjct: 237 EVLTKVLQE 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)
Query: 55 KLGEGGFGPVYKG------------VLK---NGDEIAVKRLSGRSGQGLRELKNKLRLLG 99
KLG GG VY + E +KR RE+ N +L
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-------REVHNSSQLSH 70
Query: 100 CCI--------DKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY 146
I + D L+ EY+ +L ++ T + I G+ + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH-- 128
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
+RI+HRD+K NIL+D + KI DFGIA+ L T ++GT +Y SPE A
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKG 186
Query: 207 GIFSIKSDVFSFGVLLLKIVSGK 229
+D++S G++L +++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 63/233 (27%), Positives = 92/233 (39%), Gaps = 38/233 (16%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL-------SGRSGQGLRELK------- 92
F LG+G FG VY ++ +A+K L +G Q RE++
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 93 -NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLY 142
N LRL G D LI EY P ++ + + ++ I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
H R+IHRD+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+ K D++S GVL + + GK F IS + FP
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEFTFPD 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 28/258 (10%), Positives = 64/258 (24%), Gaps = 65/258 (25%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELK---------------------- 92
LG+ + + G+ V +K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 93 ---------NKLRLLGCCIDKDEK-----------ILIYEYMPNKSLDFF--LFDWVT-- 128
+ ++ + +Y M + F L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 129 -------RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181
R+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261
Query: 182 GNELQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYR 236
G + GR + + + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTD 319
Query: 237 TYSFTLLGYISENIYEFP 254
+ +I + P
Sbjct: 320 DAALGGSEWIFRSCKNIP 337
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 49/226 (21%), Positives = 87/226 (38%), Gaps = 50/226 (22%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVK-----RLSGRSGQGLRELK----- 92
ST+ + + ++ LG+G V++G K GD A+K +RE +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 93 ---NKLRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDWVTRV------------RIIEG 135
N ++L K+LI E+ P SL + + ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRD 120
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGIARICRGNELQANTGR 191
+ G+ +L + I+HR++K NI+ D K++DFG AR +E +
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS-- 174
Query: 192 IVGTYRYMSPE--------YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ GT Y+ P+ Q + D++S GV +G
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 35/111 (31%), Positives = 51/111 (45%), Gaps = 13/111 (11%)
Query: 131 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190
I IA+ + +LH ++HRDLK SNI D K+ DFG+ +E +
Sbjct: 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 191 ----------RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231
VGT YMSPE +S K D+FS G++L +++ T
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 37/209 (17%)
Query: 49 KFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-------LREL---KNKLRLL 98
F + LG G G + + + ++AVKR+ LRE N +R
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLFDWVTR----------VRIIEGIAQGLLYLHQYSR 148
D+ + + E L ++V + + +++ GL +LH
Sbjct: 85 CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL-- 137
Query: 149 VRIIHRDLKVSNILL-----DKDMNPKISDFGIARICR-GNELQANTGRIVGTYRYMSPE 202
I+HRDLK NIL+ + ISDFG+ + G + + GT +++PE
Sbjct: 138 -NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 203 Y---AIQGIFSIKSDVFSFGVLLLKIVSG 228
+ + D+FS G + ++S
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189
V I+ I L H HRD+K NIL+ D + DFGIA +L
Sbjct: 137 VAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-L 192
Query: 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
G VGT YM+PE + + ++D+++ +L + ++G
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 66/265 (24%), Positives = 107/265 (40%), Gaps = 44/265 (16%)
Query: 22 NLTKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLK-NGDEIA 76
+ + R L +++ S+ KLG G +G V K E A
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 77 VK-----RLSGRSGQGL-RELK--------NKLRLLGCCIDKDEKILIYEYMPNKSLDFF 122
+K +S S L E+ N ++L DK L+ E L
Sbjct: 67 IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--- 123
Query: 123 LFDWVTR---------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPK 170
FD + II+ + G+ YLH+++ I+HRDLK N+LL +KD K
Sbjct: 124 -FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIK 179
Query: 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKK 230
I DFG++ + + +GT Y++PE ++ + K DV+S GV+L +++G
Sbjct: 180 IVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
Query: 231 TTGFYRTYSFTLLGYISENIYEFPS 255
F +L + + Y F S
Sbjct: 236 --PFGGQTDQEILRKVEKGKYTFDS 258
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-23
Identities = 49/226 (21%), Positives = 88/226 (38%), Gaps = 50/226 (22%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVK-----RLSGRSGQGLRELK----- 92
ST+ + + ++ LG+G V++G K GD A+K +RE +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 93 ---NKLRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDWVTR------------VRIIEG 135
N ++L K+LI E+ P SL + + + ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRD 120
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGIARICRGNELQANTGR 191
+ G+ +L + I+HR++K NI+ D K++DFG AR +E +
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS-- 174
Query: 192 IVGTYRYMSPE--------YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ GT Y+ P+ Q + D++S GV +G
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-23
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 50 FSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----------LRELK--NKL 95
F+ K+G+G FG V+KG+ + +A+K + + L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG-IA-------QGLLYLHQYS 147
+ G + + +I EY+ S D + + E IA +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
+ IHRD+K +N+LL + K++DFG+A +++ NT VGT +M+PE Q
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 208 IFSIKSDVFSFGVLLLKIVSGK 229
+ K+D++S G+ +++ G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-23
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 43/208 (20%)
Query: 55 KLGEGGFGPVYKG------------VLK---NGDEIAVKRLSGRSGQGLRELKNKLRL-- 97
LG GG V+ VL+ D R RE +N L
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-------REAQNAAALNH 71
Query: 98 --------LGCCIDKDEKI--LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLY 142
G + ++ EY+ +L + + +I Q L +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSP 201
H + IIHRD+K +NI++ K+ DFGIAR I T ++GT +Y+SP
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 202 EYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
E A +SDV+S G +L ++++G+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 48/236 (20%), Positives = 87/236 (36%), Gaps = 58/236 (24%)
Query: 41 SSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKL---- 95
S T +F + K+G G FG V+K V +G A+KR S + G + +N L
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVY 62
Query: 96 ------------RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRII-EG------- 135
R + D ++ EY SL + + + E
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 136 -IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-------------------KISDFG 175
+ +GL Y+H + ++H D+K SNI + + P KI D G
Sbjct: 123 QVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS--IKSDVFSFGVLLLKIVSGK 229
++ G R+++ E +Q ++ K+D+F+ + ++ +
Sbjct: 180 HVT------RISSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 58/248 (23%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLS---------------------GRSGQGLRELK- 92
L +G F + K+ A+K+ + EL+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 93 -------NKLRLLGCCIDKDEKILIYEYMPN--------------KSLDFFLFDWVTRVR 131
L G + DE +IYEYM N K+ F+ V +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-C 155
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
II+ + Y+H + I HRD+K SNIL+DK+ K+SDFG + +++
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G-- 209
Query: 192 IVGTYRYMSPEYAIQGIFSI---KSDVFSFGVLLLKIVSGKKTTGFYRTYSF-TLLGYIS 247
GTY +M PE S K D++S G+ L + F S L I
Sbjct: 210 SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV--VPFSLKISLVELFNNIR 266
Query: 248 ENIYEFPS 255
E+P
Sbjct: 267 TKNIEYPL 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 25 KRSKKKEVDQLPLFSFSSVSTATN---KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL 80
+ + + + L S F KLGEG +G VYK + + G +A+K++
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 81 SGRSG--------QGLRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV 130
S +++ + ++ G + ++ EY S+ D +
Sbjct: 63 PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLR 118
Query: 131 R----------IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
I++ +GL YLH R IHRD+K NILL+ + + K++DFG+A
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ NT ++GT +M+PE + ++ +D++S G+ +++ GK
Sbjct: 176 TDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 47/211 (22%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVK----RLSGRSGQGL-RELKNKLRLL---------- 98
+LG GGFG V + + G+++A+K LS ++ + E++ ++ L
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQI-MKKLNHPNVVSARE 79
Query: 99 -----GCCIDKDEKILIYEYMPNKSLDFFLFDWVTR------------VRIIEGIAQGLL 141
D +L EY L ++ + ++ I+ L
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDL----RKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 142 YLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGIARICRGNELQANTGRIVGTYRY 198
YLH+ RIIHRDLK NI+L + + KI D G A+ EL VGT +Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE--FVGTLQY 189
Query: 199 MSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
++PE Q +++ D +SFG L + ++G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 7e-22
Identities = 28/282 (9%), Positives = 63/282 (22%), Gaps = 68/282 (24%)
Query: 36 PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG------- 87
S +S K L G V+ ++ ++ A+K + +
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 88 LRELKNKLRLLGCCIDK----------------------------------DEKILIYEY 113
RLLG ++ +L+
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 114 MPNKSLDFF-----------LFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL 162
F + + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 163 LDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGV 220
+ D + D ++ Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 221 LLLKIVSGK-----KTTGFYRTYSFTLLGYISENIYEFPSVD 257
+ ++ T G ++ L + F S
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT 323
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-22
Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 38/225 (16%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-------SGRSGQGLRELK--------NKLRLLG 99
LG+G FG VY +N +A+K L G Q RE++ N LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLYLHQYSRVR 150
D+ L+ E+ P L + + + +E +A L Y H+ +
Sbjct: 82 YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCHER---K 134
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+IHRD+K N+L+ KI+DFG + T + GT Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLPPEMIEGKTHD 190
Query: 211 IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
K D++ GVL + + G F I +FP
Sbjct: 191 EKVDLWCAGVLCYEFLVGM--PPFDSPSHTETHRRIVNVDLKFPP 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 50/239 (20%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG-------------------LRELK-- 92
LG G V + + K E AVK + G LR++
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 93 -NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLY 142
N ++L L+++ M L FD++T +I+ + + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
LH+ I+HRDLK NILLD DMN K++DFG + E + GT Y++PE
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPE 193
Query: 203 ------YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+ + D++S GV++ +++G + F+ +L I Y+F S
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFWHRKQMLMLRMIMSGNYQFGS 250
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 39/203 (19%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LRELK--------NKLRL 97
LG+G FG V K G E AVK +S R + LRE++ N ++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSR 148
DK L+ E L FD + RII + G+ Y+H+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNK- 146
Query: 149 VRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
I+HRDLK N+LL KD N +I DFG++ ++ +GT Y++PE +
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPE-VL 200
Query: 206 QGIFSIKSDVFSFGVLLLKIVSG 228
G + K DV+S GV+L ++SG
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSG 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 38/202 (18%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVK-----RLSGRSGQGL-RELK--------NKLRLL 98
LG+G FG V K + E AVK + + RE++ N ++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSRV 149
D ++ E L FD + + RII+ + G+ Y+H++
Sbjct: 88 EILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 150 RIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
I+HRDLK NILL +KD + KI DFG++ + N +GT Y++PE ++
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPE-VLR 196
Query: 207 GIFSIKSDVFSFGVLLLKIVSG 228
G + K DV+S GV+L ++SG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-21
Identities = 44/211 (20%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLL------- 98
+ +LG+G FG VYK + G A K + +S + L + ++ +L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 99 -----GCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVR----------IIEGIAQGLLYL 143
G + ++ E+ P ++D + + + + + L +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE- 202
H RIIHRDLK N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEV 188
Query: 203 ----YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ K+D++S G+ L+++ +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-21
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 26/176 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK-------- 92
F K+GEG +G VYK G+ +A+K++ G +RE+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 93 NKLRLLGCCIDKDEKILIYEYMPN------KSLDFFLFDWVTRVRIIEGIAQGLLYLHQY 146
N ++LL +++ L++E++ + + + QGL + H +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
R++HRDLK N+L++ + K++DFG+AR G ++ T +V T Y +PE
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 173
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 25 KRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGR 83
+ + + FSD ++G G FG VY ++N + +A+K++S
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 84 SGQG-------------LRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVT 128
Q L++L+ N ++ GC + + L+ EY + D V
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VH 147
Query: 129 RVRIIEG-IA-------QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180
+ + E IA QGL YLH + +IHRD+K NILL + K+ DFG A
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--- 201
Query: 181 RGNELQANTGRIVGTYRYMSPE---YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
AN+ VGT +M+PE +G + K DV+S G+ +++ K
Sbjct: 202 -SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 45/247 (18%)
Query: 20 NSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLK-NGDE 74
+ + + + + + V K ++ KLG G +G V K E
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 75 IAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEKILIYEYM--PN--KSLDFF-------- 122
A+K + R + + + +I + + + PN K D F
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 123 ---------LFDWVTR---------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL- 163
LF+ + I++ I G+ YLH+++ I+HRD+K NILL
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180
Query: 164 --DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221
+ +N KI DFG++ + + +GT Y++PE ++ ++ K DV+S GV+
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236
Query: 222 LLKIVSG 228
+ ++ G
Sbjct: 237 MYILLCG 243
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 41/236 (17%)
Query: 18 PVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKN 71
PV S T F V+ + LG G FG V+K
Sbjct: 53 PVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 72 -GDEIAVKRLSGRSGQG----------LRELK--NKLRLLGCCIDKDEKILIYEYMPNKS 118
G ++A K + R + + +L N ++L K++ +L+ EY+
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172
Query: 119 LDFFLFDWVTR----------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDM 167
L FD + + ++ I +G+ ++HQ I+H DLK NIL ++D
Sbjct: 173 L----FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDA 225
Query: 168 NP-KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLL 222
KI DFG+AR + E GT +++PE S +D++S GV+
Sbjct: 226 KQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 38/195 (19%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVK-----RLSGRSGQGL-RELK--------NKLRLLG 99
LG+G FG V K + E AVK + + RE++ N ++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSRVR 150
D ++ E L FD + + RII+ + G+ Y+H+++
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 151 IIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
I+HRDLK NILL +KD + KI DFG++ + N + +GT Y++PE ++G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAPE-VLRG 197
Query: 208 IFSIKSDVFSFGVLL 222
+ K DV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 31/239 (12%), Positives = 69/239 (28%), Gaps = 74/239 (30%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK------RLSGRSGQGLRELKNKLRLLGCCIDKDEK- 107
LG+ + + G+ V R + + ++E +LRLL ++ +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 108 -----------------------------------ILIYEYMPNKSLDFF--LFDWVT-- 128
+Y M + F L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 129 -------RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181
R+++ + + L LH Y ++H L+ +I+LD+ ++ F R
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 255
Query: 182 GNELQANTGRIVGTYRYMSPEYAI-----------QGIFSIKSDVFSFGVLLLKIVSGK 229
+ + PE + + + D ++ G+++ I
Sbjct: 256 DGARV----VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 53/279 (18%)
Query: 18 PVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLK-NG 72
+N K ++ + A +F + +G G V + V + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 73 DEIAVKRLSGRSGQG------------------LRELK---NKLRLLGCCIDKDEKILIY 111
E AVK + + + LR++ + + L+ L++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 112 EYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL 162
+ M L FD++T I+ + + + +LH I+HRDLK NIL
Sbjct: 180 DLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232
Query: 163 LDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE------YAIQGIFSIKSDVF 216
LD +M ++SDFG + E + GT Y++PE + + D++
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEK-LRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 217 SFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+ GV+L +++G + F+ +L I E Y+F S
Sbjct: 290 ACGVILFTLLAG--SPPFWHRRQILMLRMIMEGQYQFSS 326
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS------GRSGQGLRELK--------N 93
K+ K+GEG +G VYK G +A+KR+ G +RE+ N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 94 KLRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDWVTRVRIIEGIAQGLLYLHQYSR 148
+ L+ + L++E+M K LD + + +G+ + HQ+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
RI+HRDLK N+L++ D K++DFG+AR G +++ T +V T Y +P+
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPD 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 49/223 (21%), Positives = 75/223 (33%), Gaps = 56/223 (25%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS-GRSGQGLRELK---------NKLRL 97
N LG G G V G +AVKR+ L E+K N +R
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR----------------VRIIEGIAQGLL 141
+ E L D V + ++ IA G+
Sbjct: 75 YCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 142 YLHQYSRVRIIHRDLKVSNILLD-------------KDMNPKISDFGIARICRGNE--LQ 186
+LH ++IIHRDLK NIL+ +++ ISDFG+ + + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 187 ANTGRIVGTYRYMSPE-------YAIQGIFSIKSDVFSFGVLL 222
N GT + +PE + + D+FS G +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 54/228 (23%), Positives = 85/228 (37%), Gaps = 37/228 (16%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL---------KNKLRLLGCCID 103
+G G + + + K E AVK + E+ N + L D
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD 87
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSRVRIIHR 154
++ E M L D + R ++ I + + YLH ++HR
Sbjct: 88 GKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHR 140
Query: 155 DLKVSNILL-DKDMNP---KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
DLK SNIL D+ NP +I DFG A+ R T T +++PE + +
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYD 198
Query: 211 IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT---LLGYISENIYEFPS 255
D++S GVLL +++G T F T +L I +
Sbjct: 199 AACDIWSLGVLLYTMLTG--YTPFANGPDDTPEEILARIGSGKFSLSG 244
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 56/249 (22%), Positives = 95/249 (38%), Gaps = 57/249 (22%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK-----RLSGRSGQGLRELKNKLRLLGCCIDKDEKIL 109
+G+G +G V + A+K +L ++G R R + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 110 --------------------IYEYM--PNKSLDFF---------LFDWVTRVRIIEGIAQ 138
+ E + PN+ + + + T + E A+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 139 --------GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190
G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ +G++ +
Sbjct: 141 FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN- 196
Query: 191 RIVGTYRYMSPEYAIQGIFSI----KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI 246
VGT +M+PE ++ I DV++ GV L V G+ F L I
Sbjct: 197 -TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CPFMDERIMCLHSKI 252
Query: 247 SENIYEFPS 255
EFP
Sbjct: 253 KSQALEFPD 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 41/214 (19%)
Query: 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---------- 87
+ T + F KLG G FG V+ + +G E +K ++ Q
Sbjct: 13 NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72
Query: 88 -LRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG--------- 135
L+ L N +++ D ++ E L + + +
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAE 128
Query: 136 ----IAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQAN 188
+ L Y H ++H+DLK NIL KI DFG+A + + +E N
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLL 222
GT YM+PE + + K D++S GV++
Sbjct: 186 ---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-20
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 38/226 (16%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG----------LRELK--NKLRLLGCC 101
+G G +G V V K A K++ + ++ L N +RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 102 IDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSRVRII 152
D + L+ E L F+ V RI++ + + Y H+ +
Sbjct: 76 EDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 153 HRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
HRDLK N L D K+ DFG+A + ++ VGT Y+SP+ ++G++
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQ-VLEGLY 184
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+ D +S GV++ ++ G F ++ I E + FP
Sbjct: 185 GPECDEWSAGVMMYVLLCG--YPPFSAPTDSEVMLKIREGTFTFPE 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 51/238 (21%), Positives = 88/238 (36%), Gaps = 39/238 (16%)
Query: 20 NSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLKN-GDE 74
++ D + V + D +LG G FG V++ + G+
Sbjct: 125 KGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN 184
Query: 75 IAVKRLSGRSGQG----------LRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFF 122
A K + + L+ + L D +E ++IYE+M L
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL--- 241
Query: 123 LFDWVTR----------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP-K 170
F+ V V + + +GL ++H+ + +H DLK NI+ K N K
Sbjct: 242 -FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELK 297
Query: 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG 228
+ DFG+ + GT + +PE A +D++S GVL ++SG
Sbjct: 298 LIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 29/182 (15%)
Query: 45 TATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----------LRELK 92
+++++F KLG G + VYKG+ G +A+K + S +G ++ELK
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 93 --NKLRLLGCCIDKDEKILIYEYM----------PNKSLDFFLFDWVTRVRIIEGIAQGL 140
N +RL +++ L++E+M + + QGL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 141 LYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200
+ H+ +I+HRDLK N+L++K K+ DFG+AR G + + +V T Y +
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRA 176
Query: 201 PE 202
P+
Sbjct: 177 PD 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 6e-20
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 47 TNKFSDA----NKLGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQGL-RELK--- 92
+ KFSD +LG+G F V + V K G E A K +LS R Q L RE +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 93 -----NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQ 138
N +RL ++ L+++ + L F+ + I+ I +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+ Y H I+HR+LK N+LL K K++DFG+A +E + GT
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHG--FAGT 170
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
Y+SPE + +S D+++ GV+L ++ G F+ L I Y++PS
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQHRLYAQIKAGAYDYPS 228
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 39/228 (17%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQG-------LRELK--NKLRLLG 99
+LG+G F V + V K G E A K +LS R Q R+L+ N +RL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLYLHQYSRVR 150
++ L+++ + L F+ + I+ I + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSNG--- 148
Query: 151 IIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
I+HR+LK N+LL K K++DFG+A +E GT Y+SPE +
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD 205
Query: 208 IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+S D+++ GV+L ++ G F+ L I Y++PS
Sbjct: 206 PYSKPVDIWACGVILYILLVG--YPPFWDEDQHRLYAQIKAGAYDYPS 251
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 44/207 (21%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS----------GRSGQGLRELK----------NK 94
LG GGFG VY G+ + + +A+K + + E+
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVT-RVRIIEG--------IAQGLLYLHQ 145
+RLL D +LI E P D LFD++T R + E + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 146 YSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
++HRD+K NIL+D + K+ DFG + + GT Y PE+
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEW- 219
Query: 205 IQGI--FSIKSDVFSFGVLLLKIVSGK 229
I+ + V+S G+LL +V G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 39/228 (17%)
Query: 24 TKRSKKKEVDQLPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLK-NGDEIAVK 78
K D + V D +LG G FG V++ V K G K
Sbjct: 23 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 82
Query: 79 RLSGRSGQG----------LRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDW 126
++ + +L + L DK E +LI E++ L FD
Sbjct: 83 FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDR 138
Query: 127 VTR----------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP-KISDF 174
+ + + +GL ++H++ I+H D+K NI+ K + KI DF
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 195
Query: 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLL 222
G+A +E+ T + +PE + +D+++ GVL
Sbjct: 196 GLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 38/226 (16%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG----------LRELK--NKLRLLGCC 101
LG G F V+ + G A+K + L+++K N + L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 102 IDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSRVRII 152
L+ + + L FD + +I+ + + YLH+ I+
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 153 HRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
HRDLK N+L +++ I+DFG++++ + + GT Y++PE Q +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAPEVLAQKPY 184
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
S D +S GV+ ++ G FY L I E YEF S
Sbjct: 185 SKAVDCWSIGVITYILLCG--YPPFYEETESKLFEKIKEGYYEFES 228
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-19
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 24/174 (13%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS-GRSGQG-----------LRELK--N 93
K+ K+GEG +G VYK G+ A+K++ + +G L+ELK N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 94 KLRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDWVTRVRIIEGIAQGLLYLHQYSR 148
++L K +L++E++ K LD + VT + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
R++HRDLK N+L++++ KI+DFG+AR G ++ T IV T Y +P+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPD 170
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 46/239 (19%)
Query: 27 SKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG 85
+ L S++ F +G G +G VYKG +K G A+K + +G
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTG 61
Query: 86 QGLRELKNKLRLL------------------GCCIDKDEKI-LIYEYMPNKSLDFFLFDW 126
E+K ++ +L D+++ L+ E+ S+ D
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT----DL 117
Query: 127 VTRVR-----------IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175
+ + I I +GL +LHQ+ ++IHRD+K N+LL ++ K+ DFG
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 176 IARICRGNELQANTGRIVGTYRYMSPE-----YAIQGIFSIKSDVFSFGVLLLKIVSGK 229
++ + NT +GT +M+PE + KSD++S G+ +++ G
Sbjct: 175 VSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 46/208 (22%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS----------GRSGQGLRE---LK--------- 92
LG+GGFG V+ G L + ++A+K + S E L
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVT-RVRIIEG--------IAQGLLYL 143
+RLL ++ +L+ E P + D LFD++T + + EG + + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
H ++HRD+K NIL+D K+ DFG + GT Y PE
Sbjct: 156 HSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPPE 208
Query: 203 YAIQGI--FSIKSDVFSFGVLLLKIVSG 228
+ I ++ + V+S G+LL +V G
Sbjct: 209 W-ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 3e-19
Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 25/175 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK-------- 92
K+ K+GEG +G V+K + + +A+KR+ G LRE+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 93 NKLRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDWVTRVRIIEGIAQGLLYLHQYS 147
N +RL + L++E+ K D D + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
++HRDLK N+L++++ K+++FG+AR G ++ + +V T Y P+
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 42/244 (17%)
Query: 43 VSTATNKFSDA----NKLGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQGL-REL 91
+ +F++ +LG+G F V + V G E A +LS R Q L RE
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61
Query: 92 K--------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIE 134
+ N +RL ++ LI++ + L F+ + I+
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQ 117
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGR 191
I + +L+ HQ ++HR+LK N+LL K K++DFG+A G +
Sbjct: 118 QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251
GT Y+SPE + + D+++ GV+L ++ G F+ L I Y
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--YPPFWDEDQHRLYQQIKAGAY 230
Query: 252 EFPS 255
+FPS
Sbjct: 231 DFPS 234
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVG 194
+A+G+ +L + + IHRDL NILL + KI DFG+AR I + + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227
++M+PE +++I+SDV+SFGVLL +I S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 32/146 (21%), Positives = 49/146 (33%), Gaps = 23/146 (15%)
Query: 54 NKLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQG-----LRELK---------N 93
LG G FG V + D+ +AVK L + + ELK N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 94 KLRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
+ LLG C + +I E+ +L +L R + +G + V I
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 153 HRDLKVSNILLDKDMNPKISDFGIAR 178
DLK + + S F +
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 39/224 (17%), Positives = 76/224 (33%), Gaps = 42/224 (18%)
Query: 41 SSVSTATNKFSDANKLGEG--GFGPVYKGV-LKNGDEIAVKRLSGRSGQG---------- 87
SS + +G+G V G+ + V+R++ +
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 88 --LRELK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVR-----------I 132
+ N + I +E ++ +M S D + I
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDLICTHFMDGMNELAIAYI 133
Query: 133 IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA-----RICRGNELQA 187
++G+ + L Y+H +HR +K S+IL+ D +S R +
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 188 NTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGK 229
V ++SPE Q + + KSD++S G+ ++ +G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK-----RLSGRSGQGL-RELK--------NKLRLLGC 100
+G+G F V + G E+A+K +L+ S Q L RE++ N ++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 101 CIDKDEKILIYEYMPNKSLDFFLFDW-VTRVRIIEG--------IAQGLLYLHQYSRVRI 151
+ LI EY + FD+ V R+ E I + Y HQ RI
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RI 135
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICR-GNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+HRDLK N+LLD DMN KI+DFG + G +L A G Y +PE QG
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPE-LFQGKKY 190
Query: 211 I--KSDVFSFGVLLLKIVSGK 229
+ DV+S GV+L +VSG
Sbjct: 191 DGPEVDVWSLGVILYTLVSGS 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 31/215 (14%), Positives = 62/215 (28%), Gaps = 42/215 (19%)
Query: 54 NKLGEGGFGPVYKGV------LKNGDEIAVKRLSGRSG---QGLRELKNKLR-------- 96
+ LGEG F VY+ KN + +K + +L +L+
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 97 -LLGCCIDKDEKILIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQ 145
+ ++ +L+ E +L + + + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 146 YSRVRIIHRDLKVSNILL-----------DKDMNPKISDFGIARICRGNELQANTGRIVG 194
IIH D+K N +L D + D G + +
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 195 TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
T + E ++ + D F + ++ G
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----------LREL 91
S + + +G G V +++A+KR++ Q + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 92 K--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------IA------ 137
N + + KDE L+ + + S+ + V + G IA
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 138 -QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGR--IV 193
+GL YLH + IHRD+K NILL +D + +I+DFG+ A + G ++ N R V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 194 GTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
GT +M+PE Q + K+D++SFG+ +++ +G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 9e-19
Identities = 60/188 (31%), Positives = 93/188 (49%), Gaps = 38/188 (20%)
Query: 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEI-AVK--RLSGRSGQ-------GLRELK 92
V + ++ + LGEG F VYK KN ++I A+K +L RS LRE+K
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 93 --------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG--------I 136
N + LL K L++++M L+ + D + +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD--NSLVLTPSHIKAYMLMT 121
Query: 137 AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT- 195
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFG+A+ G+ +A T ++V T
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TR 176
Query: 196 -YRYMSPE 202
YR +PE
Sbjct: 177 WYR--APE 182
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 56/234 (23%), Positives = 89/234 (38%), Gaps = 46/234 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK--------RLSGRSGQGLRELK--------NKLRLL 98
LGEG +G V + + + AVK R+ +E++ N ++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 99 GCCIDKDEKILIY---EYMPNKSLDFFLFDWVTRVRIIEGIAQ--------GLLYLHQYS 147
+ +EK +Y EY + + D V R A GL YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ- 128
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARI---CRGNELQANTGRIVGTYRYMSPEYA 204
I+H+D+K N+LL KIS G+A ++ + G+ + PE
Sbjct: 129 --GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSPAFQPPE-I 182
Query: 205 IQGIFS---IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
G+ + K D++S GV L I +G F + L I + Y P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYP--FEGDNIYKLFENIGKGSYAIPG 234
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 42/200 (21%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----------------LRELK--NKL 95
+LG G F V K K G E A K + R + LR++ N +
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQY 146
L ++ + +LI E + L FD++ + I+ I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 147 SRVRIIHRDLKVSNILL----DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
I H DLK NI+L + K+ DFG+A N I GT +++PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPE 188
Query: 203 YAIQGIFSIKSDVFSFGVLL 222
+++D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQG-----------LRELK--N 93
+ +KLGEG + VYKG K D + A+K + +G L++LK N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 94 KLRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDWVTRVRIIEGIAQGLLYLHQYSR 148
+ L + L++EY+ + LD + + + + +GL Y H+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
+++HRDLK N+L+++ K++DFG+AR + +V T Y P+
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPD 170
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 56/239 (23%), Positives = 87/239 (36%), Gaps = 58/239 (24%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEKIL---- 109
LG G G V + + G + A+K L +E+ + + G I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASGG-----PHIVCILD 89
Query: 110 IYEYMPNKSLDFF----------LFDWVTRVRIIEG----------------IAQGLLYL 143
+YE M + LF RI E I + +L
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFS-----RIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 144 HQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200
H I HRD+K N+L +KD K++DFG A+ N LQ T Y++
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVA 197
Query: 201 PEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFY----RTYSFTLLGYISENIYEFPS 255
PE + D++S GV++ ++ G FY + S + I Y FP+
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGF--PPFYSNTGQAISPGMKRRIRLGQYGFPN 254
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 42/200 (21%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----------------LRELK--NKL 95
+LG G F V K K G E A K + R + LR++ N +
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQY 146
L ++ + +LI E + L FD++ + I+ I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 147 SRVRIIHRDLKVSNILL-DKDMNP---KISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
I H DLK NI+L DK++ K+ DFG+A N I GT +++PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPE 188
Query: 203 YAIQGIFSIKSDVFSFGVLL 222
+++D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 39/192 (20%), Positives = 74/192 (38%), Gaps = 34/192 (17%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---------QGLRELK--NKLRLLGCCI 102
LG G FG V++ V + K + + L + N L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTR----------VRIIEGIAQGLLYLHQYSRVRII 152
+E ++I+E++ + F+ + V + + + L +LH ++ I
Sbjct: 72 SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 153 HRDLKVSNILL--DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
H D++ NI+ + KI +FG AR + + + Y +PE + S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 211 IKSDVFSFGVLL 222
+D++S G L+
Sbjct: 182 TATDMWSLGTLV 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 31/180 (17%)
Query: 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS------GRSGQGLRELK--NKLRLL 98
+++ +G G FG V++ L DE+A+K++ R Q +R +K N + L
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 99 GC----CIDKDEKI--LIYEYMPNKSLDFFLFDWVTRVRIIEG---------IAQGLLYL 143
KDE L+ EY+P +++ + + + + + L Y+
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
H + I HRD+K N+LLD K+ DFG A+I E N I Y Y +PE
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRY-YRAPE 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 46/207 (22%), Positives = 75/207 (36%), Gaps = 53/207 (25%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQG----------LRELK--NKLR 96
+G+G F V + + + G + AVK + + G LK + +
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEG------------------IAQ 138
LL +++E+M L I++ I +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL----CF-----EIVKRADAGFVYSEAVASHYMRQILE 141
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGT 195
L Y H IIHRD+K +LL + K+ FG+A + L A VGT
Sbjct: 142 ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
+M+PE + + DV+ GV+L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL------SGRSGQGLRELK-------- 92
K+ + +GEG +G V K G +A+K+ +RE+K
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 93 NKLRLLGCCIDKDEKILIYEYMPN---KSLDFF--LFDWVTRVRIIEGIAQGLLYLHQYS 147
N + LL C K L++E++ + L+ F D+ + + I G+ + H +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT--YRYMSPE 202
IIHRD+K NIL+ + K+ DFG AR + + T YR +PE
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYR--APE 194
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 47/177 (26%), Positives = 70/177 (39%), Gaps = 29/177 (16%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL------SGRSGQGLRELK-------- 92
K+ K+GEG +G V+K G +A+K+ LRE++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 93 NKLRLLGCCIDKDEKILIYEYMPN---KSLDFF--LFDWVTRVRIIEGIAQGLLYLHQYS 147
N + LL K L++EY + LD + I Q + + H++
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT--YRYMSPE 202
IHRD+K NIL+ K K+ DFG AR+ + T YR SPE
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYR--SPE 172
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-18
Identities = 55/200 (27%), Positives = 79/200 (39%), Gaps = 42/200 (21%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVK-----RLSGRSGQGLREL-------------KNKL 95
+LG G F V K K G E A K RLS RE N +
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQY 146
L +K + +LI E + L FD++ + ++ I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS- 126
Query: 147 SRVRIIHRDLKVSNILL----DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
RI H DLK NI+L + K+ DFGIA N I GT +++PE
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPE 181
Query: 203 YAIQGIFSIKSDVFSFGVLL 222
+++D++S GV+
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-18
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 35/199 (17%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK-----RLSGRSGQGLRELKNKLRLLGCCIDKDEKIL 109
LGEG +G V V + +AVK R +E+ ++L E ++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKML-----NHENVV 68
Query: 110 -IYEYMPNKSLDFF---------LFDW-VTRVRIIEGIAQ--------GLLYLHQYSRVR 150
Y + ++ + LFD + + E AQ G++YLH
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---G 125
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE-YAIQGIF 209
I HRD+K N+LLD+ N KISDFG+A + R N + ++ GT Y++PE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 210 SIKSDVFSFGVLLLKIVSG 228
+ DV+S G++L +++G
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 52/200 (26%), Positives = 79/200 (39%), Gaps = 42/200 (21%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----------------LRELK--NKL 95
+LG G F V K K G + A K + R + L+E++ N +
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQY 146
L +K + ILI E + L FD++ ++ I G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 147 SRVRIIHRDLKVSNILL----DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
I H DLK NI+L KI DFG+A N I GT +++PE
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPE 187
Query: 203 YAIQGIFSIKSDVFSFGVLL 222
+++D++S GV+
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 53/198 (26%), Positives = 78/198 (39%), Gaps = 40/198 (20%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------------LRELK---NKLRLL 98
+LG G F V + + K G E A K L R L K + L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFLFDWVTR-----------VRIIEGIAQGLLYLHQYS 147
+ E ILI EY + F +R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 148 RVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
I+H DLK NILL + KI DFG++R I+GT Y++PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEIL 205
Query: 205 IQGIFSIKSDVFSFGVLL 222
+ +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 40/183 (21%)
Query: 55 KLGEGGFGPVYKGVLK---NGDEIAVKRL--------SGRSGQGLRELK--NKLRLLGCC 101
K+G G +G VYK K + + A+K++ + R LRELK N + L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 102 IDK-DEKI-LIYEYMPN---KSLDFFLFDWVTRVRIIEGIAQ----------GLLYLHQY 146
+ D K+ L+++Y + + F + + G+ YLH
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 147 SRVRIIHRDLKVSNILLDKDMNP----KISDFGIARICRGNELQANT---GRIVGTYRYM 199
++HRDLK +NIL+ + KI+D G AR+ + L+ +V T+ Y
Sbjct: 148 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVV-TFWYR 202
Query: 200 SPE 202
+PE
Sbjct: 203 APE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 31/184 (16%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS-GRSGQG-----------LRE 90
+T+ +++ KLGEG +G VYK + + +A+KR+ +G L+E
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 91 LK--NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYL 143
L+ N + L LI+EY L ++ + + G+ +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNP-----KISDFGIARICRGNELQANTGRIVGTYRY 198
H R +HRDLK N+LL KI DFG+AR G ++ T I+ T Y
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWY 203
Query: 199 MSPE 202
PE
Sbjct: 204 RPPE 207
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 45/204 (22%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK-----RLSGRSGQGLRELKNKLRLLGCCIDKDEKIL 109
LGEG +G V V + +AVK R +E+ ++L E ++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKML-----NHENVV 68
Query: 110 -IYEYMPNKSLDFF---------LFDW-VTRVRIIEGIAQ--------GLLYLHQYSRVR 150
Y + ++ + LFD + + E AQ G++YLH
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---G 125
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
I HRD+K N+LLD+ N KISDFG+A + R N + ++ GT Y++PE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-----LLK 180
Query: 211 IK------SDVFSFGVLLLKIVSG 228
+ DV+S G++L +++G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 47/234 (20%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE----LK------NKLRLLGCCID 103
LGEG F K V K + AVK +S R ++ LK N ++L D
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTRVRIIE--------------GIAQGLLYLHQYSRV 149
+ L+ E + L F+ RI + + + ++H V
Sbjct: 78 QLHTFLVMELLNGGEL----FE-----RIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 150 RIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
++HRDLK N+L + ++ KI DFG AR+ + T T Y +PE Q
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQ 183
Query: 207 GIFSIKSDVFSFGVLLLKIVSGK-----KTTGFYRTYSFTLLGYISENIYEFPS 255
+ D++S GV+L ++SG+ T + ++ I + + F
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 47/204 (23%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQG-------------LRELK--N 93
LG G G V + ++A++ + + S + L++L
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLYLH 144
+++ D ++ ++ E M L FD V + + YLH
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 145 QYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
+ IIHRDLK N+LL ++D KI+DFG ++I L T + GT Y++P
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT--LCGTPTYLAP 310
Query: 202 E---YAIQGIFSIKSDVFSFGVLL 222
E ++ D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 47/217 (21%), Positives = 71/217 (32%), Gaps = 66/217 (30%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEK------- 107
LG G FG V+ V + E+ VK + K K+ D
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK----------KEKVLEDCWIEDPKLGKVTLEIA 81
Query: 108 ----------ILIYEYMPNKSLDFF----------LFDW-VTRVRIIEG--------IAQ 138
I + + N+ LF + R+ E +
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI-ARICRGNELQANTGRIVGTYR 197
+ YL IIHRD+K NI++ +D K+ DFG A + RG GT
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY----TFCGTIE 194
Query: 198 YMSPEYAIQGIFSIKS------DVFSFGVLLLKIVSG 228
Y +PE + +++S GV L +V
Sbjct: 195 YCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 49/208 (23%), Positives = 75/208 (36%), Gaps = 53/208 (25%)
Query: 56 LGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----------LRELK---NKLRLLGCC 101
LGEG V + E AVK + + G L + + N L L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 102 IDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIE--------------GIAQGLLYLHQYS 147
++D L++E M S+ I + +A L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LS-----HIHKRRHFNELEASVVVQDVASALDFLHN-- 129
Query: 148 RVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGR-----IVGTYRYM 199
I HRDLK NIL ++ KI DF + + N + G+ YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 200 SPE-----YAIQGIFSIKSDVFSFGVLL 222
+PE I+ + D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 47/204 (23%)
Query: 55 KLGEGGFGPVYKGVLKN-GDEIAVK-----RLSGRSGQG-------------LRELK--N 93
LG G G V + ++A+K + + S + L++L
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---------RIIEGIAQGLLYLH 144
+++ D ++ ++ E M L FD V + + YLH
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 145 QYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
+ IIHRDLK N+LL ++D KI+DFG ++I L T + GT Y++P
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT--LCGTPTYLAP 185
Query: 202 E---YAIQGIFSIKSDVFSFGVLL 222
E ++ D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 42/228 (18%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS-------GRSGQGLRELKNKLRLLGCCIDKDEK 107
LG G FG V G G ++AVK L+ G+ RE++N L+L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN-LKLF----RHPHI 73
Query: 108 ILIYEYMPNKSLDFF---------LFDW-VTRVRIIEG--------IAQGLLYLHQYSRV 149
I +Y+ + + F LFD+ R+ E I + Y H++
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH--- 130
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
++HRDLK N+LLD MN KI+DFG++ + E + G+ Y +PE I G
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-VISGRL 186
Query: 210 --SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+ D++S GV+L ++ G T F + TL I ++ P
Sbjct: 187 YAGPEVDIWSCGVILYALLCG--TLPFDDEHVPTLFKKIRGGVFYIPE 232
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 28/222 (12%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLRELKNKL---------------RLLG 99
LGEG F V A+K L R ++ +L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL-----FD-WVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
D ++ Y N L ++ FD TR E I L YLH IIH
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHGKG---IIH 153
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
RDLK NILL++DM+ +I+DFG A++ QA VGT +Y+SPE + S
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 214 DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
D+++ G ++ ++V+G F + + I + Y+FP
Sbjct: 214 DLWALGCIIYQLVAGL--PPFRAGNEYLIFQKIIKLEYDFPE 253
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK--------NKLRL 97
++D +G G FG VY+ L +G+ +A+K++ REL+ N +RL
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 98 LGCCIDKDEKI------LIYEYMPNKSLDFFLFDWVTRVRIIEG---------IAQGLLY 142
EK L+ +Y+P +++ + + + + + L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARICRGNELQANTGRIVGTYRYMSP 201
+H I HRD+K N+LLD D K+ DFG A+ E N I Y Y +P
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 202 E 202
E
Sbjct: 226 E 226
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 58/273 (21%), Positives = 99/273 (36%), Gaps = 36/273 (13%)
Query: 7 NLKANNVNIELPVNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK 66
+L N+ + + + + S+ ++ F ++LG G VY+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 67 GVLKN-GDEIAVKRLSGRSGQG--------LRELK--NKLRLLGCCIDKDEKILIYEYMP 115
K A+K L + L L N ++L E L+ E +
Sbjct: 72 CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131
Query: 116 NKSLDFFLFDWVTR---------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--- 163
L FD + ++ I + + YLH+ I+HRDLK N+L
Sbjct: 132 GGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATP 184
Query: 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLL 223
D KI+DFG+++I L + GT Y +PE + + D++S G++
Sbjct: 185 APDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAPEILRGCAYGPEVDMWSVGIITY 241
Query: 224 KIVSGKKTTGFY-RTYSFTLLGYISENIYEFPS 255
++ G FY + I Y F S
Sbjct: 242 ILLCG--FEPFYDERGDQFMFRRILNCEYYFIS 272
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 44 STATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL---SGRSGQG------------ 87
S AT+++ ++G G +G VYK +G +A+K + +G G G
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 88 LRELK-----NKLRLL----GCCIDKDEKI-LIYEYMPN------KSLDFFLFDWVTRVR 131
LR L+ N +RL+ D++ K+ L++E++ T
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
++ +GL +LH I+HRDLK NIL+ K++DFG+AR
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 41/165 (24%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEI-AVKRL---SGRSG---QGLRELK------- 92
++ ++GEG +G V+K LKNG A+KR+ +G G +RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 93 ----NKLRLL----GCCIDKDEKI-LIYEYMPN--KSLDFFLFDWVTRVRIIEG------ 135
N +RL D++ K+ L++E++ + D V +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGVPTETIKDMM 126
Query: 136 --IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
+ +GL +LH + R++HRDLK NIL+ K++DFG+AR
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 48/206 (23%)
Query: 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRL------------ 80
Q +K+ K+G+G FG V+K K G ++A+K++
Sbjct: 4 QYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62
Query: 81 SGRSGQGLRELK--NKLRLLGCCIDKDEKI--------LIYEYMPN---KSLDFFLFDWV 127
+ R + L+ LK N + L+ C K L++++ + L
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------N 116
Query: 128 TRVRIIEG--------IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR- 178
V+ + GL Y+H+ +I+HRD+K +N+L+ +D K++DFG+AR
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 179 --ICRGNELQANTGRIVGTYRYMSPE 202
+ + ++ T R+V T Y PE
Sbjct: 174 FSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 52/245 (21%), Positives = 84/245 (34%), Gaps = 57/245 (23%)
Query: 18 PVNSNLTKRSKKKEVDQLPLFSF-SSVSTATNKFSD-----ANKLGEGGFGPVYKGVLK- 70
P + + Q P F S + N D + LG G G V + K
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR 85
Query: 71 NGDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEKIL----IYEYMPNKSLDFF---- 122
++ A+K L + RE++ R C I+ +YE +
Sbjct: 86 TQEKFALKMLQ-DCPKARREVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVME 139
Query: 123 ------LFDWVTRVRIIEG----------------IAQGLLYLHQYSRVRIIHRDLKVSN 160
LF RI + I + + YLH + I HRD+K N
Sbjct: 140 CLDGGELFS-----RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191
Query: 161 ILL---DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFS 217
+L + K++DFG A+ + T T Y++PE + D++S
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHN-SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 218 FGVLL 222
GV++
Sbjct: 249 LGVIM 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 45/202 (22%), Positives = 74/202 (36%), Gaps = 52/202 (25%)
Query: 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVK------RLSGRSGQGLREL 91
+ ++F G+G FG V G K G +A+K R R Q +++L
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL 73
Query: 92 K-----NKLRLLGCCIDKDEK-------ILIYEYMP-------------NKSLD-----F 121
N ++L E+ ++ EY+P +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 122 FLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGIARIC 180
FLF + + + LH S + HRD+K N+L+++ K+ DFG A+
Sbjct: 134 FLFQ----------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 181 RGNELQANTGRIVGTYRYMSPE 202
+E N I Y Y +PE
Sbjct: 183 SPSE--PNVAYICSRY-YRAPE 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 39/201 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRL-------SGRSGQGLRELKNKLRLLGCCIDKDEK 107
LGEG FG V K ++A+K + S + RE+ L+LL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY-LKLL----RHPHI 71
Query: 108 ILIYEYMPNKSLDFF--------LFDW-VTRVRIIEG--------IAQGLLYLHQYSRVR 150
I +Y+ + + LFD+ V + R+ E I + Y H++ +
Sbjct: 72 IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF- 209
I+HRDLK N+LLD ++N KI+DFG++ I T G+ Y +PE I G
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKT--SCGSPNYAAPE-VINGKLY 184
Query: 210 -SIKSDVFSFGVLLLKIVSGK 229
+ DV+S G++L ++ G+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 40/202 (19%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLS-------GRSGQGLRELKNKLRLLGCCIDKDEK 107
LG G FG V G G ++AVK L+ G+ RE++N L+L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN-LKLF----RHPHI 78
Query: 108 ILIYEYMPNKSLDFF---------LFDW-VTRVRIIEG--------IAQGLLYLHQYSRV 149
I +Y+ + S F LFD+ R+ E I G+ Y H++
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH--- 135
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
++HRDLK N+LLD MN KI+DFG++ + E T G+ Y +PE I G
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRT--SCGSPNYAAPE-VISGRL 191
Query: 210 --SIKSDVFSFGVLLLKIVSGK 229
+ D++S GV+L ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCGT 213
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 34/201 (16%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLS-----GRSGQG--LRELKNKLRL--------LG 99
LG GGFG V+ +K ++ A K+L+ R G + E K L L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE-KKILAKVHSRFIVSLA 251
Query: 100 CCIDKDEKI-LIYEYMPNKSLDFFLFDWVTRVRIIE---------GIAQGLLYLHQYSRV 149
+ + L+ M + + +++ + I GL +LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
II+RDLK N+LLD D N +ISD G+A + + + GT +M+PE + G
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPE-LLLGEE 365
Query: 210 SIKS-DVFSFGVLLLKIVSGK 229
S D F+ GV L ++++ +
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 48/274 (17%), Positives = 79/274 (28%), Gaps = 82/274 (29%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVK-----RLSGRSGQGLRELK------------NKLR 96
+G+G +G V + A+K ++ + + + +K N R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV-------------------------- 130
L D+ L+ E L D +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 131 -----------------------RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DK 165
I+ I L YLH I HRD+K N L +K
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 166 DMNPKISDFGIARICRGNELQANTGR--IVGTYRYMSPE--YAIQGIFSIKSDVFSFGVL 221
K+ DFG+++ G GT +++PE + K D +S GVL
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 222 LLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
L ++ G F + + F +
Sbjct: 266 LHLLLMGA--VPFPGVNDADTISQVLNKKLCFEN 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 34/200 (17%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLS-----GRSGQG--------LRELKNK-----LR 96
+G GGFG VY + ++ A+K L + G+ L + +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRI-IEGIAQGLLYLHQYSRVR 150
+ D+ I + M L + L F +R I GL ++H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMHNR---F 312
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
+++RDLK +NILLD+ + +ISD G+A C ++ + + VGT+ YM+PE +G+
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHA--SVGTHGYMAPEVLQKGVAY 368
Query: 211 IKS-DVFSFGVLLLKIVSGK 229
S D FS G +L K++ G
Sbjct: 369 DSSADWFSLGCMLFKLLRGH 388
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 45/219 (20%), Positives = 89/219 (40%), Gaps = 59/219 (26%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-LRELK---------NKL 95
+ + KLG G + V++ + + N +++ VK L + RE+K N +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94
Query: 96 RLLGCCIDKDEK--ILIYEYMPNKSLD------------FFLFDWVTRVRIIEGIAQGLL 141
L D + L++E++ N F++++ I + L
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE----------ILKALD 144
Query: 142 YLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200
Y H S I+HRD+K N+++D + ++ D+G+A + Q R V + +
Sbjct: 145 YCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVR-VASRYFKG 198
Query: 201 PE---------YAIQGIFSIKSDVFSFGVLLLKIVSGKK 230
PE Y++ D++S G +L ++ K+
Sbjct: 199 PELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 56/235 (23%), Positives = 86/235 (36%), Gaps = 54/235 (22%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVK---RLSGRSGQGLRELKN-KL-------RLLGCCID 103
+G G FG + +AVK R + RE+ N + R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 104 KDEKILIYEYMPNKSLDFFLFDWVTRV-RIIEGIAQ--------GLLYLHQYSRVRIIHR 154
+I EY L ++ + R E A+ G+ Y H ++I HR
Sbjct: 88 PTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHR 140
Query: 155 DLKVSNILLDKD--MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIK 212
DLK+ N LLD KI DFG ++ + +T VGT Y++PE + +
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPE-----VLLRQ 192
Query: 213 ------SDVFSFGVLLLKIVSGK------KTTGFYRTYSFTLLGYISENIYEFPS 255
+DV+S GV L ++ G + YR + I Y P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR----KTIQRILSVKYSIPD 243
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLS-----GRSGQG--LRELKNKLRL--------LG 99
LG+GGFG V ++ ++ A K+L R G+ L E K L L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQILEKVNSRFVVSLA 250
Query: 100 CCIDKDEKI-LIYEYMPNKSLDFFL-------FDWVTRVRI-IEGIAQGLLYLHQYSRVR 150
+ + + L+ M L F + F R I GL LH+ R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLHRE---R 306
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
I++RDLK NILLD + +ISD G+A + VGT YM+PE ++
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYT 363
Query: 211 IKSDVFSFGVLLLKIVSGK 229
D ++ G LL ++++G+
Sbjct: 364 FSPDWWALGCLLYEMIAGQ 382
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 19/95 (20%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+ L YL RIIHRD+K NILLD+ + I+DF IA + T + GT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITT--MAGT 177
Query: 196 YRYMSPEYAIQGIFSIKS--------DVFSFGVLL 222
YM+PE +FS + D +S GV
Sbjct: 178 KPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTA 207
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 34/170 (20%), Positives = 69/170 (40%), Gaps = 53/170 (31%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
+++ + +G G +G V + +A+K++ R LRE+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108
Query: 93 ----NKLRLLGCCI----DKDEKI-LIYEYMP---------NKSLD-----FFLFDWVTR 129
+ +++L I +K +++ ++ E L L++
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN---- 164
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179
+ G+ Y+H I+HRDLK +N L+++D + K+ DFG+AR
Sbjct: 165 ------LLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 51/219 (23%), Positives = 82/219 (37%), Gaps = 55/219 (25%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
++ + +G G G V +A+K+LS R+ REL
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 80
Query: 93 ----NKLRLL------GCCIDKDEKILIYEYMP-------NKSLD-----FFLFDWVTRV 130
N + LL + + ++ E M LD + L+
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----- 135
Query: 131 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG 190
+ G+ +LH IIHRDLK SNI++ D KI DFG+AR T
Sbjct: 136 -----MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
V T Y +PE + + D++S G ++ +++ G
Sbjct: 186 Y-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 40/186 (21%), Positives = 68/186 (36%), Gaps = 42/186 (22%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKL----------- 95
F K+G G FG + G L + +A+K +S L+ +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSR 148
++ ++ E + SL+ LFD R + I + + Y+H +
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 149 VRIIHRDLKVSNILLDKDMNPK-----ISDFGIARICRGNELQANTGR---------IVG 194
+I+RD+K N L+ + N I DF +A+ T + + G
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI----DPETKKHIPYREHKSLTG 179
Query: 195 TYRYMS 200
T RYMS
Sbjct: 180 TARYMS 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 40/177 (22%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG--------QGLRELKNKL---RLLGCCI 102
K+G G FG +Y G ++ +E+A+K + ++ + R L+ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSRVRIIHRD 155
+ D +L+ + + SL+ LF++ +R + + + + + ++H S +HRD
Sbjct: 74 EGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRD 128
Query: 156 LKVSNILLDKDMNPK---ISDFGIARICRGNELQANTGR---------IVGTYRYMS 200
+K N L+ I DFG+A+ R +T + + GT RY S
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYRENKNLTGTARYAS 181
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 42/184 (22%), Positives = 79/184 (42%), Gaps = 40/184 (21%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG--------LRELKNKL--- 95
N++ K+G G FG +Y G + G+E+A+K ++ + ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSR 148
+ C + D +++ E + SL+ LF++ +R + + + + + Y+H +
Sbjct: 69 TIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 149 VRIIHRDLKVSNILLDKDMNPK---ISDFGIARICRGNELQANTGR---------IVGTY 196
IHRD+K N L+ I DFG+A+ R A T + + GT
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR----DARTHQHIPYRENKNLTGTA 179
Query: 197 RYMS 200
RY S
Sbjct: 180 RYAS 183
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
++ + +G G G V +A+K+LS R+ REL
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 117
Query: 93 ----NKLRLL-----GCCIDKDEKI-LIYEYMP---NKSLDFFLFDWVTRVRIIEGIAQG 139
N + LL +++ + + L+ E M + + L + + + G
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ-MLCG 176
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYM 199
+ +LH IIHRDLK SNI++ D KI DFG+AR T V T Y
Sbjct: 177 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-VVTRYYR 230
Query: 200 SPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+PE + + D++S G ++ ++V K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 38/173 (21%), Positives = 62/173 (35%), Gaps = 40/173 (23%)
Query: 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---------------LREL 91
+ ++ + G +G V GV G +A+KR+ G LRE+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 92 K--------NKLRLLGCCI----DKDEKI-LIYEYMPN------KSLDFFLFDWVTRVR- 131
+ N L L + K+ L+ E M + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP--QHIQY 138
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184
+ I GL LH+ ++HRDL NILL + + I DF +AR +
Sbjct: 139 FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 37/198 (18%), Positives = 67/198 (33%), Gaps = 53/198 (26%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
+ + + +G G +G VY +A+K+++ R LRE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNR 81
Query: 93 ----NKLRLLGCCIDKDEKI-----LIYEYMP---------NKSLD-----FFLFDWVTR 129
+RL I D ++ E L L++
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN---- 137
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189
+ G ++H+ IIHRDLK +N LL++D + K+ DFG+AR +
Sbjct: 138 ------LLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 190 GRIVGTYRYMSPEYAIQG 207
+ ++
Sbjct: 189 NDLEENEEPGPHNKNLKK 206
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 42/179 (23%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG--QGLRELKNKLRLLG---------CCI 102
++GEG FG +++G L N ++A+K RS Q E + L G
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 103 DKDEKILIYEYMPNKSLDFFLFDWVTR-------VRIIEGIAQGLLYLHQYSRVRIIHRD 155
+ +L+ + + SL+ L D R + + + +H+ S +++RD
Sbjct: 77 EGLHNVLVIDLLG-PSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131
Query: 156 LKVSNILLDKDMNPK-----ISDFGIARICRGNELQANTGR---------IVGTYRYMS 200
+K N L+ + + + DFG+ + R T + + GT RYMS
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD----PVTKQHIPYREKKNLSGTARYMS 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 41/224 (18%), Positives = 77/224 (34%), Gaps = 82/224 (36%)
Query: 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK--------NKL 95
T++ K+S LG G FG V + +G A+K++ REL N +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNII 63
Query: 96 RLLGCCIDKDEKI--------------------------------------LIYEYMP-- 115
+L+ ++ +I EY+P
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 116 -----------NKSLD-----FFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159
+S+ +++ + + + ++H + I HRD+K
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQ----------LFRAVGFIHS---LGICHRDIKPQ 170
Query: 160 NILLD-KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
N+L++ KD K+ DFG A+ + + I + Y +PE
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPE 211
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 54/193 (27%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG--------RSGQGLRELK----- 92
++++ + +GEG +G V N +A+K++S R+ LRE+K
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRF 82
Query: 93 ---NKLRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDWVTRVR 131
N + + I++ + + ++ + M + L +FL+
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ------ 136
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN--T 189
I +GL Y+H ++HRDLK SN+LL+ + KI DFG+AR+ + T
Sbjct: 137 ----ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 190 GRIVGTYRYMSPE 202
V T Y +PE
Sbjct: 190 EY-VATRWYRAPE 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 13/94 (13%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVG 194
+ + +HQ +HRD+K NIL+D + + +++DFG ++ +Q++ VG
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 238
Query: 195 TYRYMSPEYAIQGIFSIKS------DVFSFGVLL 222
T Y+SPE +Q + K D +S GV +
Sbjct: 239 TPDYISPE-ILQAMEGGKGRYGPECDWWSLGVCM 271
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 25/95 (26%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVG 194
I + +H+ +HRD+K NILLD+ + +++DFG ++ +++ VG
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVG 225
Query: 195 TYRYMSPE-------YAIQGIFSIKSDVFSFGVLL 222
T Y+SPE G + + D ++ GV
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 36/168 (21%), Positives = 67/168 (39%), Gaps = 52/168 (30%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
+ +G G +G V + ++G+++A+K+LS R+ REL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLLKH 79
Query: 93 ----NKLRLL-----GCCIDKDEKI-LIYEYMP------------NKSLDFFLFDWVTRV 130
N + LL + L+ +M + + + ++
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ----- 134
Query: 131 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
+ +GL Y+H ++HRDLK N+ +++D KI DFG+AR
Sbjct: 135 -----MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L YLH S +++RDLK+ N++LDKD + KI+DFG+ + + T GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + D + GV++
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVM 339
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 33/87 (37%), Positives = 53/87 (60%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+A L +LH II+RDLK NILLD++ + K++DFG+++ +E +A + GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
YM+PE + + +D +SFGVL+
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLM 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 44/192 (22%), Positives = 78/192 (40%), Gaps = 54/192 (28%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG--------RSGQGLRELK----- 92
++ F + LGEG +G V G+ +A+K++ R+ LRE+K
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIKILKHF 66
Query: 93 ---NKLRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDWVTRVR 131
N + + + ++ +I E M + L +F++
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ------ 120
Query: 132 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191
+ + LH +IHRDLK SN+L++ + + K+ DFG+ARI +E A+
Sbjct: 121 ----TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSE 171
Query: 192 IVGTYRYMSPEY 203
G M E+
Sbjct: 172 PTGQQSGMV-EF 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 34/172 (19%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLRELKNKL---------------RLLG 99
+G G FG V K+ ++ A+K LS + +L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 100 CCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQ--------GLLYLHQYSRVRI 151
D ++ EYMP L + ++ + E A+ L +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---F 189
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIA-RICRGNELQANTGRIVGTYRYMSPE 202
IHRD+K N+LLDK + K++DFG ++ + ++ +T VGT Y+SPE
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPE 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 42/190 (22%), Positives = 79/190 (41%), Gaps = 50/190 (26%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
K+ KLG+G +G V+K + + G+ +AVK++ R+ RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64
Query: 93 -----NKLRLLGCCI-DKDEKI-LIYEYMP--------NKSLD-----FFLFDWVTRVRI 132
N + LL D D + L+++YM L+ + ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ------- 117
Query: 133 IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRI 192
+ + + YLH ++HRD+K SNILL+ + + K++DFG++R N +
Sbjct: 118 ---LIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 193 VGTYRYMSPE 202
+ +
Sbjct: 172 SINENTENFD 181
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 9e-11
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I+ L +LHQ II+RDLK NI+L+ + K++DFG+ + + +T GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
YM+PE ++ + D +S G L+
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALM 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 1e-10
Identities = 38/211 (18%), Positives = 58/211 (27%), Gaps = 65/211 (30%)
Query: 30 KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGD---------------- 73
E Q FS T K K+GEG FG V++ + +
Sbjct: 3 GECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG 61
Query: 74 -----------EIAV-KRLSGRSGQGLRELKNKLRLLGCCI------------------- 102
EI + K LS SG+ + + L
Sbjct: 62 SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121
Query: 103 -----------DKDEKILIYEYMPN-KSLDFF---LFDWVTRVRIIEGIAQGLLYLHQYS 147
D+ ++ E+ L+ L T I+ + L
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-- 179
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
+R HRDL N+LL K K+ +
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 35/223 (15%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLREL------KNKL---------RLLG 99
LG G FG V K A+K L + L+++ K L +L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL-----FD-WVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
D ++ EY+ + L F R + I YLH +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIY 164
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
RDLK N+L+D+ +++DFG A+ ++ T + GT ++PE I K+
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPE-IILSKGYNKA 218
Query: 214 -DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
D ++ GVL+ ++ +G F+ + I FPS
Sbjct: 219 VDWWALGVLIYEMAAGY--PPFFADQPIQIYEKIVSGKVRFPS 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L YLH +++RD+K+ N++LDKD + KI+DFG+ + + T GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + D + GV++
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVM 195
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA GL +L II+RDLK+ N++LD + + KI+DFG+ + + + T GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + D ++FGVLL
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLL 532
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 53/169 (31%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
+ D +G G +G V V + G ++A+K+L R+ REL+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELRLLKH 80
Query: 93 ----NKLRLL------GCCIDKDEKILIYEYMP--------NKSLD-----FFLFDWVTR 129
N + LL D + L+ +M ++ L F ++
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ---- 136
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
+ +GL Y+H IIHRDLK N+ +++D KI DFG+AR
Sbjct: 137 ------MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 36/157 (22%), Positives = 55/157 (35%), Gaps = 48/157 (30%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNKLRLLGCCIDKDEKIL---- 109
LG G G V + K ++ A+K L + RE++ R C I+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQC-----PHIVRIVD 78
Query: 110 IYEYMPNKSLDFF----------LFDWVTRVRIIEG----------------IAQGLLYL 143
+YE + LF RI + I + + YL
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFS-----RIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 144 HQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIA 177
H + I HRD+K N+L + K++DFG A
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 53/169 (31%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSG---------RSGQGLRELK---- 92
++ + + +G G +G V K G +AVK+LS R+ REL+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKH 84
Query: 93 ----NKLRLL-----GCCIDKDEKI-LIYEYMP--------NKSLD-----FFLFDWVTR 129
N + LL +++ + L+ M + L F ++
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ---- 140
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
I +GL Y+H IIHRDLK SN+ +++D KI DFG+AR
Sbjct: 141 ------ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA GL +L II+RDLK+ N++LD + + KI+DFG+ + + + T GT
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + D ++FGVLL
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLL 211
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I L++LH II+RDLK+ N+LLD + + K++DFG+ + N + T GT
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + ++ D ++ GVLL
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLL 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 36/87 (41%), Positives = 52/87 (59%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I GL +LH I++RDLK+ NILLDKD + KI+DFG+ + + + NT GT
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + ++ D +SFGVLL
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLL 208
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
IA L YLH + I++RDLK NILLD + ++DFG+ + + +T GT
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + + D + G +L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVL 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I+ L YLH+ II+RDLK+ N+LLD + + K++D+G+ + +T GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + D ++ GVL+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLM 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 57/199 (28%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG----LRELK--------N 93
+++ D LG GG G V+ V +A+K++ Q LRE+K N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 94 KLRLL--------------GCCIDKDEKILIYEYMP--------NKSLD-----FFLFDW 126
+++ G + + ++ EYM L F++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 127 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRGNEL 185
+ +GL Y+H ++HRDLK +N+ ++ +D+ KI DFG+ARI +
Sbjct: 129 ---------LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 186 QAN--TGRIVGTYRYMSPE 202
+ +V T Y SP
Sbjct: 177 HKGHLSEGLV-TKWYRSPR 194
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
I+ L YLH+ II+RDLK+ N+LLD + + K++D+G+ + +T GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLL 222
Y++PE + D ++ GVL+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLM 243
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR--ICRGNELQANTGRIV 193
I L +LH+ II+RD+K+ NILLD + + ++DFG+++ + E A
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYD--FC 221
Query: 194 GTYRYMSPE---YAIQGIFSIKSDVFSFGVLL 222
GT YM+P+ G D +S GVL+
Sbjct: 222 GTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLM 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 58/220 (26%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG-----QGLRELK--NKLRLLGCCIDKDE 106
KLG G F V+ + N +A+K + R E+K ++ D +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVN----DADNTK 79
Query: 107 KILIYEYMPNKSLDFF--------------------LFDWVTR-------VRIIEGIAQ- 138
+ + K LD F L + + + ++ I++
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 139 ---GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP------KISDFGIARICRGNELQANT 189
GL Y+H R IIH D+K N+L++ +P KI+D G A C +E N
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTN- 194
Query: 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ T Y SPE + + +D++S L+ ++++G
Sbjct: 195 --SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 1e-09
Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 33/190 (17%)
Query: 56 LGEGGFGPVYKGVLKNGDEI-AVKRLSGRSGQGLREL------KNKL---------RLLG 99
LG G FG V+ ++ A+K L L+++ + L R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL-----FD-WVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
D + +I +Y+ L L F V + E + L YLH II+
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-VCLALEYLHSKD---IIY 129
Query: 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE + KS
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE-VVSTKPYNKS 183
Query: 214 -DVFSFGVLL 222
D +SFG+L+
Sbjct: 184 IDWWSFGILI 193
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 19/194 (9%), Positives = 50/194 (25%), Gaps = 51/194 (26%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------LRELKNKLRL--------L 98
G ++ + ++A+ + + L R+ L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
+ +++ E++ SL V +R ++ +A H R +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSI 154
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
S + + D + ++ M + + D+
Sbjct: 155 DHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------NPQDDI 185
Query: 216 FSFGVLLLKIVSGK 229
G L ++ +
Sbjct: 186 RGIGASLYALLVNR 199
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 38/189 (20%), Positives = 66/189 (34%), Gaps = 47/189 (24%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIA---VKRLSGRSGQGLRELKNKLRLLGCCID---KDEK 107
K+G GGFG +Y ++ A VK +G ELK R+ + K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 108 ILIYEYMPN-----------------------KSLDFFLFDWV------TRVRIIEGIAQ 138
L Y +P L + T +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGTFKKSTVLQLGIRMLD 162
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI--SDFGIARICRGN----ELQANTGR- 191
L Y+H+ +H D+K +N+LL ++ +D+G++ N + Q N +
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 192 IVGTYRYMS 200
GT + S
Sbjct: 220 HNGTIEFTS 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 60/213 (28%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG-----QGLRELKNKLRLLGCCIDKDEKIL 109
+G+G FG V K K +A+K + R+ Q E++ L L DKD +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIR-ILEHLRKQ-DKDNTMN 160
Query: 110 IYEYMPNKSLDFF----------------LFDW----------VTRVRII-EGIAQGLLY 142
+ L+ F L++ + VR I Q L
Sbjct: 161 VI-----HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGIARICRGNELQANTGRIVGTY---- 196
LH+ RIIH DLK NILL + K+ DFG + C ++ V TY
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ-------RVYTYIQSR 263
Query: 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
Y +PE + + + D++S G +L ++++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 37/203 (18%), Positives = 70/203 (34%), Gaps = 58/203 (28%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEI------AVKRLSGRSGQGLRELKNKLRLLGCC 101
+ +G+GGFG +Y + + + + VK +G ELK R
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 102 IDKD---EKILIYEYMPN-----------------------KSLDFFLFDWVTR------ 129
+ + L Y +P L +++ +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSRKT 153
Query: 130 -----VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI--SDFGIA-RICR 181
+RI++ + Y+H++ +H D+K SN+LL+ ++ D+G+A R C
Sbjct: 154 VLQLSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 182 GNELQANTGR----IVGTYRYMS 200
+A GT + S
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS 229
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 1e-07
Identities = 54/366 (14%), Positives = 101/366 (27%), Gaps = 109/366 (29%)
Query: 20 NSNLTKR--SKKKEVDQLPLFSFSSVSTATNKFSDANKL---GEGGFGPVYKGVLKNGDE 74
N K S+ + +L A + A + G G G K +
Sbjct: 123 NQVFAKYNVSRLQPYLKL--------RQALLELRPAKNVLIDGVLGSG---KTWV----- 166
Query: 75 IAVKRLSGRSGQGLRELKNKLRL--------LGCCIDKDEKI-----LIYEYMPN-KSLD 120
+ K + ++ L C + + L+Y+ PN S
Sbjct: 167 ---------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 121 FFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD-FGIARI 179
+ R+ I+ + LL Y ++ +++ N K + F ++
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ----------NAKAWNAFNLS-- 265
Query: 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTY 238
C +I+ T R+ K +S +
Sbjct: 266 C----------KILLTTRF-------------KQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 239 SFTLLG-YISENIYEFPS-VDTHN---VKTFG------------FLHLTIFKLFSISSVG 281
+LL Y+ + P V T N + + H+ KL +I
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 282 L----SNDI----VCLCILRY-VNI--ALLCVQESADDRPTMNDVVSMLTNEAAALLPPK 330
L + L + +I LL + + + VV+ L + PK
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 331 QPAFSY 336
+ S
Sbjct: 423 ESTISI 428
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 60/223 (26%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG-----QGLRELKNKLRLLGC 100
+++ + +G+G FG V K + +A+K + ++ Q E++ L L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVR-LLELMNK 109
Query: 101 CIDKDEKILIYEYMPNKSLDFF----------------LFDW----------VTRVRII- 133
+ + ++ F L+D + R
Sbjct: 110 HDTEMKYYIV------HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGIARICRGNELQANTGR 191
+ + LL+L + IIH DLK NILL KI DFG + C+ +
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ------- 213
Query: 192 IVGTY---R-YMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
+ Y R Y SPE + G+ + + D++S G +L+++ +G+
Sbjct: 214 RIYQYIQSRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 24/200 (12%), Positives = 56/200 (28%), Gaps = 52/200 (26%)
Query: 48 NKFSDANKLGEGGFGPVYKGV---------LKNGDEIAVKRLSGRSGQGLRELKNKLRLL 98
++ + G +Y+ + ++K L + G+ E R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 99 GCCIDKDEKILI---YEYMPN--------------------KSLDFFLFDWVTR------ 129
K L +P +SL D +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS-ALDVSPKHVLSER 159
Query: 130 --VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI--SDFGIARICRGN-- 183
+++ + L +LH+ +H ++ NI +D + ++ + +G A +
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 184 --ELQANTGR-IVGTYRYMS 200
+ G ++S
Sbjct: 217 HVAYVEGSRSPHEGDLEFIS 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 32/148 (21%), Positives = 55/148 (37%), Gaps = 56/148 (37%)
Query: 131 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--------------------------- 163
+II+ + QGL YLH ++ RIIH D+K NILL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 164 ----------------------DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
+ + KI+D G A C ++ + + T +Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHK---HFTEDIQTRQYRSL 262
Query: 202 EYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
E I ++ +D++S + ++ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 76/231 (32%)
Query: 55 KLGEGGFGPVYKGV--LKNGDEIAVKRLSGRSG-----QGLRELK--NKLRLLGCCIDKD 105
LGEG FG V + + + ++A+K + R+ E+ K++ DK+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEK----DKE 79
Query: 106 EKILIYEYMPNKSLDFF----------------LFDW----------VTRVRII-EGIAQ 138
K L D+F F++ + VR + +
Sbjct: 80 NKFLCV-----LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 139 GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-------------------KISDFGIARI 179
L +LH ++ H DLK NIL +++DFG A
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 180 CRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
+E + IV T Y PE I + ++ DV+S G +L + G
Sbjct: 190 TFDHE---HHTTIVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 45/231 (19%), Positives = 76/231 (32%), Gaps = 72/231 (31%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG-----QGLRELK--NKLRLLGCCIDKDE 106
K+G+G FG V + N AVK + R+ E K++ D +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQN----DDINN 95
Query: 107 KILIYEYMPNKSLDFF----------------LFDW----------VTRVR-IIEGIAQG 139
++ K F L++ + ++ I +
Sbjct: 96 NNIV------KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR-------- 191
L YL ++ + H DLK NILLD K T
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 192 ------------IVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGK 229
I+ T +Y +PE I + + + SD++SFG +L ++ +G
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 354 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.72 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.66 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.06 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.8 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.45 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.64 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.5 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.69 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=379.42 Aligned_cols=241 Identities=27% Similarity=0.451 Sum_probs=192.7
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++|.+.+.||+|+||.||+|+++ +++.||||+++.......+++. ||+++++++.+.+.++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467889999999999999999864 3788999999876655444443 6677888999999999
Q ss_pred EEEEecCCCCHhHHH--------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 109 LIYEYMPNKSLDFFL--------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 109 lv~e~~~~~~L~~~~--------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
+|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 999999999999986 467889999999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 247 (354)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.| |.+.+..++...+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P--f~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTEAIDCIT 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT--TCSSCHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC--CCCCCHHHHHHHHH
Confidence 99999999986554443333344578999999999999999999999999999999998 8999 45555556666655
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
++..... +..+++.+.+||.+||+.||++|||++||++.|+.+..
T Consensus 275 ~g~~~~~--------------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 275 QGRELER--------------------------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HTCCCCC--------------------------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC--------------------------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 4432111 11167789999999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=375.85 Aligned_cols=242 Identities=28% Similarity=0.480 Sum_probs=200.2
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++|.+.+.||+|+||.||+|++. +++.||||+++........++. ||+++++++.+++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367899999999999999999864 3778999999876655444333 6778888999999999
Q ss_pred EEEEecCCCCHhHHH------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 109 LIYEYMPNKSLDFFL------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
+|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999988 467889999999999999999999 99999999999999999999
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.| |.+.+..++...+.++
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~P--f~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT--TTTSCHHHHHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHcC
Confidence 999999976554443333334568999999999999999999999999999999998 8999 4555666666666554
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
...... ..+++.+.+||.+||+.||++|||+++|++.|+++...
T Consensus 247 ~~~~~p--------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQRP--------------------------------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCC--------------------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 432111 11677899999999999999999999999999998743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=370.92 Aligned_cols=248 Identities=20% Similarity=0.212 Sum_probs=199.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH-------HHHHHHHHhceeecCCceEEEEEecCCC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR-------ELKNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~-------~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
..+.|++.+.||+|+||.||+|+++ +|+.||||++........+ .+.||+++++++.+++.+|+|||||+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3467899999999999999999976 5999999999765332111 2348999999999999999999999999
Q ss_pred CHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCCccc---cc
Q 048432 118 SLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGNELQ---AN 188 (354)
Q Consensus 118 ~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~~~~---~~ 188 (354)
+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.+| .+||+|||++......... ..
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999998 788999999999999999999999 99999999999999987 6999999999865443211 11
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+|| .+.+...+...+.....+...
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf--~~~~~~~~~~~i~~~~~~~~~------------- 277 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW--TQYFRGPLCLKIASEPPPIRE------------- 277 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS--TTTCCSCCHHHHHHSCCGGGG-------------
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC--CCCCHHHHHHHHHcCCCCchh-------------
Confidence 23357999999999999999999999999999999999999995 444444455555443322111
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCC
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~ 328 (354)
.++.+++.+.+||.+||+.||++|||++|+++.|.....+...
T Consensus 278 -----------------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 278 -----------------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp -----------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred -----------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 1112677889999999999999999999999999887765443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=370.85 Aligned_cols=239 Identities=28% Similarity=0.424 Sum_probs=196.6
Q ss_pred hcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
.+++++.+.||+|+||+||+|.+. +++.||||+++..... ...++ .||+++++++.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 356778899999999999999863 4678999999754322 11222 2778889999999999
Q ss_pred EEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 108 ILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
++|||||++|+|.+++ +++..+.+++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 9999999999999988 467889999999999999999999 9999999999999999
Q ss_pred CCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhh
Q 048432 167 MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~ 245 (354)
+.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++ |..| |.+.+..++...
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P--f~~~~~~~~~~~ 259 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVVEM 259 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT--TTTCCHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC--CCCCCHHHHHHH
Confidence 9999999999986554443333444678999999999999999999999999999999998 8889 455566666666
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
+..+...... ..+++.+.+||.+||+.||++|||++||++.|+..
T Consensus 260 i~~~~~~~~p--------------------------------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNRQVLPCP--------------------------------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcCCCCCCc--------------------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 6544322111 11677899999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=376.27 Aligned_cols=232 Identities=23% Similarity=0.325 Sum_probs=187.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeecCCceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
.++|++++.||+|+||.||+|+++ +|+.||||++..... .....+ .||+++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 479999999999999999999975 599999999975432 222222 26778888999999999999
Q ss_pred EecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 112 EYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 112 e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
|||+||+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999988 467889999999999999999999 9999999999999999999999999997644322
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|++| |.+.+..++...+..+..+.....
T Consensus 180 ~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~P--F~~~~~~~~~~~i~~~~~~~~~~~------- 248 (350)
T 4b9d_A 180 E--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--FEAGSMKNLVLKIISGSFPPVSLH------- 248 (350)
T ss_dssp H--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS--CCCSSHHHHHHHHHHTCCCCCCTT-------
T ss_pred c--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC--CCCcCHHHHHHHHHcCCCCCCCcc-------
Confidence 1 11235799999999999999999999999999999999999999 555666666666665543211111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+++.+.+||.+||+.||++|||++|+++
T Consensus 249 -------------------------~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 249 -------------------------YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------------------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 5667899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=371.04 Aligned_cols=232 Identities=28% Similarity=0.371 Sum_probs=196.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HHH--------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----REL--------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~~--------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+... ... ++. .||+++++++.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999975 599999999965321 111 111 2777888899999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||+||+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|........
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999988 788999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+| |.+.+..++...+......+|..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P--F~~~~~~~~~~~i~~~~~~~p~~--------- 256 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEGLIFAKIIKLEYDFPEK--------- 256 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCCCCTT---------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC--CCCCCHHHHHHHHHcCCCCCCcc---------
Confidence 3334456899999999999999999999999999999999999999 55666777777777665544321
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
.++.+.+||.+||+.||++|||++|++
T Consensus 257 ------------------------~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 ------------------------FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------------------------CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------------------------cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 345678999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=365.39 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=190.4
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeecCCc
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~~~~ 106 (354)
..|....+++++.+.||+|+||+||+|++++ .||||+++... ....+.+. ||+++++++.. +.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 3456677899999999999999999998753 59999986542 22233333 66677777654 56
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
+++|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 89999999999999988 788999999999999999999999 999999999999999999999999999765
Q ss_pred cCCccccccccccCcccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
.............||+.|+|||++.+ ++++.++|||||||++|||++|+.|| .+.+.......+.......|...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf--~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY--SHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT--TTCCCHHHHHHHHHTTCCCCCST
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC--CCCChHHHHHHHHhcCCCCCCcc
Confidence 54333333344689999999999864 46899999999999999999999995 44333333333222222222111
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..+..+++.+.+||.+||+.||++|||++||++.|+.+...
T Consensus 261 ---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 261 ---------------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ---------------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ---------------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 00111678899999999999999999999999999988743
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=372.73 Aligned_cols=235 Identities=22% Similarity=0.336 Sum_probs=194.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh----hHHHH--------HHHHHHhceeecCCceEEEEEe
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ----GLREL--------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~----~~~~~--------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
.+.|++.+.||+|+||.||+|+++ +|+.||||++...... ..+++ .||+++++++.+++.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 467999999999999999999976 5999999999643221 12222 3778899999999999999999
Q ss_pred cCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 114 MPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 114 ~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
|+||+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++........ ..
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~ 227 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR 227 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CB
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cc
Confidence 9999999988 789999999999999999999999 99999999999999999999999999986544322 12
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...+||+.|+|||++.+..|+.++|||||||++|+|++|.+| |.+.+..+....+...........
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P--F~~~~~~~~~~~i~~~~~~~~~~~------------ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP--YFNEPPLKAMKMIRDNLPPRLKNL------------ 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT--TTTSCHHHHHHHHHHSSCCCCSCG------------
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC--CCCcCHHHHHHHHHcCCCCCCCcc------------
Confidence 335899999999999999999999999999999999999999 455566666666554332111100
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+++.+.+||.+||+.||++|||++|+++.
T Consensus 294 ------------------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 ------------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0156778999999999999999999998863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=375.31 Aligned_cols=236 Identities=22% Similarity=0.340 Sum_probs=195.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh----HHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----LREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~----~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
..+.|++.+.||+|+||.||+|+++ +|+.||||++....... .+++ .||+++++++.+++.+|+|||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 4567999999999999999999976 59999999996543221 1222 277888999999999999999
Q ss_pred ecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 113 YMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 113 ~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
||+||+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++........ .
T Consensus 229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 303 (423)
T 4fie_A 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 303 (423)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence 99999999988 788999999999999999999999 99999999999999999999999999986544322 1
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+| |.+.+..+....+...........
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P--F~~~~~~~~~~~i~~~~~~~~~~~----------- 370 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP--YFNEPPLKAMKMIRDNLPPRLKNL----------- 370 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT--TTTSCHHHHHHHHHHSCCCCCSCT-----------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC--CCCcCHHHHHHHHHcCCCCCCccc-----------
Confidence 2345899999999999999999999999999999999999999 555666666666654432111100
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+++.+.+||.+||+.||++|||++|+++.
T Consensus 371 -------------------~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 371 -------------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -------------------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0156778999999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=355.36 Aligned_cols=229 Identities=25% Similarity=0.401 Sum_probs=177.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hH----HHH--------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GL----REL--------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~----~~~--------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++.+.||+|+||+||+|+++ +|+.||+|++...... .. +++ +||+++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 378999999999999999999965 5999999999654211 11 111 2677888899999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|||| +|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|........
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999 56888877 788999999999999999999999 99999999999999999999999999976544332
Q ss_pred ccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|++|| .+.+...+.+.+..+...+|..
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF--~~~~~~~~~~~i~~~~~~~p~~-------- 234 (275)
T 3hyh_A 168 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF--DDESIPVLFKNISNGVYTLPKF-------- 234 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHTCCCCCTT--------
T ss_pred ---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC--CCCCHHHHHHHHHcCCCCCCCC--------
Confidence 223579999999999998876 68999999999999999999994 5556666666666655443321
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++.+.+||.+||+.||++|||++|+++
T Consensus 235 -------------------------~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 -------------------------LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -------------------------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------------------------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 4567889999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=364.50 Aligned_cols=250 Identities=27% Similarity=0.359 Sum_probs=198.0
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HHHH-------------HHHHHHh
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LREL-------------KNKLRLL 98 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~~~-------------~~i~~~~ 98 (354)
..+.|....++|++.+.||+|+||.||+|.+.. ++.||||.+....... ...+ .||++++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334566778899999999999999999999653 3579999997654322 1111 2567788
Q ss_pred ceeecC-CceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 048432 99 GCCIDK-DEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156 (354)
Q Consensus 99 ~~~~~~-~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 156 (354)
++|..+ +.+++|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 887654 5689999999999999988 357788999999999999999999 999999
Q ss_pred CCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcc
Q 048432 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFY 235 (354)
Q Consensus 157 kp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~ 235 (354)
||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986554433333344578999999999999999999999999999999998 89995432
Q ss_pred cccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 048432 236 RTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315 (354)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~i 315 (354)
.. ...+...+.++..... +..+++.+.+||.+||+.||++|||++||
T Consensus 292 ~~-~~~~~~~i~~g~~~~~--------------------------------p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 292 KI-DEEFCRRLKEGTRMRA--------------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp CC-SHHHHHHHHHTCCCCC--------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CH-HHHHHHHHHcCCCCCC--------------------------------CccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 21 2333344433322111 11156788999999999999999999999
Q ss_pred HHHhhhhhh
Q 048432 316 VSMLTNEAA 324 (354)
Q Consensus 316 l~~L~~~~~ 324 (354)
++.|+.+..
T Consensus 339 l~~L~~llq 347 (353)
T 4ase_A 339 VEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=359.18 Aligned_cols=231 Identities=23% Similarity=0.287 Sum_probs=190.9
Q ss_pred hcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCCh------hhHH--------HHHHHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSG------QGLR--------ELKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~------~~~~--------~~~~i~~~~~~~~~~~~~~ 108 (354)
.++|++++.||+|+||+||+|++. .++.||+|++..... ...+ .+.||+++++++.+++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 368999999999999999999863 478899999865321 1111 2348899999999999999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+|||||+||+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999988 788999999999999999999999 999999999999999999999999999754333
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. .....+||+.|+|||++.+..++.++||||+||++|+|++|.+| |.+.+..++...+.+....+|..
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P--F~~~~~~~~~~~i~~~~~~~p~~------- 248 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--FQGKDRKETMTMILKAKLGMPQF------- 248 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC--CCCcCHHHHHHHHHcCCCCCCCc-------
Confidence 21 12235799999999999999999999999999999999999999 55666677777776655443321
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM-----NDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~il~ 317 (354)
.++.+.+||.+||+.||++|||+ +|+++
T Consensus 249 --------------------------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 --------------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --------------------------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --------------------------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 45678899999999999999985 67764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=351.79 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=186.9
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHH-----------HHHHHHHHhceeecCC----ceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLR-----------ELKNKLRLLGCCIDKD----EKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~-----------~~~~i~~~~~~~~~~~----~~~lv~ 111 (354)
.++|.+.+.||+|+||+||+|++ +|+.||||++......... .+.||+++++++..++ .+|+||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 36789999999999999999998 5899999999765433221 1237788888887554 579999
Q ss_pred EecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYS-----RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|||++|+|.+++ +++..+.+++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999999998 788999999999999999999871 11299999999999999999999999999986554
Q ss_pred Cccc--cccccccCcccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 183 NELQ--ANTGRIVGTYRYMSPEYAIQG------IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 183 ~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||+.......-...
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~---------- 230 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD---------- 230 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT----------
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh----------
Confidence 3322 122235799999999998754 3577999999999999999999885432211100000
Q ss_pred CcccCCccccccchhhhhh-hhhccccCCch-hHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 255 SVDTHNVKTFGFLHLTIFK-LFSISSVGLSN-DIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..... . ........ .....++.... ...+.++..+.+||.+||+.||++|||+.||++.|+++..
T Consensus 231 -~~~~~-~---~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 231 -LVPSD-P---SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp -TSCSS-C---CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccccc-c---hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00000 0 00000000 00000000111 1123367889999999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=346.59 Aligned_cols=233 Identities=24% Similarity=0.387 Sum_probs=179.5
Q ss_pred hcCc-cccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeec----CCc
Q 048432 47 TNKF-SDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCID----KDE 106 (354)
Q Consensus 47 ~~~y-~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~----~~~ 106 (354)
.++| ++.+.||+|+||.||+|.++ +++.||+|++.... ......+. ||+++++++.+ ++.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3455 77889999999999999976 58899999996542 22222222 66677777653 356
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a~~~ 180 (354)
+|+|||||+||+|.+++ +++..+..++.||+.||.|||+++ .+|+||||||+|||++. +|.+||+|||+|...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 89999999999999998 788899999999999999999874 34999999999999984 799999999999753
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.. ......+...+..+..+...
T Consensus 183 ~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~~i~~~~~~~~~----- 251 (290)
T 3fpq_A 183 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASF----- 251 (290)
T ss_dssp CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT-CSSHHHHHHHHTTTCCCGGG-----
T ss_pred CCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC-CCcHHHHHHHHHcCCCCCCC-----
Confidence 3222 223589999999998864 699999999999999999999999532 12233344444333221100
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+...++.+.+||.+||+.||++|||++|+++
T Consensus 252 --------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0114567899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=347.81 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=161.3
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCChhh--HHH---------HHHHHHHhceeecCC
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQG--LRE---------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~~--~~~---------~~~i~~~~~~~~~~~ 105 (354)
+.++...++|++.+.||+|+||+||+|+++ .++.||+|++....... .++ +.|++++++++.+.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 455667789999999999999999999864 36789999986654321 111 126677788899999
Q ss_pred ceEEEEEecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccceeccC
Q 048432 106 EKILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRG 182 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a~~~~~ 182 (354)
.+|+|||||++++|.+++ +++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999999999998 888999999999999999999999 9999999999999876 7999999999975443
Q ss_pred Cccc--------------------------cccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcc
Q 048432 183 NELQ--------------------------ANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFY 235 (354)
Q Consensus 183 ~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~ 235 (354)
.... ......+||+.|+|||++.+.+ ++.++||||+||++|+|++|+.||. .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~-~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY-K 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS-C
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC-C
Confidence 2211 0112347999999999998764 8999999999999999999999963 3
Q ss_pred cccchhhhhh
Q 048432 236 RTYSFTLLGY 245 (354)
Q Consensus 236 ~~~~~~~~~~ 245 (354)
+.+..+.+..
T Consensus 250 ~~~~~~~l~~ 259 (361)
T 4f9c_A 250 ASDDLTALAQ 259 (361)
T ss_dssp CSSHHHHHHH
T ss_pred CCCHHHHHHH
Confidence 3334443333
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.39 Aligned_cols=231 Identities=23% Similarity=0.332 Sum_probs=167.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCC-------
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKD------- 105 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~------- 105 (354)
.++|++++.||+|+||.||+|+++ +|+.||||++...... ....+. ||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356999999999999999999975 5999999999654332 222222 5566666665433
Q ss_pred -----ceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEe
Q 048432 106 -----EKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172 (354)
Q Consensus 106 -----~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~ 172 (354)
.+|+|||||++|+|.+++ ..+..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 378999999999999998 234568899999999999999999 9999999999999999999999
Q ss_pred ecccceeccCCcccc----------ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chh
Q 048432 173 DFGIARICRGNELQA----------NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFT 241 (354)
Q Consensus 173 dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~ 241 (354)
|||+|.......... .....+||+.|+|||++.+..++.++|||||||++|+|++ || .+.. ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf--~~~~~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF--STQMERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC--SSHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC--CCccHHHH
Confidence 999997654432111 1223579999999999999999999999999999999996 54 2221 111
Q ss_pred hhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+.... .+.......+.+.+||.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~--------------------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVRNLK--------------------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHTTC--------------------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCC--------------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222221111 11112224556778999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=351.62 Aligned_cols=270 Identities=17% Similarity=0.210 Sum_probs=194.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHHH------------HHHHHhceee------cC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLRELK------------NKLRLLGCCI------DK 104 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~~------------~i~~~~~~~~------~~ 104 (354)
..++|++++.||+|+||.||+|+++ +|+.||||++...... ....+. ||+++++++. +.
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4578999999999999999999975 5999999999754321 111222 4555666543 34
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+.+|+|||||+ |+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 67899999996 5688877 788999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCc--cccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 180 CRGNE--LQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 180 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
..... ........+||+.|+|||++.+. .++.++||||+||++|+|++|.+| |.+.+..+.+..+....+..+..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~p--F~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL--FPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCS--SCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCC--CCCCCHHHHHHHHHHhcCCCChH
Confidence 54322 12223346899999999998875 469999999999999999999999 56677777777776666655443
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
........... . .................+..++.+.+||.+||+.||++|||++|+++. |++..
T Consensus 286 ~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 286 VIQAVGAERVR-A-YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GTC-----CHH-H-HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred Hhhhhhhhhhh-h-hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 32221110000 0 000000000000111112246778999999999999999999999873 55543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=354.98 Aligned_cols=235 Identities=20% Similarity=0.275 Sum_probs=197.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
..++|++.+.||+|+||.||+|.++ +|+.||+|++..........+. ||+++++++.+.+.+|+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999976 5999999999765543332222 56677888999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC--CCeEEeecccceeccCCc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNPKISDFGIARICRGNE 184 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~~l~dfg~a~~~~~~~ 184 (354)
||+||+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.......
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999887 678899999999999999999999 9999999999999854 899999999998765443
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. ...+||+.|+|||++.+..++.++|||||||++|+|++|.+| |.+.+..+....+......++......
T Consensus 312 ~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~P--f~~~~~~~~~~~i~~~~~~~~~~~~~~---- 382 (573)
T 3uto_A 312 SV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSG---- 382 (573)
T ss_dssp EE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCS--SCCSSHHHHHHHHHTTCCCCCSGGGTT----
T ss_pred ce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCC--CCCcCHHHHHHHHHhCCCCCCcccccC----
Confidence 22 235799999999999999999999999999999999999999 566677777777766655444322111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++.+.+||.+||+.||++|||++|+++
T Consensus 383 -------------------------~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 383 -------------------------ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -------------------------SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------------------------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4567889999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=354.71 Aligned_cols=234 Identities=25% Similarity=0.287 Sum_probs=188.2
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhHHH------------HHHHHHHhceeecC
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGLRE------------LKNKLRLLGCCIDK 104 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~~~------------~~~i~~~~~~~~~~ 104 (354)
+...++|++++.||+|+||.||+|+++ +|+.||+|++.+... ..... +.||+++++++.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 334578999999999999999999976 599999999964321 11111 12567778889999
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+.+|+|||||.||+|..++ +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|..
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999988 788999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 257 (354)
..... ....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||...... ...+...+.......|..
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~- 416 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS- 416 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTT-
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCcc-
Confidence 55433 223589999999999964 57999999999999999999999996433222 223333333333332211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~ 317 (354)
.++.+.+||.+||+.||++|++ ++||++
T Consensus 417 --------------------------------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 417 --------------------------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------------------------------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------------------------------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 4567899999999999999998 688765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=322.06 Aligned_cols=268 Identities=36% Similarity=0.589 Sum_probs=205.8
Q ss_pred CCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceee
Q 048432 35 LPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCI 102 (354)
Q Consensus 35 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~ 102 (354)
...+++.++....++|++.+.||+|+||.||+|.+++|+.||+|++..........+. |++++++++.
T Consensus 26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred ceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3457778888899999999999999999999999888999999999876554444443 5556677788
Q ss_pred cCCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 103 DKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
..+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEee
Confidence 888999999999999999887 678899999999999999999999 99999999999999999999999
Q ss_pred cccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-hhhhhhhhccccC
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS-FTLLGYISENIYE 252 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~ 252 (354)
||++................|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .............
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 999976544332222333467899999999998899999999999999999999999964322211 1111100000000
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
. ...............+.++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 263 ~-------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 263 G-------------------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp T-------------------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-------------------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 0 0000001111222334588899999999999999999999999999998874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.14 Aligned_cols=266 Identities=27% Similarity=0.343 Sum_probs=206.0
Q ss_pred cCCCCCccccchhhhhcCccccceecccCceeEEEEEEc--------CCCEEEEEEecCCChhh-HHH------------
Q 048432 32 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSGQG-LRE------------ 90 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vavK~~~~~~~~~-~~~------------ 90 (354)
.......+...+....++|++.+.||+|+||.||+|.+. .+..||+|++....... ...
T Consensus 53 ~~~~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 53 VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132 (382)
T ss_dssp -CCCCCCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC
T ss_pred ccccccccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc
Confidence 333333444455667789999999999999999999963 23579999997653321 111
Q ss_pred -HHHHHHHhceeecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCC
Q 048432 91 -LKNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSR 148 (354)
Q Consensus 91 -~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~ 148 (354)
+.|++++++++...+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 211 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 211 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 225566778888889999999999999999987 467889999999999999999999
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS- 227 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~- 227 (354)
|+||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++
T Consensus 212 --ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 212 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999976554433233333456789999999999999999999999999999999
Q ss_pred CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCC
Q 048432 228 GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESAD 307 (354)
Q Consensus 228 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 307 (354)
|..|| ......+....+..+....... .+++.+.+||.+||+.||+
T Consensus 290 g~~p~--~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~l~~li~~~l~~dP~ 335 (382)
T 3tt0_A 290 GGSPY--PGVPVEELFKLLKEGHRMDKPS--------------------------------NCTNELYMMMRDCWHAVPS 335 (382)
T ss_dssp SCCSS--TTCCHHHHHHHHHTTCCCCCCS--------------------------------SCCHHHHHHHHHHTCSSGG
T ss_pred CCCCC--CCCCHHHHHHHHHcCCCCCCCc--------------------------------cCCHHHHHHHHHHcCCChh
Confidence 99995 4444444444444332211111 1567789999999999999
Q ss_pred CCCCHHHHHHHhhhhhhhcCCCCCCCc
Q 048432 308 DRPTMNDVVSMLTNEAAALLPPKQPAF 334 (354)
Q Consensus 308 ~Rps~~~il~~L~~~~~~~~~~~~~~~ 334 (354)
+|||++++++.|+++.........+.+
T Consensus 336 ~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 336 QRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp GSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred hCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999976665555444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=323.70 Aligned_cols=245 Identities=27% Similarity=0.380 Sum_probs=194.3
Q ss_pred hhhhcCccccceecccCceeEEEEEEc--------CCCEEEEEEecCCChhh-HHH-------------HHHHHHHhcee
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSGQG-LRE-------------LKNKLRLLGCC 101 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vavK~~~~~~~~~-~~~-------------~~~i~~~~~~~ 101 (354)
....++|++.+.||+|+||.||+|.+. ++..||+|++....... ... +.|++++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 445689999999999999999999863 35579999997653321 111 23556677788
Q ss_pred ecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
...+.+|+||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 8889999999999999999887 256778899999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYS 239 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~ 239 (354)
|+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||. +...
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~--~~~~ 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPV 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST--TCCG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC--CCCH
Confidence 9999999999999999986554433222333456788999999999999999999999999999999 999954 3333
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
.++...+..+..... +..++..+.+||.+||+.||++|||+.++++.|
T Consensus 312 ~~~~~~~~~~~~~~~--------------------------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 312 EELFKLLKEGHRMDK--------------------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp GGHHHHHHTTCCCCC--------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC--------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 444443333221110 011567889999999999999999999999999
Q ss_pred hhhhhh
Q 048432 320 TNEAAA 325 (354)
Q Consensus 320 ~~~~~~ 325 (354)
+.+...
T Consensus 360 ~~il~~ 365 (370)
T 2psq_A 360 DRILTL 365 (370)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=317.59 Aligned_cols=273 Identities=38% Similarity=0.645 Sum_probs=208.0
Q ss_pred cccccCCCCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh-----hHHHH--------HHH
Q 048432 28 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ-----GLREL--------KNK 94 (354)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~-----~~~~~--------~~i 94 (354)
+.........+++.++....++|++.+.||+|+||.||+|.+++|+.||+|++...... ...+. .|+
T Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 89 (326)
T 3uim_A 10 PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89 (326)
T ss_dssp -----CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB
T ss_pred cccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc
Confidence 34445556779999999999999999999999999999999888999999998764321 11222 367
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhc---CCCCeEeCCCCCCCEE
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQY---SRVRIIHRDLKVSNIL 162 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~---~~~~i~H~dlkp~Nil 162 (354)
+++++++...+..++||||+.+++|.+++ +++..+..++.|++.||.|||+. + |+|+||||+||+
T Consensus 90 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil 166 (326)
T 3uim_A 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANIL 166 (326)
T ss_dssp CCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEE
T ss_pred cceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEE
Confidence 77888999999999999999999999988 67788999999999999999999 8 999999999999
Q ss_pred EcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---c
Q 048432 163 LDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY---S 239 (354)
Q Consensus 163 l~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~---~ 239 (354)
++.++.++|+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred ECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 999999999999999865443322 222345899999999998888999999999999999999999997432111 1
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
......+........ ................++..+.+++.+||+.||++|||++++++.|
T Consensus 246 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 246 VMLLDWVKGLLKEKK-------------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SBHHHHHTTTTSSCC-------------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhHHHHHHHHhhchh-------------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 111111111110000 0001111122333455788999999999999999999999999999
Q ss_pred hhhh
Q 048432 320 TNEA 323 (354)
Q Consensus 320 ~~~~ 323 (354)
++..
T Consensus 307 ~~~~ 310 (326)
T 3uim_A 307 EGDG 310 (326)
T ss_dssp HTSS
T ss_pred cCcc
Confidence 9754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.75 Aligned_cols=266 Identities=16% Similarity=0.172 Sum_probs=199.4
Q ss_pred hhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhhHHHH-----------------------HHHH
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQGLREL-----------------------KNKL 95 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~~~~~-----------------------~~i~ 95 (354)
...++|++.+.||+|+||.||+|.++. ++.||+|++.........+. .|++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456799999999999999999999764 47899999977654332221 1344
Q ss_pred HHhceeecC----CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-
Q 048432 96 RLLGCCIDK----DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD- 164 (354)
Q Consensus 96 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~- 164 (354)
++++++... ...++||||+ +++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 555665543 4589999999 99999988 678999999999999999999999 99999999999999
Q ss_pred -CCCCeEEeecccceeccCCcccc-----ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Q 048432 165 -KDMNPKISDFGIARICRGNELQA-----NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238 (354)
Q Consensus 165 -~~~~~~l~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~ 238 (354)
.++.++|+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999997654332211 112345899999999999999999999999999999999999996432222
Q ss_pred chhhhhhhhccc-cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 239 SFTLLGYISENI-YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. .......... ...+.. .+. .+. ...+++.+.+||..||+.+|++|||+++|++
T Consensus 268 ~-~~~~~~~~~~~~~~~~~----------~~~---~~~-----------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 P-KYVRDSKIRYRENIASL----------MDK---CFP-----------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp H-HHHHHHHHHHHHCHHHH----------HHH---HSC-----------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred H-HHHHHHHHHhhhhHHHH----------HHH---hcc-----------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1 1111111000 000000 000 000 0114778999999999999999999999999
Q ss_pred HhhhhhhhcCCCCCCCcccccc
Q 048432 318 MLTNEAAALLPPKQPAFSYVRN 339 (354)
Q Consensus 318 ~L~~~~~~~~~~~~~~~~~~~~ 339 (354)
.|+++...........++|...
T Consensus 323 ~l~~~~~~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 323 ILLQGLKAIGSKDDGKLDLSVV 344 (364)
T ss_dssp HHHHHHHHTTCCCCCCCCC---
T ss_pred HHHHHHHHcCCCcCCccceEec
Confidence 9999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=315.48 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=195.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
...++|++.+.||+|+||.||+|.+. +++.||+|++..........+. |++++++++.+++..++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 34689999999999999999999975 5999999998765554444333 5566777888889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999988 678899999999999999999999 99999999999999999999999999976543322
Q ss_pred ccc------------cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 186 QAN------------TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 186 ~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..|+....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 111 1134689999999999999999999999999999999999998654322211111111000000
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCC
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~ 328 (354)
..+..+++.+.+||.+||+.||++|||++++++.|+++......
T Consensus 243 -------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 243 -------------------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -------------------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -------------------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00111556788999999999999999999999999999866544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=312.66 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=191.3
Q ss_pred cchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCce
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
..+....++|++.+.||+|+||.||+|.+ .+|+.||+|++..........+ .|++++++++...+..
T Consensus 13 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SBSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cCcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 34455678999999999999999999996 4699999999865433322222 2566778888889999
Q ss_pred EEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 108 ILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
++||||+++++|.+++ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999988 778899999999999999999999 999999999999999999999999998765443
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..|| ...+.......+.........
T Consensus 170 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf--~~~~~~~~~~~~~~~~~~~~~-------- 237 (297)
T 3fxz_A 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ-------- 237 (297)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT--TTSCHHHHHHHHHHHCSCCCS--------
T ss_pred cc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCC--------
Confidence 32 122357899999999999999999999999999999999999995 333333333322221111000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...++.+.+||.+||+.||++|||++|+++
T Consensus 238 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 ----------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------------------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00115667899999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=314.29 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=187.8
Q ss_pred CccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceee
Q 048432 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCI 102 (354)
Q Consensus 37 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~ 102 (354)
.+....+....++|++.+.||+|+||.||+|++ +|+.||+|++..... .....+. |++++++++.
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 355666677789999999999999999999987 588999999876532 2222222 5566778888
Q ss_pred cCCceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 103 DKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
..+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ .+|+||||||+||+++.++.++|+||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence 888999999999999999987 567788999999999999999874 34999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
|++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||. ..+.......+........
T Consensus 184 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~--~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 184 GLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG--NLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT--TSCHHHHHHHHHHSCCCCC
T ss_pred CCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHhcCCCCC
Confidence 99875433221 1223468999999999999999999999999999999999999954 3333333333321111111
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCC
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 331 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~ 331 (354)
. +..+++.+.+||.+||+.||++|||++++++.|+.+.....+|++
T Consensus 260 ~-------------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 260 I-------------------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp C-------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred C-------------------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 0 011566789999999999999999999999999999876655544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=316.52 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=195.7
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHH-----------HHHHHHHhceeecCC-
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRE-----------LKNKLRLLGCCIDKD- 105 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~-----------~~~i~~~~~~~~~~~- 105 (354)
..-..+....++|++.+.||+|+||.||+|++. ++.||||++.......... +.|++++++++....
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cCccccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 344455566789999999999999999999985 8899999997654332221 126667777776644
Q ss_pred ---ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhc----------CCCCeEeCCCCCCCEEEcCCCC
Q 048432 106 ---EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQY----------SRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 106 ---~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~----------~~~~i~H~dlkp~Nill~~~~~ 168 (354)
.+++||||+++++|.+++ +++..+..++.|++.||.|||+. + |+||||||+||+++.++.
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCC
T ss_pred CCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCe
Confidence 369999999999999998 78899999999999999999998 8 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-----IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLL 243 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~ 243 (354)
++|+|||++................+|..|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999999776554433333445789999999998763 356688999999999999999999643222111000
Q ss_pred hhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchh-HHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 244 GYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSND-IVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
...... .+... +................. ....+++.+.+||.+||+.||++|||+++++++|+++
T Consensus 250 ~~~~~~---~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 250 EEEIGQ---HPSLE----------DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHCS---SCCHH----------HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhcc---CCchh----------hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000 00000 000000000000000110 1122677899999999999999999999999999998
Q ss_pred hh
Q 048432 323 AA 324 (354)
Q Consensus 323 ~~ 324 (354)
..
T Consensus 317 ~~ 318 (322)
T 3soc_A 317 QR 318 (322)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.71 Aligned_cols=262 Identities=18% Similarity=0.251 Sum_probs=205.4
Q ss_pred hhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh-h-HHHH---------HHHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ-G-LREL---------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~-~-~~~~---------~~i~~~~~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|+||.||+|.+ .+|+.||+|++...... . .+++ .+++++++++......++|||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4567899999999999999999996 46899999998654321 1 1222 134556677788889999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC-----eEEeecccceecc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-----PKISDFGIARICR 181 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~~l~dfg~a~~~~ 181 (354)
|+ +++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++|+|||++....
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999987 578889999999999999999999 999999999999987765 9999999998655
Q ss_pred CCccc-----cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCC
Q 048432 182 GNELQ-----ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPS 255 (354)
Q Consensus 182 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 255 (354)
..... .......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .......+.......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 1123457899999999999989999999999999999999999996543322 22222222222111110
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCcc
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFS 335 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~ 335 (354)
......+++.+.+||.+||+.||++|||+++|++.|+++...........++
T Consensus 243 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 294 (298)
T 1csn_A 243 ----------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 294 (298)
T ss_dssp ----------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred ----------------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence 0111125778999999999999999999999999999999998888888888
Q ss_pred ccc
Q 048432 336 YVR 338 (354)
Q Consensus 336 ~~~ 338 (354)
|+.
T Consensus 295 w~~ 297 (298)
T 1csn_A 295 WNL 297 (298)
T ss_dssp GGC
T ss_pred cCC
Confidence 864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=309.26 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=198.4
Q ss_pred CCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecC
Q 048432 36 PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDK 104 (354)
Q Consensus 36 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~ 104 (354)
.......+....++|++.+.||+|+||.||+|.++++..||+|++........ ++. .|++++++++.+.
T Consensus 12 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 12 AGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp ----CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 34455677778899999999999999999999998888999999976543221 111 2566778888888
Q ss_pred CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 105 DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
+..++||||+.+++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccc
Confidence 9999999999999999988 678889999999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ ......++..|+|||++.+..++.++|+||||+++|+|++ |..|| ...........+...........
T Consensus 169 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~ 245 (283)
T 3gen_A 169 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEHIAQGLRLYRPHL 245 (283)
T ss_dssp GBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTT--TTSCHHHHHHHHHTTCCCCCCTT
T ss_pred cccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCc--cccChhHHHHHHhcccCCCCCCc
Confidence 55433211 1222345778999999998999999999999999999998 99995 44444444444444332221111
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.++.+.+||.+||+.+|++|||++++++.|+++..+
T Consensus 246 --------------------------------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 246 --------------------------------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------------------------------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------------------------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 456788999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.57 Aligned_cols=237 Identities=25% Similarity=0.333 Sum_probs=193.0
Q ss_pred cchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCC--hhhHHHH------------HHHHHHhceeecCC
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRS--GQGLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~--~~~~~~~------------~~i~~~~~~~~~~~ 105 (354)
.+.....++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+ .|++++++++...+
T Consensus 8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34445678999999999999999999997 469999999996542 2222222 25566778888899
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+++||||+++++|.+++ ++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 999999999999999987 678899999999999999999999 999999999999999999999999998755
Q ss_pred cCCccccccccccCcccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFS-IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..... .....|++.|+|||++.+..+. .++||||+||++|+|++|..| |.+.+.......+..+....|..
T Consensus 165 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p--f~~~~~~~~~~~i~~~~~~~p~~--- 236 (328)
T 3fe3_A 165 TVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVLRGKYRIPFY--- 236 (328)
T ss_dssp SSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred CCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC--CCCCCHHHHHHHHHhCCCCCCCC---
Confidence 44332 2335789999999999888764 899999999999999999999 45555556666665554443321
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.++.+.+||.+||+.||++|||++|+++.
T Consensus 237 ------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 ------------------------------MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------------------------------SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------------------------------CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 35567899999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.79 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=196.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+....++|++.+.||+|+||.||+|.++++..||+|++........ ++. .|++++++++...+..++||
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 3446789999999999999999999998888999999976543221 111 25667788888889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999987 577889999999999999999999 99999999999999999999999999976544332
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. .....++..|+|||++.+..++.++|+||||+++|+|++ |..||. ..........+...........
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~------- 229 (268)
T 3sxs_A 160 VS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD--LYTNSEVVLKVSQGHRLYRPHL------- 229 (268)
T ss_dssp EE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT--TSCHHHHHHHHHTTCCCCCCTT-------
T ss_pred hc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc--ccChHHHHHHHHcCCCCCCCCc-------
Confidence 21 222355678999999998889999999999999999998 999953 3343344443333322211111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.++.+.++|.+||+.||++|||++++++.|+++...
T Consensus 230 -------------------------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 -------------------------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------------------------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------------------------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 456788999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=323.50 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=197.9
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-H----HH--------HHHHHHHhceeecCC
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-L----RE--------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~----~~--------~~~i~~~~~~~~~~~ 105 (354)
...+....++|++.+.||+|+||.||+|.++ +++.||+|++....... . ++ +.|++++++++...+
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 3455666789999999999999999999986 69999999987543211 1 11 136778888898889
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 999999999999999987 567889999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||. +.........+..+... +.
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~--~~~~~~~~~~~~~~~~~-~~--- 336 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP--NLSNQQTREFVEKGGRL-PC--- 336 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST--TSCHHHHHHHHHTTCCC-CC---
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHcCCCC-CC---
Confidence 443322222222234678999999998889999999999999999998 898853 34444444433332211 10
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+..+++.+.+||.+||+.||++|||++++++.|+++...
T Consensus 337 ----------------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 ----------------------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 011567889999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=306.40 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=197.0
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
+....++|++.+.||+|+||.||+|.+.+++.||+|++........ ++. .|++++++++.+.+..++||
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3445689999999999999999999998899999999976543221 111 25567788888889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999988 678889999999999999999999 99999999999999999999999999875443321
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
. ......++..|+|||++.+..++.++|+||||+++|+|++ |..|| ......+....+...........
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~------- 231 (269)
T 4hcu_A 162 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDISTGFRLYKPRL------- 231 (269)
T ss_dssp H-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHHHTTCCCCCCTT-------
T ss_pred c-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCC--CCCCHHHHHHHHhcCccCCCCCc-------
Confidence 1 1222356778999999998999999999999999999999 89895 44444445554443322111111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.++.+.+++.+||+.||++|||++++++.|+++..
T Consensus 232 -------------------------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 232 -------------------------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.63 Aligned_cols=295 Identities=11% Similarity=0.069 Sum_probs=209.5
Q ss_pred ccCCCCcccccccccccCCCCCccccchh--hhhcCccccceecccCceeEEEEEEcC---------CCEEEEEEecCCC
Q 048432 16 ELPVNSNLTKRSKKKEVDQLPLFSFSSVS--TATNKFSDANKLGEGGFGPVYKGVLKN---------GDEIAVKRLSGRS 84 (354)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~y~~~~~lg~G~~g~V~~a~~~~---------~~~vavK~~~~~~ 84 (354)
|.|+++-..++...........++...+- ...++|++.+.||+|+||.||+|.+.. ++.||+|++....
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~l~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~ 87 (352)
T 2jii_A 8 SSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG 87 (352)
T ss_dssp -----------CHHHHHHHSCCCCTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS
T ss_pred cccccccccccccccchhhhhhCCCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc
Confidence 34555555555554444444444433332 346899999999999999999999764 7899999997653
Q ss_pred hhh-----H--HHHHHHHHHh---------------ceeec-CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHH
Q 048432 85 GQG-----L--RELKNKLRLL---------------GCCID-KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIE 134 (354)
Q Consensus 85 ~~~-----~--~~~~~i~~~~---------------~~~~~-~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~ 134 (354)
... . -.+.|+++++ +++.. ....++||||+ +++|.+++ +++..+..++.
T Consensus 88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~ 166 (352)
T 2jii_A 88 RLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166 (352)
T ss_dssp THHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHH
Confidence 211 1 1123677743 34443 67889999999 99999998 56889999999
Q ss_pred HHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC--CeEEeecccceeccCCccc-----cccccccCcccccCccccccC
Q 048432 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM--NPKISDFGIARICRGNELQ-----ANTGRIVGTYRYMSPEYAIQG 207 (354)
Q Consensus 135 ~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~ 207 (354)
||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++......... .......++..|+|||++.+.
T Consensus 167 qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 243 (352)
T 2jii_A 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC 243 (352)
T ss_dssp HHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence 9999999999999 99999999999999998 8999999999755432211 112334789999999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHH
Q 048432 208 IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIV 287 (354)
Q Consensus 208 ~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 287 (354)
.++.++|||||||++|+|++|..||.........+...........+........ .
T Consensus 244 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~ 299 (352)
T 2jii_A 244 GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGH------------------------W 299 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSC------------------------E
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccc------------------------c
Confidence 9999999999999999999999997544323333333222111111111100000 0
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccccc
Q 048432 288 CLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338 (354)
Q Consensus 288 ~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~ 338 (354)
...++.+.+||.+||+.||++|||++++++.|+++..........+++|+.
T Consensus 300 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 300 IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 004678899999999999999999999999999999998888888888864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.09 Aligned_cols=261 Identities=17% Similarity=0.160 Sum_probs=202.6
Q ss_pred hhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh--hHHH---------HHHHHHHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ--GLRE---------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~--~~~~---------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
..++|++.+.||+|+||.||+|++ .+|+.||||++...... ...+ +.|++++++++...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 457899999999999999999996 46899999998654321 1111 12556677788888899999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC-----eEEeecccceeccC
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-----PKISDFGIARICRG 182 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~~l~dfg~a~~~~~ 182 (354)
+ +++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++|+|||++.....
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 89999887 678899999999999999999999 999999999999998887 99999999986544
Q ss_pred Ccccc-----ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCc
Q 048432 183 NELQA-----NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSV 256 (354)
Q Consensus 183 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 256 (354)
..... ......||..|+|||++.+..++.++|||||||++|+|++|..||...... ..+....+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 32211 123457899999999999999999999999999999999999996543222 222223222222111110
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccc
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSY 336 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 336 (354)
. ....++ .+.+||.+||+.+|++||++++|++.|+++...........++|
T Consensus 243 ~----------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 243 V----------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp H----------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred H----------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 0 000134 89999999999999999999999999999998887777777888
Q ss_pred ccc
Q 048432 337 VRN 339 (354)
Q Consensus 337 ~~~ 339 (354)
+..
T Consensus 294 ~~~ 296 (330)
T 2izr_A 294 IGK 296 (330)
T ss_dssp TTS
T ss_pred CCC
Confidence 653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=316.73 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=197.5
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HHHHH------------HHHHHhc
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LRELK------------NKLRLLG 99 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~ 99 (354)
.+..+....++|++.+.||+|+||.||+|++.. ++.||+|++....... ...+. |++++++
T Consensus 38 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345567778999999999999999999999753 4789999997654322 22222 5566778
Q ss_pred eeecCCceEEEEEecCCCCHhHHH-----------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCC
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL-----------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVR 150 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~-----------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ 150 (354)
++.+.+..++||||+++++|.+++ +++..++.++.||+.||.|||+.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--- 194 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 194 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 888889999999999999999887 245678899999999999999999
Q ss_pred eEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CC
Q 048432 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GK 229 (354)
Q Consensus 151 i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~ 229 (354)
|+|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999876544332222333467889999999999999999999999999999999 99
Q ss_pred CCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCC
Q 048432 230 KTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR 309 (354)
Q Consensus 230 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 309 (354)
.|| .+....+....+..+...... ..++..+.+||.+||+.||++|
T Consensus 275 ~p~--~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 275 QPY--YGMAHEEVIYYVRDGNILACP--------------------------------ENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp CTT--TTSCHHHHHHHHHTTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGS
T ss_pred CcC--CCCChHHHHHHHhCCCcCCCC--------------------------------CCCCHHHHHHHHHHcccCcccC
Confidence 894 444444444444433221110 0156778999999999999999
Q ss_pred CCHHHHHHHhhhhhhhc
Q 048432 310 PTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 310 ps~~~il~~L~~~~~~~ 326 (354)
||++++++.|+++....
T Consensus 321 ps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 321 PSFCSIHRILQRMCERA 337 (343)
T ss_dssp CCHHHHHHHHHHTTC--
T ss_pred CCHHHHHHHHHHHHhhh
Confidence 99999999999988544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=312.81 Aligned_cols=246 Identities=26% Similarity=0.443 Sum_probs=193.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~ 106 (354)
....++|++.+.||+|+||.||+|.+. .+..||||++...... ....+. |++++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 345678999999999999999999975 3446999999765322 222222 55667778888888
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999988 678899999999999999999999 999999999999999999999999999865
Q ss_pred cCCcc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 181 RGNEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... ........++..|+|||++.+..++.++|||||||++|+|++ |..| |......+....+..+.......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p--~~~~~~~~~~~~~~~~~~~~~~~-- 277 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRDVISSVEEGYRLPAPM-- 277 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT--TTTSCHHHHHHHHHTTCCCCCCT--
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC--cccCCHHHHHHHHHcCCCCCCCC--
Confidence 44321 111222345678999999998889999999999999999999 9999 44555555555544432211111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
.+++.+.+||.+||+.||++|||++++++.|+.+....
T Consensus 278 ------------------------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 278 ------------------------------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ------------------------------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 15678899999999999999999999999999988543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=311.87 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=179.6
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcC-C---CEEEEEEecCCC--hhhHHHHH------------HHHHHhce
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-G---DEIAVKRLSGRS--GQGLRELK------------NKLRLLGC 100 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~---~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~ 100 (354)
.+..+....++|++.+.||+|+||.||+|.+.. + ..||+|++.... ......+. |+++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 445566777899999999999999999999654 3 279999997642 22223333 44556666
Q ss_pred eecCCce------EEEEEecCCCCHhHHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 048432 101 CIDKDEK------ILIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL 163 (354)
Q Consensus 101 ~~~~~~~------~lv~e~~~~~~L~~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 163 (354)
+...... ++||||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEE
Confidence 6655544 9999999999999887 566789999999999999999999 9999999999999
Q ss_pred cCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 048432 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTL 242 (354)
Q Consensus 164 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~ 242 (354)
+.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..|| .+....+.
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~--~~~~~~~~ 248 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AGIENAEI 248 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTCCGGGH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCc--cccChHHH
Confidence 9999999999999976544433323333456778999999999999999999999999999999 88884 44444444
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
...+......... ..+++.+.+||.+||+.||++|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 YNYLIGGNRLKQP--------------------------------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHHHTTCCCCCC--------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCC--------------------------------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4443332211111 11566789999999999999999999999999998
Q ss_pred hhhc
Q 048432 323 AAAL 326 (354)
Q Consensus 323 ~~~~ 326 (354)
....
T Consensus 297 l~~~ 300 (323)
T 3qup_A 297 LGHL 300 (323)
T ss_dssp HHC-
T ss_pred HHHh
Confidence 8543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=319.77 Aligned_cols=258 Identities=26% Similarity=0.341 Sum_probs=198.6
Q ss_pred cCCCCCccccchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH-------------
Q 048432 32 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------- 91 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------- 91 (354)
......+..+.+....++|++.+.||+|+||.||+|++. +++.||||++...... ....+
T Consensus 6 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h 85 (359)
T 3vhe_A 6 HCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85 (359)
T ss_dssp SGGGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred hhhhCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCC
Confidence 334455677788888999999999999999999999842 3678999999764322 11112
Q ss_pred HHHHHHhceeecCC-ceEEEEEecCCCCHhHHH-----------------------------------------------
Q 048432 92 KNKLRLLGCCIDKD-EKILIYEYMPNKSLDFFL----------------------------------------------- 123 (354)
Q Consensus 92 ~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~----------------------------------------------- 123 (354)
.|++++++++...+ ..++|||||++++|.+++
T Consensus 86 pniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (359)
T 3vhe_A 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165 (359)
T ss_dssp TTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred cceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence 25566667766654 489999999999999887
Q ss_pred ------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 124 ------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 124 ------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242 (359)
T ss_dssp ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceee
Confidence 556778899999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......+..+......
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--- 318 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAP--- 318 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCCCCCC---
T ss_pred ecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCCCCCC---
Confidence 544333333334567889999999999999999999999999999998 99996433222 2222222222111100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..+++.+.++|.+||+.||++|||++++++.|+++...
T Consensus 319 -----------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 319 -----------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -----------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 01456789999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=309.18 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=197.5
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCCh-hhHHHHH------------HHHHHh
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSG-QGLRELK------------NKLRLL 98 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~ 98 (354)
+....+....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+. |+++++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 334455667899999999999999999999862 357899999976532 2222222 556677
Q ss_pred ceeecCCceEEEEEecCCCCHhHHH-----------------------------hhHHHHHHHHHHHHHHHHHHHhcCCC
Q 048432 99 GCCIDKDEKILIYEYMPNKSLDFFL-----------------------------FDWVTRVRIIEGIAQGLLYLHQYSRV 149 (354)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~~-----------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~ 149 (354)
+++...+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 170 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-- 170 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 8888888999999999999999887 356678999999999999999999
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-C
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-G 228 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g 228 (354)
|+|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 171 -ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 171 -LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp -EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred -CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999976554433323333456788999999998889999999999999999999 9
Q ss_pred CCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC
Q 048432 229 KKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD 308 (354)
Q Consensus 229 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 308 (354)
..||. +.........+......... ..+++.+.+||.+||+.||++
T Consensus 250 ~~p~~--~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~li~~~l~~dp~~ 295 (314)
T 2ivs_A 250 GNPYP--GIPPERLFNLLKTGHRMERP--------------------------------DNCSEEMYRLMLQCWKQEPDK 295 (314)
T ss_dssp CCSST--TCCGGGHHHHHHTTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCC--CCCHHHHHHHhhcCCcCCCC--------------------------------ccCCHHHHHHHHHHccCChhh
Confidence 99953 33333333333322211100 115677899999999999999
Q ss_pred CCCHHHHHHHhhhhhhh
Q 048432 309 RPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 309 Rps~~~il~~L~~~~~~ 325 (354)
|||++++++.|+++..+
T Consensus 296 Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 296 RPVFADISKDLEKMMVK 312 (314)
T ss_dssp SCCHHHHHHHHHHHHHT
T ss_pred CcCHHHHHHHHHHHHhh
Confidence 99999999999998743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=314.24 Aligned_cols=284 Identities=23% Similarity=0.238 Sum_probs=202.8
Q ss_pred ccccccccccCCCCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HH--------
Q 048432 23 LTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---RE-------- 90 (354)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~-------- 90 (354)
.+-.+..++.+.+..+++.......++|++.+.||+|+||.||+|++. +++.||+|++........ .+
T Consensus 10 ~~~~~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~ 89 (360)
T 3llt_A 10 GRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQ 89 (360)
T ss_dssp ----------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTC
T ss_pred cccceeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhc
Confidence 344567788889999999999999999999999999999999999974 589999999975322111 01
Q ss_pred -----HHHHHHHhceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 048432 91 -----LKNKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158 (354)
Q Consensus 91 -----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 158 (354)
+.|++++++++...+..++||||+ +++|.+++ ++...+..++.||+.||.|||+.+ |+||||||
T Consensus 90 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp 165 (360)
T 3llt_A 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKP 165 (360)
T ss_dssp CCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred ccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCc
Confidence 236667778888889999999999 88999887 567889999999999999999999 99999999
Q ss_pred CCEEEcC-------------------------CCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchh
Q 048432 159 SNILLDK-------------------------DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213 (354)
Q Consensus 159 ~Nill~~-------------------------~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (354)
+||+++. ++.++|+|||++....... ....+|+.|+|||++.+..++.++
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~ 240 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSS 240 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCcc
Confidence 9999975 7889999999997543322 234679999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc---ccchhhhhhhhhcc----------cc
Q 048432 214 DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF---GFLHLTIFKLFSIS----------SV 280 (354)
Q Consensus 214 DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d~~~~~~~~~~----------~~ 280 (354)
|||||||++|+|++|..|| ...+..+....+.......|.......... .............. ..
T Consensus 241 DiwslG~il~ell~g~~pf--~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 318 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLF--RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH
T ss_pred chHHHHHHHHHHHHCCCCC--CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhh
Confidence 9999999999999999995 444544555554444443332110000000 00000000000000 00
Q ss_pred CCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 281 GLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+.......+.+.+||.+||+.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp TCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0011111223477889999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=310.90 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=200.2
Q ss_pred CCCccccchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHHH------------HHH
Q 048432 35 LPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLRELK------------NKL 95 (354)
Q Consensus 35 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~~------------~i~ 95 (354)
...+..+++....++|++.+.||+|+||.||+|.+. .++.||+|++...... ....+. |++
T Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 344667778888899999999999999999999864 3778999999765432 222222 555
Q ss_pred HHhceeecCCceEEEEEecCCCCHhHHHh---------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
++++++.+.+..++||||+++++|.+++. ++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N 168 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARN 168 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGG
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccce
Confidence 66778888889999999999999999882 56788899999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYS 239 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~ 239 (354)
|+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..|| .....
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~--~~~~~ 246 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSN 246 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT--TTSCH
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcc--ccCCH
Confidence 9999999999999999875544332222223356788999999999999999999999999999999 78884 44444
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
......+......... ..++..+.+||.+||+.||++|||+.++++.|
T Consensus 247 ~~~~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 247 EQVLRFVMEGGLLDKP--------------------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp HHHHHHHHTTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCcCCCC--------------------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 4444443332211110 01567789999999999999999999999999
Q ss_pred hhhhh
Q 048432 320 TNEAA 324 (354)
Q Consensus 320 ~~~~~ 324 (354)
++...
T Consensus 295 ~~~~~ 299 (322)
T 1p4o_A 295 KEEME 299 (322)
T ss_dssp GGGSC
T ss_pred HHhhc
Confidence 98864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.88 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=186.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-----HHHH--------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----LREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-----~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||+|+||.||+|.++ +++.||+|++....... .++. .|++++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4579999999999999999999976 69999999986543211 1111 26677888899999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999998887 678899999999999999999999 999999999999999999999999999765433333
Q ss_pred cccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.......|+..|+|||++.+..+ +.++|||||||++|+|++|..||................... .+..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~--------- 231 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPW--------- 231 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-STTG---------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-CCcc---------
Confidence 33334578999999999987765 788999999999999999999975433322222221111111 1000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...++.+.+||.+||+.||++|||++|+++.
T Consensus 232 ----------------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 ----------------------KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1146677899999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=306.07 Aligned_cols=249 Identities=27% Similarity=0.333 Sum_probs=186.1
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH-----------HHHHHHhceeec----CCceEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL-----------KNKLRLLGCCID----KDEKIL 109 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~-----------~~i~~~~~~~~~----~~~~~l 109 (354)
...++|++.+.||+|+||.||+|++ +++.||||++........... .|++++++++.. ....++
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4568999999999999999999998 689999999976544322111 244555555432 345889
Q ss_pred EEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 110 IYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLH--------QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 110 v~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
||||+++++|.+++ +++..+..++.|++.||.||| +.+ |+||||||+||+++.++.++|+|||++
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999998 788999999999999999999 888 999999999999999999999999999
Q ss_pred eeccCCcccc--ccccccCcccccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCccccc-
Q 048432 178 RICRGNELQA--NTGRIVGTYRYMSPEYAIQG------IFSIKSDVFSFGVLLLKIVSG----------KKTTGFYRTY- 238 (354)
Q Consensus 178 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwSlG~~l~~ll~g----------~~p~~~~~~~- 238 (354)
.......... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 7654433221 12234789999999999876 345789999999999999999 6664322111
Q ss_pred -chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 239 -SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...............+... .......++..+.+||.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIP-------------------------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCC-------------------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCC-------------------------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 1111111111111111100 11122237889999999999999999999999999
Q ss_pred Hhhhh
Q 048432 318 MLTNE 322 (354)
Q Consensus 318 ~L~~~ 322 (354)
.|+++
T Consensus 296 ~L~~i 300 (301)
T 3q4u_A 296 TLTKI 300 (301)
T ss_dssp HHHHH
T ss_pred HHhcc
Confidence 99876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.49 Aligned_cols=236 Identities=25% Similarity=0.315 Sum_probs=193.5
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~------------~~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+ .|++++++++.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 34578999999999999999999976 5999999999754321 11122 25667788888899
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----CeEEeeccc
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGI 176 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~~l~dfg~ 176 (354)
.+++||||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999998 788999999999999999999999 99999999999998777 799999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+........ .....||+.|+|||++.+..++.++|+|||||++|+|++|.+| |.+.+..+....+......++..
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P--f~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS--SCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC--CCCCCHHHHHHHHHhcCCCCCch
Confidence 986554322 2234789999999999988999999999999999999999999 45556666666665554433221
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. ....++.+.+||.+||..||++|||++|+++
T Consensus 241 ~-----------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 241 F-----------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp H-----------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h-----------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 1115667899999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=309.22 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=191.3
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh------HHHH--------HHHHHHhceeecC
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG------LREL--------KNKLRLLGCCIDK 104 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~------~~~~--------~~i~~~~~~~~~~ 104 (354)
+-+......++|++.+.||+|+||.||+|++.+|+.||+|++....... .++. .|++++++++.+.
T Consensus 12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp ---CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred cceeecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 3345566779999999999999999999999889999999996543211 1111 2566778888889
Q ss_pred CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 105 DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
+..++||||+++ +|.+.+ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence 999999999986 666665 678889999999999999999999 9999999999999999999999999998
Q ss_pred eccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ .....++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+....+.......+...
T Consensus 168 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 168 AFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF--PGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC--CCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHHHHCCCChHH
Confidence 65433221 223467899999999876 45899999999999999999999995 44444444444444333322222
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+....... ...................+..++.+.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELP---LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSH---HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccc---hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 21111100 0000000000111111122235677899999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=323.41 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=198.7
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCC
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKD 105 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~ 105 (354)
+....+....++|++.+.||+|+||.||+|.++++..||||++...... ...+. |++++++++. .+
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 3445667778999999999999999999999988889999999865432 22222 4455666665 56
Q ss_pred ceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 106 EKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++||||+.+|+|.+++ ++...+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 789999999999999988 456678899999999999999999 9999999999999999999999999997
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ ......++..|+|||++....++.++|||||||++|+|++ |..|| .+....+....+..+......
T Consensus 333 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~--~~~~~~~~~~~i~~~~~~~~~-- 407 (454)
T 1qcf_A 333 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY--PGMSNPEVIRALERGYRMPRP-- 407 (454)
T ss_dssp GBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS--TTCCHHHHHHHHHHTCCCCCC--
T ss_pred EcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCCCC--
Confidence 65432211 1122345778999999998999999999999999999999 99995 444444555544433211100
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcC
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 327 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~ 327 (354)
..+++.+.+||.+||+.||++|||+++|++.|+++.....
T Consensus 408 ------------------------------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 408 ------------------------------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp ------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred ------------------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 1167789999999999999999999999999999875443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=305.38 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=190.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||.||+|.+. .++.||+|++..... .....+. |++++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 345689999999999999999999965 589999999854322 2222222 556677888888999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999988 678899999999999999999999 99999999999999999999999999875543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||. +................ ..
T Consensus 164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~--~~~~~~~~~~~~~~~~~--~~------ 232 (294)
T 4eqm_A 164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN--GETAVSIAIKHIQDSVP--NV------ 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC--SSCHHHHHHHHHSSCCC--CH------
T ss_pred cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC--CCChHHHHHHHhhccCC--Cc------
Confidence 3211 1223468999999999999999999999999999999999999953 33322222221111110 00
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHhhhhhhhc
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAAL 326 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~il~~L~~~~~~~ 326 (354)
........++.+.++|.+||+.||++|| +++++.+.|+.+..+.
T Consensus 233 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 --------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp --------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred --------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0001111567889999999999999998 9999999999887443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=303.39 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=195.6
Q ss_pred hhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh-hHHHHHHHH---------HHh-ceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ-GLRELKNKL---------RLL-GCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~-~~~~~~~i~---------~~~-~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|+||.||+|.+ .+++.||+|++...... .......++ ..+ .+....+..++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3568999999999999999999996 46889999987544321 111111111 122 23356778899999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccceeccCC
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a~~~~~~ 183 (354)
|+ +++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||++ +.++.++|+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 88999887 578899999999999999999999 9999999999999 78899999999999865543
Q ss_pred cccc-----ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCcc
Q 048432 184 ELQA-----NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 184 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 257 (354)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... .......+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh--
Confidence 3211 223457899999999999999999999999999999999999996433221 11222222111111110
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCcccc
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYV 337 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~ 337 (354)
......+++.+.+||.+||+.||++|||++++++.|+++.........-.++|+
T Consensus 240 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 240 --------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp --------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred --------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 000111467899999999999999999999999999999999888888888886
Q ss_pred c
Q 048432 338 R 338 (354)
Q Consensus 338 ~ 338 (354)
.
T Consensus 294 ~ 294 (296)
T 4hgt_A 294 M 294 (296)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.44 Aligned_cols=233 Identities=25% Similarity=0.370 Sum_probs=186.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCce
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~ 107 (354)
...++|++.+.||+|+||.||+|+++ +|+.||+|++..... .... .+.+++++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34579999999999999999999976 589999999975321 1111 123556677888889999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+||||+.+++|..++ +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999887 778899999999999999999999 99999999999999999999999999874322
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ......+||+.|+|||++.+..++.++|+|||||++|+|++|..| |.+.+..++...+......+|..
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P--f~~~~~~~~~~~i~~~~~~~p~~------ 246 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENEDDLFEAILNDEVVYPTW------ 246 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCTT------
T ss_pred CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC--CCCCCHHHHHHHHHcCCCCCCCC------
Confidence 21 122335789999999999988899999999999999999999999 55566666777766655444321
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH------HHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM------NDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~~il~ 317 (354)
.++.+.+||.+||+.||++||++ +++++
T Consensus 247 ---------------------------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 ---------------------------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------------------------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------------------------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 34567899999999999999998 77765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.06 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=195.6
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceE
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
.++....++|++.+.||+|+||.||+|.+++++.||+|++....... ..+. |++++++++. .+..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH-HHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 45677789999999999999999999998888899999997653221 1222 4455566655 45689
Q ss_pred EEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 109 LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 999999999999987 567788999999999999999999 9999999999999999999999999997655
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..|| ......+....+..+......
T Consensus 161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~----- 232 (279)
T 1qpc_A 161 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLERGYRMVRP----- 232 (279)
T ss_dssp SSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHTTCCCCCC-----
T ss_pred Ccccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC--cccCHHHHHHHHhcccCCCCc-----
Confidence 43322 1222356778999999988889999999999999999999 88885 344444444444332211100
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCC
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 332 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~ 332 (354)
..+++.+.+|+.+||+.||++|||++++++.|+++........+|
T Consensus 233 ---------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 233 ---------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp ---------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC------
T ss_pred ---------------------------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 015678899999999999999999999999999998766554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.10 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=200.2
Q ss_pred hhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhh-HHHHHHHHH---------Hhc-eeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQG-LRELKNKLR---------LLG-CCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~-~~~~~~i~~---------~~~-~~~~~~~~~lv~e~ 113 (354)
..++|++.+.||+|+||.||+|++ .+|+.||+|++....... ......+++ .+. +....+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 468999999999999999999996 469999999986544322 111111211 122 33566778999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a~~~~~~~ 184 (354)
+ +++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||++ +.++.++|+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9 88999887 578899999999999999999999 9999999999999 488899999999998655433
Q ss_pred ccc-----ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCccc
Q 048432 185 LQA-----NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 185 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 258 (354)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... .......+.......+.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 239 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 239 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH---
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch---
Confidence 211 123457899999999999999999999999999999999999996543221 22222222222111110
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccccc
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~ 338 (354)
......+++.+.+||.+||+.||++|||++++++.|+++......+..-.++|+.
T Consensus 240 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 240 -------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp -------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred -------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 0011125678999999999999999999999999999999988888888888875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.52 Aligned_cols=242 Identities=26% Similarity=0.437 Sum_probs=181.1
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCE----EEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCce
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDE----IAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~----vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
..++|++.+.||+|+||.||+|.+. +++. ||+|.+..... .....+. |++++++++... ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cc
Confidence 3578999999999999999999965 3444 57777754322 2222222 556667777654 48
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+++++|+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 8999999999999988 568889999999999999999999 9999999999999999999999999997655
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
............++..|+|||++.+..++.++|||||||++|+|++ |..||. +.........+..........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~---- 242 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSILEKGERLPQPP---- 242 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TCCGGGHHHHHHTTCCCCCCT----
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC--CCCHHHHHHHHHcCCCCCCCc----
Confidence 4433333333456778999999999999999999999999999999 999953 334334444333322111111
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.++..+.+||.+||+.||++|||++++++.|+.+...
T Consensus 243 ----------------------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 243 ----------------------------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----------------------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----------------------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1456789999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.81 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=193.8
Q ss_pred hhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|++. +++.||||++...... ....+ .|++++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 44578999999999999999999943 3668999999654322 11111 25667788888888
Q ss_pred ceEEEEEecCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeE
Q 048432 106 EKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPK 170 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~ 170 (354)
..++||||+++++|.+++ +++..+..++.||+.||.|||+++ |+||||||+||+++.++ .++
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999988 456788999999999999999999 99999999999999555 599
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..|| ......+....+..+
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf--~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEVLEFVTSG 302 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS--TTCCHHHHHHHHHTT
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcC
Confidence 999999875433222222233467889999999999999999999999999999998 88894 445555555555444
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
....+... ++..+.+||.+||+.||++|||+++|++.|+.+...
T Consensus 303 ~~~~~~~~--------------------------------~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRMDPPKN--------------------------------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCCCCTT--------------------------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCcc--------------------------------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 32221111 566789999999999999999999999999988753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.84 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=195.7
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc--------CCCEEEEEEecCCChh-hHHH-------------HHHHHHHhc
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSGQ-GLRE-------------LKNKLRLLG 99 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vavK~~~~~~~~-~~~~-------------~~~i~~~~~ 99 (354)
.+....++|++.+.||+|+||.||+|.+. +++.||+|++...... .... +.|++++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34455689999999999999999999863 4778999999765322 1111 225566777
Q ss_pred eeecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 158 (354)
++...+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 185 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCcc
Confidence 888889999999999999999987 356778999999999999999999 99999999
Q ss_pred CCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccc
Q 048432 159 SNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRT 237 (354)
Q Consensus 159 ~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~ 237 (354)
+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||. +.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~--~~ 263 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP--GI 263 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST--TC
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC--cC
Confidence 999999999999999999986654433222333456788999999988889999999999999999999 999953 33
Q ss_pred cchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 238 YSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+....+..+...... ..++..+.+||.+||+.+|++|||++++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 264 PVEELFKLLKEGHRMDKP--------------------------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp CHHHHHHHHHHTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCC--------------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 434444433332211100 015667899999999999999999999999
Q ss_pred HhhhhhhhcC
Q 048432 318 MLTNEAAALL 327 (354)
Q Consensus 318 ~L~~~~~~~~ 327 (354)
.|+++.....
T Consensus 312 ~L~~l~~~~~ 321 (334)
T 2pvf_A 312 DLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHhccc
Confidence 9999986544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=322.66 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=197.9
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHH--------HHHHHHhceeecCCc
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~--------~~i~~~~~~~~~~~~ 106 (354)
++...+....++|++.+.||+|+||.||+|.++++..||||++....... .++. .|++++++++.. +.
T Consensus 174 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 34456677788999999999999999999999888889999997654221 1111 255666777765 67
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++||||+.+++|.+++ +++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 89999999999999988 567788999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... ......++..|+|||++.+..++.++|||||||++|+|++ |..|| .+....+....+..+.... .
T Consensus 330 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~--~~~~~~~~~~~i~~~~~~~-~--- 402 (452)
T 1fmk_A 330 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVERGYRMP-C--- 402 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHTTCCCC-C---
T ss_pred cCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCC-C---
Confidence 5433211 1122345778999999999999999999999999999999 89994 4444445555444332111 0
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCC
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 332 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~ 332 (354)
+..+++.+.+||.+||+.||++|||+++|++.|+++.....+...+
T Consensus 403 ----------------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 403 ----------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp ----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ----------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 0116778899999999999999999999999999998666655444
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.48 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=189.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++.+.||+|+||.||+|.++ +++.||+|++....... ...+ .|++++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999976 58999999996543211 1111 256677888888999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
|++++.+..+. +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence 99875444443 678899999999999999999999 99999999999999999999999999976543322
Q ss_pred ccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......+|..|+|||++.+.. ++.++|||||||++|+|++|..|| +.+.+..+....+.+.....+...+........
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS-CCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC-cCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 122346789999999998766 799999999999999999988885 344445555555544444333332222111100
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.... .............+..++.+.+||.+||+.||++|||++|+++
T Consensus 236 ~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPY----PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCC----CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccc----ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000001111122235678899999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.36 Aligned_cols=246 Identities=21% Similarity=0.321 Sum_probs=193.3
Q ss_pred CCccccchhhhhc----------CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------
Q 048432 36 PLFSFSSVSTATN----------KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------ 92 (354)
Q Consensus 36 ~~~~~~~~~~~~~----------~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------ 92 (354)
+.++.+++....+ .|...+.||+|+||.||+|+++ +|+.||||++..........+.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 4456666655544 3778889999999999999976 6999999999765544333332
Q ss_pred HHHHHhceeecCCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 93 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
|++++++++...+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCc
Confidence 5556677888888999999999999999988 788999999999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
++|+|||++......... .....||..|+|||++.+..++.++||||||+++|+|++|..|| ...........+..
T Consensus 180 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf--~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY--FSDSPVQAMKRLRD 255 (321)
T ss_dssp EEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT--TTSCHHHHHHHHHH
T ss_pred EEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHhc
Confidence 999999998765443221 22357899999999999888999999999999999999999995 33443344433332
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
........ ....++.+.+||.+||+.||++|||++++++.
T Consensus 256 ~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 256 SPPPKLKN------------------------------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp SSCCCCTT------------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCcCc------------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22111000 00145678999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=309.21 Aligned_cols=236 Identities=20% Similarity=0.306 Sum_probs=192.7
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
..++|++.+.||+|+||.||+|.++ +++.||+|++........ +++ .|++++++++.+.+.+++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4589999999999999999999976 488899999975543221 111 2566778888899999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--CCCeEEeecccceeccCCcc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~~l~dfg~a~~~~~~~~ 185 (354)
|++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999988 678899999999999999999999 999999999999987 78999999999986554332
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....+++.|+|||++.+..++.++|||||||++|+|++|..| |...........+......++...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p--f~~~~~~~~~~~i~~~~~~~~~~~-------- 226 (321)
T 1tki_A 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEA-------- 226 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT--TCCSSHHHHHHHHHHTCCCCCHHH--------
T ss_pred ---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCC--CcCCCHHHHHHHHHcCCCCCChhh--------
Confidence 2234689999999999888889999999999999999999999 455555556665555444332211
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+..+.+||.+||..||++|||++|+++.
T Consensus 227 ---------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 ---------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11156778999999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=309.51 Aligned_cols=241 Identities=23% Similarity=0.379 Sum_probs=186.9
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCE----EEEEEecCCChh--------hHH-----HHHHHHHHhceeecCCce
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDE----IAVKRLSGRSGQ--------GLR-----ELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~----vavK~~~~~~~~--------~~~-----~~~~i~~~~~~~~~~~~~ 107 (354)
..++|++.+.||+|+||.||+|.+. +++. ||+|.+...... ... .+.|++++++++. ++..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 3578999999999999999999965 3444 788887543211 111 2347788888876 4678
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++||||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999887 567789999999999999999999 9999999999999999999999999998665
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
............++..|+|||++.+..++.++|||||||++|+|++ |..||. +.........+..+........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~--- 241 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA--GLRLAEVPDLLEKGERLAQPQI--- 241 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TSCTTHHHHHHHTTCBCCCCTT---
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc--ccCHHHHHHHHHcCCCCCCCCc---
Confidence 4443333344567789999999999999999999999999999999 999954 3333344443333322111111
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
++..+.++|.+||+.||++|||++++++.|+.+..
T Consensus 242 -----------------------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 242 -----------------------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -----------------------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -----------------------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 34456789999999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.80 Aligned_cols=233 Identities=24% Similarity=0.307 Sum_probs=188.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++..... ...... .+++++++++.+.+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 3578999999999999999999976 599999999965321 111111 145566778888899999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
||||+++++|..++ +++..++.++.||+.||.|||+++ |+||||||+||+++.+|.++|+|||++.......
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999998887 678899999999999999999999 9999999999999999999999999987532221
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..|| .+.+.......+......+|.
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf--~~~~~~~~~~~i~~~~~~~p~--------- 226 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPR--------- 226 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCT---------
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCC--CCCCHHHHHHHHHcCCCCCCC---------
Confidence 1123357899999999999989999999999999999999999994 445555555555444333221
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..++.+.+||.+||+.||++|| +++++++.
T Consensus 227 ------------------------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 227 ------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------------------------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------------------------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1456788999999999999999 89999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=303.99 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=181.0
Q ss_pred ccccCCCCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCC--hhhHHHHHHHH-----------
Q 048432 29 KKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--GQGLRELKNKL----------- 95 (354)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--~~~~~~~~~i~----------- 95 (354)
.......+.-....+....++|++.+.||+|+||.||+|++. ..||+|++.... ......+.+++
T Consensus 5 ~~~~~~~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (289)
T 3og7_A 5 HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82 (289)
T ss_dssp -------------CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccccCCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE
Confidence 333334444455566777899999999999999999999864 359999997543 23333444443
Q ss_pred -HHhceeecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 96 -RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 96 -~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
+++++ ...+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 83 v~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp CCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEee-ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCC
Confidence 34443 3456789999999999998887 678889999999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~ 245 (354)
++|+|||++................++..|+|||++. +..++.++||||||+++|+|++|..||.... ........
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~ 237 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEM 237 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHH
Confidence 9999999987554332222233356899999999986 5668899999999999999999999964322 22223333
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+..+....+... ....+++.+.+||.+||+.+|++|||++++++.|+++..
T Consensus 238 ~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 238 VGRGSLSPDLSK----------------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHTSCCCCTTS----------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hcccccCcchhh----------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 322222111110 001156789999999999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=302.32 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=187.2
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH--HHH--------HHHHHHhceeecCCceEEEEEecC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL--REL--------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~--~~~--------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
..++|++.+.||+|+||.||+|++. ++.||+|++........ .++ .|++++++++. +..++||||++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 3578999999999999999999985 78899999975432211 111 14455555554 45799999999
Q ss_pred CCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHh---cCCCCeEeCCCCCCCEEEcCCCC-eEEeecccceeccCC
Q 048432 116 NKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQ---YSRVRIIHRDLKVSNILLDKDMN-PKISDFGIARICRGN 183 (354)
Q Consensus 116 ~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~---~~~~~i~H~dlkp~Nill~~~~~-~~l~dfg~a~~~~~~ 183 (354)
+++|.+++ ++...+..++.|+++||.|||+ .+ |+||||||+||+++.++. ++|+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999998 4577889999999999999999 66 999999999999998887 799999998654322
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
. ....++..|+|||++.+..++.++||||||+++|+|++|..||.............+..+.....
T Consensus 160 ~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (307)
T 2eva_A 160 M-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------- 225 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC---------
T ss_pred c-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc---------
Confidence 1 22357899999999999899999999999999999999999975433333222222222111100
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCcccccccccc
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVRNTVTS 343 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~~~~~~ 343 (354)
...++..+.+||.+||+.||++|||++++++.|+++......... +..+......+
T Consensus 226 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~-~~~~~~~~~~~ 281 (307)
T 2eva_A 226 -----------------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE-PLQYPCQHSLP 281 (307)
T ss_dssp -----------------------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS-CCCCEECCCCC
T ss_pred -----------------------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC-ccccccccccC
Confidence 011566789999999999999999999999999999865544433 33343333333
Q ss_pred cC
Q 048432 344 TS 345 (354)
Q Consensus 344 ~~ 345 (354)
+.
T Consensus 282 ~~ 283 (307)
T 2eva_A 282 PG 283 (307)
T ss_dssp CT
T ss_pred CC
Confidence 33
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.18 Aligned_cols=234 Identities=22% Similarity=0.270 Sum_probs=189.3
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---H-------------HHHHHHHHhceeecCC
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---R-------------ELKNKLRLLGCCIDKD 105 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~-------------~~~~i~~~~~~~~~~~ 105 (354)
.....++|++.+.||+|+||.||+|+++ +++.||+|++........ . .+.+++++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3456689999999999999999999976 488999999965432111 1 1236677788889999
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+|+||||+.|++|..++ +++..++.++.||+.||.|||+++ |+||||||+||+++.+|.++|+|||++...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998887 678889999999999999999999 999999999999999999999999998753
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..| |.+.+..++...+.......+..
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P--f~~~~~~~~~~~i~~~~~~~~~~---- 261 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPN---- 261 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT--TCCSBHHHHHHHHHHSCCCCCSS----
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCC--CCCCCHHHHHHHHHhcccCCCCC----
Confidence 2221 122345789999999999999999999999999999999999999 45555556666655443332211
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
.+..+.+||.+||+.||++||++.+.+
T Consensus 262 -----------------------------~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 262 -----------------------------ITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -----------------------------SCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -----------------------------CCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 456788999999999999999985433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=311.86 Aligned_cols=268 Identities=25% Similarity=0.343 Sum_probs=185.5
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH-----------HHHHHhcee-----ecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK-----------NKLRLLGCC-----IDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~-----------~i~~~~~~~-----~~~~~ 106 (354)
.....++|++.+.||+|+||.||+|+. +++.||+|++............ |++++++.+ .....
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 345568999999999999999999987 5899999999765443332222 334444322 22335
Q ss_pred eEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhc---------CCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 107 KILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQY---------SRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~---------~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
+++||||+++++|.+++ .++..+..++.||+.||.|||+. + |+||||||+||+++.++.++|+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence 68999999999999998 67788899999999999999999 8 99999999999999999999999
Q ss_pred cccceeccCCcc------ccccccccCcccccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCcccccch
Q 048432 174 FGIARICRGNEL------QANTGRIVGTYRYMSPEYAIQ-------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240 (354)
Q Consensus 174 fg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~ 240 (354)
||++........ ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.. .....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~-~~~~~ 242 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP-GESVP 242 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST-TSCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC-ccchh
Confidence 999976543221 111223468999999999876 3456789999999999999999877422 21111
Q ss_pred hhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCch--hHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSN--DIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.............+.... ................ .....+++.+.+||.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFED----------MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CCCCTTHHHHCSSCCHHH----------HHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhcccCCCchHHH----------HHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 111111111111110000 0000000000000000 0011267789999999999999999999999999
Q ss_pred hhhhhhh
Q 048432 319 LTNEAAA 325 (354)
Q Consensus 319 L~~~~~~ 325 (354)
|+++...
T Consensus 313 L~~ll~~ 319 (336)
T 3g2f_A 313 MAELMMI 319 (336)
T ss_dssp HHHHHHC
T ss_pred HHHHHHH
Confidence 9999854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.59 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=195.6
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEE------cCCCEEEEEEecCCChh-hHHH-------------HHHHHHHh
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVL------KNGDEIAVKRLSGRSGQ-GLRE-------------LKNKLRLL 98 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vavK~~~~~~~~-~~~~-------------~~~i~~~~ 98 (354)
....+....++|++.+.||+|+||.||+|.+ .+++.||+|++...... .... +.|+++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 3445666778999999999999999999985 24678999999765432 1111 22556667
Q ss_pred ceeecCCceEEEEEecCCCCHhHHH-----------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 048432 99 GCCIDKDEKILIYEYMPNKSLDFFL-----------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155 (354)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~~-----------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 155 (354)
+++...+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 170 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRD 170 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 7888888999999999999999887 356788999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCc
Q 048432 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGF 234 (354)
Q Consensus 156 lkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~ 234 (354)
|||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999976655433223333456788999999999999999999999999999998 9999543
Q ss_pred ccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 235 YRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
.... ......+......... ...+..+.+||.+||+.||++|||+++
T Consensus 251 ~~~~-~~~~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 251 MPVD-SKFYKMIKEGFRMLSP--------------------------------EHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp CCSS-HHHHHHHHHTCCCCCC--------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccch-hHHHHHhccCCCCCCc--------------------------------ccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 3221 1122222111111000 015677899999999999999999999
Q ss_pred HHHHhhhhhhh
Q 048432 315 VVSMLTNEAAA 325 (354)
Q Consensus 315 il~~L~~~~~~ 325 (354)
+++.|+++...
T Consensus 298 ll~~L~~~~~~ 308 (313)
T 1t46_A 298 IVQLIEKQISE 308 (313)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.80 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=194.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
....++|++.+.||+|+||.||+|.+.+++.||+|++........ ++. .|++++++++.+.+..++|||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 345689999999999999999999998888999999976543221 111 255667788888889999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+++++|.+++ +++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999988 578889999999999999999999 999999999999999999999999998754432211
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
......++..|+|||++.+..++.++|+||||+++|+|++ |..|| ...........+..+.......
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~--~~~~~~~~~~~i~~~~~~~~~~--------- 228 (267)
T 3t9t_A 161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDISTGFRLYKPR--------- 228 (267)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHHHTTCCCCCCT---------
T ss_pred -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCC--CCCCHHHHHHHHhcCCcCCCCc---------
Confidence 1122356778999999998899999999999999999999 88885 4444444444443332211110
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..+..+.+++.+||+.||++|||++++++.|+++..
T Consensus 229 -----------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 -----------------------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 145678899999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.32 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=194.8
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHH------------HHHHHHhceeecCCceE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
....++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+ .||+++++++.+.+..+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 345689999999999999999999965 5889999999765321 11112 25667788889999999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCCeEEeecccceec
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGIARIC 180 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~~l~dfg~a~~~ 180 (354)
+|||||.+++|.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.++|+|||++...
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999998887 688899999999999999999999 99999999999998 4678999999999765
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|.+| |.+.+.......+..+...++...+..
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~P--f~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP--FWDEDQHRLYQQIKAGAYDFPSPEWDT 239 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS--CCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCC--CCCccHHHHHHHHHhCCCCCCcccccc
Confidence 443221 2235789999999999998999999999999999999999999 566666677777766665554433211
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.++.+.+||.+||+.||++|||++|+++.
T Consensus 240 -----------------------------~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 240 -----------------------------VTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----------------------------SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----------------------------CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 46678899999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.95 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=194.5
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceee
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCI 102 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~ 102 (354)
+.........++|++.+.||+|+||.||+|.++ +|+.||+|++..... .....+ .|++++++++.
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 334444556789999999999999999999975 589999999975432 222222 25667778888
Q ss_pred cCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeEEeec
Q 048432 103 DKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDF 174 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~l~df 174 (354)
+.+..++||||+.+++|.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeec
Confidence 899999999999999998887 678899999999999999999999 99999999999998654 5999999
Q ss_pred ccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+| |.+.+.......+..+...++
T Consensus 176 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P--f~~~~~~~~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 176 GLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--FWDEDQHRLYAQIKAGAYDYP 250 (362)
T ss_dssp TTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCCCC
T ss_pred CcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC--CCCCCHHHHHHHHHhCCCCCC
Confidence 99976543322 2235789999999999998999999999999999999999999 555555666666665555443
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+. ..++.+.+||.+||+.||++|||++++++.
T Consensus 251 ~~~~~-----------------------------~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEWD-----------------------------TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGGG-----------------------------GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccc-----------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 32211 146678999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=304.38 Aligned_cols=266 Identities=20% Similarity=0.229 Sum_probs=194.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCC--ce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKD--EK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~--~~ 107 (354)
....++|++.+.||+|+||.||+|.+.. ++.||+|++...... ..... .|++++++++.... ..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 4556899999999999999999999764 999999999754321 11111 15556666666544 78
Q ss_pred EEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCCeEEeecc
Q 048432 108 ILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFG 175 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~~l~dfg 175 (354)
++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||++ +.++.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999998 577889999999999999999999 9999999999999 777889999999
Q ss_pred cceeccCCccccccccccCcccccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--cchhhhhh
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAI--------QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT--YSFTLLGY 245 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~--~~~~~~~~ 245 (354)
++......... ....++..|+|||++. +..++.++|||||||++|+|++|..||..... ...+....
T Consensus 162 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 162 AARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99765543322 2246899999999886 46789999999999999999999999643222 22333333
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+..+............... ..................+..+.+||.+||+.||++|||++|+++...+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENG--------PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTC--------CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCC--------ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 3333221111000000000 000000111112334558889999999999999999999999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.99 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=184.7
Q ss_pred cCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||+|+||.||+|++.+|+.||+|++...... ..+++ .|++++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 689999999999999999999988999999998654321 11222 2667788888889999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+.+ +|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 986 777776 567889999999999999999999 99999999999999999999999999875443221
Q ss_pred ccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||++.+. .++.++|||||||++|+|++|..|| .+....+....+.+.....+...++.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 11224678999999998764 5899999999999999999999995 44444444444433322222222111111100
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...... ............++.+.+||.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVY----EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCC----CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccc----cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000111125677889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=306.49 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=186.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhh---HHHHH------------HHHHHhceeecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQG---LRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~---~~~~~------------~i~~~~~~~~~~~~ 106 (354)
.....++|++.+.||+|+||.||+|++ .+++.||+|++....... ...+. |++++++++.....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 345668999999999999999999996 468899999997653222 22232 55566666654443
Q ss_pred ----eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 107 ----KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 107 ----~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.|+||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 39999999999999988 678889999999999999999999 999999999999999999999999999
Q ss_pred eeccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 178 RICRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 178 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
......... .......|+..|+|||++.+..++.++|||||||++|+|++|..|| .+.................+..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf--~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPIPPSA 241 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHCCCCCHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHhcCCCCCccc
Confidence 765433221 1222346899999999999999999999999999999999999995 4344333333322222111110
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-HHHHHHHhhhhhhhcCCCCCCCcc
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-MNDVVSMLTNEAAALLPPKQPAFS 335 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~il~~L~~~~~~~~~~~~~~~~ 335 (354)
. ....+..+.+||.+||+.||++||+ ++++.+.|...... .++..|...
T Consensus 242 ~-----------------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~-~~~~~~~~~ 291 (311)
T 3ork_A 242 R-----------------------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG-EPPEAPKVL 291 (311)
T ss_dssp H-----------------------------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT-CCCSSCCCC
T ss_pred c-----------------------------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC-CCCCCCccc
Confidence 0 0115677899999999999999995 55566677776643 344444433
Q ss_pred c
Q 048432 336 Y 336 (354)
Q Consensus 336 ~ 336 (354)
.
T Consensus 292 ~ 292 (311)
T 3ork_A 292 T 292 (311)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=304.64 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=191.7
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHH-----------HHHHHHHhceeecC--
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRE-----------LKNKLRLLGCCIDK-- 104 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~-----------~~~i~~~~~~~~~~-- 104 (354)
.+........++|++.+.||+|+||.||+|++. ++.||||++.......... +.|++++++++...
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 444555677789999999999999999999985 8999999996554332211 22666677777666
Q ss_pred --CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhc--------CCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 105 --DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQY--------SRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 105 --~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~--------~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
...++||||+++++|.+++ +++..+..++.|++.||.|||+. + |+||||||+||+++.++.++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEE
Confidence 6789999999999999998 77889999999999999999998 8 99999999999999999999
Q ss_pred EeecccceeccCCcccc--ccccccCcccccCccccccCCCCch------hhHHHHHHHHHHHHhCCCC----------C
Q 048432 171 ISDFGIARICRGNELQA--NTGRIVGTYRYMSPEYAIQGIFSIK------SDVFSFGVLLLKIVSGKKT----------T 232 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwSlG~~l~~ll~g~~p----------~ 232 (354)
|+|||++.......... ......||..|+|||++.+...... +|||||||++|+|++|..| |
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997554332211 1223468999999999987765554 9999999999999999544 3
Q ss_pred Ccccccc--hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCch-hHHHHHHHHHHHHHhhccccCCCCC
Q 048432 233 GFYRTYS--FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSN-DIVCLCILRYVNIALLCVQESADDR 309 (354)
Q Consensus 233 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~R 309 (354)
....... ............. ...... .....+++.+.+||.+||+.||++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 316 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKL--------------------------RPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCC--------------------------CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGS
T ss_pred hhhcCCCCchhhhHHHHhhhcc--------------------------CccccccchhhHHHHHHHHHHHHhhhhChhhC
Confidence 2111110 0000100000000 000011 0112488899999999999999999
Q ss_pred CCHHHHHHHhhhhhhhc
Q 048432 310 PTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 310 ps~~~il~~L~~~~~~~ 326 (354)
||++++++.|+++....
T Consensus 317 ps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 317 LTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHHHhhc
Confidence 99999999999988543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.36 Aligned_cols=245 Identities=29% Similarity=0.475 Sum_probs=183.8
Q ss_pred hhhhcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCc
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~ 106 (354)
....++|.+.+.||+|+||.||+|+++ ++..||||++..... .....+. |++++++++...+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 345579999999999999999999965 577899999976532 2222222 55667788888889
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999998 677889999999999999999999 999999999999999999999999998765
Q ss_pred cCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 181 RGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..|| ......+....+..+....+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~--~~~~~~~~~~~i~~~~~~~~~~-- 273 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEMSNQDVIKAVDEGYRLPPPM-- 273 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT--TTCCHHHHHHHHHTTEECCCCT--
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCCCCc--
Confidence 433211 11111234678999999999999999999999999999998 99994 4444444444443332211111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.++..+.+||.+||+.||++|||++++++.|+++...
T Consensus 274 ------------------------------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 274 ------------------------------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------------------------------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------------------------------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1567789999999999999999999999999998643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.70 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=191.0
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-----HH---------HHHHHHHHhcee
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-----LR---------ELKNKLRLLGCC 101 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-----~~---------~~~~i~~~~~~~ 101 (354)
.+....++|++.+.||+|+||.||+|.+. .+..||+|++....... .+ .+.|++++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556789999999999999999999962 35679999997542211 11 123556677888
Q ss_pred ecCCceEEEEEecCCCCHhHHH----------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL----------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIH 153 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~----------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H 153 (354)
...+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 8889999999999999999887 256778999999999999999999 999
Q ss_pred CCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 048432 154 RDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTT 232 (354)
Q Consensus 154 ~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~ 232 (354)
+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999976544333223333456788999999999999999999999999999998 99996
Q ss_pred CcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH
Q 048432 233 GFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM 312 (354)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 312 (354)
...... ......+..+. ..+. +..+++.+.+||.+||+.||++|||+
T Consensus 276 ~~~~~~-~~~~~~~~~~~-~~~~-------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 276 PGIPVD-ANFYKLIQNGF-KMDQ-------------------------------PFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp TTCCCS-HHHHHHHHTTC-CCCC-------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCcH-HHHHHHHhcCC-CCCC-------------------------------CCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 433221 12222222111 1100 00146778999999999999999999
Q ss_pred HHHHHHhhhhhhhc
Q 048432 313 NDVVSMLTNEAAAL 326 (354)
Q Consensus 313 ~~il~~L~~~~~~~ 326 (354)
.++++.|+.+....
T Consensus 323 ~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 323 PNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHHHHHC---
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999987543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=311.80 Aligned_cols=252 Identities=18% Similarity=0.221 Sum_probs=184.2
Q ss_pred hhhcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCChhhHHHH-----------------------HHHHHH
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQGLREL-----------------------KNKLRL 97 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~~~~~~~~-----------------------~~i~~~ 97 (354)
...++|++.+.||+|+||.||+|.+. .+..||+|++.........+. .|++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 34679999999999999999999975 578899999976543221111 144556
Q ss_pred hceeec----CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-
Q 048432 98 LGCCID----KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM- 167 (354)
Q Consensus 98 ~~~~~~----~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~- 167 (354)
++++.. ....++||||+ +++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 666665 67899999999 99999988 678999999999999999999999 99999999999999887
Q ss_pred -CeEEeecccceeccCCccc-----cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchh
Q 048432 168 -NPKISDFGIARICRGNELQ-----ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT 241 (354)
Q Consensus 168 -~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~ 241 (354)
.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999765432211 1113357899999999999989999999999999999999999996432222222
Q ss_pred hhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhh
Q 048432 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321 (354)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~ 321 (354)
............+.......+ ...+++.+.++|.+||+.||++|||+++|++.|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAP------------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSC------------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHHHhhcccccHHHHhhcc------------------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 222211111111111000000 00156789999999999999999999999999998
Q ss_pred hhh
Q 048432 322 EAA 324 (354)
Q Consensus 322 ~~~ 324 (354)
...
T Consensus 326 ~~~ 328 (345)
T 2v62_A 326 HGI 328 (345)
T ss_dssp TCC
T ss_pred cCC
Confidence 764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.11 Aligned_cols=265 Identities=38% Similarity=0.574 Sum_probs=198.8
Q ss_pred CCCCccccchhhhhcCcccc------ceecccCceeEEEEEEcCCCEEEEEEecCCC----hhhHHHHH-----------
Q 048432 34 QLPLFSFSSVSTATNKFSDA------NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS----GQGLRELK----------- 92 (354)
Q Consensus 34 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~----~~~~~~~~----------- 92 (354)
....+++.++....++|... +.||+|+||.||+|.+ +++.||+|++.... ......+.
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34567777777777777665 9999999999999997 58899999986532 11122222
Q ss_pred -HHHHHhceeecCCceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 048432 93 -NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL 163 (354)
Q Consensus 93 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 163 (354)
|++++++++.+.+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 5566777888888999999999999999887 567889999999999999999999 9999999999999
Q ss_pred cCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhh
Q 048432 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLL 243 (354)
Q Consensus 164 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~ 243 (354)
+.++.++|+|||++................++..|+|||++.+ .++.++|+||||+++|+|++|..||..... ....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS--SSBT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc--hHHH
Confidence 9999999999999876554332222334578999999998764 578999999999999999999999643322 2222
Q ss_pred hhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 244 GYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
..+............ ... .......+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~--------------~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIE--------------DYI----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHH--------------HHS----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhh--------------hhc----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 221111110000000 000 00011223447889999999999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.80 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=198.4
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCc
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~ 106 (354)
++..+....++|++.+.||+|+||.||+|.++. +..||+|++........ .+. .|++++++++...+.
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 345667788999999999999999999999764 88899999976543221 111 255667788888899
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++||||+.+++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999988 677889999999999999999999 99999999999999999999999999875
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||. ..+.......+.........
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~--~~~~~~~~~~~~~~~~~~~~--- 234 (288)
T 3kfa_A 161 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKDYRMERP--- 234 (288)
T ss_dssp SCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST--TCCGGGHHHHHHTTCCCCCC---
T ss_pred ccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHhccCCCCCC---
Confidence 5433321 2223456778999999999999999999999999999999 888853 33333333333222111100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..+++.+.+||.+||+.||++|||++++++.|+++..+
T Consensus 235 -----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 235 -----------------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -----------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11567789999999999999999999999999987743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.72 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=185.5
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC---hhhHHHHH------------HHHHHhceeecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS---GQGLRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~---~~~~~~~~------------~i~~~~~~~~~~~~ 106 (354)
.....++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+. |++++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 3445678999999999999999999964 69999999997532 22222222 45566778888899
Q ss_pred eEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 107 KILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.++||||+++++|.+++ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 99999999999999887 467788999999999999999999 999999999999999999999999998
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
......... .....++..|+|||++.+..++.++|+||||+++|+|++|..||.............+....... ..
T Consensus 184 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 259 (310)
T 2wqm_A 184 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--LP 259 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC--CC
T ss_pred eeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC--Cc
Confidence 754432211 12246788999999999989999999999999999999999996443333333333333222111 00
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCC
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 331 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~ 331 (354)
. ...++.+.+||.+||+.||++|||++++++.|+++.+....|+.
T Consensus 260 ~-----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 260 S-----------------------------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp T-----------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred c-----------------------------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0 01566789999999999999999999999999999987766653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=312.77 Aligned_cols=235 Identities=25% Similarity=0.354 Sum_probs=188.1
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhH-H---------HHHHHHHHhceeecC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGL-R---------ELKNKLRLLGCCIDK 104 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~-~---------~~~~i~~~~~~~~~~ 104 (354)
......++|++.+.||+|+||.||+|+++ +|+.||+|++..... ... . .+.+++++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 34456789999999999999999999976 588999999965321 111 1 123556677888899
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+.+|+||||+++|+|..++ +++..+..++.||+.||.|||+++ |+||||||+||+++.+|.++|+|||++..
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999887 678899999999999999999999 99999999999999999999999999875
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
...... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..|| .+.+..++...+.......|..
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf--~~~~~~~~~~~i~~~~~~~p~~--- 240 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRW--- 240 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCTT---
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCC--CCCCHHHHHHHHHhCCCCCCcc---
Confidence 332211 123357899999999999989999999999999999999999994 5555556666555444333211
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN-DVV 316 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-~il 316 (354)
.++.+.+||.+||+.||++||++. +++
T Consensus 241 ------------------------------~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 241 ------------------------------LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------------------------------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------------------------------cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 456788999999999999999997 665
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.96 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=187.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc-----CCCEEEEEEecCCChhhHHHHHHH------------HHHhceeec--CC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQGLRELKNK------------LRLLGCCID--KD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~~~~~~~~~i------------~~~~~~~~~--~~ 105 (354)
...++|++.+.||+|+||.||+|++. +++.||+|++..........+.++ +++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 35689999999999999999999842 588999999987765555444444 344445432 35
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 589999999999999988 677889999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... .......++..|+|||++.+..++.++||||||+++|+|++|..|+............. . +...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~---~----~~~~- 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN---D----KQGQ- 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT---T----CCTH-
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC---c----cccc-
Confidence 5433221 11222346778999999999999999999999999999999998864332111100000 0 0000
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
..............+...+..+++.+.+||.+||+.||++|||+++++++|+++....
T Consensus 236 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 236 ----------MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp ----------HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----------hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0000000000000011112226788999999999999999999999999999998554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.70 Aligned_cols=245 Identities=20% Similarity=0.312 Sum_probs=181.6
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChh-hHHHHH------------HHHHHhceeec
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCID 103 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~ 103 (354)
.++....++|++.+.||+|+||.||+|.+.. +..||+|++...... ....+. |++++++++ .
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 3455667899999999999999999999653 456999998764322 222222 445566666 4
Q ss_pred CCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 104 KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
++..++||||+.+++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence 56789999999999999987 577889999999999999999999 999999999999999999999999998
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..|| .+....+....+........
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf--~~~~~~~~~~~i~~~~~~~~-- 238 (281)
T 1mp8_A 164 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGERLPM-- 238 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT--TTCCGGGHHHHHHTTCCCCC--
T ss_pred cccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC--CcCCHHHHHHHHHcCCCCCC--
Confidence 765443221 1122345678999999998899999999999999999996 88885 33444444444433221110
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+..+++.+.++|.+||+.||++|||++++++.|+++..
T Consensus 239 ------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 239 ------------------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01156788999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.84 Aligned_cols=229 Identities=26% Similarity=0.356 Sum_probs=189.1
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~l 109 (354)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++..... ..... +.|++++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3578999999999999999999976 599999999965321 11111 1256677888888999999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++.......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 99999999999988 678889999999999999999999 9999999999999999999999999997644322
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
....||+.|+|||++.+..++.++|+|||||++|+|++|..|| .+.+.......+......+|..
T Consensus 161 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf--~~~~~~~~~~~i~~~~~~~p~~-------- 225 (318)
T 1fot_A 161 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPF-------- 225 (318)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT--CCSSHHHHHHHHHHCCCCCCTT--------
T ss_pred -----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCCC--------
Confidence 2347899999999999999999999999999999999999994 4555555555555444333211
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
.++.+.+||.+||+.||++|| +++++++
T Consensus 226 -------------------------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 -------------------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------------------------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------------------------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 456788999999999999999 8999885
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=307.77 Aligned_cols=243 Identities=23% Similarity=0.251 Sum_probs=182.4
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH--HH--------HHHHHHHhceeecCCceE
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--RE--------LKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--~~--------~~~i~~~~~~~~~~~~~~ 108 (354)
.+......++|++.+.||+|+||.||+|+++ +++.||+|++........ ++ +.|++++++++...+..+
T Consensus 45 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 45 GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SSBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 3445667789999999999999999999976 488999999976432111 11 236778888999999999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCCeEEeecccceec
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARIC 180 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~~l~dfg~a~~~ 180 (354)
+||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999988 678899999999999999999999 999999999999975 889999999998754
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.... ........+.......+....
T Consensus 202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~i~~~~~~~~~~~~-- 275 (349)
T 2w4o_A 202 EHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-GDQFMFRRILNCEYYFISPWW-- 275 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-CHHHHHHHHHTTCCCCCTTTT--
T ss_pred Ccccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-ccHHHHHHHHhCCCccCCchh--
Confidence 43321 123468999999999999899999999999999999999999963222 222233444333322221110
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+..+.+||.+||+.||++|||+.++++.
T Consensus 276 ---------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 ---------------------------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------------------------hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0146678899999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=307.25 Aligned_cols=245 Identities=13% Similarity=0.081 Sum_probs=192.5
Q ss_pred cccchhhhhcCccccceecccCceeEEEEE------EcCCCEEEEEEecCCChhhHHHHH------------HHHHHhce
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGV------LKNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGC 100 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~------~~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~ 100 (354)
+..++....++|.+.+.||+|+||.||+|. ...++.||+|++............ ++++++++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 345566677899999999999999999994 346889999999876544332222 44556677
Q ss_pred eecCCceEEEEEecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-----
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK----- 165 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----- 165 (354)
+...+..++|||||++|+|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 77889999999999999999988 567889999999999999999999 999999999999998
Q ss_pred ------CCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Q 048432 166 ------DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS 239 (354)
Q Consensus 166 ------~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~ 239 (354)
++.++|+|||++................||..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976543332333344578999999999999999999999999999999999999953221111
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCC-CCHHHHHHH
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR-PTMNDVVSM 318 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-ps~~~il~~ 318 (354)
.. + ........ .++.+.+++..||+.+|.+| |+++++.+.
T Consensus 293 ~~----~---~~~~~~~~--------------------------------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 CK----P---EGLFRRLP--------------------------------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp EE----E---CSCCTTCS--------------------------------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ee----e---chhccccC--------------------------------cHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 00 0 00000000 35667889999999999998 688999999
Q ss_pred hhhhhhh
Q 048432 319 LTNEAAA 325 (354)
Q Consensus 319 L~~~~~~ 325 (354)
|++....
T Consensus 334 l~~~l~~ 340 (365)
T 3e7e_A 334 LKKVFQQ 340 (365)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=304.52 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=194.5
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HHHH-------------HHHHHH
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LREL-------------KNKLRL 97 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~~~-------------~~i~~~ 97 (354)
+..+.+....++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+ .|++++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 455667777899999999999999999999842 46789999997654322 1122 244455
Q ss_pred hceeecC-CceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 048432 98 LGCCIDK-DEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155 (354)
Q Consensus 98 ~~~~~~~-~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 155 (354)
++++... ...++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 5666554 4589999999999999988 467788999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCc
Q 048432 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGF 234 (354)
Q Consensus 156 lkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~ 234 (354)
|||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999976544332223333466889999999999999999999999999999998 9999643
Q ss_pred ccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 235 YRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
.... ......+..+...... ...++.+.++|.+||+.||++|||+++
T Consensus 254 ~~~~-~~~~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~e 300 (316)
T 2xir_A 254 VKID-EEFCRRLKEGTRMRAP--------------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSE 300 (316)
T ss_dssp CCCS-HHHHHHHHHTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cchh-HHHHHHhccCccCCCC--------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 3222 2222222222111000 014567899999999999999999999
Q ss_pred HHHHhhhhhhh
Q 048432 315 VVSMLTNEAAA 325 (354)
Q Consensus 315 il~~L~~~~~~ 325 (354)
+++.|+++...
T Consensus 301 ll~~L~~~~~~ 311 (316)
T 2xir_A 301 LVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=309.45 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=191.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
...++|++.+.||+|+||.||+|.++ +|+.||+|++..........+. |++++++++.+....++||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 44579999999999999999999976 5899999999766443333332 5566777888889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--CCCeEEeecccceeccCC
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNPKISDFGIARICRGN 183 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~~l~dfg~a~~~~~~ 183 (354)
||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999887 678899999999999999999999 999999999999974 467999999999865443
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. .....+|..|+|||++.+..++.++|||||||++|+|++|..|| .+.+..+....+.......+.....
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf--~~~~~~~~~~~i~~~~~~~~~~~~~---- 275 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF--AGEDDLETLQNVKRCDWEFDEDAFS---- 275 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS--CCSSHHHHHHHHHHCCCCCCSSTTT----
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCC--CCCCHHHHHHHHHhCCCCCCccccc----
Confidence 22 12246899999999999989999999999999999999999995 4455555555554443332221110
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++++++.
T Consensus 276 -------------------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 -------------------------SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -------------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -------------------------cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 146678999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=304.01 Aligned_cols=237 Identities=25% Similarity=0.322 Sum_probs=190.5
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~------------~~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+ .|++++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35578999999999999999999976 5899999998654321 11122 25567778888889
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----CeEEeeccc
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGI 176 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~~l~dfg~ 176 (354)
..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++ .++|+|||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999998 788999999999999999999999 99999999999998877 799999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+........ .....|++.|+|||++.+..++.++|||||||++|+|++|..|| .+....+....+.......+.
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf--~~~~~~~~~~~~~~~~~~~~~- 238 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF--LGDTKQETLANVSAVNYEFED- 238 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS--CCSSHHHHHHHHHHTCCCCCH-
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC--CCCCHHHHHHHHHhcCCCcCc-
Confidence 976543322 22346899999999999889999999999999999999999995 444444444444333322211
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
......+..+.+||.+||+.||++|||++++++.
T Consensus 239 ----------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 239 ----------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111256778999999999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.86 Aligned_cols=240 Identities=30% Similarity=0.466 Sum_probs=179.9
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh----HHHH------------HHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG----LREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~----~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|.+. ++.||+|++....... ...+ .|++++++++...+..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 34679999999999999999999985 8899999986543221 1122 25566778888889999
Q ss_pred EEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--------CCCeEEeeccc
Q 048432 109 LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--------DMNPKISDFGI 176 (354)
Q Consensus 109 lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--------~~~~~l~dfg~ 176 (354)
+||||+++++|.+++ +++..+..++.|++.||.|||+.+..+|+|+||||+||+++. ++.++|+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999988 788899999999999999999987444779999999999986 77899999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+........ ....++..|+|||++.+..++.++||||||+++|+|++|..|| .+.........+.......+..
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 163 AREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTT--TTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHhhhcCCCCCCCC
Confidence 875443322 1246789999999999999999999999999999999999995 3333333333332222211111
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
..+++.+.++|.+||+.||++|||++++++.|+++
T Consensus 237 -------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 -------------------------------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------------------------------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11567789999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=308.62 Aligned_cols=239 Identities=21% Similarity=0.229 Sum_probs=191.3
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH---------HHHHHHHhceeecCCceEEEEEec
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE---------LKNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~---------~~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
...++|++.+.||+|+||.||+|.++ +|+.||+|++........++ +.|++++++++.+.+..|+|||||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 35678999999999999999999976 58899999997654332222 336777888999999999999999
Q ss_pred CCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC----CCeEEeecccceeccCCcc
Q 048432 115 PNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD----MNPKISDFGIARICRGNEL 185 (354)
Q Consensus 115 ~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~~l~dfg~a~~~~~~~~ 185 (354)
.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||++... +.++|+|||++........
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999887 688899999999999999999999 9999999999998543 3499999999976543321
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccc-ccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYR-TYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
......+|..|+|||++.+..++.++|+|||||++|+|++|..||.... ....++...+..+....+...+.
T Consensus 176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~----- 248 (342)
T 2qr7_A 176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN----- 248 (342)
T ss_dssp --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT-----
T ss_pred --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc-----
Confidence 1223467999999999988888999999999999999999999975432 23444555555544433322111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..++.+.+||.+||+.||++|||++++++
T Consensus 249 ------------------------~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 249 ------------------------SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------------------------cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 14667899999999999999999999886
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=305.70 Aligned_cols=232 Identities=23% Similarity=0.364 Sum_probs=184.7
Q ss_pred hhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCCh-------hhHHHH--------HHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSG-------QGLREL--------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~-------~~~~~~--------~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+++ .|++++++++.+....+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3568999999999999999999997 4689999999864311 111121 26677888899999999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||||+ +|+|.+++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999999 66777776 678899999999999999999999 999999999999999999999999998765443
Q ss_pred ccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. .....|++.|+|||++.+..+ +.++|||||||++|+|++|..|| .+.........+.......|.
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf--~~~~~~~~~~~i~~~~~~~p~------- 229 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNLFKKVNSCVYVMPD------- 229 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS--BCSSSTTCBCCCCSSCCCCCT-------
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC--CCccHHHHHHHHHcCCCCCcc-------
Confidence 32 223478999999999987775 78999999999999999999995 333333333333322222211
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++|+++.
T Consensus 230 --------------------------~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 230 --------------------------FLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --------------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --------------------------cCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 145678899999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=300.27 Aligned_cols=234 Identities=23% Similarity=0.327 Sum_probs=180.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------------------------------hHHHH---
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------------------------------GLREL--- 91 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------------------------------~~~~~--- 91 (354)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4579999999999999999999975 5889999998654311 01111
Q ss_pred -----HHHHHHhceeec--CCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 92 -----KNKLRLLGCCID--KDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 92 -----~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
.|++++++++.+ ...+++||||+++++|.++. +++..+..++.||+.||.|||+.+ |+|+||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 255566777765 56789999999999988765 788899999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI---FSIKSDVFSFGVLLLKIVSGKKTTGFYRT 237 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlG~~l~~ll~g~~p~~~~~~ 237 (354)
|+++.++.++|+|||++......... .....++..|+|||++.+.. ++.++|||||||++|+|++|..|| ...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf--~~~ 243 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF--MDE 243 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS--CCS
T ss_pred EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC--CCc
Confidence 99999999999999999765443221 22347899999999997765 378899999999999999999995 444
Q ss_pred cchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 238 YSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
........+.......+... ..++.+.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQP-------------------------------DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSS-------------------------------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHHHHHHhcccCCCCCcc-------------------------------ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43344444433333222111 04567899999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=315.52 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=192.1
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh--HHHH--------HHHHHHhceeecCC-ceEE
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LREL--------KNKLRLLGCCIDKD-EKIL 109 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~--~~~~--------~~i~~~~~~~~~~~-~~~l 109 (354)
..+....++|++.+.||+|+||.||+|.++ |+.||||++....... .++. .|++++++++...+ .+++
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 345566789999999999999999999985 7899999997654221 1111 25666777766554 7999
Q ss_pred EEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 110 IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 110 v~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
||||+++++|.+++ ++...+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999988 467788999999999999999999 99999999999999999999999999875332
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.. ....++..|+|||++.+..++.++|||||||++|+|++ |..||. .....+....+.++.....
T Consensus 342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~--~~~~~~~~~~i~~~~~~~~------- 407 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMDA------- 407 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST--TSCTTTHHHHHHTTCCCCC-------
T ss_pred cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHcCCCCCC-------
Confidence 21 11245788999999999999999999999999999998 999954 3344444444433321110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+..+++.+.+||.+||+.||++|||+.++++.|+++...
T Consensus 408 -------------------------p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 -------------------------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111677899999999999999999999999999998743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=311.81 Aligned_cols=235 Identities=20% Similarity=0.309 Sum_probs=185.4
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------H-H---------HHHHHHHHhceeecCCce
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------L-R---------ELKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------~-~---------~~~~i~~~~~~~~~~~~~ 107 (354)
...++|++.+.||+|+||.||+|+++ +++.||+|++.+..... . . .+.|++++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 44678999999999999999999976 47889999997542111 1 1 123666778889999999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+.+|+|..++ +++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.++|+|||++.....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999998887 788899999999999999999999 99999999999999999999999999874222
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-------chhhhhhhhccccCCCC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-------SFTLLGYISENIYEFPS 255 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 255 (354)
.. ......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||...... ...+...+.......|.
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 21 1223457899999999999999999999999999999999999997433211 11122333333222221
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH------HHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM------NDVVS 317 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~~il~ 317 (354)
..+..+.+||.+||+.||++||++ +|+++
T Consensus 284 ---------------------------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 284 ---------------------------------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ---------------------------------TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ---------------------------------cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 145678899999999999999996 56654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=303.99 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=187.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEcC-----CCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCC
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKN-----GDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKD 105 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~ 105 (354)
....++|++.+.||+|+||.||+|.++. +..||+|++...... ....+. |++++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4456789999999999999999999653 235999999765322 222222 5566778888888
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999988 577889999999999999999999 99999999999999999999999999876
Q ss_pred ccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..|| ......+....+..+.......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf--~~~~~~~~~~~~~~~~~~~~~~- 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY--WELSNHEVMKAINDGFRLPTPM- 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHHHTTCCCCCCT-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc--ccCCHHHHHHHHHCCCcCCCcc-
Confidence 5433211 11122345778999999998899999999999999999998 99995 4444444444443332111000
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
.++..+.++|.+||+.+|++|||+.++++.|+++....
T Consensus 274 -------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 274 -------------------------------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -------------------------------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------------------------------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 15667899999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=306.74 Aligned_cols=241 Identities=26% Similarity=0.441 Sum_probs=182.0
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCC----EEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCce
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
..++|++.+.||+|+||.||+|.+. +++ +||+|.+..... .....+. |++++++++... ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence 3578999999999999999999964 344 358888754322 1222222 556667777764 47
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++|++|+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 8999999999999988 567889999999999999999999 9999999999999999999999999997665
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
............++..|+|||++.+..++.++|||||||++|+|++ |..||. ..........+..+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~--~~~~~~~~~~~~~~~~~~~~----- 241 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSILEKGERLPQP----- 241 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TCCGGGHHHHHHTTCCCCCC-----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc--CCCHHHHHHHHHcCCCCCCC-----
Confidence 4443333333456789999999999999999999999999999999 999954 33333333333322211110
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 242 ---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 ---------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------------------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ---------------------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0145678899999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=300.32 Aligned_cols=230 Identities=22% Similarity=0.254 Sum_probs=178.3
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---H---H---------HHHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---R---E---------LKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~---~---------~~~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||+||+|.++ +|+.||||++........ . + +.|++++++++...+..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344578999999999999999999976 699999999865422111 1 1 12556678888899999
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++||||+ +++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999 55787776 678899999999999999999999 9999999999999999999999999987654
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... .....||..|+|||++.+ .++.++|||||||++|+|++|..|+ ...... ..+..+.
T Consensus 209 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~--~~~~~~---~~~~~~~----------- 268 (311)
T 3p1a_A 209 TAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP--HGGEGW---QQLRQGY----------- 268 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC--SSHHHH---HHHTTTC-----------
T ss_pred cCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC--CCccHH---HHHhccC-----------
Confidence 4322 223468999999998875 7899999999999999999997663 222111 1111110
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.....+...++.+.+||.+||+.||++|||++++++
T Consensus 269 --------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 --------------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011222235778999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=308.84 Aligned_cols=234 Identities=26% Similarity=0.332 Sum_probs=187.9
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCCh---hhHHHH-------------HHHHHHhceeecCCce
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSG---QGLREL-------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~---~~~~~~-------------~~i~~~~~~~~~~~~~ 107 (354)
...++|++.+.||+|+||.||+|+++. |+.||+|++..... ...... .+++++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 345789999999999999999999864 88999999965321 111111 1344566777888899
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+||||++||+|..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999887 678899999999999999999999 99999999999999999999999999875322
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ......+||+.|+|||++.+..++.++|+|||||++|+|++|..|| .+.+..++...+......+|..
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf--~~~~~~~~~~~i~~~~~~~p~~------ 243 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPKS------ 243 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCTT------
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCC--CCCCHHHHHHHHHhCCCCCCCC------
Confidence 21 1223357899999999999999999999999999999999999994 5555566666665544433321
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
.+..+.+||.+||+.||++||+ ++++++.
T Consensus 244 ---------------------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 244 ---------------------------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---------------------------SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---------------------------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 4567889999999999999995 5777653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=307.48 Aligned_cols=240 Identities=24% Similarity=0.296 Sum_probs=177.8
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh--hhHHHH--------------HHHHHHhceeecCC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QGLREL--------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~~~~~--------------~~i~~~~~~~~~~~ 105 (354)
.+....++|++.+.||+|+||.||+|.+.+++.||+|++..... .....+ .|++++++++....
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 34566788999999999999999999988899999999865422 211222 24556677788888
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+++||| +.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++ ++.++|+|||++...
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999999 5677999888 678889999999999999999999 99999999999997 678999999999765
Q ss_pred cCCccccccccccCcccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQ-----------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....+...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~ 236 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDP 236 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHHHhcC
Confidence 54433323334578999999999865 668899999999999999999999964322111 111111111
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....... ...+..+.+||.+||+.||++|||++++++.
T Consensus 237 ~~~~~~~-------------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEIEFP-------------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCCCCC-------------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccCCc-------------------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1110000 0034568899999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=301.24 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=186.0
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCC--hhhHHHHH------------HHHHHhc
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRS--GQGLRELK------------NKLRLLG 99 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~ 99 (354)
-.+..+....++|.+.+.||+|+||.||+|.+.. ++.||+|++.... ......+. |++++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 4566777788999999999999999999998642 4579999997543 22222222 4455666
Q ss_pred eeecCC-----ceEEEEEecCCCCHhHHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE
Q 048432 100 CCIDKD-----EKILIYEYMPNKSLDFFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL 163 (354)
Q Consensus 100 ~~~~~~-----~~~lv~e~~~~~~L~~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 163 (354)
++.... ..++||||+.+++|.+++ +++..++.++.||+.||.|||+.+ |+|+||||+||++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 665544 359999999999999987 577899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 048432 164 DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTL 242 (354)
Q Consensus 164 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~ 242 (354)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||. .......
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~--~~~~~~~ 258 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP--GVQNHEM 258 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST--TCCGGGH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc--cCCHHHH
Confidence 9999999999999876544332222333456789999999999999999999999999999999 888853 3333333
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
...+..+...... ..+++.+.+||.+||+.||++|||++++++.|+++
T Consensus 259 ~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 259 YDYLLHGHRLKQP--------------------------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHHHTTCCCCCB--------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCC--------------------------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3333332211100 11566789999999999999999999999999998
Q ss_pred hhhc
Q 048432 323 AAAL 326 (354)
Q Consensus 323 ~~~~ 326 (354)
....
T Consensus 307 ~~~l 310 (313)
T 3brb_A 307 LESL 310 (313)
T ss_dssp HHHC
T ss_pred HHhc
Confidence 7543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.64 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=192.2
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChh-hHHHHH------------HHHHHhcee-
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCC- 101 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~- 101 (354)
...+.....+|++.+.||+|+||.||+|.+.+ +..||+|.+...... ....+. |++++++++
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 33456667789999999999999999999643 235899998764332 222222 455666764
Q ss_pred ecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
..++..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence 4566789999999999999998 567889999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCcc--ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCcccccchhhhhhhhccccC
Q 048432 176 IARICRGNEL--QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSG-KKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 176 ~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
++........ ........++..|+|||.+.+..++.++|+||||+++|+|++| .+| +......+....+..+...
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS--STTSCTTTHHHHHHTTCCC
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC--CccCCHHHHHHHHhcCCCC
Confidence 9976544322 1122234567889999999999999999999999999999995 455 3333444444443333322
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCC
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLP 328 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~ 328 (354)
..... +++.+.++|.+||+.||++|||++++++.|+++......
T Consensus 252 ~~~~~--------------------------------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 252 LQPEY--------------------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCTT--------------------------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCcc--------------------------------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111 456789999999999999999999999999999865543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=309.87 Aligned_cols=278 Identities=17% Similarity=0.209 Sum_probs=190.1
Q ss_pred ccchhhhhcCccccceeccc--CceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHH------------HHHHHHhceee
Q 048432 40 FSSVSTATNKFSDANKLGEG--GFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLREL------------KNKLRLLGCCI 102 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G--~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~------------~~i~~~~~~~~ 102 (354)
.+.+....++|++.+.||+| +||.||+|+++ +|+.||||++.... ......+ .|++++++++.
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 34556677899999999999 99999999976 59999999997543 2111222 25667788888
Q ss_pred cCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 103 DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
+.+.+++|||||++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence 999999999999999999987 567889999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCc-----cccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 176 IARICRGNE-----LQANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 176 ~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
.+....... .........++..|+|||++.+ ..++.++|||||||++|+|++|..||. +.........+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~--~~~~~~~~~~~~~ 251 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK--DMPATQMLLEKLN 251 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT--TCCSTTHHHHC--
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC--CCCHHHHHHHHhc
Confidence 876432211 1111223468889999999987 578999999999999999999999953 3333333332222
Q ss_pred cccCCCCcccCCcccc-------------ccchhhhhhhh-hccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 249 NIYEFPSVDTHNVKTF-------------GFLHLTIFKLF-SISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~-------------~~~d~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
+......... ..+.. ...+....... ...............++.+.+||.+||+.||++|||++|
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 252 GTVPCLLDTS-TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCcccccc-ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 2111000000 00000 00000000000 000000111223346778999999999999999999999
Q ss_pred HHHH--hhhhh
Q 048432 315 VVSM--LTNEA 323 (354)
Q Consensus 315 il~~--L~~~~ 323 (354)
+++. |+++.
T Consensus 331 ll~hp~f~~~~ 341 (389)
T 3gni_B 331 LLNHSFFKQIK 341 (389)
T ss_dssp HTTSGGGGGC-
T ss_pred HhcCHHHHHHh
Confidence 9865 55443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=307.16 Aligned_cols=230 Identities=23% Similarity=0.326 Sum_probs=189.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|+++ +|+.||+|++..... .....+. +++++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34579999999999999999999976 599999999865321 1111221 4556677788889999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||||+++++|.+++ ++...++.++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999888 678899999999999999999999 999999999999999999999999999765432
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
. ....||+.|+|||++.+..++.++|+|||||++|+|++|..|| .+.+.......+..+...+|..
T Consensus 195 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf--~~~~~~~~~~~i~~~~~~~p~~------- 260 (350)
T 1rdq_E 195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPSH------- 260 (350)
T ss_dssp B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred c-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC--CCCCHHHHHHHHHcCCCCCCCC-------
Confidence 2 2347899999999999989999999999999999999999994 5555566666665554433221
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~ 317 (354)
.+..+.+||.+||+.||++||+ +++|++
T Consensus 261 --------------------------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 --------------------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------------------------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------------------------CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 4567889999999999999998 888875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=319.04 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=196.7
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhH---HH--------HHHHHHHhceeecCCce
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGL---RE--------LKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~---~~--------~~~i~~~~~~~~~~~~~ 107 (354)
+..+....++|++.+.||+|+||.||+|.++. +..||||++........ ++ +.|++++++++...+.+
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 34556667889999999999999999999875 88999999976543211 11 12667788889889999
Q ss_pred EEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 108 ILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
++||||+.+++|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999988 567888999999999999999999 999999999999999999999999999865
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||. +.+...+...+..+....
T Consensus 369 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~--~~~~~~~~~~~~~~~~~~------ 439 (495)
T 1opk_A 369 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKDYRME------ 439 (495)
T ss_dssp TTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST--TCCGGGHHHHHHTTCCCC------
T ss_pred cCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHcCCCCC------
Confidence 433221 1222345678999999998889999999999999999999 888853 333334443333221110
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.+..+++.+.+||.+||+.||++|||+++|++.|+.+.
T Consensus 440 --------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 440 --------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --------------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 01116778899999999999999999999999999876
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.95 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=188.4
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---------hhHHH-----------HHHHHHHhceeec
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---------QGLRE-----------LKNKLRLLGCCID 103 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---------~~~~~-----------~~~i~~~~~~~~~ 103 (354)
...++|++.+.||+|+||.||+|++. +++.||+|++..... ...++ +.|++++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45689999999999999999999964 689999999863221 11111 2356667777765
Q ss_pred CC-----ceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 104 KD-----EKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 104 ~~-----~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
.. ..+++|||+.+ +|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 54 47999999975 888887 678899999999999999999999 999999999999999999999
Q ss_pred eecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 172 SDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 172 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
+|||++........ .....+|..|+|||++.+..++.++|||||||++|+|++|.+| |.+.+..+....+.....
T Consensus 162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p--f~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL--FCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCS--CCCSSHHHHHHHHHHHHC
T ss_pred eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCC--CCCCCHHHHHHHHHHHhC
Confidence 99999875443322 2335789999999999999999999999999999999999999 455555555555544443
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+...+....... . ...............+..++.+.+||.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLP--R----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSC--G----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhcc--c----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 33332222111100 0 000000011111222236778899999999999999999999886
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.19 Aligned_cols=238 Identities=20% Similarity=0.267 Sum_probs=179.8
Q ss_pred hhhcCcccc-ceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH---------HHHHHHHhceeec----CCceEE
Q 048432 45 TATNKFSDA-NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE---------LKNKLRLLGCCID----KDEKIL 109 (354)
Q Consensus 45 ~~~~~y~~~-~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~---------~~~i~~~~~~~~~----~~~~~l 109 (354)
...++|.+. +.||+|+||.||+|.++ +|+.||||++..... ..++ +.|++++++++.. ...+|+
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHH-HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchh-HHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 455678776 78999999999999976 589999999965322 1111 2356667776654 567899
Q ss_pred EEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCCeEEeeccccee
Q 048432 110 IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARI 179 (354)
Q Consensus 110 v~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~~l~dfg~a~~ 179 (354)
|||||++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 99999999999888 678899999999999999999999 999999999999997 78899999999975
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--hhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS--FTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 257 (354)
...... .....+|..|+|||++.+..++.++|||||||++|+|++|..||....... ......+..+...++...
T Consensus 214 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 214 TTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 443221 223477999999999998899999999999999999999999964322211 112233333333322211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+. .+++.+.+||.+||+.||++|||++++++.
T Consensus 291 ~~-----------------------------~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WS-----------------------------EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT-----------------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc-----------------------------cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 146678999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=302.85 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=193.3
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChh-hHHH-------------HHHHHHHhc
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQ-GLRE-------------LKNKLRLLG 99 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~-~~~~-------------~~~i~~~~~ 99 (354)
.+.+....++|++.+.||+|+||.||+|.+.. +..||+|++...... .... +.|++++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566778999999999999999999999653 247999999765322 1111 235566777
Q ss_pred eeecCCceEEEEEecCCCCHhHHHh-------------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFLF-------------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~~-------------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
++.+.+..++||||+++++|.+++. ++..+..++.||+.||.|||+.+ |+|+||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 8888899999999999999998872 56778999999999999999999 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYS 239 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~ 239 (354)
|+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||... ..
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~ 272 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI--LV 272 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--CS
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc--ch
Confidence 9999999999999999976544332222333456788999999999999999999999999999998 88885432 22
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
......+.......+.. ..+++.+.+||.+||+.||++|||++++++.|
T Consensus 273 ~~~~~~~~~~~~~~~~~-------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQP-------------------------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp SHHHHHHHHHTCCCCCC-------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCC-------------------------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 22222221111111100 01456789999999999999999999999999
Q ss_pred hhhhhh
Q 048432 320 TNEAAA 325 (354)
Q Consensus 320 ~~~~~~ 325 (354)
+++...
T Consensus 322 ~~~~~~ 327 (333)
T 2i1m_A 322 QEQAQE 327 (333)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 987743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=324.10 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=201.0
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHH--------HHHHHHhceeecCCc
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~--------~~i~~~~~~~~~~~~ 106 (354)
+....+....++|++.+.||+|+||.||+|.++.+..||||++....... .+++ .|++++++++.. +.
T Consensus 257 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 34556677788999999999999999999999888889999997654221 1111 255666777765 67
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+++||||+.+++|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 89999999999999988 467788999999999999999999 99999999999999999999999999975
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... ......++..|+|||++.+..++.++|||||||++|+|++ |..|| .+....+....+..+... +.
T Consensus 413 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~--~~~~~~~~~~~i~~~~~~-~~--- 485 (535)
T 2h8h_A 413 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVERGYRM-PC--- 485 (535)
T ss_dssp CCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSS--TTCCHHHHHHHHHTTCCC-CC---
T ss_pred cCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCC-CC---
Confidence 4432211 1122345778999999999999999999999999999999 89884 444445555554433211 10
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCC
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 331 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~ 331 (354)
+..+++.+.+||.+||+.||++|||+++|++.|+++.....+...
T Consensus 486 ----------------------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~ 530 (535)
T 2h8h_A 486 ----------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530 (535)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred ----------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence 011677889999999999999999999999999998865555443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.15 Aligned_cols=239 Identities=23% Similarity=0.296 Sum_probs=184.5
Q ss_pred hcCccc--cceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 47 TNKFSD--ANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 47 ~~~y~~--~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
.+.|.+ .+.||+|+||.||+|.+. +|+.||+|++..........+. |++++++++...+.+++||
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 344554 678999999999999975 5999999999876544433333 5556677888889999999
Q ss_pred EecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE--cCCCCeEEeecccceeccCC
Q 048432 112 EYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 112 e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~~~~l~dfg~a~~~~~~ 183 (354)
||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+|||++......
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999998877 567888999999999999999999 9999999999999 56678999999999865543
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..|| .+.+..+....+.......+....
T Consensus 243 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf--~~~~~~~~~~~i~~~~~~~~~~~~----- 312 (373)
T 2x4f_A 243 EKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF--LGDNDAETLNNILACRWDLEDEEF----- 312 (373)
T ss_dssp CBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTT--CCSSHHHHHHHHHHTCCCSCSGGG-----
T ss_pred ccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHhccCCCChhhh-----
Confidence 322 2246899999999998888999999999999999999999994 445555555555444332221110
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhh
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNE 322 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~ 322 (354)
...++.+.+||.+||+.||++|||++|+++ .|++.
T Consensus 313 ------------------------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 313 ------------------------QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ------------------------ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 114677899999999999999999999997 45543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=296.38 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=195.5
Q ss_pred hhhhhcCccccc-eecccCceeEEEEEEc---CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCC
Q 048432 43 VSTATNKFSDAN-KLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKD 105 (354)
Q Consensus 43 ~~~~~~~y~~~~-~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~ 105 (354)
+....++|.+.+ .||+|+||.||+|.+. +++.||+|++..... .....+. |++++++++ ..+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 445567888887 9999999999999854 577899999987532 2222222 445566666 456
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 789999999999999988 678899999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 180 CRGNEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
...... ........++..|+|||++.+..++.++|||||||++|+|++ |..|| ......+....+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~--~~~~~~~~~~~i~~~~~~~~--- 234 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIEQGKRMEC--- 234 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT--TTCCTHHHHHHHHTTCCCCC---
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc--ccCCHHHHHHHHhcCCcCCC---
Confidence 543322 111222356789999999988889999999999999999998 99995 33344444444433221100
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCC
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 331 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~ 331 (354)
+..+++.+.++|.+||+.+|++|||++++++.|+++......+..
T Consensus 235 -----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 235 -----------------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp -----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred -----------------------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 011567889999999999999999999999999999865554443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=305.46 Aligned_cols=235 Identities=23% Similarity=0.323 Sum_probs=184.7
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--------hhhH-HH--------HHHHHHHhceeecCCce
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--------GQGL-RE--------LKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--------~~~~-~~--------~~~i~~~~~~~~~~~~~ 107 (354)
..++|++.+.||+|+||.||+|.++ +|+.||+|++.... .... ++ +.|++++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999975 58999999985321 1111 11 12666778888899999
Q ss_pred EEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC---eEEeecc
Q 048432 108 ILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFG 175 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~~l~dfg 175 (354)
++|||||++++|.+.+ +++..+..++.||+.||.|||+++ |+||||||+||+++.++. ++|+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998776 467788999999999999999999 999999999999986654 9999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.. . .......+..+....+.
T Consensus 179 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~-~~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 179 VAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--T-KERLFEGIIKGKYKMNP 253 (351)
T ss_dssp TCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--S-HHHHHHHHHHTCCCCCH
T ss_pred ceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--c-HHHHHHHHHcCCCCCCc
Confidence 99765543321 2234789999999999998999999999999999999999999643 2 22333333333322211
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.. ....++.+.+||.+||+.||++|||+.++++
T Consensus 254 ~~-----------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 RQ-----------------------------WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HH-----------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc-----------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 1114677899999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=306.66 Aligned_cols=238 Identities=22% Similarity=0.275 Sum_probs=178.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH--------HHHHHHhceeecCCceEEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
....++|++.+.||+|+||.||+|+++ +++.||+|++....... .+++ .|++++++++.+....++||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 345689999999999999999999976 69999999997543211 1221 26677888899999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC--eEEeecccceeccCCc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--PKISDFGIARICRGNE 184 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~~l~dfg~a~~~~~~~ 184 (354)
||+.+++|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++. ++|+|||++.......
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999999887 678899999999999999999999 999999999999987765 9999999986432222
Q ss_pred cccccccccCcccccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccCCCCcccCCc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIK-SDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...... .......+.......+...
T Consensus 173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 245 (361)
T 3uc3_A 173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI---- 245 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS----
T ss_pred ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC----
Confidence 1223468999999999988877655 99999999999999999996432221 1222222222222222211
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++|+++.
T Consensus 246 ---------------------------~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 ---------------------------RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---------------------------CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 045678899999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=302.61 Aligned_cols=268 Identities=18% Similarity=0.247 Sum_probs=190.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--------hHH-----HHHHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--------GLR-----ELKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--------~~~-----~~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++.+.||+|+||.||+|++. +++.||+|++...... +.. .+.|++++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999976 6899999998643321 111 123788899999999999999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
+++ +|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence 985 777766 567889999999999999999999 99999999999999999999999999875433221
Q ss_pred ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+....+.+.....+...++.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF--PGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 1223467899999999876 56899999999999999999999994 45555555555555444333332222111000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhhhhc
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAAL 326 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~~~~ 326 (354)
.. ................+..++.+.+||.+||+.||++|||++|+++ .|.++....
T Consensus 234 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 234 FK---TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HH---HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred hc---ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 00 0000000001111122235678899999999999999999999987 466655433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.15 Aligned_cols=235 Identities=23% Similarity=0.378 Sum_probs=190.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCCceEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~~~~lv 110 (354)
..++|++.+.||+|+||.||+|.++ +|+.||+|++..... .....+. |++++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999975 589999999865432 2222222 556677888888999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC---eEEeecccceeccC
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGIARICRG 182 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~~l~dfg~a~~~~~ 182 (354)
|||+.+++|.+.+ ++...+..++.|++.||.|||+.+ |+|+||||+||+++.++. ++|+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999998877 678889999999999999999999 999999999999986655 99999999976554
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... ....++..|+|||++.+..++.++||||||+++|+|++|..| |.+.........+..+....+......
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p--f~~~~~~~~~~~~~~~~~~~~~~~~~~-- 233 (284)
T 3kk8_A 161 SEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--FWDEDQHRLYAQIKAGAYDYPSPEWDT-- 233 (284)
T ss_dssp SCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCCCCTTTTTT--
T ss_pred Cccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCC--CCCCchhHHHHHHHhccccCCchhhcc--
Confidence 3322 234689999999999999999999999999999999999999 455555555555555544433322111
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++.+.+||.+||+.||++|||++|+++
T Consensus 234 ---------------------------~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 234 ---------------------------VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---------------------------SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------------------------cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 4567889999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=298.26 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=185.9
Q ss_pred hhhcCccccceecccCceeEEEEEE-----cCCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecC--
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-----KNGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDK-- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~-- 104 (354)
...++|++.+.||+|+||.||+|++ .+++.||+|++..... .....+. |++++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3456799999999999999999983 3588999999975432 1122222 445566677665
Q ss_pred CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 105 DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
+.+++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 6789999999999999988 678889999999999999999999 9999999999999999999999999997
Q ss_pred eccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..|+........ .. ........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~ 247 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL---KM----IGPTHGQM 247 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HH----HCSCCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh---hc----cCCccccc
Confidence 65543321 222334678889999999998899999999999999999999988422110000 00 00000000
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.................+..+++.+.+||.+||+.||++|||+++++++|+++.
T Consensus 248 ------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 ------------TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ------------HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000000001111112226778999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.18 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=189.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~l 109 (354)
.....++|++.+.||+|+||.||+|.++. +..||+|++..........+. |++++++++.+....++
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 34567899999999999999999999764 778999998765433332222 55667788888889999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccceecc
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICR 181 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a~~~~ 181 (354)
||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999998887 678899999999999999999999 9999999999999 788899999999997654
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... .....++..|+|||++.+. ++.++||||||+++|+|++|..|| ......+....+..+....+....
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPF--SAPTDSEVMLKIREGTFTFPEKDW--- 231 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCC--CCCCHHHHHHHHHhCCCCCCchhh---
Confidence 4332 2234689999999987654 899999999999999999999995 444555555555554443322111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...++.+.+||.+||+.||++|||+.++++
T Consensus 232 --------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 --------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 114678899999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.16 Aligned_cols=234 Identities=21% Similarity=0.316 Sum_probs=183.7
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHH-------------HHHHHHHHhceeecCCceE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLR-------------ELKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~-------------~~~~i~~~~~~~~~~~~~~ 108 (354)
..++|++.+.||+|+||.||+|+++ +++.||+|++..... .... .+.|++++++++.+.+.+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3578999999999999999999976 488999999975421 1111 1225566777888889999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||||+.+++|..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999998887 678899999999999999999999 999999999999999999999999998753222
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-------chhhhhhhhccccCCCCc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-------SFTLLGYISENIYEFPSV 256 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~ 256 (354)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.. ...+...+.......|.
T Consensus 164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~- 240 (345)
T 3a8x_A 164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR- 240 (345)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT-
T ss_pred C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC-
Confidence 1 1223357899999999999989999999999999999999999997432211 11222223222222211
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH------HHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM------NDVVS 317 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~~il~ 317 (354)
..+..+.+||.+||+.||++||++ +++++
T Consensus 241 --------------------------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 241 --------------------------------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp --------------------------------TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred --------------------------------CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 145678899999999999999996 56664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=293.49 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=190.8
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-C---CEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCce
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-G---DEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~---~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
.....|.+.+.||+|+||.||+|.+.+ + ..||+|++...... ....+. |++++++++...+..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 334466778999999999999999543 2 26999999764432 222222 555667777665555
Q ss_pred -EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 108 -ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 108 -~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
++++||+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999988 567889999999999999999999 999999999999999999999999999754
Q ss_pred cCCcc--ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 181 RGNEL--QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
..... ........++..|+|||.+.+..++.++|||||||++|+|++|..|+ +...+.......+...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~- 252 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFLAQGRRLPQPEY- 252 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT-TTTSCGGGHHHHHHTTCCCCCCTT-
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC-CccCCHHHHHHHhhcCCCCCCCcc-
Confidence 43221 11222346788999999999999999999999999999999966553 333344444444433332111111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCC
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 329 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~ 329 (354)
+++.+.+||.+||+.||++|||++++++.|+++.......
T Consensus 253 -------------------------------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 253 -------------------------------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -------------------------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -------------------------------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 4567899999999999999999999999999998766543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=303.14 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=188.8
Q ss_pred hcCccccceecccCceeEEEEEE-----cCCCEEEEEEecCCChhhHHHHHHH------------HHHhceee--cCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVL-----KNGDEIAVKRLSGRSGQGLRELKNK------------LRLLGCCI--DKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vavK~~~~~~~~~~~~~~~i------------~~~~~~~~--~~~~~ 107 (354)
.++|++.+.||+|+||.||+|++ .+++.||+|++..........+.++ +++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47999999999999999999984 3588999999987765554444433 34445544 45668
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999987 578889999999999999999999 9999999999999999999999999998654
Q ss_pred CCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~--~~~~~~----- 249 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--FLRMMGC--ERDVPA----- 249 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHCC------CCH-----
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--hhhhccc--cccccc-----
Confidence 43321 1223345778899999999888999999999999999999999995332211 1000000 000000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCC
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 331 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~ 331 (354)
.. ..............+..+++.+.+||.+||+.||++|||++++++.|+.+.........
T Consensus 250 ------~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 250 ------LS----RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp ------HH----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred ------HH----HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 00 00000000111111222678899999999999999999999999999998865544443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=300.01 Aligned_cols=232 Identities=24% Similarity=0.293 Sum_probs=183.7
Q ss_pred hhcCccccceecccCceeEEEEEE----cCCCEEEEEEecCCCh----hhH----HH--------HHHHHHHhceeecCC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVL----KNGDEIAVKRLSGRSG----QGL----RE--------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~----~~~~~vavK~~~~~~~----~~~----~~--------~~~i~~~~~~~~~~~ 105 (354)
..++|++.+.||+|+||.||+|+. .+|+.||+|++..... ... .+ +.|++++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 457899999999999999999997 3699999999975421 111 11 126677788888999
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+++||||+++++|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999998887 577889999999999999999999 999999999999999999999999998643
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... ......|++.|+|||++.+..++.++|+|||||++|+|++|..|| .+.+.......+.......|..
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~p~~---- 243 (327)
T 3a62_A 172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF--TGENRKKTIDKILKCKLNLPPY---- 243 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHTCCCCCTT----
T ss_pred ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC--CCCCHHHHHHHHHhCCCCCCCC----
Confidence 32211 122346899999999999888999999999999999999999994 4455555555554443332211
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
.+..+.+||.+||+.||++|| +++++++
T Consensus 244 -----------------------------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 244 -----------------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----------------------------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----------------------------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 456788999999999999999 7888876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=297.81 Aligned_cols=236 Identities=25% Similarity=0.363 Sum_probs=175.0
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH--HHH------------HHHHHHhceeecCCce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--REL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--~~~------------~~i~~~~~~~~~~~~~ 107 (354)
+....++|++.+.||+|+||.||+|++. +|+.||+|++........ ... .|++++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3456789999999999999999999974 688999999976532211 111 2556778888889999
Q ss_pred EEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 108 ILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
++||||+++ +|.+++ +++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999986 776654 67888999999999999999998 9 999999999999999999999999998
Q ss_pred eeccCCccccccccccCcccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYA----IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
......... ....++..|+|||++ .+..++.++|||||||++|+|++|..||.............+.......
T Consensus 158 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 158 GYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred ccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 765443221 223678999999996 4556899999999999999999999997544443333333333222222
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+... .++.+.+||.+||+.||++|||++++++
T Consensus 235 ~~~~--------------------------------~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 PADK--------------------------------FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CTTT--------------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccc--------------------------------CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 4667899999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=298.79 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=183.5
Q ss_pred hhcCccccceecccCceeEEEEEEcC-C-------CEEEEEEecCCChhhHHHHH------------HHHHHhceeecCC
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKN-G-------DEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKD 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~-~-------~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~ 105 (354)
..++|++.+.||+|+||.||+|.++. + ..||+|++..........+. |++++++++...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 45789999999999999999999653 3 46999999765544333332 5566778888888
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC--------eEE
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--------PKI 171 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~~l 171 (354)
..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++|
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999998 667888999999999999999999 999999999999998887 999
Q ss_pred eecccceeccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 172 SDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 172 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
+|||++...... ....++..|+|||++.+ ..++.++|||||||++|+|++|..|+ +........... ....
T Consensus 163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~-~~~~~~~~~~~~-~~~~ 234 (289)
T 4fvq_A 163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQF-YEDR 234 (289)
T ss_dssp CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT-TTTSCHHHHHHH-HHTT
T ss_pred ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC-ccccchHHHHHH-hhcc
Confidence 999998643222 12356788999999987 66899999999999999999965552 222222222211 1111
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCC
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK 330 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~ 330 (354)
...+.. .++.+.+||.+||+.||++|||++++++.|+++.+...++.
T Consensus 235 ~~~~~~---------------------------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 235 HQLPAP---------------------------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp CCCCCC---------------------------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred CCCCCC---------------------------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 111111 23446789999999999999999999999999986554443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=312.31 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=195.1
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhH-HH--------HHHHHHHhceeec
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGL-RE--------LKNKLRLLGCCID 103 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~-~~--------~~~i~~~~~~~~~ 103 (354)
+..+....++|++.+.||+|+||.||+|+++ +++.||+|++..... ... ++ +.|++++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455667789999999999999999999976 488999999864211 111 11 1266778888999
Q ss_pred CCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 104 KDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
...+|+|||||+||+|.+++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++..
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 99999999999999999988 678889999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc--CC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGI----FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY--EF 253 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 253 (354)
....... .....+||+.|+|||++.+.. ++.++|+|||||++|+|++|.+| |.+.+..+....+..+.. .+
T Consensus 218 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P--f~~~~~~~~~~~i~~~~~~~~~ 294 (410)
T 3v8s_A 218 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYADSLVGTYSKIMNHKNSLTF 294 (410)
T ss_dssp CCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT--TCCSSHHHHHHHHHTHHHHCCC
T ss_pred eccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC--CCCCChhhHHHHHHhccccccC
Confidence 5443221 122357899999999998665 78899999999999999999999 555565666666654432 22
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
|.... .+..+.+||.+||..+|++ ||+++||++.
T Consensus 295 p~~~~-------------------------------~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 PDDND-------------------------------ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CTTCC-------------------------------CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCccc-------------------------------ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 22110 4667899999999999998 9999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.18 Aligned_cols=238 Identities=24% Similarity=0.399 Sum_probs=193.4
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
....++|.+.+.||+|+||.||+|++. +|+.||||++...... ....+ .|++++++++.+.+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 445689999999999999999999976 6999999999653211 11111 2666778888889999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999988 688999999999999999999999 99999999999999999999999999986554
Q ss_pred CccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... ....+|++.|+|||++.+..+ +.++|||||||++|+|++|..|| .+.........+..+....|..
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf--~~~~~~~~~~~i~~~~~~~p~~----- 238 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFKKICDGIFYTPQY----- 238 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS--CCSSSHHHHHHHHTTCCCCCTT-----
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC--CCCCHHHHHHHHhcCCcCCCcc-----
Confidence 332 223478999999999988765 78999999999999999999995 4445555555555444332211
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNE 322 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~ 322 (354)
.++.+.+||.+||+.||++|||++++++ .+++.
T Consensus 239 ----------------------------~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 239 ----------------------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----------------------------CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----------------------------CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 3456889999999999999999999997 35543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.85 Aligned_cols=240 Identities=24% Similarity=0.311 Sum_probs=178.5
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh--hhHHHH--------------HHHHHHhceeecCC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QGLREL--------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~~~~~--------------~~i~~~~~~~~~~~ 105 (354)
.+....++|++.+.||+|+||.||+|.+.+++.||||++..... .....+ .|++++++++...+
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34455677999999999999999999988899999999865432 222222 24556667778888
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+++||| +.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.++|+|||++...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 8999999 6678998887 567789999999999999999999 99999999999995 588999999999765
Q ss_pred cCCccccccccccCcccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQ-----------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .......+...
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~~~~~~ 283 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDP 283 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHCT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-HHHHHHHHhCc
Confidence 44332222334578999999999865 3688999999999999999999999643221 11222222221
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
....+... ..+..+.+||.+||+.||++|||++|+++.
T Consensus 284 ~~~~~~~~-------------------------------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEFPD-------------------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCCCC-------------------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCCCc-------------------------------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111100 034568899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.42 Aligned_cols=233 Identities=24% Similarity=0.303 Sum_probs=188.5
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHH------------HHHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRE------------LKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~------------~~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|+++ +|+.||+|++..... ..... +.|++++++++...+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999965 589999999865311 11111 236777888899999999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+||||+++++|..++ +++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.++|+|||++.....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999998887 6788999999999999999998 88 99999999999999999999999999874322
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..|| .+.+.......+......+|..
T Consensus 302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf--~~~~~~~~~~~i~~~~~~~p~~------ 371 (446)
T 4ejn_A 302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRT------ 371 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCTT------
T ss_pred CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCC--CCCCHHHHHHHHHhCCCCCCcc------
Confidence 22 1223357899999999999999999999999999999999999994 4555555555554443333211
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
.++.+.+||.+||+.||++|| |++|+++
T Consensus 372 ---------------------------~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 ---------------------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---------------------------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---------------------------CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 456788999999999999999 9999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=308.93 Aligned_cols=235 Identities=23% Similarity=0.349 Sum_probs=186.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||.||+|.++ +++.||+|++..... .....+ .|++++++++.+.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 445689999999999999999999976 488999999865321 111111 2556677888899999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+||||+.+++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999888 678899999999999999999999 99999999999999999999999999986544
Q ss_pred CccccccccccCcccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCccc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 258 (354)
... .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...... .......+.......|.
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~--- 241 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--- 241 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT---
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC---
Confidence 322 233578999999999864 45889999999999999999999997543322 22333333322222221
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-MNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~il~ 317 (354)
..++.+.+||.+||+.||++||+ ++++++
T Consensus 242 ------------------------------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 ------------------------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------------------------------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------------------------------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 14567899999999999999998 777664
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.92 Aligned_cols=243 Identities=25% Similarity=0.350 Sum_probs=183.3
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH--HHH--------HHHHHHhceeec-CCceE
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL--REL--------KNKLRLLGCCID-KDEKI 108 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~--~~~--------~~i~~~~~~~~~-~~~~~ 108 (354)
...+....++|++.+.||+|+||.||+|.++ |+.||+|++........ ++. .|++++++++.. .+..+
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 3344556789999999999999999999984 88999999976542211 111 255566666543 45789
Q ss_pred EEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 109 LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999888 456778999999999999999999 9999999999999999999999999987543
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||. .....+....+..+.....
T Consensus 169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~--~~~~~~~~~~~~~~~~~~~------ 235 (278)
T 1byg_A 169 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMDA------ 235 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT--TSCGGGHHHHHTTTCCCCC------
T ss_pred ccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHhcCCCCCC------
Confidence 322 12245788999999999899999999999999999998 999954 3333333333332211100
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+..+++.+.++|.+||+.||++|||+.++++.|+++...
T Consensus 236 --------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 --------------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 011567889999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=309.23 Aligned_cols=273 Identities=23% Similarity=0.331 Sum_probs=180.9
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHH----H---------HHHHHHHhceeecCC--
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLR----E---------LKNKLRLLGCCIDKD-- 105 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~----~---------~~~i~~~~~~~~~~~-- 105 (354)
....++|++.+.||+|+||.||+|.++ +|+.||+|++..... .... + +.|++++++++..++
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345689999999999999999999965 599999999864321 1111 1 225566677776443
Q ss_pred ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 106 EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.+|+|||||++ +|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 68999999985 787777 678888999999999999999999 9999999999999999999999999997653
Q ss_pred CCcc-------------------ccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchh
Q 048432 182 GNEL-------------------QANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT 241 (354)
Q Consensus 182 ~~~~-------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~ 241 (354)
.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|.+|| .+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf--~~~~~~~ 238 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF--PGSSTMN 238 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC--CCCCHHH
Confidence 3110 111233578999999999976 56899999999999999999999994 4555555
Q ss_pred hhhhhhccccCCCCcccCCccccccchhhhhhhhhcc---ccCCchhHH------------HHHHHHHHHHHhhccccCC
Q 048432 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSIS---SVGLSNDIV------------CLCILRYVNIALLCVQESA 306 (354)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~---~~~~~~~~~------------~~~~~~l~~li~~cl~~~P 306 (354)
....+.......+......... .............. .......++ ..+++.+.+||.+||+.||
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQS-PFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCC-SSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHhcCCCCHHHHHhccC-HHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 5555443332221111000000 00000000000000 000000000 0246788999999999999
Q ss_pred CCCCCHHHHHHH--hhhhh
Q 048432 307 DDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 307 ~~Rps~~~il~~--L~~~~ 323 (354)
++|||++|+++. |+...
T Consensus 318 ~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIFH 336 (388)
T ss_dssp GGSCCHHHHTTSTTTTTTC
T ss_pred ccCCCHHHHhCCHHHHHhc
Confidence 999999999987 55544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=300.69 Aligned_cols=251 Identities=22% Similarity=0.247 Sum_probs=187.7
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChhhHHHHH------------HHHHHhceee---
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCI--- 102 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~--- 102 (354)
+...+....++|++.+.||+|+||.||+|.+ .+|+.||+|++..........+. |++++++++.
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 3344555678999999999999999999997 46999999998765544443333 4455566665
Q ss_pred -cCCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEe
Q 048432 103 -DKDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172 (354)
Q Consensus 103 -~~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~ 172 (354)
.....++||||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEE
Confidence 344788999999999998887 567889999999999999999999 9999999999999999999999
Q ss_pred ecccceeccCCcccc-------ccccccCcccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCcccccchhh
Q 048432 173 DFGIARICRGNELQA-------NTGRIVGTYRYMSPEYAIQGI---FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTL 242 (354)
Q Consensus 173 dfg~a~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~ 242 (354)
|||++.......... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 999886543211100 011235688999999987554 6889999999999999999999964322221111
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
...+.. ....+.. ...+..+.+||.+||+.||++|||++++++.|+++
T Consensus 257 ~~~~~~-~~~~~~~-------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 257 ALAVQN-QLSIPQS-------------------------------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHHHHC-C--CCCC-------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hHHhhc-cCCCCcc-------------------------------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 111111 1111110 01466789999999999999999999999999988
Q ss_pred hh
Q 048432 323 AA 324 (354)
Q Consensus 323 ~~ 324 (354)
..
T Consensus 305 ~~ 306 (317)
T 2buj_A 305 QP 306 (317)
T ss_dssp CC
T ss_pred CC
Confidence 73
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.19 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=191.3
Q ss_pred hhhcCc-cccceecccCceeEEEEEEc-----CCCEEEEEEecCCChhh-HHHHH------------HHHHHhceeec--
Q 048432 45 TATNKF-SDANKLGEGGFGPVYKGVLK-----NGDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCID-- 103 (354)
Q Consensus 45 ~~~~~y-~~~~~lg~G~~g~V~~a~~~-----~~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~-- 103 (354)
...++| ++.+.||+|+||.||++.++ +++.||+|++....... ...+. |++++++++.+
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 344566 99999999999999998753 58889999998654322 22222 44556666665
Q ss_pred CCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 104 KDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
...+++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 46789999999999999998 678999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||............... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~-------- 254 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQ-------- 254 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC-HH--------
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc-cc--------
Confidence 6543321 1223345778899999999888999999999999999999999996432211111000000 00
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCC
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPK 330 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~ 330 (354)
..................+..++..+.+||.+||+.||++|||++++++.|+++......+.
T Consensus 255 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 255 ----------MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp ----------HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred ----------hhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 00000000000000111112267789999999999999999999999999999987665444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=314.72 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=196.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHHHHHHH----------HhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRELKNKLR----------LLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~~~i~~----------~~~~~~~~~~~~lv~e~ 113 (354)
..++|++.+.||+|+||.||+|.+. +++.||||++...... .......+++ +..++......++||||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4689999999999999999999964 6999999998654322 2222222222 23344567788999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a~~~~~~~ 184 (354)
+ +++|.+++ +++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++.......
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 88999988 678999999999999999999999 9999999999999 688999999999998665433
Q ss_pred ccc-----ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCccc
Q 048432 185 LQA-----NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 185 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 258 (354)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .......+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT----- 235 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-----
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-----
Confidence 211 122457899999999999999999999999999999999999996543322 122222221111100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccc
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSY 336 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 336 (354)
........++..+.+||.+||+.+|++||++++|++.|+++......+....++|
T Consensus 236 -----------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW 290 (483)
T 3sv0_A 236 -----------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW 290 (483)
T ss_dssp -----------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred -----------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence 0111112257789999999999999999999999999999977665555555555
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=302.09 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=174.0
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-----hHHHH--------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-----GLREL--------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-----~~~~~--------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||+|+||.||+|.++ +|+.||+|++...... ..+++ .|++++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999965 5899999998654321 11222 26677888888999999999
Q ss_pred EecCCCCHhHHH-----------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 112 EYMPNKSLDFFL-----------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 112 e~~~~~~L~~~~-----------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
||+++ +|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99985 887776 456778899999999999999999 999999999999999999999999999765
Q ss_pred cCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..... ......++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+....+.+.....+...+.
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF--PGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHHHhCCCChhHhh
Confidence 43221 12234678999999998764 5899999999999999999999995 4444444444444333322222211
Q ss_pred CccccccchhhhhhhhhccccCC----chhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGL----SNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
............. ....... ........+..+.+||.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQ---QRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCC---CCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccc---cccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 1111000000000 0000000 000001246678999999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.33 Aligned_cols=246 Identities=20% Similarity=0.214 Sum_probs=190.7
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC-----hhhHHHH------------HHHHHHhc
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS-----GQGLREL------------KNKLRLLG 99 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~-----~~~~~~~------------~~i~~~~~ 99 (354)
....++....++|++.+.||+|+||.||+|.++ +++.||+|++.... ......+ .|++++++
T Consensus 16 ~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp CCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 345667788899999999999999999999975 58899999986432 1111222 26667788
Q ss_pred eeecCCceEEEEEecCCCCHhHHH---------------------------------------------hhHHHHHHHHH
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL---------------------------------------------FDWVTRVRIIE 134 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~---------------------------------------------~~~~~~~~i~~ 134 (354)
++.+.+..++||||+++++|.+++ +++..+..++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 899999999999999999998876 25677889999
Q ss_pred HHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC--CeEEeecccceeccCCccc--cccccccCcccccCcccccc--CC
Q 048432 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM--NPKISDFGIARICRGNELQ--ANTGRIVGTYRYMSPEYAIQ--GI 208 (354)
Q Consensus 135 ~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~ 208 (354)
||+.||.|||+.+ |+|+||||+||+++.++ .++|+|||++......... .......+++.|+|||++.+ ..
T Consensus 176 qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 9999999999999 99999999999998776 8999999999765432211 12234568999999999875 67
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHH
Q 048432 209 FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVC 288 (354)
Q Consensus 209 ~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 288 (354)
++.++|||||||++|+|++|..|| .+....+....+.......+.... .
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~ 301 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPF--PGVNDADTISQVLNKKLCFENPNY-----------------------------N 301 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCTTSGGG-----------------------------G
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCC--CCCChHHHHHHHHhcccccCCccc-----------------------------c
Confidence 899999999999999999999994 444544555554444333222110 1
Q ss_pred HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 289 LCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 289 ~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..++.+.+||.+||+.||++|||+.++++
T Consensus 302 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 302 VLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 14667899999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=292.10 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=186.2
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDK 104 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~ 104 (354)
.+....++|++.+.||+|+||.||+|.+.+ +..||+|++..... .....+. |++++++++..
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 345567899999999999999999999653 33599999976532 2222222 44555666654
Q ss_pred CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 105 DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 5578999999999999988 577889999999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||. ..........+.........
T Consensus 162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~--~~~~~~~~~~~~~~~~~~~~-- 236 (281)
T 3cc6_A 162 YIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF--WLENKDVIGVLEKGDRLPKP-- 236 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT--TSCGGGHHHHHHHTCCCCCC--
T ss_pred cccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc--cCChHHHHHHHhcCCCCCCC--
Confidence 55433211 1222356778999999998899999999999999999998 999954 33333333333322211100
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..+++.+.++|.+||+.||++|||++++++.|+++..
T Consensus 237 ------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 237 ------------------------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0146678999999999999999999999999998763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=296.65 Aligned_cols=236 Identities=24% Similarity=0.322 Sum_probs=190.1
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~------------~~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+ .|++++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45688999999999999999999976 5899999998654321 11122 25566778888889
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----CeEEeeccc
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGI 176 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~~l~dfg~ 176 (354)
..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++ .++|+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999998 678899999999999999999999 99999999999999887 799999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+........ .....++..|+|||++.+..++.++|+|||||++|+|++|..|| .+....+....+.......+.
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf--~~~~~~~~~~~i~~~~~~~~~- 239 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF--LGDTKQETLANITSVSYDFDE- 239 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS--CCSSHHHHHHHHHTTCCCCCH-
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC--CCCCHHHHHHHHHhcccccCh-
Confidence 976554322 12346899999999999889999999999999999999999995 444444444444433322211
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
......++.+.+||.+||+.||++|||++++++
T Consensus 240 ----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 240 ----------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111225677899999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=312.65 Aligned_cols=265 Identities=22% Similarity=0.237 Sum_probs=185.1
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHH------------HHHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLREL------------KNKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~------------~~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+ .||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 45689999999999999999999965 58899999997542 1111111 2556667777544
Q ss_pred -CceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 105 -DEKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..+|+||||++++ +...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 139 ~~~~~lv~E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 139 FQDVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CCEEEEEEECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CCeEEEEEeCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 3569999999875 44444 788889999999999999999999 999999999999999999999999999765
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|++|| .+.+..+....+.+..+.........
T Consensus 215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF--~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 215 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp --CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred CCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 4332 123357899999999999999999999999999999999999995 55555555555544433322211111
Q ss_pred cccc--c-------cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTF--G-------FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~--~-------~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.... . .........................++.+.+||.+||+.||++|||++|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0 00000000000000011122233357889999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=299.83 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=192.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCE--EEEEEecCCChh-hH----H---------HHHHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDE--IAVKRLSGRSGQ-GL----R---------ELKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~--vavK~~~~~~~~-~~----~---------~~~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||.||+|+++ ++.. +|+|.+...... .. . .+.|++++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999965 4554 499988653221 11 1 12366677788888899999
Q ss_pred EEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 110 IYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 110 v~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 99999999999887 356778999999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhh
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYIS 247 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~ 247 (354)
++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..|| .+.........+.
T Consensus 181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf--~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP 255 (327)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHGG
T ss_pred EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC--CCCcHHHHHHHhh
Confidence 9999999986322211 1122345778999999988889999999999999999998 99995 4444444444443
Q ss_pred ccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcC
Q 048432 248 ENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 327 (354)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~ 327 (354)
.+...... ..+++.+.+||.+||+.||++|||++++++.|+++.....
T Consensus 256 ~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 256 QGYRLEKP--------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GTCCCCCC--------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCCCCCC--------------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 32211100 0146678999999999999999999999999999997766
Q ss_pred CCCCCCccc
Q 048432 328 PPKQPAFSY 336 (354)
Q Consensus 328 ~~~~~~~~~ 336 (354)
...+.....
T Consensus 304 ~~~~~~~~~ 312 (327)
T 1fvr_A 304 TYVNTTLYE 312 (327)
T ss_dssp CSBCCBCTT
T ss_pred Cccccchhc
Confidence 655554433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=302.60 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=168.4
Q ss_pred cCcccc---ceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH----------HHHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDA---NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE----------LKNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~---~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~----------~~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
.+|++. +.||+|+||.||+|.++ +++.||+|++.........+ +.|++++++++.+....++||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 456554 88999999999999975 58999999997654322211 33667788889999999999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeEEeecccceeccCCcc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGIARICRGNEL 185 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~l~dfg~a~~~~~~~~ 185 (354)
+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++........
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999999988 688899999999999999999999 99999999999998766 799999999975443321
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-----chhhhhhhhccccCCCCcccCC
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-----SFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||...... ..+....+..+....+.
T Consensus 165 ~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~----- 237 (325)
T 3kn6_A 165 P--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG----- 237 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS-----
T ss_pred c--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc-----
Confidence 1 22346789999999999999999999999999999999999996443221 22333444333332211
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
......++.+.+||.+||+.||++|||++++++
T Consensus 238 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 ------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111225678899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.18 Aligned_cols=233 Identities=13% Similarity=0.142 Sum_probs=177.8
Q ss_pred chhhhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCC---hhh----HHH-----------HHHHHHHh----
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRS---GQG----LRE-----------LKNKLRLL---- 98 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~---~~~----~~~-----------~~~i~~~~---- 98 (354)
.+....++|++.+.||+|+||.||+|.+ .+|+.||||++.... ... .++ +.|+++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3445568999999999999999999996 469999999986321 111 122 34888888
Q ss_pred ---ceeecCC-----------------ceEEEEEecCCCCHhHHHh-----h-------HHHHHHHHHHHHHHHHHHHhc
Q 048432 99 ---GCCIDKD-----------------EKILIYEYMPNKSLDFFLF-----D-------WVTRVRIIEGIAQGLLYLHQY 146 (354)
Q Consensus 99 ---~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~-----~-------~~~~~~i~~~i~~~l~~LH~~ 146 (354)
+++...+ ..|++|||+ +|+|.+++. + +..+..++.||+.||.|||+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 4544443 378999999 579998882 2 467788999999999999999
Q ss_pred CCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccC-----------CCCchhhH
Q 048432 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-----------IFSIKSDV 215 (354)
Q Consensus 147 ~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di 215 (354)
+ |+||||||+|||++.++.++|+|||++...... .....| ..|+|||++.+. .++.++||
T Consensus 226 ~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 226 G---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp T---EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred C---eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9 999999999999999999999999999753321 123456 899999999887 79999999
Q ss_pred HHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHH
Q 048432 216 FSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYV 295 (354)
Q Consensus 216 wSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~ 295 (354)
|||||++|+|++|..||. ..........+.... ..+++.+.
T Consensus 297 wSlG~il~elltg~~Pf~--~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~ 337 (377)
T 3byv_A 297 WALGLVIYWIWCADLPIT--KDAALGGSEWIFRSC-------------------------------------KNIPQPVR 337 (377)
T ss_dssp HHHHHHHHHHHHSSCCC--------CCSGGGGSSC-------------------------------------CCCCHHHH
T ss_pred HHHHHHHHHHHHCCCCCc--ccccccchhhhhhhc-------------------------------------cCCCHHHH
Confidence 999999999999999953 333222222221110 01466789
Q ss_pred HHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 296 NIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 296 ~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
+||.+||+.||++|||+.++++ .++++.
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 9999999999999999999986 444443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.26 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=184.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++.+.||+|+||.||+|.++ +++.||+|++..... .....+. |++++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999976 689999999865432 1112222 5566777888888999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|.+++ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999998887 678899999999999999999999 999999999999999999999999998765433222
Q ss_pred cccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.......++..|+|||++.+..+ +.++|+||||+++|+|++|..||............ ........+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~---------- 230 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNP---------- 230 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-HHTTCTTSTT----------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-hhhcccccCc----------
Confidence 22334578999999999987665 78899999999999999999996443322221111 1111110000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....++.+.+||.+||+.||++|||++|+++
T Consensus 231 ---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ---------------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------------------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0114667889999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=300.01 Aligned_cols=243 Identities=28% Similarity=0.424 Sum_probs=187.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|++. +++.||+|++..... .....+ .|++++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45689999999999999999999832 477899999975432 222222 25566778888888
Q ss_pred ceEEEEEecCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCCeE
Q 048432 106 EKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPK 170 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~~ 170 (354)
..++||||+++++|.+++ +++..++.++.||+.||.|||+.+ |+|+||||+||+++. +..++
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999988 456778999999999999999999 999999999999984 44699
Q ss_pred EeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhcc
Q 048432 171 ISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISEN 249 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 249 (354)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..|| ...........+..+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~--~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEVLEFVTSG 261 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS--TTCCHHHHHHHHHTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC--CCcCHHHHHHHHhcC
Confidence 999999875443332222333467889999999999999999999999999999998 88885 334444444444433
Q ss_pred ccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
....+.. .++..+.+||.+||+.||++|||++++++.|+.+..
T Consensus 262 ~~~~~~~--------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 GRMDPPK--------------------------------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCCCT--------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC--------------------------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 2211111 156678999999999999999999999999998874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.95 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=194.9
Q ss_pred cCCCCCccccchhhhhcCcccc-ceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHH-------------HHH
Q 048432 32 VDQLPLFSFSSVSTATNKFSDA-NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLREL-------------KNK 94 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~-------------~~i 94 (354)
++.-+-+.+.......++|.+. +.||+|+||.||+|.++ +++.||+|++...... ....+ .|+
T Consensus 12 ~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i 91 (327)
T 3lm5_A 12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91 (327)
T ss_dssp ----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred cccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence 3455667788888899999998 89999999999999976 5999999998754221 11111 255
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-- 165 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-- 165 (354)
+++++++...+..++||||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIY 168 (327)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBT
T ss_pred EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCC
Confidence 66777888889999999999999998887 678899999999999999999999 999999999999987
Q ss_pred -CCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhh
Q 048432 166 -DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244 (354)
Q Consensus 166 -~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~ 244 (354)
++.++|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++|..|| ...+..+...
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf--~~~~~~~~~~ 243 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF--VGEDNQETYL 243 (327)
T ss_dssp TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHH
T ss_pred CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCC--CCCCchHHHH
Confidence 78999999999976544322 12246899999999999999999999999999999999999995 4444444444
Q ss_pred hhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 245 YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+.......+.... ..+++.+.+||.+||+.||++|||++++++.
T Consensus 244 ~i~~~~~~~~~~~~-----------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 NISQVNVDYSEETF-----------------------------SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHTCCCCCTTTT-----------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHhcccccCchhh-----------------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 44433333222111 1156678899999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.78 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=188.9
Q ss_pred ccccchhhhhcCccccc-eecccCceeEEEEEEc---CCCEEEEEEecCCChh--hHHHHH------------HHHHHhc
Q 048432 38 FSFSSVSTATNKFSDAN-KLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ--GLRELK------------NKLRLLG 99 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~-~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~--~~~~~~------------~i~~~~~ 99 (354)
+...++....++|++.+ .||+|+||.||+|.+. .++.||+|++...... ....+. |++++++
T Consensus 6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34455566678999998 9999999999999643 3678999999765321 122222 4455666
Q ss_pred eeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
++ ..+..++||||+++++|.+++ ++...+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 66 557789999999999999988 678889999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccC
Q 048432 175 GIARICRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 175 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
|++......... .......++..|+|||.+.+..++.++||||||+++|+|++ |..|| ...........+..+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~--~~~~~~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTAMLEKGERM 239 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHTTCCC
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHHHHcCCCC
Confidence 999765443221 11222345678999999988889999999999999999999 99995 344444444443332211
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.. +..+++.+.++|.+||+.||++|||++++++.|+++...
T Consensus 240 ~~--------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 GC--------------------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CC--------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CC--------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 10 011567889999999999999999999999999998743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=315.69 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=194.4
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCCh------hhHHH---------HHHHHHHhcee
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSG------QGLRE---------LKNKLRLLGCC 101 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~------~~~~~---------~~~i~~~~~~~ 101 (354)
..+..+....++|++.+.||+|+||.||+|++++ ++.||+|++..... ....+ +.+++++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666677899999999999999999999765 78899999864211 11111 12556778889
Q ss_pred ecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
.+.+.+|+|||||.+|+|..++ +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999988 578889999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
++......... .....+||+.|+|||++. ...++.++|+|||||++|+|++|..| |.+.+..+....+....
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P--f~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYAESLVETYGKIMNHK 297 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT--TCCSSHHHHHHHHHTHH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC--CCCCChhHHHHhhhhcc
Confidence 99765433221 222357899999999987 45689999999999999999999999 45555555555554432
Q ss_pred c--CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 048432 251 Y--EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADD--RPTMNDVVSM 318 (354)
Q Consensus 251 ~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~il~~ 318 (354)
. .+|.... ..++.+.+||.+||..+|++ ||+++|+++.
T Consensus 298 ~~~~~p~~~~------------------------------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQFPTQVT------------------------------DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCCCSSCC------------------------------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCcccc------------------------------cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2 2222110 04667889999999999988 9999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.73 Aligned_cols=233 Identities=28% Similarity=0.370 Sum_probs=185.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH------------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+ .|++++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 345689999999999999999999976 47789999985432111 1111 2566778888888999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+++++|.+++ ++...+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999887 678889999999999999999999 99999999999999999999999998854333
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. .....++..|+|||++.+..++.++||||||+++|+|++|..|| ......+....+.......+..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~------ 229 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVEFTFPDF------ 229 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT--CCSSHHHHHHHHHHTCCCCCTT------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC--CCCcHHHHHHHHHhCCCCCCCc------
Confidence 22 12346789999999999888999999999999999999999995 4444444444444333322211
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.++.+.+||.+||+.||++|||++|+++.
T Consensus 230 ---------------------------~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 ---------------------------VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---------------------------SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---------------------------CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 45678899999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=295.80 Aligned_cols=233 Identities=23% Similarity=0.339 Sum_probs=176.4
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCC------
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKD------ 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~------ 105 (354)
..++|++.+.||+|+||.||+|+++ +|+.||||++...... ....+. |++++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999976 6999999999754322 222233 4455555554332
Q ss_pred ---------------------------------------------------ceEEEEEecCCCCHhHHH--------hhH
Q 048432 106 ---------------------------------------------------EKILIYEYMPNKSLDFFL--------FDW 126 (354)
Q Consensus 106 ---------------------------------------------------~~~lv~e~~~~~~L~~~~--------~~~ 126 (354)
..++|||||++++|.+++ ..+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 379999999999999998 334
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc----------cccccccCcc
Q 048432 127 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ----------ANTGRIVGTY 196 (354)
Q Consensus 127 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~----------~~~~~~~~~~ 196 (354)
..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 568899999999999999999 999999999999999999999999999865543211 1123346899
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhh
Q 048432 197 RYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFS 276 (354)
Q Consensus 197 ~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 276 (354)
.|+|||++.+..++.++|||||||++|+|++|..|+ .. .......+....
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~--~~--~~~~~~~~~~~~-------------------------- 290 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ--ME--RVRIITDVRNLK-------------------------- 290 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH--HH--HHHHHHHHHTTC--------------------------
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh--hH--HHHHHHHhhccC--------------------------
Confidence 999999999999999999999999999999987662 11 111111111110
Q ss_pred ccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 277 ISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+......++.+.+||.+||+.||++|||++|+++
T Consensus 291 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 291 ------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ------CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11222335677799999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=303.17 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=180.8
Q ss_pred hhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCCh-hhHHHHH------------HHHHHhceee-cCCc
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCI-DKDE 106 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~-~~~~ 106 (354)
.....|++.+.||+|+||.||+|.+.+ +..||+|.+..... .....+. |++++++++. .++.
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 344568889999999999999999642 23589999865432 2222222 5667777754 4567
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 89999999999999998 567889999999999999999999 999999999999999999999999999754
Q ss_pred cCCccc--cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 181 RGNELQ--ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 181 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |.+|| ...+..+....+..+.......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~--~~~~~~~~~~~~~~~~~~~~p~- 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRLLQPE- 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC--TTSCSSCHHHHHHTTCCCCCCT-
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCC--CCCCHHHHHHHHHcCCCCCCCC-
Confidence 332211 11223456778999999999999999999999999999999 56664 3333333333333332211110
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcC
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 327 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~ 327 (354)
.++..+.++|.+||+.||++|||++++++.|+++.....
T Consensus 320 -------------------------------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 320 -------------------------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 156778999999999999999999999999999986554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=297.73 Aligned_cols=241 Identities=25% Similarity=0.315 Sum_probs=179.2
Q ss_pred hhcCcccc-ceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH-------------HHHHHHHhceeecCCceEEE
Q 048432 46 ATNKFSDA-NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE-------------LKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 46 ~~~~y~~~-~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~-------------~~~i~~~~~~~~~~~~~~lv 110 (354)
..++|++. +.||+|+||.||+|.+. +++.||||++.......... +.|++++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45788885 78999999999999964 69999999997654322222 22556677888888999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC---eEEeecccceeccC
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGIARICRG 182 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~~l~dfg~a~~~~~ 182 (354)
|||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++|+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999988 678889999999999999999999 999999999999988776 99999999865432
Q ss_pred Ccc-----ccccccccCcccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-------------
Q 048432 183 NEL-----QANTGRIVGTYRYMSPEYAIQ-----GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS------------- 239 (354)
Q Consensus 183 ~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~------------- 239 (354)
... ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 111122458999999999875 457889999999999999999999964332211
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+...+..+....+ .......+..+.+||.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~i~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFP-----------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCC-----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccC-----------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111122222211111 11111256778999999999999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.10 Aligned_cols=239 Identities=27% Similarity=0.476 Sum_probs=183.1
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH-------HHHH------------HHHHHhceeecC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL-------RELK------------NKLRLLGCCIDK 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~-------~~~~------------~i~~~~~~~~~~ 104 (354)
...++|++.+.||+|+||.||+|++. +++.||+|++........ ..+. |++++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44589999999999999999999975 699999999865432111 2222 444555665544
Q ss_pred CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC-----eEEee
Q 048432 105 DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-----PKISD 173 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~~l~d 173 (354)
. ++||||+++++|.+.+ +++..+..++.|++.||.|||+.+ .+|+|+||||+||+++.++. ++|+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 3 7999999999998877 678899999999999999999874 34999999999999988776 99999
Q ss_pred cccceeccCCccccccccccCcccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 174 FGIARICRGNELQANTGRIVGTYRYMSPEYAI--QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 174 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
||++...... .....++..|+|||++. ...++.++|||||||++|+|++|..||.............+.....
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 9998743332 22346889999999984 4457899999999999999999999975544433333333322221
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.... +..+++.+.+||.+||+.||++|||++++++.|+++
T Consensus 248 ~~~~-------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPTI-------------------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCC-------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCC-------------------------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 111567889999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=312.07 Aligned_cols=244 Identities=22% Similarity=0.253 Sum_probs=191.9
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhHHH---------HHHHHHHhcee
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGLRE---------LKNKLRLLGCC 101 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~~~---------~~~i~~~~~~~ 101 (354)
+.+.++....++|++.+.||+|+||.||+|+++ +|+.||+|++.+... ....+ +.+++++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666777899999999999999999999975 699999999965321 11111 12556677888
Q ss_pred ecCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
.+.+.+|+||||+++|+|..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999987 567888999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAI-------QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
++......... .....+||+.|+|||++. ...++.++|+|||||++|+|++|..|| ...+..+....+..
T Consensus 208 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf--~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 208 SCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF--YADSTAETYGKIVH 284 (412)
T ss_dssp TCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT--CCSSHHHHHHHHHT
T ss_pred hheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC--CCCCHHHHHHHHHh
Confidence 99765433211 122357899999999987 356899999999999999999999994 55555555555543
Q ss_pred cc--cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCC---CCHHHHHHH
Q 048432 249 NI--YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR---PTMNDVVSM 318 (354)
Q Consensus 249 ~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~~il~~ 318 (354)
.. ...|.. ....++.+.+||.+||. +|++| |+++++++.
T Consensus 285 ~~~~~~~p~~------------------------------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHLSLPLV------------------------------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHCCCC----------------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCcCCCcc------------------------------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 22 111111 01156788999999999 99998 589999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=297.63 Aligned_cols=234 Identities=23% Similarity=0.341 Sum_probs=188.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC---hhhHHHH------------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS---GQGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~---~~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+ .|++++++++.+.+..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 456789999999999999999999976 48899999986542 1111222 2556778888888999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+.+++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999999887 678899999999999999999999 99999999999999999999999999976543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||. .....+....+.......+.
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~--~~~~~~~~~~~~~~~~~~~~------- 262 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPK------- 262 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC--CSSHHHHHHHHHHTCCCCCT-------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC--CCCHHHHHHHHhcCCCCCCc-------
Confidence 221 1223468899999999998889999999999999999999999953 33333333333332222211
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+..+.+||.+||+.||++|||++++++
T Consensus 263 --------------------------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 --------------------------HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --------------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --------------------------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 04556889999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.44 Aligned_cols=239 Identities=25% Similarity=0.415 Sum_probs=188.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH--------HHHHHhceeec-----------
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK--------NKLRLLGCCID----------- 103 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~--------~i~~~~~~~~~----------- 103 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++........+++. |++++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 445688999999999999999999976 6999999999876554444433 45556665543
Q ss_pred -----CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEE
Q 048432 104 -----KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI 171 (354)
Q Consensus 104 -----~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l 171 (354)
...+++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEE
Confidence 34579999999999999988 567889999999999999999999 999999999999999999999
Q ss_pred eecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 172 SDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 172 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++|..|+. ... .....+.....
T Consensus 164 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~--~~~--~~~~~~~~~~~ 236 (284)
T 2a19_B 164 GDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETS--KFFTDLRDGII 236 (284)
T ss_dssp CCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH--HHH--HHHHHHHTTCC
T ss_pred Ccchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch--hHH--HHHHHhhcccc
Confidence 99999876544332 223467899999999998889999999999999999999998842 111 11111111100
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcC
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALL 327 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~ 327 (354)
+ ...+..+.+||.+||+.||++|||+.++++.|+.+.....
T Consensus 237 --~---------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 237 --S---------------------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --C---------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --c---------------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0 0045567899999999999999999999999999885443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.10 Aligned_cols=265 Identities=17% Similarity=0.230 Sum_probs=184.7
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH----------HHHHHHhceeec--CCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL----------KNKLRLLGCCID--KDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~----------~~i~~~~~~~~~--~~~~~lv~ 111 (354)
...++|++.+.||+|+||.||+|.+. +++.||+|++........... .|++++++++.. ....++||
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 34578999999999999999999964 689999999986554332221 244555666666 66789999
Q ss_pred EecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCCccccc
Q 048432 112 EYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 112 e~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~~~~~~ 188 (354)
||+.+++|..++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++........
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--- 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--- 186 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---
Confidence 999999999988 778889999999999999999999 99999999999999777 899999999976544332
Q ss_pred cccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ...+....+.............. ......
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~ 264 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVRIAKVLGTEDLYDYID-KYNIEL 264 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS-SHHHHHHHHHHHHCHHHHHHHHH-HTTCCC
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC-chHHHHHHHHHhcCCchhhhHHH-Hhcccc
Confidence 223467889999999877 568999999999999999999999973322 22222222111111000000000 000000
Q ss_pred hhhhhhhhhccc-----cCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISS-----VGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+........... ...........++.+.+||.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 00011111225678899999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=312.82 Aligned_cols=241 Identities=25% Similarity=0.322 Sum_probs=191.4
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-------------hHHHH------------HH
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-------------GLREL------------KN 93 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-------------~~~~~------------~~ 93 (354)
........++|++.+.||+|+||.||+|.++ +++.||+|++...... ....+ .|
T Consensus 28 ~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 107 (504)
T 3q5i_A 28 RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107 (504)
T ss_dssp CEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred eccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence 3344557789999999999999999999976 4889999998654211 11111 26
Q ss_pred HHHHhceeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-
Q 048432 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM- 167 (354)
Q Consensus 94 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~- 167 (354)
++++++++.+...+++|||||.+++|.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 667788899999999999999999998887 678899999999999999999999 99999999999998776
Q ss_pred --CeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh
Q 048432 168 --NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 168 --~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~ 245 (354)
.++|+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|.+| |.+.+..+....
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p--f~~~~~~~~~~~ 258 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQDIIKK 258 (504)
T ss_dssp CSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHH
T ss_pred CccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCC--CCCCCHHHHHHH
Confidence 699999999976554332 22346899999999876 4689999999999999999999999 555666666666
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+..+...++...+ ...++.+.+||.+||+.||++|||++|+++.
T Consensus 259 i~~~~~~~~~~~~-----------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGKYYFDFNDW-----------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCCCCCCHHHH-----------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCCCcccc-----------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 6665544332111 1146778999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=296.46 Aligned_cols=250 Identities=20% Similarity=0.230 Sum_probs=181.2
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHHH------------HHHHHhceeecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRELK------------NKLRLLGCCIDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~~------------~i~~~~~~~~~~~~ 106 (354)
.....++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+. |++++++++..++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 4455689999999999999999999975 58899999997643221 12222 55667778888899
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.++++||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999988 678889999999999999999999 9999999999999999999999999987554
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..||.. .........+..... .+...
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--~~~~~~~~~~~~~~~-~~~~~---- 257 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG--DQLSVMGAHINQAIP-RPSTV---- 257 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS--CHHHHHHHHHHSCCC-CGGGT----
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC--chHHHHHHHhccCCC-Ccccc----
Confidence 33211 12234678999999999988899999999999999999999999543 332222222221111 11000
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHhhhhhhhcCC
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAALLP 328 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~il~~L~~~~~~~~~ 328 (354)
++.++..+.++|.+||+.||++|| |++++++.|++.......
T Consensus 258 -------------------------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 258 -------------------------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp -------------------------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred -------------------------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 111566788999999999999999 999999999998755443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=308.57 Aligned_cols=269 Identities=20% Similarity=0.240 Sum_probs=195.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhh-H----HHH--------HHHHHHhceeecCC--c
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG-L----REL--------KNKLRLLGCCIDKD--E 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~-~----~~~--------~~i~~~~~~~~~~~--~ 106 (354)
.....++|++.+.||+|+||.||+|.++. |+.||+|++....... . +++ .|++++++++.... .
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34567899999999999999999999764 9999999997543211 1 111 25566677776554 7
Q ss_pred eEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCCeEEeec
Q 048432 107 KILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDF 174 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~~l~df 174 (354)
.++||||+++++|.+++ +++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecC
Confidence 79999999999999988 577889999999999999999999 9999999999999 77778999999
Q ss_pred ccceeccCCccccccccccCcccccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCcccc--cchhhhh
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQ--------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT--YSFTLLG 244 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~--~~~~~~~ 244 (354)
|++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+...
T Consensus 161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 99976544332 123468999999999865 4577899999999999999999999643222 2233333
Q ss_pred hhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 245 YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.+..+.+............ ....+..............+..+.++|.+||+.||++|||++++++.|+++..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAEN--------GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHSCCTTCCEEEECSTT--------CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhheeccC--------CCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 3333322111100000000 00000000111122334588899999999999999999999999999998764
Q ss_pred h
Q 048432 325 A 325 (354)
Q Consensus 325 ~ 325 (354)
.
T Consensus 310 ~ 310 (396)
T 4eut_A 310 R 310 (396)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=297.65 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHH-----------HHHHHHHhceeecCC-
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRE-----------LKNKLRLLGCCIDKD- 105 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~-----------~~~i~~~~~~~~~~~- 105 (354)
.++.......++|++.+.||+|+||.||+|++ +|+.||+|++.......... +.|++++++++....
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 44444566778999999999999999999998 48999999997654332211 124556667776665
Q ss_pred ---ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeCCCCCCCEEEcCCCCeE
Q 048432 106 ---EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLH--------QYSRVRIIHRDLKVSNILLDKDMNPK 170 (354)
Q Consensus 106 ---~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~~ 170 (354)
..++||||+++++|.+++ +++..+..++.|++.||.||| +.+ |+|+||||+||+++.++.++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence 789999999999999998 678899999999999999999 788 99999999999999999999
Q ss_pred EeecccceeccCCcccc--ccccccCcccccCccccccCC------CCchhhHHHHHHHHHHHHhC----------CCCC
Q 048432 171 ISDFGIARICRGNELQA--NTGRIVGTYRYMSPEYAIQGI------FSIKSDVFSFGVLLLKIVSG----------KKTT 232 (354)
Q Consensus 171 l~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwSlG~~l~~ll~g----------~~p~ 232 (354)
|+|||++.......... ......++..|+|||++.+.. ++.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997655433211 223347899999999987653 33689999999999999999 5564
Q ss_pred Cccccc---chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCC
Q 048432 233 GFYRTY---SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR 309 (354)
Q Consensus 233 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 309 (354)
...... .......+...... +... .......++..+.+||.+||+.||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLR-PNIP-------------------------NRWQSCEALRVMAKIMRECWYANGAAR 321 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCC-CCCC-------------------------GGGGTSHHHHHHHHHHHHHCCSSGGGS
T ss_pred cccCcCcccHHHHHHHHHHHHhC-CCCc-------------------------ccccchhHHHHHHHHHHHHhccChhhC
Confidence 322111 11111111111110 0000 000112378889999999999999999
Q ss_pred CCHHHHHHHhhhhhhh
Q 048432 310 PTMNDVVSMLTNEAAA 325 (354)
Q Consensus 310 ps~~~il~~L~~~~~~ 325 (354)
||++++++.|+++...
T Consensus 322 ps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 322 LTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHHH
Confidence 9999999999998743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=313.71 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=193.5
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--h----hHHHH--------HHHHHHhceeec
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--Q----GLREL--------KNKLRLLGCCID 103 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~----~~~~~--------~~i~~~~~~~~~ 103 (354)
-........++|++.+.||+|+||.||+|+++ ++..||+|++..... . ..+++ .|++++++++.+
T Consensus 28 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp CCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 33444556778999999999999999999976 588999999865421 1 11121 266778889999
Q ss_pred CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CCeEEeecc
Q 048432 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFG 175 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~~l~dfg 175 (354)
...+++|||||.+++|.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.. +.++|+|||
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 99999999999999998877 678889999999999999999999 9999999999999764 459999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
++........ .....||+.|+|||++. ..++.++||||+||++|+|++|.+| |.+....++...+..+...++.
T Consensus 185 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~p--f~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 185 LSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP--FGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp TCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCCCCS
T ss_pred CCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCC--CCCCCHHHHHHHHHhCCCCCCc
Confidence 9976554332 22346899999999876 5689999999999999999999999 5556666677777666555433
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
..+.. .++.+.+||.+||+.||++|||++++++. |++..
T Consensus 259 ~~~~~-----------------------------~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 259 PEWKN-----------------------------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp GGGTT-----------------------------SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred hhccc-----------------------------CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 22111 45678899999999999999999999864 54443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=288.16 Aligned_cols=238 Identities=22% Similarity=0.310 Sum_probs=186.3
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeecC--Cce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCIDK--DEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~~--~~~ 107 (354)
....++|++.+.||+|+||.||+|.++ ++.||+|++.... ......+. |++++++++.+. +..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 345679999999999999999999985 8889999997653 22222333 556677777766 788
Q ss_pred EEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 108 ILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ..++|+||||+||+++.++.++++|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999998 578899999999999999999863 34999999999999999999999999886532
Q ss_pred cCCccccccccccCcccccCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFS---IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
.. ....+++.|+|||++.+..++ .++|||||||++|+|++|..||. ..........+.......+.
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~--~~~~~~~~~~~~~~~~~~~~-- 232 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA--DLSNMEIGMKVALEGLRPTI-- 232 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT--TSCHHHHHHHHHHSCCCCCC--
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc--ccChHHHHHHHHhcCCCCCC--
Confidence 22 123678999999999876544 48999999999999999999953 33333333332222211111
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+..+++.+.++|.+||+.||++|||++++++.|+++.
T Consensus 233 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 -----------------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0115677899999999999999999999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=303.21 Aligned_cols=237 Identities=23% Similarity=0.341 Sum_probs=187.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh----hh----HHH-------------HHHHHHHhcee
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG----QG----LRE-------------LKNKLRLLGCC 101 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~----~~----~~~-------------~~~i~~~~~~~ 101 (354)
....++|++.+.||+|++|.||+|.++ +|+.||||++..... .. ... +.|++++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445578999999999999999999986 699999999865431 00 111 12445566778
Q ss_pred ecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
......++||||+++++|.+++ +++..+..++.||+.||.|||+.| |+|+||||+||+++.++.++|+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCc
Confidence 8889999999999999999987 678889999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCccccccccccCcccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQG------IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
+........ .....|++.|+|||++.+. .++.++|||||||++|+|++|..|| ...........+..+.
T Consensus 247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf--~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF--WHRRQILMLRMIMEGQ 321 (365)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHTC
T ss_pred ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC--CCCCHHHHHHHHHhCC
Confidence 876554332 2235789999999998643 5788999999999999999999995 4444444444444433
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+...+ ...+..+.+||.+||+.||++|||++++++
T Consensus 322 ~~~~~~~~-----------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 YQFSSPEW-----------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCCHHHH-----------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCccc-----------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 32211110 114567899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.21 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=189.6
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh---------h-----HHHHHHHHHHhceeec
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ---------G-----LRELKNKLRLLGCCID 103 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~---------~-----~~~~~~i~~~~~~~~~ 103 (354)
.....+....++|++.+.||+|+||.||+|.++. .||+|++...... + .-.+.|++++++++..
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4556667778999999999999999999999753 4999998643210 0 0123488899999999
Q ss_pred CCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 104 KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++ ++.++|+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999998 678899999999999999999999 99999999999998 679999999997
Q ss_pred eeccCCc---cccccccccCcccccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhh
Q 048432 178 RICRGNE---LQANTGRIVGTYRYMSPEYAIQ---------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245 (354)
Q Consensus 178 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~ 245 (354)
....... .........++..|+|||++.+ ..++.++|||||||++|+|++|..|| ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~--~~~~~~~~~~~ 254 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEAIIWQ 254 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS--SSCCHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHH
Confidence 6543211 1112223457899999999864 34789999999999999999999995 44444444444
Q ss_pred hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+..+........ .++..+.+||.+||..||++|||++++++.|+++...
T Consensus 255 ~~~~~~~~~~~~-------------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 255 MGTGMKPNLSQI-------------------------------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHTTCCCCCCCS-------------------------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred hccCCCCCCCcC-------------------------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 433322111100 0345678999999999999999999999999999988
Q ss_pred cCCCCCCCcccccc
Q 048432 326 LLPPKQPAFSYVRN 339 (354)
Q Consensus 326 ~~~~~~~~~~~~~~ 339 (354)
......|..+|.++
T Consensus 304 ~~~~~~~~~~~~~~ 317 (319)
T 2y4i_B 304 NRRLSHPGHFWKSA 317 (319)
T ss_dssp --------------
T ss_pred hccCCCCccccccc
Confidence 88877777777653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=311.72 Aligned_cols=237 Identities=28% Similarity=0.386 Sum_probs=190.8
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-----h-hHHHH--------HHHHHHhceeecCCceE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----Q-GLREL--------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-----~-~~~~~--------~~i~~~~~~~~~~~~~~ 108 (354)
....++|++.+.||+|+||.||+|.++ +++.||+|++..... . ..+++ .|++++++++.+....+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 456789999999999999999999975 699999999854211 1 11111 26677888899999999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCCeEEeecccceec
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGIARIC 180 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~~l~dfg~a~~~ 180 (354)
+|||||.+++|.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.++|+|||++...
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999998877 678899999999999999999999 99999999999995 4567999999998755
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|.+| |.+....+....+..+....+...+.
T Consensus 175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p--f~~~~~~~~~~~i~~~~~~~~~~~~~- 247 (486)
T 3mwu_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQWR- 247 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCCSCSGGGG-
T ss_pred CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCC--CCCCCHHHHHHHHHhCCCCCCCcccC-
Confidence 43322 223468999999998875 589999999999999999999999 55666666666666655443322211
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||+.++++.
T Consensus 248 ----------------------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 ----------------------------TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----------------------------GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 146678899999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=302.27 Aligned_cols=239 Identities=10% Similarity=0.018 Sum_probs=169.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHH--------------HHHHHHHHh-------
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLR--------------ELKNKLRLL------- 98 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~--------------~~~~i~~~~------- 98 (354)
.....+|++.+.||+|+||.||+|.+. +|+.||+|++...... ... .+.|+++++
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 334566999999999999999999975 6899999999875421 111 133544433
Q ss_pred ceeecC-----------------CceEEEEEecCCCCHhHHHh------hHHHH------HHHHHHHHHHHHHHHhcCCC
Q 048432 99 GCCIDK-----------------DEKILIYEYMPNKSLDFFLF------DWVTR------VRIIEGIAQGLLYLHQYSRV 149 (354)
Q Consensus 99 ~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~------~~~~~------~~i~~~i~~~l~~LH~~~~~ 149 (354)
+++... ..+++||||++ ++|.+++. ....+ ..++.||+.||+|||+++
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 222221 33799999999 79998882 23334 677799999999999999
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHh
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVS 227 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~ 227 (354)
|+||||||+|||++.++.++|+|||++........ ...++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999986543221 2355699999999987 678999999999999999999
Q ss_pred CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCC
Q 048432 228 GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESAD 307 (354)
Q Consensus 228 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 307 (354)
|..||......................... ......+++.+.+||.+||+.||+
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~ 342 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLA--------------------------FGSCTPLPDFVKTLIGRFLNFDRR 342 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCC--------------------------CTTSSCCCHHHHHHHHHHTCSSTT
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccc--------------------------hhhccCCCHHHHHHHHHHcCCChh
Confidence 999965432221111111000000000000 000011567889999999999999
Q ss_pred CCCCHHHHHH
Q 048432 308 DRPTMNDVVS 317 (354)
Q Consensus 308 ~Rps~~~il~ 317 (354)
+|||++++++
T Consensus 343 ~Rpt~~e~l~ 352 (371)
T 3q60_A 343 RRLLPLEAME 352 (371)
T ss_dssp TCCCHHHHTT
T ss_pred hCCCHHHHhc
Confidence 9999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=293.68 Aligned_cols=235 Identities=23% Similarity=0.302 Sum_probs=188.2
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
...++|++.+.||+|+||.||+|++. +|+.||+|++..........+. |++++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45689999999999999999999975 6999999999765332222222 5566777888889999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccceeccCC
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a~~~~~~ 183 (354)
||+++++|.+++ ++...+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999998887 578889999999999999999999 9999999999999 77889999999998653332
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
. .....++..|+|||++.+..++.++|||||||++|+|++|..|| ...........+..+....+....
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~----- 231 (304)
T 2jam_A 163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF--YEETESKLFEKIKEGYYEFESPFW----- 231 (304)
T ss_dssp T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT--TTSCHHHHHHHHHHCCCCCCTTTT-----
T ss_pred c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC--CCCCHHHHHHHHHcCCCCCCcccc-----
Confidence 1 12246789999999999989999999999999999999999994 444445555555544433222111
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...++.+.+||.+||+.||++|||++++++
T Consensus 232 ------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 232 ------------------------DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ------------------------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 014667899999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.37 Aligned_cols=263 Identities=21% Similarity=0.259 Sum_probs=182.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HHHH------------HHHHHHhceeecCCceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
.++|++.+.||+|+||.||+|.+. +|+.||+|++....... ...+ .|++++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 478999999999999999999976 49999999986553321 1111 25567788888889999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
||+++++|..++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999998887 678899999999999999999999 999999999999999999999999999765433221
Q ss_pred cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....++..|+|||++.+ ..++.++||||||+++|+|++|..||. +....+....+...................
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP--GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC--CSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHHHHhccccccccccccccc
Confidence 123467899999999876 567999999999999999999999953 344333333332222211110000000000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+.... ...............+..+..+.+||.+||+.||++|||++|+++.
T Consensus 235 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGV--KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTC--CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccC--cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000000000000112256778999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=301.15 Aligned_cols=272 Identities=18% Similarity=0.231 Sum_probs=192.3
Q ss_pred CCCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------------HH
Q 048432 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------------NK 94 (354)
Q Consensus 34 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------------~i 94 (354)
....+.+.......++|++.+.||+|+||.||+|.+. +++.||||++...... ..... ++
T Consensus 40 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~i 118 (382)
T 2vx3_A 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHDTEMKYYI 118 (382)
T ss_dssp TTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHH-HHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred CCCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHH-HHHHHHHHHHHHHHHhcccccceeE
Confidence 3344666777778899999999999999999999976 5888999999754321 11111 13
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHH--hcCCCCeEeCCCCCCCEEEc-
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLH--QYSRVRIIHRDLKVSNILLD- 164 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nill~- 164 (354)
+++++++...+..++||||+.+ +|.+++ +++..+..++.|++.||.||| ..+ |+||||||+||+++
T Consensus 119 v~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 119 VHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCN 194 (382)
T ss_dssp CCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESS
T ss_pred EEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEec
Confidence 4455667778899999999975 888877 567889999999999999999 467 99999999999995
Q ss_pred -CCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhh
Q 048432 165 -KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLL 243 (354)
Q Consensus 165 -~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~ 243 (354)
.++.++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|.+|| .+.+..+..
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf--~~~~~~~~~ 267 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF--SGANEVDQM 267 (382)
T ss_dssp TTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHH
T ss_pred CCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHH
Confidence 47789999999997654322 2346789999999999999999999999999999999999995 445544544
Q ss_pred hhhhccccCCCCcccCCccc-c---------------------ccchhh---hhhhhhc------cccCCchhHHHHHHH
Q 048432 244 GYISENIYEFPSVDTHNVKT-F---------------------GFLHLT---IFKLFSI------SSVGLSNDIVCLCIL 292 (354)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~---------------------~~~d~~---~~~~~~~------~~~~~~~~~~~~~~~ 292 (354)
..+.......+.......+. . .+..+. ....... ..............+
T Consensus 268 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (382)
T 2vx3_A 268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL 347 (382)
T ss_dssp HHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHH
T ss_pred HHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhH
Confidence 44444333222211100000 0 000000 0000000 000000111223557
Q ss_pred HHHHHHhhccccCCCCCCCHHHHHH
Q 048432 293 RYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 293 ~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+.+||.+||+.||++|||++|+++
T Consensus 348 ~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 348 KFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhcCCChhhCCCHHHHhc
Confidence 8999999999999999999999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=300.31 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=183.2
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------HHHH--------HHHHHHhceeecCCc
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LREL--------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------~~~~--------~~i~~~~~~~~~~~~ 106 (354)
......++|++.+.||+|+||.||+|.+. +++.||+|++....... .++. .|++++++++.+.+.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34556689999999999999999999965 68899999996543221 1111 266778888889999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-----CCCCeEEeeccc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-----KDMNPKISDFGI 176 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-----~~~~~~l~dfg~ 176 (354)
.++||||+++ +|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.++|+|||+
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999986 888877 678889999999999999999999 99999999999995 445599999999
Q ss_pred ceeccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
+........ ......++..|+|||++.+. .++.++|||||||++|+|++|..|| ......+....+.......+.
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf--~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF--PGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc--CCCCHHHHHHHHHHHhCCCch
Confidence 975543221 12224678999999999875 4899999999999999999999995 444444444444333332222
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+........... ..................++.+.+||.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQ---SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCT---TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhh---hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 22111111000000 000000011111112225678899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=290.03 Aligned_cols=234 Identities=22% Similarity=0.296 Sum_probs=179.4
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
...++|++.+.||+|+||.||+|.++ ++..||+|++...... ....+ .|++++++++.+....++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 45689999999999999999999975 5899999998654321 11112 2556778888888999999
Q ss_pred EEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccce
Q 048432 111 YEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIAR 178 (354)
Q Consensus 111 ~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a~ 178 (354)
|||+++++|.+.+ +++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999998877 567789999999999999999999 9999999999999 456789999999997
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... .....++..|+|||++. ..++.++|||||||++|+|++|..|| .+.........+.......+....
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF--TGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCC--C
T ss_pred ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCC--CCCCHHHHHhhhccCCcccccccC
Confidence 5443322 22346789999999875 56899999999999999999999995 344433333333222221111100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..++.+.+||.+||+.||++|||++|+++
T Consensus 250 ------------------------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 250 ------------------------------PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------------------------------CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ------------------------------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 03567889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=323.80 Aligned_cols=233 Identities=26% Similarity=0.352 Sum_probs=189.8
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH-------------HHHHHHhceeecCCce
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL-------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~-------------~~i~~~~~~~~~~~~~ 107 (354)
...++|++.+.||+|+||.||+|+++ +++.||||++..... ...... .+++.++.++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999976 588999999875321 111111 1334456677888899
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+||||+.+++|..++ +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999888 678899999999999999999999 99999999999999999999999999975332
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|.+| |.+.+..++...+......+|..
T Consensus 495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~P--f~~~~~~~~~~~i~~~~~~~p~~------ 564 (674)
T 3pfq_A 495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDELFQSIMEHNVAYPKS------ 564 (674)
T ss_dssp TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHSSCCCCCTT------
T ss_pred CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCC--CCCCCHHHHHHHHHhCCCCCCcc------
Confidence 221 22345789999999999999999999999999999999999999 55666677777776655544321
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM-----NDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~il~ 317 (354)
.++.+.+||.+||+.||++||++ +||++
T Consensus 565 ---------------------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 ---------------------------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------------------------SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------------------------CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 45678899999999999999997 77764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=295.33 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=180.9
Q ss_pred CCCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHH---------HHHHHHHhce
Q 048432 34 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRE---------LKNKLRLLGC 100 (354)
Q Consensus 34 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~---------~~~i~~~~~~ 100 (354)
....+.+..+....++|++.+.||+|+||.||+|++. +|+.||+|++....... ..+ +.|+++++++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 3455778888889999999999999999999999974 68999999986543211 111 1244556666
Q ss_pred eec------CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 048432 101 CID------KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167 (354)
Q Consensus 101 ~~~------~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 167 (354)
+.. .+..++||||+++++|.+++ ++...+..++.||+.||.|||+.+ |+|+||||+||+++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 655 46789999999999999987 567788999999999999999999 99999999999999999
Q ss_pred CeEEeecccceeccCCccccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhh
Q 048432 168 NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTL 242 (354)
Q Consensus 168 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~ 242 (354)
.++|+|||++........ ......++..|+|||++. +..++.++|||||||++|+|++|..|| ........
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~--~~~~~~~~ 242 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--CDMHPMRA 242 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT--TTSCHHHH
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC--CCCcHHHH
Confidence 999999999875443221 122346789999999987 456889999999999999999999995 33333333
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+....... ... ..++..+.+||.+||..||++|||++++++
T Consensus 243 ~~~~~~~~~~~--~~~-----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPRNPAPR--LKS-----------------------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHSCCCC--CSC-----------------------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhcCcccc--CCc-----------------------------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 33332222111 000 004567899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=294.74 Aligned_cols=251 Identities=23% Similarity=0.263 Sum_probs=180.5
Q ss_pred ccCCCCCccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh--hhHHHH--------------HHH
Q 048432 31 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QGLREL--------------KNK 94 (354)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~~~~~--------------~~i 94 (354)
.......+.+..+....++|++.+.||+|+||.||+|.+.+++.||+|++..... .....+ .|+
T Consensus 11 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 90 (313)
T 3cek_A 11 VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90 (313)
T ss_dssp ---------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTB
T ss_pred ccCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCce
Confidence 3445566888899999999999999999999999999988899999999965422 122222 134
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCe
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP 169 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 169 (354)
+++++++...+..+++|| +.+++|.+++ ++...+..++.|++.||.|||+.+ |+|+||||+||+++. +.+
T Consensus 91 v~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 91 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp CCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEE
T ss_pred EEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeE
Confidence 556677788888999999 5678998887 677889999999999999999999 999999999999964 889
Q ss_pred EEeecccceeccCCccccccccccCcccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-----------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~ 238 (354)
+|+|||++................++..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 9999999976544332222233468999999999865 46889999999999999999999996432222
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.. ....+.......... ...+..+.+||.+||+.||++|||++++++.
T Consensus 246 ~~-~~~~~~~~~~~~~~~-------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 IS-KLHAIIDPNHEIEFP-------------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH-HHHHHHCTTSCCCCC-------------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-HHHHHHhcccccCCc-------------------------------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 111111111110000 0035678899999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=300.23 Aligned_cols=274 Identities=21% Similarity=0.257 Sum_probs=186.3
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.+. +|+.||||++..... .....+. |++++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 44689999999999999999999975 599999999965322 1111222 455566666654
Q ss_pred -CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 -DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..+|+||||+ +++|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 3469999999 77998887 678889999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
.... .....+|..|+|||++.+ ..++.++||||+||++|+|++|++|| .+.+..+....+.+..+..+....
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf--~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4432 223467899999999887 67899999999999999999999994 455555555555444443332211
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HhhhhhhhcCCCCC
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALLPPKQ 331 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~~~~~~~~~ 331 (354)
...... .....................+..++.+.+||.+||..||++|||++++++ .|++.......|..
T Consensus 251 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 323 (367)
T 1cm8_A 251 QRLQSD--EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV 323 (367)
T ss_dssp HTCSCH--HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC
T ss_pred HHhhhH--HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC
Confidence 111000 000000000000000001111225678899999999999999999999998 46666544433333
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.30 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=189.9
Q ss_pred hhhcCccccc-eecccCceeEEEEEEc---CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCce
Q 048432 45 TATNKFSDAN-KLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~-~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
...+++.+.. .||+|+||.||+|.++ ++..||||++..... .....+. |++++++++.. +.+
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3444555555 8999999999999864 466799999976432 2222222 55667777765 568
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++|||||.+++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999988 678899999999999999999999 9999999999999999999999999997544
Q ss_pred CCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 182 GNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 182 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..... .......++..|+|||++.+..++.++|||||||++|+|++ |..|| .+....++...+..+.....
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf--~~~~~~~~~~~i~~~~~~~~----- 560 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIEQGKRMEC----- 560 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTCCSHHHHHHHHTTCCCCC-----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC--CCCCHHHHHHHHHcCCCCCC-----
Confidence 32211 11112234678999999999999999999999999999998 99995 44444555555544332110
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCC
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQ 331 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~ 331 (354)
+..+++.+.+||.+||+.+|++|||+++|++.|+.+.........
T Consensus 561 ---------------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 561 ---------------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp ---------------------------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred ---------------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 111677899999999999999999999999999998765554433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=289.76 Aligned_cols=235 Identities=27% Similarity=0.435 Sum_probs=164.2
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~ 106 (354)
+....++|++.+.||+|+||.||+|.+. +|+.||+|++...... ....+ .|++++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 4455678999999999999999999974 6999999999643211 11122 255667788888899
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999999987 578899999999999999999999 999999999999999999999999998765
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
...... .....++..|+|||++.+..++.++|+||||+++|+|++|..||... ........+.......+
T Consensus 163 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~------ 232 (278)
T 3cok_A 163 KMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD--TVKNTLNKVVLADYEMP------ 232 (278)
T ss_dssp C------------------------------CTHHHHHHHHHHHHHHSSCSSCCC--SCC-----CCSSCCCCC------
T ss_pred cCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh--hHHHHHHHHhhcccCCc------
Confidence 432211 12246789999999999888999999999999999999999996432 22222222111111000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+.+||.+||+.||++|||++++++
T Consensus 233 ---------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 ---------------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---------------------------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 014567889999999999999999999886
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.85 Aligned_cols=264 Identities=19% Similarity=0.210 Sum_probs=185.8
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHHH--------------HHHHHhceeecC
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---RELK--------------NKLRLLGCCIDK 104 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~~--------------~i~~~~~~~~~~ 104 (354)
.....++|++.+.||+|+||.||+|.+. +++.||||++........ .++. |++++++++...
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3456688999999999999999999975 488999999976532111 1111 345556677788
Q ss_pred CceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC--eEEeecc
Q 048432 105 DEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--PKISDFG 175 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~~l~dfg 175 (354)
+.+++||||+.+ +|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++|+|||
T Consensus 172 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 899999999964 787776 577889999999999999999999 999999999999999887 9999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|.+|| .+.+..+.+..+.......+.
T Consensus 248 ~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf--~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 248 SSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL--PGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCCCCH
T ss_pred cceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHcCCCCH
Confidence 996543322 2246789999999999999999999999999999999999995 444444444433332222211
Q ss_pred cccCCcc-ccccc---------------hhhh------hhhhh----ccccCCchhHHHHHHHHHHHHHhhccccCCCCC
Q 048432 256 VDTHNVK-TFGFL---------------HLTI------FKLFS----ISSVGLSNDIVCLCILRYVNIALLCVQESADDR 309 (354)
Q Consensus 256 ~~~~~~~-~~~~~---------------d~~~------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 309 (354)
....... ...+. +... ..... ..............++.+.+||.+||++||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 1000000 00000 0000 00000 000000011111136778999999999999999
Q ss_pred CCHHHHHH
Q 048432 310 PTMNDVVS 317 (354)
Q Consensus 310 ps~~~il~ 317 (354)
||++|+++
T Consensus 401 pta~e~L~ 408 (429)
T 3kvw_A 401 MTPGQALR 408 (429)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=300.38 Aligned_cols=240 Identities=22% Similarity=0.269 Sum_probs=185.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEE----cCCCEEEEEEecCCCh--------------hhHH---HHHHHHHHhcee
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVL----KNGDEIAVKRLSGRSG--------------QGLR---ELKNKLRLLGCC 101 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~----~~~~~vavK~~~~~~~--------------~~~~---~~~~i~~~~~~~ 101 (354)
.....++|++.+.||+|+||.||+|+. .+++.||||++..... ..+. .+.|++++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 344558999999999999999999997 3689999999864210 1111 223667778888
Q ss_pred ecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
...+..++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 8899999999999999999988 678889999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCccccccccccCcccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccC
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYE 252 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~ 252 (354)
+......... ......||..|+|||++.+. .++.++|||||||++|+|++|..||...... ...+...+......
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC
Confidence 9765432221 12235789999999999863 4789999999999999999999996533222 12222222222211
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHHh
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSML 319 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~L 319 (354)
.+ ...+..+.+||.+||+.||++|| |++++++..
T Consensus 285 ~~---------------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 YP---------------------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CC---------------------------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CC---------------------------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 11456788999999999999999 999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=313.30 Aligned_cols=238 Identities=28% Similarity=0.383 Sum_probs=193.6
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCC
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~ 105 (354)
......++|++.+.||+|+||.||+|+++ +|+.||||++..... .....+ .|++++++++...+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 33456689999999999999999999976 699999999864321 111111 26677888889999
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---cCCCCeEEeecccc
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGIA 177 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~~l~dfg~a 177 (354)
..++|||||.+++|.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999998887 778899999999999999999999 9999999999999 56789999999998
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ .....||+.|+|||++.+ .++.++|||||||++|+|++|.+| |.+.+..+....+..+...++...
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p--f~~~~~~~~~~~i~~~~~~~~~~~ 250 (484)
T 3nyv_A 177 THFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP--FNGANEYDILKKVEKGKYTFELPQ 250 (484)
T ss_dssp HHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred EEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC--CCCCCHHHHHHHHHcCCCCCCCcc
Confidence 75544322 223468999999998865 689999999999999999999999 555666667777666655443222
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+. ..++.+.+||.+||+.||++|||++++++
T Consensus 251 ~~-----------------------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 251 WK-----------------------------KVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GG-----------------------------GSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-----------------------------cCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11 14667899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=286.44 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=188.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH------------HHHHHHhceeecCCc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~------------~~i~~~~~~~~~~~~ 106 (354)
..++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+ .|++++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3478999999999999999999976 5999999998654211 11122 255667788888899
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----CeEEeecccc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGIA 177 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~~l~dfg~a 177 (354)
.++||||+++++|.+++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999988 678899999999999999999999 99999999999998877 8999999999
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
........ .....++..|+|||++.+..++.++|+||||+++|+|++|..|| ......+....+.......+
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~--- 231 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF--LGETKQETLTNISAVNYDFD--- 231 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT--CCSSHHHHHHHHHTTCCCCC---
T ss_pred eeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC--CCcchHHHHHHhHhcccCCc---
Confidence 76543322 12246789999999999889999999999999999999999995 34444444444333222211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEAA 324 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~~ 324 (354)
.......++.+.+||.+||+.||++|||++++++ .++++..
T Consensus 232 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 232 --------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1111225677899999999999999999999997 4566553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.77 Aligned_cols=236 Identities=24% Similarity=0.408 Sum_probs=187.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeecCCceEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~~~~~~lv 110 (354)
...+.|++.+.||+|+||.||+|.+. +++.||+|++..... .....+. |++++++++......++|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 45578999999999999999999965 589999999965432 2222222 445667778888899999
Q ss_pred EEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 111 YEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 111 ~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 9999999999988 678999999999999999999999 999999999999999999999999999765443221
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||. ..........+.........
T Consensus 176 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~----------- 240 (303)
T 3a7i_A 176 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS--ELHPMKVLFLIPKNNPPTLE----------- 240 (303)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT--TSCHHHHHHHHHHSCCCCCC-----------
T ss_pred --cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC--CcCHHHHHHHhhcCCCCCCc-----------
Confidence 223467899999999998889999999999999999999999953 33333333333222111000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHh
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L 319 (354)
..++..+.+||.+||+.||++|||++++++..
T Consensus 241 ---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 241 ---------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 01456789999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.08 Aligned_cols=235 Identities=23% Similarity=0.336 Sum_probs=188.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC---hhhHHHH------------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS---GQGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~---~~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+ .|++++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 356689999999999999999999976 48899999986542 1112222 2556777888888999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999999887 678899999999999999999999 99999999999999999999999999876543
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
... ......++..|+|||++.+..++.++|+||||+++|+|++|..||. .....+....+.......+.
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~~------- 236 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPK------- 236 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC--CSSHHHHHHHHHTTCCCCCT-------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC--CCCHHHHHHHHhhccCCCcc-------
Confidence 221 1223468899999999988889999999999999999999999953 33333333333332222111
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++++++.
T Consensus 237 --------------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 237 --------------------------HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --------------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------------------------ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 145678899999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=285.82 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=191.5
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hh-HHHH--------HHHHHHhceeecCCce
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QG-LREL--------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~-~~~~--------~~i~~~~~~~~~~~~~ 107 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++..... .. .++. .|++++++++.+.+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999976 477899999864321 11 1111 2556777888888999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
++||||+++++|.+++ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999887 578889999999999999999999 99999999999999999999999999865443
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|..||. .....+....+.......+.
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~--~~~~~~~~~~~~~~~~~~~~------- 233 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNVDLKFPP------- 233 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC--CSSHHHHHHHHHTTCCCCCT-------
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC--CCCHhHHHHHHhccccCCCC-------
Confidence 22 123467899999999998889999999999999999999999953 33333444433332222211
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HhhhhhhhcCCC
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALLPP 329 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~~~~~~~ 329 (354)
..+..+.+||.+||+.||++|||++++++ .+++......||
T Consensus 234 --------------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 234 --------------------------FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp --------------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred --------------------------cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 14567889999999999999999999987 455444333333
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=298.13 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=165.8
Q ss_pred ccccccccccCCCCCccccchhhhhcCccccc-eecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH---------
Q 048432 23 LTKRSKKKEVDQLPLFSFSSVSTATNKFSDAN-KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL--------- 91 (354)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~-~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~--------- 91 (354)
.+++++.....+-|....- ...++|++.+ .||+|+||.||+|.++ +|+.||+|++....... .+.
T Consensus 6 ~~~~~~~~~~~~~p~~~~~---~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~e~~~~~~~~~h 81 (336)
T 3fhr_A 6 HHHSSGLEVLFQGPEPKKY---AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASGG 81 (336)
T ss_dssp --------------CCBCS---CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHH-HHHHHHHHHTTS
T ss_pred ccccCCccccccCCCCCCc---cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHH-HHHHHHHHhcCC
Confidence 3444444444444444333 4558999965 6999999999999976 59999999997643222 222
Q ss_pred HHHHHHhceeec----CCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 048432 92 KNKLRLLGCCID----KDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSN 160 (354)
Q Consensus 92 ~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 160 (354)
.|++++++++.. ....++||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 82 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~N 158 (336)
T 3fhr_A 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 158 (336)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 255666777654 44589999999999999988 678899999999999999999999 9999999999
Q ss_pred EEEcC---CCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Q 048432 161 ILLDK---DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT 237 (354)
Q Consensus 161 ill~~---~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~ 237 (354)
|+++. ++.++|+|||++....... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 99986 4559999999997544322 1224678999999999888889999999999999999999999633222
Q ss_pred cc--hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 048432 238 YS--FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315 (354)
Q Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~i 315 (354)
.. ......+.......+.... ..+++.+.+||.+||+.||++|||++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~el 285 (336)
T 3fhr_A 235 QAISPGMKRRIRLGQYGFPNPEW-----------------------------SEVSEDAKQLIRLLLKTDPTERLTITQF 285 (336)
T ss_dssp ----------------CCCTTTS-----------------------------TTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhhhhHHHhhhccccccCchhh-----------------------------ccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11 1111111111111111110 1156778999999999999999999999
Q ss_pred HH--Hhhhhh
Q 048432 316 VS--MLTNEA 323 (354)
Q Consensus 316 l~--~L~~~~ 323 (354)
++ .|.+..
T Consensus 286 l~hp~~~~~~ 295 (336)
T 3fhr_A 286 MNHPWINQSM 295 (336)
T ss_dssp HHSHHHHTGG
T ss_pred hcCccccccc
Confidence 98 444433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=293.37 Aligned_cols=267 Identities=19% Similarity=0.237 Sum_probs=188.3
Q ss_pred cchhhhhcCccccceecccCceeEEEEEE-c-CCCEEEEEEecCCChhh---HHHH------H--------HHHHHhcee
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVL-K-NGDEIAVKRLSGRSGQG---LREL------K--------NKLRLLGCC 101 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~-~~~~vavK~~~~~~~~~---~~~~------~--------~i~~~~~~~ 101 (354)
.......++|++.+.||+|+||.||+|.+ + +++.||+|++....... ..+. . +++++++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 34455678999999999999999999997 3 58899999997643211 1111 1 134556677
Q ss_pred ecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---------
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--------- 165 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--------- 165 (354)
...+..++||||+ +++|.+++ ++...+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence 8888999999999 77888887 457889999999999999999999 999999999999987
Q ss_pred ----------CCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Q 048432 166 ----------DMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFY 235 (354)
Q Consensus 166 ----------~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~ 235 (354)
++.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~- 236 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT- 236 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC-
Confidence 6789999999997643322 234679999999999998999999999999999999999999643
Q ss_pred cccchhhhhhhhccccCCCCcccCCccccccc--------hhh--hhhhhhcc-ccCCchhHHHHHHHHHHHHHhhcccc
Q 048432 236 RTYSFTLLGYISENIYEFPSVDTHNVKTFGFL--------HLT--IFKLFSIS-SVGLSNDIVCLCILRYVNIALLCVQE 304 (354)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------d~~--~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~ 304 (354)
.+..+....+.......|...........+. ... ........ ...........+++.+.+||.+||+.
T Consensus 237 -~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 237 -HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp -SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred -CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 3433333333333333322111000000000 000 00000000 00000011123678899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048432 305 SADDRPTMNDVVSM 318 (354)
Q Consensus 305 ~P~~Rps~~~il~~ 318 (354)
||++|||++|+++.
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=296.55 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=188.1
Q ss_pred hhcCccccceecccCceeEEEEEE-----cCCCEEEEEEecCCChhhHHHHHHH------------HHHhceeecC--Cc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVL-----KNGDEIAVKRLSGRSGQGLRELKNK------------LRLLGCCIDK--DE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vavK~~~~~~~~~~~~~~~i------------~~~~~~~~~~--~~ 106 (354)
..++|++.+.||+|+||.||+|++ .+++.||+|++..........+.++ +++++++... ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 457899999999999999999984 2588999999987655544444433 3444555443 36
Q ss_pred eEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.++||||+++++|.+++ +++..+..++.|++.||.+||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999988 577889999999999999999999 999999999999999999999999999865
Q ss_pred cCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
...... .......++..|+|||++.+..++.++|||||||++|+|++|..|+...... ......... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~----~~~-- 266 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDK----QGQ-- 266 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTC----CTH--
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhcccc----chh--
Confidence 543221 1122235677899999999888999999999999999999999885322111 000000000 000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
.. ................+..+++.+.+||.+||+.||++|||+.++++.|+++....
T Consensus 267 ------~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 267 ------MI---VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp ------HH---HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------hh---HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00 00000000000000111126778999999999999999999999999999988543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=298.87 Aligned_cols=231 Identities=29% Similarity=0.458 Sum_probs=180.9
Q ss_pred hhhcCccccceecccCceeEEEEEE-cCCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVL-KNGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
...+.|++.+.||+|+||.||+|++ .+|+.||||++...... ....+ .|++++++++...+..+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 3456799999999999999999996 46899999999754321 11122 25566778888889999
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+||||+.| ++.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 131 lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99999985 666655 678889999999999999999999 99999999999999999999999999875432
Q ss_pred CccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
. ....|++.|+|||++. ...++.++|||||||++|+|++|..|| .+.+.......+..........
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~--~~~~~~~~~~~~~~~~~~~~~~--- 275 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQS--- 275 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTT--TTSCHHHHHHHHHHSCCCCCCC---
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHhcCCCCCCC---
Confidence 2 2346899999999985 466899999999999999999999995 3444333333333322111000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...++.+.+||.+||+.||++|||++++++.
T Consensus 276 ----------------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 ----------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----------------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0045678899999999999999999998864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=301.86 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=186.0
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH--------HHHHHHhceeec----------
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL--------KNKLRLLGCCID---------- 103 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~--------~~i~~~~~~~~~---------- 103 (354)
+....++|++.+.||+|+||.||+|.+. +|+.||+|++........+++ .|++++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 3456789999999999999999999964 699999999866543332222 267777777633
Q ss_pred ----------------------------CCceEEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhc
Q 048432 104 ----------------------------KDEKILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQY 146 (354)
Q Consensus 104 ----------------------------~~~~~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~ 146 (354)
...+++||||+++ +|.+.+ +++..+..++.||+.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3448899999985 766555 56788999999999999999999
Q ss_pred CCCCeEeCCCCCCCEEEc-CCCCeEEeecccceeccCCccccccccccCcccccCccccccCC-CCchhhHHHHHHHHHH
Q 048432 147 SRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLK 224 (354)
Q Consensus 147 ~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ 224 (354)
+ |+||||||+||+++ .++.++|+|||++......... ....++..|+|||++.+.. ++.++||||+||++|+
T Consensus 161 g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 161 G---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp T---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred c---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 9 99999999999998 6889999999999865443322 2246788999999987754 8999999999999999
Q ss_pred HHhCCCCCCcccccchhhhhhhhccccCCCCcccC----CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhh
Q 048432 225 IVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH----NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL 300 (354)
Q Consensus 225 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 300 (354)
|++|.+|| .+.+..+....+.+.....+..... ......+. ...........+...++.+.+||.+
T Consensus 235 ll~g~~pf--~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 235 LILGKPLF--SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP--------TLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHSSCSS--CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCC--------CCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHhCCCCC--CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCC--------ccCcccHHhhCCCCCCHHHHHHHHH
Confidence 99999995 4455444444443332221110000 00000000 0000001111222256778999999
Q ss_pred ccccCCCCCCCHHHHHH--Hhhhhhh
Q 048432 301 CVQESADDRPTMNDVVS--MLTNEAA 324 (354)
Q Consensus 301 cl~~~P~~Rps~~~il~--~L~~~~~ 324 (354)
||+.||++|||+.|+++ .++++..
T Consensus 305 ~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HccCChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999985 3555443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=287.69 Aligned_cols=235 Identities=23% Similarity=0.381 Sum_probs=180.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~ 106 (354)
.....++|++.+.||+|+||.||+|.++ +|+.||+|++..... .....+ .|++++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 3456689999999999999999999976 699999999865321 111111 255667788888899
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.++||||+.+++|.+++ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999988 578889999999999999999999 9999999999999999999999999987654
Q ss_pred CCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... .....++..|+|||++.+..+ +.++|+||||+++|+|++|..|| ...........+.......+..
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~---- 233 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFKKIRGGVFYIPEY---- 233 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCTT----
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC--CCCcHHHHHHHhhcCcccCchh----
Confidence 3321 122467889999999987765 68999999999999999999995 3344444444443333222110
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+..+.++|.+||+.||++|||++++++.
T Consensus 234 -----------------------------~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 -----------------------------LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----------------------------cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 35668899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=289.75 Aligned_cols=243 Identities=24% Similarity=0.294 Sum_probs=185.4
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceee--cCCce
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCI--DKDEK 107 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~--~~~~~ 107 (354)
...++|++.+.||+|+||.||+|.++ +++.||+|++..... .....+. |++++++++. .....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 45689999999999999999999976 589999999975432 2222222 4455566553 45678
Q ss_pred EEEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 108 ILIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
++||||+++++|.+++ +++..+..++.|++.||.|||+.+ ..+++|+||||+||+++.++.++|+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999987 567789999999999999999976 23499999999999999999999999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
+......... .....++..|+|||++.+..++.++||||||+++|+|++|..||. ..........+..+......
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~i~~~~~~~~~- 237 (279)
T 2w5a_A 163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIREGKFRRIP- 237 (279)
T ss_dssp HHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC--CSSHHHHHHHHHHTCCCCCC-
T ss_pred heeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc--ccCHHHHHHHHhhcccccCC-
Confidence 8654332211 112467899999999998889999999999999999999999954 33444444444433321100
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
..++..+.++|.+||+.||++|||++++++.+....
T Consensus 238 -------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 238 -------------------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -------------------------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 015677899999999999999999999999776544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=286.32 Aligned_cols=228 Identities=20% Similarity=0.318 Sum_probs=177.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HH-------------HHHHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LR-------------ELKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~-------------~~~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|.+. +++.||+|++....... .. .+.|++++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34688999999999999999999976 69999999987542211 11 1235667788888899999
Q ss_pred EEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-------------
Q 048432 109 LIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD------------- 166 (354)
Q Consensus 109 lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~------------- 166 (354)
+||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999988 467889999999999999999999 9999999999999844
Q ss_pred ------CCeEEeecccceeccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Q 048432 167 ------MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS 239 (354)
Q Consensus 167 ------~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~ 239 (354)
..++|+|||.+....... ...++..|+|||++.+. .++.++|||||||++|+|++|.+++. ....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~--~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--NGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS--SSHH
T ss_pred cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc--chhH
Confidence 479999999987654432 23578999999999876 56789999999999999999987742 2211
Q ss_pred hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+..+...... ..+++.+.+||.+||+.||++|||++++++.
T Consensus 237 ---~~~~~~~~~~~~~--------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---WHEIRQGRLPRIP--------------------------------QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HHHHHTTCCCCCS--------------------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHHHcCCCCCCC--------------------------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1112111111000 0146678999999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=295.46 Aligned_cols=265 Identities=21% Similarity=0.336 Sum_probs=188.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh------HHHH--------HHHHHHhceeec-------
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LREL--------KNKLRLLGCCID------- 103 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~------~~~~--------~~i~~~~~~~~~------- 103 (354)
..++|++.+.||+|+||.||+|++. +|+.||+|++....... .++. .|++++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4579999999999999999999974 69999999985543211 1222 155566666655
Q ss_pred -CCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 104 -KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 104 -~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
.+.+++||||+.+ ++...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999987 555554 678899999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCcc--ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCC
Q 048432 177 ARICRGNEL--QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253 (354)
Q Consensus 177 a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 253 (354)
+........ ........+++.|+|||++.+. .++.++|||||||++|+|++|.+| |.+.........+.......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p--f~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS--CCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC--CCCCChHHHHHHHHHHhCCC
Confidence 976543221 1222335679999999998764 579999999999999999999999 45555555555555554444
Q ss_pred CCcccCCccccccchhhhhhhhhccccCCchhHH-HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIV-CLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 254 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+...++........+... .............. ...++.+.+||.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLE--LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSC--CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Chhhccccccchhhcccc--cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 443333322211111000 00000000000000 0125678999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.76 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=183.8
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---------hHHHH--------HHHHHHhceeecC
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---------GLREL--------KNKLRLLGCCIDK 104 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---------~~~~~--------~~i~~~~~~~~~~ 104 (354)
+....++|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+++ .|++++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 4556789999999999999999999975 5899999998653211 11121 2666778888888
Q ss_pred CceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 105 DEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
+..++||||+++ +|..++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999987 777776 567889999999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+| |.+.+..+....+.......+...
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~--~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC--CCCCCHHHHHHHHHHHcCCCChhh
Confidence 6543321 12234679999999998764 489999999999999999999988 444555555555544433332222
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
+...... .+.. .................++.+.+||.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSL--PDYV---TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSS--TTCC---CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccC--cccc---cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 2111100 0000 000000000011112256789999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=306.67 Aligned_cols=270 Identities=19% Similarity=0.254 Sum_probs=189.1
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHH--------HHHHHHhceeecCC------ceE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLREL--------KNKLRLLGCCIDKD------EKI 108 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~--------~~i~~~~~~~~~~~------~~~ 108 (354)
......+|++.+.||+|+||.||+|++..+..||+|++........++. .|++++++++.... .++
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3445678999999999999999999987777799998865433222222 36777788774333 378
Q ss_pred EEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCeEEeeccccee
Q 048432 109 LIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARI 179 (354)
Q Consensus 109 lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~~ 179 (354)
+||||+.++.+.... +++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.++|+|||++..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999886554433 567788999999999999999999 99999999999999 789999999999976
Q ss_pred ccCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... ....+++.|+|||++.+. .++.++||||+||++|+|++|.+|| .+.+..+....+.+.....+....
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf--~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF--PGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5443322 234678999999998765 4899999999999999999999994 445544444444433322211100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA 324 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~ 324 (354)
..... .+... .............+....++.+.+||.+||+.||++|||+.++++. ++++..
T Consensus 267 ~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 267 KTMNP-NYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHCG-GGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HhhCh-hhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00000 00000 0000000000011112256789999999999999999999999975 666554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=296.21 Aligned_cols=265 Identities=20% Similarity=0.224 Sum_probs=179.7
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCC----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKD---- 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~---- 105 (354)
...++|++.+.||+|+||.||+|.+. +++.||||++..... .....+. |++++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 35689999999999999999999965 588999999975321 1112222 4455666665544
Q ss_pred --ceEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 --EKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 --~~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..++||||+++ +|.+.+ ++...+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ccceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999986 566665 678889999999999999999999 999999999999999999999999999755
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..|| .+.+..+....+.+............
T Consensus 178 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 178 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 4322 122346889999999999989999999999999999999999995 44444444444433332211110000
Q ss_pred ccc---------cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKT---------FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~---------~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
... ..+........................+..+.+||.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 0000000000000000011122334467889999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=286.22 Aligned_cols=238 Identities=23% Similarity=0.310 Sum_probs=187.6
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-----h----hHHH-------------HHHHHHHhc
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-----Q----GLRE-------------LKNKLRLLG 99 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-----~----~~~~-------------~~~i~~~~~ 99 (354)
.....++|++.+.||+|++|.||+|.++ +|+.||+|++..... . .... +.|++++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999999976 588999999965431 0 0111 225556677
Q ss_pred eeecCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 100 CCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
++...+..++||||+++++|.+++ ++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 888889999999999999999987 678899999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAI------QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
|++........ .....++..|+|||++. ...++.++||||||+++|+|++|..|| ...........+..
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~--~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 169 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHRKQMLMLRMIMS 243 (298)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHH
T ss_pred cchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC--cCccHHHHHHHHhc
Confidence 99876544322 12346789999999885 345789999999999999999999995 44444445555444
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.....+.... ...+..+.+||.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~~~-----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQFGSPEW-----------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCCCCTTTG-----------------------------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcccCcccc-----------------------------cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 4333222110 015667899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=297.18 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=185.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHHH------------HHHHHhceeecCCceEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~~~~~~l 109 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+. |++++++++...+..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 445679999999999999999999976 58999999997653222 22222 55667778888899999
Q ss_pred EEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
||||+++++|.+++ +++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999988 66788999999999999999996 8 999999999999999999999999998644322
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcc----ccCCCCcccC
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN----IYEFPSVDTH 259 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 259 (354)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||...... +....+... ....+.....
T Consensus 186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK--ELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH--HHHHHHC----------------
T ss_pred c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccCCCCCCCccc
Confidence 1 12346799999999999999999999999999999999999996543322 211111000 0000000000
Q ss_pred Ccccc----------ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 260 NVKTF----------GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 260 ~~~~~----------~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..... .............. .........+..+.+||.+||+.||++|||++++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEP---PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------CCCHHHHHHHHHHSC---CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccccccCCCCcccchhhhhHHhccC---CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000 00000000000000 0000011146679999999999999999999999873
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=292.99 Aligned_cols=227 Identities=25% Similarity=0.325 Sum_probs=183.8
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---------------hHH-----HHHHHHHHhceeec
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---------------GLR-----ELKNKLRLLGCCID 103 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---------------~~~-----~~~~i~~~~~~~~~ 103 (354)
...++|++.+.||+|+||.||+|.++ +++.||+|++...... +.. .+.|++++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45679999999999999999999965 5889999998754210 111 12478889999999
Q ss_pred CCceEEEEEecCCC-CHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 104 KDEKILIYEYMPNK-SLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 104 ~~~~~lv~e~~~~~-~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.+..++||||+.+| +|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 99999999998776 888887 678899999999999999999999 999999999999999999999999999
Q ss_pred eeccCCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ........+.
T Consensus 178 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~- 245 (335)
T 3dls_A 178 AYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPY- 245 (335)
T ss_dssp EECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSS-
T ss_pred eECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCc-
Confidence 765543321 23468999999999988876 8899999999999999999999632110 0000100000
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++++++.
T Consensus 246 --------------------------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 246 --------------------------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------------------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------------------------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 045678999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.65 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=184.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HH----HH--------HHHHHHhceeecCCceE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LR----EL--------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~----~~--------~~i~~~~~~~~~~~~~~ 108 (354)
....++|++.+.||+|+||.||+|++. +|+.||+|++....... .. +. .|++++++++...+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 344579999999999999999999976 48999999986543221 11 11 25667788888899999
Q ss_pred EEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 109 LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+||||+++++|..+. +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999999998876 678899999999999999999999 999999999999999999999999998754432
Q ss_pred ccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.. ......++..|+|||++.+. .++.++|||||||++|+|++|..|| ......+....+.......+......+.
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF--PGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC--CCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 21 12234678999999999875 6899999999999999999999995 3344333333322222111110000000
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....... ................+.+++.+.+||.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAG--VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTT--CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hcccccc--ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0000000001111112235788999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=291.56 Aligned_cols=257 Identities=24% Similarity=0.271 Sum_probs=176.4
Q ss_pred CccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH-------------HHHHHhcee-
Q 048432 37 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK-------------NKLRLLGCC- 101 (354)
Q Consensus 37 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~-------------~i~~~~~~~- 101 (354)
.+....+.....+|++.+.||+|+||.||+|++. +++.||+|++..........+. |++++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred HhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 4455667777789999999999999999999975 6899999998665543333222 444455555
Q ss_pred -------ecCCceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC
Q 048432 102 -------IDKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD 166 (354)
Q Consensus 102 -------~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 166 (354)
......+++|||+. |+|.+++ +++..+..++.||+.||.|||+.+ .+|+|+||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence 33445789999996 5777766 677889999999999999999873 249999999999999999
Q ss_pred CCeEEeecccceeccCCcccc----------ccccccCcccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 048432 167 MNPKISDFGIARICRGNELQA----------NTGRIVGTYRYMSPEYA---IQGIFSIKSDVFSFGVLLLKIVSGKKTTG 233 (354)
Q Consensus 167 ~~~~l~dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwSlG~~l~~ll~g~~p~~ 233 (354)
+.++|+|||++.......... ......+++.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999997654332111 11123578999999998 45678999999999999999999999963
Q ss_pred cccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 048432 234 FYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313 (354)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 313 (354)
. ......... ....+... ..+..+.+||.+||+.||++|||++
T Consensus 255 ~--~~~~~~~~~----~~~~~~~~-------------------------------~~~~~~~~li~~~l~~~p~~Rps~~ 297 (337)
T 3ll6_A 255 D--GAKLRIVNG----KYSIPPHD-------------------------------TQYTVFHSLIRAMLQVNPEERLSIA 297 (337)
T ss_dssp -----------------CCCCTTC-------------------------------CSSGGGHHHHHHHSCSSGGGSCCHH
T ss_pred c--hhHHHhhcC----cccCCccc-------------------------------ccchHHHHHHHHHccCChhhCcCHH
Confidence 2 222111111 11111100 0234467899999999999999999
Q ss_pred HHHHHhhhhhhhcCCCCCC
Q 048432 314 DVVSMLTNEAAALLPPKQP 332 (354)
Q Consensus 314 ~il~~L~~~~~~~~~~~~~ 332 (354)
++++.|+.+.......+.+
T Consensus 298 e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 298 EVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp HHHHHHHHHHHHTTCCTTS
T ss_pred HHHHHHHHHHhccCCCCCc
Confidence 9999999998765444443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=306.56 Aligned_cols=180 Identities=23% Similarity=0.372 Sum_probs=133.2
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceee-----cC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCI-----DK 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~-----~~ 104 (354)
...++|++.+.||+|+||.||+|.++ +++.||||++..... .....+. ||+++++++. ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 34589999999999999999999965 589999999865322 1112222 4556666663 33
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..+|+||||+. ++|..++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 57899999985 5787777 788899999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccc-------------------------cccccccCcccccCcccc-ccCCCCchhhHHHHHHHHHHHHhC
Q 048432 180 CRGNELQ-------------------------ANTGRIVGTYRYMSPEYA-IQGIFSIKSDVFSFGVLLLKIVSG 228 (354)
Q Consensus 180 ~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlG~~l~~ll~g 228 (354)
....... ......+||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 5422110 112335779999999976 456699999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=295.91 Aligned_cols=271 Identities=19% Similarity=0.233 Sum_probs=189.7
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHHH------------HHHHHhceeecC-
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCIDK- 104 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~~- 104 (354)
-.++....++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+. |++++++++...
T Consensus 19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 3445556789999999999999999999975 58889999997543222 12222 444555665443
Q ss_pred ----CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 105 ----DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 105 ----~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
...++||||+.+ +|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcc
Confidence 468999999985 888777 778899999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCcccc-ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 177 ARICRGNELQA-NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 177 a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
+.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+|| .+....+....+.......+
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf--~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF--PGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS--CCSSGGGHHHHHHHHHCSCC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC--CCCChHHHHHHHHHHhCCCC
Confidence 97654432211 1233578999999998764 45899999999999999999999994 45555555555443333222
Q ss_pred CcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.......... .....................+..++.+.+||.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCH--HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhh--hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2111100000 0000000000000000111122356788999999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=301.28 Aligned_cols=184 Identities=24% Similarity=0.382 Sum_probs=144.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHHH------------HHHHHhceeecC-----
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLRELK------------NKLRLLGCCIDK----- 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~~------------~i~~~~~~~~~~----- 104 (354)
...++|++.+.||+|+||.||+|.++ +++.||||++...... ....+. |++++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 34589999999999999999999975 4888999999754221 112222 445566666554
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..+|+||||+.+ +|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 578999999875 888887 688999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccc--------------------cccccccCcccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 048432 180 CRGNELQ--------------------ANTGRIVGTYRYMSPEYA-IQGIFSIKSDVFSFGVLLLKIVSGKKTT 232 (354)
Q Consensus 180 ~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlG~~l~~ll~g~~p~ 232 (354)
....... .......+|+.|+|||++ .+..++.++||||+||++|+|++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 5433211 112345789999999986 4566999999999999999999865553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=284.35 Aligned_cols=234 Identities=24% Similarity=0.299 Sum_probs=179.4
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh----hhHHHHH------------HHHHHhcee--ecCCc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG----QGLRELK------------NKLRLLGCC--IDKDE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~----~~~~~~~------------~i~~~~~~~--~~~~~ 106 (354)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+. |++++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4589999999999999999999975 588999999965421 1122222 455666666 34567
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++||||+.++ +.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999987 55554 677889999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
..............++..|+|||++.+.. ++.++||||||+++|+|++|..|| .+.........+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~--~~~~~~~~~~~i~~~~~~~~~-- 234 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF--EGDNIYKLFENIGKGSYAIPG-- 234 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHCCCCCCS--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC--CCchHHHHHHHHhcCCCCCCC--
Confidence 54433222233456899999999987654 378999999999999999999995 444444444444433322211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+++.+.+||.+||+.||++|||++++++.
T Consensus 235 -------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 235 -------------------------------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------------------------------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------------------------------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 145678899999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.29 Aligned_cols=262 Identities=20% Similarity=0.216 Sum_probs=181.2
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHH----------------HHHHHHhceee
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---REL----------------KNKLRLLGCCI 102 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~----------------~~i~~~~~~~~ 102 (354)
.....++|++.+.||+|+||.||+|++. +++.||+|++........ +++ .|++++++++.
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3445689999999999999999999965 588999999976432111 111 12444555554
Q ss_pred ----cCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCC---
Q 048432 103 ----DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDM--- 167 (354)
Q Consensus 103 ----~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~--- 167 (354)
....+++||||+.+ ++.+.+ +++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 45678999999955 554444 57788999999999999999998 9 99999999999998775
Q ss_pred ----------------------------------------------CeEEeecccceeccCCccccccccccCcccccCc
Q 048432 168 ----------------------------------------------NPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201 (354)
Q Consensus 168 ----------------------------------------------~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 201 (354)
.++|+|||++...... .....+|..|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999765432 2234679999999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc----chhhhhhhhccccCCCCccc-------------CCcccc
Q 048432 202 EYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY----SFTLLGYISENIYEFPSVDT-------------HNVKTF 264 (354)
Q Consensus 202 E~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~-------------~~~~~~ 264 (354)
|++.+..++.++|||||||++|+|++|..||...... .......+.+.....|.... ......
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9999999999999999999999999999997543322 11222222222222111000 000000
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....+. ...... ......+...+..+.+||.+||+.||++|||++|+++
T Consensus 343 ~~~~~~--~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPW--GLFEVL--VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCC--CHHHHH--HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCc--chhHhh--hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000 000000 0001123447889999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.08 Aligned_cols=243 Identities=27% Similarity=0.383 Sum_probs=179.4
Q ss_pred hhhcCccccceecccCceeEEEEEEc--CCC--EEEEEEecCCC---hhhHHHHH------------HHHHHhceeecCC
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK--NGD--EIAVKRLSGRS---GQGLRELK------------NKLRLLGCCIDKD 105 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~--~vavK~~~~~~---~~~~~~~~------------~i~~~~~~~~~~~ 105 (354)
...++|++.+.||+|+||.||+|.+. +++ .||+|++.... ......+. |++++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence 34679999999999999999999854 233 68999987542 12222222 445556666654
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++|+||+.+++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 488999999999999887 567889999999999999999999 99999999999999999999999999876
Q ss_pred ccCCccc-cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQ-ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..|| ...........+.......+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW--IGLNGSQILHKIDKEGERLPRPE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHHHTSCCCCCCCT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc--ccCCHHHHHHHHHccCCCCCCCc
Confidence 5443321 11223456778999999988888999999999999999999 99995 44444444444433322221111
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.++..+.++|.+||+.||++|||++++++.|+++..
T Consensus 249 -------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 249 -------------------------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------------------------------CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 156778999999999999999999999999998873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=291.14 Aligned_cols=274 Identities=18% Similarity=0.201 Sum_probs=189.7
Q ss_pred CCCCCccccchhhhhcCccccceecccCceeEEEEEEcC-C-CEEEEEEecCCChhhH---HHHH--------H------
Q 048432 33 DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN-G-DEIAVKRLSGRSGQGL---RELK--------N------ 93 (354)
Q Consensus 33 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~-~~vavK~~~~~~~~~~---~~~~--------~------ 93 (354)
+....+.........++|++.+.||+|+||.||+|.+.. + +.||+|++........ .++. +
T Consensus 4 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 83 (355)
T 2eu9_A 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83 (355)
T ss_dssp CTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSC
T ss_pred ccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCcee
Confidence 444556666667778999999999999999999999753 4 6899999976432111 1111 0
Q ss_pred HHHHhceeecCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE---
Q 048432 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--- 163 (354)
Q Consensus 94 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--- 163 (354)
++.+++++...+..++||||+.+ ++.+.+ +++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNS 159 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCC
T ss_pred EEEeeeeeeeCCeEEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecc
Confidence 23344566778899999999955 555554 567889999999999999999999 9999999999999
Q ss_pred ----------------cCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 048432 164 ----------------DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS 227 (354)
Q Consensus 164 ----------------~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~ 227 (354)
+.++.++|+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 668899999999997543322 23468999999999999999999999999999999999
Q ss_pred CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhh----------hhhhhcc-ccCCchhHHHHHHHHHHH
Q 048432 228 GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI----------FKLFSIS-SVGLSNDIVCLCILRYVN 296 (354)
Q Consensus 228 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~----------~~~~~~~-~~~~~~~~~~~~~~~l~~ 296 (354)
|..|| ......+....+.......|................. ....... ............+..+.+
T Consensus 235 g~~pf--~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 235 GFTLF--QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp SSCSC--CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCC--CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 99995 4444444444444333333321110000000000000 0000000 000000011225678999
Q ss_pred HHhhccccCCCCCCCHHHHHH
Q 048432 297 IALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 297 li~~cl~~~P~~Rps~~~il~ 317 (354)
||.+||+.||++|||++|+++
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCChhhCcCHHHHhc
Confidence 999999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.43 Aligned_cols=235 Identities=26% Similarity=0.338 Sum_probs=187.0
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HHH--------HHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----REL--------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~~--------~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|+++ +|+.||+|++..... ... .+. .+++++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999975 699999999865321 111 111 15566777888889999
Q ss_pred EEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 109 LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
+||||+.||+|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999887 678899999999999999999999 9999999999999999999999999997654
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--chhhhhhhhccccCCCCcccC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY--SFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||...... ...+...+......++.
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~---- 410 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE---- 410 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT----
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc----
Confidence 4332 12247899999999999888999999999999999999999996443221 22233333322222211
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
..++.+.+||.+||+.||++|| +++|+++.
T Consensus 411 -----------------------------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 411 -----------------------------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----------------------------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----------------------------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1466789999999999999999 78888753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=287.55 Aligned_cols=237 Identities=24% Similarity=0.412 Sum_probs=180.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
....++|++.+.||+|+||.||+|.++ +|+.||+|++....... ..++ .|++++++++...+..++|||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 455688999999999999999999976 49999999997654221 1221 256677788888899999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999887 678889999999999999999999 99999999999999999999999999976543321
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
......++..|+|||++.+..++.++||||||+++|+|++|..||. ..........+...... ...
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~--~~~--------- 246 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA--DIHPMRAIFMIPTNPPP--TFR--------- 246 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT--TSCHHHHHHHHHHSCCC--CCS---------
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC--CCChHHHHHHHhcCCCc--ccC---------
Confidence 1223467899999999998889999999999999999999999954 33322222222111110 000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...+..+.+||.+||+.||++|||++++++
T Consensus 247 -------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 -------------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00114667899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.77 Aligned_cols=237 Identities=21% Similarity=0.366 Sum_probs=180.2
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv 110 (354)
....++|++.+.||+|+||.||+|.+. +++.||+|++..........+. |++++++++...+..++|
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 456789999999999999999999976 4899999999765443333322 556677788888899999
Q ss_pred EEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCc
Q 048432 111 YEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 111 ~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~ 184 (354)
|||+++++|..++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999887 678889999999999999999999 9999999999999999999999999875322111
Q ss_pred cccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 185 LQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.......++..|+|||++. +..++.++|+||||+++|+|++|..||. ..+.......+........ .
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~--~~~~~~~~~~~~~~~~~~~--~-- 243 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH--ELNPMRVLLKIAKSDPPTL--L-- 243 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT--TSCHHHHHHHHHHSCCCCC--S--
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc--cCCHHHHHHHHhccCCccc--C--
Confidence 1112246789999999884 5678899999999999999999999954 3333333333322221110 0
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+..++..+.+||.+||+.||++|||++++++
T Consensus 244 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 --------------------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --------------------------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --------------------------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00114667899999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=310.22 Aligned_cols=235 Identities=25% Similarity=0.361 Sum_probs=185.7
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHHH------------HHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|+++ +|+.||+|++...... ....+ .++++++.++.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999976 5999999999653211 11111 14456677788889999
Q ss_pred EEEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 109 LIYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 109 lv~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+||||++|++|..++ +++..++.++.||+.||.|||+.+ |+||||||+||+++.+|.++|+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999998887 567888999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--cchhhhhhhhccccCCCCcc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRT--YSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 257 (354)
....... ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ....+...+.......|.
T Consensus 339 ~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~-- 414 (543)
T 3c4z_A 339 LKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD-- 414 (543)
T ss_dssp CCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--
T ss_pred ccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--
Confidence 5443221 2234789999999999998999999999999999999999999644322 123333333333322221
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTM-----NDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~il~ 317 (354)
..++.+.+||.+||+.||++||++ ++|++
T Consensus 415 -------------------------------~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 -------------------------------KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------------------------------TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------------------------------ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 146678899999999999999964 66764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=284.48 Aligned_cols=236 Identities=27% Similarity=0.370 Sum_probs=178.3
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~ 111 (354)
...++|.....||+|+||.||+|.+. +++.||+|++..........+. |++++++++...+..++||
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 33456667779999999999999975 5889999999765443322222 5566778888888999999
Q ss_pred EecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-CCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~~l~dfg~a~~~~~ 182 (354)
||+++++|.+++ +++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999987 346778889999999999999999 999999999999987 89999999999876543
Q ss_pred CccccccccccCcccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGI--FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||.................. .+.
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~----- 246 (295)
T 2clq_A 176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV--HPE----- 246 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC--CCC-----
T ss_pred CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc--ccc-----
Confidence 221 122346789999999987654 789999999999999999999996432222211111111000 000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...++.+.+||.+||+.||++|||++++++
T Consensus 247 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 -------------------------IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -------------------------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00115667899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.53 Aligned_cols=279 Identities=21% Similarity=0.242 Sum_probs=179.0
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecC----
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDK---- 104 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~---- 104 (354)
....++|++.+.||+|+||.||+|.+. +|+.||||++..... .....+. |++++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 344589999999999999999999965 588999999965321 1111221 455566666543
Q ss_pred --CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 105 --DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 105 --~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
...++++|++ +++|..++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999998 67888877 788899999999999999999999 9999999999999999999999999987
Q ss_pred eccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+....+.+..+..+...
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf--~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCCHHH
Confidence 54332 223467999999999877 67899999999999999999999994 45555555555544433322211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhhhcCCCCCCCcc
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALLPPKQPAFS 335 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~~~~~~~~~~~~ 335 (354)
......... ......... ..........+..++.+.+||.+||+.||++|||++++++. |++.......|..++++
T Consensus 254 ~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~ 331 (367)
T 2fst_X 254 LKKISSESA-RNYIQSLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 331 (367)
T ss_dssp HTTCCCHHH-HHHHHTSCC-CCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCCCC
T ss_pred HHHhhhHHH-HHHHhccCC-CCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCCCC
Confidence 111100000 000000000 00000011112246778999999999999999999999874 55544333333333333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=315.09 Aligned_cols=246 Identities=20% Similarity=0.315 Sum_probs=190.1
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChhh-HHHH------------HHHHHHhceee
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCI 102 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~ 102 (354)
........++|++.+.||+|+||.||+|.+.. +..||+|++....... ...+ .|++++++++.
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34455567889999999999999999999753 4579999987643322 1222 25566677774
Q ss_pred cCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccc
Q 048432 103 DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGI 176 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 176 (354)
++..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 46789999999999999987 567888999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCC
Q 048432 177 ARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 177 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
+......... ......++..|+|||++.+..++.++|||||||++|+|++ |..|| .+....+....+..+.....
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf--~~~~~~~~~~~i~~~~~~~~- 613 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGERLPM- 613 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHHHHTCCCCC-
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC--CCCCHHHHHHHHHcCCCCCC-
Confidence 9765433221 1122345778999999998999999999999999999997 88884 44444444444433321110
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+..+++.+.+||.+||+.||++|||+.++++.|+++..
T Consensus 614 -------------------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 614 -------------------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01156788999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=293.37 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=190.3
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh---------------------hhHHHH--------HHH
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG---------------------QGLREL--------KNK 94 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~---------------------~~~~~~--------~~i 94 (354)
....++|++.+.||+|+||.||+|.+ +|+.||+|++..... ...++. .|+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 34468999999999999999999999 899999999864321 111111 255
Q ss_pred HHHhceeecCCceEEEEEecCCCCHhHH------H-------hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCC
Q 048432 95 LRLLGCCIDKDEKILIYEYMPNKSLDFF------L-------FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSN 160 (354)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~-------~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~N 160 (354)
+++++++.+.+..++||||+++++|.++ + +++..+..++.|++.||.|||+ .+ ++|+||||+|
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 6778888888999999999999999887 3 6788999999999999999999 98 9999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCccccc
Q 048432 161 ILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG-IFSI-KSDVFSFGVLLLKIVSGKKTTGFYRTY 238 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwSlG~~l~~ll~g~~p~~~~~~~ 238 (354)
|+++.++.++|+|||++....... .....++..|+|||++.+. .++. ++|||||||++|+|++|..||. ...
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~--~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS--LKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC--CSS
T ss_pred EEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC--CCC
Confidence 999999999999999997654432 2234678999999999877 5665 9999999999999999999964 333
Q ss_pred c-hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 239 S-FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. .+....+.......+.......... . ...........+..+.+||.+||+.||++|||++++++
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPL--T------------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTT--C------------C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHhccCcCCccchhhhhccc--c------------ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3 4555555555444443221110000 0 00001111225778899999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=290.16 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=163.9
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHH-------------HHHHHHHhceeecCC
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LRE-------------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~-------------~~~i~~~~~~~~~~~ 105 (354)
..+....++|++.+.||+|+||.||+|.++ +|+.||+|++....... ... +.|++++++++...+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 344556689999999999999999999975 68999999997653221 111 125667788888889
Q ss_pred ceEEEEEecCCCCHhHHH----------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeec
Q 048432 106 EKILIYEYMPNKSLDFFL----------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDF 174 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~----------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~df 174 (354)
..++||||+.+ +|.+++ +++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999986 666554 46778899999999999999998 9 999999999999999999999999
Q ss_pred ccceeccCCccccccccccCcccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYA----IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
|++........ .....++..|+|||++ .+..++.++|||||||++|+|++|..||....... +....+..+.
T Consensus 171 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~ 246 (327)
T 3aln_A 171 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQLTQVVKGD 246 (327)
T ss_dssp SSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSC
T ss_pred CCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHHHHHhcCC
Confidence 99875543321 1223678999999998 45668999999999999999999999965432211 1222221111
Q ss_pred c-CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 251 Y-EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 251 ~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. ..+.... ..+++.+.+||.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~-----------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEE-----------------------------REFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSS-----------------------------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCccc-----------------------------ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1 1111000 014667899999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=287.28 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=187.4
Q ss_pred hhhhcCccccceecccCceeEEEEEEc--CCCEEEEEEecCCCh------hhHH-----------HHHHHHHHhceee--
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK--NGDEIAVKRLSGRSG------QGLR-----------ELKNKLRLLGCCI-- 102 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vavK~~~~~~~------~~~~-----------~~~~i~~~~~~~~-- 102 (354)
....++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+ .+.|++++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 345689999999999999999999973 588899999854221 1111 1235566677765
Q ss_pred ---cCCceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEe
Q 048432 103 ---DKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKIS 172 (354)
Q Consensus 103 ---~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~ 172 (354)
.....++||||+.+ +|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 55678999999984 888877 578889999999999999999999 9999999999999999999999
Q ss_pred ecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC
Q 048432 173 DFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 173 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..|| .+.........+......
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf--~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC--CCCCHHHHHHHHHHHcCC
Confidence 999987544322 122346789999999999989999999999999999999999995 444444444444333222
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...+...... .. ..................+..+.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVAL--PR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSS--CG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCcccccc--ch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 211111100000 00 000000001111122235778899999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=299.09 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=175.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------------hHHHH--------HHHHHHhceee
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------------GLREL--------KNKLRLLGCCI 102 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------------~~~~~--------~~i~~~~~~~~ 102 (354)
....++|.+.+.||+|+||.||+|.++ +++.||+|++...... ..+++ .|++++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445789999999999999999999975 5899999998653210 11111 25666777765
Q ss_pred cCCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC---CeEEeec
Q 048432 103 DKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDF 174 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~~l~df 174 (354)
. +..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 4 5589999999999998887 788999999999999999999999 99999999999997544 5999999
Q ss_pred ccceeccCCccccccccccCcccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 175 GIARICRGNELQANTGRIVGTYRYMSPEYAIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 175 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ........+..+..
T Consensus 287 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-TQVSLKDQITSGKY 362 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS-SSCCHHHHHHTTCC
T ss_pred ccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc-chHHHHHHHhcCCC
Confidence 99976543321 223468999999999863 567889999999999999999999964321 12222222322222
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
... .......++.+.+||.+||+.||++|||++|+++
T Consensus 363 ~~~-----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NFI-----------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCC-----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-----------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111 1111125678899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=286.73 Aligned_cols=236 Identities=23% Similarity=0.311 Sum_probs=178.3
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------------hHHHH--------HHHHHHhceeec
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------------GLREL--------KNKLRLLGCCID 103 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------------~~~~~--------~~i~~~~~~~~~ 103 (354)
...++|++.+.||+|+||.||+|.++ +++.||||++...... ...++ .|++++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45689999999999999999999975 4889999998653210 01111 255566677665
Q ss_pred CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC---eEEeecc
Q 048432 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFG 175 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~~l~dfg 175 (354)
+ ..++||||+++++|.+++ ++...+..++.||+.||.|||+.+ |+|+||||+||+++.++. ++|+|||
T Consensus 87 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 E-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred C-ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 4 489999999999998887 678889999999999999999999 999999999999987664 9999999
Q ss_pred cceeccCCccccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
++........ .....++..|+|||++. ...++.++|||||||++|+|++|..||..... .......+..+...
T Consensus 163 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-SSCHHHHHHHTCCC
T ss_pred cceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-HHHHHHHHHhCccc
Confidence 9976543321 12246789999999874 45688999999999999999999999643221 11222222222211
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
. ........++.+.+||.+||+.||++|||++++++
T Consensus 239 ~-----------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 F-----------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-----------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-----------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 11111225678899999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=295.40 Aligned_cols=270 Identities=19% Similarity=0.204 Sum_probs=183.2
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh-----------hHHHHH------------HHH
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ-----------GLRELK------------NKL 95 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~-----------~~~~~~------------~i~ 95 (354)
.+.++....++|++.+.||+|+||.||+|.+.+|+.||||++...... ....+. |++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456678888999999999999999999999888999999998543211 011222 455
Q ss_pred HHhceee-----cCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 048432 96 RLLGCCI-----DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD 164 (354)
Q Consensus 96 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~ 164 (354)
++++++. ....+++||||+.+ +|.+.+ +++..+..++.||+.||.|||+.+ |+|+||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEc
Confidence 5666663 33467999999985 666665 678899999999999999999999 99999999999999
Q ss_pred CCCCeEEeecccceeccCCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhh
Q 048432 165 KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLL 243 (354)
Q Consensus 165 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~ 243 (354)
.++.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf--~~~~~~~~~ 243 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF--RGSTFYNQL 243 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHH
T ss_pred CCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC--CCCCHHHHH
Confidence 999999999999864333221 223467889999999877 66899999999999999999999995 444444444
Q ss_pred hhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 244 GYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+.......+.............+ ..................+..++.+.+||.+||+.||++|||++++++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARD-YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHH-HTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhH-HHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 4443333222111000000000000 0000000000001112222356778999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=294.45 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=184.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh--HHHH------------HHHHHHhceeecCCce---
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG--LREL------------KNKLRLLGCCIDKDEK--- 107 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~--~~~~------------~~i~~~~~~~~~~~~~--- 107 (354)
..++|.+.+.||+|+||.||+|.++ +|+.||+|++....... ...+ .|++++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4589999999999999999999975 58999999997643221 1222 1555667777766654
Q ss_pred ---EEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ---ILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ---~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++||||+.+ +|...+ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 999999984 777776 788999999999999999999999 9999999999999999999999999987543
Q ss_pred CCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+....+.......+......
T Consensus 196 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 196 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF--KGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC--CCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 32 223467899999999887 67899999999999999999999994 45554454544443333222211111
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.... ........ .............+..++.+.+||.+||+.||++|||++|+++.
T Consensus 269 ~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDK-AAKSYIQS-LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCH-HHHHHHHH-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhh-hhhhhhhc-cCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1000 00000000 00000000111122357889999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=286.46 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=173.3
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHH------------HHHHHHHhceeecCCceE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRE------------LKNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~------------~~~i~~~~~~~~~~~~~~ 108 (354)
+....++|++.+.||+|+||.||+|.+. +++.||+|++...... .... +.|++++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4455689999999999999999999954 6899999998654221 1111 236777888888899999
Q ss_pred EEEEecCCCCHhHHH-------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 109 LIYEYMPNKSLDFFL-------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 109 lv~e~~~~~~L~~~~-------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
+||||+++++|.+++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999887 467889999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCcc---ccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc
Q 048432 176 IARICRGNEL---QANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY 251 (354)
Q Consensus 176 ~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 251 (354)
++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~ 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP--MKVLMLTLQNDP 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHHTSSC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch--hhHHHHHhccCC
Confidence 9865433211 111223468899999999876 5689999999999999999999999644322 222221111111
Q ss_pred CCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 252 EFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 252 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...... .. ........+..+.+||.+||+.||++|||++++++
T Consensus 245 ~~~~~~---~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETG---VQ--------------------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC----------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccc---cc--------------------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 100000 00 00000114567899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=313.23 Aligned_cols=234 Identities=27% Similarity=0.373 Sum_probs=181.7
Q ss_pred ceecccCceeEEEEEEc---CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||.||+|.+. .++.||||++..... ....++. |++++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 367899999976432 1122222 55667777764 568999999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-ccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL-QANTG 190 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~-~~~~~ 190 (354)
++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ .....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 9999998 678889999999999999999999 99999999999999999999999999976543321 11122
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...++..|+|||++.+..++.++|||||||++|+|++ |..|| .+....+....+..+......
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf--~~~~~~~~~~~i~~~~~~~~p-------------- 594 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTAMLEKGERMGCP-------------- 594 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHTTCCCCCC--------------
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCCCC--------------
Confidence 2345678999999999999999999999999999998 99994 455555555555444321111
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..+++.+.+||.+||+.||++|||+++|++.|+++..+
T Consensus 595 ------------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 595 ------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11677899999999999999999999999999987644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=300.14 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=180.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH--------HHHHHHhceeec------CCceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL--------KNKLRLLGCCID------KDEKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~--------~~i~~~~~~~~~------~~~~~lv~ 111 (354)
..+|++.+.||+|+||.||+|++. +|+.||||++........+++ .|++++++++.. ...+++||
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 457999999999999999999976 599999999866543222222 366777776632 22467999
Q ss_pred EecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccceecc
Q 048432 112 EYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICR 181 (354)
Q Consensus 112 e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a~~~~ 181 (354)
||+++ ++...+ +++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++....
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99987 454443 567788999999999999999999 9999999999999965 568999999998654
Q ss_pred CCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc---
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD--- 257 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 257 (354)
..... ....++..|+|||++.+. .++.++|||||||++|+|++|++|| .+.+..+.+..+.+.........
T Consensus 209 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf--~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp TTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 43321 224679999999998765 6899999999999999999999995 44444444433333222111100
Q ss_pred -cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 258 -THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 258 -~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
...+....+... ....+...+.+..++.+.+||.+||+.||++|||+.|+++ .++++.
T Consensus 284 ~~~~~~~~~~p~~--------~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 284 MNPNYTEFKFPQI--------KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HCSCCCCCCCCCC--------CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hChhhhhhccCcc--------CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 000000000000 0000000011124678899999999999999999999986 355444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=283.26 Aligned_cols=237 Identities=26% Similarity=0.348 Sum_probs=186.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHH------------HHHHHHhceeecCCce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLREL------------KNKLRLLGCCIDKDEK 107 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~------------~~i~~~~~~~~~~~~~ 107 (354)
.....++|++.+.||+|+||.||+|.++ +++.||+|++..... .....+ .|++++++++...+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4556789999999999999999999976 699999999864321 111122 2556677888888999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC---CCeEEeeccccee
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGIARI 179 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~~l~dfg~a~~ 179 (354)
++|+||+.+++|.+++ +++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.++|+|||++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999998877 678899999999999999999999 9999999999999754 4699999999875
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
....... ....++..|+|||++.+ .++.++|+||||+++|+|++|..|| .+.+..+....+..+....+....
T Consensus 174 ~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~~- 246 (287)
T 2wei_A 174 FQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQW- 246 (287)
T ss_dssp BCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCSGGG-
T ss_pred ecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHcCCCCCCchhh-
Confidence 4433211 22357889999998765 4899999999999999999999994 445555555555444433221110
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...+..+.+||.+||+.||++|||++++++
T Consensus 247 ----------------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 ----------------------------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 014667899999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=292.24 Aligned_cols=271 Identities=17% Similarity=0.185 Sum_probs=178.5
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---hHHH--------HHHHHHHhceeecCCc-
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---GLRE--------LKNKLRLLGCCIDKDE- 106 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---~~~~--------~~~i~~~~~~~~~~~~- 106 (354)
........++|++.+.||+|+||.||+|+++ +|+.||||++...... .... +.|++++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3445667789999999999999999999975 5899999998654321 1111 2356677777754332
Q ss_pred ------eEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHH--hcCCCCeEeCCCCCCCEEEcC-CCCe
Q 048432 107 ------KILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLH--QYSRVRIIHRDLKVSNILLDK-DMNP 169 (354)
Q Consensus 107 ------~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nill~~-~~~~ 169 (354)
.++||||+.++.+..+. ++...+..++.|++.||.||| +.+ |+||||||+||+++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999875333222 567788999999999999999 998 999999999999996 8999
Q ss_pred EEeecccceeccCCccccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
+|+|||++......... ....++..|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+.......+.+
T Consensus 172 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf--~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF--RGDNSAGQLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc--CCCChHHHHHHHHH
Confidence 99999999765443321 2346789999999987654 899999999999999999999994 44554444444444
Q ss_pred cccCCCCcccCCcc----ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhh
Q 048432 249 NIYEFPSVDTHNVK----TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNE 322 (354)
Q Consensus 249 ~~~~~~~~~~~~~~----~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~ 322 (354)
.....+........ .....+.....+... ........++.+.+||.+||+.||++|||++|+++. |++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV-----FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHH-----TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccc-----cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 33322211100000 000000000000000 000011156789999999999999999999999974 5555
Q ss_pred h
Q 048432 323 A 323 (354)
Q Consensus 323 ~ 323 (354)
.
T Consensus 322 ~ 322 (360)
T 3e3p_A 322 H 322 (360)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=289.77 Aligned_cols=271 Identities=20% Similarity=0.210 Sum_probs=186.6
Q ss_pred hhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHHH------------HHHHHhceeecC----
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCIDK---- 104 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~~~---- 104 (354)
+....++|++.+.||+|+||.||+|.+. +|+.||||++....... ...+. |++++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 4456789999999999999999999976 58899999997543221 12222 444555554433
Q ss_pred -CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 105 -DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 105 -~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
...++||||+.+ +|.+++ +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 86 FNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 678999999975 888877 778899999999999999999999 99999999999999999999999999976
Q ss_pred ccCCcccc--------ccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 180 CRGNELQA--------NTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 180 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|.+|| .+.+..+....+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf--~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLLLIFGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC--CCCCcHHHHHHHHHHh
Confidence 54322111 1123467999999998765 67899999999999999999999995 4444333333332222
Q ss_pred cCCCCcccCCccccccchhhhhhhhhcc---ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSIS---SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
...+....... ............. .........+..++.+.+||.+||+.||++|||++++++ .|+...
T Consensus 240 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 240 GTPHSDNDLRC----IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCCSTTTTTT----CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCchhccccc----cccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 21111110000 0000000000000 000011112236778899999999999999999999987 355443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.34 Aligned_cols=226 Identities=14% Similarity=0.161 Sum_probs=165.1
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHHHHHHHHhcee----------------
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRELKNKLRLLGCC---------------- 101 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~~~i~~~~~~~---------------- 101 (354)
.+.....+|.+.+.||+|+||.||+|.+. +|+.||||++....... ...+.+++.++..+
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 34445567889999999999999999965 59999999987432222 22232222211111
Q ss_pred ------------------ec-----CCceEEEEEecCCCCHhHHH------------hhHHHHHHHHHHHHHHHHHHHhc
Q 048432 102 ------------------ID-----KDEKILIYEYMPNKSLDFFL------------FDWVTRVRIIEGIAQGLLYLHQY 146 (354)
Q Consensus 102 ------------------~~-----~~~~~lv~e~~~~~~L~~~~------------~~~~~~~~i~~~i~~~l~~LH~~ 146 (354)
.. ...++++|+++ +++|.+++ +++..+..++.||+.||.|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 12356677765 56888776 56778899999999999999999
Q ss_pred CCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCcccc----------ccCCCCchhhHH
Q 048432 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA----------IQGIFSIKSDVF 216 (354)
Q Consensus 147 ~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Diw 216 (354)
+ |+||||||+|||++.++.+||+|||++...... .....| ..|+|||++ .+..++.++|||
T Consensus 231 ~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 231 G---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp T---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred C---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9 999999999999999999999999998754333 223466 899999999 444578899999
Q ss_pred HHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHH
Q 048432 217 SFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVN 296 (354)
Q Consensus 217 SlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 296 (354)
||||++|+|++|+.||. ..+.......+..... ..++.+.+
T Consensus 302 SlGvil~elltg~~Pf~--~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~ 342 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNT--DDAALGGSEWIFRSCK-------------------------------------NIPQPVRA 342 (413)
T ss_dssp HHHHHHHHHHHSSCCCC--TTGGGSCSGGGGSSCC-------------------------------------CCCHHHHH
T ss_pred HHHHHHHHHHHCCCCCC--CcchhhhHHHHHhhcc-------------------------------------cCCHHHHH
Confidence 99999999999999953 3222222221111000 04567899
Q ss_pred HHhhccccCCCCCCCHHHHH
Q 048432 297 IALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 297 li~~cl~~~P~~Rps~~~il 316 (354)
||.+||+.||++|||+.+++
T Consensus 343 li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 343 LLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHccCChhhCcCHHHHH
Confidence 99999999999999977664
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=290.32 Aligned_cols=265 Identities=20% Similarity=0.239 Sum_probs=184.1
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---------HH-------------HHHHHHHhceee
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---------RE-------------LKNKLRLLGCCI 102 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---------~~-------------~~~i~~~~~~~~ 102 (354)
..++|++.+.||+|+||.||+|++. +++.||+|++........ .. +.|++++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4579999999999999999999974 688999999975432110 11 124555666665
Q ss_pred cCC----ceEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEc------
Q 048432 103 DKD----EKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLD------ 164 (354)
Q Consensus 103 ~~~----~~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~------ 164 (354)
..+ .++++||++ +++|.+++ +++..+..++.||+.||.|||++ + |+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 443 789999999 88998887 56788999999999999999998 9 99999999999995
Q ss_pred CCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc----ch
Q 048432 165 KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY----SF 240 (354)
Q Consensus 165 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~----~~ 240 (354)
..+.++|+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 33479999999997654322 2246799999999999999999999999999999999999996533221 22
Q ss_pred hhhhhhhccccCCCCcccCCcc-------------ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCC
Q 048432 241 TLLGYISENIYEFPSVDTHNVK-------------TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESAD 307 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 307 (354)
.....+.......|........ .............. ......+...+..+.+||.+||+.||+
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL----TEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH----HHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh----hhcccCCcchHHHHHHHHHHHhccCcc
Confidence 2222333322222221100000 00000000000000 001122345789999999999999999
Q ss_pred CCCCHHHHHH--Hhhhhh
Q 048432 308 DRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 308 ~Rps~~~il~--~L~~~~ 323 (354)
+|||++|+++ .+.+..
T Consensus 324 ~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred ccCCHHHHhhChhhhccc
Confidence 9999999988 455543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.56 Aligned_cols=270 Identities=20% Similarity=0.260 Sum_probs=171.8
Q ss_pred hhhcCccc-cceecccCceeEEEEEEc---CCCEEEEEEecCCChh--hHHHH--------HHHHHHhceee--cCCceE
Q 048432 45 TATNKFSD-ANKLGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ--GLREL--------KNKLRLLGCCI--DKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~-~~~lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~--~~~~~--------~~i~~~~~~~~--~~~~~~ 108 (354)
...+.|++ .+.||+|+||.||+|+++ +++.||+|++...... ..+++ .|++++++++. ....++
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34456776 568999999999999965 4789999999765322 12222 25667777774 467899
Q ss_pred EEEEecCCCCHhHHH--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEE----cCCCCeE
Q 048432 109 LIYEYMPNKSLDFFL--------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPK 170 (354)
Q Consensus 109 lv~e~~~~~~L~~~~--------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~~ 170 (354)
+||||+.+ +|.+++ +++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999986 555554 566778999999999999999999 9999999999999 6778999
Q ss_pred EeecccceeccCCcc-ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCccccc-------chh
Q 048432 171 ISDFGIARICRGNEL-QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-------SFT 241 (354)
Q Consensus 171 l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-------~~~ 241 (354)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999976543221 1222335789999999999874 4899999999999999999999997433321 123
Q ss_pred hhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCc-hh----HHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLS-ND----IVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~-~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
.+..+.......+...+......................... .. .....++.+.+||.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 333333333333322222221110000000000000000000 00 0000256788999999999999999999998
Q ss_pred HH
Q 048432 317 SM 318 (354)
Q Consensus 317 ~~ 318 (354)
+.
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=285.48 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=169.3
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH--H---H---------HHHHHHHhceeecCC
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--R---E---------LKNKLRLLGCCIDKD 105 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--~---~---------~~~i~~~~~~~~~~~ 105 (354)
.......++|++.+.||+|+||.||+|.++ +|+.||+|++........ + + +.|++++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 344556789999999999999999999975 699999999976532211 1 1 125667788888899
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhc-CCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++||||+ ++.+..+. +++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 999999999 55555554 56788999999999999999995 8 9999999999999999999999999986
Q ss_pred eccCCccccccccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC-
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE- 252 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 252 (354)
....... .....++..|+|||++. ...++.++|||||||++|+|++|..||..... .......+......
T Consensus 174 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 174 RLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-DFEVLTKVLQEEPPL 249 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHHSCCCC
T ss_pred hccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cHHHHHHHhccCCCC
Confidence 5443321 12246789999999984 45688999999999999999999999643222 22333333222211
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+... .++..+.+||.+||+.||++|||++++++
T Consensus 250 ~~~~~-------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPGHM-------------------------------GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCSSS-------------------------------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccC-------------------------------CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11100 04667899999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=278.44 Aligned_cols=236 Identities=24% Similarity=0.376 Sum_probs=177.8
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeec----C
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCID----K 104 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~----~ 104 (354)
......|++.+.||+|+||.||+|.+. ++..||+|++.... ......+. |++++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344566899999999999999999975 58889999986542 22223333 44455555543 4
Q ss_pred CceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCeEEeecccce
Q 048432 105 DEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIAR 178 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~ 178 (354)
..+++||||+++++|.+++ +++..+..++.||+.||.|||+.+ .+|+|+||||+||+++ .++.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5689999999999999998 678889999999999999999874 3499999999999997 78999999999986
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
...... .....++..|+|||++. +.++.++|||||||++|+|++|..||.... ........+..+.....
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~---- 250 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPAS---- 250 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGG----
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhccCCccc----
Confidence 433322 12346789999999876 458999999999999999999999964322 22223332222211100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+...++.+.+||.+||+.||++|||++++++
T Consensus 251 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 ---------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---------------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01113467899999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=280.82 Aligned_cols=235 Identities=24% Similarity=0.345 Sum_probs=172.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeec---------
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCID--------- 103 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~--------- 103 (354)
..++|++.+.||+|+||.||+|++. +|+.||+|++..... ....+. |++++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH-HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4578999999999999999999975 699999999965322 222333 33444444432
Q ss_pred ----CCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEee
Q 048432 104 ----KDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISD 173 (354)
Q Consensus 104 ----~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~d 173 (354)
....++||||+++++|.+++ ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 45678999999999999998 456788999999999999999999 99999999999999999999999
Q ss_pred cccceeccCCcc------------ccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccch
Q 048432 174 FGIARICRGNEL------------QANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF 240 (354)
Q Consensus 174 fg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~ 240 (354)
||++........ ........++..|+|||++.+. .++.++|||||||++|+|++ ||. ......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~-~~~~~~ 235 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS-TGMERV 235 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS-SHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC-CchhHH
Confidence 999875442210 1112234678999999998764 68999999999999999998 421 122233
Q ss_pred hhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 241 TLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.....+.......+... ....+..+.+||.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDF-----------------------------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCCTTC-----------------------------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccCccc-----------------------------cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 33333333332222211 1114567889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.93 Aligned_cols=238 Identities=23% Similarity=0.336 Sum_probs=181.0
Q ss_pred cCCCCCccccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-------------h---HHHH---
Q 048432 32 VDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-------------G---LREL--- 91 (354)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-------------~---~~~~--- 91 (354)
..+....+........++|++.+.||+|+||.||+|.+. +++.||+|++...... + ...+
T Consensus 27 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 106 (320)
T 3a99_A 27 LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106 (320)
T ss_dssp -------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSS
T ss_pred hhhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccC
Confidence 333444566677778899999999999999999999964 5889999998654211 1 1111
Q ss_pred -HHHHHHhceeecCCceEEEEEecCC-CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc
Q 048432 92 -KNKLRLLGCCIDKDEKILIYEYMPN-KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD 164 (354)
Q Consensus 92 -~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~ 164 (354)
.|++++++++...+..++|+|++.+ ++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183 (320)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEe
Confidence 3567778888999999999999976 8998887 678889999999999999999999 99999999999999
Q ss_pred -CCCCeEEeecccceeccCCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhh
Q 048432 165 -KDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTL 242 (354)
Q Consensus 165 -~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~ 242 (354)
.++.++|+|||++....... .....++..|+|||++.+..+ +.++|||||||++|+|++|..||.... .
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-
T ss_pred CCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----h-
Confidence 78899999999987655432 123468999999999987765 688999999999999999999964221 1
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+.......+ . ..++.+.+||.+||+.||++|||++++++
T Consensus 255 ---~~~~~~~~~-----------------------------~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ---IIRGQVFFR-----------------------------Q----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHCCCCCS-----------------------------S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhccccccc-----------------------------c----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111000 0 04567889999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.93 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=177.8
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhhHHHHHHH------------HHHhcee----------
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQGLRELKNK------------LRLLGCC---------- 101 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~~~~~~~i------------~~~~~~~---------- 101 (354)
...++|++.+.||+|+||.||+|.+.. |+.||+|++..........+.++ +++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 456899999999999999999999764 89999999977655444444433 3444444
Q ss_pred ----ecCCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCeEEe
Q 048432 102 ----IDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKIS 172 (354)
Q Consensus 102 ----~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~~l~ 172 (354)
......++||||+. ++|.+++ ++...+..++.|++.||.|||+.+ |+|+||||+||+++ .++.++|+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 33467899999998 4888887 678889999999999999999999 99999999999997 56789999
Q ss_pred ecccceeccCCcc-ccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccc
Q 048432 173 DFGIARICRGNEL-QANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI 250 (354)
Q Consensus 173 dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 250 (354)
|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+....+....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf--~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF--AGAHELEQMQLILESI 241 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhc
Confidence 9999876543211 111223456889999998875 67899999999999999999999995 4444444444333322
Q ss_pred cCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 251 YEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 251 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
............. ...... ...............+..+..+.+||.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLS--VIPVYI-RNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHT--TSCHHH-HHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhh--cCcccc-cccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 2111100000000 000000 000000000011112235788999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=286.26 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=183.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh--hHHHH------------HHHHHHhceeecCCc----
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ--GLREL------------KNKLRLLGCCIDKDE---- 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~--~~~~~------------~~i~~~~~~~~~~~~---- 106 (354)
..++|.+.+.||+|+||.||+|.++ +|+.||||++...... ....+ .|++++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3579999999999999999999975 5899999999654321 11122 145566677765543
Q ss_pred --eEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 107 --KILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 107 --~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
.+++|||+.+ +|..++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 4999999984 777766 788999999999999999999999 9999999999999999999999999987543
Q ss_pred CCccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+....+.+.....+......
T Consensus 178 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF--KGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS--BSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 123467899999999877 67899999999999999999999995 44444444444433322221111110
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
..... ............ ........+..++.+.+||.+||+.||++|||++++++. ++...
T Consensus 251 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 251 LNDKA-AKSYIQSLPQTP-RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CSCHH-HHHHHHTSCBCS-SCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhHH-HHHHHHhCcCCC-CccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00000 000000000000 000011112257789999999999999999999999863 44433
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=280.21 Aligned_cols=231 Identities=21% Similarity=0.347 Sum_probs=173.1
Q ss_pred ccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-------------hHH---------HHHHHHH
Q 048432 40 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-------------GLR---------ELKNKLR 96 (354)
Q Consensus 40 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-------------~~~---------~~~~i~~ 96 (354)
..+.....++|++.+.||+|+||.||+|.+. +++.||+|++...... +.. .+.|+++
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 3445667789999999999999999999964 5889999999654221 111 2346677
Q ss_pred HhceeecCCceEEEEEe-cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCe
Q 048432 97 LLGCCIDKDEKILIYEY-MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNP 169 (354)
Q Consensus 97 ~~~~~~~~~~~~lv~e~-~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~ 169 (354)
+++++...+..++|+|+ +.+++|.+++ +++..+..++.||+.||.|||+.+ |+|+||||+||+++ .++.+
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 78888888899999999 7899999988 678899999999999999999999 99999999999999 88999
Q ss_pred EEeecccceeccCCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 170 KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 170 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
+|+|||++........ ....++..|+|||++.+..+ +.++|||||||++|+|++|..||... . . +..
T Consensus 180 kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~--~----~~~ 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--Q--E----ILE 247 (312)
T ss_dssp EECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--H--H----HHH
T ss_pred EEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--H--H----Hhh
Confidence 9999999876554322 23467899999999887765 45899999999999999999996321 1 1 111
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.....+ ...+..+.+||.+||+.||++|||++++++.
T Consensus 248 ~~~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 AELHFP---------------------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TCCCCC---------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hccCCc---------------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 0145678899999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.35 Aligned_cols=236 Identities=24% Similarity=0.263 Sum_probs=170.6
Q ss_pred cCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh-HH---------HHHHHHHHhceeecCCceEEEEEecCCC
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LR---------ELKNKLRLLGCCIDKDEKILIYEYMPNK 117 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~-~~---------~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (354)
+.|.+.+.||+|+||+||.+...+|+.||||++....... .. .+.|++++++++.+.+.+++|||||. +
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4556678999999999987776689999999986543221 11 23366777888888899999999996 5
Q ss_pred CHhHHHh------------hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-------------CCeEEe
Q 048432 118 SLDFFLF------------DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-------------MNPKIS 172 (354)
Q Consensus 118 ~L~~~~~------------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-------------~~~~l~ 172 (354)
+|.+++. .+..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.++|+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 9988882 11234679999999999999999 9999999999999754 479999
Q ss_pred ecccceeccCCcccc--ccccccCcccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhh
Q 048432 173 DFGIARICRGNELQA--NTGRIVGTYRYMSPEYAIQ-------GIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTL 242 (354)
Q Consensus 173 dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~ 242 (354)
|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 999998655432211 1223578999999999975 568999999999999999998 8999643222211
Q ss_pred hhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+..+....+.... ......++.+.+||.+||+.||++|||+.++++
T Consensus 249 --~i~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 --NIIRGIFSLDEMKC--------------------------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHTCCCCCCCTT--------------------------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHhcCCCCcccccc--------------------------cccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 12222211111100 001226788999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.41 Aligned_cols=239 Identities=21% Similarity=0.267 Sum_probs=171.6
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh-HH---------HHHHHHHHhceeecCCceEEEEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LR---------ELKNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~-~~---------~~~~i~~~~~~~~~~~~~~lv~e 112 (354)
+.....+|.+.+.||+|+||+||.....+|+.||||++....... .+ .+.|++++++++.+....++|||
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 344456799999999999999776556679999999986543211 11 23477788888999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-----CCCeEEeecccceecc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGIARICR 181 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~~l~dfg~a~~~~ 181 (354)
||.+ +|.+++ .....+..++.||+.||.|||+.+ |+||||||+||+++. ...++|+|||++....
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9975 888887 234467799999999999999999 999999999999953 2357899999997654
Q ss_pred CCcc-ccccccccCcccccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCc
Q 048432 182 GNEL-QANTGRIVGTYRYMSPEYAI---QGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSV 256 (354)
Q Consensus 182 ~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (354)
.... ........||+.|+|||++. ...++.++|||||||++|+|++ |..||........ ...+. .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~~--~~~~~~~ 250 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLG--ACSLDCL 250 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHTT--CCCCTTS
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHhc--cCCcccc
Confidence 3321 11223357899999999997 4567889999999999999999 8888532221111 11111 1000000
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.. ....+..+.+||.+||+.||++|||++++++
T Consensus 251 ~~----------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 HP----------------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT----------------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc----------------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 0115667889999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=272.23 Aligned_cols=221 Identities=13% Similarity=0.072 Sum_probs=167.4
Q ss_pred hhhcCccccceecccCceeEEEEEEcC-CCEEEEEEecCCChhh---HHHH------------HHHHHHhceeecCCceE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG---LREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~~~~~~---~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
...++|++.+.||+|+||.||+|.+.. |+.||+|++....... ...+ .|++++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 456889999999999999999999764 8999999997653321 1111 15667788888889999
Q ss_pred EEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 109 LIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 109 lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
+||||++|++|.+++ .....+.+++.|++.||.|||+.+ |+||||||+||+++.+|.++|++++.
T Consensus 108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~--------- 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT--------- 175 (286)
T ss_dssp EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc---------
Confidence 999999999999998 334567889999999999999999 99999999999999999999974432
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
++ +++.++|||||||++|+|++|..||.. .+.........+.....+..
T Consensus 176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~--~~~~~~~~~~~~~~~~~~~~--------- 224 (286)
T 3uqc_A 176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPE--AGVRSGLAPAERDTAGQPIE--------- 224 (286)
T ss_dssp -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCC--CSBCCCSEECCBCTTSCBCC---------
T ss_pred -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCc--CCcchhhHHHHHHhccCCCC---------
Confidence 22 268899999999999999999999643 22221111000000000000
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhc
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~ 326 (354)
.......+++.+.+||.+||+.||++| |++++++.|+++....
T Consensus 225 -----------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 -----------------PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -----------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -----------------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 001112257789999999999999999 9999999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=268.65 Aligned_cols=224 Identities=18% Similarity=0.244 Sum_probs=165.6
Q ss_pred hhhcCcccc-ceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHH---------HHHHHHHhceeec----CCceEE
Q 048432 45 TATNKFSDA-NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRE---------LKNKLRLLGCCID----KDEKIL 109 (354)
Q Consensus 45 ~~~~~y~~~-~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~---------~~~i~~~~~~~~~----~~~~~l 109 (354)
...++|.+. +.||+|+||.||+|.+. +++.||+|++...... .++ +.|++++++++.. ....++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHH-HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHH-HHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 455778887 78999999999999974 6899999999754321 112 1255667777765 677899
Q ss_pred EEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCCeEEeeccccee
Q 048432 110 IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARI 179 (354)
Q Consensus 110 v~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~~l~dfg~a~~ 179 (354)
||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++. ++.++|+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 99999999999988 678899999999999999999999 999999999999998 78899999998853
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.. +..++.++|||||||++|+|++|..||.. .........+.........
T Consensus 170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~--~~~~~~~~~~~~~~~~~~~---- 219 (299)
T 3m2w_A 170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS--NHGLAISPGMKTRIRMGQY---- 219 (299)
T ss_dssp CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCCSSCTTCC----
T ss_pred cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC--CcchhhhHHHHHHHhhccc----
Confidence 22 13356789999999999999999999632 2222111111110000000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
.........+++.+.+||.+||+.||++|||++|+++ .|.+..
T Consensus 220 ---------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 220 ---------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ---------------------SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ---------------------cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0011111225778999999999999999999999997 344444
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.66 Aligned_cols=228 Identities=20% Similarity=0.312 Sum_probs=177.6
Q ss_pred hhhhcCccccceecccCceeEEEEEEc--CCCEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCc--
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK--NGDEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDE-- 106 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~-- 106 (354)
....++|++.+.||+|+||.||+|.+. +|+.||||++...... ....+ .||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 345689999999999999999999975 5899999998654322 22122 266677777776555
Q ss_pred ---eEEEEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 107 ---KILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ---~~lv~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.|+||||+++++|.+++ +++..+..++.||+.||.|||+.+ |+||||||+||+++.+ .++|+|||++...
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 79999999999998887 789999999999999999999999 9999999999999885 8999999999765
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.. .... ..+
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~--~~~~-----------~~~------ 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG--RYVD-----------GLP------ 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT--EECS-----------SCC------
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc--cccc-----------ccc------
Confidence 433 2346899999999987664 8999999999999999999888431 1000 000
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-TMNDVVSMLTNEA 323 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~il~~L~~~~ 323 (354)
........++.+.+||.+||+.||++|| +++++.+.|.++.
T Consensus 286 ----------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 ----------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0001112457789999999999999999 5777777777654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=293.22 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=176.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhHHHHH------------HHHHHhceeec------
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGLRELK------------NKLRLLGCCID------ 103 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~~~~~------------~i~~~~~~~~~------ 103 (354)
....++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+. |++++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 344589999999999999999999974 589999999876432 2222222 33444444433
Q ss_pred CCceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC---eEEe
Q 048432 104 KDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKIS 172 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~~l~ 172 (354)
.+..++||||+++++|.+++ +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++. ++|+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence 66789999999999999988 457788999999999999999999 999999999999997765 8999
Q ss_pred ecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC
Q 048432 173 DFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 173 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|..||.... ........+......
T Consensus 167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-QPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-HHHHSSTTCC-----
T ss_pred ccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-chhhhhhhhhcccch
Confidence 9999976544332 223478999999999999999999999999999999999999963221 111111110000000
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH-----HHHHhhhhhh
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND-----VVSMLTNEAA 324 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~-----il~~L~~~~~ 324 (354)
.......... ..................++.+.+||.+||+.||++|||+++ ..+.++++..
T Consensus 243 ~~~~~~~l~g----------~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTG----------AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSS----------SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhcc----------ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000000 000000000011112226788999999999999999999987 5566666553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.87 Aligned_cols=226 Identities=16% Similarity=0.167 Sum_probs=172.1
Q ss_pred hhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh-----------hh-H------H--H---------------
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG-----------QG-L------R--E--------------- 90 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~-----------~~-~------~--~--------------- 90 (354)
..++|++.+.||+|+||.||+|++ +|+.||||++..... .. . . .
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999998 689999999975421 10 0 1 1
Q ss_pred -----------HHHHHHHhceeec-------------CCceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHH
Q 048432 91 -----------LKNKLRLLGCCID-------------KDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLY 142 (354)
Q Consensus 91 -----------~~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~ 142 (354)
+.|++++++++.+ .+.+|+|||||.+|++.+.+ +++..++.++.||+.||.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 3677788887765 78899999999998655544 6889999999999999999
Q ss_pred HH-hcCCCCeEeCCCCCCCEEEcCCC--------------------CeEEeecccceeccCCccccccccccCcccccCc
Q 048432 143 LH-QYSRVRIIHRDLKVSNILLDKDM--------------------NPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201 (354)
Q Consensus 143 LH-~~~~~~i~H~dlkp~Nill~~~~--------------------~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 201 (354)
|| +.+ |+||||||+|||++.++ .+||+|||++...... ...||..|+||
T Consensus 177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 99 899 99999999999999887 8999999999865432 23689999999
Q ss_pred cccccCCCCchhhHHHHHHH-HHHHHhCCCCCCcccccc-hhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccc
Q 048432 202 EYAIQGIFSIKSDVFSFGVL-LLKIVSGKKTTGFYRTYS-FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISS 279 (354)
Q Consensus 202 E~~~~~~~~~~~DiwSlG~~-l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 279 (354)
|++.+.. +.++||||++++ .++++.|..||. .... ......+..... ..
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~--~~~~~~~~~~~~~~~~~-~~------------------------- 297 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS--NVLWLHYLTDKMLKQMT-FK------------------------- 297 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH--HHHHHHHHHHHHHHTCC-CS-------------------------
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCc--chhhhhHHHHhhhhhhc-cC-------------------------
Confidence 9998766 899999998777 777888998842 1110 111111110000 00
Q ss_pred cCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 048432 280 VGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316 (354)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il 316 (354)
...........++.+.+||.+||+.| |++|++
T Consensus 298 ~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 298 TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00122234458899999999999977 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=228.21 Aligned_cols=171 Identities=16% Similarity=0.120 Sum_probs=109.0
Q ss_pred eecccCceeEEEEEE-cCCCEEEEEEecCCC----------hhhHHHHH-------------HHHHHhceeecCCceEEE
Q 048432 55 KLGEGGFGPVYKGVL-KNGDEIAVKRLSGRS----------GQGLRELK-------------NKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 55 ~lg~G~~g~V~~a~~-~~~~~vavK~~~~~~----------~~~~~~~~-------------~i~~~~~~~~~~~~~~lv 110 (354)
..+.|+.|....++. --|+.|++|++.... ....+++. |++++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 345566665555552 248889999996542 11122333 334566788899999999
Q ss_pred EEecCCCCHhHHHh--hHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 111 YEYMPNKSLDFFLF--DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 111 ~e~~~~~~L~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
|||++|++|.+++. ......+|+.||+.||.|+|++| |+||||||+|||++.+|.+||+|||+++....... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--W 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--C
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--c
Confidence 99999999999981 11123468999999999999999 99999999999999999999999999976543321 1
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
....+||+.|+|||++.+ .+...+|+||+|++++++.++..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 223578999999998875 456789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-22 Score=198.27 Aligned_cols=172 Identities=20% Similarity=0.220 Sum_probs=124.8
Q ss_pred cccceecccCceeEEEEEEcCCCEEEEEEecCCCh--hh------HHHHHHHHHH------------hceeecCCceEEE
Q 048432 51 SDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--QG------LRELKNKLRL------------LGCCIDKDEKILI 110 (354)
Q Consensus 51 ~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--~~------~~~~~~i~~~------------~~~~~~~~~~~lv 110 (354)
...+.||+|+||.||+|.. .++.+++|+...... .. ...+.+++++ ..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567999999999999954 578899998754321 11 1112233222 3344466677999
Q ss_pred EEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc---
Q 048432 111 YEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA--- 187 (354)
Q Consensus 111 ~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~--- 187 (354)
|||+++++|.+++.. ...++.|++.+|.|||+++ |+||||||+||+++. .++|+|||++..........
T Consensus 418 mE~~~ggsL~~~l~~---~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 418 MSYINGKLAKDVIED---NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp EECCCSEEHHHHSTT---CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred EECCCCCCHHHHHHH---HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 999999999998865 7789999999999999999 999999999999999 99999999998765532211
Q ss_pred --ccccccCcccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 188 --NTGRIVGTYRYMSPEYAIQ--GIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 188 --~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 1123578999999999976 5577889999988888777766655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-22 Score=179.53 Aligned_cols=139 Identities=17% Similarity=0.120 Sum_probs=105.9
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh------------------hHHHHHHH---------HHH
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ------------------GLRELKNK---------LRL 97 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~------------------~~~~~~~i---------~~~ 97 (354)
.....|.+.+.||+|+||.||+|.+.+|+.||+|++...... ....+.++ +++
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v 166 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 166 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCc
Confidence 334455566999999999999999977999999999643211 11122222 344
Q ss_pred hceeecCCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccc
Q 048432 98 LGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIA 177 (354)
Q Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a 177 (354)
.+++. .+..++||||++|++|.+ + .......++.|++.||.+||+.+ |+||||||+||+++ ++.++|+|||++
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l-~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-V-RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-C-CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-c-chhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 45443 356799999999999988 3 33456689999999999999999 99999999999999 999999999998
Q ss_pred eeccCCccccccccccCcccccCccccc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAI 205 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (354)
.. +..+.|||.+.
T Consensus 240 ~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 240 VE---------------VGEEGWREILE 252 (282)
T ss_dssp EE---------------TTSTTHHHHHH
T ss_pred eE---------------CCCCCHHHHHH
Confidence 52 33567888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.1e-18 Score=150.25 Aligned_cols=129 Identities=17% Similarity=0.155 Sum_probs=95.1
Q ss_pred hhcCccccceecccCceeEEEEEE-cCCCE--EEEEEecCCChh----------------------------hHHHHHHH
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVL-KNGDE--IAVKRLSGRSGQ----------------------------GLRELKNK 94 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~--vavK~~~~~~~~----------------------------~~~~~~~i 94 (354)
...-|.+.+.||+|+||.||+|.+ .+|+. ||||++...... ...++.+.
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 334478899999999999999997 67989 999997543111 11222222
Q ss_pred HHHhce------eecCCceEEEEEecCC-C----CHhHHHhh--HHHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCCC
Q 048432 95 LRLLGC------CIDKDEKILIYEYMPN-K----SLDFFLFD--WVTRVRIIEGIAQGLLYLH-QYSRVRIIHRDLKVSN 160 (354)
Q Consensus 95 ~~~~~~------~~~~~~~~lv~e~~~~-~----~L~~~~~~--~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~N 160 (354)
.++... ....+..++||||+.+ | +|.+.... ...+..++.|++.+|.+|| +.+ |+||||||+|
T Consensus 125 ~~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~N 201 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYN 201 (258)
T ss_dssp HHHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTS
T ss_pred HHHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence 222211 1112356799999942 3 67766533 5578899999999999999 999 9999999999
Q ss_pred EEEcCCCCeEEeeccccee
Q 048432 161 ILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 161 ill~~~~~~~l~dfg~a~~ 179 (354)
||++. .++|+|||++..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 899999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=153.76 Aligned_cols=134 Identities=14% Similarity=0.154 Sum_probs=102.3
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCCh--------------------------hhHHHHHHHH
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSG--------------------------QGLRELKNKL 95 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~i~ 95 (354)
.......=|.+.+.||.|++|.||+|...+|+.||||+++.... ....++.++.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33334445999999999999999999998999999998753210 0123456777
Q ss_pred HHhceeecCCc------eEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC-
Q 048432 96 RLLGCCIDKDE------KILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN- 168 (354)
Q Consensus 96 ~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~- 168 (354)
+++........ .++||||++|+.|..+. .......++.||+.+|.+||+.| |+||||||.|||++.++.
T Consensus 169 rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~-~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS-SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp HHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC-CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred HHHhcCCCCCeeeeccCceEEEEecCCccHhhhc-ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 77654433222 36999999998886553 33445678899999999999999 999999999999987763
Q ss_pred ---------eEEeeccccee
Q 048432 169 ---------PKISDFGIARI 179 (354)
Q Consensus 169 ---------~~l~dfg~a~~ 179 (354)
+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 89999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.6e-10 Score=102.35 Aligned_cols=133 Identities=18% Similarity=0.133 Sum_probs=97.6
Q ss_pred hhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCC---ChhhHHHHHHHH----------HHhceeecCCceEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR---SGQGLRELKNKL----------RLLGCCIDKDEKILIY 111 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~---~~~~~~~~~~i~----------~~~~~~~~~~~~~lv~ 111 (354)
.....|++...++.|+.+.||++... ++.+++|+.... ..........++ +++.++.+.+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34567999999999999999999864 788999998752 222222211222 2344556667889999
Q ss_pred EecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 048432 112 EYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYS-------------------------------------------- 147 (354)
Q Consensus 112 e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 147 (354)
|+++|.++.....+......++.+++.+++.||+..
T Consensus 90 e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 90 SEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp ECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred EecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 999999988764334445678899999999999811
Q ss_pred ------------CCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 148 ------------RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 148 ------------~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=6.7e-10 Score=97.85 Aligned_cols=133 Identities=14% Similarity=0.103 Sum_probs=89.4
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-HHHH---HH-------HHHhceeecCCceEEEE
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-RELK---NK-------LRLLGCCIDKDEKILIY 111 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~~~~---~i-------~~~~~~~~~~~~~~lv~ 111 (354)
+......|.+....+.|..+.||++...+|..+++|+......... .+.. .+ .+++.+....+..++||
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred HHHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3444456665544456667999999877788899999866422111 1111 11 12344445556789999
Q ss_pred EecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 048432 112 EYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYS-------------------------------------------- 147 (354)
Q Consensus 112 e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 147 (354)
||++|.++. . .......++.+++..+..||+..
T Consensus 95 e~i~G~~l~--~-~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 95 GEVPGQDLL--S-SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp ECCSSEETT--T-SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EecCCcccC--c-CcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 999998885 2 22223467777888888888753
Q ss_pred -----------CCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 148 -----------RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 148 -----------~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-08 Score=94.31 Aligned_cols=129 Identities=14% Similarity=0.263 Sum_probs=88.4
Q ss_pred ccccceecccCceeEEEEEEcCCCEEEEEEec--CCC----hhhHHHHHHHHH-----------HhceeecC---CceEE
Q 048432 50 FSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS--GRS----GQGLRELKNKLR-----------LLGCCIDK---DEKIL 109 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~--~~~----~~~~~~~~~i~~-----------~~~~~~~~---~~~~l 109 (354)
....+.|+.|.++.||++... +..+++|+.. ... .........+++ ++.++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 344778999999999999875 4678899886 322 111211112222 22333333 34789
Q ss_pred EEEecCCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 048432 110 IYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYS--------------------------------------- 147 (354)
Q Consensus 110 v~e~~~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 147 (354)
||||++|..+.+.. ++......++.+++..|+.||+..
T Consensus 119 vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp EEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99999998774322 456677888999999999999731
Q ss_pred ----------------CCCeEeCCCCCCCEEEcCCCC--eEEeeccccee
Q 048432 148 ----------------RVRIIHRDLKVSNILLDKDMN--PKISDFGIARI 179 (354)
Q Consensus 148 ----------------~~~i~H~dlkp~Nill~~~~~--~~l~dfg~a~~ 179 (354)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 235999999999999997753 58999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.66 E-value=2.1e-08 Score=90.86 Aligned_cols=168 Identities=19% Similarity=0.183 Sum_probs=105.4
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHHHHHHHhc---------------eeecCC---ceEEEEEec
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLRLLG---------------CCIDKD---EKILIYEYM 114 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~~i~~~~~---------------~~~~~~---~~~lv~e~~ 114 (354)
++.++.|....||++. ..+++|+.... .....+.++..++. ...... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 5679999999999874 45899987543 11222222222211 111112 247899999
Q ss_pred CCCCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 048432 115 PNKSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYS-------------------------------------------- 147 (354)
Q Consensus 115 ~~~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 147 (354)
+|.++.... ++......++.+++..++.||+..
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 998887543 455667778888888888888621
Q ss_pred -----------CCCeEeCCCCCCCEEEcC--CCCeEEeecccceeccCCccccccccccCcccc---cCcccccc-----
Q 048432 148 -----------RVRIIHRDLKVSNILLDK--DMNPKISDFGIARICRGNELQANTGRIVGTYRY---MSPEYAIQ----- 206 (354)
Q Consensus 148 -----------~~~i~H~dlkp~Nill~~--~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~----- 206 (354)
...++|+|++|.||+++. .+.+.++||+.+........... .... ..|+....
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~------~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS------LMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT------TCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH------HHhhccccCHHHHHHHHHHc
Confidence 134899999999999998 45678999998865432211100 0000 12221110
Q ss_pred CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 048432 207 GIF---------SIKSDVFSFGVLLLKIVSGKKTT 232 (354)
Q Consensus 207 ~~~---------~~~~DiwSlG~~l~~ll~g~~p~ 232 (354)
+.. ....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999999773
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1e-05 Score=71.37 Aligned_cols=131 Identities=19% Similarity=0.184 Sum_probs=88.0
Q ss_pred hcCccccceecccCce-eEEEEEEc-CCCEEEEEEecCCChhhHHHHHHHH----------HHhceeecCCceEEEEEec
Q 048432 47 TNKFSDANKLGEGGFG-PVYKGVLK-NGDEIAVKRLSGRSGQGLRELKNKL----------RLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g-~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~~i~----------~~~~~~~~~~~~~lv~e~~ 114 (354)
...|+. +.+..|..+ .||+.... .+..+++|+-..............+ +++.++.+.+..++||+++
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 334443 345556555 68998864 4677999997654333322222222 2344566778889999999
Q ss_pred CCCCHhHHH-hhHHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 048432 115 PNKSLDFFL-FDWVTRVRIIEGIAQGLLYLHQYSR--------------------------------------------- 148 (354)
Q Consensus 115 ~~~~L~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~--------------------------------------------- 148 (354)
+|.++.+.. ........+..++...+..||....
T Consensus 103 ~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 103 PGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp CSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred CCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 998887665 2233445667777777788875320
Q ss_pred ----------CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 ----------VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ----------~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++|+|+++.||+++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 128999999999999987777799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=2.9e-05 Score=70.13 Aligned_cols=121 Identities=22% Similarity=0.215 Sum_probs=75.8
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHHHHHHHhc---------------ee-ecCCceEEEEEecCC
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLRLLG---------------CC-IDKDEKILIYEYMPN 116 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~~i~~~~~---------------~~-~~~~~~~lv~e~~~~ 116 (354)
.+.++.|....||+. |..+++|+.... .....+.++..++. +. ...+..++||++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 566888999999998 566889985332 22222333322221 11 123457899999999
Q ss_pred CCHhHHH---hhHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 048432 117 KSLDFFL---FDWVTRVRIIEGIAQGLLYLHQYS---------------------------------------------- 147 (354)
Q Consensus 117 ~~L~~~~---~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 147 (354)
..+.... ++......++.++...|+.||+..
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 8886532 233334444444544444444321
Q ss_pred -----------CCCeEeCCCCCCCEEEcC---CCCe-EEeeccccee
Q 048432 148 -----------RVRIIHRDLKVSNILLDK---DMNP-KISDFGIARI 179 (354)
Q Consensus 148 -----------~~~i~H~dlkp~Nill~~---~~~~-~l~dfg~a~~ 179 (354)
...++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999987 4555 8999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=2.4e-05 Score=72.08 Aligned_cols=30 Identities=17% Similarity=0.257 Sum_probs=25.3
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++|+|+++.||+++.+..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 359999999999999964457899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=5.7e-05 Score=70.69 Aligned_cols=30 Identities=27% Similarity=0.328 Sum_probs=25.3
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++|+|+++.||+++.++ +.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 3599999999999998764 89999987754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00017 Score=64.26 Aligned_cols=73 Identities=18% Similarity=0.219 Sum_probs=46.2
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHH---HHHHHhc-e-------eecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK---NKLRLLG-C-------CIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~---~i~~~~~-~-------~~~~~~~~lv~e~~~ 115 (354)
+....-++.+|.|..+.||++...+|+.|++|+...........+. ..++.+. . ....+.-++|||+++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~ 93 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVD 93 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCC
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeec
Confidence 3455567889999999999999989999999997654332211122 2222221 1 011123478999988
Q ss_pred CCCH
Q 048432 116 NKSL 119 (354)
Q Consensus 116 ~~~L 119 (354)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00058 Score=61.98 Aligned_cols=30 Identities=20% Similarity=0.295 Sum_probs=26.8
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 359999999999999888889999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00036 Score=65.80 Aligned_cols=79 Identities=9% Similarity=-0.012 Sum_probs=45.6
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccC---CCCchhhHHHHHHHHHHH
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG---IFSIKSDVFSFGVLLLKI 225 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwSlG~~l~~l 225 (354)
..++|+|+++.||+++.++ +.++||+.+............ ...-...|.+|+..... .......+..+...+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3499999999999998876 999999988653322110000 00001234555433211 112234555777777777
Q ss_pred HhCC
Q 048432 226 VSGK 229 (354)
Q Consensus 226 l~g~ 229 (354)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0012 Score=59.74 Aligned_cols=67 Identities=15% Similarity=0.114 Sum_probs=43.8
Q ss_pred ccceecccCceeEEEEEEcCCCEEEEEEecCCChhhHHHHHHHH------------HHhceeecCCceEEEEEecCCCCH
Q 048432 52 DANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKL------------RLLGCCIDKDEKILIYEYMPNKSL 119 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~~i~------------~~~~~~~~~~~~~lv~e~~~~~~L 119 (354)
-.+.|+.|....+|+... ++..+++|+...............+ +++.+....+..++|||++++..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 356789999999999986 4678899998654322221111111 122333445678999999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00096 Score=60.20 Aligned_cols=139 Identities=15% Similarity=0.139 Sum_probs=73.8
Q ss_pred cccchhhhhcCccc-----cceecccCceeEEEEEEcCCCEEEEEEecCC-ChhhHHHHHHHHHH---hc-----ee---
Q 048432 39 SFSSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGR-SGQGLRELKNKLRL---LG-----CC--- 101 (354)
Q Consensus 39 ~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~-~~~~~~~~~~i~~~---~~-----~~--- 101 (354)
+.+.+.....+|.+ .+.|+.|....+|++...+| .+++|+.... ..........+++. .+ .+
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 33444444455554 35567788899999987655 5889998763 22222221111111 11 11
Q ss_pred ------ecCCceEEEEEecCCCCHh-----HHH---------------h-----------hHHHHHH------------H
Q 048432 102 ------IDKDEKILIYEYMPNKSLD-----FFL---------------F-----------DWVTRVR------------I 132 (354)
Q Consensus 102 ------~~~~~~~lv~e~~~~~~L~-----~~~---------------~-----------~~~~~~~------------i 132 (354)
...+..++++++++|..+. .+. + .|..... +
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 1124568899999886531 110 0 0111000 0
Q ss_pred HHHHHHHHHHHHhc----CCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 133 IEGIAQGLLYLHQY----SRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 133 ~~~i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
...+...+..++.. ....++|+|+++.||+++.++.+.++||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133344455432 12349999999999999987666899999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0033 Score=57.04 Aligned_cols=32 Identities=25% Similarity=0.426 Sum_probs=27.2
Q ss_pred CCeEeCCCCCCCEEEcCC----CCeEEeecccceec
Q 048432 149 VRIIHRDLKVSNILLDKD----MNPKISDFGIARIC 180 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~----~~~~l~dfg~a~~~ 180 (354)
..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 359999999999999874 67899999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0047 Score=55.15 Aligned_cols=119 Identities=14% Similarity=0.156 Sum_probs=69.5
Q ss_pred cceecccCceeEEEEEEcCCCEEEEEEecCCChh---hHHHHH--HHHHHhce-----eecCCceEEEEEec-CCCCHhH
Q 048432 53 ANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ---GLRELK--NKLRLLGC-----CIDKDEKILIYEYM-PNKSLDF 121 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~---~~~~~~--~i~~~~~~-----~~~~~~~~lv~e~~-~~~~L~~ 121 (354)
.+.|+.|....+|++ ..+++|+....... ...+.. ..+.-.++ ......-+++++|+ +|.++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~~ 97 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMSP 97 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECCH
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCCH
Confidence 788999999999999 45899988653221 112221 11111111 12333456899999 6655532
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------CCCe
Q 048432 122 FLFDWVTRVRIIEGIAQGLLYLHQYS--------------------------------------------------RVRI 151 (354)
Q Consensus 122 ~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------------~~~i 151 (354)
..+.. ...++.++++.|+.||+.+ ...+
T Consensus 98 ~~~~~--~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 98 EKFKT--RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp HHHHH--STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred hhHhh--hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 11100 0123334444444444322 2248
Q ss_pred EeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 152 IHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 152 ~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+|+|+.+.||+ ..++.+.++||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5667789999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0063 Score=55.48 Aligned_cols=31 Identities=19% Similarity=0.354 Sum_probs=27.3
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.018 Score=48.66 Aligned_cols=96 Identities=13% Similarity=0.048 Sum_probs=59.6
Q ss_pred CHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccccc
Q 048432 118 SLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR 191 (354)
Q Consensus 118 ~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~ 191 (354)
+|.+.+ +++.+++.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence 566666 7899999999999999876522110 11233456889999999887753 1110
Q ss_pred ccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 048432 192 IVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKT 231 (354)
Q Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p 231 (354)
.....+.+||... ...+.+.-|||||+++|.-+-=..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123567888653 3456889999999999998863333
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0062 Score=54.92 Aligned_cols=29 Identities=38% Similarity=0.464 Sum_probs=24.8
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3489999999999999 4 899999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.012 Score=55.48 Aligned_cols=31 Identities=6% Similarity=0.124 Sum_probs=24.7
Q ss_pred ccceecccCceeEEEEEEcC--------CCEEEEEEecC
Q 048432 52 DANKLGEGGFGPVYKGVLKN--------GDEIAVKRLSG 82 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~--------~~~vavK~~~~ 82 (354)
-.+.|+.|....+|++...+ ++.+++|+...
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~ 115 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN 115 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC
Confidence 35678889999999998653 57899999954
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.016 Score=55.18 Aligned_cols=30 Identities=7% Similarity=-0.091 Sum_probs=22.1
Q ss_pred cceecccCceeEEEEEEcC-CCEEEEEEecC
Q 048432 53 ANKLGEGGFGPVYKGVLKN-GDEIAVKRLSG 82 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~-~~~vavK~~~~ 82 (354)
.+.|+.|....+|++...+ +..+++|+...
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~ 143 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGP 143 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCC
Confidence 4578888889999999764 47889998854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.024 Score=52.51 Aligned_cols=29 Identities=28% Similarity=0.385 Sum_probs=26.2
Q ss_pred CeEeCCCCCCCEEEcCC----CCeEEeecccce
Q 048432 150 RIIHRDLKVSNILLDKD----MNPKISDFGIAR 178 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~----~~~~l~dfg~a~ 178 (354)
.++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 59999999999999876 789999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.041 Score=50.52 Aligned_cols=29 Identities=24% Similarity=0.393 Sum_probs=24.2
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++|+|+++.||+++.++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 599999999999998655 89999987753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.023 Score=52.98 Aligned_cols=30 Identities=27% Similarity=0.367 Sum_probs=25.1
Q ss_pred CeEeCCCCCCCEEE------cCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILL------DKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill------~~~~~~~l~dfg~a~~ 179 (354)
.++|+|+.+.||++ +.+..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 3456799999998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.26 Score=46.16 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=26.3
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 35999999999999 7888999999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 354 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-59
Identities = 66/304 (21%), Positives = 124/304 (40%), Gaps = 56/304 (18%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGLRELK------------NKL 95
+ + ++G G FG VYKG + + ++ + Q L+ K N L
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
+G + ++ ++ SL L F+ + + I AQG+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA---IQ 206
IIHRDLK +NI L +D+ KI DFG+A + ++ G+ +M+PE +
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 207 GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266
+S +SDV++FG++L ++++G+ + + + ++ Y P +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSN---- 237
Query: 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 326
C + C+++ D+RP +++ + A +L
Sbjct: 238 -----------------------CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
Query: 327 LPPK 330
PK
Sbjct: 275 --PK 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-54
Identities = 71/304 (23%), Positives = 121/304 (39%), Gaps = 56/304 (18%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK--------NKLR 96
KLG+G FG V+ G +A+K L + L+E + ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFLFD-------WVTRVRIIEGIAQGLLYLHQYSRV 149
L ++ ++ EYM SL FL V + IA G+ Y+ +
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 132
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
+HRDL+ +NIL+ +++ K++DFG+AR+ NE A G ++ +PE A+ G F
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 191
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269
+IKSDV+SFG+LL ++ + + Y + E Y P
Sbjct: 192 TIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPE----------- 238
Query: 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPP 329
C ++ C ++ ++RPT + + L + + P
Sbjct: 239 --------------------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
Query: 330 KQPA 333
QP
Sbjct: 279 YQPG 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-54
Identities = 77/290 (26%), Positives = 117/290 (40%), Gaps = 56/290 (19%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK--------NKLR 96
+LG G FG V+ G ++AVK L S L E +R
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
L + +I EYM N SL FL + + IA+G+ ++ + +
Sbjct: 73 LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
IHRDL+ +NIL+ ++ KI+DFG+AR+ NE A G ++ +PE G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTF 187
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269
+IKSDV+SFG+LL +IV+ + Y + + E Y D
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDN----------- 234
Query: 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
C + LC +E +DRPT + + S+L
Sbjct: 235 --------------------CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-53
Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 54/283 (19%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK--------NKLRLLGCCI 102
++G G FG V+ G N D++A+K + + + E + ++L G C+
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 103 DKDEKILIYEYMPNKSLDFF------LFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156
++ L++E+M + L + LF T + + + +G+ YL + +IHRDL
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 127
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVF 216
N L+ ++ K+SDFG+ R ++ ++ ++ SPE +S KSDV+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 217 SFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFS 276
SFGVL+ ++ S K R+ S + + P
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR--------------------- 225
Query: 277 ISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
L I C +E +DRP + ++ L
Sbjct: 226 ------------LASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-53
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 34/298 (11%)
Query: 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----LRELK------- 92
+ F ++LG G G V+K K +G +A K + +REL+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 93 -NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQY 146
+ G E + E+M SLD L ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-- 121
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
+ +I+HRD+K SNIL++ K+ DFG++ + VGT YMSPE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQG 177
Query: 207 GIFSIKSDVFSFGVLLLKIVSGKK------TTGFYRTYSFTLLGYISENIYE--FPSVDT 258
+S++SD++S G+ L+++ G+ + + G +E P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCI-LRYVNIALLCVQESADDRPTMNDV 315
+ + IF+L + L + + C+ ++ +R + +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-52
Identities = 65/299 (21%), Positives = 108/299 (36%), Gaps = 46/299 (15%)
Query: 55 KLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG-LREL----------KNKLRLLGCCID 103
+G+G FG V++G + G+E+AVK S R + RE +N L +
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 104 KDEKI----LIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQ-----YSRVR 150
+ L+ +Y + SL +L +++ A GL +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICR--GNELQANTGRIVGTYRYMSPEYAIQGI 208
I HRDLK NIL+ K+ I+D G+A + + VGT RYM+PE I
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188
Query: 209 ------FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
++D+++ G++ +I G + Y Y + + V
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLVPSDPSVEEMRKVV 245
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321
L I + C + I C + R T + L+
Sbjct: 246 CEQKLRPNIPNRWQ----------SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 9e-51
Identities = 71/317 (22%), Positives = 128/317 (40%), Gaps = 71/317 (22%)
Query: 38 FSFSSVSTATNKFSDA---------NKLGEGGFGPVYKGVLKNGDE----IAVKRL-SGR 83
F+F + A +F+ +G G FG V G LK + +A+K L SG
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 84 SGQGLRELKNKLRLLG------------CCIDKDEKILIYEYMPNKSLDFFL------FD 125
+ + R+ ++ ++G ++I E+M N SLD FL F
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 126 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185
+ V ++ GIA G+ YL +HRDL NIL++ ++ K+SDFG++R +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 186 QANTGRIVG---TYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTL 242
+G R+ +PE F+ SDV+S+G+++ +++S + ++ + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMTNQDV 242
Query: 243 LGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCV 302
+ I ++ P +D C + L C
Sbjct: 243 INAIEQDYRLPPPMD--------------------------------CPSALHQLMLDCW 270
Query: 303 QESADDRPTMNDVVSML 319
Q+ + RP +V+ L
Sbjct: 271 QKDRNHRPKFGQIVNTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 1e-50
Identities = 68/320 (21%), Positives = 109/320 (34%), Gaps = 84/320 (26%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-----LRELK---- 92
N +GEG FG V++ +AVK L + RE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 93 ----NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------------- 123
N ++LLG C L++EYM L+ FL
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 124 ----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179
++ I +A G+ YL + + +HRDL N L+ ++M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYS 239
+ G R+M PE ++ +SDV+++GV+L +I S + +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 240 FTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIAL 299
+ NI P C L N+
Sbjct: 250 EVIYYVRDGNILACPEN---------------------------------CPLELYNLMR 276
Query: 300 LCVQESADDRPTMNDVVSML 319
LC + DRP+ + +L
Sbjct: 277 LCWSKLPADRPSFCSIHRIL 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-50
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELK--------NKLRLLGCCI 102
+LG G FG V G + ++A+K + S + E K ++L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 103 DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156
+ +I EYM N L +L F + + + + + + YL + +HRDL
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 126
Query: 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVF 216
N L++ K+SDFG++R +E ++ G R+ PE + FS KSD++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 217 SFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFS 276
+FGVL+ +I S K + R + +I++ + +
Sbjct: 186 AFGVLMWEIYSLGKMP-YERFTNSETAEHIAQGLRLYRPH-------------------- 224
Query: 277 ISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321
L + I C E AD+RPT ++S + +
Sbjct: 225 ------------LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 2e-50
Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 56/291 (19%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG---LRELK--------NKL 95
+ +KLG G +G VY+GV K +AVK L + + L+E N +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSR 148
+LLG C + +I E+M +L +L V + + I+ + YL +
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 134
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
IHRDL N L+ ++ K++DFG++R+ G+ A+ G ++ +PE
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNK 192
Query: 209 FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268
FSIKSDV++FGVLL +I + + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSP---------------------------------YPG 219
Query: 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
+ + +++ + + C + + C Q + DRP+ ++
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-48
Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 66/295 (22%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------LRELK------ 92
FSD ++G G FG VY ++N + +A+K++S Q ++E++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 93 --NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ 145
N ++ GC + + L+ EY + D V + G QGL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 146 YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
+ +IHRD+K NILL + K+ DFG A I A VGT +M+PE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 206 ---QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
+G + K DV+S G+ +++ K + + + L +I++N
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSALYHIAQNESPAL-------- 234
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317
S S N C+Q+ DRPT ++
Sbjct: 235 ---------------QSGHWSEYF--------RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-48
Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 60/290 (20%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LRELK--------NKLRL 97
+ +G+G FG V G + G+++AVK + + L E N ++L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 98 LGCCIDKDEKI-LIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRV 149
LG +++ + ++ EYM SL +L ++ + + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
+HRDL N+L+ +D K+SDFG+ + E + ++ +PE + F
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKF 177
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269
S KSDV+SFG+LL +I S + + +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVP---------------------------------YPRI 204
Query: 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
+ + G D C + C A RP+ + L
Sbjct: 205 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-47
Identities = 65/293 (22%), Positives = 110/293 (37%), Gaps = 62/293 (21%)
Query: 54 NKLGEGGFGPVYKGVLKNGD----EIAVKRLSGRSGQG-----LRELK--------NKLR 96
+G G FG VY G L + D AVK L+ + G L E N L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 97 LLGCCIDKDEKI-LIYEYMPNKSLDFF------LFDWVTRVRIIEGIAQGLLYLHQYSRV 149
LLG C+ + ++ YM + L F + +A+G+ +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASK 149
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR--IVGTYRYMSPEYAIQG 207
+ +HRDL N +LD+ K++DFG+AR E + + ++M+ E
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 208 IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267
F+ KSDV+SFGVLL ++++ + +F + Y+ +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQPEY---------- 258
Query: 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320
C + L C A+ RP+ +++VS ++
Sbjct: 259 ----------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-47
Identities = 66/316 (20%), Positives = 104/316 (32%), Gaps = 83/316 (26%)
Query: 55 KLGEGGFGPVYKGVLKNGDE------IAVKRLSGRSGQG-----LRELK---------NK 94
LG G FG V + +AVK L ++ + ELK N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL----------------------------FDW 126
+ LLG C LI+EY L +L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 127 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186
+ +A+G+ +L +HRDL N+L+ KI DFG+AR +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI 246
G ++M+PE +GI++IKSDV+S+G+LL +I S
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-------------- 266
Query: 247 SENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESA 306
+P + + + G D I C +
Sbjct: 267 ------YPGIPVDAN------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 308
Query: 307 DDRPTMNDVVSMLTNE 322
RP+ ++ S L +
Sbjct: 309 RKRPSFPNLTSFLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 62/293 (21%), Positives = 106/293 (36%), Gaps = 60/293 (20%)
Query: 52 DANKLGEGGFGPVYKGVLKN---GDEIAVKRLSGRSGQG------LRELK--------NK 94
+ +LG G FG V KG + +AVK L + L E
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRV 149
+R++G C + + +L+ E L+ +L + ++ ++ G+ YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTG-RIVGTYRYMSPEYAIQGI 208
+HRDL N+LL KISDFG+++ R +E ++ +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 209 FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268
FS KSDV+SFGVL+ + S + +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP---------------------------------YRG 213
Query: 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321
+ ++ ++ G C ++ LC ++RP V L N
Sbjct: 214 MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 61/297 (20%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDE-----IAVKRLSGRSGQG-----LRELK----- 92
+ + +G G FG VYKG+LK +A+K L + L E
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 93 ---NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYL 143
N +RL G ++I EYM N +LD FL F + V ++ GIA G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT-GRIVGTYRYMSPE 202
+ +HRDL NIL++ ++ K+SDFG++R+ + T R+ +PE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
F+ SDV+SFG+++ ++++ +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERP------------------------------ 213
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
+ L+ ++ + G C + + C Q+ RP D+VS+L
Sbjct: 214 ---YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-47
Identities = 66/318 (20%), Positives = 100/318 (31%), Gaps = 78/318 (24%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-----LRELK---- 92
N+ S LG G FG V + +AVK L + + ELK
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 93 -----NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------------------F 124
N + LLG C ++I EY L FL
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 125 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184
D + +A+G+ +L IHRDL NILL KI DFG+AR + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244
G ++M+PE +++ +SDV+S+G+ L ++ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 245 YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQE 304
I E G +I C
Sbjct: 260 MIKE--------------------------------GFRMLSPEHAPAEMYDIMKTCWDA 287
Query: 305 SADDRPTMNDVVSMLTNE 322
RPT +V ++ +
Sbjct: 288 DPLKRPTFKQIVQLIEKQ 305
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-46
Identities = 57/289 (19%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 55 KLGEGGFGPVYKGVLKNGD---EIAVKRLSGRSGQG-----LRELK--------NKLRLL 98
+LG G FG V +GV + ++A+K L + + +RE + +RL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 99 GCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G C + +L+ E L FL ++ ++ G+ YL + + +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 131
Query: 153 HRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
HRDL N+LL KISDFG+++ + + ++ +PE FS
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 212 KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY-EFPSVDTHNVKTFGFLHLT 270
+SDV+S+GV + + +S + + + ++ +I + E P
Sbjct: 192 RSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGKRMECPP--------------- 235
Query: 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
++ + C +DRP V +
Sbjct: 236 ----------ECPPEL--------YALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 5e-46
Identities = 58/289 (20%), Positives = 106/289 (36%), Gaps = 63/289 (21%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LRELK--------NKLRLL 98
++G G F VYKG+ E+A L R E + N +R
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 99 GCCID----KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRV 149
K +L+ E M + +L +L I +GL +LH +
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 150 RIIHRDLKVSNILL-DKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI 208
IIHRDLK NI + + KI D G+A + R + ++GT +M+PE +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YEEK 188
Query: 209 FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268
+ DV++FG+ +L++ + + + + + + + S D
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKV--------- 237
Query: 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317
I I C++++ D+R ++ D+++
Sbjct: 238 ---------------------AIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-45
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 59/293 (20%)
Query: 50 FSDANKLGEGGFGPVYKGVLKNGDE-----IAVKRLS-GRSGQGLRELKNKLRLLG---- 99
F LG G FG VYKG+ E +A+K L S + +E+ ++ ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 100 -------CCIDKDEKILIYEYMPNKSLDFF------LFDWVTRVRIIEGIAQGLLYLHQY 146
LI + MP L + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 147 SRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ 206
R++HRDL N+L+ + KI+DFG+A++ E + + ++M+ E +
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 207 GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266
I++ +SDV+S+GV + ++++ Y + + I E P
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGERLPQPPI-------- 237
Query: 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSML 319
C + I + C AD RP +++
Sbjct: 238 -----------------------CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-45
Identities = 69/323 (21%), Positives = 121/323 (37%), Gaps = 72/323 (22%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-----LRELK---- 92
K + + +LG+G FG VY+GV K +A+K ++ + L E
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 93 ----NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLF---------------DWVTRVRII 133
+ +RLLG ++I E M L +L +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 134 EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIV 193
IA G+ YL+ + +HRDL N ++ +D KI DFG+ R + G+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEF 253
R+MSPE G+F+ SDV+SFGV+L +I + + + L + + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 254 PSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313
P C + +C Q + RP+
Sbjct: 257 PDN---------------------------------CPDMLFELMRMCWQYNPKMRPSFL 283
Query: 314 DVVSMLTNEAAALLPPKQPAFSY 336
+++S + E ++ +F Y
Sbjct: 284 EIISSIKEEMEP--GFREVSFYY 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-45
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 55/284 (19%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----LRELK--------NKLRLLG 99
LGEG +G V V + + +AVK + + +E+ N ++ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 100 CCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ + + L EY L + R + G++YLH I HR
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 127
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF-SIKS 213
D+K N+LLD+ N KISDFG+A + R N + ++ GT Y++PE + F +
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 214 DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFK 273
DV+S G++L +++G+ D + + K
Sbjct: 188 DVWSCGIVLTAMLAGE------------------------LPWDQPSDSCQEYSDWKEKK 223
Query: 274 LFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317
+ + + + L + + + E+ R T+ D+
Sbjct: 224 TYLNPWKKIDSAPLAL-LHK-------ILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-45
Identities = 69/310 (22%), Positives = 113/310 (36%), Gaps = 77/310 (24%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGD---EIAVKRLSGRSGQG-----LRELK------- 92
N + +GEG FG V K +K + A+KR+ + + EL+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 93 --NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTR 129
N + LLG C + L EY P+ +L FL
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 130 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189
+ +A+G+ YL Q + IHRDL NIL+ ++ KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISEN 249
R+M+ E +++ SDV+S+GVLL +IVS T
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------- 226
Query: 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDR 309
+ +T +L+ G + C ++ C +E +R
Sbjct: 227 ----------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
Query: 310 PTMNDVVSML 319
P+ ++ L
Sbjct: 271 PSFAQILVSL 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-45
Identities = 65/232 (28%), Positives = 90/232 (38%), Gaps = 30/232 (12%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LRELK--------NKLRL 97
LG+G FG VY K + +A+K L + RE++ N LRL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152
G D LI EY P ++ L FD I +A L Y H R+I
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 128
Query: 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIK 212
HRD+K N+LL KI+DFG + + + GT Y+ PE + K
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 213 SDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264
D++S GVL + + GK F IS + FP T +
Sbjct: 185 VDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISRVEFTFPDFVTEGARDL 234
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-44
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 20/220 (9%)
Query: 54 NKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------------LRELK--NKLRL 97
LGEG F V L E A+K L R + L ++L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLFDW--VTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
D ++ Y N L ++ A+ + L IIHRD
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 133
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
LK NILL++DM+ +I+DFG A++ QA VGT +Y+SPE + SD+
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 193
Query: 216 FSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
++ G ++ ++V+G F + + I + Y+FP
Sbjct: 194 WALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-44
Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 31/230 (13%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGC 100
+LG+G FG VYK K A K + +S + L + N ++LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 101 CIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
++ ++ E+ ++D + + + L YLH +IIHR
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHR 134
Query: 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-----QGIF 209
DLK NIL D + K++DFG++ + ++ +GT +M+PE + +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPY 192
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259
K+DV+S G+ L+++ + + +L I+++ + +
Sbjct: 193 DYKADVWSLGITLIEMAEIE--PPHHELNPMRVLLKIAKSEPPTLAQPSR 240
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 64/291 (21%), Positives = 104/291 (35%), Gaps = 64/291 (21%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG------LRELK--------NKLRLL 98
+G G +G K K +G + K L S + E+ N +R
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 99 GCCIDKDEKIL--IYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYS 147
ID+ L + EY L + D +R++ + L H+ S
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 148 RV--RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
++HRDLK +N+ LD N K+ DFG+ARI + A VGT YMSPE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265
+ ++ KSD++S G LL ++ + F L G I E +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQKELAGKIREGKFRRIPYR-------- 237
Query: 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVV 316
S+++ I + RP++ +++
Sbjct: 238 ----------------YSDEL--------NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 7e-44
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG----LRELK- 92
S SV K++ K+G+G G VY + + G E+A+++++ + + E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 93 -------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLL 141
N + L + DE ++ EY+ SL + D + Q L
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSP 201
+LH ++IHRD+K NILL D + K++DFG + + +T +VGT +M+P
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 185
Query: 202 EYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
E + + K D++S G++ ++++ G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-43
Identities = 67/293 (22%), Positives = 101/293 (34%), Gaps = 62/293 (21%)
Query: 54 NKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRSGQG-------LRELK--------NK 94
KLG+G FG V +G +AVK L +RE+ N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 95 LRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSR 148
+RL G + K+ + E P SL L F T R +A+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMSPEYAIQG 207
R IHRDL N+LL KI DFG+ R + + ++ + + +PE
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 208 IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267
FS SD + FGV L ++ + + + +L I + P +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDKEGERLPRPED--------- 239
Query: 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLT 320
C N+ + C +DRPT + L
Sbjct: 240 ----------------------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-42
Identities = 66/316 (20%), Positives = 102/316 (32%), Gaps = 77/316 (24%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-----LRELK---- 92
++ LG G FG V + +AVK L + + ELK
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 93 -----NKLRLLGCCIDKDEKILI-YEYMPNKSLDFFL---------------------FD 125
N + LLG C +++ E+ +L +L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 126 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185
+ +A+G+ +L + IHRDL NILL + KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGY 245
G ++M+PE +++I+SDV+SFGVLL +I S +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 246 ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQES 305
+ E G L C
Sbjct: 250 LKE--------------------------------GTRMRAPDYTTPEMYQTMLDCWHGE 277
Query: 306 ADDRPTMNDVVSMLTN 321
RPT +++V L N
Sbjct: 278 PSQRPTFSELVEHLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-42
Identities = 49/290 (16%), Positives = 98/290 (33%), Gaps = 61/290 (21%)
Query: 55 KLGEGGFGPVYKGVLKNGDE----IAVKRLSGRSGQGLREL-------------KNKLRL 97
+GEG FG V++G+ + + +A+K + +RE + ++L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
+G + + +I E L FL D + + ++ L YL R
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RF 129
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
+HRD+ N+L+ + K+ DFG++R + + ++M+PE F+
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTS 188
Query: 212 KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTI 271
SDV+ FGV + +I+ + + + P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 232
Query: 272 FKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321
+ ++ C RP ++ + L+
Sbjct: 233 ---------NCPPTL--------YSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-41
Identities = 68/315 (21%), Positives = 108/315 (34%), Gaps = 79/315 (25%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK--------NGDEIAVKRLSGRSGQG-----LRELK-- 92
++ LGEG FG V ++AVK L + + + E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 93 -------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------F 124
N + LLG C +I EY +L +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 125 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNE 184
V +A+G+ YL + IHRDL N+L+ +D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG 244
T ++M+PE I++ +SDV+SFGVLL +I + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP------------ 237
Query: 245 YISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQE 304
+ + + +LF + G D C + C
Sbjct: 238 ---------------------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA 276
Query: 305 SADDRPTMNDVVSML 319
RPT +V L
Sbjct: 277 VPSQRPTFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (351), Expect = 7e-39
Identities = 47/222 (21%), Positives = 81/222 (36%), Gaps = 29/222 (13%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG----LRELK--------NKLRLLGCC 101
+LG G FG V++ V G K ++ E+ + L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 102 IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
DK E +LI E++ L + + + +GL ++H I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 156 LKVSNILLDKDMNP--KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
+K NI+ + KI DFG+A +E+ T + +PE + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYT 209
Query: 214 DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
D+++ GVL ++SG F L + +EF
Sbjct: 210 DMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDE 249
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 137 bits (346), Expect = 4e-38
Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 29/228 (12%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG----LRELK--------NKLRLLGCC 101
+LG G FG V++ G+ A K + +E++ + L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 102 IDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
D +E ++IYE+M L + V + + +GL ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 156 LKVSNILLDKDMNP--KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKS 213
LK NI+ + K+ DFG+ + + GT + +PE A +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 214 DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261
D++S GVL ++SG F L + + +
Sbjct: 207 DMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSGI 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (333), Expect = 6e-37
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 42/247 (17%)
Query: 49 KFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------------LRELK-- 92
+ LG G V + + E AVK + G L+E+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 93 -------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGL 140
N ++L L+++ M L +L +I+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 141 LYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMS 200
LH ++ I+HRDLK NILLD DMN K++DFG + E + GT Y++
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLA 177
Query: 201 PEYA------IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254
PE + + D++S GV++ +++G F+ +L I Y+F
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQFG 235
Query: 255 SVDTHNV 261
S + +
Sbjct: 236 SPEWDDY 242
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (334), Expect = 9e-37
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 25/229 (10%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK---------------NKLRL 97
LG G FG V+ + NG A+K L L++++ +R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 98 LGCCIDKDEKILIYEYMPNKSLDFFLF--DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRD 155
G D + +I +Y+ L L A+ L L II+RD
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 156 LKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDV 215
LK NILLDK+ + KI+DFG A+ + T + GT Y++PE ++ D
Sbjct: 130 LKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 216 FSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264
+SFG+L+ ++++G FY + + I FP +VK
Sbjct: 185 WSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 29/224 (12%)
Query: 54 NKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK----------------NKLR 96
LG+G FG V+ K A+K L +++
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 97 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRI 151
+ K+ + EY+ L + + FD I GL +LH I
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GI 124
Query: 152 IHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
++RDLK+ NILLDKD + KI+DFG+ + + + NT GT Y++PE + ++
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNH 182
Query: 212 KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
D +SFGVLL +++ G+ + F+ L I + +P
Sbjct: 183 SVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPFYPR 224
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-36
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 31/293 (10%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----LRELK-------- 92
++++ + +GEG +G V N +A+K++S Q LRE+K
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------WVTRVRIIEGIAQGLLYLH 144
N + + + + Y+ + L+ + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT-GRIVGTYRYMSPEY 203
++HRDLK SN+LL+ + KI DFG+AR+ + V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 204 AIQGIFSIKS-DVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
+ KS D++S G +L +++S + F + L +I + PS + N
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGILGS-PSQEDLNCI 240
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ L + V + +++ + + R +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (324), Expect = 2e-35
Identities = 48/234 (20%), Positives = 86/234 (36%), Gaps = 24/234 (10%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----LRELK-------- 92
+ + + LG G F V + +A+K ++ ++ +G E+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYS 147
N + L LI + + L + + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQG 207
V + + LD+D ISDFG++++ + GT Y++PE Q
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQK 184
Query: 208 IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261
+S D +S GV+ ++ G FY L I + YEF S ++
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWDDI 236
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 128 bits (322), Expect = 2e-35
Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 31/241 (12%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-------LRELK------ 92
++++ LG GG V+ L+ ++AVK L + RE +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 93 --NKLRLLGCCIDKDEKI----LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLL 141
+ + + ++ EY+ +L + + +I Q L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 142 YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR-ICRGNELQANTGRIVGTYRYMS 200
+ HQ IIHRD+K +NI++ K+ DFGIAR I T ++GT +Y+S
Sbjct: 126 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 201 PEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260
PE A +SDV+S G +L ++++G+ F ++ PS
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 261 V 261
+
Sbjct: 241 L 241
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-35
Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 28/221 (12%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LRELK--------NKLRLLGCCI 102
LG G FG V++ V + K + + +E+ N L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 103 DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156
+E ++I+E++ + + + V + + + L +LH + I H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDI 128
Query: 157 KVSNILLDKDMNP--KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSD 214
+ NI+ + KI +FG AR + + N + Y +PE + S +D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 215 VFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
++S G L+ ++SG F + ++ I Y F
Sbjct: 186 MWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDE 224
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (325), Expect = 5e-35
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 32/207 (15%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLS---GRSGQGLRELKNK--------- 94
N FS +G GGFG VY G A+K L + QG N+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 95 ------LRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----WVTRVRIIEGIAQGLLYL 143
+ + D+ I + M L + L I GL ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H +++RDLK +NILLD+ + +ISD G+A + VGT+ YM+PE
Sbjct: 124 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 176
Query: 204 AIQGI-FSIKSDVFSFGVLLLKIVSGK 229
+G+ + +D FS G +L K++ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 5e-35
Identities = 62/300 (20%), Positives = 111/300 (37%), Gaps = 44/300 (14%)
Query: 46 ATNKFSDANKLGEGGFGPVYKGVLK--NGDEIAVKRLSGRSGQG------LRELK----- 92
A ++ ++GEG +G V+K G +A+KR+ ++G+ +RE+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 93 ------NKLRLLGCCIDKDEK-----ILIYEYMPNKSLDFFL------FDWVTRVRIIEG 135
N +RL C L++E++ + T ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 136 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGT 195
+ +GL +LH + R++HRDLK NIL+ K++DFG+ARI +V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 196 YRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
Y +PE +Q ++ D++S G + ++ K F + LG I + I
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGE 236
Query: 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
D I D + +L C+ + R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL------KCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 2e-34
Identities = 58/288 (20%), Positives = 108/288 (37%), Gaps = 31/288 (10%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLS------GRSGQGLRELK--------N 93
K+ K+GEG +G VYK G+ A+K++ G +RE+ N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSR 148
++L K +L++E++ + VT + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI-QG 207
R++HRDLK N+L++++ KI+DFG+AR + + T Y +P+ +
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSK 176
Query: 208 IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267
+S D++S G + ++V+G F L I + S + NV
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ + I ++ ++ + R T
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGI----DLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 40/306 (13%)
Query: 54 NKLGEGGFGPVYKGVLKN-GDEIAVKRLSGRSGQG---------LRELK--------NKL 95
+ LGEG F VYK KN +A+K++ LRE+K N +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFF-----LFDWVTRVRIIEGIAQGLLYLHQYSRVR 150
LL K L++++M + + QGL YLHQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQ-GIF 209
I+HRDLK +N+LLD++ K++DFG+A+ V T Y +PE ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMY 178
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF-GFLH 268
+ D+++ G +L +++ L I E + ++ + ++
Sbjct: 179 GVGVDMWAVGCILAELLLRV--PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAAL 326
F + + + L +++ + R T + M +N
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQ------GLFLFNPCARITATQALKMKYFSNRPGPT 290
Query: 327 LPPKQP 332
+ P
Sbjct: 291 PGCQLP 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (313), Expect = 6e-34
Identities = 37/209 (17%), Positives = 77/209 (36%), Gaps = 30/209 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG-----------LRELKNKL 95
+ ++GEG FG +++G L N ++A+K RS L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFF-----LFDWVTRVRIIEGIAQGLLYLHQYSRVR 150
+ + +L+ + + D F T + + + +H+
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 151 IIHRDLKVSNILLDKDMNP-----KISDFGIARICRGNELQAN-----TGRIVGTYRYMS 200
+++RD+K N L+ + + + DFG+ + R + + + GT RYMS
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 201 PEYAIQGIFSIKSDVFSFGVLLLKIVSGK 229
+ S + D+ + G + + + G
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (311), Expect = 1e-33
Identities = 54/299 (18%), Positives = 100/299 (33%), Gaps = 55/299 (18%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQG--------LRELKNKL--- 95
N++ K+G G FG +Y G + G+E+A+K ++ + ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVR 150
+ C + D +++ E + D F F T + + + + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 151 IIHRDLKVSNIL---LDKDMNPKISDFGIARICRGNELQAN-----TGRIVGTYRYMSPE 202
IHRD+K N L K I DFG+A+ R + + GT RY S
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
+ S + D+ S G +L+ G + + T + S +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGS--LPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTN 321
G ++ C DD+P + + + N
Sbjct: 242 K-----------------GYPSEF--------ATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-33
Identities = 59/291 (20%), Positives = 108/291 (37%), Gaps = 37/291 (12%)
Query: 50 FSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK--------NKLRLLGC 100
++D +G G FG VY+ L +G+ +A+K++ REL+ N +RL
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 101 CIDKDEK------ILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQY 146
EK L+ +Y+P + + + + L Y+H +
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 147 SRVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAI 205
I HRD+K N+LLD D K+ DFG A+ E + + + Y +PE
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIF 195
Query: 206 QGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264
++ DV+S G +L +++ G+ F L I + + +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ--PIFPGDSGVDQLVEIIKVLGTPTREQIREMNP- 252
Query: 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ T FK I + + + + ++ + R T +
Sbjct: 253 ---NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 56/285 (19%), Positives = 108/285 (37%), Gaps = 25/285 (8%)
Query: 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLS------GRSGQGLRELK--------N 93
F K+GEG +G VYK K G+ +A+K++ G +RE+ N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFLFDWVTRV---RIIEGIAQGLLYLHQYSRVR 150
++LL +++ L++E++ F +T + I + Q L L R
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
++HRDLK N+L++ + K++DFG+AR G ++ T +V + +S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 211 IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270
D++S G + ++V+ + F L I + V V + +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
K + + ++ + + R +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGR----SLLSQMLHYDPNKRISAKAA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 41/301 (13%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK-------- 92
+K+ K+G+G FG V+K K G ++A+K++ G LRE+K
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 93 NKLRLLGCCIDKDEKI--------LIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQG 139
N + L+ C K L++++ + F R+++ + G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 140 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGR--IVGTYR 197
L Y+H+ +I+HRD+K +N+L+ +D K++DFG+AR + V T
Sbjct: 130 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 198 YMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSV 256
Y PE + + D++ G ++ ++ + L IS+
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS--PIMQGNTEQHQLALISQLCGSITPE 244
Query: 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL--CVQESADDRPTMND 314
NV + V D + + + L+ + R +D
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKV---KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 315 V 315
Sbjct: 302 A 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-31
Identities = 54/226 (23%), Positives = 83/226 (36%), Gaps = 22/226 (9%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-------LRELK------- 92
N F LG+G FG V K G A+K L + E +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 93 -NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRV 149
L D + EY L F L T R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 150 RIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
+++RD+K+ N++LDKD + KI+DFG+ + + A GT Y++PE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDY 182
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
D + GV++ +++ G+ FY L I FP
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRFPR 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 46/204 (22%), Positives = 71/204 (34%), Gaps = 36/204 (17%)
Query: 55 KLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELK--------------------N 93
LG GGFG VY G+ + + +A+K + EL
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 94 KLRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYS 147
+RLL D +LI E F + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 148 RVRIIHRDLKVSNILLDKD-MNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY-AI 205
++HRD+K NIL+D + K+ DFG + + GT Y PE+
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRY 183
Query: 206 QGIFSIKSDVFSFGVLLLKIVSGK 229
+ V+S G+LL +V G
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-31
Identities = 48/285 (16%), Positives = 105/285 (36%), Gaps = 23/285 (8%)
Query: 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLS------GRSGQGLRELK-------- 92
K+ K+GEG +G V+K + + +A+KR+ G LRE+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 93 NKLRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--WVTRVRIIEGIAQGLLYLHQYSRVR 150
N +RL + L++E+ +F + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFS 210
++HRDLK N+L++++ K+++FG+AR G ++ + +V + ++S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 211 IKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLT 270
D++S G + ++ + + F L I + ++
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 271 IFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ S V + + ++ ++ + R + +
Sbjct: 240 PMYPATTSLVNVVPKLNATGR----DLLQNLLKCNPVQRISAEEA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 59/226 (26%), Positives = 89/226 (39%), Gaps = 30/226 (13%)
Query: 55 KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG----------LRELK--------NKL 95
+LG G F V K K G + A K + R + RE+ N +
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 96 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD--WVTRVRIIEGIAQGLLYLHQYSRVRIIH 153
L +K + ILI E + L FL + +T E + Q L ++ ++I H
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 154 RDLKVSNILLDKDMNP----KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIF 209
DLK NI+L P KI DFG+A I GT +++PE
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPL 193
Query: 210 SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255
+++D++S GV+ ++SG F L +S YEF
Sbjct: 194 GLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFED 237
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-30
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 37/234 (15%)
Query: 56 LGEGGFGPVYKGV-LKNGDEIAVKRLSGRSGQGLRELKNKLRLLGC-------------C 101
LG G G V + + ++ A+K L + RE++ R C
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLY 78
Query: 102 IDKDEKILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154
+ +++ E + L + F I++ I + + YLH + I HR
Sbjct: 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHR 135
Query: 155 DLKVSNILLDKDMNP---KISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSI 211
D+K N+L K++DFG A+ + T Y++PE +
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDK 192
Query: 212 KSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENI----YEFPSVDTHNV 261
D++S GV++ ++ G FY + + + I YEFP+ + V
Sbjct: 193 SCDMWSLGVIMYILLCGY--PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (284), Expect = 2e-29
Identities = 56/257 (21%), Positives = 102/257 (39%), Gaps = 32/257 (12%)
Query: 21 SNLTKRSKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVK 78
++ + K + D L + S +TA ++F LG G FG V ++G+ A+K
Sbjct: 13 ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 79 RLSGRSGQGLRELKNKLR---------------LLGCCIDKDEKILIYEYMPNKSLDFFL 123
L + L+++++ L L D ++ EY+ + L
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 124 -----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
F I YLH +I+RDLK N+L+D+ +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238
+G + GT ++PE + ++ D ++ GVL+ ++ +G F+
Sbjct: 190 RVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFADQ 242
Query: 239 SFTLLGYISENIYEFPS 255
+ I FPS
Sbjct: 243 PIQIYEKIVSGKVRFPS 259
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 8e-27
Identities = 52/319 (16%), Positives = 111/319 (34%), Gaps = 37/319 (11%)
Query: 19 VNSNLTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKNGDEIAV 77
VN++ + E + + + + KLG G + V++ + + N +++ V
Sbjct: 13 VNTHRPREYWDYESHVVEWGNQ-------DDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 78 KRLSGRSGQGL-RELK---------NKLRLLGCCIDKDEK--ILIYEYMPNKSLDFFL-- 123
K L + + RE+K N + L D + L++E++ N
Sbjct: 66 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 125
Query: 124 FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARICRG 182
+ I + L Y H + I+HRD+K N+++D + ++ D+G+A
Sbjct: 126 LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 183 NELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFT 241
+ V + + PE + ++ D++S G +L ++ K+ F+ +
Sbjct: 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNY 237
Query: 242 LLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALL- 300
+ + + K L + S V V+ L
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 301 ----CVQESADDRPTMNDV 315
++ R T +
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-26
Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 35/292 (11%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK-------- 92
+ D +G G +G V V + G ++A+K+L + + REL+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 93 NKLRLLGCCIDKD------EKILIYEYMPNKSLDFFL---FDWVTRVRIIEGIAQGLLYL 143
N + LL + + L+ +M ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 144 HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEY 203
H IIHRDLK N+ +++D KI DFG+AR TG +V +
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVI 190
Query: 204 AIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263
++ D++S G ++ ++++GK T F + L I + P+ +++
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK--TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ + L + ++ + L VN+ + A+ R T +
Sbjct: 249 DEAKNY-MKGLPELEKKDFASILTNASPL-AVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-25
Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 28/226 (12%)
Query: 54 NKLGEGGFGPVYKGVL----KNGDEIAVKRLS----GRSGQGLRELKNKLRLL------- 98
LG G +G V+ G A+K L + + + + ++L
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 99 ------GCCIDKDEKILIYEYMPNKSLDFFLFDWV--TRVRIIEGIAQGLLYLHQYSRVR 150
+ + LI +Y+ L L T + + + +L L ++
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 149
Query: 151 IIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGI-- 208
II+RD+K+ NILLD + + ++DFG+++ +E + GT YM+P+ G
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSG 208
Query: 209 FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254
D +S GVL+ ++++G F IS I +
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSE 252
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 2e-24
Identities = 64/322 (19%), Positives = 114/322 (35%), Gaps = 45/322 (13%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK-------- 92
++ + +G G G V +A+K+LS + + REL
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 93 NKLRLLGCCIDKD------EKILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLH 144
N + LL + + L+ E M D ++ + G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 145 QYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYA 204
IIHRDLK SNI++ D KI DFG+AR + + V T Y +PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190
Query: 205 IQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264
+ + D++S G ++ ++V K F + E + ++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 265 ---------GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ LT KLF S ++ L + ++ + R +++D
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 316 -----VSMLTNEAAALLPPKQP 332
+++ + A PP Q
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQI 330
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 1e-22
Identities = 60/293 (20%), Positives = 112/293 (38%), Gaps = 35/293 (11%)
Query: 47 TNKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLS------GRSGQGLRELK------- 92
++ + + +G G +G V K G +AVK+LS + + REL+
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 93 -NKLRLLGCCIDKD-----EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLY 142
N + LL + + ++ L+ + +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 143 LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPE 202
+H IIHRDLK SN+ +++D KI DFG+AR TG + +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 189
Query: 203 YAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262
++ D++S G ++ ++++G+ T F T L I + + +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDV 315
+ + I L + + +N + L V++ + +D R T
Sbjct: 248 SESARN-YIQSLTQMPKMNFANVFIGANPL-AVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.3 bits (233), Expect = 2e-22
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 40/270 (14%)
Query: 48 NKFSDANKLGEGGFGPVYKGV-LKNGDEIAVKRLSGRSG---QGLRELK----------- 92
++ KLG G F V+ + N +A+K + G E+K
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 93 --------NKLRLLGCCIDKDEKILIYEYMPNKSLDFFL----------FDWVTRVRIIE 134
+ L+LL K + + + L + +I +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 135 GIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGIARICRGNELQANTGRIV 193
+ GL Y+H+ R IIH D+K N+L++ D + IA + + +
Sbjct: 133 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 194 GTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK----KTTGFYRTYSFTLLGYISEN 249
T Y SPE + + +D++S L+ ++++G G T + I E
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 250 IYEFPSVDTHNVKTFGFLHLTIFKLFSISS 279
+ E PS N K + L +IS
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISK 280
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 5e-19
Identities = 23/151 (15%), Positives = 52/151 (34%), Gaps = 32/151 (21%)
Query: 54 NKLGEGGFGPVYKGVLKNGDEIAVK--RLSGRSGQGLRELKNKL---------------- 95
+GEG V+ + E VK ++ S + ++E ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 96 ----RLLGCCI----DKDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYS 147
+L G + + ++ E + K + + +++ I + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK--ELYRVRVENPDEVLDMILEEVAKFYHR- 122
Query: 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178
I+H DL N+L+ + I DF +
Sbjct: 123 --GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 354 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.1 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=352.84 Aligned_cols=240 Identities=26% Similarity=0.432 Sum_probs=187.8
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.++|++.+.||+|+||.||+|++++++.||||++........ +++ +||+++++++..++..++|||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468999999999999999999998888999999976543221 111 277888999999999999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+|+|.+++ +++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence 99999987 678889999999999999999999 999999999999999999999999999765443322 12
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
....||..|+|||++.+..++.++|||||||++|||+++..|+ +......++...+..+.......
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~-~~~~~~~~~~~~i~~~~~~~~p~------------- 225 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGFRLYKPR------------- 225 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT-TCSCCHHHHHHHHHHTCCCCCCT-------------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC-CCCCCHHHHHHHHHhcCCCCCcc-------------
Confidence 2346789999999999999999999999999999999954442 33444555555554443221111
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.+++.+.+||.+||+.||++|||++||++.|+++.
T Consensus 226 -------------------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 -------------------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp -------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 15678899999999999999999999999999886
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=355.65 Aligned_cols=236 Identities=25% Similarity=0.334 Sum_probs=187.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-----HHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-----LREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-----~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
.++|++.+.||+|+||+||+|+++ +|+.||||++....... .+++ +||+++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999975 59999999986543211 1122 277788899999999999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
||++|+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999887 788999999999999999999999 9999999999999999999999999998765443333
Q ss_pred ccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|++||............ ........+..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~~~~~~~~---------- 229 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNPW---------- 229 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTTCTTSTTG----------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCCCCcc----------
Confidence 3445689999999999988776 67899999999999999999997443322222211 11111111000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
...++.+.+||.+||+.||++|||++|+++
T Consensus 230 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 ---------------------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 014567789999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=352.43 Aligned_cols=247 Identities=29% Similarity=0.436 Sum_probs=197.7
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEE
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~l 109 (354)
.+|....++|++.+.||+|+||.||+|.+++++.||||++........ +++ +||+++++++.. +..++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 345556789999999999999999999998888999999976543221 111 266778887754 56799
Q ss_pred EEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 110 IYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 110 v~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 99999999998877 678889999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... ......+++.|+|||++.+..++.++|||||||++|||++|..|+ +......++...+..+......
T Consensus 162 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~-~~~~~~~~~~~~i~~~~~~~~p------- 232 (272)
T d1qpca_ 162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMVRP------- 232 (272)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS-STTCCHHHHHHHHHTTCCCCCC-------
T ss_pred Cccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC-CCCCCHHHHHHHHHhcCCCCCc-------
Confidence 4322 223346789999999999889999999999999999999966553 3334444555555443221111
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..+++.+.+||.+||+.||++|||+++|++.|++..+.
T Consensus 233 -------------------------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 -------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 11567789999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=353.99 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=188.0
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeecCCce
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
+|+...++|++.+.||+|+||+||+|+++ ..||||++.... ......+. ||+++++++. ++.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 45566789999999999999999999864 359999986542 22333333 5566666654 4668
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++|||||++|+|.+++ +++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999988 678999999999999999999999 9999999999999999999999999997665
Q ss_pred CCccccccccccCcccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.................|...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf--~~~~~~~~~~~~~~~~~~~p~~~- 232 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIFMVGRGYLSPDLS- 232 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT--TTCCCHHHHHHHHHHTSCCCCGG-
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC--CCCChHHHHHHHHhcCCCCCcch-
Confidence 4433333344578999999999864 35899999999999999999999995 44333333222222222121111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
..+..+++.+.+||.+||+.||++|||++||++.|+.+..
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 --------------------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --------------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------------------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111267789999999999999999999999999998874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=354.18 Aligned_cols=234 Identities=23% Similarity=0.391 Sum_probs=190.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH------------HHHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL------------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~lv~e 112 (354)
+.++|++.+.||+|+||.||+|.++ +|+.||||++........+.+ .||+++++++.+++.+|+|||
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4568999999999999999999965 599999999865433222222 266778888999999999999
Q ss_pred ecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 113 YMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 113 ~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
||+||+|..++ +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........ .
T Consensus 98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 99999999887 778899999999999999999999 99999999999999999999999999986544332 2
Q ss_pred cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhcccc-CCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIY-EFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 267 (354)
.....||+.|+|||++.+..++.++||||+||++|+|++|.+|| .+.+.......+..... ..+.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf--~~~~~~~~~~~~~~~~~~~~~~------------ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQN------------ 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTT--TTSCHHHHHHHHHHHCSCCCSS------------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCC--CCCCHHHHHHHHHhCCCCCCCC------------
Confidence 23357999999999999999999999999999999999999995 44444444444333221 1111
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+...++.+.+||.+||+.||++|||++|+++
T Consensus 239 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 -------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -------------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------------------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0115677899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=351.09 Aligned_cols=229 Identities=29% Similarity=0.399 Sum_probs=192.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hh-HHHH--------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QG-LREL--------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~-~~~~--------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++.+.||+|+||.||+|+++ +|+.||+|++..... .. .+++ +||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999976 589999999864321 11 1111 2778889999999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||++|+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999887 788999999999999999999999 9999999999999999999999999997544332
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....||+.|+|||++.+..++.++|||||||++|+|++|..| |.+.+..+....+.+.....|..
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P--f~~~~~~~~~~~i~~~~~~~p~~--------- 226 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISRVEFTFPDF--------- 226 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT--TCCSSHHHHHHHHHTTCCCCCTT---------
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC--CCCCCHHHHHHHHHcCCCCCCcc---------
Confidence 2234789999999999999999999999999999999999999 45566666666665554433321
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++.+.+||.+||+.||++|||++|+++
T Consensus 227 ------------------------~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 ------------------------VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------------------CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 4567889999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=345.08 Aligned_cols=238 Identities=27% Similarity=0.410 Sum_probs=198.1
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEEEecC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIYEYMP 115 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~e~~~ 115 (354)
.++|++.+.||+|+||.||+|++++++.||||+++....... ++. +||+++++++.+++.+++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 478999999999999999999998888999999976543221 121 277788899999999999999999
Q ss_pred CCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccccc
Q 048432 116 NKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 116 ~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
+|++..++ +++..+.+++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence 99999886 667889999999999999999999 999999999999999999999999999765443322 22
Q ss_pred ccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccch
Q 048432 190 GRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLH 268 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 268 (354)
....+|..|+|||++.+..++.++|||||||++|||++ |+.| |...+..++...+.++........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~P--f~~~~~~~~~~~i~~~~~~~~p~~----------- 225 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSETAEHIAQGLRLYRPHL----------- 225 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT--TTTSCHHHHHHHHHTTCCCCCCTT-----------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCC--CCCCCHHHHHHHHHhCCCCCCccc-----------
Confidence 23568899999999999999999999999999999998 7888 455556666666655433221111
Q ss_pred hhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 269 LTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
+++.+.+||.+||+.||++|||+++|++.|.++
T Consensus 226 ---------------------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ---------------------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---------------------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---------------------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 567889999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=353.20 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=198.8
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCc
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~ 106 (354)
.+..|....++|++.+.||+|+||+||+|.++ +|+.||||++........ +++ +||+++++++.+++.
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 34556667789999999999999999999976 488999999976543221 111 267788889999999
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+++|||||++|+|..++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999887 578889999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
....... ......++..|+|||++.+..++.++|||||||++|+|++|+.|| +...+...+...+..+... +.
T Consensus 165 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~-~~~~~~~~~~~~i~~~~~~-~~---- 237 (287)
T d1opja_ 165 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRM-ER---- 237 (287)
T ss_dssp CCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS-STTCCHHHHHHHHHTTCCC-CC----
T ss_pred cCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC-CCcchHHHHHHHHhcCCCC-CC----
Confidence 5443322 222345788999999999999999999999999999999977664 3333333444433332211 10
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+..+++.+.+||.+||+.||++|||+++|++.|+.+.
T Consensus 238 ---------------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 ---------------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1115678899999999999999999999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=349.21 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=197.5
Q ss_pred ccccchhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCc
Q 048432 38 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDE 106 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~ 106 (354)
.+-.+|....++|++.+.||+|+||+||+|.+++++.||||++........ +++ .||+++++++. ++.
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 85 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCC
Confidence 334445555789999999999999999999998888999999976543221 111 26677888875 456
Q ss_pred eEEEEEecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 107 KILIYEYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
+++|||||++|+|..++ +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhh
Confidence 89999999999998887 678899999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
...... .......+++.|+|||++....++.++|||||||++|||++|+.|+ +......++...+..+... +..
T Consensus 163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~-~~~~~~~~~~~~i~~~~~~-~~~--- 236 (285)
T d1fmka3 163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRM-PCP--- 236 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS-STTCCHHHHHHHHHTTCCC-CCC---
T ss_pred ccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC-CCCCCHHHHHHHHHhcCCC-CCC---
Confidence 543332 2223356899999999999999999999999999999999976664 3334445555555433221 110
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCC
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQP 332 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~ 332 (354)
..+++.+.+||.+||+.||++|||+++|++.|+...+...|+..|
T Consensus 237 ----------------------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 237 ----------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp ----------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ----------------------------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 115678899999999999999999999999999988655544433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=354.40 Aligned_cols=232 Identities=28% Similarity=0.384 Sum_probs=189.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HH--------HHHHHHHhceeecCCceEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----RE--------LKNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~--------~~~i~~~~~~~~~~~~~~lv~ 111 (354)
++|++.+.||+|+||.||+|+++ +|+.||||++..... ... ++ +.|++++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 599999999864321 111 11 126677888899999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|||++|+|.+++ +++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.........
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999998887 788999999999999999999999 999999999999999999999999999876544333
Q ss_pred cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.......||+.|+|||++.+..++.++|||||||++|+|++|..| |.+.+..++...+.+....+|..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P--f~~~~~~~~~~~i~~~~~~~p~~---------- 232 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK---------- 232 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHTTCCCCCTT----------
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCC--CCCcCHHHHHHHHHcCCCCCCcc----------
Confidence 333345799999999999999999999999999999999999999 55566666666666555443321
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.++.+.+||.+||+.||++|||++|++.
T Consensus 233 -----------------------~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 233 -----------------------FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----------------------CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----------------------CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 4566889999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=348.92 Aligned_cols=233 Identities=24% Similarity=0.356 Sum_probs=188.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH----HHH--------HHHHHHhceeecCCceEEEEEec
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL----REL--------KNKLRLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~----~~~--------~~i~~~~~~~~~~~~~~lv~e~~ 114 (354)
+.|++.+.||+|+||.||+|+++ +|+.||+|++........ +++ .||+++++++.+++.+++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999975 589999999976543322 221 37788899999999999999999
Q ss_pred CCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 115 PNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 115 ~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
++|+|..++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence 999999886 678899999999999999999999 99999999999999999999999999865433211 1
Q ss_pred cccccCcccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 189 TGRIVGTYRYMSPEYAI-----QGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.....||+.|+|||++. +..++.++|||||||++|+|++|.+| |.+.+..+....+.....+....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P--f~~~~~~~~~~~i~~~~~~~~~~------- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLAQ------- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT--TTTSCGGGHHHHHHHSCCCCCSS-------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC--CCCCCHHHHHHHHHcCCCCCCCc-------
Confidence 22357899999999984 44588999999999999999999999 45555555555554443221110
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+..+++.+.+||.+||+.||++|||++|+++
T Consensus 238 -----------------------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -----------------------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------------------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0115678899999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=353.73 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=190.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC-C-----CEEEEEEecCCChhh-----HH---------HHHHHHHHhceee
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN-G-----DEIAVKRLSGRSGQG-----LR---------ELKNKLRLLGCCI 102 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~-----~~vavK~~~~~~~~~-----~~---------~~~~i~~~~~~~~ 102 (354)
|....++|++.+.||+|+||+||+|++.. + ..||+|++....... .+ .+.||+++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34456789999999999999999999653 2 268999986542211 11 1247788889999
Q ss_pred cCCceEEEEEecCCCCHhHHH----------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeC
Q 048432 103 DKDEKILIYEYMPNKSLDFFL----------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHR 154 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~----------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 154 (354)
+.+.+++|||||++|+|.+++ +++..++.++.||+.||+|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999887 356788999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 048432 155 DLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTG 233 (354)
Q Consensus 155 dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~ 233 (354)
||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |.+||
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf- 267 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY- 267 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS-
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC-
Confidence 9999999999999999999999976555443333334567999999999999999999999999999999997 89995
Q ss_pred cccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 048432 234 FYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN 313 (354)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 313 (354)
.+......+..+.......+. +..+++.+.+||.+||+.||++|||++
T Consensus 268 -~~~~~~~~~~~~~~~~~~~~~-------------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 268 -PGIPVDANFYKLIQNGFKMDQ-------------------------------PFYATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp -TTCCCSHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -CCCCHHHHHHHHHhcCCCCCC-------------------------------CCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 333333333333222221111 111567899999999999999999999
Q ss_pred HHHHHhh
Q 048432 314 DVVSMLT 320 (354)
Q Consensus 314 ~il~~L~ 320 (354)
||++.|.
T Consensus 316 ei~~~L~ 322 (325)
T d1rjba_ 316 NLTSFLG 322 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999995
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-47 Score=348.19 Aligned_cols=240 Identities=28% Similarity=0.469 Sum_probs=185.2
Q ss_pred hcCccccceecccCceeEEEEEEcC-C---CEEEEEEecCCChh-hHHHH------------HHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-G---DEIAVKRLSGRSGQ-GLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~---~~vavK~~~~~~~~-~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||+||+|.++. + ..||||.+...... ....+ .||+++++++.+++.+++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4678999999999999999999753 3 25899998654332 22222 267788889999999999
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999877 678899999999999999999999 999999999999999999999999999765543
Q ss_pred ccccc---cccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 184 ELQAN---TGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 184 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..... .....+|+.|+|||.+.+..++.++|||||||++|||++ |.+| |.+....++...+.++.......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P--f~~~~~~~~~~~i~~~~~~~~~~--- 256 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVINAIEQDYRLPPPM--- 256 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT--TTTCCHHHHHHHHHTTCCCCCCT---
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC--CCCCCHHHHHHHHHcCCCCCCCc---
Confidence 22211 122357889999999999999999999999999999998 8889 45555556666655443221111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.+++.+.+||.+||+.||++|||++||++.|+++.
T Consensus 257 -----------------------------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 257 -----------------------------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----------------------------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 16778899999999999999999999999999876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=345.03 Aligned_cols=235 Identities=26% Similarity=0.326 Sum_probs=177.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeec--CCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCID--KDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~--~~~~~l 109 (354)
.++|++.+.||+|+||.||+|+++ +|+.||+|++..... ...+.+. |++++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999975 589999999876532 2222222 55667777754 456899
Q ss_pred EEEecCCCCHhHHH---------hhHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 110 IYEYMPNKSLDFFL---------FDWVTRVRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 110 v~e~~~~~~L~~~~---------~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
|||||++|+|.+++ +++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999887 567889999999999999999864 1349999999999999999999999999997
Q ss_pred eccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..|| .+.+..++...+..+........
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf--~~~~~~~~~~~i~~~~~~~~~~~- 237 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKFRRIPYR- 237 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHTCCCCCCTT-
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC--CCCCHHHHHHHHHcCCCCCCCcc-
Confidence 65433211 22357899999999999999999999999999999999999994 45555566655554433211111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+++.+.+||.+||+.||++|||++|+++
T Consensus 238 -------------------------------~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 -------------------------------YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------------------------cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 5667899999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=349.94 Aligned_cols=237 Identities=24% Similarity=0.306 Sum_probs=183.6
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH-----HHH--------HHHHHHhceeecCCceEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL-----REL--------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~-----~~~--------~~i~~~~~~~~~~~~~~lv 110 (354)
...+.|++.+.||+|+||+||+|+++ +|+.||||++........ +++ .||+++++++.+++.+|+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45578999999999999999999976 589999999865432111 111 2778888999999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCCeEEeecccceeccC
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGIARICRG 182 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~~l~dfg~a~~~~~ 182 (354)
||||+||+|.+++ +++..+..++.||+.||.|||+++ |+||||||+||++. .++.+||+|||++.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999988 789999999999999999999999 99999999999995 478999999999976544
Q ss_pred CccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|.+| |.+....+....+.+.....+.....
T Consensus 163 ~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P--f~~~~~~~~~~~i~~~~~~~~~~~~~--- 234 (307)
T d1a06a_ 163 GSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWD--- 234 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS--CCCSSHHHHHHHHHTTCCCCCTTTTT---
T ss_pred CCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCC--CCCCCHHHHHHHHhccCCCCCCcccc---
Confidence 3322 234789999999999999999999999999999999999999 45555566666666555444332211
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++|+++.
T Consensus 235 --------------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 --------------------------DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --------------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------------------------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 156678999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-47 Score=353.04 Aligned_cols=240 Identities=20% Similarity=0.268 Sum_probs=198.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
..++|++.+.||+|+||.||+|+++ +|+.||||++..........+. ||+++++++.+++.+|+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4579999999999999999999975 5899999999776544333222 56677888999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC--CCCeEEeecccceeccCCc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNPKISDFGIARICRGNE 184 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~~l~dfg~a~~~~~~~ 184 (354)
||+||+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998887 788999999999999999999999 999999999999964 6789999999998655443
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|..| |.+.+..+....+.......+....
T Consensus 181 ~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~P--f~~~~~~~~~~~i~~~~~~~~~~~~------ 249 (350)
T d1koaa2 181 SV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAF------ 249 (350)
T ss_dssp CE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCCSCCGGG------
T ss_pred cc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCC--CCCCCHHHHHHHHHhCCCCCCcccc------
Confidence 22 234789999999999999999999999999999999999999 4556666666666655544332211
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNE 322 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~ 322 (354)
...++.+.+||.+||+.||++|||++|+++. |++.
T Consensus 250 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 250 -----------------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp -----------------------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred -----------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1146678999999999999999999999985 5544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=347.39 Aligned_cols=248 Identities=27% Similarity=0.346 Sum_probs=183.4
Q ss_pred cccchhhhhcCccccceecccCceeEEEEEEcC------CCEEEEEEecCCChhh-HHHHH-------------HHHHHh
Q 048432 39 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKN------GDEIAVKRLSGRSGQG-LRELK-------------NKLRLL 98 (354)
Q Consensus 39 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vavK~~~~~~~~~-~~~~~-------------~i~~~~ 98 (354)
..+.|....++|++.+.||+|+||.||+|.+.. ++.||||++....... .+.+. |++.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 445555667899999999999999999999642 4679999997543322 22221 223344
Q ss_pred ceee-cCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 048432 99 GCCI-DKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDL 156 (354)
Q Consensus 99 ~~~~-~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 156 (354)
+++. .++.+++|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 4443 345689999999999999987 456789999999999999999999 999999
Q ss_pred CCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCcc
Q 048432 157 KVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK-KTTGFY 235 (354)
Q Consensus 157 kp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~-~p~~~~ 235 (354)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++|. +|| .
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~--~ 238 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--P 238 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS--T
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC--C
Confidence 9999999999999999999998665544433444467899999999999999999999999999999999875 564 3
Q ss_pred ccc-chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 236 RTY-SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
+.. .......+..+.... . +..+++.+.+||.+||+.||++|||++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~-------------------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~e 286 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMR-A-------------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSE 286 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCC-C-------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCHHHHHHHHHhcCCCCC-C-------------------------------CccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 332 223333333222111 0 0115667899999999999999999999
Q ss_pred HHHHhhhhh
Q 048432 315 VVSMLTNEA 323 (354)
Q Consensus 315 il~~L~~~~ 323 (354)
++++|+++.
T Consensus 287 il~~L~~il 295 (299)
T d1ywna1 287 LVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-47 Score=350.94 Aligned_cols=236 Identities=23% Similarity=0.293 Sum_probs=197.6
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
..++|++++.||+|+||.||+|+++ +|+.||||++..........+. ||+++++++.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3478999999999999999999975 6999999999765543332222 66778888999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc--CCCCeEEeecccceeccCCc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KDMNPKISDFGIARICRGNE 184 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~~l~dfg~a~~~~~~~ 184 (354)
||+||+|.+.+ +++..++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||++.......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999998876 788999999999999999999999 99999999999997 57899999999998765443
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. ....+++.|+|||++.+..++.++|||||||++|+|++|.+| |.+.+..+....+.......+......
T Consensus 184 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P--f~~~~~~~~~~~i~~~~~~~~~~~~~~---- 254 (352)
T d1koba_ 184 IV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSS---- 254 (352)
T ss_dssp CE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCS--SCCSSHHHHHHHHHHCCCCCCSSTTTT----
T ss_pred ce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCC--CCCCCHHHHHHHHHhCCCCCCcccccC----
Confidence 22 234689999999999999999999999999999999999999 566666667777766665544332111
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.++.+.+||.+||+.||++|||++|+++.
T Consensus 255 -------------------------~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 -------------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -------------------------SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -------------------------CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 46678999999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=340.11 Aligned_cols=242 Identities=28% Similarity=0.475 Sum_probs=186.8
Q ss_pred hcCccccceecccCceeEEEEEEcCC-----CEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNG-----DEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKI 108 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~ 108 (354)
.++|.+.+.||+|+||.||+|.++.+ ..||||++....... ...+ +|++++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46899999999999999999997642 369999996543322 1122 26677888899999999
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+|||||.++++.+++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998877 678889999999999999999999 99999999999999999999999999976544
Q ss_pred Ccc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 183 NEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 183 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
... ........||+.|+|||++.+..++.++|||||||++|||++|..|+ +......++...+..+.......
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~-~~~~~~~~~~~~i~~~~~~~~~~----- 236 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAINDGFRLPTPM----- 236 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT-TTTCCHHHHHHHHHTTCCCCCCT-----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc-cccCCHHHHHHHHhccCCCCCch-----
Confidence 322 22223346789999999999999999999999999999999976664 33344445555554433211111
Q ss_pred cccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 262 KTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 262 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.++..+.+||.+||+.||++|||+.||++.|+++..
T Consensus 237 ---------------------------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 237 ---------------------------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---------------------------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------------------------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 156778999999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=347.56 Aligned_cols=246 Identities=27% Similarity=0.453 Sum_probs=198.5
Q ss_pred cchhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HHHHH------------HHHHHhcee
Q 048432 41 SSVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCC 101 (354)
Q Consensus 41 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~ 101 (354)
.++..+.++|++.+.||+|+||+||+|+++ +++.||||++....... ..++. |++++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445567789999999999999999999965 35689999997654332 22233 555667788
Q ss_pred ecCCceEEEEEecCCCCHhHHH-----------------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL-----------------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRII 152 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~-----------------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 152 (354)
...+..+++|||+.+|+|.+++ +++..+..++.|++.||+|||+++ ++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 8888999999999999999987 356789999999999999999999 99
Q ss_pred eCCCCCCCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CC
Q 048432 153 HRDLKVSNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK-KT 231 (354)
Q Consensus 153 H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~-~p 231 (354)
||||||+|||++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999997654443333333456788999999999999999999999999999999986 55
Q ss_pred CCcccccchhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC
Q 048432 232 TGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT 311 (354)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 311 (354)
|.+.+..++...+.++...... ..+++.+.+||.+||+.+|++|||
T Consensus 243 --~~~~~~~e~~~~v~~~~~~~~p--------------------------------~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 243 --YYGMAHEEVIYYVRDGNILACP--------------------------------ENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp --TTTSCHHHHHHHHHTTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CCCCCHHHHHHHHHcCCCCCCC--------------------------------ccchHHHHHHHHHHcCCChhHCcC
Confidence 5555666666666554432111 115677899999999999999999
Q ss_pred HHHHHHHhhhhh
Q 048432 312 MNDVVSMLTNEA 323 (354)
Q Consensus 312 ~~~il~~L~~~~ 323 (354)
+.||++.|+++.
T Consensus 289 ~~ev~~~L~~i~ 300 (301)
T d1lufa_ 289 FCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHhc
Confidence 999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-47 Score=347.09 Aligned_cols=229 Identities=29% Similarity=0.463 Sum_probs=186.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH------------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
.+.|++++.||+|+||.||+|++. +|+.||||++....... ...+ .||+++++++.+++.+|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 456999999999999999999975 58889999997654221 1112 2667788899999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||.+|++..+. +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 9999999987665 789999999999999999999999 999999999999999999999999999754332
Q ss_pred ccccccccCcccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQ---GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+.......+..+........
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf--~~~~~~~~~~~i~~~~~~~~~~~----- 237 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSG----- 237 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT--TTSCHHHHHHHHHHSCCCCCSCT-----
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC--CCCCHHHHHHHHHhCCCCCCCCC-----
Confidence 23578999999999864 45889999999999999999999994 44444444444444332221110
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.+++.+.+||.+||+.||++|||++|+++
T Consensus 238 --------------------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 --------------------------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------------------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 14677899999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=339.87 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=192.5
Q ss_pred hhcCccccce-ecccCceeEEEEEEc---CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCCceE
Q 048432 46 ATNKFSDANK-LGEGGFGPVYKGVLK---NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKDEKI 108 (354)
Q Consensus 46 ~~~~y~~~~~-lg~G~~g~V~~a~~~---~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~~~~ 108 (354)
..++|.+... ||+|+||.||+|.++ ++..||||++...... ....+. ||+++++++.. +.++
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3467777775 999999999999864 3557999999765332 222222 66677787764 5689
Q ss_pred EEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 109 LIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 109 lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
+|||||++|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999987 678899999999999999999999 99999999999999999999999999987654
Q ss_pred Ccc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 183 NEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 183 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |..|| .+....++...+.++.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf--~~~~~~~~~~~i~~~~~~~~------ 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIEQGKRMEC------ 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT--TTCCTHHHHHHHHTTCCCCC------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC--CCCCHHHHHHHHHcCCCCCC------
Confidence 332 222333467899999999999999999999999999999998 89995 44445555555554432111
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+..+++.+.+||.+||+.||++|||+.+|++.|+....
T Consensus 234 --------------------------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 --------------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------------------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11167788999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=348.12 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=188.8
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCCceEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~~~~lv~ 111 (354)
..++|++++.||+|+||+||+|+++ +|+.||+|++....... ...+ +||+++++++.+++.+|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999975 58999999997543322 1222 26778888999999999999
Q ss_pred EecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 112 EYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 112 e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|||++|+|.+++ +++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+|.......
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999988 7889999999999999999997 58 9999999999999999999999999997543322
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhh-hcc-ccCCCCccc-C---
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYI-SEN-IYEFPSVDT-H--- 259 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~-~~~~~~~~~-~--- 259 (354)
....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.............. ..+ ....+.... .
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2235799999999999999999999999999999999999999644332221111110 000 000000000 0
Q ss_pred -------CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--Hhhhhh
Q 048432 260 -------NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEA 323 (354)
Q Consensus 260 -------~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~ 323 (354)
..+.... ................ ....+..+.+||.+||+.||++|||++|+++ .|++..
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAI-FELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCH-HHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhH-HHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000000 0000000000000000 0013567899999999999999999999987 365543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=338.76 Aligned_cols=235 Identities=26% Similarity=0.335 Sum_probs=193.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhH----HH--------HHHHHHHhceeecCCc
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGL----RE--------LKNKLRLLGCCIDKDE 106 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~----~~--------~~~i~~~~~~~~~~~~ 106 (354)
..++|++.+.||+|+||.||+|+++ +|+.||||++..... ... ++ ++|++++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3478999999999999999999975 699999999864321 111 11 2377888999999999
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC----CeEEeecccc
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGIA 177 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~~l~dfg~a 177 (354)
+|+|||||++|+|.+++ +++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+|++|||++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999988 788999999999999999999999 99999999999998776 5999999999
Q ss_pred eeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 178 RICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
......... ....+++.|+|||++.+..++.++||||+||++|+|++|..| |.+.+..+....+.......+.
T Consensus 165 ~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P--f~~~~~~~~~~~i~~~~~~~~~-- 237 (293)
T d1jksa_ 165 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFED-- 237 (293)
T ss_dssp EECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHTTCCCCCH--
T ss_pred hhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC--CCCCCHHHHHHHHHhcCCCCCc--
Confidence 866544322 234678999999999998999999999999999999999999 4555666666666554433322
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
......++.+.+||.+||+.||++|||++|+++
T Consensus 238 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 ---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112225678899999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-46 Score=336.09 Aligned_cols=244 Identities=22% Similarity=0.278 Sum_probs=186.7
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHHH------------HHHHHhceeecCC----
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLRELK------------NKLRLLGCCIDKD---- 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~~------------~i~~~~~~~~~~~---- 105 (354)
..++|++.+.||+|+||.||+|.+. +|+.||||++..... .....+. |++++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4578999999999999999999975 699999999975432 2222233 4455566665433
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+|+|||||+|++|..++ +++..++.++.||+.||.|||+++ |+||||||+||+++.++..+++|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 378999999999999887 788999999999999999999999 999999999999999999999999998654
Q ss_pred cCCcc-ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNEL-QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..... ........||+.|+|||++.+..++.++||||+||++|+|++|.+|| .+.+..+....+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf--~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCC--CCcCHHHHHHHHHhcCCCCCchhcc
Confidence 33322 22233457899999999999999999999999999999999999995 4555555555444443332222111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-TMNDVVSMLTNEA 323 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~il~~L~~~~ 323 (354)
..++.+.+||.+||+.||++|| |++++++.|.++.
T Consensus 240 -----------------------------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 240 -----------------------------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----------------------------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------------------------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1567889999999999999999 8999999998775
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=339.11 Aligned_cols=245 Identities=28% Similarity=0.388 Sum_probs=195.7
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC--------CCEEEEEEecCCChhh-HHH-------------HHHHHHHhce
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN--------GDEIAVKRLSGRSGQG-LRE-------------LKNKLRLLGC 100 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~--------~~~vavK~~~~~~~~~-~~~-------------~~~i~~~~~~ 100 (354)
|....++|++.+.||+|+||.||+|+... +..||||++....... ..+ +.||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44567899999999999999999998542 2479999997654322 111 2267788889
Q ss_pred eecCCceEEEEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 048432 101 CIDKDEKILIYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS 159 (354)
Q Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 159 (354)
+.+++.+++|||||++|+|.+++ +++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 99999999999999999999988 478889999999999999999999 999999999
Q ss_pred CEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCccccc
Q 048432 160 NILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTY 238 (354)
Q Consensus 160 Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~ 238 (354)
|||++.++.+||+|||++................+++.|+|||.+.++.++.++|||||||++|+|++ |.+| |.+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p--~~~~~ 242 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVP 242 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS--STTCC
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC--CCCCC
Confidence 99999999999999999987666554444455678999999999999999999999999999999998 6777 44455
Q ss_pred chhhhhhhhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 239 SFTLLGYISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
...+...+..+...... ..+++.+.+||.+||+.||++|||+.||++.
T Consensus 243 ~~~~~~~i~~~~~~~~p--------------------------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 290 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKP--------------------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290 (299)
T ss_dssp HHHHHHHHHTTCCCCCC--------------------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCC--------------------------------ccchHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 55555554443221111 1156778999999999999999999999999
Q ss_pred hhhhhh
Q 048432 319 LTNEAA 324 (354)
Q Consensus 319 L~~~~~ 324 (354)
|+++.+
T Consensus 291 L~~i~a 296 (299)
T d1fgka_ 291 LDRIVA 296 (299)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=335.47 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=183.9
Q ss_pred hhhhhcCccccceecccCceeEEEEEEcC----CCEEEEEEecCCChhh-HHHH------------HHHHHHhceeecCC
Q 048432 43 VSTATNKFSDANKLGEGGFGPVYKGVLKN----GDEIAVKRLSGRSGQG-LREL------------KNKLRLLGCCIDKD 105 (354)
Q Consensus 43 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vavK~~~~~~~~~-~~~~------------~~i~~~~~~~~~~~ 105 (354)
++...++|++.+.||+|+||.||+|.+.. +..||+|++....... ...+ +||+++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 34456799999999999999999998653 3468999986543322 2222 26677778775 56
Q ss_pred ceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 106 EKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.+++|||||++|++..++ +++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 789999999999999876 678899999999999999999999 99999999999999999999999999976
Q ss_pred ccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 180 CRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+|| .+....++...+..+.....
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~--~~~~~~~~~~~i~~~~~~~~---- 230 (273)
T d1mp8a_ 158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGERLPM---- 230 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT--TTCCGGGHHHHHHTTCCCCC----
T ss_pred ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC--CCCCHHHHHHHHHcCCCCCC----
Confidence 5443322 2223467899999999999999999999999999999998 78884 44455555555554432111
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
++.+++.+.+||.+||+.||++|||++||++.|+.+..
T Consensus 231 ----------------------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 231 ----------------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11156789999999999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=342.97 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=192.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhH----HHH--------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGL----REL--------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~----~~~--------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++++.||+|+||.||+|+++ +|+.||+|++.+... ... ++. .||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999975 699999999964321 111 111 2666778889999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||+||+|..++ +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 9999999998888 778899999999999999999999 99999999999999999999999999975433221
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.+| |.+.+..++.+.+......+|..
T Consensus 161 --~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~p--f~~~~~~~~~~~i~~~~~~~p~~--------- 227 (337)
T d1o6la_ 161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILMEEIRFPRT--------- 227 (337)
T ss_dssp --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCTT---------
T ss_pred --ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCC--CCCcCHHHHHHHHhcCCCCCCcc---------
Confidence 22335799999999999999999999999999999999999999 55666666666666655444321
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~~ 318 (354)
.++.+.+||.+||+.||++|++ ++|+++.
T Consensus 228 ------------------------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 228 ------------------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------------------------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------------------------CCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 4566789999999999999995 8888863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=335.18 Aligned_cols=232 Identities=27% Similarity=0.378 Sum_probs=182.2
Q ss_pred ceecccCceeEEEEEEcC---CCEEEEEEecCCChh--hHHHHH------------HHHHHhceeecCCceEEEEEecCC
Q 048432 54 NKLGEGGFGPVYKGVLKN---GDEIAVKRLSGRSGQ--GLRELK------------NKLRLLGCCIDKDEKILIYEYMPN 116 (354)
Q Consensus 54 ~~lg~G~~g~V~~a~~~~---~~~vavK~~~~~~~~--~~~~~~------------~i~~~~~~~~~~~~~~lv~e~~~~ 116 (354)
+.||+|+||+||+|.+++ ++.||||+++..... ....+. |++++++++.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 567999999654221 122222 66677788764 567899999999
Q ss_pred CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc-ccccc
Q 048432 117 KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL-QANTG 190 (354)
Q Consensus 117 ~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~-~~~~~ 190 (354)
|+|.+++ +++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+++....... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999988 788999999999999999999999 99999999999999999999999999986544322 22223
Q ss_pred cccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCccccccchh
Q 048432 191 RIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFLHL 269 (354)
Q Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 269 (354)
...||+.|+|||++.+..++.++|||||||++|||++ |.+|| .+.+..++...+.++.....
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf--~~~~~~~~~~~i~~~~~~~~--------------- 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTAMLEKGERMGC--------------- 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHTTCCCCC---------------
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCC--CCCCHHHHHHHHHcCCCCCC---------------
Confidence 3568899999999999999999999999999999998 89995 44455555555554332111
Q ss_pred hhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 270 TIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
+..+++.+.+||.+||+.||++|||+++|++.|+...
T Consensus 232 -----------------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 -----------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----------------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1115778899999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=330.87 Aligned_cols=233 Identities=24% Similarity=0.390 Sum_probs=178.4
Q ss_pred hcCc-cccceecccCceeEEEEEEc-CCCEEEEEEecCCC--hhhHHHHH------------HHHHHhceeec----CCc
Q 048432 47 TNKF-SDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRS--GQGLRELK------------NKLRLLGCCID----KDE 106 (354)
Q Consensus 47 ~~~y-~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~--~~~~~~~~------------~i~~~~~~~~~----~~~ 106 (354)
.++| ++.+.||+|+||+||+|.++ +++.||+|++.... ......+. ||+++++++.+ ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 4455 67889999999999999976 58899999986542 22223333 55566666543 456
Q ss_pred eEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc-CCCCeEEeecccceec
Q 048432 107 KILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGIARIC 180 (354)
Q Consensus 107 ~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~~l~dfg~a~~~ 180 (354)
+|+|||||++|+|.+++ +++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 79999999999999988 678889999999999999999874 3499999999999996 5789999999999753
Q ss_pred cCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (354)
.... .....||+.|+|||++.+ +++.++|||||||++|+|++|..||... .+...+.+.+..+..+...
T Consensus 166 ~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-~~~~~~~~~i~~~~~~~~~----- 234 (270)
T d1t4ha_ 166 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGVKPASF----- 234 (270)
T ss_dssp CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTCCCGGG-----
T ss_pred cCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-ccHHHHHHHHHcCCCCccc-----
Confidence 3322 223578999999998865 6999999999999999999999996322 2233344444433221100
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+...++.+.+||.+||+.||++|||++|+++
T Consensus 235 --------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 --------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0114566889999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-46 Score=339.14 Aligned_cols=229 Identities=27% Similarity=0.367 Sum_probs=191.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++++.||+|+||+||+|+++ +|+.||||++..... .....+ .||+++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 367999999999999999999975 599999999864321 111111 2677788899999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||.|+++..++ ++...++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 9999999998888 677888899999999999999999 9999999999999999999999999998654432
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
...+||+.|+|||++.+..++.++|||||||++|+|++|..| |.+.+..+....+..+....|..
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P--f~~~~~~~~~~~i~~~~~~~p~~--------- 223 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPF--------- 223 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT--TCCSSHHHHHHHHHHCCCCCCTT---------
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC--CCCcCHHHHHHHHHcCCCCCCCC---------
Confidence 235789999999999999999999999999999999999999 55566666666665554443321
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVSM 318 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~~ 318 (354)
.++.+.++|.+||+.||++|+ |++++++.
T Consensus 224 ------------------------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 ------------------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------------------------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------------------------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 456688999999999999996 89999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=329.93 Aligned_cols=238 Identities=25% Similarity=0.366 Sum_probs=186.1
Q ss_pred hhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh--HHH--------HHHHHHHhceeec-CCceEEEEE
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG--LRE--------LKNKLRLLGCCID-KDEKILIYE 112 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~--~~~--------~~~i~~~~~~~~~-~~~~~lv~e 112 (354)
....++|++.+.||+|+||.||+|+++ |..||||+++...... .++ ++|++++++++.+ .+.+++|||
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 345678999999999999999999984 7889999997654322 111 1267778887754 456899999
Q ss_pred ecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 113 YMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 113 ~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|+++|+|.+++ +++..+++++.||+.||.|||+.+ |+||||||+||+++.++.++++|||++.......
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999987 578889999999999999999999 9999999999999999999999999987543322
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
....++..|+|||.+.+..++.++|||||||++|||++ |.+|| ......++...+..+....
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~--~~~~~~~~~~~i~~~~~~~----------- 220 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMD----------- 220 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC--TTSCGGGHHHHHTTTCCCC-----------
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCC--CCCCHHHHHHHHHcCCCCC-----------
Confidence 12356889999999999999999999999999999998 67774 4445555555554332211
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
.+..+++.+.+||.+||..||++|||+.++++.|+++++
T Consensus 221 ---------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 ---------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111256788999999999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=336.65 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.8
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhhH-HH-------------HHHHHHHhcee
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQGL-RE-------------LKNKLRLLGCC 101 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~~-~~-------------~~~i~~~~~~~ 101 (354)
.|....++|++.+.||+|+||.||+|++. .++.||||+++....... .+ +.|++++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 35556689999999999999999999853 356899999976543221 11 23667778889
Q ss_pred ecCCceEEEEEecCCCCHhHHH-----------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 048432 102 IDKDEKILIYEYMPNKSLDFFL-----------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKV 158 (354)
Q Consensus 102 ~~~~~~~lv~e~~~~~~L~~~~-----------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 158 (354)
.+.+.++++||||++|+|..++ +++..+..++.||+.||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 9999999999999999999887 456789999999999999999999 99999999
Q ss_pred CCEEEcCCCCeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Q 048432 159 SNILLDKDMNPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY 238 (354)
Q Consensus 159 ~Nill~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~ 238 (354)
+||+++.++.++++|||++................+|+.|+|||.+.+..++.++|||||||++|+|++++.|+ +....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~-~~~~~ 252 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMP 252 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS-STTCC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC-CCCCC
Confidence 99999999999999999998766554444444567899999999999999999999999999999999955443 22223
Q ss_pred chhhhhh-hhccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 239 SFTLLGY-ISENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
..+.+.. +..+...... ..+++.+.+||.+||+.||++|||+++|++
T Consensus 253 ~~~~~~~~i~~~~~~~~~--------------------------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSP--------------------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCCCCC--------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCc--------------------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222222 2222211111 115677899999999999999999999999
Q ss_pred Hhhhhhhh
Q 048432 318 MLTNEAAA 325 (354)
Q Consensus 318 ~L~~~~~~ 325 (354)
.|++..++
T Consensus 301 ~L~~~i~~ 308 (311)
T d1t46a_ 301 LIEKQISE 308 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHhhcc
Confidence 99987754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-45 Score=331.27 Aligned_cols=235 Identities=24% Similarity=0.337 Sum_probs=193.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-------------hHH---------HHHHHHHHhceeec
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-------------GLR---------ELKNKLRLLGCCID 103 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-------------~~~---------~~~~i~~~~~~~~~ 103 (354)
.++|++.+.||+|+||+||+|+++ +|+.||||++...... ..+ .+.|++++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999975 6899999998654211 011 12366788889999
Q ss_pred CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
++..|+|||||++|+|.+++ +++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999998 789999999999999999999999 9999999999999999999999999998
Q ss_pred eccCCccccccccccCcccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQ------GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE 252 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 252 (354)
....... .....||..|.|||.+.+ ..++.++||||+||++|+|++|+.| |.+.+..+..+.+..+...
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P--f~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHTCCC
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCC--CCCCCHHHHHHHHHhCCCC
Confidence 7654332 223578999999999863 3468899999999999999999999 5555666666666655544
Q ss_pred CCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 253 FPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 253 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.+.... ...++.+.+||.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~-----------------------------~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 FGSPEW-----------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCTTTG-----------------------------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCccc-----------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 332221 1156789999999999999999999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-45 Score=343.17 Aligned_cols=231 Identities=25% Similarity=0.283 Sum_probs=183.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh------hhHHH------------HHHHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG------QGLRE------------LKNKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~------~~~~~------------~~~i~~~~~~~~~~~~~ 107 (354)
.++|++.+.||+|+||.||+|+++ +|+.||||++..... ..... +.|++++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999976 599999999854321 11111 12566777888899999
Q ss_pred EEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 108 ILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|+|||||+||+|..++ +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999988 678899999999999999999999 99999999999999999999999999986554
Q ss_pred CccccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccch-hhhhhhhccccCCCCcccCC
Q 048432 183 NELQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF-TLLGYISENIYEFPSVDTHN 260 (354)
Q Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 260 (354)
... ....||+.|+|||++.. ..++.++|||||||++|+|++|..||........ .+...+.......+.
T Consensus 160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 230 (364)
T d1omwa3 160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----- 230 (364)
T ss_dssp SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS-----
T ss_pred Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----
Confidence 332 23478999999999875 5689999999999999999999999644332221 122222221111111
Q ss_pred ccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 048432 261 VKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPT-----MNDVVS 317 (354)
Q Consensus 261 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~il~ 317 (354)
..++.+.+||.+||+.||++||| |+|+++
T Consensus 231 ----------------------------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 ----------------------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----------------------------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----------------------------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 14667899999999999999999 788875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=338.83 Aligned_cols=236 Identities=20% Similarity=0.306 Sum_probs=194.9
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhH---HHH--------HHHHHHhceeecCCceEEEEE
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL---REL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~---~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
...++|++.+.||+|+||+||+|.++ +|+.||+|++........ +++ .||+++++++.+++.+|+|||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35689999999999999999999976 588999999976543321 111 266778889999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC--CCeEEeecccceeccCCc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNPKISDFGIARICRGNE 184 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~~l~dfg~a~~~~~~~ 184 (354)
||+|++|.+++ +++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.++|+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999988 678899999999999999999999 9999999999999854 479999999998655433
Q ss_pred cccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTF 264 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (354)
.. ....+++.|+|||.+.+..++.++||||+||++|+|++|..| |.+.+..+....+.+....++...
T Consensus 159 ~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~P--f~~~~~~~~~~~i~~~~~~~~~~~------- 226 (321)
T d1tkia_ 159 NF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEA------- 226 (321)
T ss_dssp EE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT--TCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred cc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCC--CCCCCHHHHHHHHHhCCCCCChhh-------
Confidence 22 224678999999999999999999999999999999999999 555666666666665554433211
Q ss_pred ccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 265 GFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 265 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
....++.+.+||.+||+.||++|||++|+++
T Consensus 227 ----------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 ----------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1114667899999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-45 Score=339.25 Aligned_cols=228 Identities=23% Similarity=0.331 Sum_probs=191.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---hhHHHH------------HHHHHHhceeecCCceEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---QGLREL------------KNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~~~~~~------------~~i~~~~~~~~~~~~~~lv 110 (354)
.++|++++.||+|+||.||+|+++ +|+.||||++..... .....+ .||+++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 368999999999999999999975 599999999864321 111111 2666778888899999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
|||+.+|+|..++ +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.......
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 9999999998888 778899999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
....||+.|+|||++.+..++.++|||||||++|+|++|..|| .+.+.......+..+....|..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf--~~~~~~~~~~~i~~~~~~~p~~--------- 260 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPSH--------- 260 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHCCCCCCTT---------
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC--CCcCHHHHHHHHhcCCCCCCcc---------
Confidence 2357899999999999999999999999999999999999994 5566666666666555443321
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
.++.+.+||.+||+.||++|+ |++++++
T Consensus 261 ------------------------~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 ------------------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------------------------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------------------------CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 456788999999999999994 8999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=337.94 Aligned_cols=236 Identities=20% Similarity=0.281 Sum_probs=184.3
Q ss_pred hhcCccccc-eecccCceeEEEEEEc-CCCEEEEEEecCCChhhH--------HHHHHHHHHhceeec----CCceEEEE
Q 048432 46 ATNKFSDAN-KLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGL--------RELKNKLRLLGCCID----KDEKILIY 111 (354)
Q Consensus 46 ~~~~y~~~~-~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~--------~~~~~i~~~~~~~~~----~~~~~lv~ 111 (354)
..++|++.. .||+|+||.||+|++. +++.||||++........ ..++|++++++++.+ +..+|+||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 457899875 6999999999999974 589999999975432111 112366777777754 46789999
Q ss_pred EecCCCCHhHHH-------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC---CCCeEEeecccceecc
Q 048432 112 EYMPNKSLDFFL-------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGIARICR 181 (354)
Q Consensus 112 e~~~~~~L~~~~-------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~~l~dfg~a~~~~ 181 (354)
|||+||+|.+++ +++..++.++.||+.||+|||+++ |+||||||+||+++. .+.+||+|||++....
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeeecc
Confidence 999999999988 688999999999999999999999 999999999999985 5679999999998655
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhh----hhhccccCCCCcc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLG----YISENIYEFPSVD 257 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~ 257 (354)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|++|| .+.+...... .+......+|.
T Consensus 166 ~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf--~~~~~~~~~~~~~~~i~~~~~~~~~-- 238 (335)
T d2ozaa1 166 SHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYEFPN-- 238 (335)
T ss_dssp CCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC--EETTCC--------CCCSCSSSCCT--
T ss_pred CCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC--CCCCHHHHHHHHHHHHhcCCCCCCC--
Confidence 4332 22357899999999999999999999999999999999999995 3333222222 22222222211
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
......++.+.+||.+||+.||++|||++|+++.
T Consensus 239 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 ---------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---------------------------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122357789999999999999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=340.87 Aligned_cols=230 Identities=27% Similarity=0.384 Sum_probs=191.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh---h----hHH---------HHHHHHHHhceeecCCceEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG---Q----GLR---------ELKNKLRLLGCCIDKDEKILI 110 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~---~----~~~---------~~~~i~~~~~~~~~~~~~~lv 110 (354)
++|++.+.||+|+||+||+|+++ +|+.||||++.+... . ... .+.||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999976 589999999964321 0 111 123677888999999999999
Q ss_pred EEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcc
Q 048432 111 YEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 111 ~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~ 185 (354)
||||++|+|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 9999999999988 778899999999999999999999 9999999999999999999999999997544332
Q ss_pred ccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 186 QANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.| |.+.+...+...+..+....|..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P--F~~~~~~~~~~~i~~~~~~~p~~--------- 225 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIRMDNPFYPRW--------- 225 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHCCCCCCTT---------
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC--CCCCCHHHHHHHHHcCCCCCCcc---------
Confidence 222345789999999999999999999999999999999999999 55666666666665554433321
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMN-DVVS 317 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-~il~ 317 (354)
.++.+.+||.+||+.||++|||+. ++++
T Consensus 226 ------------------------~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 ------------------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------------------------SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------------------------CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 456789999999999999999995 6754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=334.82 Aligned_cols=239 Identities=26% Similarity=0.440 Sum_probs=184.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCC----EEEEEEecCCCh-hhHHHH------------HHHHHHhceeecCCceEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGD----EIAVKRLSGRSG-QGLREL------------KNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vavK~~~~~~~-~~~~~~------------~~i~~~~~~~~~~~~~~l 109 (354)
++|++++.||+|+||+||+|.+. +|+ +||+|.+..... ....++ +||+++++++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 57999999999999999999965 344 589998864322 222222 266777888875 45778
Q ss_pred EEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 110 IYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 110 v~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
+++++.+++|.+.+ +++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999998877 678889999999999999999999 999999999999999999999999999866554
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccCCcc
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVK 262 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (354)
..........||+.|+|||++.++.++.++|||||||++|||++ |.+|| .+....++...+.++.....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~--~~~~~~~~~~~i~~~~~~~~-------- 234 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--DGIPASEISSILEKGERLPQ-------- 234 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT--TTSCGGGHHHHHHHTCCCCC--------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC--CCCCHHHHHHHHHcCCCCCC--------
Confidence 43333334568999999999999999999999999999999998 67784 34444444444444332111
Q ss_pred ccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhh
Q 048432 263 TFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 324 (354)
Q Consensus 263 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~ 324 (354)
+..+++.+.+||.+||+.||++|||+.||++.|..+..
T Consensus 235 ------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 235 ------------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11156788999999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=330.14 Aligned_cols=239 Identities=28% Similarity=0.389 Sum_probs=182.7
Q ss_pred hcCccccceecccCceeEEEEEEcC--C--CEEEEEEecCCC---hhhHHHHH------------HHHHHhceeecCCce
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN--G--DEIAVKRLSGRS---GQGLRELK------------NKLRLLGCCIDKDEK 107 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~--~--~~vavK~~~~~~---~~~~~~~~------------~i~~~~~~~~~~~~~ 107 (354)
.++|++.+.||+|+||.||+|++.. + ..||||++.... ......+. ||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999998542 3 368999986542 22222222 55667777765 567
Q ss_pred EEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 108 ILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 108 ~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
++|||||+++++.+.+ +++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999998877 678899999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccc-ccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 182 GNELQA-NTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVS-GKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..| |.+.+..+....+.+.....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~P--f~~~~~~~~~~~i~~~~~~~~~~~-- 238 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGERLPRPE-- 238 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT--TTTCCHHHHHHHHHTSCCCCCCCT--
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCC--CCCcCHHHHHHHHHhCCCCCCCcc--
Confidence 443222 2223457789999999999999999999999999999998 8999 556666666666655443322211
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNE 322 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~ 322 (354)
.++..+.+||.+||+.||++|||+++|++.|++.
T Consensus 239 -----------------------------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 -----------------------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1567789999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=331.81 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=198.9
Q ss_pred chhhhhcCccccceecccCceeEEEEEEc------CCCEEEEEEecCCChhh-HHHHH------------HHHHHhceee
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLK------NGDEIAVKRLSGRSGQG-LRELK------------NKLRLLGCCI 102 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vavK~~~~~~~~~-~~~~~------------~i~~~~~~~~ 102 (354)
+|....++|++.+.||+|+||.||+|.++ .++.||||++....... ...+. |++++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 46666799999999999999999999864 25789999997653322 22222 6667778888
Q ss_pred cCCceEEEEEecCCCCHhHHH---------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC
Q 048432 103 DKDEKILIYEYMPNKSLDFFL---------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM 167 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~---------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 167 (354)
.++..++|||||.+|+|.+++ +++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 889999999999999999987 255678899999999999999999 99999999999999999
Q ss_pred CeEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCcccccchhhhhhh
Q 048432 168 NPKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGK-KTTGFYRTYSFTLLGYI 246 (354)
Q Consensus 168 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~-~p~~~~~~~~~~~~~~~ 246 (354)
.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++|. +| +.+.+..+....+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p--~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 248 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT--TTTSCHHHHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC--CCCCCHHHHHHHH
Confidence 99999999998665544433344456889999999999999999999999999999999985 66 4455555556555
Q ss_pred hccccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhh
Q 048432 247 SENIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEA 323 (354)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~ 323 (354)
.++...... ..+++.+.+||.+||+.+|++|||+++|+++|++..
T Consensus 249 ~~~~~~~~p--------------------------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 MEGGLLDKP--------------------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTTCCCCCC--------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HhCCCCCCc--------------------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 443321111 115678999999999999999999999999998875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=332.35 Aligned_cols=240 Identities=28% Similarity=0.383 Sum_probs=191.1
Q ss_pred hcCccccceecccCceeEEEEEEcC-CC--EEEEEEecCCChh-h----HH---------HHHHHHHHhceeecCCceEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKN-GD--EIAVKRLSGRSGQ-G----LR---------ELKNKLRLLGCCIDKDEKIL 109 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~-~~--~vavK~~~~~~~~-~----~~---------~~~~i~~~~~~~~~~~~~~l 109 (354)
.++|++.+.||+|+||.||+|.+++ |. .||||.+...... . .+ +++||+++++++.+++.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3789999999999999999999764 43 4788887543221 1 11 13477888899999999999
Q ss_pred EEEecCCCCHhHHH---------------------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCC
Q 048432 110 IYEYMPNKSLDFFL---------------------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN 168 (354)
Q Consensus 110 v~e~~~~~~L~~~~---------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 168 (354)
||||+++|+|.+++ +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999987 467788999999999999999999 999999999999999999
Q ss_pred eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhc
Q 048432 169 PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISE 248 (354)
Q Consensus 169 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 248 (354)
+||+|||++......... ....+|..|+|||.+.+..++.++|||||||++|||++|..|+ |.+.+..++...+.+
T Consensus 166 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p-~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 241 (309)
T ss_dssp EEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT-TTTCCHHHHHHHGGG
T ss_pred eEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCC-CCCCCHHHHHHHHHh
Confidence 999999998754332221 2246789999999999999999999999999999999976432 455566666666554
Q ss_pred cccCCCCcccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 249 NIYEFPSVDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
+...... ..+++.+.+||.+||+.||++|||+++|++.|+++...
T Consensus 242 ~~~~~~~--------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 GYRLEKP--------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp TCCCCCC--------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCC--------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4221111 11567899999999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=331.25 Aligned_cols=258 Identities=23% Similarity=0.256 Sum_probs=186.8
Q ss_pred ccceecccCceeEEEEEEc-CCCEEEEEEecCCChh---------hHHHH--------HHHHHHhceeecCCceEEEEEe
Q 048432 52 DANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ---------GLREL--------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~---------~~~~~--------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
.++.||+|+||+||+|+++ +|+.||||++...... ..+++ .|++++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999975 5999999998654321 11222 3777888999999999999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
|.++++..+. +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-- 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-- 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--
Confidence 9998777665 678889999999999999999999 999999999999999999999999999765443322
Q ss_pred cccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....+|+.|+|||++.+. .++.++||||+||++|+|++|.+| |.+.+..+....+.+.....+.............
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p--f~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS--SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC--CCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2224789999999998754 579999999999999999999999 4555555666555544433322221111110000
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhh
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTN 321 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~ 321 (354)
.. ................++.+.+||.+||+.||++||||+|+++. |++
T Consensus 235 ~~-----~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 235 VT-----FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CC-----CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hh-----hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 00000000011112246778999999999999999999999873 544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=327.32 Aligned_cols=265 Identities=21% Similarity=0.277 Sum_probs=191.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++++.||+|+||+||+|.+. +|+.||||++...... ..+++ .|++++++++.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 6999999999654221 11222 266778888999999999999
Q ss_pred ecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc
Q 048432 113 YMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ 186 (354)
Q Consensus 113 ~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~ 186 (354)
|+.++.+.... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99876555443 688999999999999999999999 99999999999999999999999999976543322
Q ss_pred cccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 ANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
......||+.|+|||++.... ++.++||||+||++|+|++|+.|| .+.+..+....+...........+.......
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC--CCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 222347899999999887665 588999999999999999999995 4445444444444333332222222111110
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhh
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEA 323 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~ 323 (354)
.... ..............+..++.+.+||.+||+.||++|||++|+++. |+++.
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 235 DYKP----SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TCCT----TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccc----ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0000 000000011111122356788999999999999999999999985 66554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-44 Score=323.44 Aligned_cols=259 Identities=21% Similarity=0.301 Sum_probs=190.7
Q ss_pred cCccccceecccCceeEEEEEEcCCCEEEEEEecCCChh------hHHHH--------HHHHHHhceeecCCceEEEEEe
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ------GLREL--------KNKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~------~~~~~--------~~i~~~~~~~~~~~~~~lv~e~ 113 (354)
++|++++.||+|+||+||+|++++|+.||||++...... ..+++ .|++++++++.+++..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999654321 11222 2667788889999999999999
Q ss_pred cCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccccc
Q 048432 114 MPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQAN 188 (354)
Q Consensus 114 ~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~~ 188 (354)
+.++++..+. ++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||.+.........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence 9988777776 789999999999999999999999 999999999999999999999999999765443321
Q ss_pred cccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccccc
Q 048432 189 TGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGFL 267 (354)
Q Consensus 189 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (354)
.....+++.|+|||.+.+. .++.++||||+||++|+|++|++|| .+.+..+...++.......+.............
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC--CCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2234678899999998765 4699999999999999999999995 455555555554444443332222211111100
Q ss_pred hhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 268 HLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 268 d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
... ................++.+.+||.+||+.||++|||++|+++
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPN----FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTT----CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccc----cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000111112222235678899999999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=324.04 Aligned_cols=264 Identities=24% Similarity=0.302 Sum_probs=187.5
Q ss_pred hcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhhH-HH----------HHHHHHHhceeecCC----ceEEEE
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQGL-RE----------LKNKLRLLGCCIDKD----EKILIY 111 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~~-~~----------~~~i~~~~~~~~~~~----~~~lv~ 111 (354)
.++|.+.+.||+|+||.||+|++ +|+.||||++........ .+ ++||+++++++.+++ .+++||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46788999999999999999997 588999999976543321 11 236778888886543 579999
Q ss_pred EecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeCCCCCCCEEEcCCCCeEEeecccceeccC
Q 048432 112 EYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYS-----RVRIIHRDLKVSNILLDKDMNPKISDFGIARICRG 182 (354)
Q Consensus 112 e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~ 182 (354)
|||++|+|.+++ +++.....++.|++.||.|+|+.. .++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999999998 688999999999999999999741 12399999999999999999999999999986654
Q ss_pred Cccc--cccccccCcccccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCC
Q 048432 183 NELQ--ANTGRIVGTYRYMSPEYAIQGI------FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFP 254 (354)
Q Consensus 183 ~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 254 (354)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||........ ....+.....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-~~~~~~~~~~--- 236 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVPSDP--- 236 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSCSSC---
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-chhhcccccc---
Confidence 3321 1233457899999999987542 56789999999999999999888543221110 0000000000
Q ss_pred CcccCCccccccchhhhhhhhhccccCC-chhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 255 SVDTHNVKTFGFLHLTIFKLFSISSVGL-SNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 255 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
.. ............++.. ...........+.+||.+||+.||++|||+.||++.|+++...
T Consensus 237 ~~----------~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SV----------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CH----------HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hH----------HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00 0000000000000111 1111233677899999999999999999999999999998743
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=325.56 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=187.3
Q ss_pred hhcCccccceecccCceeEEEEEEc-C-CCEEEEEEecCCCh------hhHHH-----------HHHHHHHhceee----
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-N-GDEIAVKRLSGRSG------QGLRE-----------LKNKLRLLGCCI---- 102 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~-~~~vavK~~~~~~~------~~~~~-----------~~~i~~~~~~~~---- 102 (354)
..++|++++.||+|+||+||+|++. + ++.||||++..... ...++ +.|++++++++.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4589999999999999999999974 4 56799999854211 11111 235566676664
Q ss_pred -cCCceEEEEEecCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecc
Q 048432 103 -DKDEKILIYEYMPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 175 (354)
Q Consensus 103 -~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg 175 (354)
....++++|||+.++++.... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 335689999999998776554 678889999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 176 IARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 176 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
++....... ......||+.|+|||++.+.+++.++||||+||++|+|++|.+|| .+.+..+....+.......+.
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf--~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC--CCCCHHHHHHHHHHhhCCCch
Confidence 987543332 223457899999999999999999999999999999999999994 555555555554433332222
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..+...... .. ..................++.+.+||.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVAL--PR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSS--CG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccc--hh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111110000 00 0000000111111222256778899999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=320.55 Aligned_cols=238 Identities=26% Similarity=0.409 Sum_probs=184.2
Q ss_pred ccceecccCceeEEEEEEcCC----CEEEEEEecCC-ChhhHHHHH------------HHHHHhceeec-CCceEEEEEe
Q 048432 52 DANKLGEGGFGPVYKGVLKNG----DEIAVKRLSGR-SGQGLRELK------------NKLRLLGCCID-KDEKILIYEY 113 (354)
Q Consensus 52 ~~~~lg~G~~g~V~~a~~~~~----~~vavK~~~~~-~~~~~~~~~------------~i~~~~~~~~~-~~~~~lv~e~ 113 (354)
+.++||+|+||+||+|.+.++ ..||||++... ......++. |++++++++.. ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999996532 25899999753 333323332 66677787654 5678999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCccc-
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQ- 186 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~- 186 (354)
|++++|.+++ .++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999988 557788999999999999999999 999999999999999999999999999865443322
Q ss_pred -cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccccc
Q 048432 187 -ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFG 265 (354)
Q Consensus 187 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (354)
.......||..|+|||.+....++.++||||||+++|||++|+.||.. ..+..+....+..+......
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~-~~~~~~~~~~i~~g~~~~~p---------- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVYLLQGRRLLQP---------- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCC----------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCCCCCCc----------
Confidence 122234678999999999999999999999999999999998877532 23344444444443321111
Q ss_pred cchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhh
Q 048432 266 FLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 325 (354)
Q Consensus 266 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~ 325 (354)
..+++.+.+||.+||+.||++|||+.||++.|+++...
T Consensus 257 ----------------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 ----------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11567789999999999999999999999999999854
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-43 Score=318.03 Aligned_cols=260 Identities=18% Similarity=0.263 Sum_probs=200.2
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-hhH-HHHH---------HHHHHhceeecCCceEEEEEe
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-QGL-RELK---------NKLRLLGCCIDKDEKILIYEY 113 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-~~~-~~~~---------~i~~~~~~~~~~~~~~lv~e~ 113 (354)
.+++|++.+.||+|+||.||+|++. +|+.||||++..... ... .+++ +++.++.++......++||||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 3689999999999999999999975 588999999865432 112 2221 334456677788889999999
Q ss_pred cCCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcC-----CCCeEEeecccceeccC
Q 048432 114 MPNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGIARICRG 182 (354)
Q Consensus 114 ~~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~~l~dfg~a~~~~~ 182 (354)
+ +++|.+++ ++...+..++.|++.||.|||+++ |+||||||+||+++. ++.++|+|||++.....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 8 67888777 678889999999999999999999 999999999999974 57899999999987543
Q ss_pred Cccc-----cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-chhhhhhhhccccCCCCc
Q 048432 183 NELQ-----ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY-SFTLLGYISENIYEFPSV 256 (354)
Q Consensus 183 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 256 (354)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-- 236 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-- 236 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC--
Confidence 3211 1233457999999999999999999999999999999999999997543332 2222222221111110
Q ss_pred ccCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccc
Q 048432 257 DTHNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSY 336 (354)
Q Consensus 257 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~ 336 (354)
..+....+++++.+++..|+..+|++||+++.+.+.|+++........+-.|||
T Consensus 237 --------------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 237 --------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp --------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred --------------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 111112256789999999999999999999999999999887777777777777
Q ss_pred c
Q 048432 337 V 337 (354)
Q Consensus 337 ~ 337 (354)
.
T Consensus 291 ~ 291 (293)
T d1csna_ 291 N 291 (293)
T ss_dssp G
T ss_pred C
Confidence 5
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=318.68 Aligned_cols=224 Identities=24% Similarity=0.351 Sum_probs=179.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh-------------hh---HHH----HHHHHHHhceeecCC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG-------------QG---LRE----LKNKLRLLGCCIDKD 105 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~-------------~~---~~~----~~~i~~~~~~~~~~~ 105 (354)
.++|++.+.||+|+||.||+|++. +|+.||||++..... .+ +.. +.|++++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 578999999999999999999975 689999999864211 01 111 246888999999999
Q ss_pred ceEEEEEecCC-CCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCC-CCeEEeecccce
Q 048432 106 EKILIYEYMPN-KSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGIAR 178 (354)
Q Consensus 106 ~~~lv~e~~~~-~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~~l~dfg~a~ 178 (354)
..++||||+.+ +++.+++ +++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 5666665 788999999999999999999999 9999999999999854 789999999997
Q ss_pred eccCCccccccccccCcccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcc
Q 048432 179 ICRGNELQANTGRIVGTYRYMSPEYAIQGIF-SIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVD 257 (354)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (354)
...... .....||+.|+|||++.+..+ +.++||||+||++|+|++|..||... + .+.++....+.
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~------~i~~~~~~~~~-- 225 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--E------EIIRGQVFFRQ-- 225 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--H------HHHHCCCCCSS--
T ss_pred eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--h------HHhhcccCCCC--
Confidence 654332 223578999999999987765 67799999999999999999996421 1 11122111111
Q ss_pred cCCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 258 THNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 258 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
..++.+.+||.+||+.||++|||++|+++.
T Consensus 226 -------------------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 226 -------------------------------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -------------------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------------------------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 045678999999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=322.73 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=190.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHHHHHH----------HHhceeecCCceEEEEEec
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRELKNKL----------RLLGCCIDKDEKILIYEYM 114 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~~~i~----------~~~~~~~~~~~~~lv~e~~ 114 (354)
+++|++.+.||+|+||.||+|++. +|+.||||++...... .......++ .+..+..+.+..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 468999999999999999999975 5889999998654332 111111121 2233456677888999999
Q ss_pred CCCCHhHHH------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEc---CCCCeEEeecccceeccCCcc
Q 048432 115 PNKSLDFFL------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGIARICRGNEL 185 (354)
Q Consensus 115 ~~~~L~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~~l~dfg~a~~~~~~~~ 185 (354)
.+ ++...+ +++..+..++.|++.||+|||+++ |+||||||+||+++ .+..++++|||++........
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 55 554444 788999999999999999999999 99999999999986 455799999999987654332
Q ss_pred c-----cccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccch-hhhhhhhccccCCCCcccC
Q 048432 186 Q-----ANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSF-TLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 186 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 259 (354)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .............+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----- 236 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----- 236 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-----
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-----
Confidence 1 122345799999999999999999999999999999999999999643322211 11111111000000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHhhhhhhhcCCCCCCCccccc
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALLPPKQPAFSYVR 338 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~L~~~~~~~~~~~~~~~~~~~ 338 (354)
.......+++.+.+||.+||+.+|++||+++++.+.|+.+.........-.|+|+.
T Consensus 237 -----------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~ 292 (299)
T d1ckia_ 237 -----------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292 (299)
T ss_dssp -----------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred -----------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence 11111226788999999999999999999999999999987666666666777754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=326.58 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=184.5
Q ss_pred CccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHHHH--------HHHHHHhceee------cCCceEEEEEe
Q 048432 49 KFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLREL--------KNKLRLLGCCI------DKDEKILIYEY 113 (354)
Q Consensus 49 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~~~--------~~i~~~~~~~~------~~~~~~lv~e~ 113 (354)
+|+..++||+|+||+||+|+++ +|+.||||++........+++ .|++++++++. +..++++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 6999999999999999999976 599999999976554333332 26667777763 23457899999
Q ss_pred cCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCCc
Q 048432 114 MPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGNE 184 (354)
Q Consensus 114 ~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~~ 184 (354)
|+++++..+. +++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++.......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 9887544443 678889999999999999999999 99999999999999775 89999999998665443
Q ss_pred cccccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCccc
Q 048432 185 LQANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKT 263 (354)
Q Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (354)
.. ....|+..|+|||.+.+ ..++.++||||+||++|+|++|.+|| ...+..+....+.+..+..+.........
T Consensus 178 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf--~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 178 PN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp CC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS--CCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred cc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC--CCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 22 22478999999998875 46899999999999999999999995 44444444444433222211100000000
Q ss_pred cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhh
Q 048432 264 FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA 324 (354)
Q Consensus 264 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~ 324 (354)
...+.. ..............+..++.+.+||.+||+.||++|||++|+++. |+++..
T Consensus 253 -~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 253 -NYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp ----CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred -chhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000000 000000000000011246678999999999999999999999963 666653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=321.85 Aligned_cols=274 Identities=21% Similarity=0.256 Sum_probs=185.5
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCC-----
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKD----- 105 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~----- 105 (354)
..++|++++.||+|+||+||+|.++ +|+.||||++..... .....+. |++++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4579999999999999999999975 599999999975422 1122222 4455666665443
Q ss_pred -ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 -EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 -~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
.+|+||||| +.+|..+. +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 579999999 55777666 889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCccccccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... ....+++.|+|||++.+. .++.++||||+||++|+|++|.+|| .+.+.......+.......+.....
T Consensus 172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC--CCCChHHHHHHHHhccCCCcHHHHh
Confidence 4432 235789999999998764 5689999999999999999999994 5555555554444443333321111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhhhcCCCCCC
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALLPPKQP 332 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~~~~~~~~~ 332 (354)
..... ........................++.+.+||.+||..||++|||++|+++. |+++......|..+
T Consensus 245 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~ 317 (346)
T d1cm8a_ 245 RLQSD--EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 317 (346)
T ss_dssp TCSCH--HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred hhcch--hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC
Confidence 10000 0000000000000001111112246678899999999999999999999985 77765444444333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=311.41 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=190.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceeecCCceEEEEE
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCIDKDEKILIYE 112 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~~~~~~~lv~e 112 (354)
++|++++.||+|+||+||+|++. +|+.||||+++.... .....+. |++++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 689999999865432 2222222 55666778888899999999
Q ss_pred ecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCCcccc
Q 048432 113 YMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGNELQA 187 (354)
Q Consensus 113 ~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~~~~~ 187 (354)
++.++++..++ +++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||.+.........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 99999888776 678889999999999999999999 999999999999999999999999999876544322
Q ss_pred ccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCcccccc
Q 048432 188 NTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNVKTFGF 266 (354)
Q Consensus 188 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (354)
.....++..|+|||++.+.. ++.++||||+||++|+|++|+.|| +.+.+..+....+.......+...........
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP- 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS-CCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST-
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC-CCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc-
Confidence 22235678899999987665 689999999999999999999986 33444444444444333332222211111000
Q ss_pred chhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 267 LHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 267 ~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
+.. ..................++.+.+||.+||+.||++||||+|+++
T Consensus 235 -~~~--~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 -DYK--PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp -TCC--CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccc--ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000011111222235667899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-42 Score=315.12 Aligned_cols=260 Identities=17% Similarity=0.229 Sum_probs=181.9
Q ss_pred hhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhhHH-HH---------HHHHHHhceee--cCCceEEEEE
Q 048432 46 ATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQGLR-EL---------KNKLRLLGCCI--DKDEKILIYE 112 (354)
Q Consensus 46 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~~~-~~---------~~i~~~~~~~~--~~~~~~lv~e 112 (354)
..++|++++.||+|+||+||+|+++ +|+.||||++......... ++ .|++++++++. ....+++|||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 3478999999999999999999975 5899999999765543322 11 24455566665 3456899999
Q ss_pred ecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCC-CeEEeecccceeccCCcccccc
Q 048432 113 YMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGIARICRGNELQANT 189 (354)
Q Consensus 113 ~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~~l~dfg~a~~~~~~~~~~~~ 189 (354)
||.+++|..+. +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .++|+|||++........ .
T Consensus 113 ~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~ 186 (328)
T d3bqca1 113 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---Y 186 (328)
T ss_dssp CCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---C
T ss_pred ecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc---c
Confidence 99999998776 788999999999999999999999 99999999999998765 589999999986554332 2
Q ss_pred ccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccC---------CCCcccC
Q 048432 190 GRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYE---------FPSVDTH 259 (354)
Q Consensus 190 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 259 (354)
....+|..|+|||.+.+.. ++.++||||+||++|+|++|..||...... .+....+...... .......
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh-HHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 2346799999999987654 799999999999999999999996443322 1111111111100 0000000
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS 317 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~ 317 (354)
.......... ...+... .........++.+.+||.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~-~~~~~~~----~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 266 RFNDILGRHS-RKRWERF----VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGTCCCCC-CCCGGGG----CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhccccc-ccchhhc----ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0000000 011111124667899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-42 Score=312.64 Aligned_cols=265 Identities=21% Similarity=0.331 Sum_probs=182.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hh----HHHHH--------HHHHHhceeec--------
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QG----LRELK--------NKLRLLGCCID-------- 103 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~----~~~~~--------~i~~~~~~~~~-------- 103 (354)
.++|++++.||+|+||+||+|+++ +|+.||||++..... .. .+++. |++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 589999999999999999999975 699999999854322 11 12221 33344444432
Q ss_pred CCceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 104 KDEKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
.+.++++||||.++++.... ++...++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 45689999999887776554 677888999999999999999999 9999999999999999999999999997
Q ss_pred eccCCccc--cccccccCcccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCC
Q 048432 179 ICRGNELQ--ANTGRIVGTYRYMSPEYAIQG-IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPS 255 (354)
Q Consensus 179 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 255 (354)
........ .......||+.|+|||++.+. .++.++||||+||++|+|++|+.| |.+.+.......+.+.....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p--f~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS--CCCSSHHHHHHHHHHHHCCCCT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC--CCCCCHHHHHHHHHHhcCCCCh
Confidence 65533221 122234689999999998765 689999999999999999999999 4555555555555554444433
Q ss_pred cccCCccccccchhhhhhhhhccccCCchhH-HHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 256 VDTHNVKTFGFLHLTIFKLFSISSVGLSNDI-VCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 256 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
............... .............. .....+.+.+||.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC---------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhh--cccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 322222111100000 00000000000000 11135677899999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=316.77 Aligned_cols=272 Identities=19% Similarity=0.220 Sum_probs=182.7
Q ss_pred hhhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChh-hHHHHH------------HHHHHhceeecCC----
Q 048432 44 STATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQ-GLRELK------------NKLRLLGCCIDKD---- 105 (354)
Q Consensus 44 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~-~~~~~~------------~i~~~~~~~~~~~---- 105 (354)
...+.+|++++.||+|+||+||+|.++ +|+.||||++...... ....+. |++++++++....
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 345678999999999999999999964 6999999999765432 222233 3334455554332
Q ss_pred ceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 106 EKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
..+++++++.+++|.+++ +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 234555667789999998 789999999999999999999999 9999999999999999999999999997654
Q ss_pred CCccc-cccccccCcccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 182 GNELQ-ANTGRIVGTYRYMSPEYAIQ-GIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 182 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
..... .......|++.|+|||++.. ..++.++||||+||++|+|++|..|| .+.+..+..................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf--~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF--PGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC--CCCCHHHHHHHHhhhccCCChhhhh
Confidence 43322 22334578999999999854 56789999999999999999999995 3333333333322222111110000
Q ss_pred Cccccccchhhhhhhhhcc--ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--hhhhhh
Q 048432 260 NVKTFGFLHLTIFKLFSIS--SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM--LTNEAA 324 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~--L~~~~~ 324 (354)
... ............ .........+..+..+.+||.+||+.||++|||++|+++. |++...
T Consensus 239 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 239 CII----NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp TCC----CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhh----hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 000 000000000000 0000011112245678899999999999999999999985 665543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=316.63 Aligned_cols=266 Identities=21% Similarity=0.225 Sum_probs=182.4
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHH------------HHHHHhceee------c
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELK------------NKLRLLGCCI------D 103 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~------------~i~~~~~~~~------~ 103 (354)
...++|++++.||+|+||+||+|+++ +|+.||||++..... .....+. |++++++++. .
T Consensus 14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 35589999999999999999999976 599999999975432 2212222 4455666664 3
Q ss_pred CCceEEEEEecCCCCHhHHH--hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceecc
Q 048432 104 KDEKILIYEYMPNKSLDFFL--FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICR 181 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~ 181 (354)
...+|+|||||.++++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence 46789999999887665554 888999999999999999999999 9999999999999999999999999987655
Q ss_pred CCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccCCc
Q 048432 182 GNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTHNV 261 (354)
Q Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (354)
.... .....+|+.|+|||++.+..++.++||||+||++|+|++|++|| .+.+.......+.......+.......
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF--~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 171 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS--CCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC--CCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 4332 23346899999999999999999999999999999999999995 444444443333322221111100000
Q ss_pred cc---------cccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 048432 262 KT---------FGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVSM 318 (354)
Q Consensus 262 ~~---------~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~~ 318 (354)
.. ...........................++.+.+||.+||..||++||||+|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000001111111222222333445578889999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=313.66 Aligned_cols=279 Identities=19% Similarity=0.241 Sum_probs=189.3
Q ss_pred hhhcCccccceecccCceeEEEEEEc-CCCEEEEEEecCCCh--hhHHHHHHH------------HHHhceeec-----C
Q 048432 45 TATNKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSG--QGLRELKNK------------LRLLGCCID-----K 104 (354)
Q Consensus 45 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~--~~~~~~~~i------------~~~~~~~~~-----~ 104 (354)
...++|++++.||+|+||+||+|++. +|+.||||++..... .....+.++ +++++++.. +
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 34678999999999999999999975 699999999975432 222223333 334444432 2
Q ss_pred CceEEEEEecCCCCHhHHH----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 105 DEKILIYEYMPNKSLDFFL----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 105 ~~~~lv~e~~~~~~L~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
...+++++++.+++|.+++ +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||++...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 3346677888899999988 789999999999999999999999 999999999999999999999999998654
Q ss_pred cCCccccccccccCcccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCcccC
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQGI-FSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDTH 259 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (354)
.... ....|+..|+|||++.+.. ++.++||||+||++|+|++|.+|| .+.+.......+.......+.....
T Consensus 172 ~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF--~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC--CCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Cccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcCCCChHHhh
Confidence 3222 2346789999999877654 689999999999999999999994 5555555555544444333221111
Q ss_pred CccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HhhhhhhhcCCCCCCCcc
Q 048432 260 NVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALLPPKQPAFS 335 (354)
Q Consensus 260 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~il~--~L~~~~~~~~~~~~~~~~ 335 (354)
...... ..... ..................++.+.+||.+||+.||++|||++|+++ .|++.......|....++
T Consensus 245 ~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~ 320 (348)
T d2gfsa1 245 KISSES-ARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 320 (348)
T ss_dssp TCCCHH-HHHHH-TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCC
T ss_pred hccchh-hhhhh-hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCC
Confidence 110000 00000 000000000000111124667899999999999999999999998 477665444444344333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=307.10 Aligned_cols=236 Identities=22% Similarity=0.259 Sum_probs=182.7
Q ss_pred hcCccccceecccCceeEEEEEEc----CCCEEEEEEecCCC--------------hhhHHHH---HHHHHHhceeecCC
Q 048432 47 TNKFSDANKLGEGGFGPVYKGVLK----NGDEIAVKRLSGRS--------------GQGLREL---KNKLRLLGCCIDKD 105 (354)
Q Consensus 47 ~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vavK~~~~~~--------------~~~~~~~---~~i~~~~~~~~~~~ 105 (354)
.++|++++.||+|+||+||+|+.. +|+.||||++.... ...+..+ .|++++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 377999999999999999999853 38899999985321 0111111 36778888999999
Q ss_pred ceEEEEEecCCCCHhHHH-----hhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceec
Q 048432 106 EKILIYEYMPNKSLDFFL-----FDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARIC 180 (354)
Q Consensus 106 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~ 180 (354)
..+++|||+.+++|.+++ +....+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999888 567888999999999999999999 999999999999999999999999999765
Q ss_pred cCCccccccccccCcccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccchhhhhhhhccccCCCCccc
Q 048432 181 RGNELQANTGRIVGTYRYMSPEYAIQG--IFSIKSDVFSFGVLLLKIVSGKKTTGFYRTYSFTLLGYISENIYEFPSVDT 258 (354)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (354)
....... .....+++.|.+||.+.+. .++.++|||||||+||+|++|..|| .+.........+.+.........
T Consensus 180 ~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF--~~~~~~~~~~~i~~~~~~~~~~~- 255 (322)
T d1vzoa_ 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF--TVDGEKNSQAEISRRILKSEPPY- 255 (322)
T ss_dssp CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT--SCTTSCCCHHHHHHHHHHCCCCC-
T ss_pred ccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHHHhcccCCCCC-
Confidence 4433222 2235789999999999764 3688999999999999999999995 33333333333322221111100
Q ss_pred CCccccccchhhhhhhhhccccCCchhHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 048432 259 HNVKTFGFLHLTIFKLFSISSVGLSNDIVCLCILRYVNIALLCVQESADDRP-----TMNDVVS 317 (354)
Q Consensus 259 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~il~ 317 (354)
+...++.+.+||.+||+.||++|| |++|+++
T Consensus 256 ----------------------------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 256 ----------------------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------------------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------------------------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011577889999999999999999 4889886
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-37 Score=283.81 Aligned_cols=280 Identities=19% Similarity=0.214 Sum_probs=178.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCCEEEEEEecCCChhh---HHHH-------------------HHHHHHhceee--
Q 048432 48 NKFSDANKLGEGGFGPVYKGVLK-NGDEIAVKRLSGRSGQG---LREL-------------------KNKLRLLGCCI-- 102 (354)
Q Consensus 48 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vavK~~~~~~~~~---~~~~-------------------~~i~~~~~~~~-- 102 (354)
++|++++.||+|+||+||+|+++ +|+.||||++....... .+++ .|++++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 56999999999999999999975 69999999998654321 1111 12333454443
Q ss_pred cCCceEEEEEecCCCCHhHHH--------hhHHHHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEEcCCCC-----
Q 048432 103 DKDEKILIYEYMPNKSLDFFL--------FDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMN----- 168 (354)
Q Consensus 103 ~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~----- 168 (354)
.....+.++.++..+...... +....+..++.||+.||.|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 334566677776554332222 6678899999999999999997 88 999999999999986654
Q ss_pred -eEEeecccceeccCCccccccccccCcccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCccccc----chhhh
Q 048432 169 -PKISDFGIARICRGNELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVLLLKIVSGKKTTGFYRTY----SFTLL 243 (354)
Q Consensus 169 -~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~l~~ll~g~~p~~~~~~~----~~~~~ 243 (354)
++++|||.+...... .....|++.|+|||++.+..++.++|+||+||++++|++|+.||...... ..+..
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 899999998754332 22357899999999999999999999999999999999999996432211 11111
Q ss_pred hhhhccccCCCCcccCCccc-cccchhh--hhhhhhcc------ccCCchhHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 048432 244 GYISENIYEFPSVDTHNVKT-FGFLHLT--IFKLFSIS------SVGLSNDIVCLCILRYVNIALLCVQESADDRPTMND 314 (354)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~d~~--~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~ 314 (354)
.......+..+......... ....+.. ........ ............++.+.+||.+||++||++||||+|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111111111100000000 0000000 00000000 000011122347888999999999999999999999
Q ss_pred HHHH--hhhhh--hhcCCCCCCCcc
Q 048432 315 VVSM--LTNEA--AALLPPKQPAFS 335 (354)
Q Consensus 315 il~~--L~~~~--~~~~~~~~~~~~ 335 (354)
+|+. |++.. .....|..+.++
T Consensus 325 ~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HhcCcccCCCCCcccCCCCCcccCC
Confidence 9985 66442 234444444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.5e-22 Score=168.08 Aligned_cols=161 Identities=17% Similarity=0.111 Sum_probs=106.5
Q ss_pred ccccceecccCceeEEEEEEcCCCEEEEEEecCCChh----------------------hHHHHHHHHHHhceeec----
Q 048432 50 FSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQ----------------------GLRELKNKLRLLGCCID---- 103 (354)
Q Consensus 50 y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~----------------------~~~~~~~i~~~~~~~~~---- 103 (354)
+-+.+.||+|+||.||+|.+.+|+.||||++...... ...++.++.++.+....
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3568999999999999999888999999987532110 01122333444332211
Q ss_pred CCceEEEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEEcCCCCeEEeecccceeccCC
Q 048432 104 KDEKILIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGIARICRGN 183 (354)
Q Consensus 104 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~~~~~ 183 (354)
....+++|||+++..+.. +.......++.|++.++.+||+.+ |+||||||+|||++.++ ++|+|||++......
T Consensus 82 ~~~~~lvme~~~~~~~~~--l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~ 155 (191)
T d1zara2 82 WEGNAVLMELIDAKELYR--VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE 155 (191)
T ss_dssp EETTEEEEECCCCEEGGG--CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEETTST
T ss_pred ecCCEEEEEeeccccccc--hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccCCCC
Confidence 122369999999876544 345556789999999999999999 99999999999999765 899999998754322
Q ss_pred ccccccccccCcccccCccccccCCCCchhhHHHHHHH
Q 048432 184 ELQANTGRIVGTYRYMSPEYAIQGIFSIKSDVFSFGVL 221 (354)
Q Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG~~ 221 (354)
.........+. .-.+ +....|+..+|+||+.--
T Consensus 156 ~~~~~l~rd~~----~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 156 GWREILERDVR----NIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp THHHHHHHHHH----HHHH-HHHHHHCCCCCHHHHHHH
T ss_pred CcHHHHHHHHH----HHHH-HHcCCCCCcccHHHHHHH
Confidence 21000000000 0011 223456788999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=5.6e-07 Score=77.14 Aligned_cols=136 Identities=18% Similarity=0.118 Sum_probs=91.9
Q ss_pred chhhhhcCccccceecccCceeEEEEEEcCCCEEEEEEecCCChhh---HHHHHHHH----------HHhceeecCCceE
Q 048432 42 SVSTATNKFSDANKLGEGGFGPVYKGVLKNGDEIAVKRLSGRSGQG---LRELKNKL----------RLLGCCIDKDEKI 108 (354)
Q Consensus 42 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vavK~~~~~~~~~---~~~~~~i~----------~~~~~~~~~~~~~ 108 (354)
++......|++.+..+.++.+.||+... +++.+++|+........ .......+ +++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4455667888887766666689999875 46667888876543221 11111111 2233445677789
Q ss_pred EEEEecCCCCHhHHHhhHHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 048432 109 LIYEYMPNKSLDFFLFDWVTRVRIIEGIAQGLLYLHQYSR---------------------------------------- 148 (354)
Q Consensus 109 lv~e~~~~~~L~~~~~~~~~~~~i~~~i~~~l~~LH~~~~---------------------------------------- 148 (354)
+||++++|.++.....+......++.++++.++.||+...
T Consensus 87 lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred EEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 9999999988876655444455566677777777775321
Q ss_pred ----------------CCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 149 ----------------VRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 149 ----------------~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
..++|+|+.|.||++++++..-|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 128999999999999987666799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=1.6e-05 Score=67.39 Aligned_cols=121 Identities=16% Similarity=0.159 Sum_probs=75.4
Q ss_pred eecccCc-eeEEEEEEcCCCEEEEEEecCCChhhHHHHHHHHH-----------HhceeecCCceEEEEEecCCCCHhHH
Q 048432 55 KLGEGGF-GPVYKGVLKNGDEIAVKRLSGRSGQGLRELKNKLR-----------LLGCCIDKDEKILIYEYMPNKSLDFF 122 (354)
Q Consensus 55 ~lg~G~~-g~V~~a~~~~~~~vavK~~~~~~~~~~~~~~~i~~-----------~~~~~~~~~~~~lv~e~~~~~~L~~~ 122 (354)
.+..|.. +.||+.....+..+++|................++ ++.+..+.+..++||++++|.++...
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 4455554 68999998788889999887665444332222222 23445566788999999988765432
Q ss_pred HhhHHHHHHHHHHHHHHHHHHHhc---------------------------------------------------C----
Q 048432 123 LFDWVTRVRIIEGIAQGLLYLHQY---------------------------------------------------S---- 147 (354)
Q Consensus 123 ~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------------~---- 147 (354)
.... ...+.++...++.||+. .
T Consensus 97 ~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 97 HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 1110 11122333333333321 1
Q ss_pred CCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 148 RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 148 ~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
...++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1238999999999999987667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.13 E-value=0.0011 Score=59.78 Aligned_cols=29 Identities=28% Similarity=0.361 Sum_probs=25.4
Q ss_pred CeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 150 RIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 150 ~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
.++|+|+++.|||++.++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 499999999999998765 89999998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.09 E-value=0.0011 Score=57.59 Aligned_cols=140 Identities=12% Similarity=0.010 Sum_probs=75.7
Q ss_pred ccccchhhhhcCccccceec-----ccCceeEEEEEEcCCCEEEEEEecCCCh-hhHHHHHHHHHH---hce--------
Q 048432 38 FSFSSVSTATNKFSDANKLG-----EGGFGPVYKGVLKNGDEIAVKRLSGRSG-QGLRELKNKLRL---LGC-------- 100 (354)
Q Consensus 38 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~a~~~~~~~vavK~~~~~~~-~~~~~~~~i~~~---~~~-------- 100 (354)
++.+++.....+|.+++... .|.--+.|+....+|+ +++|++..... .........+.. .++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence 45667777788887755444 5556788999986665 89999866432 222212112111 111
Q ss_pred ------eecCCceEEEEEecCCCCHhH-----HH-------------------------h----------------hHHH
Q 048432 101 ------CIDKDEKILIYEYMPNKSLDF-----FL-------------------------F----------------DWVT 128 (354)
Q Consensus 101 ------~~~~~~~~lv~e~~~~~~L~~-----~~-------------------------~----------------~~~~ 128 (354)
.........++.+..+..... .. . ....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 112334456677666543311 00 0 0001
Q ss_pred HHHHHHHHHHHHHHHHhcC-CCCeEeCCCCCCCEEEcCCCCeEEeecccce
Q 048432 129 RVRIIEGIAQGLLYLHQYS-RVRIIHRDLKVSNILLDKDMNPKISDFGIAR 178 (354)
Q Consensus 129 ~~~i~~~i~~~l~~LH~~~-~~~i~H~dlkp~Nill~~~~~~~l~dfg~a~ 178 (354)
....+..+...+...+..+ +.+++|+|+.++||+++.+...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1222333333333333221 3459999999999999988877899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.66 E-value=0.003 Score=55.05 Aligned_cols=29 Identities=34% Similarity=0.413 Sum_probs=23.6
Q ss_pred CCeEeCCCCCCCEEEcCCCCeEEeeccccee
Q 048432 149 VRIIHRDLKVSNILLDKDMNPKISDFGIARI 179 (354)
Q Consensus 149 ~~i~H~dlkp~Nill~~~~~~~l~dfg~a~~ 179 (354)
..++|+|+.+.||+++.+ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 459999999999999743 46899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.10 E-value=0.011 Score=52.68 Aligned_cols=31 Identities=6% Similarity=0.117 Sum_probs=23.6
Q ss_pred cceecccCceeEEEEEEcC--------CCEEEEEEecCC
Q 048432 53 ANKLGEGGFGPVYKGVLKN--------GDEIAVKRLSGR 83 (354)
Q Consensus 53 ~~~lg~G~~g~V~~a~~~~--------~~~vavK~~~~~ 83 (354)
++.|+.|..-.+|++...+ .+.|++++....
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~ 85 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP 85 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc
Confidence 5688889999999998653 356888887643
|